##fileformat=VCFv4.2
##FILTER=<ID=PASS,Description="All filters passed">
##CADD_phred=CADD_phred from dbNSFP file
##FATHMM_pred=FATHMM_pred from dbNSFP file
##FILTER=<ID=HighNormalVAF,Description="VAF of variant in normal sample is either greater than 0.2, or greater than or equal to VAF in tumor sample (as computed by NYGC's pileup method)">
##FILTER=<ID=LowNormalDP,Description="DP of variant in normal sample is less than 2 (as computed by NYGC's pileup method)">
##FILTER=<ID=LowTumorDP,Description="DP of variant in tumor sample is less than 2 (as computed by NYGC's pileup method)">
##FILTER=<ID=LowTumorVAF,Description="VAF of variant in tumor sample is less than 0.0001 (as computed by NYGC's pileup method)">
##FILTER=<ID=PON,Description="Variant in panel of normal database">
##FILTER=<ID=PartOfMNV,Description="The candidate SNV is part of a MNV">
##FILTER=<ID=SUPPORT,Description="Variant from Validation caller">
##FILTER=<ID=SplitToSNVs,Description="The candidate MNV is now split into multiple SNVs">
##FORMAT=<ID=AD,Number=R,Type=Integer,Description="Allelic depths for the ref and alt alleles.">
##FORMAT=<ID=AF,Number=A,Type=Float,Description="Allele fraction of alternate allele in the sample.">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Depth of coverage: Number of (filtered) reads covering site.">
##GERP++_RS=GERP++_RS from dbNSFP file
##INFO=<ID=AFR_AF_1000G,Number=.,Type=String,Description="AFR_AF_1000G field from phase3 1000genomes">
##INFO=<ID=AF_1000G,Number=.,Type=String,Description="AF_1000G field from phase3 1000genomes">
##INFO=<ID=AMR_AF_1000G,Number=.,Type=String,Description="AMR_AF_1000G field from phase3 1000genomes">
##INFO=<ID=CLINVAR_INTRONIC,Number=.,Type=String,Description="/cromwell_root/nygc-resources-public/annotations/clinvar_deep_intronics_09012020.vcf.gz (exact)">
##INFO=<ID=CLINVAR_INTRONIC_INTRONIC,Number=.,Type=String,Description="INTRONIC field from /cromwell_root/nygc-resources-public/annotations/clinvar_deep_intronics_09012020.vcf.gz">
##INFO=<ID=CLN_Exact,Number=.,Type=String,Description="ensembl_vep/annotations/clinvar.vep.vcf.gz (exact)">
##INFO=<ID=CLN_Exact_CLIN_ID,Number=.,Type=String,Description="CLIN_ID field from ensembl_vep/annotations/clinvar.vep.vcf.gz">
##INFO=<ID=CLN_Exact_CLNDN,Number=.,Type=String,Description="CLNDN field from ensembl_vep/annotations/clinvar.vep.vcf.gz">
##INFO=<ID=CLN_Exact_CLNREVSTAT,Number=.,Type=String,Description="CLNREVSTAT field from ensembl_vep/annotations/clinvar.vep.vcf.gz">
##INFO=<ID=CLN_Exact_CLNSIG,Number=.,Type=String,Description="CLNSIG field from ensembl_vep/annotations/clinvar.vep.vcf.gz">
##INFO=<ID=CLN_Overlap,Number=.,Type=String,Description="ensembl_vep/annotations/clinvar.vep.vcf.gz (overlap)">
##INFO=<ID=CLN_Overlap_CLIN_ID,Number=.,Type=String,Description="CLIN_ID field from ensembl_vep/annotations/clinvar.vep.vcf.gz">
##INFO=<ID=CLN_Overlap_CLNDN,Number=.,Type=String,Description="CLNDN field from ensembl_vep/annotations/clinvar.vep.vcf.gz">
##INFO=<ID=CLN_Overlap_CLNREVSTAT,Number=.,Type=String,Description="CLNREVSTAT field from ensembl_vep/annotations/clinvar.vep.vcf.gz">
##INFO=<ID=CLN_Overlap_CLNSIG,Number=.,Type=String,Description="CLNSIG field from ensembl_vep/annotations/clinvar.vep.vcf.gz">
##INFO=<ID=CSQ,Number=.,Type=String,Description="Consequence annotations from Ensembl VEP. Format: Gene|BIOTYPE|CLIN_SIG|Consequence|CosmicCoding|CosmicCoding_AA|CosmicNonCoding|Existing_variation|GnomadExomes_AF|GnomadGenomes_AF|HGVSc|HGVSp|IMPACT|Polyphen2_HVAR_pred|FATHMM_pred|fathmm-MKL_coding_pred|SIFT4G_pred|SIFT_pred|SYMBOL|SYMBOL_SOURCE|AF_1000G">
##INFO=<ID=CancerGeneCensus,Number=.,Type=String,Description="Consequence annotations from Cancer Gene Census. Format: Tier|Hallmark|Somatic|Germline|Tumour Types(Somatic)|Tumour Types(Germline)|Cancer Syndrome|Tissue Type|Molecular Genetics|Role in Cancer|Mutation Types">
##INFO=<ID=CosmicCoding,Number=.,Type=String,Description="/cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz (exact)">
##INFO=<ID=CosmicCoding_AA,Number=.,Type=String,Description="AA field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_CDS,Number=.,Type=String,Description="CDS field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_GENE,Number=.,Type=String,Description="GENE field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_HGVSG,Number=.,Type=String,Description="HGVSG field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_HGVSP,Number=.,Type=String,Description="HGVSP field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_IS_CANONICAL,Number=.,Type=String,Description="IS_CANONICAL field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_LEGACY_ID,Number=.,Type=String,Description="LEGACY_ID field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_SAMPLE_COUNT,Number=.,Type=String,Description="SAMPLE_COUNT field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_TIER,Number=.,Type=String,Description="TIER field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicCoding_TRANSCRIPT,Number=.,Type=String,Description="TRANSCRIPT field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_GenomeScreensMutant_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicNonCoding,Number=.,Type=String,Description="/cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_NonCodingVariants_Normal_v98_GRCh38.vcf.gz (exact)">
##INFO=<ID=CosmicNonCoding_GENE,Number=.,Type=String,Description="GENE field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_NonCodingVariants_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicNonCoding_HGVSG,Number=.,Type=String,Description="HGVSG field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_NonCodingVariants_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicNonCoding_IS_CANONICAL,Number=.,Type=String,Description="IS_CANONICAL field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_NonCodingVariants_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicNonCoding_LEGACY_ID,Number=.,Type=String,Description="LEGACY_ID field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_NonCodingVariants_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicNonCoding_SAMPLE_COUNT,Number=.,Type=String,Description="SAMPLE_COUNT field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_NonCodingVariants_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicNonCoding_TIER,Number=.,Type=String,Description="TIER field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_NonCodingVariants_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=CosmicNonCoding_TRANSCRIPT,Number=.,Type=String,Description="TRANSCRIPT field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/chr1/Cosmic_NonCodingVariants_Normal_v98_GRCh38.vcf.gz">
##INFO=<ID=DIALS,Number=.,Type=String,Description="ensembl_vep/annotations/dials_genes_b38.vcf.gz (overlap)">
##INFO=<ID=DIALS_DIALS_GENE,Number=.,Type=String,Description="DIALS_GENE field from ensembl_vep/annotations/dials_genes_b38.vcf.gz">
##INFO=<ID=EAS_AF_1000G,Number=.,Type=String,Description="EAS_AF_1000G field from phase3 1000genomes">
##INFO=<ID=EUR_AF_1000G,Number=.,Type=String,Description="EUR_AF_1000G field from phase3 1000genomes">
##INFO=<ID=GnomadExomes,Number=.,Type=String,Description="/cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz (exact)">
##INFO=<ID=GnomadExomes_AF,Number=.,Type=String,Description="AF field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_afr,Number=.,Type=String,Description="AF_afr field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_afr_female,Number=.,Type=String,Description="AF_afr_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_afr_male,Number=.,Type=String,Description="AF_afr_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_amr,Number=.,Type=String,Description="AF_amr field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_amr_female,Number=.,Type=String,Description="AF_amr_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_amr_male,Number=.,Type=String,Description="AF_amr_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_asj,Number=.,Type=String,Description="AF_asj field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_asj_female,Number=.,Type=String,Description="AF_asj_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_asj_male,Number=.,Type=String,Description="AF_asj_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_eas,Number=.,Type=String,Description="AF_eas field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_eas_female,Number=.,Type=String,Description="AF_eas_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_eas_male,Number=.,Type=String,Description="AF_eas_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_female,Number=.,Type=String,Description="AF_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_fin,Number=.,Type=String,Description="AF_fin field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_fin_female,Number=.,Type=String,Description="AF_fin_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_fin_male,Number=.,Type=String,Description="AF_fin_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_male,Number=.,Type=String,Description="AF_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_nfe,Number=.,Type=String,Description="AF_nfe field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_nfe_female,Number=.,Type=String,Description="AF_nfe_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_nfe_male,Number=.,Type=String,Description="AF_nfe_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_oth,Number=.,Type=String,Description="AF_oth field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_oth_female,Number=.,Type=String,Description="AF_oth_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_oth_male,Number=.,Type=String,Description="AF_oth_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_sas,Number=.,Type=String,Description="AF_sas field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_sas_female,Number=.,Type=String,Description="AF_sas_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AF_sas_male,Number=.,Type=String,Description="AF_sas_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_AN,Number=.,Type=String,Description="AN field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_nhomalt,Number=.,Type=String,Description="nhomalt field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF,Number=.,Type=String,Description="non_cancer_AF field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_afr,Number=.,Type=String,Description="non_cancer_AF_afr field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_afr_female,Number=.,Type=String,Description="non_cancer_AF_afr_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_afr_male,Number=.,Type=String,Description="non_cancer_AF_afr_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_amr,Number=.,Type=String,Description="non_cancer_AF_amr field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_amr_female,Number=.,Type=String,Description="non_cancer_AF_amr_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_amr_male,Number=.,Type=String,Description="non_cancer_AF_amr_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_asj,Number=.,Type=String,Description="non_cancer_AF_asj field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_asj_female,Number=.,Type=String,Description="non_cancer_AF_asj_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_asj_male,Number=.,Type=String,Description="non_cancer_AF_asj_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_eas,Number=.,Type=String,Description="non_cancer_AF_eas field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_eas_female,Number=.,Type=String,Description="non_cancer_AF_eas_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_eas_male,Number=.,Type=String,Description="non_cancer_AF_eas_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_female,Number=.,Type=String,Description="non_cancer_AF_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_fin,Number=.,Type=String,Description="non_cancer_AF_fin field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_fin_female,Number=.,Type=String,Description="non_cancer_AF_fin_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_fin_male,Number=.,Type=String,Description="non_cancer_AF_fin_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_male,Number=.,Type=String,Description="non_cancer_AF_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_nfe,Number=.,Type=String,Description="non_cancer_AF_nfe field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_nfe_female,Number=.,Type=String,Description="non_cancer_AF_nfe_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_nfe_male,Number=.,Type=String,Description="non_cancer_AF_nfe_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_oth,Number=.,Type=String,Description="non_cancer_AF_oth field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_oth_female,Number=.,Type=String,Description="non_cancer_AF_oth_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_oth_male,Number=.,Type=String,Description="non_cancer_AF_oth_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_sas,Number=.,Type=String,Description="non_cancer_AF_sas field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_sas_female,Number=.,Type=String,Description="non_cancer_AF_sas_female field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AF_sas_male,Number=.,Type=String,Description="non_cancer_AF_sas_male field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_AN,Number=.,Type=String,Description="non_cancer_AN field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadExomes_non_cancer_nhomalt,Number=.,Type=String,Description="non_cancer_nhomalt field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.exomes.r2.1.1.sites.pass.chr1.norm.liftover_grch38.vcf.gz">
##INFO=<ID=GnomadGenomes,Number=.,Type=String,Description="/cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz (exact)">
##INFO=<ID=GnomadGenomes_AF,Number=.,Type=String,Description="AF field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_XX,Number=.,Type=String,Description="AF_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_XY,Number=.,Type=String,Description="AF_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_afr,Number=.,Type=String,Description="AF_afr field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_afr_XX,Number=.,Type=String,Description="AF_afr_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_afr_XY,Number=.,Type=String,Description="AF_afr_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_ami,Number=.,Type=String,Description="AF_ami field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_ami_XX,Number=.,Type=String,Description="AF_ami_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_ami_XY,Number=.,Type=String,Description="AF_ami_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_amr,Number=.,Type=String,Description="AF_amr field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_amr_XX,Number=.,Type=String,Description="AF_amr_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_amr_XY,Number=.,Type=String,Description="AF_amr_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_asj,Number=.,Type=String,Description="AF_asj field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_asj_XX,Number=.,Type=String,Description="AF_asj_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_asj_XY,Number=.,Type=String,Description="AF_asj_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_eas,Number=.,Type=String,Description="AF_eas field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_eas_XX,Number=.,Type=String,Description="AF_eas_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_eas_XY,Number=.,Type=String,Description="AF_eas_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_fin,Number=.,Type=String,Description="AF_fin field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_fin_XX,Number=.,Type=String,Description="AF_fin_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_fin_XY,Number=.,Type=String,Description="AF_fin_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_mid,Number=.,Type=String,Description="AF_mid field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_mid_XX,Number=.,Type=String,Description="AF_mid_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_mid_XY,Number=.,Type=String,Description="AF_mid_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_nfe,Number=.,Type=String,Description="AF_nfe field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_nfe_XX,Number=.,Type=String,Description="AF_nfe_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_nfe_XY,Number=.,Type=String,Description="AF_nfe_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer,Number=.,Type=String,Description="AF_non_cancer field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_XX,Number=.,Type=String,Description="AF_non_cancer_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_XY,Number=.,Type=String,Description="AF_non_cancer_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_afr,Number=.,Type=String,Description="AF_non_cancer_afr field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_afr_XX,Number=.,Type=String,Description="AF_non_cancer_afr_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_afr_XY,Number=.,Type=String,Description="AF_non_cancer_afr_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_ami,Number=.,Type=String,Description="AF_non_cancer_ami field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_ami_XX,Number=.,Type=String,Description="AF_non_cancer_ami_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_ami_XY,Number=.,Type=String,Description="AF_non_cancer_ami_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_amr,Number=.,Type=String,Description="AF_non_cancer_amr field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_amr_XX,Number=.,Type=String,Description="AF_non_cancer_amr_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_amr_XY,Number=.,Type=String,Description="AF_non_cancer_amr_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_asj,Number=.,Type=String,Description="AF_non_cancer_asj field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_asj_XX,Number=.,Type=String,Description="AF_non_cancer_asj_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_asj_XY,Number=.,Type=String,Description="AF_non_cancer_asj_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_eas,Number=.,Type=String,Description="AF_non_cancer_eas field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_eas_XX,Number=.,Type=String,Description="AF_non_cancer_eas_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_eas_XY,Number=.,Type=String,Description="AF_non_cancer_eas_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_fin,Number=.,Type=String,Description="AF_non_cancer_fin field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_fin_XX,Number=.,Type=String,Description="AF_non_cancer_fin_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_fin_XY,Number=.,Type=String,Description="AF_non_cancer_fin_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_mid,Number=.,Type=String,Description="AF_non_cancer_mid field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_mid_XX,Number=.,Type=String,Description="AF_non_cancer_mid_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_mid_XY,Number=.,Type=String,Description="AF_non_cancer_mid_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_nfe,Number=.,Type=String,Description="AF_non_cancer_nfe field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_nfe_XX,Number=.,Type=String,Description="AF_non_cancer_nfe_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_nfe_XY,Number=.,Type=String,Description="AF_non_cancer_nfe_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_oth,Number=.,Type=String,Description="AF_non_cancer_oth field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_oth_XX,Number=.,Type=String,Description="AF_non_cancer_oth_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_oth_XY,Number=.,Type=String,Description="AF_non_cancer_oth_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_sas,Number=.,Type=String,Description="AF_non_cancer_sas field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_sas_XX,Number=.,Type=String,Description="AF_non_cancer_sas_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_non_cancer_sas_XY,Number=.,Type=String,Description="AF_non_cancer_sas_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_oth,Number=.,Type=String,Description="AF_oth field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_oth_XX,Number=.,Type=String,Description="AF_oth_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_oth_XY,Number=.,Type=String,Description="AF_oth_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_sas,Number=.,Type=String,Description="AF_sas field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_sas_XX,Number=.,Type=String,Description="AF_sas_XX field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AF_sas_XY,Number=.,Type=String,Description="AF_sas_XY field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AN,Number=.,Type=String,Description="AN field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_AN_non_cancer,Number=.,Type=String,Description="AN_non_cancer field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_nhomalt,Number=.,Type=String,Description="nhomalt field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=GnomadGenomes_nhomalt_non_cancer,Number=.,Type=String,Description="nhomalt_non_cancer field from /cromwell_root/nygc-comp-s-fd4e-input/somatic/ensembl_vep/gnomad.genomes.v3.1.2.sites.pass.chr1.norm.vcf.gz">
##INFO=<ID=HighConfidence,Number=0,Type=Flag,Description="High Confidence variant">
##INFO=<ID=INTRONIC,Number=.,Type=String,Description="/cromwell_root/nygc-resources-public/annotations/deep_intronic_whitelist_08132020.vcf.gz (exact)">
##INFO=<ID=INTRONIC_INTRONIC,Number=.,Type=String,Description="INTRONIC field from /cromwell_root/nygc-resources-public/annotations/deep_intronic_whitelist_08132020.vcf.gz">
##INFO=<ID=PLI,Number=.,Type=String,Description="ensembl_vep/annotations/pli_hg38.vcf.gz (overlap)">
##INFO=<ID=PLI_mis_z,Number=.,Type=String,Description="mis_z field from ensembl_vep/annotations/pli_hg38.vcf.gz">
##INFO=<ID=PLI_pLI,Number=.,Type=String,Description="pLI field from ensembl_vep/annotations/pli_hg38.vcf.gz">
##INFO=<ID=SAS_AF_1000G,Number=.,Type=String,Description="SAS_AF_1000G field from phase3 1000genomes">
##INFO=<ID=SPLICEAI,Number=.,Type=String,Description="ensembl_vep/annotations/spliceai_scores.hg38.sorted.vcf.gz (exact)">
##INFO=<ID=SPLICEAI_DS_AG,Number=.,Type=String,Description="DS_AG field from ensembl_vep/annotations/spliceai_scores.hg38.sorted.vcf.gz">
##INFO=<ID=SPLICEAI_DS_AL,Number=.,Type=String,Description="DS_AL field from ensembl_vep/annotations/spliceai_scores.hg38.sorted.vcf.gz">
##INFO=<ID=SPLICEAI_DS_DG,Number=.,Type=String,Description="DS_DG field from ensembl_vep/annotations/spliceai_scores.hg38.sorted.vcf.gz">
##INFO=<ID=SPLICEAI_DS_DL,Number=.,Type=String,Description="DS_DL field from ensembl_vep/annotations/spliceai_scores.hg38.sorted.vcf.gz">
##INFO=<ID=TYPE,Number=1,Type=String,Description="Variant type (SNV,INS,DEL,MNV,COMPLEX,MULTI)">
##INFO=<ID=called_by,Number=.,Type=String,Description="Name of the variant caller(s) that the variant was called by">
##INFO=<ID=num_callers,Number=1,Type=Integer,Description="Number of callers">
##INFO=<ID=supported_by,Number=.,Type=String,Description="Name of the tool(s) apart from the main variant callers in the pipeline that support the variant">
##LRT_pred=LRT_pred from dbNSFP file
##MaxEntScan_alt=MaxEntScan alternate sequence score
##MaxEntScan_diff=MaxEntScan score difference
##MaxEntScan_ref=MaxEntScan reference sequence score
##MetaSVM_pred=MetaSVM_pred from dbNSFP file
##MutationAssessor_pred=MutationAssessor_pred from dbNSFP file
##MutationTaster_pred=MutationTaster_pred from dbNSFP file
##PROVEAN_pred=PROVEAN_pred from dbNSFP file
##Polyphen2_HVAR_pred=Polyphen2_HVAR_pred from dbNSFP file
##PrimateAI_pred=PrimateAI_pred from dbNSFP file
##REVEL_score=REVEL_score from dbNSFP file
##SIFT4G_pred=SIFT4G_pred from dbNSFP file
##SIFT_pred=SIFT_pred from dbNSFP file
##VEP="v97" time="2024-01-03 03:40:03" cache="ensembl_vep/homo_sapiens_refseq/97_GRCh38" ensembl-variation=97.26a059c ensembl=97.378db18 ensembl-io=97.dc917e1 ensembl-funcgen=97.24f4d3c 1000genomes="phase3" COSMIC="88" ClinVar="201904" ESP="V2-SSA137" HGMD-PUBLIC="20184" assembly="GRCh38.p12" dbSNP="151" gencode="GENCODE 31" genebuild="2014-07" gnomAD="r2.1" polyphen="2.2.2" refseq="2019-01-30 12:28:51 - interim_GRCh38.p12_top_level_2019-01-25.gff3" regbuild="1.0" sift="sift5.2.2"
##ada_score=dbscSNV ADA score
##bcftools_viewCommand=view --regions chr1 FULL.HG008-T--HG008-N.snv.indel.v7.chr1.vcf.gz; Date=Wed Jan  3 03:23:09 2024
##bcftools_viewVersion=1.17+htslib-1.17
##cmdline=/usr/local/bin/configManta.py --normalBam /cromwell_root/nygc-comp-s-fd4e-workspace/SomaticDNA/7fc933e1-2d3f-4d0b-a826-cb32f6edc6a3/call-Preprocess/shard-0/Preprocess/b030c45b-4a7d-4484-af13-11ed4ac09bb4/call-MergeBams/MergeBams/9ab74061-d3b8-45f8-99b5-ca7c8d4cbb46/call-PrintReads/cacheCopy/HG008-N.final.bam --tumorBam /cromwell_root/nygc-comp-s-fd4e-workspace/SomaticDNA/7fc933e1-2d3f-4d0b-a826-cb32f6edc6a3/call-Preprocess/shard-1/Preprocess/6aaee6fd-c8a9-4900-80c2-19de6856f215/call-MergeBams/MergeBams/71bf2ac4-2b94-4ec4-8d12-b850ac648cd4/call-PrintReads/cacheCopy/HG008-T.final.bam --referenceFasta /cromwell_root/nygc-comp-s-fd4e-output/giab/somatic/IndexBwaMem_GRCh38_GIABv3_no_alt/GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta --callRegions /cromwell_root/nygc-resources-public/GRCh38_full_analysis_set_plus_decoy_hla/internal/GRCh38.callregions.bed.gz --runDir HG008-T--HG008-N.MantaRaw
##contig=<ID=chr1,length=248956422,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr2,length=242193529,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr3,length=198295559,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr4,length=190214555,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr5,length=181538259,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr6,length=170805979,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr7,length=159345973,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr8,length=145138636,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr9,length=138394717,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr10,length=133797422,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr11,length=135086622,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr12,length=133275309,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr13,length=114364328,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14,length=107043718,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr15,length=101991189,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr16,length=90338345,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr17,length=83257441,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr18,length=80373285,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr19,length=58617616,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr20,length=64444167,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr21,length=46709983,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22,length=50818468,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrX,length=156040895,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrY,length=57227415,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrM,length=16569,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270706v1_random,length=175055,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270707v1_random,length=32032,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270708v1_random,length=127682,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270709v1_random,length=66860,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270710v1_random,length=40176,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270711v1_random,length=42210,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270712v1_random,length=176043,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270713v1_random,length=40745,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr1_KI270714v1_random,length=41717,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr2_KI270715v1_random,length=161471,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr2_KI270716v1_random,length=153799,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr3_GL000221v1_random,length=155397,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr4_GL000008v2_random,length=209709,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr5_GL000208v1_random,length=92689,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr9_KI270717v1_random,length=40062,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr9_KI270718v1_random,length=38054,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr9_KI270719v1_random,length=176845,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr9_KI270720v1_random,length=39050,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr11_KI270721v1_random,length=100316,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14_GL000009v2_random,length=201709,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14_GL000225v1_random,length=211173,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14_KI270722v1_random,length=194050,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14_GL000194v1_random,length=191469,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14_KI270723v1_random,length=38115,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14_KI270724v1_random,length=39555,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14_KI270725v1_random,length=172810,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr14_KI270726v1_random,length=43739,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr15_KI270727v1_random,length=448248,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr16_KI270728v1_random,length=1872759,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr17_GL000205v2_random,length=185591,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr17_KI270729v1_random,length=280839,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr17_KI270730v1_random,length=112551,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270731v1_random,length=150754,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270732v1_random,length=41543,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270733v1_random,length=179772,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270734v1_random,length=165050,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270735v1_random,length=42811,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270736v1_random,length=181920,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270737v1_random,length=103838,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270738v1_random,length=99375,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chr22_KI270739v1_random,length=73985,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrY_KI270740v1_random,length=37240,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270302v1,length=2274,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270304v1,length=2165,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270303v1,length=1942,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270305v1,length=1472,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270322v1,length=21476,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270320v1,length=4416,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270310v1,length=1201,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270316v1,length=1444,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270315v1,length=2276,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270312v1,length=998,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270311v1,length=12399,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270317v1,length=37690,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270412v1,length=1179,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270411v1,length=2646,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270414v1,length=2489,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270419v1,length=1029,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270418v1,length=2145,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270420v1,length=2321,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270424v1,length=2140,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270417v1,length=2043,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270422v1,length=1445,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270423v1,length=981,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270425v1,length=1884,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270429v1,length=1361,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270442v1,length=392061,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270466v1,length=1233,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270465v1,length=1774,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270467v1,length=3920,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270435v1,length=92983,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270438v1,length=112505,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270468v1,length=4055,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270510v1,length=2415,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270509v1,length=2318,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270518v1,length=2186,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270508v1,length=1951,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270516v1,length=1300,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270512v1,length=22689,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270519v1,length=138126,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270522v1,length=5674,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270511v1,length=8127,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270515v1,length=6361,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270507v1,length=5353,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270517v1,length=3253,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270529v1,length=1899,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270528v1,length=2983,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270530v1,length=2168,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270539v1,length=993,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270538v1,length=91309,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270544v1,length=1202,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270548v1,length=1599,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270583v1,length=1400,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270587v1,length=2969,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270580v1,length=1553,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270581v1,length=7046,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270579v1,length=31033,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270589v1,length=44474,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270590v1,length=4685,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270584v1,length=4513,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270582v1,length=6504,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270588v1,length=6158,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270593v1,length=3041,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270591v1,length=5796,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270330v1,length=1652,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270329v1,length=1040,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270334v1,length=1368,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270333v1,length=2699,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270335v1,length=1048,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270338v1,length=1428,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270340v1,length=1428,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270336v1,length=1026,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270337v1,length=1121,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270363v1,length=1803,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270364v1,length=2855,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270362v1,length=3530,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270366v1,length=8320,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270378v1,length=1048,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270379v1,length=1045,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270389v1,length=1298,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270390v1,length=2387,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270387v1,length=1537,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270395v1,length=1143,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270396v1,length=1880,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270388v1,length=1216,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270394v1,length=970,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270386v1,length=1788,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270391v1,length=1484,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270383v1,length=1750,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270393v1,length=1308,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270384v1,length=1658,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270392v1,length=971,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270381v1,length=1930,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270385v1,length=990,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270382v1,length=4215,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270376v1,length=1136,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270374v1,length=2656,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270372v1,length=1650,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270373v1,length=1451,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270375v1,length=2378,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270371v1,length=2805,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270448v1,length=7992,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270521v1,length=7642,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000195v1,length=182896,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000219v1,length=179198,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000220v1,length=161802,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000224v1,length=179693,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270741v1,length=157432,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000226v1,length=15008,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000213v1,length=164239,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270743v1,length=210658,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270744v1,length=168472,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270745v1,length=41891,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270746v1,length=66486,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270747v1,length=198735,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270748v1,length=93321,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270749v1,length=158759,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270750v1,length=148850,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270751v1,length=150742,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270752v1,length=27745,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270753v1,length=62944,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270754v1,length=40191,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270755v1,length=36723,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270756v1,length=79590,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270757v1,length=71251,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000214v1,length=137718,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_KI270742v1,length=186739,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000216v2,length=176608,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrUn_GL000218v1,length=161147,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=chrEBV,length=171823,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=MAP2K3_chr17_22578583_22605165,length=26582,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KCNJ18_chr17_22629421_22688415,length=58994,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr21_7687010_7731520,length=44510,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr15_6020392_6062903,length=42511,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr13_14464876_14502703,length=37827,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr13_14211849_14228603,length=16754,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr13_10688343_10754814,length=66471,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr13_10744786_10790087,length=45301,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr13_11526357_11569988,length=43631,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr13_11559977_11592630,length=32653,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr13_14408161_14474907,length=66746,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr14_3553442_3620349,length=66907,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr14_3610318_3640421,length=30103,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr15_5960377_6027329,length=66952,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr2_89596961_89613143,length=16182,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr2_90170767_90210396,length=39629,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr21_7659652_7674726,length=15074,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr21_8616365_8659521,length=43156,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr21_8649510_8682182,length=32672,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr22_6626735_6693166,length=66431,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr22_6683135_6713219,length=30084,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr22_11126384_11167180,length=40796,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##contig=<ID=KMT2C_chr22_11157169_11189815,length=32646,assembly=GRCh38_GIABv3_no_alt_analysis_set_maskedGRC_decoys_MAP2K3_KMT2C_KCNJ18.fasta>
##fathmm-MKL_coding_pred=fathmm-MKL_coding_pred from dbNSFP file
##phyloP100way_vertebrate=phyloP100way_vertebrate from dbNSFP file
##rf_score=dbscSNV RF score
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	HG008-N	HG008-T
chr1	978957	.	GGCC	G	.	PASS	CSQ=84808|protein_coding||inframe_deletion|||||||NM_001291366.1:c.2070_2072del|NP_001278295.1:p.Ala691del|MODERATE||||||PERM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	97,78:175:0.4457
chr1	1334073	COSV100229757;COSV100229757;COSV100229757;COSV100229757;COSV100229757;COSV100229757;COSV100229757	G	A	.	PASS	CSQ=1855|protein_coding||downstream_gene_variant|COSV100229757|p.R723H|COSV100229757&COSV100229757&COSV100229757&COSV100229757&COSV100229757&COSV100229757|rs756175053|1.81086e-05|1.97062e-05|||MODIFIER||||||DVL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	104,0:104:0	0,221:221:1
chr1	1830137	.	ATAGTTT	A	.	PASS	CSQ=2782|protein_coding||intron_variant|||||||NM_002074.5:c.-46-4644_-46-4639del||MODIFIER||||||GNB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	83,84:167:0.503
chr1	1886301	.	G	A	.	PASS	CSQ=2782|protein_coding||intron_variant|||||||NM_002074.5:c.-96+4519C>T||MODIFIER||||||GNB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	149,14:163:0.0859
chr1	2003623	.	C	T	.	PASS	CSQ=85452|protein_coding||intron_variant||||rs1015873437||1.9713e-05|NM_001304360.2:c.-20+78G>A||MODIFIER||||||CFAP74|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	0,175:175:1
chr1	2166083	.	A	T	.	PASS	CSQ=5590|protein_coding||intron_variant|||||||NM_002744.6:c.975-3435A>T||MODIFIER||||||PRKCZ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,195:195:1
chr1	2289168	.	G	A	.	PASS	CSQ=6497|protein_coding||intron_variant|||||||NM_003036.4:c.970-13810G>A||MODIFIER||||||SKI|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/SKI|y|n|melanoma|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,168:169:0.9941
chr1	2820415	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	74,91:165:0.5515
chr1	3100206	.	C	T	.	PASS	CSQ=63976|protein_coding||intron_variant|||||||NM_022114.4:c.37+30910C>T||MODIFIER||||||PRDM16|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PRDM16|y|n|MDS,AML|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	159,0:159:0	101,102:203:0.5025
chr1	3776793	.	C	T	.	PASS	CSQ=57470|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LRRC47|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	160,0:160:0	0,208:208:1
chr1	4048306	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1355508550||1.97044e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	176,18:194:0.0928
chr1	4483650	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	86,85:171:0.4971
chr1	4751788	.	C	G	.	PASS	CSQ=55966|protein_coding||intron_variant|||||||NM_018836.3:c.830-18065C>G||MODIFIER||||||AJAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	73,72:145:0.4966
chr1	4990512	.	CC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	108,0:109:0	50,68:118:0.5763
chr1	5023298	.	CGGAGGTTGCAGTGAGCTGAGATGACACCACTGCACTCCAGCCTGGGT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	92,54:146:0.3699
chr1	5415291	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,137:137:1
chr1	5479550	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:124:0	0,170:170:1
chr1	5777940	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs770183060||1.97304e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	76,72:148:0.4865
chr1	6123898	.	G	C	.	PASS	CSQ=26038|protein_coding||intron_variant|||||||NM_015557.3:c.4699+50C>G||MODIFIER||||||CHD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	0,160:160:1
chr1	6123901	.	A	C	.	PASS	CSQ=26038|protein_coding||intron_variant|||||||NM_015557.3:c.4699+47T>G||MODIFIER||||||CHD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	0,158:158:1
chr1	6171344	.	G	T	.	PASS	CSQ=26038|protein_coding||intron_variant|||||||NM_015557.3:c.80-3067C>A||MODIFIER||||||CHD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	78,98:176:0.5568
chr1	6182093	.	G	A	.	PASS	CSQ=6146|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||RPL22|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RPL22|y|n|AML,CML|||L|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	0,212:212:1
chr1	6182254	.	G	C	.	PASS	CSQ=6146|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||RPL22|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RPL22|y|n|AML,CML|||L|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	0,144:145:0.9931
chr1	8018537	.	C	G	.	PASS	CSQ=54206|protein_coding||intron_variant|||||||NM_018948.4:c.-73-2845G>C||MODIFIER||||||ERRFI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	65,83:148:0.5608
chr1	8591150	.	C	A	.	PASS	CSQ=473|protein_coding||intron_variant|||||||NM_001042681.2:c.522+23411G>T||MODIFIER||||||RERE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	88,95:183:0.5191
chr1	8642087	.	AT	A	.	PASS	CSQ=473|protein_coding||intron_variant|||||||NM_001042681.2:c.325+13885del||MODIFIER||||||RERE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	125,40:165:0.2424
chr1	9004863	.	C	A	.	PASS	CSQ=155184|protein_coding||synonymous_variant|||||||NM_207420.2:c.1209G>T|NP_997303.2:p.Val403=|LOW||||||SLC2A7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	83,62:145:0.4276
chr1	9611636	.	G	A	.	PASS	CSQ=199953|protein_coding||intron_variant|||||||NM_001130924.3:c.1766-117G>A||MODIFIER||||||TMEM201|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	141,0:141:0	85,110:195:0.5641
chr1	10090737	.	G	T	.	PASS	CSQ=10277|protein_coding||intron_variant|||||||NM_001105562.3:c.212-4724G>T||MODIFIER||||||UBE4B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	85,85:170:0.5
chr1	10317325	.	G	A	.	PASS	CSQ=23095|protein_coding||intron_variant|||||||NM_015074.3:c.1978-2718G>A||MODIFIER||||||KIF1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:148:0	103,88:191:0.4607
chr1	10643531	.	A	G	.	PASS	CSQ=54897|protein_coding||intron_variant|||||||NM_001079843.3:c.3869-220T>C||MODIFIER||||||CASZ1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	95,96:191:0.5026
chr1	10820350	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	90,89:179:0.4972
chr1	11309339	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:120:0	87,69:156:0.4423
chr1	11532724	.	C	G	.	PASS	CSQ=57540|protein_coding||intron_variant|||||||NM_020780.2:c.3375+1014C>G||MODIFIER||||||DISP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	73,91:164:0.5549
chr1	11613277	.	C	T	.	PASS	CSQ=101929181|lncRNA||non_coding_transcript_exon_variant||||||6.57013e-06|NR_104624.1:n.1207C>T||MODIFIER||||||LINC01647|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	131,0:131:0	85,94:180:0.5222
chr1	11825276	.	A	T	.	PASS	CSQ=1185|protein_coding||intron_variant|||||||NM_001286.4:c.648+723A>T||MODIFIER||||||CLCN6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	67,87:154:0.5649
chr1	12242764	.	C	G	.	PASS	CSQ=55187|protein_coding||intron_variant|||||||NM_015378.4:c.175+174C>G||MODIFIER||||||VPS13D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,148:148:1
chr1	12501847	.	C	T	.	PASS	CSQ=55187|protein_coding||intron_variant||||||6.57082e-06|NM_015378.4:c.12794+4216C>T||MODIFIER||||||VPS13D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	180,8:188:0.0426
chr1	12738804	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	109,111:220:0.5045
chr1	13394559	.	T	C	.	PASS	CSQ=391004|protein_coding||downstream_gene_variant||||rs1304381935|||||MODIFIER||||||PRAMEF17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	64,1:65:0.0154	0,10:10:1
chr1	14006334	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	120,9:129:0.0698
chr1	15657806	.	A	G	.	PASS	CSQ=84301|protein_coding||intron_variant|||||||NM_032341.5:c.*46+1127A>G||MODIFIER||||||DDI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	158,8:166:0.0482
chr1	16436370	.	G	A	.	PASS	CSQ=55707|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NECAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	81,66:147:0.449
chr1	16624396	.	C	G	.	PASS	CSQ=84809|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_026752.1:n.723+1379G>C||MODIFIER||||||CROCCP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	466,0:466:0	523,109:632:0.1725
chr1	16624958	.	A	G	.	PASS	CSQ=84809|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||rs1236936708|||NR_026752.1:n.723+817T>C||MODIFIER||||||CROCCP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	365,0:366:0	342,116:458:0.2533
chr1	16794402	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	327,0:327:0	234,76:310:0.2452
chr1	17245014	.	G	A	.	PASS	CSQ=29943|protein_coding||3_prime_UTR_variant|||||||NM_013358.3:c.*771G>A||MODIFIER||||||PADI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	107,0:107:0	82,87:169:0.5148
chr1	17515439	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs961825824||0.000118632|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,125:125:1
chr1	18208376	.	A	AATATAT	.	PASS	CSQ=84966|protein_coding||intron_variant||||rs5772795||0.000226943|NM_032880.5:c.71-19507_71-19502dup||MODIFIER||||||IGSF21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	14,0:55:0	33,63:97:0.6495
chr1	18258604	.	G	GA	.	PASS	CSQ=84966|protein_coding||intron_variant|||||||NM_032880.5:c.183+30596dup||MODIFIER||||||IGSF21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	68,68:137:0.4964
chr1	18319617	.	G	A	.	PASS	CSQ=84966|protein_coding||intron_variant|||||||NM_032880.5:c.306-15275G>A||MODIFIER||||||IGSF21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,152:152:1
chr1	18689435	.	G	A	.	PASS	CSQ=5081|protein_coding||intron_variant|||||||NM_001135254.2:c.587-2319G>A||MODIFIER||||||PAX7|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PAX7|y|n|alveolar_rhabdomyosarcoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:129:0	0,161:161:1
chr1	19584562	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs72954377||0.0123443|||MODIFIER||||||||0.0126;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	94,81:175:0.4629
chr1	20104493	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	88,91:179:0.5084
chr1	20272537	.	CC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:106:0	81,80:163:0.4908
chr1	20508307	.	A	C	.	PASS	CSQ=79594|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MUL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	0,161:161:1
chr1	20533678	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1012501191||3.94514e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,176:176:1
chr1	21408488	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	78,92:170:0.5412
chr1	21419470	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,160:160:1
chr1	21496316	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	8,156:165:0.9455
chr1	21605452	.	T	C	.	PASS	CSQ=5909|protein_coding||intron_variant||||rs942336530|||NM_001350526.1:c.1428+614A>G||MODIFIER||||||RAP1GAP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,172:172:1
chr1	21969815	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	163,13:176:0.0739
chr1	21969981	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	182,23:205:0.1122
chr1	22192109	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	59,76:135:0.563
chr1	22233367	.	ATCTGGGAGGCATC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	101,95:196:0.4847
chr1	22498064	.	A	G	.	PASS	CSQ=9923|protein_coding||intron_variant|||||||NM_014870.4:c.832-3428A>G||MODIFIER||||||ZBTB40|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,149:149:1
chr1	22637861	.	G	C	.	PASS	CSQ=102466615|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR6127|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	109,0:109:0	74,70:144:0.4861
chr1	22736252	.	G	A	.	PASS	CSQ=2048|protein_coding||intron_variant|||||||NM_017449.4:c.61+25209G>A||MODIFIER||||||EPHB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	180,13:193:0.0674
chr1	23785056	.	G	C	.	PASS	CSQ=57095|protein_coding||intron_variant|||||||NM_020362.5:c.321-619G>C||MODIFIER||||||PITHD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,78:78:1
chr1	23848200	.	G	A	.	PASS	CSQ=2517|protein_coding||intron_variant|||||||NM_000147.4:c.1160+449C>T||MODIFIER||||||FUCA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,61:61:1
chr1	23848914	.	G	C	.	PASS	CSQ=2517|protein_coding||intron_variant|||||||NM_000147.4:c.970-75C>G||MODIFIER||||||FUCA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	0,74:75:0.9867
chr1	24231025	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,71:71:1
chr1	26414820	.	C	G	.	PASS	CSQ=79727|protein_coding||intron_variant||||rs997878305|||NM_024674.6:c.228+3238C>G||MODIFIER||||||LIN28A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,76:76:1
chr1	26937950	.	G	T	.	PASS	CSQ=10726|protein_coding||intron_variant|||||||NM_006600.4:c.160-3507G>T||MODIFIER||||||NUDC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,99:99:1
chr1	28123992	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,75:75:1
chr1	28645446	.	G	C	.	PASS	CSQ=6883|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TAF12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:78:0	0,61:61:1
chr1	29523114	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	62,12:74:0.1622
chr1	30061119	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs1007263538||0.00156885|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	1,56:57:0.9825
chr1	30489918	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	135,0:135:0	86,6:92:0.0652
chr1	30552265	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,93:93:1
chr1	32405468	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1050891591||2.64414e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,83:83:1
chr1	32766842	.	A	T	.	PASS	CSQ=57648|protein_coding||intron_variant|||||||NM_020888.3:c.236-945A>T||MODIFIER||||||KIAA1522|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:134:0	0,92:92:1
chr1	33054294	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	0,77:77:1
chr1	35099049	.	A	C	.	PASS	CSQ=79830|protein_coding||intron_variant|||||||NM_024772.5:c.419+1483A>C||MODIFIER||||||ZMYM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	105,0:105:0	1,80:81:0.9877
chr1	35735609	.	G	A	.	PASS	CSQ=63967|protein_coding||3_prime_UTR_variant|||||||NM_022111.4:c.*887C>T||MODIFIER||||||CLSPN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	107,0:107:0	0,85:86:0.9884
chr1	37090575	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,90:90:1
chr1	38815013	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs987005720||1.97104e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	4,72:76:0.9474
chr1	39134203	.	G	A	.	PASS	CSQ=23499|protein_coding||intron_variant|||||||NM_012090.5:c.220+49765G>A||MODIFIER||||||MACF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:102:0	0,72:72:1
chr1	40143456	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	2,90:92:0.9783
chr1	41332139	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs948482263|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,104:104:1
chr1	41835250	.	A	AT	.	PASS	CSQ=59269|protein_coding||intron_variant||||rs962140463||6.57428e-06|NM_024503.5:c.-801+83162dup||MODIFIER||||||HIVEP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	6,74:80:0.925
chr1	45427615	.	G	T	.	PASS	CSQ=10420|protein_coding||intron_variant|||||||NM_007170.3:c.223-5769C>A||MODIFIER||||||TESK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	84,18:102:0.1765
chr1	46307104	.	G	A	.	PASS	CSQ=7388|protein_coding||intron_variant|||||||NM_006004.4:c.55-1997G>A||MODIFIER||||||UQCRH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,105:105:1
chr1	46889377	.	G	C	.	PASS	CSQ=163720|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_002788.2:n.361-2082C>G||MODIFIER||||||CYP4Z2P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	13,69:82:0.8415
chr1	47154404	.	C	A	.	PASS	CSQ=284541|protein_coding||downstream_gene_variant||||rs981367754|||||MODIFIER||||||CYP4A22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,73:73:1
chr1	48528045	.	A	T	.	PASS	CSQ=84871|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||AGBL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:124:0	0,101:101:1
chr1	48650154	.	G	C	.	PASS	CSQ=84871|protein_coding||intron_variant|||||||NM_032785.4:c.839+3183C>G||MODIFIER||||||AGBL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,72:72:1
chr1	49131080	.	C	T	.	PASS	CSQ=84871|protein_coding||intron_variant|||||||NM_032785.4:c.378-85280G>A||MODIFIER||||||AGBL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	0,82:82:1
chr1	49325804	.	T	G	.	PASS	CSQ=84871|protein_coding||intron_variant|||||||NM_032785.4:c.283-79940A>C||MODIFIER||||||AGBL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,78:78:1
chr1	49518808	.	T	A	.	PASS	CSQ=84871|protein_coding||intron_variant|||||||NM_032785.4:c.282+178505A>T||MODIFIER||||||AGBL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,83:83:1
chr1	50116420	.	G	A	.	PASS	CSQ=1996|protein_coding||intron_variant|||||||NM_001144774.2:c.9+7222G>A||MODIFIER||||||ELAVL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,79:79:1
chr1	50125862	.	G	C	.	PASS	CSQ=1996|protein_coding||intron_variant|||||||NM_001144774.2:c.9+16664G>C||MODIFIER||||||ELAVL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,73:73:1
chr1	50285332	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,70:70:1
chr1	50421227	.	C	T	.	PASS	CSQ=63950|protein_coding||missense_variant|||||||NM_032110.3:c.310G>A|NP_115486.1:p.Glu104Lys|MODERATE|D&D|T&T|D|D&D|D&D|DMRTA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	160,0:160:0	0,104:104:1
chr1	51040005	COSV66842625	T	TA	.	PASS	CSQ=|||intergenic_variant|||COSV66842625|rs989775604||0.000168108|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	10,89:99:0.899
chr1	51481991	.	GA	AT	.	PASS	CSQ=2060|protein_coding||intron_variant|||||||NM_001981.3:c.34-678_34-677delinsAT||MODIFIER||||||EPS15|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/EPS15|y|n|ALL|||L|Dom|TSG,fusion|T;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	103,0:103:0	0,72:72:1
chr1	52561113	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	115,0:116:0	0,76:76:1
chr1	52968393	.	C	T	.	PASS	CSQ=6342|protein_coding||intron_variant|||||||NM_002979.5:c.524-6376C>T||MODIFIER||||||SCP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,103:103:1
chr1	54458148	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	1,80:81:0.9877
chr1	55122694	.	G	A	.	PASS	CSQ=23358|protein_coding||intron_variant|||||||NM_015306.3:c.4276+753C>T||MODIFIER||||||USP24|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	0,73:73:1
chr1	55495382	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:102:0	0,69:69:1
chr1	55558406	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,84:84:1
chr1	56266133	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,79:79:1
chr1	56733008	.	T	A	.	PASS	CSQ=199920|protein_coding||intron_variant|||||||NM_001004303.5:c.1793+4079A>T||MODIFIER||||||FYB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,63:63:1
chr1	56763623	.	C	A	.	PASS	CSQ=199920|protein_coding||intron_variant|||||||NM_001004303.5:c.1063+4206G>T||MODIFIER||||||FYB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,80:80:1
chr1	57112833	.	A	C	.	PASS	CSQ=1600|protein_coding||intron_variant|||||||NM_021080.4:c.306+23710T>G||MODIFIER||||||DAB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,1:131:0.0076	0,99:99:1
chr1	57207029	.	C	T	.	PASS	CSQ=1600|protein_coding||intron_variant||||rs946248379||1.63532e-05|NM_021080.4:c.68-61600G>A||MODIFIER||||||DAB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,64:64:1
chr1	57335986	.	C	T	.	PASS	CSQ=1600|protein_coding||intron_variant|||||||NM_021080.4:c.-136-44820G>A||MODIFIER||||||DAB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,82:82:1
chr1	57492763	.	G	A	.	PASS	CSQ=1600|protein_coding||intron_variant|||||||NM_021080.4:c.-137+156829C>T||MODIFIER||||||DAB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,67:67:1
chr1	58816334	.	A	C	.	PASS	CSQ=100131060|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_034014.1:n.155+31029A>C||MODIFIER||||||LINC01135|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,80:80:1
chr1	59057039	.	C	A	.	PASS	CSQ=101926925|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110626.2:n.239-30976C>A||MODIFIER||||||LINC01358|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	2,77:79:0.9747
chr1	59737734	.	G	A	.	PASS	CSQ=55277|protein_coding||intron_variant|||||||NM_018291.3:c.1513-20197G>A||MODIFIER||||||FGGY|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,93:93:1
chr1	59911567	.	C	T	.	PASS	CSQ=1573|protein_coding||intron_variant|||||||NM_000775.4:c.684+41G>A||MODIFIER||||||CYP2J2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	113,0:113:0	0,75:75:1
chr1	59911586	.	T	G	.	PASS	CSQ=1573|protein_coding||intron_variant|||||||NM_000775.4:c.684+22A>C||MODIFIER||||||CYP2J2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	125,0:125:0	0,75:75:1
chr1	61520316	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,77:77:1
chr1	62203354	.	C	T	.	PASS	CSQ=54596|protein_coding||intron_variant|||||||NM_019079.5:c.-110-3165C>T||MODIFIER||||||L1TD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	126,0:126:0	0,70:70:1
chr1	62693487	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,104:104:1
chr1	63607515	.	A	T	.	PASS	CSQ=5236|protein_coding||intron_variant|||||||NM_002633.3:c.246+13781A>T||MODIFIER||||||PGM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,73:73:1
chr1	63837612	.	G	T	.	PASS	CSQ=4919|protein_coding||intron_variant|||||||NM_005012.4:c.91+63104G>T||MODIFIER||||||ROR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,57:57:1
chr1	64319889	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,96:96:1
chr1	64325618	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs756264756|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	0,79:79:1
chr1	66334144	.	G	A	.	PASS	CSQ=5142|protein_coding||intron_variant|||||||NM_002600.4:c.747+1524G>A||MODIFIER||||||PDE4B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,70:70:1
chr1	66533078	.	A	T	.	PASS	CSQ=84251|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SGIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,87:87:1
chr1	66678399	.	T	A	.	PASS	CSQ=84251|protein_coding||intron_variant|||||||NM_032291.4:c.740-1279T>A||MODIFIER||||||SGIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	8,97:105:0.9238
chr1	66979414	.	ATTT	A	.	PASS	CSQ=57708|protein_coding||intron_variant|||||||NM_001077700.2:c.1230-2363_1230-2361del||MODIFIER||||||MIER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,74:74:1
chr1	67348572	.	G	A	.	PASS	CSQ=3595|protein_coding||intron_variant|||||||NM_001559.2:c.1039-2298G>A||MODIFIER||||||IL12RB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,82:82:1
chr1	67485817	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,78:78:1
chr1	68595613	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,1:129:0.0078	0,78:78:1
chr1	68782699	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,57:57:1
chr1	69115494	.	A	T	.	PASS	CSQ=105378785|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146608.1:n.317+26932A>T||MODIFIER||||||LINC01707|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	1,48:49:0.9796
chr1	69657332	.	G	T	.	PASS	CSQ=57554|protein_coding||intron_variant|||||||NM_001366838.1:c.3-21049G>T||MODIFIER||||||LRRC7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,90:90:1
chr1	69980225	.	C	A	.	PASS	CSQ=57554|protein_coding||intron_variant|||||||NM_001366838.1:c.712-154C>A||MODIFIER||||||LRRC7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	32,51:83:0.6145
chr1	70097454	COSV50476851;COSV50476851;COSV50476851	CT	C	.	PASS	CSQ=57554|protein_coding||intron_variant|COSV50476851&COSV50476851&COSV50476851|p.?&p.?&p.?||rs1261094213||7.90014e-05|NM_001366838.1:c.4404+7643del||MODIFIER||||||LRRC7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	5,63:68:0.9265
chr1	70717111	.	G	A	.	PASS	CSQ=101927244|lncRNA||intron_variant&non_coding_transcript_variant||||rs1309919865||1.31447e-05|NR_125938.1:n.637+3804G>A||MODIFIER||||||LINC01788|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,70:70:1
chr1	70753849	.	TG	AT	.	PASS	CSQ=101927244|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125938.1:n.638-23681_638-23680delinsAT||MODIFIER||||||LINC01788|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	116,0:116:0	0,71:71:1
chr1	70799228	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	54,10:64:0.1562
chr1	70862533	.	C	T	.	PASS	CSQ=5733|protein_coding||intron_variant||||rs368607921||1.31486e-05|NM_198714.1:c.*24-9674G>A||MODIFIER||||||PTGER3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	103,0:103:0	70,6:76:0.0789
chr1	70988734	.	C	A	.	PASS	CSQ=5733|protein_coding||intron_variant|||||||NM_198719.1:c.1078-14346G>T||MODIFIER||||||PTGER3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,65:65:1
chr1	71162824	.	T	G	.	PASS	CSQ=100852410|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046217.1:n.132-60233T>G||MODIFIER||||||ZRANB2-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,85:85:1
chr1	71269206	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1195956750||2.63744e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	6,56:62:0.9032
chr1	71564974	.	A	T	.	PASS	CSQ=257194|protein_coding||intron_variant|||||||NM_173808.3:c.940+27843T>A||MODIFIER||||||NEGR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,89:89:1
chr1	71924677	.	T	G	.	PASS	CSQ=257194|protein_coding||intron_variant|||||||NM_173808.3:c.409+10402A>C||MODIFIER||||||NEGR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,64:64:1
chr1	72066930	.	C	T	.	PASS	CSQ=257194|protein_coding||intron_variant|||||||NM_173808.3:c.177-131619G>A||MODIFIER||||||NEGR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,71:71:1
chr1	72083192	.	A	T	.	PASS	CSQ=257194|protein_coding||intron_variant|||||||NM_173808.3:c.177-147881T>A||MODIFIER||||||NEGR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	32,45:77:0.5844
chr1	72271947	.	G	T	.	PASS	CSQ=257194|protein_coding||intron_variant|||||||NM_173808.3:c.176+10372C>A||MODIFIER||||||NEGR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,77:77:1
chr1	72284593	.	TTTA	T	.	PASS	CSQ=257194|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NEGR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,77:77:1
chr1	72302547	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	0,82:82:1
chr1	72622524	.	CT	C	.	PASS	CSQ=|||intergenic_variant||||rs772377317||0.00163104|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,1:104:0.0096	15,67:82:0.8171
chr1	72798431	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1240591574|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,84:84:1
chr1	73072642	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,74:74:1
chr1	73459617	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	59,12:71:0.169
chr1	73460261	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	49,8:57:0.1404
chr1	73643466	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,80:80:1
chr1	73747233	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,79:79:1
chr1	73956310	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,90:90:1
chr1	74120124	.	G	GT	.	PASS	CSQ=127255|protein_coding||intron_variant||||rs377163655||0.00344474|NM_001105659.2:c.708-10572dup||MODIFIER||||||LRRIQ3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	15,56:72:0.7778
chr1	74363709	.	G	GT	.	PASS	CSQ=100526835|protein_coding||intron_variant|||||||NM_001112808.2:c.1520-3546dup||MODIFIER||||||FPGT-TNNI3K|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	4,57:61:0.9344
chr1	74859945	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	59,9:68:0.1324
chr1	74918341	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,74:74:1
chr1	74943418	.	G	GTCTC	.	PASS	CSQ=|||intergenic_variant||||rs1248458887|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	20,35:55:0.6364
chr1	74943422	COSV50630595	G	C	.	PASS	CSQ=|||intergenic_variant|||COSV50630595|rs114631334||6.93414e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	102,5:107:0.0467	0,57:57:1
chr1	75342438	.	C	A	.	PASS	CSQ=204962|protein_coding||intron_variant|||||||NM_152697.4:c.53-2808G>T||MODIFIER||||||SLC44A5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,64:64:1
chr1	76333923	.	C	A	.	PASS	CSQ=256435|protein_coding||intron_variant|||||||NM_152996.4:c.213+19924C>A||MODIFIER||||||ST6GALNAC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,64:64:1
chr1	76387746	.	TC	T	.	PASS	CSQ=256435|protein_coding||intron_variant|||||||NM_152996.4:c.214-24261del||MODIFIER||||||ST6GALNAC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,74:74:1
chr1	76502323	.	T	A	.	PASS	CSQ=256435|protein_coding||intron_variant|||||||NM_152996.4:c.623+89906T>A||MODIFIER||||||ST6GALNAC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,80:80:1
chr1	76948453	.	G	GA	.	PASS	CSQ=81849|protein_coding||intron_variant|||||||NM_030965.3:c.261+79712dup||MODIFIER||||||ST6GALNAC5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	121,0:121:0	15,66:81:0.8148
chr1	76948461	.	G	A	.	PASS	CSQ=81849|protein_coding||intron_variant|||||||NM_030965.3:c.261+79719G>A||MODIFIER||||||ST6GALNAC5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	120,0:120:0	0,68:68:1
chr1	77130102	.	C	A	.	PASS	CSQ=10026|protein_coding||intron_variant|||||||NM_005482.3:c.987-7743G>T||MODIFIER||||||PIGK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,71:71:1
chr1	77130122	.	C	A	.	PASS	CSQ=10026|protein_coding||intron_variant|||||||NM_005482.3:c.987-7763G>T||MODIFIER||||||PIGK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	0,69:69:1
chr1	78971170	.	C	T	.	PASS	CSQ=64123|protein_coding||intron_variant|||||||NM_022159.4:c.173-24744G>A||MODIFIER||||||ADGRL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,85:85:1
chr1	79349822	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,74:74:1
chr1	79928937	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	5,75:80:0.9375
chr1	80009956	.	TTC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	0,37:37:1
chr1	80069337	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,1:127:0.0079	0,60:60:1
chr1	80071663	.	TTTAGTGGTGA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,76:76:1
chr1	80298999	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	39,30:69:0.4348
chr1	80364527	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,78:78:1
chr1	80459700	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,62:62:1
chr1	80600219	.	AC	A	.	PASS	CSQ=101927412|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125940.1:n.237-44004del||MODIFIER||||||LINC01781|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,75:75:1
chr1	80600221	.	C	A	.	PASS	CSQ=101927412|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125940.1:n.237-44004C>A||MODIFIER||||||LINC01781|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,74:74:1
chr1	80721421	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	0,85:85:1
chr1	81325829	.	C	CA	.	PASS	CSQ=23266|protein_coding||intron_variant|||||||NM_001366003.1:c.-437-886dup||MODIFIER||||||ADGRL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	4,68:72:0.9444
chr1	82156020	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1347479061||1.97156e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,71:71:1
chr1	82398237	.	CC	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	118,0:118:0	0,77:77:1
chr1	82409860	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||6.5716e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	3,87:90:0.9667
chr1	82626839	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,72:72:1
chr1	82910029	.	G	T	.	PASS	CSQ=103283057|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147074.1:n.756+2447G>T||MODIFIER||||||LINC01362|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,77:77:1
chr1	83112147	.	C	T	.	PASS	CSQ=103283057|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147074.1:n.1539+15170C>T||MODIFIER||||||LINC01362|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,70:70:1
chr1	83128401	.	T	TA	.	PASS	CSQ=103283057|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147074.1:n.1539+31431dup||MODIFIER||||||LINC01362|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	5,72:77:0.9351
chr1	83354050	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	74,0:75:0	0,51:51:1
chr1	83777197	.	G	A	.	PASS	CSQ=101927587|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_119375.1:n.179-26898C>T||MODIFIER||||||LINC01725|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,89:89:1
chr1	84937334	.	G	A	.	PASS	CSQ=255231|protein_coding||intron_variant||||rs1413141508||3.94244e-05|NM_153259.4:c.1335+421C>T||MODIFIER||||||MCOLN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,91:91:1
chr1	85209625	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	77,4:81:0.0494
chr1	85565040	.	C	CA	.	PASS	CSQ=23576|protein_coding||intron_variant||||rs560705676||0.00691824|NM_001134445.1:c.-123+12943dup||MODIFIER||||||DDAH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	15,53:69:0.7681
chr1	86621466	.	C	T	.	PASS	CSQ=105378828|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135837.1:n.1293-50058G>A||MODIFIER||||||LOC105378828|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,99:99:1
chr1	86769450	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	0,77:77:1
chr1	86930566	.	G	C	.	PASS	CSQ=9653|protein_coding||intron_variant|||||||NM_012262.4:c.124+15406G>C||MODIFIER||||||HS2ST1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,86:86:1
chr1	86935971	.	G	A	.	PASS	CSQ=9653|protein_coding||intron_variant||||||6.57393e-06|NM_012262.4:c.124+20811G>A||MODIFIER||||||HS2ST1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,68:68:1
chr1	86937296	.	C	A	.	PASS	CSQ=9653|protein_coding||intron_variant|||||||NM_012262.4:c.124+22136C>A||MODIFIER||||||HS2ST1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,1:128:0.0078	0,89:89:1
chr1	87704826	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	29,45:74:0.6081
chr1	88109114	.	TTTATGAAGGTCTTTTTCTTAAGAGCTAAAAAACAAGCA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	0,70:70:1
chr1	89026126	.	T	C	.	PASS	CSQ=2635|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GBP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,79:79:1
chr1	89220206	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,79:79:1
chr1	90602637	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	2,78:80:0.975
chr1	90688309	.	CC	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	108,0:109:0	0,72:72:1
chr1	91588169	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,85:85:1
chr1	92228765	.	A	T	.	PASS	CSQ=388649|protein_coding||intron_variant|||||||NM_001012425.2:c.-39-2617A>T||MODIFIER||||||C1orf146|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,80:80:1
chr1	92494766	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,76:76:1
chr1	93027890	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,94:94:1
chr1	93028924	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	85,17:102:0.1667
chr1	93029783	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,81:81:1
chr1	93574556	.	C	G	.	PASS	CSQ=8412|protein_coding||intron_variant|||||||NM_003567.4:c.1802+1458G>C||MODIFIER||||||BCAR3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,89:89:1
chr1	95325462	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,88:88:1
chr1	96063846	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	5,51:56:0.9107
chr1	96507946	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	70,4:74:0.0541
chr1	97100601	.	C	G	.	PASS	CSQ=100873932|lncRNA||intron_variant&non_coding_transcript_variant||||rs1248840490|||NR_046590.1:n.64+4615C>G||MODIFIER||||||DPYD-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,1:121:0.0083	0,65:65:1
chr1	99829216	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,97:97:1
chr1	100854157	.	TGCACACACACAC	T	.	PASS	CSQ=|||intergenic_variant||||rs1437011955||6.57851e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,86:86:1
chr1	101136847	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs572586069||1.31441e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,69:69:1
chr1	101331466	.	T	TG	.	PASS	CSQ=104355286|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126402.1:n.39+7595dup||MODIFIER||||||LINC01307|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	7,79:86:0.9186
chr1	101764015	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	62,14:76:0.1842
chr1	101852891	.	C	T	.	PASS	CSQ=118427|protein_coding||intron_variant|||||||NM_058170.3:c.70-15866G>A||MODIFIER||||||OLFM3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,68:68:1
chr1	102127148	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,68:68:1
chr1	102656176	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	64,8:72:0.1111
chr1	102735171	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,69:69:1
chr1	102854104	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1057343559||1.31427e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,79:80:0.9875
chr1	102854656	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1419455281|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,72:72:1
chr1	102870454	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,77:77:1
chr1	102963337	.	C	A	.	PASS	CSQ=1301|protein_coding||intron_variant|||||||NM_001854.4:c.2917-577G>T||MODIFIER||||||COL11A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,78:78:1
chr1	103106617	.	TC	AT	.	PASS	CSQ=1301|protein_coding||intron_variant|||||||NM_001854.4:c.106+1455_106+1456delinsAT||MODIFIER||||||COL11A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	127,0:127:0	0,85:85:1
chr1	103242310	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	9,63:72:0.875
chr1	103311421	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,65:65:1
chr1	103496499	.	A	G	.	PASS	CSQ=101928436|protein_coding||intron_variant|||||||NM_001347929.1:c.-83-27109T>C||MODIFIER||||||LOC101928436|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	4,64:68:0.9412
chr1	104437137	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,81:81:1
chr1	104682716	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,76:76:1
chr1	104965345	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	68,0:68:0	0,53:53:1
chr1	105200607	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,70:70:1
chr1	105248523	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,70:70:1
chr1	105769122	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,79:79:1
chr1	105928275	.	C	T	.	PASS	CSQ=105378884|lncRNA||intron_variant&non_coding_transcript_variant||||rs1443221509||1.97265e-05|NR_146609.1:n.897-561G>A||MODIFIER||||||LINC01677|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	79,7:86:0.0814
chr1	106442747	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	0,65:65:1
chr1	106459991	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	2,51:53:0.9623
chr1	106709489	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,57:57:1
chr1	106750488	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs987035394||1.97252e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,81:81:1
chr1	107257459	.	C	A	.	PASS	CSQ=22854|protein_coding||intron_variant|||||||NM_001113226.2:c.247-66823C>A||MODIFIER||||||NTNG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	5,72:77:0.9351
chr1	107407991	.	C	A	.	PASS	CSQ=22854|protein_coding||intron_variant|||||||NM_001113226.2:c.1087+283C>A||MODIFIER||||||NTNG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	126,0:126:0	0,83:83:1
chr1	107468235	.	C	A	.	PASS	CSQ=22854|protein_coding||intron_variant|||||||NM_001113226.2:c.1391-12376C>A||MODIFIER||||||NTNG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,1:135:0.0074	0,62:62:1
chr1	107843881	.	G	A	.	PASS	CSQ=10451|protein_coding||intron_variant||||rs946535126||1.97304e-05|NM_006113.5:c.321+31020C>T||MODIFIER||||||VAV3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,78:78:1
chr1	108816886	.	G	A	.	PASS	CSQ=254268|protein_coding||intron_variant|||||||NM_152763.5:c.2379+162C>T||MODIFIER||||||AKNAD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,75:75:1
chr1	108883999	.	C	A	.	PASS	CSQ=29899|protein_coding||intron_variant|||||||NM_013296.5:c.-248-1276C>A||MODIFIER||||||GPSM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	0,76:76:1
chr1	108906236	.	A	AT	.	PASS	CSQ=29899|protein_coding||intron_variant||||||6.58605e-06|NM_013296.5:c.1192+1985dup||MODIFIER||||||GPSM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	4,73:77:0.9481
chr1	109204352	.	C	CT	.	PASS	CSQ=57535|protein_coding||3_prime_UTR_variant|||||||NM_020775.5:c.*1348dup||MODIFIER||||||KIAA1324|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	119,0:119:0	9,96:106:0.9057
chr1	109299492	.	T	G	.	PASS	CSQ=343263|protein_coding||intron_variant|||||||NM_001010985.3:c.146-1235A>C||MODIFIER||||||MYBPHL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	0,103:103:1
chr1	110423210	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,80:81:0.9877
chr1	110916002	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1037866204||1.31487e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,77:77:1
chr1	111829221	.	G	A	.	PASS	CSQ=3752|protein_coding||intron_variant|||||||NM_004980.4:c.1107-42115C>T||MODIFIER||||||KCND3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,75:75:1
chr1	112197044	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,79:79:1
chr1	112277725	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,84:84:1
chr1	112689169	.	G	A	.	PASS	CSQ=4343|protein_coding||intron_variant|||||||NM_001321324.1:c.341+31G>A||MODIFIER||||||MOV10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	0,106:106:1
chr1	116497678	.	TCAGGGACTATTACTCTGAGGCC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,95:95:1
chr1	118068535	.	ACAGCAC	A	.	PASS	CSQ=200162|protein_coding||intron_variant|||||||NM_206996.3:c.2386-1642_2386-1637del||MODIFIER||||||SPAG17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,71:71:1
chr1	119118618	.	G	T	.	PASS	CSQ=10352|protein_coding||intron_variant|||||||NM_015836.3:c.90+21937C>A||MODIFIER||||||WARS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	101,0:101:0	0,66:66:1
chr1	119563599	.	C	T	.	PASS	CSQ=128102|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||HSD3BP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	0,85:85:1
chr1	124101990	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1306284559|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	176,9:186:0.0484	14,4:18:0.2222
chr1	124424792	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1247375941|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	263,5:268:0.0187	1,1:2:0.5
chr1	124801921	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1201898643|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	51,58:109:0.5321
chr1	125072229	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1332733343||2.66709e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:148:0	63,72:135:0.5333
chr1	143541843	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.7703e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	56,65:121:0.5372
chr1	143705368	.	G	C	.	PASS	CSQ=|||intergenic_variant||||||3.38776e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	79,51:130:0.3923
chr1	145475116	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	78,68:146:0.4658
chr1	145656117	.	AC	A	.	PASS	CSQ=653519|protein_coding||intron_variant|||||||NM_001097612.2:c.910-7210del||MODIFIER||||||GPR89A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	66,84:150:0.56
chr1	145711480	.	G	A	.	PASS	CSQ=5174|protein_coding||upstream_gene_variant||||rs1053193292||3.28519e-05|||MODIFIER||||||PDZK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	91,82:173:0.474
chr1	145763203	.	C	G	.	PASS	CSQ=27246|protein_coding||intron_variant|||||||NM_014455.4:c.428+8508G>C||MODIFIER||||||RNF115|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	72,87:159:0.5472
chr1	146012066	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	76,77:153:0.5033
chr1	147161421	.	C	A	.	PASS	CSQ=5565|protein_coding||intron_variant|||||||NM_005399.5:c.741+291G>T||MODIFIER||||||PRKAB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	119,0:119:0	88,42:130:0.3231
chr1	147273933	.	G	A	.	PASS	CSQ=9557|protein_coding||intron_variant|||||||NM_004284.6:c.1271-1421G>A||MODIFIER||||||CHD1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	111,77:188:0.4096
chr1	147376388	.	GTCA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	72,32:104:0.3077
chr1	147376393	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,32:103:0.3107
chr1	147474432	.	G	A	.	PASS	CSQ=100289211|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038423.2:n.700+39906C>T||MODIFIER||||||LINC00624|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	85,58:143:0.4056
chr1	147512731	.	G	A	.	PASS	CSQ=100289211|lncRNA||intron_variant&non_coding_transcript_variant||||rs587664641||0.000262954|NR_038423.2:n.700+1607C>T||MODIFIER||||||LINC00624|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	71,68:139:0.4892
chr1	148088141	.	C	T	.	PASS	CSQ=728920|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_146087.1:n.642-2216C>T||MODIFIER||||||PDE4DIPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	95,56:151:0.3709
chr1	148378490	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||4.60139e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	108,0:108:0	62,80:142:0.5634
chr1	149784719	.	T	C	.	PASS	CSQ=2209|protein_coding||intron_variant||||rs2260130||0.00122062|NM_000566.3:c.307+462T>C||MODIFIER||||||FCGR1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	64,64:128:0.5
chr1	150018373	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	64,75:139:0.5396
chr1	150253762	.	C	G	.	PASS	CSQ=23632|protein_coding||upstream_gene_variant||||rs1318471644||6.60205e-06|||MODIFIER||||||CA14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	65,81:146:0.5548
chr1	150438908	.	C	T	.	PASS	CSQ=23248|protein_coding||intron_variant|||||||NM_015203.4:c.336-2015C>T||MODIFIER||||||RPRD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	126,7:133:0.0526
chr1	150728437	.	C	T	.	PASS	CSQ=1520|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CTSS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	112,82:194:0.4227
chr1	150907844	.	G	A	.	PASS	CSQ=100996521|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_148929.1:n.62-4398G>A||MODIFIER||||||CTXND2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	76,54:130:0.4154
chr1	151023495	.	G	A	.	PASS	CSQ=58497|protein_coding||intron_variant||||rs970088676|||NM_021222.3:c.336-1116G>A||MODIFIER||||||PRUNE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	128,5:133:0.0376
chr1	151155924	.	G	A	.	PASS	CSQ=388695|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LYSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	65,53:118:0.4492
chr1	151921552	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	55,94:149:0.6309
chr1	151952105	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	93,66:159:0.4151
chr1	151952347	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	87,59:146:0.4041
chr1	152300566	.	C	T	.	PASS	CSQ=2312|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FLG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	77,77:154:0.5
chr1	152797952	.	G	T	.	PASS	CSQ=353134|protein_coding||missense_variant|||||||NM_178352.2:c.158G>T|NP_848129.1:p.Gly53Val|MODERATE|D|T|D|D||LCE1D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	96,0:96:0	82,72:154:0.4675
chr1	153014677	.	TGTTG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	68,63:131:0.4809
chr1	153209095	.	G	A	.	PASS	CSQ=149018|protein_coding||downstream_gene_variant||||||6.57307e-06|||MODIFIER||||||LELP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	71,64:135:0.4741
chr1	153249573	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	76,75:151:0.4967
chr1	153254793	.	C	T	.	PASS	CSQ=4014|protein_coding||upstream_gene_variant||||rs909779329||4.60006e-05|||MODIFIER||||||LOR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	73,83:156:0.5321
chr1	153932882	.	T	C	.	PASS	CSQ=9909|protein_coding||missense_variant|||||||NM_014856.3:c.3602A>G|NP_055671.2:p.Gln1201Arg|MODERATE|B&.|T&T|D|T&.|D&D|DENND4B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	96,77:173:0.4451
chr1	155098011	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	87,58:145:0.4
chr1	156058793	.	G	A	.	PASS	CSQ=57111|protein_coding||upstream_gene_variant||||rs757986758|||||MODIFIER||||||RAB25|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	156,10:166:0.0602
chr1	156250269	.	A	T	.	PASS	CSQ=23381|protein_coding||3_prime_UTR_variant|||||||NM_015327.3:c.*318T>A||MODIFIER||||||SMG5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	74,102:176:0.5795
chr1	156324960	.	C	A	.	PASS	CSQ=7203|protein_coding||intron_variant||||rs1290471419|||NM_005998.5:c.422+12G>T||MODIFIER||||||CCT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:111:0	85,61:146:0.4178
chr1	156440991	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	58,88:146:0.6027
chr1	156609249	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	108,70:178:0.3933
chr1	156835559	.	G	T	.	PASS	CSQ=3645|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||INSRR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	93,64:157:0.4076
chr1	157023066	.	T	A	.	PASS	CSQ=9826|protein_coding||intron_variant|||||||NM_198236.2:c.32+21233A>T||MODIFIER||||||ARHGEF11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	82,81:163:0.4969
chr1	157029523	.	C	T	.	PASS	CSQ=9826|protein_coding||intron_variant|||||||NM_198236.2:c.32+14776G>A||MODIFIER||||||ARHGEF11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	68,91:159:0.5723
chr1	157452486	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	66,38:104:0.3654
chr1	157851145	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	44,71:116:0.6121
chr1	157965157	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	76,71:147:0.483
chr1	158347102	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1195093758||2.63404e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	64,96:160:0.6
chr1	158462295	.	T	A	.	PASS	CSQ=391109|protein_coding||upstream_gene_variant||||rs1031972490||1.35613e-05|||MODIFIER||||||OR10K1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	72,54:126:0.4286
chr1	158547848	.	C	A	.	PASS	CSQ=391112|protein_coding||missense_variant||||rs771617005|7.96876e-06||NM_001005189.1:c.258G>T|NP_001005189.1:p.Met86Ile|MODERATE|B&B&B|.&.&T|D|.&.&T|.&.&D|OR6Y1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	102,0:102:0	101,25:126:0.1984
chr1	159316872	.	C	T	.	PASS	CSQ=441911|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||OR10J3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	57,88:146:0.6027
chr1	159340622	.	TCCTAGG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	64,51:115:0.4435
chr1	159513383	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	140,9:149:0.0604
chr1	160059048	.	C	T	.	PASS	CSQ=3766|protein_coding||intron_variant||||rs192556119||0.000197176|NM_002241.5:c.-1+10974G>A||MODIFIER||||||KCNJ10|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	84,65:149:0.4362
chr1	160394118	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	157,65:222:0.2928
chr1	160668582	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	169,61:230:0.2652
chr1	161025023	.	A	G	.	PASS	CSQ=50848|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||F11R|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	68,82:150:0.5467
chr1	162074828	.	C	T	.	PASS	CSQ=9722|protein_coding||intron_variant|||||||NM_014697.3:c.105+4546C>T||MODIFIER||||||NOS1AP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	56,75:131:0.5725
chr1	162075298	.	C	T	.	PASS	CSQ=9722|protein_coding||intron_variant|||||||NM_014697.3:c.105+5016C>T||MODIFIER||||||NOS1AP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	67,95:162:0.5864
chr1	162417377	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs986421455||5.25659e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	144,6:150:0.04
chr1	162577392	.	C	G	.	PASS	CSQ=6675|protein_coding||intron_variant|||||||NM_001324116.1:c.485+411C>G||MODIFIER||||||UAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	74,0:74:0	55,51:106:0.4811
chr1	162909898	.	A	AG	.	PASS	CSQ=|||intergenic_variant||||rs1404131576||1.32705e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	88,67:159:0.4214
chr1	162917381	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	90,49:140:0.35
chr1	163719038	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	65,61:127:0.4803
chr1	163997625	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs750173349||3.94888e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	46,65:111:0.5856
chr1	164135369	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	60,58:118:0.4915
chr1	164491769	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,82:150:0.5467
chr1	164492448	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	82,60:142:0.4225
chr1	165818901	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	72,73:145:0.5034
chr1	165992894	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	83,64:147:0.4354
chr1	166072727	.	A	T	.	PASS	CSQ=149297|protein_coding||intron_variant|||||||NM_001017961.4:c.264-1964T>A||MODIFIER||||||FAM78B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	67,82:149:0.5503
chr1	166282757	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	158,0:158:0	73,75:148:0.5068
chr1	166299773	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs754673952||0.000184097|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	67,66:133:0.4962
chr1	166345975	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	89,75:164:0.4573
chr1	166572055	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	68,63:131:0.4809
chr1	166603807	.	C	CA	.	PASS	CSQ=116123|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||FMO9P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	103,0:103:0	71,71:142:0.5
chr1	166659869	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	73,75:148:0.5068
chr1	167158097	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	77,55:132:0.4167
chr1	167438316	.	G	A	.	PASS	CSQ=919|protein_coding||intron_variant|||||||NM_198053.2:c.300+254C>T||MODIFIER||||||CD247|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	120,14:134:0.1045
chr1	168350776	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	59,90:149:0.604
chr1	169689615	.	TG	AC	.	PASS	CSQ=6402|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SELL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	79,0:79:0	48,57:105:0.5429
chr1	170092097	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs768018474|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	90,58:148:0.3919
chr1	170116341	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	59,100:159:0.6289
chr1	170577967	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,1:140:0.0071	76,68:144:0.4722
chr1	171072650	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1282027415||6.57151e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	52,59:111:0.5315
chr1	171387922	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	77,58:135:0.4296
chr1	171791199	.	C	T	.	PASS	CSQ=51603|protein_coding||intron_variant|||||||NM_015935.5:c.1474+583C>T||MODIFIER||||||METTL13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	62,77:139:0.554
chr1	172157613	.	A	T	.	PASS	CSQ=26052|protein_coding||intron_variant|||||||NM_015569.5:c.1659+26325A>T||MODIFIER||||||DNM3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	146,5:151:0.0331
chr1	173083694	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	132,0:132:0	89,73:162:0.4506
chr1	173236292	.	TCCTTG	T	.	PASS	CSQ=100506023|lncRNA||non_coding_transcript_exon_variant|||||||NR_037845.1:n.4382_4386del||MODIFIER||||||LOC100506023|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	90,0:90:0	43,65:108:0.6019
chr1	173295441	.	C	G	.	PASS	CSQ=100506023|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037845.1:n.656-55418G>C||MODIFIER||||||LOC100506023|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	63,82:145:0.5655
chr1	173328515	.	T	TA	.	PASS	CSQ=100506023|lncRNA||intron_variant&non_coding_transcript_variant||||rs1342256980|||NR_037845.1:n.656-88493dup||MODIFIER||||||LOC100506023|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	62,48:111:0.4324
chr1	173418805	.	G	C	.	PASS	CSQ=100506023|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037845.1:n.655+43519C>G||MODIFIER||||||LOC100506023|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	87,71:158:0.4494
chr1	173454453	.	T	A	.	PASS	CSQ=100506023|lncRNA||intron_variant&non_coding_transcript_variant||||||6.57212e-06|NR_037845.1:n.655+7871A>T||MODIFIER||||||LOC100506023|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	80,56:136:0.4118
chr1	173577321	.	C	A	.	PASS	CSQ=284525|protein_coding||intron_variant|||||||NM_178527.4:c.803-561G>T||MODIFIER||||||SLC9C2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	58,85:143:0.5944
chr1	174623028	.	C	T	.	PASS	CSQ=9910|protein_coding||intron_variant|||||||NM_001366446.1:c.1711-14347C>T||MODIFIER||||||RABGAP1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	54,86:140:0.6143
chr1	174773034	.	T	A	.	PASS	CSQ=9910|protein_coding||intron_variant|||||||NM_001366446.1:c.2211+20680T>A||MODIFIER||||||RABGAP1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	60,87:147:0.5918
chr1	174975964	.	C	T	.	PASS	CSQ=9910|protein_coding||intron_variant|||||||NM_001366446.1:c.2545-114C>T||MODIFIER||||||RABGAP1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	66,64:130:0.4923
chr1	174977495	.	G	A	.	PASS	CSQ=9910|protein_coding||intron_variant|||||||NM_001366446.1:c.2650-1312G>A||MODIFIER||||||RABGAP1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	117,17:134:0.1269
chr1	175145875	.	G	T	.	PASS	CSQ=63923|protein_coding||intron_variant|||||||NM_022093.1:c.3760-1056G>T||MODIFIER||||||TNN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	77,52:129:0.4031
chr1	175153091	.	T	C	.	PASS	CSQ=9674|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||KIAA0040|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	75,52:127:0.4094
chr1	175158078	.	G	C	.	PASS	CSQ=9674|protein_coding||3_prime_UTR_variant|||||||NM_014656.3:c.*2636C>G||MODIFIER||||||KIAA0040|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	76,77:153:0.5033
chr1	175168166	.	G	T	.	PASS	CSQ=9674|protein_coding||intron_variant|||||||NM_014656.3:c.-309-1429C>A||MODIFIER||||||KIAA0040|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	70,57:127:0.4488
chr1	175174065	.	C	A	.	PASS	CSQ=9674|protein_coding||intron_variant|||||||NM_014656.3:c.-310+3546G>T||MODIFIER||||||KIAA0040|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	71,42:113:0.3717
chr1	175179672	.	C	A	.	PASS	CSQ=9674|protein_coding||intron_variant|||||||NM_014656.3:c.-383-1988G>T||MODIFIER||||||KIAA0040|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	84,50:134:0.3731
chr1	175234089	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	60,70:130:0.5385
chr1	175300703	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	64,89:153:0.5817
chr1	175314147	.	T	A	.	PASS	CSQ=7143|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TNR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	58,80:138:0.5797
chr1	175448746	.	G	A	.	PASS	CSQ=7143|protein_coding||intron_variant||||rs185360668||9.19939e-05|NM_003285.3:c.-63-41969C>T||MODIFIER||||||TNR|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	71,46:117:0.3932
chr1	175464696	.	C	A	.	PASS	CSQ=7143|protein_coding||intron_variant|||||||NM_003285.3:c.-63-57919G>T||MODIFIER||||||TNR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	69,48:117:0.4103
chr1	175675111	.	G	T	.	PASS	CSQ=7143|protein_coding||intron_variant|||||||NM_003285.3:c.-165+68115C>A||MODIFIER||||||TNR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	57,70:127:0.5512
chr1	175757760	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	94,83:177:0.4689
chr1	175981491	.	G	A	.	PASS	CSQ=64326|protein_coding||intron_variant|||||||NM_022457.7:c.2133+5452C>T||MODIFIER||||||COP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	152,8:160:0.05
chr1	176030142	.	G	C	.	PASS	CSQ=64326|protein_coding||intron_variant|||||||NM_022457.7:c.1613-2454C>G||MODIFIER||||||COP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	70,56:126:0.4444
chr1	176049875	.	C	T	.	PASS	CSQ=64326|protein_coding||intron_variant|||||||NM_022457.7:c.1278-3551G>A||MODIFIER||||||COP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	54,67:121:0.5537
chr1	176050154	.	C	G	.	PASS	CSQ=64326|protein_coding||intron_variant|||||||NM_022457.7:c.1278-3830G>C||MODIFIER||||||COP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	56,68:124:0.5484
chr1	176050358	.	C	T	.	PASS	CSQ=64326|protein_coding||intron_variant|||||||NM_022457.7:c.1278-4034G>A||MODIFIER||||||COP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	51,68:119:0.5714
chr1	176262278	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1324872354||1.31653e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	50,68:118:0.5763
chr1	176499203	.	G	A	.	PASS	CSQ=60676|protein_coding||intron_variant|||||||NM_020318.3:c.-917+35785G>A||MODIFIER||||||PAPPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	58,62:120:0.5167
chr1	176550260	COSV106530545;COSV106530545;COSV106530545	C	T	.	PASS	CSQ=60676|protein_coding||intron_variant|COSV106530545&COSV106530545|p.?&p.?|COSV106530545||||NM_020318.3:c.-916-5147C>T||MODIFIER||||||PAPPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	70,77:147:0.5238
chr1	176587137	.	G	GT	.	PASS	CSQ=60676|protein_coding||intron_variant||||rs1365218219|||NM_020318.3:c.920-7377dup||MODIFIER||||||PAPPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	67,45:113:0.3982
chr1	176594433	.	C	A	.	PASS	CSQ=60676|protein_coding||intron_variant|||||||NM_020318.3:c.920-91C>A||MODIFIER||||||PAPPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	136,0:136:0	77,60:137:0.438
chr1	176599272	.	G	T	.	PASS	CSQ=60676|protein_coding||intron_variant|||||||NM_020318.3:c.1991+3677G>T||MODIFIER||||||PAPPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	64,58:122:0.4754
chr1	176783170	.	G	A	.	PASS	CSQ=60676|protein_coding||intron_variant|||||||NM_020318.3:c.4716-6639G>A||MODIFIER||||||PAPPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	132,6:138:0.0435
chr1	176904680	.	G	A	.	PASS	CSQ=460|protein_coding||intron_variant|||||||NM_004319.3:c.2672-9850C>T||MODIFIER||||||ASTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	66,47:113:0.4159
chr1	176966469	.	G	T	.	PASS	CSQ=460|protein_coding||intron_variant|||||||NM_004319.3:c.1524-1232C>A||MODIFIER||||||ASTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	133,0:133:0	129,6:135:0.0444
chr1	176975148	COSV56077360;COSV56077360;COSV56077360;COSV56077360	T	A	.	PASS	CSQ=460|protein_coding||intron_variant|COSV56077360&COSV56077360&COSV56077360|p.?&p.?&p.?|COSV56077360||||NM_004319.3:c.1524-9911A>T||MODIFIER||||||ASTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	60,74:134:0.5522
chr1	176983460	.	C	T	.	PASS	CSQ=460|protein_coding||intron_variant|||||||NM_004319.3:c.1524-18223G>A||MODIFIER||||||ASTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	81,55:137:0.4015
chr1	176987342	.	G	T	.	PASS	CSQ=460|protein_coding||intron_variant|||||||NM_004319.3:c.1524-22105C>A||MODIFIER||||||ASTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	74,62:136:0.4559
chr1	177042299	.	G	C	.	PASS	CSQ=460|protein_coding||intron_variant|||||||NM_004319.3:c.472-9450C>G||MODIFIER||||||ASTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	62,85:147:0.5782
chr1	177072949	COSV56085919;COSV56085919;COSV56085919	G	GA	.	PASS	CSQ=460|protein_coding||intron_variant|COSV56085919&COSV56085919&COSV56085919|p.?&p.?&p.?||rs1034534079||6.73473e-05|NM_004319.3:c.284-11685dup||MODIFIER||||||ASTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	74,51:126:0.4048
chr1	177095783	.	A	G	.	PASS	CSQ=460|protein_coding||intron_variant|||||||NM_004319.3:c.284-34518T>C||MODIFIER||||||ASTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	69,56:126:0.4444
chr1	177502092	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1199190974||2.00238e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	53,56:109:0.5138
chr1	177874958	.	G	GTA	.	PASS	CSQ=|||intergenic_variant||||rs150555219||0.00640043|||MODIFIER||||||||0.0218;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	91,73:165:0.4424
chr1	178220059	.	C	G	.	PASS	CSQ=9462|protein_coding||intron_variant|||||||NM_170692.2:c.203-63505C>G||MODIFIER||||||RASAL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	55,67:122:0.5492
chr1	178446711	.	G	T	.	PASS	CSQ=9462|protein_coding||intron_variant|||||||NM_170692.2:c.1627+1049G>T||MODIFIER||||||RASAL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	67,92:159:0.5786
chr1	178546367	.	A	T	.	PASS	CSQ=400798|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033186.1:n.781+464A>T||MODIFIER||||||C1orf220|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	49,77:126:0.6111
chr1	178576056	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	119,16:135:0.1185
chr1	178675534	.	A	T	.	PASS	CSQ=100616328|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR4424|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	72,80:152:0.5263
chr1	178933669	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	47,66:113:0.5841
chr1	179479172	.	G	A	.	PASS	CSQ=126859|protein_coding||intron_variant|||||||NM_144696.6:c.1998-3956G>A||MODIFIER||||||AXDND1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	65,77:142:0.5423
chr1	180433629	.	G	A	.	PASS	CSQ=100423032|miRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR3121|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	80,57:137:0.4161
chr1	180971525	.	C	T	.	PASS	CSQ=10228|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||STX6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	72,81:153:0.5294
chr1	181432374	.	T	A	.	PASS	CSQ=|||intergenic_variant||||||6.57333e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	55,95:150:0.6333
chr1	181688414	.	T	G	.	PASS	CSQ=777|protein_coding||intron_variant|||||||NM_001205293.3:c.1056-22540T>G||MODIFIER||||||CACNA1E|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	86,59:145:0.4069
chr1	181700994	.	A	G	.	PASS	CSQ=777|protein_coding||intron_variant|||||||NM_001205293.3:c.1056-9960A>G||MODIFIER||||||CACNA1E|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	82,69:151:0.457
chr1	181763130	.	C	A	.	PASS	CSQ=777|protein_coding||intron_variant|||||||NM_001205293.3:c.4690-276C>A||MODIFIER||||||CACNA1E|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	99,54:153:0.3529
chr1	181911226	.	CT	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	116,0:116:0	67,48:115:0.4174
chr1	181960945	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1425446923||6.5864e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	35,57:92:0.6196
chr1	182020606	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	94,61:155:0.3935
chr1	182168386	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	68,71:139:0.5108
chr1	182170892	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	72,79:151:0.5232
chr1	182656864	.	C	A	.	PASS	CSQ=85397|protein_coding||intron_variant|||||||NM_001102450.2:c.194-8561G>T||MODIFIER||||||RGS8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	61,78:139:0.5612
chr1	182787802	.	G	C	.	PASS	CSQ=80896|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NPL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	53,71:124:0.5726
chr1	183094528	.	G	A	.	PASS	CSQ=3915|protein_coding||intron_variant|||||||NM_002293.4:c.419-8800G>A||MODIFIER||||||LAMC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	83,69:152:0.4539
chr1	183123870	.	GG	TT	.	PASS	CSQ=3915|protein_coding||intron_variant|||||||NM_002293.4:c.2402-761_2402-760delinsTT||MODIFIER||||||LAMC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	118,0:118:0	61,83:144:0.5764
chr1	183281111	.	C	T	.	PASS	CSQ=23057|protein_coding||intron_variant|||||||NM_015039.4:c.575-2482G>A||MODIFIER||||||NMNAT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	66,81:147:0.551
chr1	183451358	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	68,61:129:0.4729
chr1	183453652	.	TATTTATGAGTCTGTC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	138,0:138:0.007082	145,6:151:0.047
chr1	183569461	.	G	A	.	PASS	CSQ=4688|protein_coding||intron_variant|||||||NM_000433.3:c.670-276C>T||MODIFIER||||||NCF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	144,13:157:0.0828
chr1	184141993	COSV58327327	G	GT	.	PASS	CSQ=|||intergenic_variant|||COSV58327327|rs1483145857||0.000211985|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,1:107:0.0093	84,42:126:0.3333
chr1	184172447	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	65,70:135:0.5185
chr1	184337944	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	68,48:116:0.4138
chr1	184505253	.	C	G	.	PASS	CSQ=81563|protein_coding||intron_variant|||||||NM_030806.4:c.95-2335C>G||MODIFIER||||||C1orf21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	70,0:70:0	51,47:98:0.4796
chr1	184839817	.	G	T	.	PASS	CSQ=116496|protein_coding||intron_variant|||||||NM_052966.4:c.602-7855C>A||MODIFIER||||||FAM129A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	79,60:139:0.4317
chr1	184880590	.	T	A	.	PASS	CSQ=116496|protein_coding||intron_variant|||||||NM_052966.4:c.601+4043A>T||MODIFIER||||||FAM129A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	85,52:137:0.3796
chr1	185134173	.	T	A	.	PASS	CSQ=81627|protein_coding||intron_variant|||||||NM_030934.5:c.1513+3433A>T||MODIFIER||||||TRMT1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,1:119:0.0084	77,65:142:0.4577
chr1	186013658	.	A	C	.	PASS	CSQ=83872|protein_coding||intron_variant|||||||NM_031935.3:c.4631-1501A>C||MODIFIER||||||HMCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	70,60:130:0.4615
chr1	186033043	.	G	T	.	PASS	CSQ=83872|protein_coding||intron_variant|||||||NM_031935.3:c.5750-4891G>T||MODIFIER||||||HMCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	72,67:139:0.482
chr1	186052309	.	G	C	.	PASS	CSQ=83872|protein_coding||intron_variant|||||||NM_031935.3:c.6578-643G>C||MODIFIER||||||HMCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	126,8:134:0.0597
chr1	186070915	COSV54912259	C	A	.	PASS	CSQ=83872|protein_coding||intron_variant|COSV54912259|p.?||rs909494867||6.59744e-06|NM_031935.3:c.8139+158C>A||MODIFIER||||||HMCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,1:129:0.0078	80,68:148:0.4595
chr1	186515179	.	GG	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	128,0:128:0	75,45:120:0.375
chr1	186688269	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	53,85:138:0.6159
chr1	187005064	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	68,72:140:0.5143
chr1	187042488	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	71,53:124:0.4274
chr1	187251147	.	C	T	.	PASS	CSQ=104169671|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126347.1:n.106-52319C>T||MODIFIER||||||LINC01036|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	67,58:125:0.464
chr1	187465958	.	G	A	.	PASS	CSQ=106144535|lncRNA||intron_variant&non_coding_transcript_variant||||||6.57125e-06|NR_132374.1:n.100-4113G>A||MODIFIER||||||LINC01037|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	83,57:140:0.4071
chr1	187494097	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	57,62:119:0.521
chr1	187543028	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	45,79:124:0.6371
chr1	187570512	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	78,64:142:0.4507
chr1	187793417	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	66,46:112:0.4107
chr1	187827390	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	55,94:149:0.6309
chr1	187905042	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1007692914||6.58918e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	81,51:133:0.3835
chr1	187943765	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	128,19:147:0.1293
chr1	188093053	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs895808988||3.94477e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	48,74:122:0.6066
chr1	188235955	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	65,36:101:0.3564
chr1	188341798	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	51,41:92:0.4457
chr1	188429377	.	GCCAGA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	45,52:97:0.5361
chr1	188503089	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	62,94:156:0.6026
chr1	188589361	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1195975379||6.58683e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	46,68:114:0.5965
chr1	188616667	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	69,73:142:0.5141
chr1	188773747	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	66,43:109:0.3945
chr1	188822275	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	68,62:130:0.4769
chr1	188872163	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	109,21:130:0.1615
chr1	188982519	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	54,76:130:0.5846
chr1	189044489	COSV61840651	GA	G	.	PASS	CSQ=|||intergenic_variant|||COSV61840651|rs1017574880||0.000195436|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:83:0	72,50:122:0.4098
chr1	189073770	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	78,54:132:0.4091
chr1	189247815	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	65,77:142:0.5423
chr1	189288825	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	73,51:124:0.4113
chr1	189300349	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	46,79:125:0.632
chr1	189338648	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	71,43:114:0.3772
chr1	189360320	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs966183996|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	71,65:136:0.4779
chr1	189361013	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:98:0	42,50:92:0.5435
chr1	189416612	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	40,64:104:0.6154
chr1	189476371	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	44,82:127:0.6457
chr1	189511378	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1167349157||1.3165e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:128:0	73,41:114:0.3596
chr1	189605203	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1030007665||6.57955e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	82,63:145:0.4345
chr1	189665350	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	42,56:98:0.5714
chr1	189671855	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	72,48:120:0.4
chr1	189870594	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1407144592||1.46783e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	68,39:107:0.3645
chr1	189890725	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs184092758|||||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	74,61:135:0.4519
chr1	189964948	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	54,68:122:0.5574
chr1	190217020	.	C	T	.	PASS	CSQ=339479|protein_coding||intron_variant||||rs982579099||6.58233e-06|NM_199051.3:c.961+9062G>A||MODIFIER||||||BRINP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	73,56:129:0.4341
chr1	190504768	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs555691865||1.9727e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	84,57:141:0.4043
chr1	190514351	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs917034359||5.26357e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	63,80:143:0.5594
chr1	190566225	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	64,42:106:0.3962
chr1	190746695	.	G	T	.	PASS	CSQ=440704|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033922.1:n.217+8185G>T||MODIFIER||||||LINC01720|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	54,66:120:0.55
chr1	190748347	.	G	A	.	PASS	CSQ=440704|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033922.1:n.217+9837G>A||MODIFIER||||||LINC01720|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	55,56:111:0.5045
chr1	190829318	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	70,68:138:0.4928
chr1	190841720	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	77,46:123:0.374
chr1	190874357	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	86,58:144:0.4028
chr1	190953953	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	61,80:141:0.5674
chr1	190967032	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	71,52:123:0.4228
chr1	191321819	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	49,53:102:0.5196
chr1	191626480	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	46,67:113:0.5929
chr1	191688447	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	86,58:144:0.4028
chr1	191782039	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	71,53:124:0.4274
chr1	191879758	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	87,54:141:0.383
chr1	191996785	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs918477095||0.000436766|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	74,41:115:0.3565
chr1	192102571	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	54,67:121:0.5537
chr1	192214768	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:124:0.0081	51,85:136:0.625
chr1	192264765	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1187361132||0.000388153|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	65,43:108:0.3981
chr1	192345179	.	GCTTTTGGATTA	G	.	PASS	CSQ=431704|protein_coding||intron_variant|||||||NM_001039152.3:c.11+2133_12-2123del||MODIFIER||||||RGS21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	74,55:129:0.4264
chr1	192705413	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	54,101:156:0.6474
chr1	192765180	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	80,60:140:0.4286
chr1	193269272	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	138,9:147:0.0612
chr1	193338491	.	C	T	.	PASS	CSQ=101929184|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125789.1:n.195-10642C>T||MODIFIER||||||LINC01031|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	89,68:157:0.4331
chr1	193741882	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	133,5:138:0.0362
chr1	194243538	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	108,23:131:0.1756
chr1	194308287	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	53,87:140:0.6214
chr1	194321457	COSV65485762	A	G	.	PASS	CSQ=|||intergenic_variant|||COSV65485762|rs920950677||0.00112422|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	69,46:115:0.4
chr1	194326161	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	42,64:106:0.6038
chr1	194329678	.	A	ATGATGG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	111,11:122:0.0902
chr1	194528480	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	74,60:134:0.4478
chr1	194738812	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	78,54:132:0.4091
chr1	194893112	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs919073346||0.00018107|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	118,11:129:0.0853
chr1	194969734	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	81,45:126:0.3571
chr1	195113630	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||0.00034096|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	64,4:68:0.0588	73,70:143:0.4895
chr1	195141085	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	64,63:127:0.4961
chr1	195511253	COSV62807567	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV62807567||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	54,72:126:0.5714
chr1	195662594	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1344307623||1.31582e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	44,54:98:0.551
chr1	196192163	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	55,75:130:0.5769
chr1	196404146	.	G	GT	.	PASS	CSQ=343450|protein_coding||intron_variant|||||||NM_001287819.2:c.1186-5476dup||MODIFIER||||||KCNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	49,75:124:0.6048
chr1	196575170	.	A	T	.	PASS	CSQ=343450|protein_coding||intron_variant|||||||NM_001287819.2:c.95+33045T>A||MODIFIER||||||KCNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	69,64:133:0.4812
chr1	196609243	.	C	T	.	PASS	CSQ=343450|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||KCNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	84,62:146:0.4247
chr1	196669236	.	A	T	.	PASS	CSQ=3075|protein_coding||intron_variant|||||||NM_000186.3:c.59-3742A>T||MODIFIER||||||CFH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	62,78:140:0.5571
chr1	196823568	.	T	A	.	PASS	CSQ=3078|protein_coding||intron_variant|||||||NM_002113.2:c.59-1909T>A||MODIFIER||||||CFHR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	128,11:139:0.0791
chr1	197277706	.	G	C	.	PASS	CSQ=23418|protein_coding||intron_variant|||||||NM_201253.3:c.70+9224G>C||MODIFIER||||||CRB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	92,53:145:0.3655
chr1	197521974	.	T	A	.	PASS	CSQ=163486|protein_coding||intron_variant|||||||NM_001195215.2:c.1516-9021A>T||MODIFIER||||||DENND1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	82,50:132:0.3788
chr1	197776611	.	G	T	.	PASS	CSQ=163486|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||DENND1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	53,76:129:0.5891
chr1	197957324	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	55,81:136:0.5956
chr1	198046452	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	59,70:129:0.5426
chr1	198265289	.	TAA	T	.	PASS	CSQ=140609|protein_coding||intron_variant|||||||NM_133494.3:c.372+1056_372+1057del||MODIFIER||||||NEK7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	72,84:156:0.5385
chr1	198543577	.	C	A	.	PASS	CSQ=127124|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ATP6V1G3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	58,86:144:0.5972
chr1	198806823	.	T	G	.	PASS	CSQ=100131234|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR181A1HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	64,98:162:0.6049
chr1	198991969	.	C	T	.	PASS	CSQ=102800316|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01222|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	69,88:157:0.5605
chr1	199232187	.	T	C	.	PASS	CSQ=400800|lncRNA||intron_variant&non_coding_transcript_variant||||rs1401414308|||NR_147896.1:n.309+69617T>C||MODIFIER||||||LOC400800|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	80,58:138:0.4203
chr1	199234019	.	T	G	.	PASS	CSQ=400800|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147896.1:n.309+71449T>G||MODIFIER||||||LOC400800|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	56,84:140:0.6
chr1	199867273	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1449602819||0.0107968|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	57,49:108:0.4537
chr1	200191809	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	63,48:111:0.4324
chr1	200231167	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	60,91:151:0.6026
chr1	200689812	.	C	T	.	PASS	CSQ=101929224|lncRNA||intron_variant&non_coding_transcript_variant||||rs531761727||6.57722e-06|NR_110787.1:n.117-497C>T||MODIFIER||||||LOC101929224|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	159,19:178:0.1067
chr1	200899209	.	TC	T	.	PASS	CSQ=55765|protein_coding||intron_variant|||||||NM_001142569.3:c.56-261del||MODIFIER||||||INAVA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	105,46:151:0.3046
chr1	200965389	.	C	A	.	PASS	CSQ=23046|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||KIF21B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	78,69:147:0.4694
chr1	201403964	.	G	T	.	PASS	CSQ=3898|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||LAD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	126,0:126:0	77,63:140:0.45
chr1	202022806	.	CTGCCTTCT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	63,67:130:0.5154
chr1	203257004	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	68,83:151:0.5497
chr1	203387604	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1201965569||4.60435e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	66,71:138:0.5145
chr1	203418468	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	75,63:138:0.4565
chr1	204131792	.	G	T	.	PASS	CSQ=55224|protein_coding||3_prime_UTR_variant|||||||NM_018208.4:c.*392C>A||MODIFIER||||||ETNK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	93,98:191:0.5131
chr1	204299060	.	G	C	.	PASS	CSQ=22874|protein_coding||intron_variant|||||||NM_014935.5:c.-94-24251C>G||MODIFIER||||||PLEKHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	98,67:165:0.4061
chr1	205176800	.	C	T	.	PASS	CSQ=25778|protein_coding||intron_variant|||||||NM_015375.3:c.655-6968G>A||MODIFIER||||||DSTYK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	79,59:138:0.4275
chr1	205324760	.	G	A	.	PASS	CSQ=81788|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NUAK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	69,82:151:0.543
chr1	205504848	.	G	A	.	PASS	CSQ=5129|protein_coding||5_prime_UTR_variant|||||||NM_002596.3:c.-52G>A||MODIFIER||||||CDK18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	103,65:168:0.3869
chr1	206042347	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	44,66:110:0.6
chr1	206478355	.	G	A	.	PASS	CSQ=9641|protein_coding||intron_variant|||||||NM_014002.4:c.992+16G>A||MODIFIER||||||IKBKE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	112,0:112:0	57,79:136:0.5809
chr1	206964196	.	TTCTC	T	.	PASS	CSQ=83953|protein_coding||intron_variant|||||||NM_001170631.2:c.313+1515_313+1518del||MODIFIER||||||FCAMR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	56,50:106:0.4717
chr1	206998455	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	96,78:174:0.4483
chr1	207040032	.	T	TG	.	PASS	CSQ=55432|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||YOD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	123,6:129:0.0465
chr1	207067372	.	G	A	.	PASS	CSQ=5208|protein_coding||intron_variant|||||||NM_006212.2:c.633-127G>A||MODIFIER||||||PFKFB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	129,0:129:0	90,76:167:0.4551
chr1	207139723	.	C	T	.	PASS	CSQ=722|protein_coding||intron_variant|||||||NM_000715.4:c.1274-1383C>T||MODIFIER||||||C4BPA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	82,66:148:0.4459
chr1	207244872	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	58,84:142:0.5915
chr1	207850168	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	76,75:151:0.4967
chr1	208582785	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	49,56:105:0.5333
chr1	208769060	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs576260328||1.31456e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	74,78:152:0.5132
chr1	208927295	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs925397610||7.24418e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	63,43:106:0.4057
chr1	208929637	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	88,58:146:0.3973
chr1	208961596	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	78,62:140:0.4429
chr1	208961831	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	61,71:132:0.5379
chr1	209196274	.	G	C	.	PASS	CSQ=|||intergenic_variant||||||1.31446e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	86,46:132:0.3485
chr1	209384722	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	128,36:164:0.2195
chr1	209441994	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	75,73:148:0.4932
chr1	209592183	COSV50521189;COSV50521189	G	GA	.	PASS	CSQ=57172|protein_coding||intron_variant|COSV50521189&COSV50521189|p.?&p.?||rs900035886||6.61061e-06|NM_020439.3:c.-29-2764dup||MODIFIER||||||CAMK1G|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	66,71:137:0.5182
chr1	209901315	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	73,79:152:0.5197
chr1	209953370	.	G	C	.	PASS	CSQ=255928|protein_coding||intron_variant|||||||NM_153262.3:c.61+614G>C||MODIFIER||||||SYT14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	85,79:164:0.4817
chr1	209963117	.	T	G	.	PASS	CSQ=255928|protein_coding||intron_variant|||||||NM_153262.3:c.61+10361T>G||MODIFIER||||||SYT14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	60,85:145:0.5862
chr1	210032097	.	C	T	.	PASS	CSQ=255928|protein_coding||intron_variant|||||||NM_153262.3:c.442+10843C>T||MODIFIER||||||SYT14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	135,7:142:0.0493
chr1	210191981	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	112,0:112:0	73,79:152:0.5197
chr1	210333844	.	A	G	.	PASS	CSQ=55733|protein_coding||intron_variant|||||||NM_018194.6:c.-44+4740A>G||MODIFIER||||||HHAT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	61,47:108:0.4352
chr1	210652728	.	C	G	.	PASS	CSQ=55733|protein_coding||intron_variant|||||||NM_018194.6:c.1391-21560C>G||MODIFIER||||||HHAT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	53,109:162:0.6728
chr1	210734455	.	A	G	.	PASS	CSQ=3756|protein_coding||intron_variant|||||||NM_172362.3:c.2112+40893T>C||MODIFIER||||||KCNH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	76,75:151:0.4967
chr1	210766147	.	TG	T	.	PASS	CSQ=3756|protein_coding||intron_variant|||||||NM_172362.3:c.2112+9200del||MODIFIER||||||KCNH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	141,14:155:0.0903
chr1	210772973	.	GT	G	.	PASS	CSQ=3756|protein_coding||intron_variant||||rs962075503||0.000132844|NM_172362.3:c.2112+2374del||MODIFIER||||||KCNH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	76,79:155:0.5097
chr1	210954464	.	C	T	.	PASS	CSQ=3756|protein_coding||intron_variant||||rs1485613865||6.57082e-06|NM_172362.3:c.1033-34395G>A||MODIFIER||||||KCNH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	82,67:149:0.4497
chr1	210963213	.	T	TA	.	PASS	CSQ=3756|protein_coding||intron_variant||||rs1244848821||0.00193316|NM_172362.3:c.1033-43145dup||MODIFIER||||||KCNH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	86,52:138:0.3768
chr1	211118802	.	C	T	.	PASS	CSQ=3756|protein_coding||intron_variant||||rs565974812||1.974e-05|NM_172362.3:c.80-11425G>A||MODIFIER||||||KCNH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	52,60:112:0.5357
chr1	211179663	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.57022e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	132,5:137:0.0365
chr1	211566155	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs201915991||0.0119249|||MODIFIER||||||||0.0369;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	78,51:130:0.3923
chr1	211712149	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	52,95:147:0.6463
chr1	211855678	.	C	T	.	PASS	CSQ=102723727|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC102723727|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	62,87:149:0.5839
chr1	211889183	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	73,86:159:0.5409
chr1	212404564	.	C	G	.	PASS	CSQ=55248|protein_coding||intron_variant|||||||NM_018252.2:c.133+5861G>C||MODIFIER||||||TMEM206|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	71,86:157:0.5478
chr1	212833110	.	C	T	.	PASS	CSQ=149643|protein_coding||intron_variant|||||||NM_001024601.2:c.277+2763G>A||MODIFIER||||||SPATA45|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	75,85:160:0.5312
chr1	213183972	.	A	G	.	PASS	CSQ=26750|protein_coding||intron_variant||||rs894094894||1.3143e-05|NM_012424.6:c.1044+7480A>G||MODIFIER||||||RPS6KC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	68,55:123:0.4472
chr1	213308661	COSV51353006	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV51353006|rs887868993||1.31518e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	71,70:141:0.4965
chr1	213358595	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	121,11:132:0.0833
chr1	213521880	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs982327625||8.54207e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:134:0	65,80:145:0.5517
chr1	213875825	.	C	T	.	PASS	CSQ=100505832|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037850.2:n.505+18838G>A||MODIFIER||||||PROX1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	66,70:136:0.5147
chr1	213876785	.	C	T	.	PASS	CSQ=100505832|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037850.2:n.505+17878G>A||MODIFIER||||||PROX1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	58,91:149:0.6107
chr1	213921182	.	G	C	.	PASS	CSQ=100861504|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC00538|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	90,64:154:0.4156
chr1	214810517	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	54,117:171:0.6842
chr1	214906872	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	68,83:151:0.5497
chr1	215042116	.	C	T	.	PASS	CSQ=3776|protein_coding||intron_variant|||||||NM_001017424.2:c.34+36161C>T||MODIFIER||||||KCNK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	77,64:141:0.4539
chr1	215288528	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	52,74:126:0.5873
chr1	215436746	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.57168e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	73,78:151:0.5166
chr1	215626405	.	C	T	.	PASS	CSQ=7399|protein_coding||intron_variant|||||||NM_206933.3:c.15520-535G>A||MODIFIER||||||USH2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	65,59:124:0.4758
chr1	215910810	.	C	G	.	PASS	CSQ=7399|protein_coding||intron_variant|||||||NM_206933.3:c.7301-9905G>C||MODIFIER||||||USH2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	66,79:145:0.5448
chr1	216068401	.	C	T	.	PASS	CSQ=7399|protein_coding||intron_variant|||||||NM_206933.3:c.6049+1700G>A||MODIFIER||||||USH2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	61,93:154:0.6039
chr1	216507109	.	C	A	.	PASS	CSQ=2104|protein_coding||stop_gained|||||||NM_001438.4:c.1207G>T|NP_001429.2:p.Glu403Ter|HIGH|.&.&.&.&.&.&.&.&.&.&.&.&.&.||D|.&.&.&.&.&.&.&.&.&.&.&.&.&.|.&.&.&.&.&.&.&.&.&.&.&.&.&.|ESRRG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	62,65:127:0.5118
chr1	216718461	.	C	CA	.	PASS	CSQ=2104|protein_coding||intron_variant|||||||NM_001438.4:c.56+4782dup||MODIFIER||||||ESRRG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	78,58:136:0.4265
chr1	216996034	.	C	CA	.	PASS	CSQ=2104|protein_coding||intron_variant||||rs907013949||0.000386713|NM_001134285.2:c.-229-36350dup||MODIFIER||||||ESRRG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	77,47:125:0.376
chr1	217325655	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	85,61:146:0.4178
chr1	217482529	.	T	C	.	PASS	CSQ=55105|protein_coding||intron_variant|||||||NM_018040.5:c.1277+9151A>G||MODIFIER||||||GPATCH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	55,65:120:0.5417
chr1	217642436	COSV65126074	C	A	.	PASS	CSQ=128153|protein_coding||intron_variant|COSV65126074|p.?|||||NM_138796.4:c.69-6446C>A||MODIFIER||||||SPATA17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	81,58:139:0.4173
chr1	218778748	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	58,63:121:0.5207
chr1	219130109	.	C	A	.	PASS	CSQ=643723|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038845.1:n.492+19830G>T||MODIFIER||||||LYPLAL1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	67,88:155:0.5677
chr1	219379786	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	93,86:179:0.4804
chr1	219591822	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,0:73:0	46,44:91:0.4835
chr1	219655252	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	66,64:130:0.4923
chr1	219757682	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57142e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	84,77:161:0.4783
chr1	219823034	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	72,75:147:0.5102
chr1	219823037	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,70:142:0.493
chr1	219876187	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	56,51:107:0.4766
chr1	220072286	.	C	G	.	PASS	CSQ=10380|protein_coding||intron_variant|||||||NM_006085.6:c.333+564G>C||MODIFIER||||||BPNT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	61,82:143:0.5734
chr1	220473841	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,59:133:0.4436
chr1	220743101	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	49,88:137:0.6423
chr1	220796636	.	C	T	.	PASS	CSQ=64757|protein_coding||splice_region_variant&intron_variant||||rs765403977|4.58749e-06||NM_022746.4:c.450-7C>T||LOW||||||MARC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	84,72:156:0.4615
chr1	220979132	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	91,54:145:0.3724
chr1	222145524	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1481840491||1.97488e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	66,65:131:0.4962
chr1	222225680	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	84,71:155:0.4581
chr1	222378347	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	97,65:162:0.4012
chr1	222477049	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	85,41:126:0.3254
chr1	222480815	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	55,74:129:0.5736
chr1	222733435	.	G	C	.	PASS	CSQ=148362|protein_coding||3_prime_UTR_variant|||||||NM_144695.4:c.*721G>C||MODIFIER||||||BROX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:111:0	91,53:144:0.3681
chr1	222853092	.	G	A	.	PASS	CSQ=84976|protein_coding||intron_variant|||||||NM_032890.4:c.-244+37921G>A||MODIFIER||||||DISP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	97,47:144:0.3264
chr1	223095056	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	123,9:132:0.0682
chr1	223368715	.	C	G	.	PASS	CSQ=55061|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SUSD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	63,88:151:0.5828
chr1	223483912	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	72,89:161:0.5528
chr1	223970857	.	G	C	.	PASS	CSQ=441124|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||rs1323659952||1.31404e-05|NR_132119.1:n.1404+6023C>G||MODIFIER||||||GTF2IP20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,72:151:0.4768
chr1	224141175	.	A	G	.	PASS	CSQ=23219|protein_coding||intron_variant||||rs1371681279||6.86361e-06|NM_015176.4:c.516+6963A>G||MODIFIER||||||FBXO28|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	80,53:134:0.3955
chr1	224165984	.	C	G	.	PASS	CSQ=23219|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FBXO28|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	87,51:138:0.3696
chr1	224183745	.	G	C	.	PASS	CSQ=8560|protein_coding||intron_variant||||rs1310756700||6.56771e-06|NM_003676.4:c.82+327G>C||MODIFIER||||||DEGS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	167,0:167:0	117,93:210:0.4429
chr1	224183750	.	G	T	.	PASS	CSQ=8560|protein_coding||intron_variant|||||||NM_003676.4:c.82+332G>T||MODIFIER||||||DEGS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	165,0:165:0	118,90:208:0.4327
chr1	224324133	.	A	T	.	PASS	CSQ=4931|protein_coding||intron_variant|||||||NM_002533.4:c.131+2258T>A||MODIFIER||||||NVL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	76,68:144:0.4722
chr1	225417714	.	A	ATT	.	PASS	CSQ=3930|protein_coding||intron_variant|||||||NM_002296.4:c.837+268_837+269dup||MODIFIER||||||LBR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	90,48:138:0.3478
chr1	225919134	.	G	T	.	PASS	CSQ=29920|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PYCR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	161,34:195:0.1744
chr1	225957196	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	110,65:175:0.3714
chr1	226127405	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,1:125:0.008	85,87:172:0.5058
chr1	226236712	.	C	A	.	PASS	CSQ=286826|protein_coding||intron_variant|||||||NM_001366245.1:c.1245+2259G>T||MODIFIER||||||LIN9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	80,91:171:0.5322
chr1	226604922	.	G	T	.	PASS	CSQ=375057|protein_coding||3_prime_UTR_variant|||||||NM_001003665.4:c.*2882G>T||MODIFIER||||||STUM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	130,0:130:0	78,91:169:0.5385
chr1	226639977	.	C	T	.	PASS	CSQ=3707|protein_coding||intron_variant|||||||NM_002221.3:c.2452-319G>A||MODIFIER||||||ITPKB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	79,92:171:0.538
chr1	227501057	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	62,91:153:0.5948
chr1	227675515	.	T	C	.	PASS	CSQ=339500|misc_RNA||intron_variant&non_coding_transcript_variant||||rs1218372065||6.56901e-06|NR_102302.2:n.652-1664T>C||MODIFIER||||||ZNF678|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	87,67:154:0.4351
chr1	227728795	.	C	A	.	PASS	CSQ=65094|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||JMJD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	126,0:126:0	86,75:161:0.4658
chr1	227910432	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	130,20:150:0.1333
chr1	227910434	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	129,20:149:0.1342
chr1	228202182	.	C	A	.	PASS	CSQ=574407|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||OBSCN-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	147,8:155:0.0516
chr1	228332075	.	C	A	.	PASS	CSQ=84033|protein_coding||intron_variant|||||||NM_001271223.2:c.18524-785C>A||MODIFIER||||||OBSCN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,1:105:0.0095	83,72:155:0.4645
chr1	228651731	.	C	T	.	PASS	CSQ=574029|transcribed_pseudogene||non_coding_transcript_exon_variant|||||||NR_002834.1:n.1791C>T||MODIFIER||||||DUSP5P1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	105,0:105:0	68,68:136:0.5
chr1	228676723	.	G	A	.	PASS	CSQ=58480|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_037962.1:n.386+31691G>A||MODIFIER||||||RHOU|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	62,81:143:0.5664
chr1	228761885	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	73,88:161:0.5466
chr1	228892754	.	T	TTTTC	.	PASS	CSQ=|||intergenic_variant||||rs1446915564|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	124,0:125:0	66,40:106:0.3774
chr1	229540163	.	G	C	.	PASS	CSQ=23456|protein_coding||intron_variant|||||||NM_012089.3:c.1203+443C>G||MODIFIER||||||ABCB10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	70,87:157:0.5541
chr1	229779055	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	105,74:179:0.4134
chr1	229857905	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	139,8:147:0.0544
chr1	229910854	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	118,10:128:0.0781
chr1	229954816	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	48,69:117:0.5897
chr1	231647800	.	T	C	.	PASS	CSQ=100303453|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_028393.1:n.788+30894T>C||MODIFIER||||||TSNAX-DISC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	59,69:128:0.5391
chr1	231875647	.	G	GT	.	PASS	CSQ=100303453|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_028393.1:n.2647+57133dup||MODIFIER||||||TSNAX-DISC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	64,75:139:0.5396
chr1	232190933	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	88,65:153:0.4248
chr1	232193423	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	63,82:145:0.5655
chr1	232252805	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	66,48:114:0.4211
chr1	232413923	.	C	A	.	PASS	CSQ=57568|protein_coding||intron_variant|||||||NM_020808.4:c.4762+1571G>T||MODIFIER||||||SIPA1L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	53,72:125:0.576
chr1	232433754	.	G	C	.	PASS	CSQ=57568|protein_coding||intron_variant|||||||NM_020808.4:c.4032-1283C>G||MODIFIER||||||SIPA1L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,61:131:0.4656
chr1	232788178	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	84,79:163:0.4847
chr1	232799478	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	56,51:107:0.4766
chr1	232883992	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:120:0	82,63:145:0.4345
chr1	232979914	.	TGGAGCTGGTCAGCCCCA	T	.	PASS	CSQ=84284|protein_coding||3_prime_UTR_variant|||||||NM_032324.3:c.*1685_*1701del||MODIFIER||||||NTPCR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	77,87:164:0.5305
chr1	233199720	.	A	T	.	PASS	CSQ=80003|protein_coding||intron_variant|||||||NM_014801.4:c.2974+434T>A||MODIFIER||||||PCNX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	56,49:105:0.4667
chr1	233340080	.	G	C	.	PASS	CSQ=84451|protein_coding||intron_variant|||||||NM_032435.3:c.806-6362G>C||MODIFIER||||||MAP3K21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	84,56:140:0.4
chr1	233387578	.	C	CA	.	PASS	CSQ=84451|protein_coding||downstream_gene_variant||||rs1469701568||0.000125447|||MODIFIER||||||MAP3K21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,1:136:0.0074	74,89:163:0.546
chr1	233436811	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	78,67:145:0.4621
chr1	233869801	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	91,62:153:0.4052
chr1	234157930	.	T	G	.	PASS	CSQ=148641|protein_coding||intron_variant|||||||NM_173508.4:c.284-73487T>G||MODIFIER||||||SLC35F3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	82,72:154:0.4675
chr1	234679116	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs996013615||4.60127e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	65,92:157:0.586
chr1	235031480	.	TTC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	75,48:123:0.3902
chr1	235464749	.	C	T	.	PASS	CSQ=148789|protein_coding||intron_variant||||rs566571988||9.24312e-05|NM_152490.5:c.841+887G>A||MODIFIER||||||B3GALNT2|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	71,94:165:0.5697
chr1	235464864	.	C	G	.	PASS	CSQ=148789|protein_coding||intron_variant|||||||NM_152490.5:c.841+772G>C||MODIFIER||||||B3GALNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	76,82:158:0.519
chr1	235465571	COSV58357346;COSV58357346	C	G	.	PASS	CSQ=148789|protein_coding||intron_variant|COSV58357346&COSV58357346|p.?&p.?|||||NM_152490.5:c.841+65G>C||MODIFIER||||||B3GALNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:106:0.0094	58,94:152:0.6184
chr1	235465745	.	C	T	.	PASS	CSQ=148789|protein_coding||intron_variant|||||||NM_152490.5:c.763-31G>A||MODIFIER||||||B3GALNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	100,0:100:0	46,87:133:0.6541
chr1	235466162	.	C	T	.	PASS	CSQ=148789|protein_coding||intron_variant|||||||NM_152490.5:c.763-448G>A||MODIFIER||||||B3GALNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	70,97:167:0.5808
chr1	235467506	.	C	T	.	PASS	CSQ=148789|protein_coding||intron_variant||||rs758207944|||NM_152490.5:c.763-1792G>A||MODIFIER||||||B3GALNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:102:0	58,70:129:0.5426
chr1	235541500	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.57488e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	111,0:111:0	133,7:140:0.05
chr1	236164786	.	G	A	.	PASS	CSQ=7107|protein_coding||intron_variant|||||||NM_003272.4:c.415-3920G>A||MODIFIER||||||GPR137B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	71,70:141:0.4965
chr1	236472748	.	C	T	.	PASS	CSQ=128178|protein_coding||intron_variant|||||||NM_080738.3:c.235+4472C>T||MODIFIER||||||EDARADD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	57,78:135:0.5778
chr1	236478837	.	C	T	.	PASS	CSQ=128178|protein_coding||intron_variant||||rs1057285398||0.000157691|NM_080738.3:c.236-3430C>T||MODIFIER||||||EDARADD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	54,91:145:0.6276
chr1	236600287	.	C	T	.	PASS	CSQ=55127|protein_coding||intron_variant|||||||NM_018072.6:c.360-663G>A||MODIFIER||||||HEATR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	143,14:157:0.0892
chr1	236844136	.	G	A	.	PASS	CSQ=4548|protein_coding||intron_variant|||||||NM_000254.2:c.1515+5537G>A||MODIFIER||||||MTR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	74,79:153:0.5163
chr1	236974958	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1327813723||2.65442e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:86:0	51,70:121:0.5785
chr1	237098127	.	G	A	.	PASS	CSQ=6262|protein_coding||intron_variant|||||||NM_001035.3:c.48+55558G>A||MODIFIER||||||RYR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:131:0	70,74:144:0.5139
chr1	237118107	.	C	A	.	PASS	CSQ=6262|protein_coding||intron_variant|||||||NM_001035.3:c.48+75538C>A||MODIFIER||||||RYR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	83,58:142:0.4085
chr1	237246298	.	G	A	.	PASS	CSQ=6262|protein_coding||intron_variant|||||||NM_001035.3:c.49-24199G>A||MODIFIER||||||RYR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	116,5:121:0.0413
chr1	237468723	.	G	A	.	PASS	CSQ=100616141|miRNA||upstream_gene_variant||||rs542355814||9.20399e-05|||MODIFIER||||||MIR4428|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	64,93:157:0.5924
chr1	237577488	.	G	T	.	PASS	CSQ=6262|protein_coding||intron_variant||||||6.64443e-06|NM_001035.3:c.3598+8169G>T||MODIFIER||||||RYR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	67,52:119:0.437
chr1	237632137	.	C	T	.	PASS	CSQ=6262|protein_coding||intron_variant|||||||NM_001035.3:c.6555+596C>T||MODIFIER||||||RYR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	119,9:128:0.0703
chr1	237816592	.	G	T	.	PASS	CSQ=6262|protein_coding||intron_variant|||||||NM_001035.3:c.14434-2444G>T||MODIFIER||||||RYR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	67,66:133:0.4962
chr1	237923324	.	G	GT	.	PASS	CSQ=100130331|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||rs201595897||0.0101522|NR_027247.2:n.1554+2016dup||MODIFIER||||||LOC100130331|EntrezGene|0.0118;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	66,70:136:0.5147
chr1	237977816	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,50:117:0.4274
chr1	238133639	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	112,17:129:0.1318
chr1	238437899	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	91,61:152:0.4013
chr1	238601544	.	CC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	113,0:113:0	64,76:140:0.5429
chr1	238723404	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	117,5:122:0.041
chr1	238782877	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	56,70:126:0.5556
chr1	238784428	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	52,72:124:0.5806
chr1	239277623	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	79,46:125:0.368
chr1	240018424	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	80,64:144:0.4444
chr1	240072150	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	58,79:137:0.5766
chr1	240385383	.	C	A	.	PASS	CSQ=56776|protein_coding||intron_variant|||||||NM_020066.5:c.4859-7128C>A||MODIFIER||||||FMN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	80,74:154:0.4805
chr1	240804602	.	T	TA	.	PASS	CSQ=6000|protein_coding||intron_variant||||rs1400302591||2.63144e-05|NM_001282775.2:c.1269+1537dup||MODIFIER||||||RGS7|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/RGS7|y|n|melanoma|||E|||Mis;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	134,0:134:0	155,14:169:0.0828
chr1	240819739	COSV58565355;COSV58565355;COSV58565355;COSV58565355;COSV58565355	C	CA	.	PASS	CSQ=6000|protein_coding||intron_variant|COSV58565355&COSV58565355&COSV58565355&COSV58565355|p.?&p.?&p.?&p.?|COSV58565355|rs201568599||0.000217761|NM_001282775.2:c.685-3325dup||MODIFIER||||||RGS7|EntrezGene|0.0008;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/RGS7|y|n|melanoma|||E|||Mis;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	99,43:142:0.3028
chr1	240919644	.	C	T	.	PASS	CSQ=6000|protein_coding||intron_variant|||||||NM_001282775.2:c.385+11073G>A||MODIFIER||||||RGS7|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/RGS7|y|n|melanoma|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	66,77:143:0.5385
chr1	240962081	.	C	T	.	PASS	CSQ=6000|protein_coding||intron_variant|||||||NM_001282775.2:c.226+20998G>A||MODIFIER||||||RGS7|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/RGS7|y|n|melanoma|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:127:0	95,19:114:0.1667
chr1	241049851	.	T	C	.	PASS	CSQ=6000|protein_coding||intron_variant|||||||NM_001282775.2:c.175+48815A>G||MODIFIER||||||RGS7|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/RGS7|y|n|melanoma|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	77,49:126:0.3889
chr1	241731796	.	G	A	.	PASS	CSQ=128025|protein_coding||intron_variant|||||||NM_001367482.1:c.1195-6567G>A||MODIFIER||||||WDR64|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	88,69:157:0.4395
chr1	242086405	.	C	T	.	PASS	CSQ=200150|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PLD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	71,100:171:0.5848
chr1	242307809	.	T	A	.	PASS	CSQ=200150|protein_coding||intron_variant|||||||NM_152666.2:c.327-19279A>T||MODIFIER||||||PLD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	55,71:126:0.5635
chr1	242525253	.	C	T	.	PASS	CSQ=200150|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PLD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	79,72:152:0.4737
chr1	242528270	.	G	C	.	PASS	CSQ=200150|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PLD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	83,60:143:0.4196
chr1	242529195	.	G	T	.	PASS	CSQ=200150|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PLD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	78,75:153:0.4902
chr1	242529453	.	G	A	.	PASS	CSQ=200150|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PLD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	72,52:124:0.4194
chr1	242529626	.	G	A	.	PASS	CSQ=200150|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PLD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	104,0:104:0	77,54:131:0.4122
chr1	242529670	.	G	A	.	PASS	CSQ=200150|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PLD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	105,0:105:0	69,47:116:0.4052
chr1	242529704	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	70,48:118:0.4068
chr1	242531138	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1262263963||6.56987e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	87,74:161:0.4596
chr1	242532253	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	80,48:128:0.375
chr1	242532768	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	84,66:150:0.44
chr1	242532787	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	71,67:138:0.4855
chr1	242664531	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,1:138:0.0072	67,50:117:0.4274
chr1	242680268	.	G	GCTCGTTCCCA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	77,83:160:0.5188
chr1	243095122	.	C	T	.	PASS	CSQ=731275|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_029401.1:n.601+869G>A||MODIFIER||||||LINC01347|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,1:145:0.0069	77,63:140:0.45
chr1	243269702	.	CC	TT	.	PASS	CSQ=10806|protein_coding||intron_variant|||||||NM_006642.5:c.68-403_68-402delinsTT||MODIFIER||||||SDCCAG8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	102,0:102:0	52,79:131:0.6031
chr1	243571100	.	C	T	.	PASS	CSQ=10000|protein_coding||intron_variant||||rs1029747592||2.63258e-05|NM_005465.5:c.819+1826G>A||MODIFIER||||||AKT3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/AKT3|y|n|GBM|||O||oncogene|A;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	134,8:142:0.0563
chr1	243736438	.	GG	AT	.	PASS	CSQ=10000|protein_coding||intron_variant|||||||NM_005465.5:c.47-40723_47-40722delinsAT||MODIFIER||||||AKT3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/AKT3|y|n|GBM|||O||oncogene|A;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	117,0:118:0	77,80:158:0.5063
chr1	243895361	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	81,67:148:0.4527
chr1	244038915	.	A	AT	.	PASS	CSQ=339529|lncRNA||intron_variant&non_coding_transcript_variant||||rs914031731||0.000997727|NR_033883.1:n.1054-2503dup||MODIFIER||||||LOC339529|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	97,55:153:0.3595
chr1	244140643	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	57,75:132:0.5682
chr1	244263028	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	62,68:130:0.5231
chr1	244379245	.	A	T	.	PASS	CSQ=200159|protein_coding||intron_variant||||rs570412908|||NM_001012970.2:c.325+606A>T||MODIFIER||||||C1orf100|EntrezGene|0.0128;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:106:0.0094	57,66:123:0.5366
chr1	244804350	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	79,77:156:0.4936
chr1	244804367	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	82,74:156:0.4744
chr1	244982583	.	G	A	.	PASS	CSQ=84288|protein_coding||intron_variant|||||||NM_001290327.1:c.-58+12140G>A||MODIFIER||||||EFCAB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	53,76:129:0.5891
chr1	244990210	.	C	T	.	PASS	CSQ=84288|protein_coding||intron_variant|||||||NM_001290327.1:c.-57-11911C>T||MODIFIER||||||EFCAB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	71,81:152:0.5329
chr1	246822423	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1031025098||0.000151224|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	46,68:114:0.5965
chr1	246976877	.	C	A	.	PASS	CSQ=100533111|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037894.1:n.740+2963G>T||MODIFIER||||||ZNF670-ZNF695|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	65,70:135:0.5185
chr1	247018430	.	C	A	.	PASS	CSQ=100533111|lncRNA||intron_variant&non_coding_transcript_variant||||rs983600046||7.23999e-05|NR_037894.1:n.221-18356G>T||MODIFIER||||||ZNF670-ZNF695|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	57,79:136:0.5809
chr1	247072909	.	A	T	.	PASS	CSQ=93474|protein_coding||intron_variant||||rs960818362|||NM_033213.5:c.3+5685T>A||MODIFIER||||||ZNF670|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,49:126:0.3889
chr1	247348020	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.56875e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	86,70:156:0.4487
chr1	247379953	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	59,76:135:0.563
chr1	247731916	.	G	T	.	PASS	CSQ=388761|protein_coding||intron_variant|||||||NM_001355292.1:c.-20+1367C>A||MODIFIER||||||OR14A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	64,79:143:0.5524
chr1	247747024	.	C	T	.	PASS	CSQ=388761|protein_coding||intron_variant||||rs775703347|||NM_001355292.1:c.-434+847G>A||MODIFIER||||||OR14A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	68,79:147:0.5374
chr1	247747385	.	G	A	.	PASS	CSQ=388761|protein_coding||intron_variant||||rs571084601||8.24153e-05|NM_001355292.1:c.-434+486C>T||MODIFIER||||||OR14A2|EntrezGene|0.0010;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	57,65:122:0.5328
chr1	248067758	.	A	G	.	PASS	CSQ=284521|protein_coding||intron_variant||||rs1367652636||3.94125e-05|NM_175911.3:c.-143-30893A>G||MODIFIER||||||OR2L13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	162,0:162:0	52,87:139:0.6259
chr1	248147153	.	A	AT	.	PASS	CSQ=127059|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||OR2M5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	141,0:142:0	109,10:119:0.084
chr1	248174187	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs943502946||6.59057e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	107,14:122:0.1148
chr1	248232685	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	62,65:127:0.5118
chr1	248236794	.	C	CA	.	PASS	CSQ=26245|protein_coding||upstream_gene_variant||||rs1455176980||4.60345e-05|||MODIFIER||||||OR2M4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	76,56:132:0.4242
chr1	248369079	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	84,78:162:0.4815
chr1	248564848	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	60,69:129:0.5349
chr1	248611440	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1171529645||7.03958e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	62,0:62:0	5,49:54:0.9074
chr1	248710376	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,1:116:0.0086	62,44:106:0.4151
chr1	248771254	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	59,70:129:0.5426
chr2	24583	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1046085878||5.25818e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,63:130:0.4846
chr2	126252	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs967040848||0.000133351|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	47,69:116:0.5948
chr2	448563	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	68,72:140:0.5143
chr2	451255	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs557381783||0.0311723|||MODIFIER||||||||0.0331;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	80,66:146:0.4521
chr2	458160	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||1.31392e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	88,80:168:0.4762
chr2	586286	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1024815544|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	75,72:147:0.4898
chr2	696643	.	GC	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	121,0:121:0	69,62:131:0.4733
chr2	722161	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	69,70:139:0.5036
chr2	956285	.	C	T	.	PASS	CSQ=101060391|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC101060391|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	51,58:109:0.5321
chr2	986119	.	T	A	.	PASS	CSQ=54221|protein_coding||intron_variant|||||||NM_018968.4:c.72+35051T>A||MODIFIER||||||SNTG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	64,46:110:0.4182
chr2	1412920	.	G	A	.	PASS	CSQ=7173|protein_coding||upstream_gene_variant||||rs1379390596||6.57281e-06|||MODIFIER||||||TPO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	65,68:133:0.5113
chr2	1744622	.	G	A	.	PASS	CSQ=7837|protein_coding||upstream_gene_variant||||||6.57203e-06|||MODIFIER||||||PXDN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	130,0:130:0	95,109:204:0.5343
chr2	1798429	.	G	A	.	PASS	CSQ=23040|protein_coding||intron_variant|||||||NM_001303052.1:c.3276+3267C>T||MODIFIER||||||MYT1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	75,79:154:0.513
chr2	2231446	.	T	A	.	PASS	CSQ=23040|protein_coding||intron_variant|||||||NM_001303052.1:c.-421+52958A>T||MODIFIER||||||MYT1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,1:113:0.0088	71,70:141:0.4965
chr2	2518086	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	89,66:155:0.4258
chr2	2529348	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	76,53:129:0.4109
chr2	2650804	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs574638815||0.000440199|||MODIFIER||||||||0.0008;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,70:139:0.5036
chr2	2668725	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	82,78:160:0.4875
chr2	2771727	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1343027193||1.31437e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	73,70:143:0.4895
chr2	2895831	.	C	T	.	PASS	CSQ=101927554|lncRNA||non_coding_transcript_exon_variant|||||||NR_110228.1:n.1561G>A||MODIFIER||||||LINC01250|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	87,76:163:0.4663
chr2	3074671	.	G	A	.	PASS	CSQ=101927554|lncRNA||intron_variant&non_coding_transcript_variant||||rs560510787||2.62736e-05|NR_110228.1:n.438+50624C>T||MODIFIER||||||LINC01250|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	164,0:164:0	92,82:174:0.4713
chr2	3198794	.	G	C	.	PASS	CSQ=7260|protein_coding||intron_variant|||||||NM_003310.3:c.517-1777C>G||MODIFIER||||||EIPR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	57,62:119:0.521
chr2	4562571	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,69:138:0.5
chr2	4676830	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	55,49:104:0.4712
chr2	4810659	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57384e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	78,73:151:0.4834
chr2	4866136	.	TGAAAAACAG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	64,65:129:0.5039
chr2	5068257	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	61,64:125:0.512
chr2	5084516	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs963585508||1.97119e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	61,91:152:0.5987
chr2	5185699	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	82,68:150:0.4533
chr2	5249684	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs975195075||1.97104e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	74,78:152:0.5132
chr2	5314558	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs956523979||0.000382082|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	69,45:114:0.3947
chr2	5497157	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	65,85:150:0.5667
chr2	5516694	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	60,68:128:0.5312
chr2	5727037	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	57,63:120:0.525
chr2	5803245	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1219680677|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	70,57:127:0.4488
chr2	5882297	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	66,78:144:0.5417
chr2	6201534	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	68,69:137:0.5036
chr2	6255297	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs532872569||0.0312338|||MODIFIER||||||||0.0399;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,2:128:0.0156	73,51:124:0.4113
chr2	6273389	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,60:127:0.4724
chr2	6273803	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	63,75:138:0.5435
chr2	6275501	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	83,78:161:0.4845
chr2	6275515	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	81,79:160:0.4938
chr2	6740398	.	G	A	.	PASS	CSQ=400941|lncRNA||intron_variant&non_coding_transcript_variant||||rs1040520613||1.31555e-05|NR_038369.1:n.234-3683C>T||MODIFIER||||||LINC00487|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	77,79:156:0.5064
chr2	6759179	.	C	A	.	PASS	CSQ=400941|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038369.1:n.233+10900G>T||MODIFIER||||||LINC00487|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	81,78:159:0.4906
chr2	7207585	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	77,0:77:0	52,39:91:0.4286
chr2	7267950	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	82,65:147:0.4422
chr2	7322519	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs938436768||3.29021e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	46,70:116:0.6034
chr2	7930735	.	C	G	.	PASS	CSQ=339788|lncRNA||intron_variant&non_coding_transcript_variant||||rs1274350586||1.97127e-05|NR_015405.1:n.242-6387G>C||MODIFIER||||||LINC00298|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	83,84:167:0.503
chr2	7938075	.	T	A	.	PASS	CSQ=339788|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_015405.1:n.242-13727A>T||MODIFIER||||||LINC00298|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	77,68:145:0.469
chr2	8654865	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs201338593||0.00423235|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	88,51:140:0.3643
chr2	8783732	.	G	A	.	PASS	CSQ=57498|protein_coding||intron_variant||||rs918841983||8.55038e-05|NM_001348732.1:c.2229+2009C>T||MODIFIER||||||KIDINS220|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	92,82:174:0.4713
chr2	9711082	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	80,86:166:0.5181
chr2	10476958	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs375878230||6.58545e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	95,89:184:0.4837
chr2	10860359	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	75,94:169:0.5562
chr2	11148925	.	G	A	.	PASS	CSQ=130813|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||C2orf50|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	64,70:134:0.5224
chr2	11309759	.	C	G	.	PASS	CSQ=9475|protein_coding||intron_variant|||||||NM_004850.5:c.142-22023G>C||MODIFIER||||||ROCK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	77,94:171:0.5497
chr2	11323755	.	C	T	.	PASS	CSQ=9475|protein_coding||intron_variant|||||||NM_004850.5:c.141+20241G>A||MODIFIER||||||ROCK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	76,79:155:0.5097
chr2	11564491	.	C	T	.	PASS	CSQ=9687|protein_coding||intron_variant|||||||NM_014668.4:c.277+1909C>T||MODIFIER||||||GREB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	125,44:169:0.2604
chr2	11594685	.	T	TTTG	.	PASS	CSQ=9687|protein_coding||intron_variant|||||||NM_014668.4:c.1697-564_1697-563insGTT||MODIFIER||||||GREB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	120,0:120:0	88,43:131:0.3282
chr2	11594688	.	T	G	.	PASS	CSQ=9687|protein_coding||intron_variant||||rs1310071851|||NM_014668.4:c.1697-563T>G||MODIFIER||||||GREB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,3:118:0.0254	70,66:136:0.4853
chr2	11903929	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	95,70:165:0.4242
chr2	11906850	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	75,74:149:0.4966
chr2	12514087	.	C	T	.	PASS	CSQ=100506457|lncRNA||intron_variant&non_coding_transcript_variant||||rs1277798823||1.31959e-05|NR_110196.1:n.425-44119C>T||MODIFIER||||||MIR3681HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:93:0	173,14:187:0.0749
chr2	12700682	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	66,74:140:0.5286
chr2	12730596	.	G	T	.	PASS	CSQ=28951|protein_coding||intron_variant||||rs917805776||6.58241e-06|NM_021643.3:c.563+7044G>T||MODIFIER||||||TRIB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	89,74:163:0.454
chr2	12733028	.	C	G	.	PASS	CSQ=28951|protein_coding||intron_variant|||||||NM_021643.3:c.564-7298C>G||MODIFIER||||||TRIB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	71,59:130:0.4538
chr2	12985003	.	C	G	.	PASS	CSQ=100506474|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038434.1:n.611-3885G>C||MODIFIER||||||LOC100506474|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	91,72:163:0.4417
chr2	13085757	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	83,79:162:0.4877
chr2	13485051	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	74,86:160:0.5375
chr2	13831001	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	76,67:143:0.4685
chr2	13904156	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	67,56:123:0.4553
chr2	13987603	.	CTTTAA	C	.	PASS	CSQ=|||intergenic_variant||||rs1428566495||9.8609e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	84,56:140:0.4
chr2	14259142	.	C	T	.	PASS	CSQ=100499171|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_103814.2:n.252-23192G>A||MODIFIER||||||LINC00276|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	83,76:159:0.478
chr2	14306403	.	G	C	.	PASS	CSQ=100499171|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_103814.2:n.251+10566C>G||MODIFIER||||||LINC00276|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	73,73:146:0.5
chr2	14536324	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	82,73:155:0.471
chr2	14640919	.	TACCAGATTTAGCAAATAAAAATAC	T	.	PASS	CSQ=151354|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FAM84A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	154,0:154:0	105,86:191:0.4503
chr2	14845040	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	55,88:143:0.6154
chr2	14882026	.	AGAG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	93,71:164:0.4329
chr2	14956593	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	72,68:140:0.4857
chr2	14966639	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs962353728||6.57549e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	68,78:146:0.5342
chr2	14967827	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	76,64:140:0.4571
chr2	15733626	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	78,79:157:0.5032
chr2	15828042	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1009310984||2.63199e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	76,77:153:0.5033
chr2	15973369	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	73,62:135:0.4593
chr2	15999673	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	66,63:129:0.4884
chr2	16195293	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	116,18:134:0.1343
chr2	16572393	.	C	A	.	PASS	CSQ=81553|protein_coding||intron_variant|||||||NM_030797.4:c.71-6626G>T||MODIFIER||||||FAM49A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	110,41:151:0.2715
chr2	16627175	.	T	A	.	PASS	CSQ=81553|protein_coding||intron_variant|||||||NM_030797.4:c.-166-3156A>T||MODIFIER||||||FAM49A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,1:129:0.0078	100,69:169:0.4083
chr2	16688978	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	50,71:121:0.5868
chr2	16728707	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	78,76:154:0.4935
chr2	16785586	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	68,89:157:0.5669
chr2	17074481	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	79,80:159:0.5031
chr2	17271292	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	143,8:151:0.053
chr2	17561570	.	A	C	.	PASS	CSQ=7447|protein_coding||intron_variant|||||||NM_003385.4:c.-6+20652A>C||MODIFIER||||||VSNL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	80,80:160:0.5
chr2	17879332	.	C	T	.	PASS	CSQ=3790|protein_coding||intron_variant|||||||NM_002252.5:c.-252+526C>T||MODIFIER||||||KCNS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	80,84:164:0.5122
chr2	18030801	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs931907687||4.75234e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	102,0:102:0	155,13:168:0.0774
chr2	18632760	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,87:166:0.5241
chr2	18642923	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	84,84:168:0.5
chr2	18732592	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs779083281||0.000118655|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	86,84:171:0.4912
chr2	18753950	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	81,81:162:0.5
chr2	18801339	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1432147081||1.97626e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	61,57:118:0.4831
chr2	19669361	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs548479613||5.25942e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	79,89:168:0.5298
chr2	19960503	.	G	T	.	PASS	CSQ=57539|protein_coding||intron_variant||||rs776310407||6.57774e-06|NM_020779.3:c.1255+51C>A||MODIFIER||||||WDR35|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	104,0:104:0	76,70:146:0.4795
chr2	20032831	.	G	A	.	PASS	CSQ=9741|protein_coding||3_prime_UTR_variant|||||||NM_014713.5:c.*374C>T||MODIFIER||||||LAPTM4A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	81,0:81:0	110,44:154:0.2857
chr2	20232599	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	88,80:168:0.4762
chr2	20698859	.	C	G	.	PASS	CSQ=60526|protein_coding||intron_variant|||||||NM_021925.4:c.786+2711G>C||MODIFIER||||||LDAH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	84,73:157:0.465
chr2	20836842	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.58519e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	64,73:137:0.5328
chr2	21182679	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	64,68:132:0.5152
chr2	21262776	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	84,72:156:0.4615
chr2	21298952	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	109,38:147:0.2585
chr2	21484483	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs11419201||0.0109364|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	68,51:119:0.4286
chr2	21675665	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	86,56:142:0.3944
chr2	21678428	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	62,73:135:0.5407
chr2	21810518	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	77,55:133:0.4135
chr2	21854051	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	92,77:169:0.4556
chr2	22101610	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	87,67:154:0.4351
chr2	22230249	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1363292749|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	62,57:119:0.479
chr2	22389856	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs142569686||0.00389126|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	93,0:93:0	108,26:134:0.194
chr2	22467884	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	79,83:162:0.5123
chr2	22481489	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	61,79:140:0.5643
chr2	22617446	.	TAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	77,48:125:0.384
chr2	22685589	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	109,17:126:0.1349
chr2	22729296	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1021035981||6.84444e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	89,85:174:0.4885
chr2	22774869	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	88,72:160:0.45
chr2	22804742	.	T	TG	.	PASS	CSQ=|||intergenic_variant||||rs1318746848||2.64061e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	76,58:134:0.4328
chr2	22918303	.	CA	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	130,0:131:0	68,83:151:0.5497
chr2	23593104	.	TGGGA	T	.	PASS	CSQ=114818|protein_coding||intron_variant|||||||NM_052920.2:c.285+30624_285+30627del||MODIFIER||||||KLHL29|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	67,57:125:0.456
chr2	24135334	.	G	A	.	PASS	CSQ=375190|protein_coding||intron_variant|||||||NM_001145710.2:c.168+147G>A||MODIFIER||||||FAM228B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	77,81:158:0.5127
chr2	24465257	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1031337192|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:104:0	88,76:164:0.4634
chr2	25086531	.	C	G	.	PASS	CSQ=22979|protein_coding||intron_variant|||||||NM_014971.2:c.8-4794C>G||MODIFIER||||||EFR3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	74,90:164:0.5488
chr2	25330422	.	C	T	.	PASS	CSQ=1788|protein_coding||intron_variant|||||||NM_022552.4:c.-178+11404G>A||MODIFIER||||||DNMT3A|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/DNMT3A|y|n|AML|||L|Dom|TSG|Mis,F,N,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	83,92:175:0.5257
chr2	26158466	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs943662096||1.97897e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	81,59:141:0.4184
chr2	26376856	.	T	C	.	PASS	CSQ=85465|protein_coding||intron_variant||||rs1231333516|||NM_033505.4:c.682+1708T>C||MODIFIER||||||SELENOI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	83,78:161:0.4845
chr2	26376859	.	C	T	.	PASS	CSQ=85465|protein_coding||intron_variant|||||||NM_033505.4:c.682+1711C>T||MODIFIER||||||SELENOI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:130:0	89,80:169:0.4734
chr2	27313264	.	C	G	.	PASS	CSQ=4358|protein_coding||intron_variant|||||||NM_002437.5:c.71-155G>C||MODIFIER||||||MPV17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	82,89:171:0.5205
chr2	27510109	.	C	T	.	PASS	CSQ=2646|protein_coding||intron_variant||||rs981248667|||NM_001486.4:c.1422+1858C>T||MODIFIER||||||GCKR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	163,9:172:0.0523
chr2	27524259	.	C	T	.	PASS	CSQ=2646|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||GCKR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	78,77:155:0.4968
chr2	27626486	.	C	T	.	PASS	CSQ=84450|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZNF512|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:117:0	96,62:158:0.3924
chr2	27761186	.	TAAGGGAGG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	81,70:151:0.4636
chr2	27917418	.	C	G	.	PASS	CSQ=9577|protein_coding||intron_variant|||||||NM_199191.2:c.129-12414C>G||MODIFIER||||||BABAM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	93,100:193:0.5181
chr2	27965747	.	T	C	.	PASS	CSQ=9577|protein_coding||intron_variant|||||||NM_199191.2:c.206-22246T>C||MODIFIER||||||BABAM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	165,10:175:0.0571
chr2	28683945	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	91,86:177:0.4859
chr2	28848271	.	C	T	.	PASS	CSQ=245711|protein_coding||intron_variant|||||||NM_182756.4:c.851-1579C>T||MODIFIER||||||SPDYA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	96,83:179:0.4637
chr2	29001689	.	C	A	.	PASS	CSQ=165186|protein_coding||intron_variant|||||||NM_199280.2:c.428-847C>A||MODIFIER||||||TOGARAM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	90,89:179:0.4972
chr2	29639564	.	ATATT	A	.	PASS	CSQ=238|protein_coding||intron_variant|||||||NM_004304.5:c.952+55282_952+55285del||MODIFIER||||||ALK|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ALK|y|y|ALCL,NSCLC,neuroblastoma,inflammatory_myofibroblastic_tumour,Spitzoid_tumour|neuroblastoma|familial_neuroblastoma|L,E,M|Dom|oncogene,fusion|T,Mis,A;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	73,71:144:0.4931
chr2	29769121	.	A	G	.	PASS	CSQ=238|protein_coding||intron_variant|||||||NM_004304.5:c.668-51424T>C||MODIFIER||||||ALK|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ALK|y|y|ALCL,NSCLC,neuroblastoma,inflammatory_myofibroblastic_tumour,Spitzoid_tumour|neuroblastoma|familial_neuroblastoma|L,E,M|Dom|oncogene,fusion|T,Mis,A;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	74,92:166:0.5542
chr2	30277832	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	89,90:179:0.5028
chr2	32616480	.	C	T	.	PASS	CSQ=57448|protein_coding||intron_variant||||||1.38295e-05|NM_016252.3:c.14395-1245C>T||MODIFIER||||||BIRC6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/BIRC6|y|n|melanoma,gastric_adenocarcinoma,lung_adenocarcinoma|||E||oncogene,fusion|T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	59,78:137:0.5693
chr2	32828014	.	C	T	.	PASS	CSQ=285045|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027099.2:n.78+2504C>T||MODIFIER||||||LINC00486|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	160,8:168:0.0476
chr2	33141920	.	G	T	.	PASS	CSQ=4052|protein_coding||intron_variant|||||||NM_206943.3:c.1201+6960G>T||MODIFIER||||||LTBP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	144,22:166:0.1325
chr2	33142098	.	C	T	.	PASS	CSQ=4052|protein_coding||intron_variant|||||||NM_206943.3:c.1201+7138C>T||MODIFIER||||||LTBP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	95,78:173:0.4509
chr2	33740797	.	G	A	.	PASS	CSQ=104355287|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126403.1:n.68+33844G>A||MODIFIER||||||LINC01317|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	64,82:146:0.5616
chr2	33761636	.	G	A	.	PASS	CSQ=104355287|lncRNA||intron_variant&non_coding_transcript_variant||||rs1173285019|||NR_126403.1:n.68+54683G>A||MODIFIER||||||LINC01317|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	84,56:141:0.3972
chr2	33969132	.	T	A	.	PASS	CSQ=104355287|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126403.1:n.389+24579T>A||MODIFIER||||||LINC01317|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	69,76:145:0.5241
chr2	34895041	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,1:122:0.0082	80,57:137:0.4161
chr2	34972811	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	75,71:146:0.4863
chr2	35135177	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs528731726||0.000112617|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	76,60:136:0.4412
chr2	35381751	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	77,82:159:0.5157
chr2	35465764	COSV50623641	C	CT	.	PASS	CSQ=|||intergenic_variant|||COSV50623641|rs906945889||0.00141359|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	83,69:153:0.451
chr2	35620190	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	81,58:139:0.4173
chr2	35637300	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:108:0	125,9:134:0.0672
chr2	35670968	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	84,79:163:0.4847
chr2	35936756	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1006797841|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	79,65:144:0.4514
chr2	35969624	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	74,81:155:0.5226
chr2	35993525	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs1314806234|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	80,75:155:0.4839
chr2	36157654	.	CTTAATATAATTAA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	101,79:180:0.4389
chr2	36157676	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	99,72:171:0.4211
chr2	36204185	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	66,96:162:0.5926
chr2	36419419	.	A	T	.	PASS	CSQ=51232|protein_coding||intron_variant|||||||NM_016441.3:c.506-21839A>T||MODIFIER||||||CRIM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	93,91:184:0.4946
chr2	36738809	.	GA	TT	.	PASS	CSQ=5212|protein_coding||intron_variant|||||||NM_001177969.1:c.119-4291_119-4290delinsTT||MODIFIER||||||VIT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	126,0:126:0	99,72:171:0.4211
chr2	37016749	.	C	T	.	PASS	CSQ=54497|protein_coding||intron_variant|||||||NM_019024.3:c.4105-2729G>A||MODIFIER||||||HEATR5B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	75,79:154:0.513
chr2	37300779	.	CT	AC	.	PASS	CSQ=23683|protein_coding||intron_variant|||||||NM_005813.5:c.289-7509_289-7508delinsGT||MODIFIER||||||PRKD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	107,0:107:0	100,73:173:0.422
chr2	37597156	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1045223962|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	106,82:188:0.4362
chr2	37831603	.	A	T	.	PASS	CSQ=101929559|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110012.1:n.287-2565T>A||MODIFIER||||||LINC00211|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	78,82:160:0.5125
chr2	37845041	.	TCTC	T	.	PASS	CSQ=101929559|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110012.1:n.287-16006_287-16004del||MODIFIER||||||LINC00211|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	70,83:153:0.5425
chr2	38755938	.	C	T	.	PASS	CSQ=6432|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SRSF7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	91,91:182:0.5
chr2	39435457	.	C	T	.	PASS	CSQ=728730|lncRNA||upstream_gene_variant||||||6.57134e-06|||MODIFIER||||||LOC728730|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	82,85:167:0.509
chr2	39615606	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	88,94:182:0.5165
chr2	39789308	.	AGTGGGTTACTGGCCTGTTTACACAGAGGATGGGAAGAAAGGCTTGGGCTTAATAACTCAAAGCTTTTTTAAGCCTTCTAAGTTCCAAG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=mantaSV	AD:DP:AF	197,1:198:0.005288	169,74:243:0.295
chr2	39867959	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	159,18:177:0.1017
chr2	39895303	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	104,72:176:0.4091
chr2	39984899	.	CTGTT	C	.	PASS	CSQ=100128590|lncRNA||intron_variant&non_coding_transcript_variant||||rs1406037921||6.57748e-06|NR_038441.1:n.67+62014_67+62017del||MODIFIER||||||SLC8A1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	83,58:141:0.4113
chr2	40811724	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	115,11:126:0.0873
chr2	40899162	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	77,70:147:0.4762
chr2	41122651	COSV70204034	CT	C	.	PASS	CSQ=|||intergenic_variant|||COSV70204034|rs888494591|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,1:137:0.0073	63,61:124:0.4919
chr2	41265116	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	57,61:118:0.5169
chr2	41484605	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	162,10:172:0.0581
chr2	41876101	.	C	T	.	PASS	CSQ=388942|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01913|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	77,81:158:0.5127
chr2	41906926	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	85,81:166:0.488
chr2	41945448	.	C	A	.	PASS	CSQ=400950|protein_coding||intron_variant|||||||NM_001242815.1:c.385+2047G>T||MODIFIER||||||C2orf91|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	112,78:190:0.4105
chr2	42497313	COSV60151141;COSV60151141;COSV60151141	G	A	.	PASS	CSQ=170850|protein_coding||upstream_gene_variant|COSV60151141|p.?|COSV60151141&COSV60151141|rs546652839||0.000157909|||MODIFIER||||||KCNG3|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	86,73:160:0.4562
chr2	42799457	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	92,73:165:0.4424
chr2	43062159	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1435273868|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	73,102:176:0.5795
chr2	43185840	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1362749576|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	86,61:148:0.4122
chr2	44332732	.	C	T	.	PASS	CSQ=9581|protein_coding||intron_variant|||||||NM_001171613.1:c.889-76G>A||MODIFIER||||||PREPL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	142,0:143:0	83,72:155:0.4645
chr2	44604125	.	G	A	.	PASS	CSQ=79823|protein_coding||intron_variant|||||||NM_024766.5:c.377-100158G>A||MODIFIER||||||CAMKMT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	86,82:168:0.4881
chr2	45192130	.	C	T	.	PASS	CSQ=400952|lncRNA||intron_variant&non_coding_transcript_variant||||rs755829847|||NR_033831.1:n.421+10G>A||MODIFIER||||||LINC01121|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	71,78:149:0.5235
chr2	45225901	.	G	A	.	PASS	CSQ=400952|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033831.1:n.275+28766C>T||MODIFIER||||||LINC01121|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	88,85:173:0.4913
chr2	46400240	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	100,91:191:0.4764
chr2	46475573	.	T	C	.	PASS	CSQ=388946|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TMEM247|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	67,82:149:0.5503
chr2	46839548	.	G	C	.	PASS	CSQ=100134259|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_024452.1:n.221+11464G>C||MODIFIER||||||LINC01119|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	104,89:193:0.4611
chr2	46908809	.	C	T	.	PASS	CSQ=90411|protein_coding||intron_variant|||||||NM_139279.5:c.149+214G>A||MODIFIER||||||MCFD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	82,95:177:0.5367
chr2	47206934	.	A	T	.	PASS	CSQ=101927043|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110208.1:n.404-7391T>A||MODIFIER||||||LOC101927043|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	84,88:172:0.5116
chr2	47561701	.	C	T	.	PASS	CSQ=56660|protein_coding||intron_variant|||||||NM_022055.1:c.391+8240G>A||MODIFIER||||||KCNK12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	81,87:168:0.5179
chr2	47617749	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	75,98:173:0.5665
chr2	47780551	.	A	T	.	PASS	CSQ=2956|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MSH6|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MSH6|y|y|colorectal|colorectal,endometrial,ovarian|hereditary_non-polyposis_colorectal_cancer|E|Rec|TSG|Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	84,76:160:0.475
chr2	47805530	.	G	A	.	PASS	CSQ=2956|protein_coding||intron_variant||||rs899998557|||NM_000179.2:c.3557-88G>A||MODIFIER||||||MSH6|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MSH6|y|y|colorectal|colorectal,endometrial,ovarian|hereditary_non-polyposis_colorectal_cancer|E|Rec|TSG|Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	101,114:215:0.5302
chr2	47806423	.	ATGTATCGCT	A	.	PASS	CSQ=80204|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FBXO11|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FBXO11|y|n|DLBCL|||L|Rec|TSG|Mis,F,D;HighConfidence;TYPE=DEL;called_by=mutect2,lancet;num_callers=2	AD:DP:AF	125,0:125:0	73,1:74:0.0135
chr2	47806433	.	A	AAAAAAAAAAAAAAAAAAAAAAAGAAAAAGC	.	PASS	CSQ=80204|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FBXO11|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FBXO11|y|n|DLBCL|||L|Rec|TSG|Mis,F,D;HighConfidence;TYPE=INS;called_by=mutect2,lancet;num_callers=2	AD:DP:AF	141,0:141:0.006666	90,44:134:0.31
chr2	48445913	.	TG	T	.	PASS	CSQ=129285|protein_coding||intron_variant|||||||NM_001135629.3:c.57+4905del||MODIFIER||||||PPP1R21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	81,75:156:0.4808
chr2	48684052	.	GA	G	.	PASS	CSQ=3973|protein_coding||downstream_gene_variant||||rs938798374|||||MODIFIER||||||LHCGR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	69,82:151:0.543
chr2	49013051	.	C	A	.	PASS	CSQ=2492|protein_coding||intron_variant|||||||NM_000145.3:c.374+4438G>T||MODIFIER||||||FSHR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	77,64:141:0.4539
chr2	49193823	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	57,86:143:0.6014
chr2	49253884	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	67,76:143:0.5315
chr2	49265971	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs538370953||2.63089e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	72,74:146:0.5068
chr2	49367156	.	TCCTCCCAATTGCCA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	75,78:153:0.5098
chr2	49409500	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	58,75:133:0.5639
chr2	49471274	.	ATACAGTCAGTCAGC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	103,37:140:0.2643
chr2	49536304	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs942414044||3.29099e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,73:142:0.5141
chr2	49660887	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs891087594|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	146,80:226:0.354
chr2	49725511	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	130,0:130:0	132,6:138:0.0435
chr2	49738078	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	102,12:114:0.1053
chr2	49786019	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	64,69:133:0.5188
chr2	49815149	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs201539915||0.0119108|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	77,56:136:0.4118
chr2	49841139	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs532887485||6.57013e-06|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	76,83:159:0.522
chr2	50110880	.	C	T	.	PASS	CSQ=9378|protein_coding||intron_variant|||||||NM_001330078.2:c.3547-19386G>A||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	91,71:162:0.4383
chr2	50176494	.	C	T	.	PASS	CSQ=9378|protein_coding||intron_variant|||||||NM_001330078.2:c.3546+60295G>A||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	63,63:126:0.5
chr2	50181133	.	C	A	.	PASS	CSQ=9378|protein_coding||intron_variant|||||||NM_001330078.2:c.3546+55656G>T||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	68,76:144:0.5278
chr2	50579357	.	C	T	.	PASS	CSQ=9378|protein_coding||intron_variant|||||||NM_001330078.2:c.1321-26332G>A||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	73,85:159:0.5346
chr2	50736413	.	G	A	.	PASS	CSQ=9378|protein_coding||intron_variant||||rs1252220904|||NM_001330078.2:c.833-112798C>T||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	62,73:135:0.5407
chr2	50760394	.	C	T	.	PASS	CSQ=9378|protein_coding||intron_variant|||||||NM_001330078.2:c.833-136779G>A||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:129:0	68,79:147:0.5374
chr2	50772100	.	G	A	.	PASS	CSQ=9378|protein_coding||intron_variant|||||||NM_001330078.2:c.833-148485C>T||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	105,6:111:0.0541
chr2	50816074	.	A	T	.	PASS	CSQ=9378|protein_coding||intron_variant|||||||NM_001330078.2:c.832+105795T>A||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	62,69:131:0.5267
chr2	50909770	.	T	G	.	PASS	CSQ=9378|protein_coding||intron_variant|||||||NM_001330078.2:c.832+12099A>C||MODIFIER||||||NRXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	79,70:149:0.4698
chr2	51232048	.	G	A	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.515-96341G>A||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	76,80:156:0.5128
chr2	51349685	.	C	A	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.615+21196C>A||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	84,71:155:0.4581
chr2	51539223	.	G	A	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.753+11563G>A||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	71,70:141:0.4965
chr2	51542455	.	A	G	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.753+14795A>G||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,67:134:0.5
chr2	51609495	.	C	T	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.753+81835C>T||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	72,80:152:0.5263
chr2	51627228	.	G	A	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.753+99568G>A||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	67,52:119:0.437
chr2	51795329	.	A	T	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.839+33155A>T||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	74,69:143:0.4825
chr2	51845191	.	C	A	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant||||rs551980940||0.000111776|NR_135237.1:n.840-16258C>A||MODIFIER||||||LOC730100|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	68,57:125:0.456
chr2	52158948	.	GCT	G	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.880-157283_880-157282del||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	120,0:120:0	72,62:137:0.4526
chr2	52158953	.	G	T	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135237.1:n.880-157279G>T||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	118,0:118:0	73,64:137:0.4672
chr2	52195200	.	G	C	.	PASS	CSQ=730100|lncRNA||intron_variant&non_coding_transcript_variant||||rs1248653310|||NR_135237.1:n.880-121032G>C||MODIFIER||||||LOC730100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	78,91:169:0.5385
chr2	52431684	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs999705204||6.57263e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	140,13:153:0.085
chr2	52802461	.	G	C	.	PASS	CSQ=|||intergenic_variant||||||6.57194e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	96,74:171:0.4327
chr2	53576937	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	74,80:154:0.5195
chr2	54074528	.	TA	T	.	PASS	CSQ=98|protein_coding||intron_variant|||||||NM_001320586.2:c.277+17171del||MODIFIER||||||ACYP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	89,77:166:0.4639
chr2	54534929	.	C	A	.	PASS	CSQ=6711|protein_coding||intron_variant|||||||NM_003128.3:c.148+8363C>A||MODIFIER||||||SPTBN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	83,92:175:0.5257
chr2	54968121	.	G	C	.	PASS	CSQ=57142|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||RTN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	125,0:125:0	93,105:198:0.5303
chr2	55646209	.	CATTAGCA	C	.	PASS	CSQ=87178|protein_coding||intron_variant|||||||NM_033109.5:c.1738+43_1738+49del||MODIFIER||||||PNPT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	86,77:163:0.4724
chr2	56044693	.	C	CT	.	PASS	CSQ=104355290|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126406.1:n.105+2528dup||MODIFIER||||||MIR217HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	94,75:169:0.4438
chr2	56071754	.	G	C	.	PASS	CSQ=101927165|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01813|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	99,56:155:0.3613
chr2	56325796	.	T	A	.	PASS	CSQ=114800|protein_coding||intron_variant|||||||NM_001080433.2:c.1241-17083T>A||MODIFIER||||||CCDC85A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	92,66:158:0.4177
chr2	56562794	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	67,55:122:0.4508
chr2	56781212	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	81,63:144:0.4375
chr2	56876099	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	70,74:144:0.5139
chr2	56899738	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1013033812||5.92518e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,81:156:0.5192
chr2	57121457	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs971503607|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	93,78:171:0.4561
chr2	57338040	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1403213958||6.5735e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	64,84:148:0.5676
chr2	57514634	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1416771575||0.00256014|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	83,45:128:0.3516
chr2	57516448	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	61,74:135:0.5481
chr2	57584893	.	CT	C	.	PASS	CSQ=|||intergenic_variant||||rs904854000||0.000134586|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	82,60:142:0.4225
chr2	57972594	.	G	A	.	PASS	CSQ=7444|protein_coding||intron_variant|||||||NM_001288837.1:c.-556-53071G>A||MODIFIER||||||VRK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	85,72:157:0.4586
chr2	57973676	.	G	A	.	PASS	CSQ=7444|protein_coding||intron_variant|||||||NM_001288837.1:c.-556-51989G>A||MODIFIER||||||VRK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	66,71:137:0.5182
chr2	57992788	.	G	A	.	PASS	CSQ=7444|protein_coding||intron_variant||||rs1355473637||1.31964e-05|NM_001288837.1:c.-556-32877G>A||MODIFIER||||||VRK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	73,54:127:0.4252
chr2	58291717	.	A	C	.	PASS	CSQ=105374744|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147010.1:n.307-1972A>C||MODIFIER||||||LINC01795|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	67,76:143:0.5315
chr2	58400314	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,1:85:0.0118	149,17:166:0.1024
chr2	58496114	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	80,71:151:0.4702
chr2	58713719	.	T	A	.	PASS	CSQ=400955|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033873.1:n.247+57008T>A||MODIFIER||||||LINC01122|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	72,77:149:0.5168
chr2	58853718	.	G	C	.	PASS	CSQ=400955|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033873.1:n.424+3112G>C||MODIFIER||||||LINC01122|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	73,69:142:0.4859
chr2	58937235	.	T	C	.	PASS	CSQ=400955|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033873.1:n.833+11326T>C||MODIFIER||||||LINC01122|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	55,68:123:0.5528
chr2	59449772	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	90,88:179:0.4916
chr2	59475209	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	99,66:165:0.4
chr2	59476834	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1254257744||6.58692e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	93,67:160:0.4188
chr2	59517846	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	86,78:165:0.4727
chr2	59564858	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs951122296||6.57073e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	82,71:153:0.4641
chr2	59902674	.	TGAATCCAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	57,60:117:0.5128
chr2	60061556	.	TAAAAATAATCAAGGAAGTAGACA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	147,23:170:0.1353
chr2	60571790	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	77,78:155:0.5032
chr2	61306017	.	C	T	.	PASS	CSQ=9736|protein_coding||intron_variant|||||||NM_014709.3:c.3818-4563G>A||MODIFIER||||||USP34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	81,72:153:0.4706
chr2	61903555	COSV61278402;COSV61278402;COSV61278402;COSV61278402	C	CT	.	PASS	CSQ=150684|protein_coding||upstream_gene_variant|||COSV61278402&COSV61278402&COSV61278402&COSV61278402|rs1197180019|||||MODIFIER||||||COMMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	81,57:139:0.4101
chr2	62427620	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	90,88:178:0.4944
chr2	62482921	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.57091e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	76,74:150:0.4933
chr2	62588944	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	78,85:163:0.5215
chr2	62852475	.	G	A	.	PASS	CSQ=23301|protein_coding||intron_variant|||||||NM_001142616.2:c.635-6694G>A||MODIFIER||||||EHBP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	79,83:162:0.5123
chr2	64024887	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	70,74:144:0.5139
chr2	64338882	.	A	T	.	PASS	CSQ=100616265|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR4433A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	92,76:168:0.4524
chr2	64587604	.	G	C	.	PASS	CSQ=54812|protein_coding||intron_variant|||||||NM_017657.4:c.2579+2059G>C||MODIFIER||||||AFTPH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	98,91:189:0.4815
chr2	64792146	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1261776448||1.31522e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	82,94:176:0.5341
chr2	65575865	.	T	TG	.	PASS	CSQ=|||intergenic_variant||||rs57395739||0.154219|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,2:110:0.0182	124,76:200:0.38
chr2	65615589	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs200828246||0.0223774|||MODIFIER||||||||0.0266;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	89,79:168:0.4702
chr2	65906815	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	90,91:181:0.5028
chr2	66719831	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	82,71:153:0.4641
chr2	67287860	.	G	C	.	PASS	CSQ=102800447|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110564.1:n.524+42G>C||MODIFIER||||||LINC01828|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	77,93:170:0.5471
chr2	67900631	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	60,81:141:0.5745
chr2	68493287	.	GT	G	.	PASS	CSQ=200558|protein_coding||intron_variant|||||||NM_173545.3:c.168+3031del||MODIFIER||||||APLF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	80,82:162:0.5062
chr2	68660149	.	C	G	.	PASS	CSQ=10887|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PROKR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	79,65:148:0.4392
chr2	69002651	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,90:154:0.5844
chr2	69143895	.	C	A	.	PASS	CSQ=84168|protein_coding||intron_variant|||||||NM_032208.2:c.952-8274C>A||MODIFIER||||||ANTXR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	104,39:143:0.2727
chr2	69575037	.	C	A	.	PASS	CSQ=22848|protein_coding||intron_variant||||rs1250533169|||NM_014911.4:c.164-18059G>T||MODIFIER||||||AAK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	107,109:216:0.5046
chr2	69675874	.	T	G	.	PASS	CSQ=307|protein_coding||intron_variant|||||||NM_001320698.1:c.-145+22592T>G||MODIFIER||||||ANXA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	80,69:149:0.4631
chr2	70672843	.	T	A	.	PASS	CSQ=119|protein_coding||intron_variant|||||||NM_001617.4:c.1870+35A>T||MODIFIER||||||ADD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	74,69:143:0.4825
chr2	71001956	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	84,95:179:0.5307
chr2	71277241	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	93,77:170:0.4529
chr2	71471015	.	C	T	.	PASS	CSQ=8291|protein_coding||intron_variant|||||||NM_001130987.2:c.91+4082C>T||MODIFIER||||||DYSF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	78,89:167:0.5329
chr2	71670736	.	T	A	.	PASS	CSQ=8291|protein_coding||intron_variant|||||||NM_001130987.2:c.5784+990T>A||MODIFIER||||||DYSF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	97,81:179:0.4525
chr2	71937996	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1258384437||1.31416e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:140:0	86,88:174:0.5057
chr2	72041698	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	63,79:142:0.5563
chr2	72518400	.	C	T	.	PASS	CSQ=23233|protein_coding||intron_variant|||||||NM_015189.2:c.916-3274G>A||MODIFIER||||||EXOC6B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	76,72:148:0.4865
chr2	72912597	.	C	T	.	PASS	CSQ=2016|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||EMX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	92,79:171:0.462
chr2	72925582	.	C	T	.	PASS	CSQ=2016|protein_coding||intron_variant|||||||NM_004097.2:c.705+1089C>T||MODIFIER||||||EMX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	98,63:161:0.3913
chr2	73493773	.	G	A	.	PASS	CSQ=7840|protein_coding||intron_variant||||rs1002137378|||NM_015120.4:c.9539+2275G>A||MODIFIER||||||ALMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	178,7:185:0.0378
chr2	73588863	.	G	T	.	PASS	CSQ=7840|protein_coding||intron_variant|||||||NM_015120.4:c.11548-10538G>T||MODIFIER||||||ALMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	148,10:158:0.0633
chr2	73756539	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	76,66:142:0.4648
chr2	74023276	.	G	T	.	PASS	CSQ=200424|protein_coding||intron_variant|||||||NM_001287491.2:c.360+20110G>T||MODIFIER||||||TET3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	95,101:196:0.5153
chr2	74542306	.	C	G	.	PASS	CSQ=84695|protein_coding||intron_variant||||rs199829072|||NM_032603.5:c.693-5378G>C||MODIFIER||||||LOXL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	90,68:158:0.4304
chr2	74764715	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1223749199||6.56978e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	91,73:164:0.4451
chr2	74772825	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	78,87:165:0.5273
chr2	74907163	.	G	T	.	PASS	CSQ=102724515|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01291|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	79,74:153:0.4837
chr2	75133788	.	G	T	.	PASS	CSQ=6869|protein_coding||intron_variant|||||||NM_001058.4:c.390-13020C>A||MODIFIER||||||TACR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,1:146:0.0068	93,75:168:0.4464
chr2	75501618	.	GC	G	.	PASS	CSQ=84141|protein_coding||intron_variant|||||||NM_001135032.2:c.86-8010del||MODIFIER||||||EVA1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	67,76:143:0.5315
chr2	76268058	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	75,64:139:0.4604
chr2	76356187	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	53,75:128:0.5859
chr2	76362086	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	113,42:155:0.271
chr2	76531289	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,1:105:0.0095	83,59:142:0.4155
chr2	76531305	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	89,61:150:0.4067
chr2	76548007	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||||5.37634e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	65,0:65:0	8,63:71:0.8873
chr2	76702539	.	CCG	TTT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	84,0:84:0	50,48:99:0.4848
chr2	76779568	.	A	T	.	PASS	CSQ=80059|protein_coding||intron_variant|||||||NM_001134745.2:c.1552-30652T>A||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	74,37:111:0.3333
chr2	76877055	.	T	A	.	PASS	CSQ=80059|protein_coding||intron_variant|||||||NM_001134745.2:c.1552-128139A>T||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	108,13:121:0.1074
chr2	76933411	.	A	AT	.	PASS	CSQ=80059|protein_coding||intron_variant||||rs201572040||0.0146042|NM_001134745.2:c.1552-184496dup||MODIFIER||||||LRRTM4|EntrezGene|0.0304;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	61,55:116:0.4741
chr2	76939034	.	A	T	.	PASS	CSQ=80059|protein_coding||intron_variant|||||||NM_001134745.2:c.1552-190118T>A||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	63,60:123:0.4878
chr2	77034797	.	T	C	.	PASS	CSQ=80059|protein_coding||intron_variant||||||6.58042e-06|NM_001134745.2:c.1552-285881A>G||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	149,7:156:0.0449
chr2	77044616	.	AT	A	.	PASS	CSQ=80059|protein_coding||intron_variant||||rs951629070||0.00113585|NM_001134745.2:c.1552-295701del||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	73,61:134:0.4552
chr2	77092103	.	T	A	.	PASS	CSQ=80059|protein_coding||intron_variant|||||||NM_001134745.2:c.1552-343187A>T||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	87,63:151:0.4172
chr2	77250901	.	C	T	.	PASS	CSQ=80059|protein_coding||intron_variant||||rs955532856||3.29051e-05|NM_001134745.2:c.1551+267417G>A||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	64,68:132:0.5152
chr2	77274765	.	G	A	.	PASS	CSQ=80059|protein_coding||intron_variant|||||||NM_001134745.2:c.1551+243553C>T||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	88,73:161:0.4534
chr2	77296145	.	AT	A	.	PASS	CSQ=80059|protein_coding||intron_variant|||||||NM_001134745.2:c.1551+222172del||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,69:145:0.4759
chr2	77296406	.	C	A	.	PASS	CSQ=80059|protein_coding||intron_variant|||||||NM_001134745.2:c.1551+221912G>T||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	79,62:141:0.4397
chr2	77452271	.	G	A	.	PASS	CSQ=80059|protein_coding||intron_variant|||||||NM_001134745.2:c.1551+66047C>T||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	71,50:121:0.4132
chr2	77469282	.	C	T	.	PASS	CSQ=80059|protein_coding||intron_variant||||rs901985586||2.62902e-05|NM_001134745.2:c.1551+49036G>A||MODIFIER||||||LRRTM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	87,78:165:0.4727
chr2	77618303	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	117,10:127:0.0787
chr2	77981148	.	T	TA	.	PASS	CSQ=101927967|lncRNA||intron_variant&non_coding_transcript_variant||||rs1461559286||0.00285919|NR_110288.1:n.345-106087dup||MODIFIER||||||LOC101927967|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,51:120:0.425
chr2	77999788	.	C	A	.	PASS	CSQ=101927967|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110288.1:n.345-124726G>T||MODIFIER||||||LOC101927967|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	61,64:125:0.512
chr2	78090026	.	C	A	.	PASS	CSQ=101927948|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110287.1:n.62+1235C>A||MODIFIER||||||LOC101927948|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	121,19:140:0.1357
chr2	78163498	.	C	G	.	PASS	CSQ=101927967|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110288.1:n.344+126890G>C||MODIFIER||||||LOC101927967|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	74,68:142:0.4789
chr2	78269002	.	C	G	.	PASS	CSQ=101927967|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110288.1:n.344+21386G>C||MODIFIER||||||LOC101927967|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	70,69:139:0.4964
chr2	78495556	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	56,70:126:0.5556
chr2	78561654	.	A	G	.	PASS	CSQ=105374820|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_136312.1:n.149-202A>G||MODIFIER||||||LOC105374820|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	78,82:160:0.5125
chr2	78652631	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	73,71:144:0.4931
chr2	78687217	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	62,57:119:0.479
chr2	78798007	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	70,54:124:0.4355
chr2	78800617	.	TC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:106:0	53,53:106:0.5
chr2	78881101	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1021072907||1.31567e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	78,58:136:0.4265
chr2	79017851	.	CTTGG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	66,62:128:0.4844
chr2	79076443	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	69,71:140:0.5071
chr2	79134333	.	C	A	.	PASS	CSQ=5969|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||REG1CP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	139,8:147:0.0544
chr2	79171953	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	80,81:162:0.5
chr2	79198917	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	77,71:148:0.4797
chr2	79215454	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	82,56:138:0.4058
chr2	79246052	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	57,80:137:0.5839
chr2	79435920	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	71,71:142:0.5
chr2	79478215	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	61,74:135:0.5481
chr2	79545927	.	C	A	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.-6+32720C>A||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	159,5:164:0.0305
chr2	79622931	.	C	T	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.-5-28621C>T||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	73,86:159:0.5409
chr2	79758633	.	C	T	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.298+14051C>T||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	54,58:112:0.5179
chr2	79797145	.	C	CT	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.298+52568dup||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	85,58:143:0.4056
chr2	79906025	.	T	A	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.853-3569T>A||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	66,59:125:0.472
chr2	79914131	.	C	T	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.1056+4334C>T||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,66:149:0.443
chr2	80009505	.	C	A	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.1056+99708C>A||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	80,72:152:0.4737
chr2	80010481	.	A	G	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.1056+100684A>G||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	71,75:146:0.5137
chr2	80203342	.	C	T	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.1057-189869C>T||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	81,69:150:0.46
chr2	80472356	.	C	T	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.1290+52755C>T||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	132,64:196:0.3265
chr2	80547065	.	C	T	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.1540+1002C>T||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	127,68:196:0.3469
chr2	80601902	.	G	A	.	PASS	CSQ=1496|protein_coding||intron_variant|||||||NM_001282597.2:c.2190-2172G>A||MODIFIER||||||CTNNA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	149,9:158:0.057
chr2	80689192	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	75,138:213:0.6479
chr2	80759860	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	170,81:251:0.3227
chr2	80778583	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs752657612||2.62988e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	139,56:196:0.2857
chr2	81066554	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	130,76:206:0.3689
chr2	81072516	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,1:104:0.0096	128,36:165:0.2182
chr2	81133641	.	TTCTGACTAGGAAAAAAAACTACCAGTTCTTTTA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	201,57:258:0.2209
chr2	81133679	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	165,23:188:0.1223
chr2	81136848	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	160,72:232:0.3103
chr2	81136858	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	160,78:238:0.3277
chr2	81212293	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	68,119:187:0.6364
chr2	81401912	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,1:131:0.0076	169,73:242:0.3017
chr2	81418202	COSV71539660	GT	G	.	PASS	CSQ=|||intergenic_variant|||COSV71539660|rs1031421729||0.000429649|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,1:98:0.0102	84,121:206:0.5874
chr2	81507264	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	74,151:225:0.6711
chr2	81570431	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	147,63:210:0.3
chr2	81747415	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,0:73:0	145,83:228:0.364
chr2	81787460	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	152,81:233:0.3476
chr2	81986625	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	148,68:216:0.3148
chr2	81999303	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	124,61:185:0.3297
chr2	82010533	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	132,74:206:0.3592
chr2	82205293	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	155,85:240:0.3542
chr2	82248010	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	188,41:229:0.179
chr2	82303639	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	162,74:236:0.3136
chr2	82325341	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs925536856|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	133,68:201:0.3383
chr2	82400482	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	194,7:201:0.0348
chr2	82408883	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	156,79:235:0.3362
chr2	82863613	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1393232036||1.31482e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	112,26:138:0.1884
chr2	82919482	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	83,87:170:0.5118
chr2	83095046	.	CTCAAGAAAAT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	76,58:134:0.4328
chr2	83257948	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	75,75:150:0.5
chr2	83351293	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	72,69:141:0.4894
chr2	83558703	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	76,84:160:0.525
chr2	83635894	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	54,78:132:0.5909
chr2	83754284	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	130,10:140:0.0714
chr2	83848858	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	94,76:170:0.4471
chr2	83896731	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	76,90:166:0.5422
chr2	84786968	.	G	A	.	PASS	CSQ=1768|protein_coding||intron_variant||||rs899631239||0.000111755|NM_001370.1:c.11101-196G>A||MODIFIER||||||DNAH6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	90,77:167:0.4611
chr2	85068810	.	C	T	.	PASS	CSQ=100996478|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01964|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:127:0	91,93:184:0.5054
chr2	85094766	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	80,96:176:0.5455
chr2	85240475	.	G	C	.	PASS	CSQ=83439|protein_coding||intron_variant||||||6.57402e-06|NM_031283.3:c.442-43020G>C||MODIFIER||||||TCF7L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	105,89:194:0.4588
chr2	85754619	.	C	T	.	PASS	CSQ=84913|protein_coding||missense_variant|||||||NM_032827.7:c.430C>T|NP_116216.2:p.Pro144Ser|MODERATE|B|D|N|T|T|ATOH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	150,0:150:0	97,77:174:0.4425
chr2	86397674	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	105,100:205:0.4878
chr2	86405961	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,1:116:0.0086	69,91:160:0.5687
chr2	86474156	.	G	T	.	PASS	CSQ=55818|protein_coding||intron_variant|||||||NM_018433.6:c.1725-620G>T||MODIFIER||||||KDM3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	173,14:187:0.0749
chr2	87337314	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	82,79:161:0.4907
chr2	88332662	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1442039101|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	69,81:150:0.54
chr2	88530059	.	A	C	.	PASS	CSQ=200523|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TEX37|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	83,94:177:0.5311
chr2	88932795	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	76,79:155:0.5097
chr2	89536595	.	T	TCC	.	PASS	CSQ=|||intergenic_variant||||rs1414653299|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	213,0:216:0	176,36:214:0.1682
chr2	89754400	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	225,0:225:0	182,29:211:0.1374
chr2	89789093	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	180,0:180:0	131,5:136:0.0368
chr2	89917032	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	98,36:134:0.2687
chr2	90170182	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	70,43:113:0.3805
chr2	90222140	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs58028063|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	68,36:104:0.3462
chr2	90244484	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.5697e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	162,0:162:0	124,31:155:0.2
chr2	91766149	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	104,10:114:0.0877
chr2	91971541	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	31,80:111:0.7207
chr2	92395949	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	171,0:171:0	181,33:214:0.1542
chr2	92395951	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	181,0:181:0	180,33:213:0.1549
chr2	93161653	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1303725459|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	67,22:89:0.2472
chr2	93405550	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1487032262|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	250,0:250:0	123,62:185:0.3351
chr2	94226408	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	236,0:236:0	179,97:276:0.3514
chr2	94776705	.	C	T	.	PASS	CSQ=729171|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003366.2:n.3529+13466G>A||MODIFIER||||||ANKRD20A8P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	34,73:107:0.6822
chr2	94993261	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs113374159|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	39,91:130:0.7
chr2	95053107	.	A	G	.	PASS	CSQ=4118|protein_coding||intron_variant|||||||NM_002371.4:c.388-274A>G||MODIFIER||||||MAL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	57,37:94:0.3936
chr2	95172965	.	A	AT	.	PASS	CSQ=7549|protein_coding||intron_variant||||rs1244369957||0.0012303|NM_021088.4:c.-39-3209dup||MODIFIER||||||ZNF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,1:113:0.0088	57,48:106:0.4528
chr2	95698727	.	G	C	.	PASS	CSQ=|||intergenic_variant||||||3.28515e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	90,43:133:0.3233
chr2	96496195	.	G	A	.	PASS	CSQ=93082|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||NEURL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	98,32:130:0.2462
chr2	96655616	.	T	C	.	PASS	CSQ=90342|protein_coding||intron_variant|||||||NM_001293083.2:c.747+1120T>C||MODIFIER||||||FER1L5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	36,78:114:0.6842
chr2	96876529	.	G	A	.	PASS	CSQ=51252|protein_coding||intron_variant|||||||NM_001122646.3:c.2008-221C>T||MODIFIER||||||FAM178B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	80,43:123:0.3496
chr2	97806753	.	G	A	.	PASS	CSQ=23505|protein_coding||intron_variant|||||||NM_015348.2:c.2056-1050C>T||MODIFIER||||||TMEM131|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	84,46:130:0.3538
chr2	97927412	COSV104386333	T	TA	.	PASS	CSQ=23505|protein_coding||intron_variant|COSV104386333|p.?||rs773803737||1.31987e-05|NM_015348.2:c.249+13dup||MODIFIER||||||TMEM131|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	108,0:108:0	43,73:117:0.6239
chr2	98643808	.	G	T	.	PASS	CSQ=11320|protein_coding||intron_variant|||||||NM_012214.3:c.1020+115C>A||MODIFIER||||||MGAT4A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	54,72:126:0.5714
chr2	98705875	.	G	C	.	PASS	CSQ=11320|protein_coding||intron_variant|||||||NM_012214.3:c.94+20364C>G||MODIFIER||||||MGAT4A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	112,0:112:0	83,32:115:0.2783
chr2	99151457	.	C	G	.	PASS	CSQ=150590|protein_coding||3_prime_UTR_variant|||||||NM_144706.3:c.*623C>G||MODIFIER||||||C2orf15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	89,0:90:0	29,58:87:0.6667
chr2	99311287	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	62,44:106:0.4151
chr2	99626911	.	C	CT	.	PASS	CSQ=3899|protein_coding||intron_variant|||||||NM_002285.2:c.1184+22714dup||MODIFIER||||||AFF3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/AFF3|y|n|ALL,T-ALL|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	77,33:111:0.2973
chr2	99853776	.	C	T	.	PASS	CSQ=3899|protein_coding||intron_variant|||||||NM_002285.2:c.874-16252G>A||MODIFIER||||||AFF3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/AFF3|y|n|ALL,T-ALL|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	95,40:135:0.2963
chr2	100019875	.	G	A	.	PASS	CSQ=3899|protein_coding||intron_variant|||||||NM_002285.2:c.54-10943C>T||MODIFIER||||||AFF3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/AFF3|y|n|ALL,T-ALL|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	61,29:90:0.3222
chr2	100280524	.	C	T	.	PASS	CSQ=164832|protein_coding||3_prime_UTR_variant|||||||NM_198461.3:c.*3774G>A||MODIFIER||||||LONRF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	130,0:130:0	41,94:135:0.6963
chr2	100351041	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	92,40:132:0.303
chr2	100376626	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	79,36:115:0.313
chr2	101351753	.	C	A	.	PASS	CSQ=200407|protein_coding||intron_variant|||||||NM_153836.4:c.726-683G>T||MODIFIER||||||CREG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	136,4:140:0.0286
chr2	103037929	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	65,39:104:0.375
chr2	103127312	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	82,42:124:0.3387
chr2	103292729	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1387698046||6.57921e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	35,72:107:0.6729
chr2	103337599	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.58172e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	103,11:114:0.0965
chr2	103579288	.	GC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	44,74:118:0.6271
chr2	103751025	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1036996699||3.9559e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	39,71:110:0.6455
chr2	104056612	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	37,64:101:0.6337
chr2	104249579	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs990510060||8.54308e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	73,31:104:0.2981
chr2	104537238	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1455864523||6.57307e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	34,78:112:0.6964
chr2	104563467	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	158,0:158:0	69,41:110:0.3727
chr2	104575397	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,37:109:0.3394
chr2	104725917	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs957831058|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	49,81:130:0.6231
chr2	105189864	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs758096738||0.00026946|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	35,60:95:0.6316
chr2	105255131	.	G	A	.	PASS	CSQ=9392|protein_coding||intron_variant|||||||NM_001328646.1:c.2407-4719C>T||MODIFIER||||||TGFBRAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	76,50:126:0.3968
chr2	106903015	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	110,13:123:0.1057
chr2	106949618	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	25,87:112:0.7768
chr2	107002040	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	103,7:110:0.0636
chr2	107007406	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	61,27:88:0.3068
chr2	107388986	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	78,30:108:0.2778
chr2	107487626	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	72,47:119:0.395
chr2	107541116	.	T	A	.	PASS	CSQ=105373537|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146968.1:n.401+9337T>A||MODIFIER||||||LINC01886|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	33,62:95:0.6526
chr2	107561440	.	C	A	.	PASS	CSQ=105373537|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01886|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	37,70:107:0.6542
chr2	108074660	COSV61945303	TA	T	.	PASS	CSQ=|||intergenic_variant|||COSV61945303|rs532106919||0.00155275|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,1:94:0.0106	35,58:94:0.617
chr2	108253497	.	A	ACTGAAGATAT	.	PASS	CSQ=442038|protein_coding||intron_variant|||||||NM_001320878.1:c.399+58_399+67dup||MODIFIER||||||SULT1C3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	33,73:106:0.6887
chr2	108253512	.	C	G	.	PASS	CSQ=442038|protein_coding||intron_variant|||||||NM_001320878.1:c.399+70C>G||MODIFIER||||||SULT1C3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,0:127:0	37,67:104:0.6442
chr2	108284942	.	G	A	.	PASS	CSQ=6819|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SULT1C2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	74,42:116:0.3621
chr2	108432526	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	88,40:128:0.3125
chr2	108939707	.	G	C	.	PASS	CSQ=10913|protein_coding||intron_variant||||rs1010948077|||NM_022336.4:c.-18-8675C>G||MODIFIER||||||EDAR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	39,91:130:0.7
chr2	109008588	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	37,87:124:0.7016
chr2	109148176	.	G	A	.	PASS	CSQ=344558|protein_coding||intron_variant|||||||NM_001099289.2:c.573+18063G>A||MODIFIER||||||SH3RF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	37,74:111:0.6667
chr2	109658027	.	GTTATTATAATAGTTA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	83,26:109:0.2385
chr2	110813674	.	C	T	.	PASS	CSQ=55289|protein_coding||intron_variant|||||||NM_001142807.2:c.753+8279C>T||MODIFIER||||||ACOXL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	41,66:107:0.6168
chr2	111239640	.	C	A	.	PASS	CSQ=541471|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_136164.1:n.544-30979G>T||MODIFIER||||||MIR4435-2HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	72,43:115:0.3739
chr2	111542715	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,1:103:0.0097	94,14:108:0.1296
chr2	111970416	.	C	G	.	PASS	CSQ=10461|protein_coding||intron_variant|||||||NM_006343.2:c.960+2164C>G||MODIFIER||||||MERTK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	32,91:123:0.7398
chr2	112370618	.	C	T	.	PASS	CSQ=727851|protein_coding||intron_variant|||||||NM_001164463.1:c.5264-406G>A||MODIFIER||||||RGPD8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	57,48:105:0.4571
chr2	112660128	.	T	C	.	PASS	CSQ=6574|protein_coding||intron_variant|||||||NM_005415.5:c.1608-259T>C||MODIFIER||||||SLC20A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	85,34:119:0.2857
chr2	113310825	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	127,0:127:0	129,6:135:0.0444
chr2	114225931	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs780635266||6.57307e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	49,72:121:0.595
chr2	114381279	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	81,44:125:0.352
chr2	114392816	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	75,37:112:0.3304
chr2	114398096	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	70,28:98:0.2857
chr2	114450883	.	G	A	.	PASS	CSQ=57628|protein_coding||intron_variant|||||||NM_020868.4:c.60+8045G>A||MODIFIER||||||DPP10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	40,68:108:0.6296
chr2	114875964	.	G	T	.	PASS	CSQ=57628|protein_coding||intron_variant|||||||NM_001321905.1:c.111+168790G>T||MODIFIER||||||DPP10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	116,1:117:0.0085	92,6:98:0.0612
chr2	115001503	.	C	G	.	PASS	CSQ=57628|protein_coding||intron_variant|||||||NM_001321905.1:c.111+294329C>G||MODIFIER||||||DPP10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	33,73:106:0.6887
chr2	115144177	.	C	A	.	PASS	CSQ=57628|protein_coding||intron_variant||||||1.31437e-05|NM_001321905.1:c.112-165062C>A||MODIFIER||||||DPP10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	104,0:104:0	40,61:101:0.604
chr2	115432532	.	T	G	.	PASS	CSQ=57628|protein_coding||intron_variant|||||||NM_001004360.3:c.251-66978T>G||MODIFIER||||||DPP10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	58,32:90:0.3556
chr2	115840613	.	C	T	.	PASS	CSQ=57628|protein_coding||intron_variant||||rs897753050||2.63491e-05|NM_001004360.3:c.2162-137C>T||MODIFIER||||||DPP10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	56,32:88:0.3636
chr2	115862408	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	70,30:100:0.3
chr2	115869127	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	82,30:112:0.2679
chr2	115872322	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1396721351||6.57324e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,1:99:0.0101	74,27:101:0.2673
chr2	115938020	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs547010756||3.70793e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	69,0:69:0	12,39:52:0.75
chr2	115985610	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	34,55:89:0.618
chr2	116242378	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	117,0:117:0	37,60:97:0.6186
chr2	116363376	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,36:112:0.3214
chr2	116399839	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	20,74:94:0.7872
chr2	116455223	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	76,37:113:0.3274
chr2	116512461	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1441293020|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	80,35:115:0.3043
chr2	116612770	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	32,56:88:0.6364
chr2	116879033	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	94,8:102:0.0784
chr2	116946084	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	61,34:95:0.3579
chr2	116988659	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1188548377|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	89,44:133:0.3308
chr2	117813557	.	C	A	.	PASS	CSQ=8886|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||DDX18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	38,74:112:0.6607
chr2	118169807	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	38,78:116:0.6724
chr2	118235145	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	34,63:97:0.6495
chr2	118353023	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	79,36:115:0.313
chr2	118358263	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs200218912||0.0115532|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,1:107:0.0093	75,29:104:0.2788
chr2	118425055	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	46,67:113:0.5929
chr2	118858747	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	154,0:154:0	104,57:161:0.354
chr2	118865618	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	83,41:124:0.3306
chr2	118866063	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	97,36:133:0.2707
chr2	118923128	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	42,94:136:0.6912
chr2	119252889	.	A	G	.	PASS	CSQ=100874111|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||STEAP3-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	109,5:114:0.0439
chr2	119521937	.	A	G	.	PASS	CSQ=6344|protein_coding||intron_variant|||||||NM_002980.2:c.72+2218T>C||MODIFIER||||||SCTR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	75,49:124:0.3952
chr2	119662766	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	69,35:104:0.3365
chr2	119948146	.	A	T	.	PASS	CSQ=5775|protein_coding||intron_variant|||||||NM_002830.4:c.1656+1572A>T||MODIFIER||||||PTPN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	93,36:129:0.2791
chr2	120118351	.	T	A	.	PASS	CSQ=57669|protein_coding||intron_variant||||rs543519181||1.31389e-05|NM_020909.4:c.1338-9337T>A||MODIFIER||||||EPB41L5|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	47,80:127:0.6299
chr2	120202611	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	93,41:134:0.306
chr2	120438935	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	84,49:133:0.3684
chr2	120590969	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	30,86:117:0.735
chr2	121029249	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	63,31:94:0.3298
chr2	121199791	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	36,60:96:0.625
chr2	121307040	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	84,32:116:0.2759
chr2	121553768	.	T	C	.	PASS	CSQ=23332|protein_coding||intron_variant|||||||NM_015282.2:c.196-23443A>G||MODIFIER||||||CLASP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	92,48:140:0.3429
chr2	121710576	.	TG	T	.	PASS	CSQ=254128|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037857.1:n.1083+4670del||MODIFIER||||||NIFK-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	83,33:116:0.2845
chr2	121934073	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	105,20:125:0.16
chr2	122214985	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs577665036||4.60096e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	75,41:116:0.3534
chr2	122304641	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	74,31:105:0.2952
chr2	122359718	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1401487699||1.97272e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	28,74:102:0.7255
chr2	122398566	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs200865363||0.0241779|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	87,0:87:0	46,50:97:0.5155
chr2	122616204	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs894095171||1.32116e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	82,31:113:0.2743
chr2	122789004	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.5703e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	69,37:106:0.3491
chr2	122795632	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1313164330||6.57289e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	110,6:116:0.0517
chr2	122858727	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	50,27:77:0.3506
chr2	123088373	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	82,39:121:0.3223
chr2	123122584	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	72,33:105:0.3143
chr2	123194959	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	53,26:79:0.3291
chr2	123392833	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	83,5:88:0.0568
chr2	123416234	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	88,17:105:0.1619
chr2	123438363	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	31,68:99:0.6869
chr2	123447155	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	62,32:94:0.3404
chr2	123559614	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	46,85:131:0.6489
chr2	123854264	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs954528800||8.59072e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	47,67:114:0.5877
chr2	123879485	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	74,10:84:0.119
chr2	123897619	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1020751004||0.00144476|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	40,56:96:0.5833
chr2	123920054	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	34,71:105:0.6762
chr2	124018972	.	C	T	.	PASS	CSQ=107985820|lncRNA||intron_variant&non_coding_transcript_variant||||rs1470074668||6.57557e-06|NR_147976.1:n.501-2072G>A||MODIFIER||||||LOC107985820|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	103,8:111:0.0721
chr2	124193335	.	C	T	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.83-28370C>T||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	44,57:101:0.5644
chr2	124236267	.	T	G	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.188-5933T>G||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	92,12:104:0.1154
chr2	124252243	.	G	A	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.381+9850G>A||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	83,41:124:0.3306
chr2	124313507	.	G	A	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.381+71114G>A||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	26,89:115:0.7739
chr2	124399669	.	C	G	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.382-17774C>G||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	52,31:83:0.3735
chr2	124472806	.	A	G	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.919-1933A>G||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	73,28:101:0.2772
chr2	124475232	.	C	A	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.1062+350C>A||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	83,35:118:0.2966
chr2	124496595	.	C	A	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.1063-7697C>A||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	27,67:94:0.7128
chr2	124522341	.	CTGCTGCTACT	C	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.1328-1960_1328-1951del||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	97,13:110:0.1182
chr2	124522355	.	GGTGAGATCCTCT	G	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.1328-1947_1328-1936del||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	95,13:108:0.1204
chr2	124615295	.	A	T	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.1876+5375A>T||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	32,61:93:0.6559
chr2	124732427	.	CAGACCATGAGG	C	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.2078-14800_2078-14790del||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	32,64:96:0.6667
chr2	124732513	.	A	T	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.2078-14716A>T||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	17,62:79:0.7848
chr2	124857355	.	C	A	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.3218-7951C>A||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	27,45:72:0.625
chr2	124897778	.	A	T	.	PASS	CSQ=129684|protein_coding||intron_variant|||||||NM_001367498.1:c.3437-5104A>T||MODIFIER||||||CNTNAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	103,14:117:0.1197
chr2	124953714	.	TAAAAAGGC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	80,7:87:0.0805
chr2	124962676	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	53,26:80:0.325
chr2	125280972	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	63,26:89:0.2921
chr2	125361656	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	30,87:117:0.7436
chr2	125402877	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	89,33:122:0.2705
chr2	125513930	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	43,57:100:0.57
chr2	125766091	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,43:120:0.3583
chr2	125794732	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	92,15:107:0.1402
chr2	126018716	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	106,8:114:0.0702
chr2	126088260	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	34,78:112:0.6964
chr2	126133753	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	60,35:95:0.3684
chr2	126155088	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.58267e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	90,27:117:0.2308
chr2	126187026	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,1:137:0.0073	35,79:114:0.693
chr2	126359713	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	93,13:106:0.1226
chr2	126382209	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	144,0:144:0	101,6:107:0.0561
chr2	126401596	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs940843995||1.31558e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	61,48:109:0.4404
chr2	126663568	.	G	T	.	PASS	CSQ=2995|protein_coding||intron_variant|||||||NM_002101.5:c.49+7256G>T||MODIFIER||||||GYPC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	86,43:129:0.3333
chr2	126930728	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	81,41:122:0.3361
chr2	127330107	.	G	A	.	PASS	CSQ=10746|protein_coding||intron_variant|||||||NM_006609.4:c.379-99C>T||MODIFIER||||||MAP3K2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	97,0:97:0	92,48:140:0.3429
chr2	127817345	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	34,76:110:0.6909
chr2	128162027	.	G	A	.	PASS	CSQ=56886|protein_coding||intron_variant|||||||NM_020120.3:c.2825+759G>A||MODIFIER||||||UGGT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	115,83:198:0.4192
chr2	128203189	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	200,10:210:0.0476
chr2	129046842	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||3.28446e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	87,38:125:0.304
chr2	129211584	.	AGTCTCGCTGT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	34,65:99:0.6566
chr2	129267051	.	C	A	.	PASS	CSQ=151121|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_122041.1:n.285+6556G>T||MODIFIER||||||LINC01854|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	23,64:87:0.7356
chr2	129384615	.	TCTTAATGTTAGAGAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	103,10:113:0.0885
chr2	129421129	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	37,60:97:0.6186
chr2	129437870	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	72,39:111:0.3514
chr2	129480089	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	54,36:90:0.4
chr2	129483657	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	73,24:97:0.2474
chr2	129547092	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs922970116||0.000145079|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	28,77:105:0.7333
chr2	129582737	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	73,42:115:0.3652
chr2	129594327	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:139:0	43,81:124:0.6532
chr2	129600057	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,7:87:0.0805
chr2	129826181	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs989593936||4.60012e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	33,73:106:0.6887
chr2	129832143	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	70,37:107:0.3458
chr2	129965056	.	G	T	.	PASS	CSQ=100131320|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||RAB6C-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	108,19:127:0.1496
chr2	130622940	.	T	C	.	PASS	CSQ=653781|protein_coding||intron_variant|||||||NM_001277083.1:c.945-1124T>C||MODIFIER||||||POTEJ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	38,41:79:0.519
chr2	130747475	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	117,15:132:0.1136
chr2	130936065	.	C	CA	.	PASS	CSQ=50649|protein_coding||intron_variant||||rs138097945||0.0151466|NM_001367493.1:c.3858+4819dup||MODIFIER||||||ARHGEF4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	82,40:123:0.3252
chr2	130956806	.	A	T	.	PASS	CSQ=50649|protein_coding||intron_variant|||||||NM_001367493.1:c.3985+10171A>T||MODIFIER||||||ARHGEF4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	43,0:43:0	27,15:43:0.3488
chr2	131298549	.	A	T	.	PASS	CSQ=440910|lncRNA||intron_variant&non_coding_transcript_variant||||rs1388470443||7.4209e-05|NR_030728.1:n.707-238A>T||MODIFIER||||||LOC440910|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	39,65:104:0.625
chr2	131310369	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs890951554||1.31916e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	83,34:118:0.2881
chr2	131652522	.	C	G	.	PASS	CSQ=101927994|lncRNA||downstream_gene_variant||||rs1279241116||1.97171e-05|||MODIFIER||||||LINC01087|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	39,74:113:0.6549
chr2	131725933	.	A	AT	.	PASS	CSQ=29798|protein_coding||intron_variant|||||||NM_001354871.1:c.-368+3293dup||MODIFIER||||||C2orf27A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	52,74:127:0.5827
chr2	131786609	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	93,37:130:0.2846
chr2	131907328	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	78,35:113:0.3097
chr2	131907354	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	79,29:108:0.2685
chr2	131996625	.	G	A	.	PASS	CSQ=101928067|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146485.1:n.404-1638C>T||MODIFIER||||||LINC01945|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	49,82:131:0.626
chr2	132074814	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	73,36:109:0.3303
chr2	132262814	.	GC	CA	.	PASS	CSQ=554226|misc_RNA||upstream_gene_variant|||||||||MODIFIER||||||ANKRD30BL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	161,0:161:0	140,28:168:0.1667
chr2	132356104	.	G	A	.	PASS	CSQ=339742|lncRNA||downstream_gene_variant||||rs1296203370||1.31453e-05|||MODIFIER||||||FAM201B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	91,40:131:0.3053
chr2	132439548	.	C	T	.	PASS	CSQ=2863|protein_coding||intron_variant|||||||NM_001508.3:c.856+21650C>T||MODIFIER||||||GPR39|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	37,73:110:0.6636
chr2	132525160	.	C	G	.	PASS	CSQ=2863|protein_coding||intron_variant||||rs1316985116||6.57073e-06|NM_001508.3:c.856+107262C>G||MODIFIER||||||GPR39|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	87,31:118:0.2627
chr2	132742351	.	G	A	.	PASS	CSQ=344148|protein_coding||intron_variant||||rs958604420||4.60751e-05|NM_207363.3:c.5129-10300C>T||MODIFIER||||||NCKAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	73,34:107:0.3178
chr2	132915819	.	C	G	.	PASS	CSQ=344148|protein_coding||intron_variant|||||||NM_207363.3:c.580-36903G>C||MODIFIER||||||NCKAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	91,25:116:0.2155
chr2	133125269	.	C	A	.	PASS	CSQ=344148|protein_coding||intron_variant|||||||NM_207363.3:c.341+4709G>T||MODIFIER||||||NCKAP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	64,23:87:0.2644
chr2	133294588	.	C	T	.	PASS	CSQ=344148|protein_coding||intron_variant||||rs571597428||2.62936e-05|NM_207363.3:c.143+8449G>A||MODIFIER||||||NCKAP5|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	76,52:128:0.4062
chr2	133590073	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	90,37:127:0.2913
chr2	134013914	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	89,17:106:0.1604
chr2	134081358	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs996370161||0.000147596|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	45,71:116:0.6121
chr2	134715166	.	T	C	.	PASS	CSQ=81615|protein_coding||intron_variant|||||||NM_030923.5:c.203-1847A>G||MODIFIER||||||TMEM163|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	74,36:110:0.3273
chr2	134749108	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	83,33:116:0.2845
chr2	134992072	.	G	A	.	PASS	CSQ=80122|protein_coding||intron_variant|||||||NM_025052.4:c.575-492C>T||MODIFIER||||||MAP3K19|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	39,85:124:0.6855
chr2	135693011	.	CT	C	.	PASS	CSQ=23518|protein_coding||intron_variant|||||||NM_015361.3:c.2354+12692del||MODIFIER||||||R3HDM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	86,36:122:0.2951
chr2	135949983	.	T	G	.	PASS	CSQ=1615|protein_coding||intron_variant|||||||NM_001349.4:c.321-6503A>C||MODIFIER||||||DARS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	80,38:118:0.322
chr2	136041515	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	102,39:141:0.2766
chr2	136195005	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	106,37:143:0.2587
chr2	136300144	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	76,35:111:0.3153
chr2	136367902	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	39,69:108:0.6389
chr2	136558526	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	76,37:113:0.3274
chr2	136768497	.	G	T	.	PASS	CSQ=80731|protein_coding||intron_variant|||||||NM_001316349.2:c.-36+2810G>T||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	83,32:115:0.2783
chr2	136818267	.	A	T	.	PASS	CSQ=80731|protein_coding||intron_variant|||||||NM_001316349.2:c.-36+52580A>T||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	30,60:90:0.6667
chr2	136876364	.	TA	T	.	PASS	CSQ=80731|protein_coding||intron_variant||||||1.31392e-05|NM_001316349.2:c.-35-5779del||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	34,84:118:0.7119
chr2	136896530	.	CA	C	.	PASS	CSQ=80731|protein_coding||intron_variant|||||||NM_001316349.2:c.139+14217del||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	49,49:98:0.5
chr2	136900645	.	G	T	.	PASS	CSQ=80731|protein_coding||intron_variant|||||||NM_001316349.2:c.139+18328G>T||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	27,86:113:0.7611
chr2	136968242	.	A	T	.	PASS	CSQ=80731|protein_coding||intron_variant|||||||NM_001316349.2:c.139+85925A>T||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	68,44:112:0.3929
chr2	137252736	.	CT	GC	.	PASS	CSQ=80731|protein_coding||intron_variant|||||||NM_001316349.2:c.2266+10164_2266+10165delinsGC||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	119,0:119:0	27,70:97:0.7216
chr2	137344472	.	G	A	.	PASS	CSQ=80731|protein_coding||intron_variant|||||||NM_001316349.2:c.2501-61141G>A||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	85,38:123:0.3089
chr2	137597720	.	T	A	.	PASS	CSQ=80731|protein_coding||intron_variant|||||||NM_001316349.2:c.3424-18455T>A||MODIFIER||||||THSD7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	34,75:109:0.6881
chr2	137766096	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	43,93:136:0.6838
chr2	137783140	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	92,43:135:0.3185
chr2	137876921	.	G	C	.	PASS	CSQ=101928273|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC101928273|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	78,36:114:0.3158
chr2	137912442	.	T	C	.	PASS	CSQ=101928273|lncRNA||intron_variant&non_coding_transcript_variant||||rs1325858960||1.31366e-05|NR_120402.1:n.203+13795A>G||MODIFIER||||||LOC101928273|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	38,77:115:0.6696
chr2	138346052	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs907675926||0.0120857|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:104:0	38,60:99:0.6061
chr2	138480363	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	38,87:125:0.696
chr2	138683103	.	C	T	.	PASS	CSQ=11249|protein_coding||intron_variant|||||||NM_007226.3:c.52-11438G>A||MODIFIER||||||NXPH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	36,75:111:0.6757
chr2	138816269	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	87,31:118:0.2627
chr2	138950380	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	71,36:107:0.3364
chr2	139044731	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	31,77:108:0.713
chr2	139144263	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	71,38:109:0.3486
chr2	139144971	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	42,68:110:0.6182
chr2	139248513	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1051409600|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	76,41:117:0.3504
chr2	139272602	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	37,50:87:0.5747
chr2	139334024	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	84,12:96:0.125
chr2	139473433	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	70,39:109:0.3578
chr2	139521387	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	91,15:106:0.1415
chr2	139544814	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs921368608|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	31,72:103:0.699
chr2	139663153	COSV69128677	C	G	.	PASS	CSQ=|||intergenic_variant|||COSV69128677||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	34,68:102:0.6667
chr2	139673956	COSV71444711	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV71444711|rs765833365||3.29455e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	64,33:97:0.3402
chr2	139872526	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	74,29:103:0.2816
chr2	139882108	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	32,68:100:0.68
chr2	140027110	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	78,9:87:0.1034
chr2	140044009	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	36,65:101:0.6436
chr2	140153091	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	70,30:100:0.3
chr2	140224918	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	95,14:109:0.1284
chr2	140459762	.	G	A	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.9626-2111C>T||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	37,69:106:0.6509
chr2	140549746	.	C	T	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.7195-7775G>A||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	35,85:120:0.7083
chr2	140767153	.	A	G	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.5758+2060T>C||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	70,25:95:0.2632
chr2	140943688	.	G	A	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.3136+6547C>T||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	69,37:106:0.3491
chr2	140982896	.	T	TA	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.2771-621dup||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,28:110:0.2545
chr2	140984765	.	C	G	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.2771-2489G>C||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,18:93:0.1935
chr2	141082717	.	G	A	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.1014-20444C>T||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	33,55:88:0.625
chr2	141228496	.	G	A	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.850+687C>T||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	21,52:73:0.7123
chr2	141349945	.	G	A	.	PASS	CSQ=53353|protein_coding||intron_variant||||rs769215200|||NM_018557.2:c.344-95304C>T||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	71,39:110:0.3545
chr2	141426498	.	C	T	.	PASS	CSQ=53353|protein_coding||intron_variant|||||||NM_018557.2:c.343+53898G>A||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	46,81:127:0.6378
chr2	141438422	.	G	A	.	PASS	CSQ=53353|protein_coding||intron_variant||||rs1168974261||6.57843e-06|NM_018557.2:c.343+41974C>T||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	84,31:115:0.2696
chr2	141968602	.	G	GA	.	PASS	CSQ=53353|protein_coding||intron_variant||||rs969807046||1.98657e-05|NM_018557.2:c.83-158202dup||MODIFIER||||||LRP1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LRP1B|y|n|CLL,ovarian_cancer,oesophageal_squamous_cell_carcinoma,urothelial_cancer|||E,L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	39,59:98:0.602
chr2	142168000	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	67,32:99:0.3232
chr2	142423069	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	67,30:97:0.3093
chr2	142597042	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs911910596||6.60589e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	72,30:102:0.2941
chr2	143217286	.	T	A	.	PASS	CSQ=55843|protein_coding||intron_variant|||||||NM_018460.4:c.296+841T>A||MODIFIER||||||ARHGAP15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	46,72:118:0.6102
chr2	143245145	.	TG	T	.	PASS	CSQ=55843|protein_coding||intron_variant|||||||NM_018460.4:c.385-5363del||MODIFIER||||||ARHGAP15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	65,33:98:0.3367
chr2	143450169	.	T	A	.	PASS	CSQ=55843|protein_coding||intron_variant||||rs1432494818||2.70739e-05|NM_018460.4:c.703+13127T>A||MODIFIER||||||ARHGAP15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,39:108:0.3611
chr2	143606951	.	C	G	.	PASS	CSQ=55843|protein_coding||intron_variant|||||||NM_018460.4:c.1004-17182C>G||MODIFIER||||||ARHGAP15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	90,37:127:0.2913
chr2	143644857	.	C	T	.	PASS	CSQ=55843|protein_coding||intron_variant||||rs1276127887||6.5773e-06|NM_018460.4:c.1138+20590C>T||MODIFIER||||||ARHGAP15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	72,36:108:0.3333
chr2	143732786	.	T	C	.	PASS	CSQ=55843|protein_coding||intron_variant|||||||NM_018460.4:c.1244+29262T>C||MODIFIER||||||ARHGAP15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	101,8:110:0.0727
chr2	143898110	.	GG	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:107:0	24,66:90:0.7333
chr2	143937488	.	C	G	.	PASS	CSQ=101928386|lncRNA||non_coding_transcript_exon_variant||||rs1413592208||1.31505e-05|NR_110237.1:n.422C>G||MODIFIER||||||LOC101928386|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	147,0:148:0	37,78:115:0.6783
chr2	143937541	.	C	T	.	PASS	CSQ=101928386|lncRNA||non_coding_transcript_exon_variant||||rs758347257||1.97112e-05|NR_110237.1:n.475C>T||MODIFIER||||||LOC101928386|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	149,0:149:0	41,84:125:0.672
chr2	144033496	.	C	T	.	PASS	CSQ=79712|protein_coding||intron_variant|||||||NM_001006636.3:c.522-25961G>A||MODIFIER||||||GTDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:142:0	75,51:126:0.4048
chr2	144165650	.	G	T	.	PASS	CSQ=79712|protein_coding||intron_variant|||||||NM_001006636.3:c.180-19911C>A||MODIFIER||||||GTDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	67,29:96:0.3021
chr2	144176278	.	A	G	.	PASS	CSQ=79712|protein_coding||intron_variant|||||||NM_001006636.3:c.180-30539T>C||MODIFIER||||||GTDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	35,57:92:0.6196
chr2	144591355	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	71,38:109:0.3486
chr2	144623801	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs981313170||8.58709e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	48,73:121:0.6033
chr2	144684734	.	G	T	.	PASS	CSQ=401014|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033870.2:n.142+16626G>T||MODIFIER||||||TEX41|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	71,21:92:0.2283
chr2	144961312	.	T	C	.	PASS	CSQ=401014|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033870.2:n.463+57509T>C||MODIFIER||||||TEX41|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	35,71:106:0.6698
chr2	145356582	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	25,75:100:0.75
chr2	145377109	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	65,35:100:0.35
chr2	145438018	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	67,33:100:0.33
chr2	145617705	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	93,5:98:0.051
chr2	145717629	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	93,31:124:0.25
chr2	145791689	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	100,10:110:0.0909
chr2	145948968	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	36,73:109:0.6697
chr2	146123414	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	37,61:98:0.6224
chr2	146207913	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	40,78:118:0.661
chr2	146806661	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	92,7:99:0.0707
chr2	146983694	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	39,70:109:0.6422
chr2	147039390	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1411493447||1.31428e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	37,81:118:0.6864
chr2	147097285	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	20,73:93:0.7849
chr2	147327794	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1008798473||1.3155e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	32,87:119:0.7311
chr2	148015103	.	T	A	.	PASS	CSQ=5000|protein_coding||intron_variant|||||||NM_181741.3:c.-18+5530A>T||MODIFIER||||||ORC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	29,66:95:0.6947
chr2	148022623	.	A	T	.	PASS	CSQ=5000|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ORC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	77,38:115:0.3304
chr2	148196358	.	G	T	.	PASS	CSQ=55777|protein_coding||intron_variant|||||||NM_018328.4:c.-831+17565G>T||MODIFIER||||||MBD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	98,35:133:0.2632
chr2	148253866	.	G	C	.	PASS	CSQ=55777|protein_coding||intron_variant||||||6.57091e-06|NM_018328.4:c.-680+20471G>C||MODIFIER||||||MBD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	89,43:132:0.3258
chr2	148299134	.	CT	C	.	PASS	CSQ=55777|protein_coding||intron_variant||||rs1450256157||0.00069886|NM_018328.4:c.-679-43068del||MODIFIER||||||MBD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:103:0	97,34:131:0.2595
chr2	148430484	.	G	A	.	PASS	CSQ=55777|protein_coding||intron_variant|||||||NM_018328.4:c.-556-27719G>A||MODIFIER||||||MBD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	128,9:137:0.0657
chr2	148514107	.	TT	AA	.	PASS	CSQ=55777|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MBD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	116,0:116:0	79,32:111:0.2883
chr2	148911767	.	G	A	.	PASS	CSQ=3800|protein_coding||intron_variant|||||||NM_004522.3:c.127-10370G>A||MODIFIER||||||KIF5C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,44:124:0.3548
chr2	149642021	.	T	A	.	PASS	CSQ=101929231|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110240.1:n.493+54171T>A||MODIFIER||||||LOC101929231|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	72,42:114:0.3684
chr2	150109224	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	38,64:102:0.6275
chr2	150109228	.	GTCAGCCTCAGCTCCCCAT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	35,85:120:0.7083
chr2	150182134	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	85,43:128:0.3359
chr2	150524946	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	68,47:116:0.4052
chr2	150718082	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	72,25:97:0.2577
chr2	151212308	.	G	C	.	PASS	CSQ=|||intergenic_variant||||||6.58163e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	84,43:127:0.3386
chr2	151516323	.	G	C	.	PASS	CSQ=4703|protein_coding||intron_variant|||||||NM_001271208.2:c.23010+136C>G||MODIFIER||||||NEB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	86,41:127:0.3228
chr2	151761822	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	38,97:135:0.7185
chr2	151805919	.	C	A	.	PASS	CSQ=26225|protein_coding||intron_variant|||||||NM_012097.4:c.491+902G>T||MODIFIER||||||ARL5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	32,65:97:0.6701
chr2	152455118	.	G	A	.	PASS	CSQ=114793|protein_coding||intron_variant||||rs1444200577|||NM_052905.4:c.118-66825G>A||MODIFIER||||||FMNL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	123,0:123:0	82,27:109:0.2477
chr2	152455121	.	GACAGCTCTTTCCT	G	.	PASS	CSQ=114793|protein_coding||intron_variant|||||||NM_052905.4:c.118-66817_118-66805del||MODIFIER||||||FMNL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	128,0:128:0	90,30:120:0.25
chr2	152455136	.	C	G	.	PASS	CSQ=114793|protein_coding||intron_variant|||||||NM_052905.4:c.118-66807C>G||MODIFIER||||||FMNL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	119,0:119:0	88,25:113:0.2212
chr2	152855318	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	72,44:116:0.3793
chr2	153321529	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	110,37:147:0.2517
chr2	153338110	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs935393556|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	65,23:88:0.2614
chr2	153411298	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	70,32:102:0.3137
chr2	153642260	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	76,34:110:0.3091
chr2	153741422	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	74,46:120:0.3833
chr2	153821696	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs973788417|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	73,38:111:0.3423
chr2	153922639	.	T	A	.	PASS	CSQ=114805|protein_coding||intron_variant|||||||NM_052917.4:c.-105+21632T>A||MODIFIER||||||GALNT13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	55,33:88:0.375
chr2	154107773	.	A	AT	.	PASS	CSQ=114805|protein_coding||intron_variant||||rs1262708195|||NM_052917.4:c.143-32555dup||MODIFIER||||||GALNT13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	43,62:105:0.5905
chr2	154114731	.	T	A	.	PASS	CSQ=114805|protein_coding||intron_variant|||||||NM_052917.4:c.143-25606T>A||MODIFIER||||||GALNT13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	41,64:105:0.6095
chr2	154137923	.	C	T	.	PASS	CSQ=114805|protein_coding||intron_variant|||||||NM_052917.4:c.143-2414C>T||MODIFIER||||||GALNT13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	64,30:94:0.3191
chr2	154232058	.	G	C	.	PASS	CSQ=114805|protein_coding||intron_variant|||||||NM_052917.4:c.312-9972G>C||MODIFIER||||||GALNT13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	55,43:98:0.4388
chr2	154272162	.	C	T	.	PASS	CSQ=114805|protein_coding||intron_variant|||||||NM_052917.4:c.975+13024C>T||MODIFIER||||||GALNT13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	80,43:123:0.3496
chr2	154611433	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:123:0	83,27:110:0.2455
chr2	154615075	.	GA	G	.	PASS	CSQ=|||intergenic_variant||||rs978548318||5.27113e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	45,53:98:0.5408
chr2	154821401	.	G	A	.	PASS	CSQ=3760|protein_coding||intron_variant||||rs1002276197||6.57298e-06|NM_002239.4:c.920-33326G>A||MODIFIER||||||KCNJ3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	84,35:119:0.2941
chr2	154915706	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	33,61:94:0.6489
chr2	155007514	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	75,24:99:0.2424
chr2	155100710	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	64,30:94:0.3191
chr2	155315282	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	74,29:103:0.2816
chr2	155409157	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.57212e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	88,33:121:0.2727
chr2	155547608	COSV64668931	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV64668931|rs976869158||7.23304e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	70,38:108:0.3519
chr2	155943564	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	48,79:127:0.622
chr2	155998542	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,1:122:0.0082	69,37:106:0.3491
chr2	156613928	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	54,31:85:0.3647
chr2	156870134	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs576778776||0.000448744|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	61,36:97:0.3711
chr2	156875904	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	64,28:92:0.3043
chr2	157058382	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	118,7:125:0.056
chr2	157140009	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	33,79:113:0.6991
chr2	157328023	.	C	G	.	PASS	CSQ=57471|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ERMN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,1:115:0.0087	39,92:131:0.7023
chr2	157602037	.	C	T	.	PASS	CSQ=130399|protein_coding||intron_variant||||rs1048088092||1.97112e-05|NM_145259.3:c.74-14620G>A||MODIFIER||||||ACVR1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	115,6:121:0.0496
chr2	157876381	.	G	C	.	PASS	CSQ=90|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ACVR1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ACVR1|y|n|DIPG|||O|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	83,43:126:0.3413
chr2	157966037	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	45,74:119:0.6218
chr2	158261321	.	G	A	.	PASS	CSQ=130940|protein_coding||intron_variant|||||||NM_138803.3:c.1111-10409C>T||MODIFIER||||||CCDC148|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	80,36:116:0.3103
chr2	158361509	.	G	T	.	PASS	CSQ=130940|protein_coding||intron_variant|||||||NM_138803.3:c.26-2939C>A||MODIFIER||||||CCDC148|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	33,77:110:0.7
chr2	158410938	.	C	A	.	PASS	CSQ=130940|protein_coding||intron_variant|||||||NM_138803.3:c.25+45477G>T||MODIFIER||||||CCDC148|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	89,24:113:0.2124
chr2	159122167	.	G	T	.	PASS	CSQ=85461|protein_coding||intron_variant|||||||NM_033394.3:c.260-14027G>T||MODIFIER||||||TANC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	95,41:136:0.3015
chr2	159419780	.	C	T	.	PASS	CSQ=29994|protein_coding||intron_variant|||||||NM_013450.4:c.2467-7235G>A||MODIFIER||||||BAZ2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	119,9:128:0.0703
chr2	159501214	.	T	TTA	.	PASS	CSQ=29994|protein_coding||intron_variant||||rs1399058738||0.00022964|NM_013450.4:c.-2-22495_-2-22494dup||MODIFIER||||||BAZ2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	25,0:25:0	45,41:88:0.4659
chr2	159841291	.	C	T	.	PASS	CSQ=4065|protein_coding||intron_variant|||||||NM_002349.4:c.3281-336G>A||MODIFIER||||||LY75|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	35,105:140:0.75
chr2	160747001	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs753978683||3.94566e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	43,93:136:0.6838
chr2	161777626	.	C	T	.	PASS	CSQ=57282|protein_coding||intron_variant|||||||NM_001178015.2:c.130+6572C>T||MODIFIER||||||SLC4A10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	42,77:119:0.6471
chr2	162196467	.	C	A	.	PASS	CSQ=2191|protein_coding||intron_variant|||||||NM_004460.5:c.1403-1719G>T||MODIFIER||||||FAP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	38,88:126:0.6984
chr2	162378539	.	G	T	.	PASS	CSQ=90134|protein_coding||intron_variant|||||||NM_033272.3:c.3131+1314C>A||MODIFIER||||||KCNH7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	95,37:132:0.2803
chr2	162918310	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	78,38:116:0.3276
chr2	162943075	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	79,36:115:0.313
chr2	163267913	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	76,41:117:0.3504
chr2	163382233	.	GT	G	.	PASS	CSQ=|||intergenic_variant||||rs1206000267|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	102,46:148:0.3108
chr2	163425627	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	44,70:114:0.614
chr2	163475221	COSV70437589	T	TA	.	PASS	CSQ=|||intergenic_variant|||COSV70437589|rs560998268||0.00947145|||MODIFIER||||||||0.0078;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	47,79:126:0.627
chr2	163648576	.	G	A	.	PASS	CSQ=55137|protein_coding||intron_variant||||rs1052948157||3.28658e-05|NM_018086.4:c.26-36770C>T||MODIFIER||||||FIGN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	48,78:126:0.619
chr2	163719902	.	T	G	.	PASS	CSQ=55137|protein_coding||intron_variant|||||||NM_018086.4:c.25+15001A>C||MODIFIER||||||FIGN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	51,79:130:0.6077
chr2	163777297	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	33,69:102:0.6765
chr2	163922926	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1170278442||1.97994e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	38,75:113:0.6637
chr2	164055913	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:131:0	58,32:90:0.3556
chr2	164120091	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	76,36:112:0.3214
chr2	164120093	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	76,35:111:0.3153
chr2	164236365	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57281e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	45,76:121:0.6281
chr2	164236369	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1053039037|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,1:141:0.0071	75,42:117:0.359
chr2	164356690	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	24,61:85:0.7176
chr2	164571981	.	T	G	.	PASS	CSQ=2888|protein_coding||intron_variant|||||||NM_004490.2:c.325-24165A>C||MODIFIER||||||GRB14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	78,40:118:0.339
chr2	164886542	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	103,17:120:0.1417
chr2	164954900	.	A	AT	.	PASS	CSQ=151258|protein_coding||intron_variant|||||||NM_001351537.1:c.40-156dup||MODIFIER||||||SLC38A11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	71,32:103:0.3107
chr2	164998450	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	86,43:129:0.3333
chr2	165060499	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	129,0:130:0	77,27:105:0.2571
chr2	165220119	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	80,28:108:0.2593
chr2	165220126	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	77,28:105:0.2667
chr2	165413654	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	41,68:109:0.6239
chr2	165828852	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs773943906||0.000480219|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	68,29:97:0.299
chr2	165838858	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	72,31:103:0.301
chr2	166216715	.	T	C	.	PASS	CSQ=101929680|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110260.1:n.611+16897T>C||MODIFIER||||||LOC101929680|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	77,43:120:0.3583
chr2	166395833	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1233032812||6.67994e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	39,51:90:0.5667
chr2	166535277	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	62,30:92:0.3261
chr2	166560226	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	31,82:113:0.7257
chr2	166591568	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	38,49:87:0.5632
chr2	166655008	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	85,38:123:0.3089
chr2	166732117	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	33,78:111:0.7027
chr2	166760256	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	81,18:99:0.1818
chr2	166848818	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	38,68:106:0.6415
chr2	166905451	.	G	A	.	PASS	CSQ=129446|protein_coding||intron_variant|||||||NM_152381.5:c.408+1561G>A||MODIFIER||||||XIRP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	41,69:110:0.6273
chr2	166913902	.	C	T	.	PASS	CSQ=129446|protein_coding||intron_variant||||||6.57384e-06|NM_152381.5:c.408+10012C>T||MODIFIER||||||XIRP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	79,47:126:0.373
chr2	166914333	.	AT	A	.	PASS	CSQ=129446|protein_coding||intron_variant||||||3.29863e-05|NM_152381.5:c.408+10451del||MODIFIER||||||XIRP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	71,39:110:0.3545
chr2	167047599	COSV54742420;COSV54742420;COSV54742420	C	T	.	PASS	CSQ=129446|protein_coding||intron_variant|COSV54742420&COSV54742420&COSV54742420|p.?&p.?&p.?||rs942800618||5.2712e-05|NM_152381.5:c.409-88310C>T||MODIFIER||||||XIRP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	70,36:106:0.3396
chr2	167157593	.	G	C	.	PASS	CSQ=129446|protein_coding||intron_variant|||||||NM_152381.5:c.562+21531G>C||MODIFIER||||||XIRP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	85,37:122:0.3033
chr2	167343017	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs543773249||6.57333e-06|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	59,40:99:0.404
chr2	167456068	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	67,39:106:0.3679
chr2	167565637	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	39,66:105:0.6286
chr2	167601079	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	36,77:113:0.6814
chr2	168199306	.	G	C	.	PASS	CSQ=27347|protein_coding||intron_variant|||||||NM_013233.3:c.209-17216C>G||MODIFIER||||||STK39|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	37,81:118:0.6864
chr2	168204969	.	C	A	.	PASS	CSQ=27347|protein_coding||intron_variant|||||||NM_013233.3:c.209-22879G>T||MODIFIER||||||STK39|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	114,5:119:0.042
chr2	168231473	.	A	C	.	PASS	CSQ=27347|protein_coding||intron_variant|||||||NM_013233.3:c.208+15755T>G||MODIFIER||||||STK39|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	30,59:89:0.6629
chr2	168390426	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	78,36:114:0.3158
chr2	169215086	.	G	A	.	PASS	CSQ=4036|protein_coding||intron_variant||||rs924805228||3.28623e-05|NM_004525.3:c.5826+1167C>T||MODIFIER||||||LRP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	122,19:141:0.1348
chr2	169417443	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1424352141||3.29142e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	46,62:108:0.5741
chr2	169629404	.	G	A	.	PASS	CSQ=9360|protein_coding||intron_variant|||||||NM_004792.3:c.548-1370G>A||MODIFIER||||||PPIG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	58,83:141:0.5887
chr2	169807134	.	G	A	.	PASS	CSQ=29081|protein_coding||downstream_gene_variant||||rs1283492286|||||MODIFIER||||||METTL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	108,5:113:0.0442
chr2	169957268	.	T	C	.	PASS	CSQ=130507|protein_coding||intron_variant|||||||NM_172070.3:c.3546-1170T>C||MODIFIER||||||UBR3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	124,28:152:0.1842
chr2	170327683	.	C	G	.	PASS	CSQ=140469|protein_coding||intron_variant|||||||NM_138995.4:c.750-7702C>G||MODIFIER||||||MYO3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	124,7:131:0.0534
chr2	170382024	.	G	A	.	PASS	CSQ=140469|protein_coding||missense_variant||||rs567243576&COSM1009425&COSM1009426|2.00694e-05|6.57004e-06|NM_138995.4:c.980G>A|NP_620482.3:p.Arg327Lys|MODERATE|B&B&.|T&T&T|D|.&.&T|T&T&T|MYO3B|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	129,0:129:0	75,30:105:0.2857
chr2	170578797	.	T	C	.	PASS	CSQ=140469|protein_coding||intron_variant|||||||NM_138995.4:c.3733+34809T>C||MODIFIER||||||MYO3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	81,34:115:0.2957
chr2	170957510	.	A	T	.	PASS	CSQ=26003|protein_coding||intron_variant|||||||NM_015530.5:c.823+951A>T||MODIFIER||||||GORASP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	53,78:131:0.5954
chr2	171442578	.	A	AG	.	PASS	CSQ=80067|protein_coding||intron_variant||||rs976651516||2.66301e-05|NM_025000.4:c.231-945_231-944insG||MODIFIER||||||DCAF17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	82,29:112:0.2589
chr2	171767790	.	CTAA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	73,40:113:0.354
chr2	172239304	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	82,34:116:0.2931
chr2	172287707	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	69,48:117:0.4103
chr2	173174262	.	T	C	.	PASS	CSQ=51776|protein_coding||intron_variant|||||||NM_016653.3:c.247+4370T>C||MODIFIER||||||MAP3K20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	92,43:135:0.3185
chr2	173496935	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,1:137:0.0073	28,89:117:0.7607
chr2	173618021	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	73,42:115:0.3652
chr2	174092834	.	G	C	.	PASS	CSQ=29789|protein_coding||intron_variant|||||||NM_013341.5:c.729-10770C>G||MODIFIER||||||OLA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	34,78:112:0.6964
chr2	174147442	.	G	GA	.	PASS	CSQ=29789|protein_coding||intron_variant||||rs1006587737||6.6038e-06|NM_013341.5:c.374-5443dup||MODIFIER||||||OLA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	79,36:115:0.313
chr2	174264080	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs541740929||6.57229e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	78,42:120:0.35
chr2	174489834	.	C	CA	.	PASS	CSQ=151556|protein_coding||upstream_gene_variant||||rs1210782046||0.00343753|||MODIFIER||||||GPR155|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	45,43:89:0.4831
chr2	174792248	COSV68893625;COSV68893625	G	GA	.	PASS	CSQ=|||intergenic_variant|||COSV68893625&COSV68893625|rs199504519||0.000244835|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	48,67:115:0.5826
chr2	174797559	.	TA	T	.	PASS	CSQ=1123|protein_coding||downstream_gene_variant||||rs1265690799||0.000444185|||MODIFIER||||||CHN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	40,83:123:0.6748
chr2	174842663	.	C	T	.	PASS	CSQ=1123|protein_coding||intron_variant|||||||NM_001822.5:c.627+4217G>A||MODIFIER||||||CHN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	49,51:100:0.51
chr2	175858127	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1464801826||6.57237e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	29,66:95:0.6947
chr2	176628185	.	A	G	.	PASS	CSQ=375295|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01116|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	49,58:107:0.5421
chr2	177282241	.	G	A	.	PASS	CSQ=100130691|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC100130691|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	155,0:155:0	138,52:190:0.2737
chr2	177285112	.	T	A	.	PASS	CSQ=100130691|lncRNA||non_coding_transcript_exon_variant|||||||NR_026966.1:n.3602A>T||MODIFIER||||||LOC100130691|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	137,40:177:0.226
chr2	177298209	.	G	A	.	PASS	CSQ=100130691|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_026966.1:n.880-10375C>T||MODIFIER||||||LOC100130691|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	119,40:159:0.2516
chr2	177312811	.	G	C	.	PASS	CSQ=100130691|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_026966.1:n.712-1483C>G||MODIFIER||||||LOC100130691|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	130,49:179:0.2737
chr2	177312833	.	A	G	.	PASS	CSQ=102465255|miRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR6512|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	132,46:178:0.2584
chr2	177372975	.	C	T	.	PASS	CSQ=100130691|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_026966.1:n.119+19598G>A||MODIFIER||||||LOC100130691|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	113,41:154:0.2662
chr2	177375981	.	C	T	.	PASS	CSQ=100130691|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_026966.1:n.119+16592G>A||MODIFIER||||||LOC100130691|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	125,39:164:0.2378
chr2	177376764	COSV67956337	C	A	.	PASS	CSQ=100130691|lncRNA||intron_variant&non_coding_transcript_variant|COSV67956337|p.?|||||NR_026966.1:n.119+15809G>T||MODIFIER||||||LOC100130691|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	122,47:169:0.2781
chr2	177927606	.	T	C	.	PASS	CSQ=50940|protein_coding||intron_variant|||||||NM_016953.4:c.1072-22419A>G||MODIFIER||||||PDE11A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	39,80:119:0.6723
chr2	178159912	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	105,44:149:0.2953
chr2	179069286	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	75,46:121:0.3802
chr2	179090734	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	32,78:110:0.7091
chr2	179109165	.	GCT	G	.	PASS	CSQ=91404|protein_coding||3_prime_UTR_variant|||||||NM_178123.5:c.*732_*733del||MODIFIER||||||SESTD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	48,83:131:0.6336
chr2	179215027	.	G	C	.	PASS	CSQ=91404|protein_coding||intron_variant|||||||NM_178123.5:c.-25-23161C>G||MODIFIER||||||SESTD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	43,93:136:0.6838
chr2	179420172	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	35,81:116:0.6983
chr2	179489346	.	C	A	.	PASS	CSQ=151126|protein_coding||intron_variant|||||||NM_152520.6:c.553-5912G>T||MODIFIER||||||ZNF385B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	40,94:134:0.7015
chr2	179913130	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	86,36:122:0.2951
chr2	180017130	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	37,52:89:0.5843
chr2	180401165	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1033995641|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	82,35:117:0.2991
chr2	181296100	.	CCTA	C	.	PASS	CSQ=101927156|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_130784.1:n.358+33124_358+33126del||MODIFIER||||||LINC01934|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	79,36:115:0.313
chr2	182035639	.	A	T	.	PASS	CSQ=151242|protein_coding||intron_variant|||||||NM_001080545.2:c.143-25803A>T||MODIFIER||||||PPP1R1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	39,87:126:0.6905
chr2	182113377	.	C	A	.	PASS	CSQ=151242|protein_coding||intron_variant|||||||NM_001080545.2:c.242-3830C>A||MODIFIER||||||PPP1R1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	100,39:139:0.2806
chr2	182389216	.	G	C	.	PASS	CSQ=5136|protein_coding||intron_variant|||||||NM_001363871.1:c.53+37362C>G||MODIFIER||||||PDE1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	70,41:111:0.3694
chr2	182804182	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,48:128:0.375
chr2	182867319	.	G	A	.	PASS	CSQ=2487|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||FRZB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	31,83:114:0.7281
chr2	183111896	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	75,38:114:0.3333
chr2	183283386	COSV68121540	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV68121540|rs993226583||0.000118334|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	113,41:154:0.2662
chr2	183522327	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	105,4:109:0.0367
chr2	184010873	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	33,90:123:0.7317
chr2	184030265	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	59,31:90:0.3444
chr2	184114898	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	31,62:93:0.6667
chr2	184221017	COSV63009115	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV63009115||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	64,30:94:0.3191
chr2	184271719	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	32,78:110:0.7091
chr2	184338458	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	96,48:144:0.3333
chr2	184366748	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	61,35:96:0.3646
chr2	184441933	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs905740539||6.58545e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	31,67:98:0.6837
chr2	184514578	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	25,59:84:0.7024
chr2	184519523	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	33,85:118:0.7203
chr2	184667003	.	T	A	.	PASS	CSQ=91752|protein_coding||intron_variant|||||||NM_194250.2:c.111+67933T>A||MODIFIER||||||ZNF804A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	42,68:110:0.6182
chr2	185415251	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	71,31:102:0.3039
chr2	185804505	.	G	A	.	PASS	CSQ=107985781|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||FSIP2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	95,0:95:0	33,83:116:0.7155
chr2	186136206	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	93,36:129:0.2791
chr2	186232867	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	38,72:110:0.6545
chr2	187167667	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,1:103:0.0097	87,11:98:0.1122
chr2	187244823	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	72,31:103:0.301
chr2	187420089	.	C	T	.	PASS	CSQ=10203|protein_coding||intron_variant|||||||NM_005795.6:c.-293+27950G>A||MODIFIER||||||CALCRL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	86,41:127:0.3228
chr2	187590368	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	79,18:97:0.1856
chr2	187805230	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	65,35:100:0.35
chr2	188092874	.	C	T	.	PASS	CSQ=104355152|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126396.1:n.381-57163G>A||MODIFIER||||||LINC01090|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	77,37:114:0.3246
chr2	188450947	.	C	A	.	PASS	CSQ=51454|protein_coding||intron_variant|||||||NM_016315.4:c.-44-26712C>A||MODIFIER||||||GULP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	80,34:114:0.2982
chr2	188477545	.	G	T	.	PASS	CSQ=51454|protein_coding||intron_variant|||||||NM_016315.4:c.-44-114G>T||MODIFIER||||||GULP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	131,0:131:0	81,45:126:0.3571
chr2	188746808	.	G	T	.	PASS	CSQ=116093|protein_coding||intron_variant|||||||NM_052952.2:c.-29-11859C>A||MODIFIER||||||DIRC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	45,61:106:0.5755
chr2	189021876	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	38,69:107:0.6449
chr2	189045475	.	C	G	.	PASS	CSQ=1290|protein_coding||intron_variant|||||||NM_000393.5:c.3310-243G>C||MODIFIER||||||COL5A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	31,82:113:0.7257
chr2	189121437	.	G	A	.	PASS	CSQ=1290|protein_coding||intron_variant||||||6.58085e-06|NM_000393.5:c.98-10988C>T||MODIFIER||||||COL5A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	37,77:114:0.6754
chr2	189465596	.	G	C	.	PASS	CSQ=84128|protein_coding||intron_variant|||||||NM_032168.3:c.1289+342G>C||MODIFIER||||||WDR75|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	28,77:105:0.7333
chr2	190140845	.	T	A	.	PASS	CSQ=84281|protein_coding||intron_variant|||||||NM_001042521.1:c.-290+2996T>A||MODIFIER||||||C2orf88|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	39,88:127:0.6929
chr2	190152780	.	TTAAC	T	.	PASS	CSQ=84281|protein_coding||intron_variant|||||||NM_001042520.1:c.-165+2334_-165+2337del||MODIFIER||||||C2orf88|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	40,78:118:0.661
chr2	190615959	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	85,44:129:0.3411
chr2	191506575	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs796748596||0.00145301|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,1:111:0.009	79,30:109:0.2752
chr2	191540021	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	44,88:132:0.6667
chr2	191548705	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	34,91:125:0.728
chr2	192280321	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	29,89:118:0.7542
chr2	192750646	.	G	GA	.	PASS	CSQ=64002|lncRNA||intron_variant&non_coding_transcript_variant||||rs199812983||0.000124681|NR_152587.1:n.185-134dup||MODIFIER||||||PCGEM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	48,67:115:0.5826
chr2	192872418	COSV68515336	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV68515336||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	30,57:87:0.6552
chr2	192888623	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	66,37:103:0.3592
chr2	192981792	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	80,30:110:0.2727
chr2	193153217	.	ATAT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	54,35:89:0.3933
chr2	193191014	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	43,77:120:0.6417
chr2	193221360	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	41,64:105:0.6095
chr2	193338476	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:90:0	71,33:104:0.3173
chr2	193360504	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	74,20:94:0.2128
chr2	193552355	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1269513158||1.31638e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	71,31:102:0.3039
chr2	193776800	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	34,78:112:0.6964
chr2	193959782	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	37,73:110:0.6636
chr2	194298502	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs578234432||0.000434473|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	36,64:100:0.64
chr2	194402716	.	T	C	.	PASS	CSQ=101927406|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110222.1:n.537-13480T>C||MODIFIER||||||LINC01821|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	25,54:79:0.6835
chr2	194465807	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	38,74:112:0.6607
chr2	194513252	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs531697319||0.033374|||MODIFIER||||||||0.0349;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	79,35:114:0.307
chr2	194964170	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	37,76:113:0.6726
chr2	195061126	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	26,70:96:0.7292
chr2	195292499	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	81,29:110:0.2636
chr2	195346146	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	78,29:107:0.271
chr2	195553079	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	37,71:109:0.6514
chr2	195717445	.	C	T	.	PASS	CSQ=57181|protein_coding||intron_variant||||rs542442659||1.31572e-05|NM_020342.3:c.2065+440C>T||MODIFIER||||||SLC39A10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	43,88:131:0.6718
chr2	195844561	.	T	C	.	PASS	CSQ=56171|protein_coding||intron_variant|||||||NM_018897.3:c.8945+441A>G||MODIFIER||||||DNAH7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	60,31:91:0.3407
chr2	196344744	.	C	T	.	PASS	CSQ=57520|protein_coding||intron_variant|||||||NM_001348768.2:c.293-980G>A||MODIFIER||||||HECW2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	92,40:132:0.303
chr2	196911305	.	AG	A	.	PASS	CSQ=80055|protein_coding||intron_variant|||||||NM_024989.4:c.649+1576del||MODIFIER||||||PGAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	27,0:27:0	15,9:24:0.375
chr2	196914504	.	C	T	.	PASS	CSQ=80055|protein_coding||intron_variant|||||||NM_024989.4:c.478-1451G>A||MODIFIER||||||PGAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	75,0:75:0	64,37:101:0.3663
chr2	197050762	.	C	T	.	PASS	CSQ=91526|protein_coding||intron_variant|||||||NM_001195144.2:c.1651-25495G>A||MODIFIER||||||ANKRD44|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	72,43:115:0.3739
chr2	197377748	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	39,104:143:0.7273
chr2	197641762	.	C	G	.	PASS	CSQ=130132|protein_coding||intron_variant|||||||NM_144629.2:c.438+2396G>C||MODIFIER||||||RFTN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	76,48:124:0.3871
chr2	197713687	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs896184573||6.57298e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	96,8:104:0.0769
chr2	197725074	.	A	AT	.	PASS	CSQ=66037|protein_coding||downstream_gene_variant||||||6.57402e-06|||MODIFIER||||||BOLL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	72,34:106:0.3208
chr2	197981316	.	G	A	.	PASS	CSQ=5334|protein_coding||intron_variant|||||||NM_006226.4:c.241-102442G>A||MODIFIER||||||PLCL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	104,9:113:0.0796
chr2	198004697	.	G	T	.	PASS	CSQ=5334|protein_coding||intron_variant|||||||NM_006226.4:c.241-79061G>T||MODIFIER||||||PLCL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	98,30:128:0.2344
chr2	198321827	.	G	A	.	PASS	CSQ=101927619|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110267.1:n.358-20011C>T||MODIFIER||||||LINC01923|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	75,47:122:0.3852
chr2	198342704	.	T	TA	.	PASS	CSQ=101927619|lncRNA||intron_variant&non_coding_transcript_variant||||rs1328275586||6.07042e-05|NR_110267.1:n.357+31771_357+31772insT||MODIFIER||||||LINC01923|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	68,18:86:0.2093
chr2	198872361	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1330500774||2.63459e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	115,6:121:0.0496
chr2	198889008	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	93,39:132:0.2955
chr2	199138217	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	82,25:107:0.2336
chr2	199290426	.	C	G	.	PASS	CSQ=23314|protein_coding||intron_variant|||||||NM_001172509.2:c.1741-17754G>C||MODIFIER||||||SATB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,1:130:0.0077	81,39:120:0.325
chr2	199294905	.	G	C	.	PASS	CSQ=23314|protein_coding||intron_variant||||rs1412661280||1.316e-05|NM_001172509.2:c.1740+13855C>G||MODIFIER||||||SATB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	92,37:129:0.2868
chr2	199574310	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	96,20:116:0.1724
chr2	199630039	.	G	A	.	PASS	CSQ=101927641|lncRNA||non_coding_transcript_exon_variant|||||||NR_110270.1:n.323G>A||MODIFIER||||||LINC01877|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	103,0:103:0	76,41:117:0.3504
chr2	199630709	.	G	GA	.	PASS	CSQ=101927641|lncRNA||non_coding_transcript_exon_variant||||rs1331849813||0.00114762|NR_110270.1:n.857dup||MODIFIER||||||LINC01877|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	108,0:108:0	44,65:110:0.5909
chr2	199742007	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs376783215||1.97366e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	66,35:101:0.3465
chr2	199785948	.	G	T	.	PASS	CSQ=348751|protein_coding||intron_variant|||||||NM_001350854.1:c.*20-25113C>A||MODIFIER||||||FTCDNL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	37,77:114:0.6754
chr2	199790215	.	C	T	.	PASS	CSQ=348751|protein_coding||intron_variant||||rs755135235||8.56796e-05|NM_001350854.1:c.*20-29380G>A||MODIFIER||||||FTCDNL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:95:0	42,73:115:0.6348
chr2	200592861	.	G	GA	.	PASS	CSQ=316|protein_coding||intron_variant||||rs1163972308||1.31615e-05|NM_001159.4:c.46-279dup||MODIFIER||||||AOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	82,35:117:0.2991
chr2	200613751	.	A	G	.	PASS	CSQ=316|protein_coding||intron_variant|||||||NM_001159.4:c.1449-53A>G||MODIFIER||||||AOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	101,0:101:0	47,93:140:0.6643
chr2	201584652	.	G	A	.	PASS	CSQ=151254|protein_coding||intron_variant||||rs1438577077||3.29524e-05|NM_001168221.2:c.517-2435C>T||MODIFIER||||||C2CD6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	75,43:118:0.3644
chr2	201666959	.	T	C	.	PASS	CSQ=58538|protein_coding||intron_variant|||||||NM_033066.3:c.1013-587A>G||MODIFIER||||||MPP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	38,85:123:0.6911
chr2	202491176	.	C	T	.	PASS	CSQ=659|protein_coding||intron_variant|||||||NM_001204.6:c.419-22543C>T||MODIFIER||||||BMPR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	41,61:102:0.598
chr2	202633870	.	CC	AA	.	PASS	CSQ=150864|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||FAM117B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:106:0	69,33:103:0.3204
chr2	202661821	.	C	T	.	PASS	CSQ=150864|protein_coding||intron_variant|||||||NM_173511.4:c.601+26033C>T||MODIFIER||||||FAM117B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	34,81:115:0.7043
chr2	203120580	.	G	T	.	PASS	CSQ=65065|protein_coding||intron_variant|||||||NM_001114132.1:c.2506-1674G>T||MODIFIER||||||NBEAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	48,73:121:0.6033
chr2	203582298	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	39,87:126:0.6905
chr2	203620101	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	33,71:104:0.6827
chr2	203827858	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	39,83:122:0.6803
chr2	204056112	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	82,31:113:0.2743
chr2	204673724	.	C	G	.	PASS	CSQ=117583|protein_coding||intron_variant|||||||NM_001302769.2:c.121-12457C>G||MODIFIER||||||PARD3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	95,41:136:0.3015
chr2	205040638	.	G	GT	.	PASS	CSQ=117583|protein_coding||intron_variant||||||6.57488e-06|NM_001302769.2:c.395-6936dup||MODIFIER||||||PARD3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	60,60:121:0.4959
chr2	205271556	.	G	T	.	PASS	CSQ=117583|protein_coding||intron_variant|||||||NM_001302769.2:c.2185+25734G>T||MODIFIER||||||PARD3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	91,41:132:0.3106
chr2	205740913	.	A	G	.	PASS	CSQ=8828|protein_coding||intron_variant||||rs532982447||6.56875e-06|NM_003872.2:c.1291+250A>G||MODIFIER||||||NRP2|EntrezGene|0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	54,80:134:0.597
chr2	205897887	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	80,32:112:0.2857
chr2	205968065	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:110:0	35,71:106:0.6698
chr2	206352050	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	73,28:101:0.2772
chr2	206354401	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	67,39:106:0.3679
chr2	206559408	.	G	A	.	PASS	CSQ=8745|protein_coding||intron_variant|||||||NM_003812.4:c.1006-547G>A||MODIFIER||||||ADAM23|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	37,71:108:0.6574
chr2	207061780	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs556874328||0.000289223|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	34,78:112:0.6964
chr2	207067832	.	CT	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	113,0:114:0	26,72:98:0.7347
chr2	207147400	.	C	T	.	PASS	CSQ=8609|protein_coding||intron_variant|||||||NM_003709.4:c.102+18067G>A||MODIFIER||||||KLF7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	84,39:123:0.3171
chr2	207279380	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	29,72:101:0.7129
chr2	207372843	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	112,9:121:0.0744
chr2	207372872	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	120,11:131:0.084
chr2	207373357	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1363895816||6.57575e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	122,0:122:0	108,10:118:0.0847
chr2	207375917	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	97,9:106:0.0849
chr2	207458935	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs918535310||6.67352e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	87,40:127:0.315
chr2	207676697	.	G	C	.	PASS	CSQ=102724714|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135566.1:n.329+1624G>C||MODIFIER||||||LINC01857|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	62,0:63:0	63,25:94:0.266
chr2	207677606	COSV63017702;COSV63017702	G	A	.	PASS	CSQ=102724714|lncRNA||intron_variant&non_coding_transcript_variant|||COSV63017702&COSV63017702||||NR_135566.1:n.330-936G>A||MODIFIER||||||LINC01857|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	102,37:139:0.2662
chr2	207677739	.	G	C	.	PASS	CSQ=102724714|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135566.1:n.330-803G>C||MODIFIER||||||LINC01857|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	71,42:113:0.3717
chr2	208080986	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	59,35:94:0.3723
chr2	208231406	.	A	G	.	PASS	CSQ=3417|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||IDH1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/IDH1|y|n|glioblastoma|||O|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	38,65:103:0.6311
chr2	209069246	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	78,31:109:0.2844
chr2	209180288	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	85,48:133:0.3609
chr2	209200566	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	28,81:109:0.7431
chr2	209382895	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	35,78:113:0.6903
chr2	209907363	.	G	A	.	PASS	CSQ=285175|protein_coding||intron_variant|||||||NM_032504.1:c.4584+2398G>A||MODIFIER||||||UNC80|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	75,27:102:0.2647
chr2	210159771	.	GC	G	.	PASS	CSQ=151050|protein_coding||intron_variant|||||||NM_152519.4:c.-29-5161del||MODIFIER||||||KANSL1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	51,82:133:0.6165
chr2	210195252	.	C	T	.	PASS	CSQ=33|protein_coding||synonymous_variant||||rs377739826|4.78053e-05|5.25852e-05|NM_001608.4:c.1071G>A|NP_001599.1:p.Ala357=|LOW||||||ACADL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	130,0:130:0	33,88:121:0.7273
chr2	210352446	.	C	A	.	PASS	CSQ=102724820|lncRNA||intron_variant&non_coding_transcript_variant||||rs1446850759||6.57125e-06|NR_110604.1:n.123+27612C>A||MODIFIER||||||LANCL1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,41:107:0.3832
chr2	210497477	.	A	G	.	PASS	CSQ=1373|protein_coding||intron_variant|||||||NM_001122633.2:c.3+19711A>G||MODIFIER||||||CPS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	54,28:82:0.3415
chr2	210704978	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	70,39:109:0.3578
chr2	210943999	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	58,44:102:0.4314
chr2	211265966	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs947844356|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,42:116:0.3621
chr2	211341085	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	66,39:105:0.3714
chr2	211433364	.	G	A	.	PASS	CSQ=2066|protein_coding||intron_variant||||rs996985620||4.60842e-05|NM_005235.3:c.2488-2264C>T||MODIFIER||||||ERBB4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERBB4|y|y|melanoma,gastric,NSCLC|||E|Dom|oncogene,TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	62,48:110:0.4364
chr2	211644724	.	A	C	.	PASS	CSQ=2066|protein_coding||intron_variant|||||||NM_005235.3:c.1946+13030T>G||MODIFIER||||||ERBB4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERBB4|y|y|melanoma,gastric,NSCLC|||E|Dom|oncogene,TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	25,78:103:0.7573
chr2	211792417	.	G	A	.	PASS	CSQ=2066|protein_coding||intron_variant||||rs919933319||2.6396e-05|NM_005235.3:c.422-4258C>T||MODIFIER||||||ERBB4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERBB4|y|y|melanoma,gastric,NSCLC|||E|Dom|oncogene,TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	37,77:114:0.6754
chr2	211924488	.	G	C	.	PASS	CSQ=2066|protein_coding||intron_variant|||||||NM_005235.3:c.421+22942C>G||MODIFIER||||||ERBB4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERBB4|y|y|melanoma,gastric,NSCLC|||E|Dom|oncogene,TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	40,74:114:0.6491
chr2	212077380	.	CA	C	.	PASS	CSQ=2066|protein_coding||intron_variant|||||||NM_005235.3:c.234+47371del||MODIFIER||||||ERBB4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERBB4|y|y|melanoma,gastric,NSCLC|||E|Dom|oncogene,TSG|Mis,N;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	35,68:103:0.6602
chr2	212253746	.	A	T	.	PASS	CSQ=2066|protein_coding||intron_variant|||||||NM_005235.3:c.83-128843T>A||MODIFIER||||||ERBB4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERBB4|y|y|melanoma,gastric,NSCLC|||E|Dom|oncogene,TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	37,65:102:0.6373
chr2	212443309	.	G	C	.	PASS	CSQ=2066|protein_coding||intron_variant|||||||NM_005235.3:c.82+95140C>G||MODIFIER||||||ERBB4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERBB4|y|y|melanoma,gastric,NSCLC|||E|Dom|oncogene,TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	50,86:136:0.6324
chr2	212474378	.	T	A	.	PASS	CSQ=2066|protein_coding||intron_variant|||||||NM_005235.3:c.82+64071A>T||MODIFIER||||||ERBB4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERBB4|y|y|melanoma,gastric,NSCLC|||E|Dom|oncogene,TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	36,81:117:0.6923
chr2	212563316	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	79,28:107:0.2617
chr2	212864487	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	36,82:118:0.6949
chr2	213224335	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	41,78:119:0.6555
chr2	213284310	.	G	A	.	PASS	CSQ=100130451|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||LOC100130451|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	136,0:136:0	57,98:155:0.6323
chr2	213625096	.	G	GT	.	PASS	CSQ=79582|protein_coding||intron_variant|||||||NM_024532.5:c.1070+135012dup||MODIFIER||||||SPAG16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	47,66:113:0.5841
chr2	213675494	.	TC	T	.	PASS	CSQ=79582|protein_coding||intron_variant|||||||NM_024532.5:c.1070+185405del||MODIFIER||||||SPAG16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	82,35:117:0.2991
chr2	213990036	.	G	A	.	PASS	CSQ=79582|protein_coding||intron_variant||||rs1192177582||6.57696e-06|NM_024532.5:c.1401-23915G>A||MODIFIER||||||SPAG16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	24,88:112:0.7857
chr2	214213287	.	A	AT	.	PASS	CSQ=79582|protein_coding||intron_variant|||||||NM_024532.5:c.1720+64028dup||MODIFIER||||||SPAG16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	72,35:107:0.3271
chr2	214337985	.	G	A	.	PASS	CSQ=79582|protein_coding||intron_variant||||||6.57877e-06|NM_024532.5:c.1721-72155G>A||MODIFIER||||||SPAG16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	100,39:139:0.2806
chr2	214373977	.	C	T	.	PASS	CSQ=79582|protein_coding||intron_variant|||||||NM_024532.5:c.1721-36163C>T||MODIFIER||||||SPAG16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	33,88:121:0.7273
chr2	214487109	.	G	A	.	PASS	CSQ=402117|protein_coding||intron_variant|||||||NM_001080500.4:c.520+50351G>A||MODIFIER||||||VWC2L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	36,84:120:0.7
chr2	214651248	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	75,45:120:0.375
chr2	214809866	.	G	A	.	PASS	CSQ=101928103|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC101928103|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	92,57:149:0.3826
chr2	215364615	.	G	T	.	PASS	CSQ=2335|protein_coding||intron_variant|||||||NM_212482.3:c.7251+264C>A||MODIFIER||||||FN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	43,101:144:0.7014
chr2	215713490	.	C	A	.	PASS	CSQ=105373869|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01614|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	78,48:126:0.381
chr2	216245260	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	62,32:94:0.3404
chr2	216275567	.	T	A	.	PASS	CSQ=57574|protein_coding||intron_variant|||||||NM_020814.3:c.865+2105A>T||MODIFIER||||||MARCH4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	38,79:117:0.6752
chr2	216294215	.	C	T	.	PASS	CSQ=57574|protein_coding||intron_variant|||||||NM_020814.3:c.517-10486G>A||MODIFIER||||||MARCH4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	80,39:119:0.3277
chr2	216423391	.	TCACAACC	T	.	PASS	CSQ=50485|protein_coding||intron_variant|||||||NM_014140.3:c.1097-240_1097-234del||MODIFIER||||||SMARCAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	83,30:113:0.2655
chr2	216629301	.	C	T	.	PASS	CSQ=3485|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||IGFBP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	107,16:123:0.1301
chr2	216679597	.	A	T	.	PASS	CSQ=3488|protein_coding||intron_variant|||||||NM_000599.4:c.338-518T>A||MODIFIER||||||IGFBP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	41,92:133:0.6917
chr2	217216247	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,1:103:0.0097	37,73:110:0.6636
chr2	217303083	.	C	T	.	PASS	CSQ=105373877|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_133642.1:n.400+298C>T||MODIFIER||||||DIRC3-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	39,84:123:0.6829
chr2	217408138	.	G	A	.	PASS	CSQ=729582|lncRNA||intron_variant&non_coding_transcript_variant||||rs1188324845|||NR_026597.2:n.2290+17164C>T||MODIFIER||||||DIRC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,33:104:0.3173
chr2	217426766	.	T	C	.	PASS	CSQ=729582|lncRNA||non_coding_transcript_exon_variant|||||||NR_026597.2:n.1894A>G||MODIFIER||||||DIRC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	100,0:100:0	31,84:115:0.7304
chr2	217760364	.	G	A	.	PASS	CSQ=729582|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||DIRC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	42,78:120:0.65
chr2	217965154	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	43,93:136:0.6838
chr2	217981729	.	CC	AA	.	PASS	CSQ=105373878|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135524.1:n.138+2885_138+2886delinsAA||MODIFIER||||||LOC105373878|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	115,0:115:0	63,31:94:0.3298
chr2	218312213	.	CTCTT	C	.	PASS	CSQ=25953|protein_coding||intron_variant||||rs1421864996||1.97086e-05|NM_015488.5:c.237-27564_237-27561del||MODIFIER||||||PNKD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	123,0:123:0	107,37:144:0.2569
chr2	218371453	.	G	T	.	PASS	CSQ=375307|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CATIP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	42,77:120:0.6417
chr2	218681446	COSV55327813;COSV55327813;COSV55327813;COSV55327813;COSV55327813	G	GT	.	PASS	CSQ=27148|protein_coding||intron_variant|COSV55327813&COSV55327813&COSV55327813|p.?&p.?&p.?|COSV55327813&COSV55327813|rs1218756262||2.63616e-05|NM_015690.5:c.1236+752dup||MODIFIER||||||STK36|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	49,64:114:0.5614
chr2	218811230	.	C	G	.	PASS	CSQ=1593|protein_coding||intron_variant|||||||NM_000784.4:c.447-992C>G||MODIFIER||||||CYP27A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	84,51:135:0.3778
chr2	219564941	.	C	T	.	PASS	CSQ=23363|protein_coding||intron_variant||||rs1446861868||1.31439e-05|NM_015311.3:c.2407+301G>A||MODIFIER||||||OBSL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	39,84:123:0.6829
chr2	220100021	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs868545850||5.2596e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	36,60:96:0.625
chr2	220799698	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	55,90:145:0.6207
chr2	220882739	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	68,32:100:0.32
chr2	221050088	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	67,34:101:0.3366
chr2	221827283	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	112,31:143:0.2168
chr2	221922759	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	95,38:133:0.2857
chr2	222291557	.	C	A	.	PASS	CSQ=5077|protein_coding||intron_variant|||||||NM_181459.3:c.586+2610G>T||MODIFIER||||||PAX3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PAX3|y|n|alveolar_rhabdomyosarcoma|||M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	75,32:107:0.2991
chr2	222592504	.	ATCTGT	A	.	PASS	CSQ=10056|protein_coding||intron_variant|||||||NM_005687.4:c.1618+7419_1618+7423del||MODIFIER||||||FARSB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	96,39:135:0.2889
chr2	222844201	.	T	TTG	.	PASS	CSQ=|||intergenic_variant||||rs1386630400|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	64,5:69:0.0725	31,58:92:0.6304
chr2	223213754	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	88,43:131:0.3282
chr2	223507883	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	25,70:95:0.7368
chr2	224392754	.	C	CA	.	PASS	CSQ=79843|protein_coding||intron_variant||||rs1397211946||0.020256|NM_001122779.2:c.732+8282dup||MODIFIER||||||FAM124B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	72,23:98:0.2347
chr2	224439627	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	104,7:111:0.0631
chr2	224478406	.	GC	G	.	PASS	CSQ=8452|protein_coding||intron_variant|||||||NM_003590.5:c.2030-62del||MODIFIER||||||CUL3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CUL3|y|n|lung_cancer|||E||TSG|N;HighConfidence;TYPE=DEL;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	138,0:138:0	37,57:94:0.6064
chr2	224478410	.	A	T	.	PASS	CSQ=8452|protein_coding||intron_variant|||||||NM_003590.5:c.2030-65T>A||MODIFIER||||||CUL3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CUL3|y|n|lung_cancer|||E||TSG|N;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	135,0:135:0	37,57:94:0.6064
chr2	224478413	.	ATAAT	A	.	PASS	CSQ=8452|protein_coding||intron_variant|||||||NM_003590.5:c.2030-72_2030-69del||MODIFIER||||||CUL3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CUL3|y|n|lung_cancer|||E||TSG|N;HighConfidence;TYPE=DEL;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	127,0:127:0	38,55:93:0.5914
chr2	224594781	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	35,66:101:0.6535
chr2	224826643	.	C	T	.	PASS	CSQ=55619|protein_coding||intron_variant||||rs896060482||3.28744e-05|NM_001290263.1:c.3019-2996G>A||MODIFIER||||||DOCK10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	34,81:115:0.7043
chr2	225307881	COSV62145901	A	T	.	PASS	CSQ=|||intergenic_variant|||COSV62145901|rs765468412|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	113,0:113:0	107,4:111:0.036
chr2	225404163	.	G	T	.	PASS	CSQ=57624|protein_coding||intron_variant|||||||NM_020864.1:c.-18+3120G>T||MODIFIER||||||NYAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	121,5:126:0.0397
chr2	225491487	.	G	T	.	PASS	CSQ=57624|protein_coding||intron_variant|||||||NM_020864.1:c.222-21884G>T||MODIFIER||||||NYAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	82,41:123:0.3333
chr2	225691193	.	AGC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	42,59:101:0.5842
chr2	225691238	.	CAGCTTTATGAGCCTAT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	47,65:112:0.5804
chr2	225694435	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	41,74:115:0.6435
chr2	225698612	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	35,63:98:0.6429
chr2	225704896	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	31,63:94:0.6702
chr2	225717358	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	31,67:98:0.6837
chr2	225723012	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	39,67:106:0.6321
chr2	225723183	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	44,66:110:0.6
chr2	225732681	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	41,81:122:0.6639
chr2	225751051	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:106:0.0094	72,33:105:0.3143
chr2	225860358	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	34,76:110:0.6909
chr2	226051911	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	52,78:130:0.6
chr2	226257090	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	90,31:121:0.2562
chr2	226264871	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	42,83:125:0.664
chr2	226510864	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs375691550||6.57384e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	89,47:136:0.3456
chr2	226805740	.	A	AT	.	PASS	CSQ=84236|protein_coding||intron_variant|||||||NM_001349069.1:c.-479-1740dup||MODIFIER||||||RHBDD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	87,46:134:0.3433
chr2	227676145	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs112476952||0.106465|||MODIFIER||||||||0.1206;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	68,40:110:0.3636
chr2	227764198	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1321545112||1.31626e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	35,71:106:0.6698
chr2	227892903	.	A	G	.	PASS	CSQ=164781|protein_coding||intron_variant||||rs895173951||1.31392e-05|NM_178821.3:c.318-892A>G||MODIFIER||||||DAW1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	83,39:122:0.3197
chr2	228324413	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	74,32:106:0.3019
chr2	228356041	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	66,39:105:0.3714
chr2	228510212	.	A	G	.	PASS	CSQ=101928765|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_151716.1:n.145-3703T>C||MODIFIER||||||LINC01807|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	69,32:101:0.3168
chr2	228522057	.	G	C	.	PASS	CSQ=101928765|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_151716.1:n.145-15548C>G||MODIFIER||||||LINC01807|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	72,32:104:0.3077
chr2	228824972	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	85,43:128:0.3359
chr2	228951698	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs553961361||1.97288e-05|||MODIFIER||||||||0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	63,37:100:0.37
chr2	229054096	.	TA	T	.	PASS	CSQ=55022|protein_coding||intron_variant||||rs904247723||2.96745e-05|NM_001100818.1:c.178-27989del||MODIFIER||||||PID1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	46,59:105:0.5619
chr2	229103738	.	G	A	.	PASS	CSQ=55022|protein_coding||intron_variant||||rs1298742603||5.26759e-05|NM_001100818.1:c.177+52080C>T||MODIFIER||||||PID1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	28,60:88:0.6818
chr2	229194232	.	C	T	.	PASS	CSQ=55022|protein_coding||intron_variant||||rs918340719|||NM_001100818.1:c.31-38268G>A||MODIFIER||||||PID1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	79,44:123:0.3577
chr2	229233867	.	G	T	.	PASS	CSQ=55022|protein_coding||intron_variant|||||||NM_001100818.1:c.30+37147C>A||MODIFIER||||||PID1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	38,78:116:0.6724
chr2	229284120	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1454534673|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:103:0	37,91:128:0.7109
chr2	229706896	.	A	AT	.	PASS	CSQ=92737|protein_coding||intron_variant||||rs1211719849||0.00013209|NM_139072.4:c.276+7251dup||MODIFIER||||||DNER|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	47,92:139:0.6619
chr2	230228336	.	G	C	.	PASS	CSQ=3431|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SP110|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	51,87:138:0.6304
chr2	230248469	.	G	GA	.	PASS	CSQ=11262|protein_coding||intron_variant||||rs1378693227||3.29889e-05|NM_007237.5:c.893-408dup||MODIFIER||||||SP140|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	117,0:117:0	61,19:80:0.2375
chr2	230366602	.	T	A	.	PASS	CSQ=93349|protein_coding||intron_variant|||||||NM_138402.5:c.524-4306T>A||MODIFIER||||||SP140L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	103,32:135:0.237
chr2	231451606	.	G	A	.	PASS	CSQ=6082|snoRNA||downstream_gene_variant||||rs1226489719||1.97122e-05|||MODIFIER||||||SNORD20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	39,80:119:0.6723
chr2	231553168	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	90,46:136:0.3382
chr2	231556253	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||||8.17702e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	43,65:108:0.6019
chr2	231573095	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	88,40:128:0.3125
chr2	231607962	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	75,39:114:0.3421
chr2	231863002	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	33,79:112:0.7054
chr2	232765832	.	G	C	.	PASS	CSQ=3769|protein_coding||3_prime_UTR_variant|||||||NM_002242.4:c.*2359C>G||MODIFIER||||||KCNJ13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2,lancet;num_callers=2	AD:DP:AF	113,0:120:0	45,83:137:0.6058
chr2	233046611	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	80,48:128:0.375
chr2	233070564	.	C	T	.	PASS	CSQ=3635|protein_coding||intron_variant|||||||NM_001017915.3:c.135-8771C>T||MODIFIER||||||INPP5D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	35,85:120:0.7083
chr2	233183969	.	G	A	.	PASS	CSQ=3635|protein_coding||intron_variant|||||||NM_001017915.3:c.2162-439G>A||MODIFIER||||||INPP5D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	81,47:128:0.3672
chr2	233551661	.	T	A	.	PASS	CSQ=55230|protein_coding||intron_variant|||||||NM_001365479.1:c.694-142A>T||MODIFIER||||||USP40|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	38,81:119:0.6807
chr2	233561100	.	T	C	.	PASS	CSQ=55230|protein_coding||intron_variant|||||||NM_001365479.1:c.268-1176A>G||MODIFIER||||||USP40|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	37,83:120:0.6917
chr2	233851519	.	G	A	.	PASS	CSQ=55355|protein_coding||intron_variant|||||||NM_018410.5:c.240+1046C>T||MODIFIER||||||HJURP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	84,39:123:0.3171
chr2	234125814	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs573865679||0.237467|||MODIFIER||||||||0.2720;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	104,0:104:0	74,21:97:0.2165
chr2	234823103	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	89,12:101:0.1188
chr2	234831374	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	35,86:121:0.7107
chr2	235067435	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1324149737||3.95023e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	94,51:145:0.3517
chr2	235327814	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	54,86:140:0.6143
chr2	235822795	.	G	A	.	PASS	CSQ=116987|protein_coding||intron_variant|||||||NM_001037131.3:c.1050+15464G>A||MODIFIER||||||AGAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	46,90:136:0.6618
chr2	236423339	.	T	A	.	PASS	CSQ=79781|protein_coding||intron_variant|||||||NM_024726.5:c.1012-4068A>T||MODIFIER||||||IQCA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:95:0	41,90:131:0.687
chr2	236428792	.	T	A	.	PASS	CSQ=79781|protein_coding||intron_variant|||||||NM_024726.5:c.1012-9521A>T||MODIFIER||||||IQCA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	48,73:121:0.6033
chr2	236761019	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	41,67:108:0.6204
chr2	236820746	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	40,81:121:0.6694
chr2	237636113	.	AAAT	A	.	PASS	CSQ=9208|protein_coding||intron_variant|||||||NM_001137550.2:c.96+8374_96+8376del||MODIFIER||||||LRRFIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	86,32:118:0.2712
chr2	237775260	.	G	A	.	PASS	CSQ=9208|protein_coding||intron_variant|||||||NM_001137550.2:c.1812+798G>A||MODIFIER||||||LRRFIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	82,57:139:0.4101
chr2	238143960	.	G	C	.	PASS	CSQ=377007|protein_coding||intron_variant|||||||NM_198582.4:c.908-942G>C||MODIFIER||||||KLHL30|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	118,46:164:0.2805
chr2	238290337	.	C	G	.	PASS	CSQ=8864|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PER2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:108:0	74,34:108:0.3148
chr2	238575168	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	37,69:106:0.6509
chr2	238594077	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	72,41:113:0.3628
chr2	238755307	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	36,69:105:0.6571
chr2	239724296	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.56927e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	92,35:127:0.2756
chr2	239919987	.	T	C	.	PASS	CSQ=4705|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_136158.1:n.4034-6997A>G||MODIFIER||||||NDUFA10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	119,16:136:0.1176
chr2	240096180	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	85,37:122:0.3033
chr2	240382614	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	45,87:132:0.6591
chr2	240635908	.	G	A	.	PASS	CSQ=2859|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||GPR35|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	85,48:133:0.3609
chr2	240840961	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	117,49:166:0.2952
chr3	265855	.	G	A	.	PASS	CSQ=10752|protein_coding||intron_variant|||||||NM_006614.4:c.-95+21163G>A||MODIFIER||||||CHL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,67:67:1
chr3	528560	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,71:71:1
chr3	533770	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	73,4:77:0.0519
chr3	585377	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	1,60:61:0.9836
chr3	988561	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	127,0:127:0	79,4:83:0.0482
chr3	1230540	.	G	T	.	PASS	CSQ=27255|protein_coding||intron_variant||||||6.57289e-06|NM_001289080.2:c.358+2547G>T||MODIFIER||||||CNTN6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	59,11:70:0.1571
chr3	1405729	.	G	A	.	PASS	CSQ=27255|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CNTN6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,86:86:1
chr3	1726662	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	34,25:59:0.4237
chr3	1796620	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,86:86:1
chr3	1800833	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	100,0:100:0	0,57:57:1
chr3	1872471	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,74:74:1
chr3	1913509	.	T	TG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	2,86:88:0.9773
chr3	2030524	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,71:71:1
chr3	2060793	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1296800238|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	9,52:62:0.8387
chr3	2123770	.	C	T	.	PASS	CSQ=100873976|lncRNA||intron_variant&non_coding_transcript_variant||||||6.57151e-06|NR_046555.1:n.202+8591G>A||MODIFIER||||||CNTN4-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	51,3:54:0.0556
chr3	2257459	.	A	T	.	PASS	CSQ=152330|protein_coding||intron_variant|||||||NM_175607.3:c.-144-81719A>T||MODIFIER||||||CNTN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,93:93:1
chr3	2442301	.	C	CA	.	PASS	CSQ=152330|protein_coding||intron_variant||||rs1407024775||1.31954e-05|NM_175607.3:c.-89+103075dup||MODIFIER||||||CNTN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	6,49:55:0.8909
chr3	2544496	.	A	T	.	PASS	CSQ=152330|protein_coding||intron_variant|||||||NM_175607.3:c.-88-26920A>T||MODIFIER||||||CNTN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,69:69:1
chr3	2858334	.	T	A	.	PASS	CSQ=152330|protein_coding||intron_variant|||||||NM_175607.3:c.455-8418T>A||MODIFIER||||||CNTN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	0,90:90:1
chr3	3100682	.	A	T	.	PASS	CSQ=3568|protein_coding||intron_variant|||||||NM_175726.3:c.367+1010T>A||MODIFIER||||||IL5RA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,69:69:1
chr3	3220402	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	4,71:75:0.9467
chr3	3358526	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,76:76:1
chr3	3379465	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	54,9:63:0.1429
chr3	3471582	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,77:77:1
chr3	3618352	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,65:65:1
chr3	3695482	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs369717098||2.62936e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,72:72:1
chr3	3795692	.	T	A	.	PASS	CSQ=57633|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||LRRN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,86:86:1
chr3	3872468	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,83:83:1
chr3	3901818	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,94:94:1
chr3	4317147	COSV62781295;COSV62781295;COSV62781295;COSV62781295;COSV62781295;COSV62781295	C	T	.	PASS	CSQ=6419|protein_coding||synonymous_variant|COSV62781295&COSV62781295|p.F513&p.F652|COSV62781295&COSV62781295&COSV62781295&COSV62781295|rs1310506493&COSM6291195|2.63258e-05|1.97254e-05|NM_006515.3:c.1956C>T|NP_006506.3:p.Phe652=|LOW||||||SETMAR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	91,0:91:0	0,86:86:1
chr3	5215829	.	T	A	.	PASS	CSQ=9695|protein_coding||missense_variant&splice_region_variant|||||||NM_014674.3:c.1885T>A|NP_055489.1:p.Cys629Ser|MODERATE|D|D|D|D|D|EDEM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	119,0:119:0	0,86:86:1
chr3	5349555	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,93:93:1
chr3	5872464	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	2,77:79:0.9747
chr3	5946864	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1051565012||7.89214e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,59:59:1
chr3	6121516	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1247098232||1.35853e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:91:0	0,68:68:1
chr3	6465460	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs867980126||5.26579e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,61:61:1
chr3	6600589	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,70:70:1
chr3	6818163	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1309580516|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	65,10:75:0.1333
chr3	7020883	.	G	C	.	PASS	CSQ=2917|protein_coding||intron_variant||||||6.57281e-06|NM_000844.4:c.520-125569G>C||MODIFIER||||||GRM7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,66:66:1
chr3	7421996	.	G	A	.	PASS	CSQ=2917|protein_coding||intron_variant|||||||NM_000844.4:c.1174+6833G>A||MODIFIER||||||GRM7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,68:68:1
chr3	8109417	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||||6.57808e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	10,68:78:0.8718
chr3	8175297	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs770768098||6.57903e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	1,76:77:0.987
chr3	8324158	.	G	A	.	PASS	CSQ=100288428|lncRNA||intron_variant&non_coding_transcript_variant||||rs896934836||1.31435e-05|NR_033378.1:n.575-101439C>T||MODIFIER||||||LMCD1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,89:89:1
chr3	8402325	.	C	T	.	PASS	CSQ=100288428|lncRNA||intron_variant&non_coding_transcript_variant||||rs535105872||6.57125e-06|NR_033378.1:n.574+92356G>A||MODIFIER||||||LMCD1-AS1|EntrezGene|0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,87:87:1
chr3	8834999	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,89:89:1
chr3	10053151	.	G	T	.	PASS	CSQ=2177|protein_coding||intron_variant|||||||NM_001018115.2:c.1656+654G>T||MODIFIER||||||FANCD2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FANCD2|n|y||AML,leukaemia|Fanconi_anaemia_D2|L|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	11,79:90:0.8778
chr3	10164790	.	G	A	.	PASS	CSQ=3656|protein_coding||upstream_gene_variant||||rs1294422776||6.57099e-06|||MODIFIER||||||IRAK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	123,0:123:0	0,64:64:1
chr3	10350826	.	T	C	.	PASS	CSQ=491|protein_coding||intron_variant|||||||NM_001001331.4:c.2137-249A>G||MODIFIER||||||ATP2B2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,88:88:1
chr3	10586994	.	A	T	.	PASS	CSQ=491|protein_coding||intron_variant|||||||NM_001353564.1:c.-415+32923T>A||MODIFIER||||||ATP2B2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,87:87:1
chr3	10662445	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs201346463||0.0112193|||MODIFIER||||||||0.2774;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	60,3:63:0.0476	0,8:8:1
chr3	10662503	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs200960968||0.011513|||MODIFIER||||||||0.2879;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	58,4:62:0.0645	0,13:13:1
chr3	11052016	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1385827204||1.31447e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	1,85:86:0.9884
chr3	11278208	.	C	G	.	PASS	CSQ=10533|protein_coding||intron_variant|||||||NM_001349232.1:c.-365-2786C>G||MODIFIER||||||ATG7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	0,68:68:1
chr3	11334992	.	C	G	.	PASS	CSQ=10533|protein_coding||intron_variant||||rs1367599780|||NM_001349232.1:c.889+1899C>G||MODIFIER||||||ATG7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,72:74:0.973
chr3	11336140	.	TC	T	.	PASS	CSQ=10533|protein_coding||intron_variant|||||||NM_001349232.1:c.889+3048del||MODIFIER||||||ATG7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	5,69:74:0.9324
chr3	11336144	.	C	T	.	PASS	CSQ=10533|protein_coding||intron_variant|||||||NM_001349232.1:c.889+3051C>T||MODIFIER||||||ATG7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	0,66:66:1
chr3	11337474	.	C	G	.	PASS	CSQ=10533|protein_coding||intron_variant|||||||NM_001349232.1:c.890-3171C>G||MODIFIER||||||ATG7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	2,79:81:0.9753
chr3	11337723	.	C	T	.	PASS	CSQ=10533|protein_coding||intron_variant|||||||NM_001349232.1:c.890-2922C>T||MODIFIER||||||ATG7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,79:79:1
chr3	12427063	.	C	T	.	PASS	CSQ=5468|protein_coding||intron_variant||||rs1427003678||1.3147e-05|NM_138711.3:c.1187-6835C>T||MODIFIER||||||PPARG|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PPARG|y|n|follicular_thyroid|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,79:79:1
chr3	12843456	.	A	C	.	PASS	CSQ=6161|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||RPL32|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,78:78:1
chr3	12915667	.	C	T	.	PASS	CSQ=9922|protein_coding||missense_variant||||rs202207235|2.38595e-05|6.57056e-06|NM_001134382.3:c.2087G>A|NP_001127854.1:p.Arg696Gln|MODERATE|B&.&.&.&.&.&.|T&.&.&.&.&.&.|D|T&.&T&.&T&.&.|T&.&.&.&.&.&.|IQSEC1|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:112:0	0,93:93:1
chr3	13303584	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	0,90:90:1
chr3	13308682	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,86:86:1
chr3	13843149	.	G	A	.	PASS	CSQ=7476|protein_coding||intron_variant|||||||NM_004625.3:c.570+11383C>T||MODIFIER||||||WNT7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	1,89:90:0.9889
chr3	13984643	.	G	T	.	PASS	CSQ=348825|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_002223.3:n.173+47164G>T||MODIFIER||||||TPRXL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,75:75:1
chr3	14537017	.	G	C	.	PASS	CSQ=80852|protein_coding||intron_variant|||||||NM_001080423.4:c.40+3252C>G||MODIFIER||||||GRIP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,80:80:1
chr3	14800420	.	C	CT	.	PASS	CSQ=152274|lncRNA||non_coding_transcript_exon_variant|||||||NR_135245.1:n.2740dup||MODIFIER||||||LINC02011|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	6,68:74:0.9189
chr3	15856334	.	GT	G	.	PASS	CSQ=23243|protein_coding||intron_variant|||||||NM_015199.3:c.27+3042del||MODIFIER||||||ANKRD28|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,83:83:1
chr3	16012002	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	65,11:76:0.1447
chr3	16482793	.	G	A	.	PASS	CSQ=23180|protein_coding||intron_variant||||rs1463171982|7.32365e-06||NM_015150.2:c.145+10932C>T||MODIFIER||||||RFTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	131,0:131:0	0,88:88:1
chr3	16616018	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,73:73:1
chr3	17325025	.	G	A	.	PASS	CSQ=9779|protein_coding||intron_variant|||||||NM_001349078.1:c.996-16891C>T||MODIFIER||||||TBC1D5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,78:78:1
chr3	17442160	.	C	A	.	PASS	CSQ=9779|protein_coding||intron_variant|||||||NM_001349078.1:c.98-13641G>T||MODIFIER||||||TBC1D5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,81:81:1
chr3	17452231	.	A	T	.	PASS	CSQ=9779|protein_coding||intron_variant|||||||NM_001349078.1:c.98-23712T>A||MODIFIER||||||TBC1D5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,76:76:1
chr3	17781256	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	68,8:76:0.1053
chr3	17817896	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs927727651||1.97428e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,82:82:1
chr3	18217784	.	G	T	.	PASS	CSQ=339862|protein_coding||intron_variant|||||||NM_001257177.1:c.317-49234G>T||MODIFIER||||||LOC339862|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	27,24:51:0.4706
chr3	18779772	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,86:86:1
chr3	19239905	.	G	T	.	PASS	CSQ=131096|protein_coding||intron_variant|||||||NM_144633.3:c.77-13749G>T||MODIFIER||||||KCNH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	66,7:73:0.0959
chr3	19330720	.	A	C	.	PASS	CSQ=131096|protein_coding||intron_variant|||||||NM_144633.3:c.443-11867A>C||MODIFIER||||||KCNH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,74:74:1
chr3	19539453	.	C	A	.	PASS	CSQ=131096|protein_coding||downstream_gene_variant||||rs1413736778||3.28511e-05|||MODIFIER||||||KCNH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	63,10:73:0.137
chr3	19549374	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,91:91:1
chr3	20176905	.	C	A	.	PASS	CSQ=100874028|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_132785.1:n.325-312C>A||MODIFIER||||||SGO1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	2,89:91:0.978
chr3	20536680	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	0,77:77:1
chr3	20614331	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs957528233|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	61,10:71:0.1408
chr3	20730272	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,64:64:1
chr3	20902620	.	ATAAGAAACCAC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	4,68:72:0.9444
chr3	21304148	COSV50167606	A	G	.	PASS	CSQ=|||intergenic_variant|||COSV50167606|rs866700311||0.0116554|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	8,71:79:0.8987
chr3	21437833	.	G	T	.	PASS	CSQ=79750|protein_coding||intron_variant|||||||NM_024697.3:c.440-630C>A||MODIFIER||||||ZNF385D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	3,62:65:0.9538
chr3	21447136	.	G	T	.	PASS	CSQ=79750|protein_coding||intron_variant|||||||NM_024697.3:c.440-9933C>A||MODIFIER||||||ZNF385D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	155,0:155:0	0,79:79:1
chr3	21501231	.	G	A	.	PASS	CSQ=79750|protein_coding||intron_variant|||||||NM_024697.3:c.439+9630C>T||MODIFIER||||||ZNF385D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,64:64:1
chr3	21551319	.	C	A	.	PASS	CSQ=100874216|lncRNA||intron_variant&non_coding_transcript_variant||||rs979888836||2.62822e-05|NR_046731.1:n.207+8324C>A||MODIFIER||||||ZNF385D-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	36,43:79:0.5443
chr3	22058969	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1036182189||5.26434e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,71:71:1
chr3	22215118	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,71:71:1
chr3	22311595	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs553423702||0.000204066|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	71,12:83:0.1446
chr3	22351849	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,1:95:0.0105	0,56:56:1
chr3	22509701	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,60:60:1
chr3	22801360	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||1.31477e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,79:79:1
chr3	23018116	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1189773422||0.00054396|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,1:98:0.0102	7,51:59:0.8644
chr3	23076039	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,84:84:1
chr3	23099295	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,100:100:1
chr3	23420181	.	C	T	.	PASS	CSQ=7325|protein_coding||intron_variant||||||1.31465e-05|NM_152653.4:c.228-79427C>T||MODIFIER||||||UBE2E2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,75:75:1
chr3	23698895	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,73:73:1
chr3	24764825	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,83:83:1
chr3	24997983	.	C	G	.	PASS	CSQ=5915|protein_coding||intron_variant|||||||NM_001290216.2:c.-331-62142C>G||MODIFIER||||||RARB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,86:86:1
chr3	25155816	.	C	T	.	PASS	CSQ=5915|protein_coding||intron_variant|||||||NM_001290216.2:c.-279-18303C>T||MODIFIER||||||RARB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,58:58:1
chr3	25250688	.	A	T	.	PASS	CSQ=5915|protein_coding||intron_variant|||||||NM_001290216.2:c.178+76113A>T||MODIFIER||||||RARB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,66:66:1
chr3	25918576	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,61:61:1
chr3	27025155	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,79:79:1
chr3	27847710	.	C	T	.	PASS	CSQ=105377007|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146630.1:n.511-991C>T||MODIFIER||||||LINC01980|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,81:81:1
chr3	27847756	.	C	A	.	PASS	CSQ=105377007|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146630.1:n.511-945C>A||MODIFIER||||||LINC01980|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,76:76:1
chr3	28398789	.	G	C	.	PASS	CSQ=152098|protein_coding||intron_variant|||||||NM_001040432.4:c.-14+8172G>C||MODIFIER||||||ZCWPW2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,69:69:1
chr3	28640874	.	C	A	.	PASS	CSQ=645206|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038840.1:n.322+64378C>A||MODIFIER||||||LINC00693|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,81:81:1
chr3	28704766	.	G	T	.	PASS	CSQ=645206|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038840.1:n.323-51992G>T||MODIFIER||||||LINC00693|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,61:61:1
chr3	28920165	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,64:64:1
chr3	29143708	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,106:106:1
chr3	29160962	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,99:99:1
chr3	29243767	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	49,39:88:0.4432
chr3	29593549	.	A	G	.	PASS	CSQ=27303|protein_coding||intron_variant|||||||NM_001003793.2:c.399+6344A>G||MODIFIER||||||RBMS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	0,74:74:1
chr3	29650180	.	CAGAAA	C	.	PASS	CSQ=27303|protein_coding||intron_variant||||rs1338160527||6.59309e-06|NM_001003793.2:c.399+62982_399+62986del||MODIFIER||||||RBMS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	7,71:78:0.9103
chr3	30627819	.	CTTGAAT	C	.	PASS	CSQ=7048|protein_coding||intron_variant|||||||NM_001024847.2:c.169+4549_169+4554del||MODIFIER||||||TGFBR2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TGFBR2|y|y|head_and_neck,colorectal|colorectal|Hereditary_Nonpolyposis_Colorectal_Cancer_type_6|E|Rec|TSG|Mis,F,N;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,78:78:1
chr3	31315228	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,61:61:1
chr3	31740779	.	C	CA	.	PASS	CSQ=114884|protein_coding||intron_variant||||rs1177880794||0.00146585|NM_017784.4:c.940+7130dup||MODIFIER||||||OSBPL10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	5,50:55:0.9091
chr3	33167829	.	C	T	.	PASS	CSQ=26032|protein_coding||intron_variant|||||||NM_015551.2:c.598+7057G>A||MODIFIER||||||SUSD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,81:81:1
chr3	33363905	.	CT	C	.	PASS	CSQ=25827|protein_coding||intron_variant|||||||NM_012157.4:c.196-719del||MODIFIER||||||FBXL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,85:85:1
chr3	34867890	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,74:74:1
chr3	35135385	.	G	C	.	PASS	CSQ=101928135|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110817.1:n.206+171086C>G||MODIFIER||||||LOC101928135|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	0,58:58:1
chr3	35544934	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,58:58:1
chr3	36366634	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,85:85:1
chr3	36497910	.	AC	A	.	PASS	CSQ=6769|protein_coding||intron_variant|||||||NM_003149.2:c.766+4683del||MODIFIER||||||STAC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	2,67:69:0.971
chr3	36556948	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,78:78:1
chr3	36929753	.	C	T	.	PASS	CSQ=9881|protein_coding||intron_variant|||||||NM_001329998.1:c.23+15034G>A||MODIFIER||||||TRANK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	166,0:166:0	0,72:72:1
chr3	40090388	.	G	A	.	PASS	CSQ=25924|protein_coding||intron_variant|||||||NM_015460.4:c.332+46117G>A||MODIFIER||||||MYRIP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,16:86:0.186
chr3	41720432	.	C	A	.	PASS	CSQ=54986|protein_coding||intron_variant|||||||NM_017886.4:c.2322-2571G>T||MODIFIER||||||ULK4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,90:90:1
chr3	42962569	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs971896691||7.46907e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	8,86:94:0.9149
chr3	43204750	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,74:74:1
chr3	43848026	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,81:81:1
chr3	43985648	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	83,5:88:0.0568
chr3	44057969	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,73:73:1
chr3	44548481	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.57073e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,79:79:1
chr3	45589707	.	CAGGCTGGAGAACAGTGGTGCG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,81:81:1
chr3	47976048	.	C	T	.	PASS	CSQ=4134|protein_coding||intron_variant|||||||NM_002375.4:c.292+1817G>A||MODIFIER||||||MAP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,80:80:1
chr3	47976050	.	A	T	.	PASS	CSQ=4134|protein_coding||intron_variant|||||||NM_002375.4:c.292+1815T>A||MODIFIER||||||MAP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,80:80:1
chr3	48196086	.	G	A	.	PASS	CSQ=100616407|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR4443|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:144:0	0,84:84:1
chr3	48471542	.	G	C	.	PASS	CSQ=51246|protein_coding||intron_variant|||||||NM_016479.4:c.315-1699C>G||MODIFIER||||||SHISA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	61,0:61:0	0,53:54:0.9815
chr3	48938585	.	C	G	.	PASS	CSQ=10425|protein_coding||intron_variant|||||||NM_001317333.1:c.255+10772C>G||MODIFIER||||||ARIH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,91:91:1
chr3	49147596	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1437737693|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,54:54:1
chr3	49570430	.	G	T	.	PASS	CSQ=8927|protein_coding||intron_variant||||rs981501364||3.94529e-05|NM_003458.4:c.224+15604G>T||MODIFIER||||||BSN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,89:89:1
chr3	49799694	.	T	C	.	PASS	CSQ=389118|protein_coding||intron_variant|||||||NM_001007540.4:c.49+70A>G||MODIFIER||||||CDHR4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	139,0:139:0	0,85:85:1
chr3	50783140	.	G	A	.	PASS	CSQ=1795|protein_coding||intron_variant||||rs1314394287||1.31508e-05|NM_004947.5:c.121+4382G>A||MODIFIER||||||DOCK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,93:93:1
chr3	51313595	.	G	C	.	PASS	CSQ=1795|protein_coding||intron_variant|||||||NM_004947.5:c.3253+693G>C||MODIFIER||||||DOCK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,63:63:1
chr3	51760440	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1364663572||1.97441e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,64:64:1
chr3	52699962	.	C	A	.	PASS	CSQ=55830|protein_coding||intron_variant|||||||NM_001010983.2:c.115+300G>T||MODIFIER||||||GLT8D1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	124,0:124:0	72,5:77:0.0649
chr3	52773704	.	G	A	.	PASS	CSQ=3697|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ITIH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,83:83:1
chr3	53690158	.	C	A	.	PASS	CSQ=776|protein_coding||intron_variant|||||||NM_001128840.3:c.1221-12483C>A||MODIFIER||||||CACNA1D|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/CACNA1D|y|n|adrenal_aldosterone_producing_adenoma|||E|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,65:65:1
chr3	53719553	.	C	T	.	PASS	CSQ=776|protein_coding||intron_variant||||rs749656127||6.57229e-06|NM_001128840.3:c.1479-202C>T||MODIFIER||||||CACNA1D|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/CACNA1D|y|n|adrenal_aldosterone_producing_adenoma|||E|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,86:86:1
chr3	53919274	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	113,0:113:0	0,75:76:0.9868
chr3	54014810	.	GCTAAT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	58,0:58:0	21,13:34:0.3824
chr3	54798328	.	A	T	.	PASS	CSQ=55799|protein_coding||intron_variant|||||||NM_018398.2:c.1381-18525A>T||MODIFIER||||||CACNA2D3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,85:85:1
chr3	54814102	.	C	G	.	PASS	CSQ=55799|protein_coding||intron_variant|||||||NM_018398.2:c.1381-2751C>G||MODIFIER||||||CACNA2D3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,10:80:0.125
chr3	55136140	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,73:73:1
chr3	55276072	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,89:89:1
chr3	55463389	.	C	A	.	PASS	CSQ=7474|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||WNT5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,80:80:1
chr3	55581698	.	T	A	.	PASS	CSQ=26059|protein_coding||intron_variant|||||||NM_015576.3:c.*40-70422A>T||MODIFIER||||||ERC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,90:90:1
chr3	55583630	.	C	A	.	PASS	CSQ=26059|protein_coding||intron_variant|||||||NM_015576.3:c.*40-72354G>T||MODIFIER||||||ERC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	0,63:63:1
chr3	55583819	.	G	T	.	PASS	CSQ=26059|protein_coding||intron_variant|||||||NM_015576.3:c.*40-72543C>A||MODIFIER||||||ERC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	0,54:54:1
chr3	55839067	.	G	T	.	PASS	CSQ=26059|protein_coding||intron_variant|||||||NM_015576.3:c.2564+49322C>A||MODIFIER||||||ERC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,77:77:1
chr3	56029582	.	C	T	.	PASS	CSQ=26059|protein_coding||intron_variant|||||||NM_015576.3:c.1642-10551G>A||MODIFIER||||||ERC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,86:86:1
chr3	56100984	.	G	GA	.	PASS	CSQ=26059|protein_coding||intron_variant||||rs546255121||0.00395392|NM_015576.3:c.1474-20001dup||MODIFIER||||||ERC2|EntrezGene|0.0044;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	4,81:85:0.9529
chr3	56583506	.	G	A	.	PASS	CSQ=285331|protein_coding||intron_variant|||||||NM_001141947.2:c.937-9464G>A||MODIFIER||||||CCDC66|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,82:82:1
chr3	57394659	.	T	C	.	PASS	CSQ=201625|protein_coding||intron_variant||||rs1165693586||6.57125e-06|NM_001366028.1:c.6949-327A>G||MODIFIER||||||DNAH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,104:104:1
chr3	57630634	.	G	A	.	PASS	CSQ=201627|protein_coding||intron_variant|||||||NM_152678.3:c.1517+81C>T||MODIFIER||||||DENND6A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	130,0:130:0	0,86:86:1
chr3	57788513	.	AT	A	.	PASS	CSQ=7871|protein_coding||intron_variant|||||||NM_001304420.2:c.198+30665del||MODIFIER||||||SLMAP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	2,102:104:0.9808
chr3	57884393	.	G	C	.	PASS	CSQ=7871|protein_coding||intron_variant|||||||NM_001304420.2:c.1250-5648G>C||MODIFIER||||||SLMAP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,93:93:1
chr3	57957373	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	1,74:75:0.9867
chr3	57975335	.	GG	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	131,0:131:0	0,67:68:0.9853
chr3	58643051	.	C	G	.	PASS	CSQ=131177|protein_coding||intron_variant|||||||NM_138805.3:c.322+611G>C||MODIFIER||||||FAM3D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,87:87:1
chr3	58676391	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,87:87:1
chr3	58886711	.	T	TA	.	PASS	CSQ=200844|protein_coding||intron_variant||||rs1310705179||2.01194e-05|NM_001351530.1:c.551-16403dup||MODIFIER||||||C3orf67|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	15,78:95:0.8211
chr3	59372218	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,63:63:1
chr3	59552447	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,77:77:1
chr3	59622663	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	1,77:78:0.9872
chr3	59720133	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,74:74:1
chr3	60300627	.	G	T	.	PASS	CSQ=2272|protein_coding||intron_variant|||||||NM_002012.4:c.103+236233C>A||MODIFIER||||||FHIT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FHIT|y|n|pleomorphic_salivary_gland_adenoma|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,62:62:1
chr3	60742687	.	G	A	.	PASS	CSQ=2272|protein_coding||intron_variant|||||||NM_002012.4:c.-18+79232C>T||MODIFIER||||||FHIT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FHIT|y|n|pleomorphic_salivary_gland_adenoma|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	67,8:75:0.1067
chr3	60750243	.	C	G	.	PASS	CSQ=2272|protein_coding||intron_variant|||||||NM_002012.4:c.-18+71676G>C||MODIFIER||||||FHIT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FHIT|y|n|pleomorphic_salivary_gland_adenoma|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	81,11:92:0.1196
chr3	60750511	.	C	T	.	PASS	CSQ=2272|protein_coding||intron_variant|||||||NM_002012.4:c.-18+71408G>A||MODIFIER||||||FHIT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FHIT|y|n|pleomorphic_salivary_gland_adenoma|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	132,0:132:0	52,15:67:0.2239
chr3	61029547	.	C	A	.	PASS	CSQ=2272|protein_coding||intron_variant|||||||NM_002012.4:c.-111+12500G>T||MODIFIER||||||FHIT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FHIT|y|n|pleomorphic_salivary_gland_adenoma|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,61:61:1
chr3	61046416	.	T	C	.	PASS	CSQ=2272|protein_coding||intron_variant|||||||NM_002012.4:c.-163-4317A>G||MODIFIER||||||FHIT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FHIT|y|n|pleomorphic_salivary_gland_adenoma|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,65:65:1
chr3	61176507	.	C	A	.	PASS	CSQ=2272|protein_coding||intron_variant|||||||NM_002012.4:c.-164+24110G>T||MODIFIER||||||FHIT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FHIT|y|n|pleomorphic_salivary_gland_adenoma|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,75:75:1
chr3	61211843	.	G	A	.	PASS	CSQ=2272|protein_coding||intron_variant||||rs994715512|||NM_002012.4:c.-212-11178C>T||MODIFIER||||||FHIT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FHIT|y|n|pleomorphic_salivary_gland_adenoma|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,64:64:1
chr3	61374201	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	95,7:102:0.0686
chr3	62056973	.	C	T	.	PASS	CSQ=5793|protein_coding||intron_variant|||||||NM_002841.4:c.520-21190C>T||MODIFIER||||||PTPRG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,78:78:1
chr3	62431404	.	C	CT	.	PASS	CSQ=8618|protein_coding||intron_variant||||rs1001592279||0.00101716|NM_003716.4:c.3777+6699dup||MODIFIER||||||CADPS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	94,0:96:0	53,19:72:0.2639
chr3	62753549	.	G	T	.	PASS	CSQ=8618|protein_coding||synonymous_variant|||||||NM_003716.4:c.780C>A|NP_003707.2:p.Ala260=|LOW||||||CADPS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,1:103:0.0097	46,14:60:0.2333
chr3	63074400	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,1:119:0.0084	0,81:81:1
chr3	63118335	.	T	C	.	PASS	CSQ=285401|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027104.1:n.423-364T>C||MODIFIER||||||LINC00698|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	64,5:69:0.0725
chr3	63406486	.	A	T	.	PASS	CSQ=132204|protein_coding||intron_variant||||rs1219341902|||NM_001130003.2:c.85-74346A>T||MODIFIER||||||SYNPR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,63:63:1
chr3	63823809	.	T	A	.	PASS	CSQ=132200|protein_coding||intron_variant|||||||NM_001355236.2:c.445+240T>A||MODIFIER||||||C3orf49|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	6,82:88:0.9318
chr3	63865048	.	C	A	.	PASS	CSQ=80145|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||THOC7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	95,0:95:0	0,89:89:1
chr3	64076056	.	A	AT	.	PASS	CSQ=100652759|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_045697.1:n.198+7896dup||MODIFIER||||||PRICKLE2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	71,16:87:0.1839
chr3	66179566	.	C	T	.	PASS	CSQ=115286|protein_coding||intron_variant|||||||NM_173471.3:c.-353-41176C>T||MODIFIER||||||SLC25A26|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,92:92:1
chr3	66311077	.	C	G	.	PASS	CSQ=115286|protein_coding||intron_variant|||||||NM_173471.3:c.454-35287C>G||MODIFIER||||||SLC25A26|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,85:85:1
chr3	66378719	.	A	AT	.	PASS	CSQ=26018|protein_coding||downstream_gene_variant||||rs796921869||0.000989953|||MODIFIER||||||LRIG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	125,0:125:0	13,79:93:0.8495
chr3	66799187	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1386175114||7.40752e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	0,77:77:1
chr3	67102747	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs953014025|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	0,98:98:1
chr3	67901657	.	G	A	.	PASS	CSQ=101927111|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109992.1:n.1714+12548G>A||MODIFIER||||||SUCLG2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	81,4:85:0.0471
chr3	68051950	.	G	C	.	PASS	CSQ=407738|protein_coding||intron_variant|||||||NM_213609.4:c.118+45206G>C||MODIFIER||||||FAM19A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,68:68:1
chr3	69372090	.	G	T	.	PASS	CSQ=23150|protein_coding||intron_variant||||rs1253797652||6.57618e-06|NM_015123.3:c.162+13738C>A||MODIFIER||||||FRMD4B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	95,5:100:0.05
chr3	69593316	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,76:77:0.987
chr3	69917883	.	C	T	.	PASS	CSQ=4286|protein_coding||intron_variant||||rs1277616266||6.57756e-06|NM_001354604.1:c.355-19939C>T||MODIFIER||||||MITF|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MITF|y|n|melanoma|||E|Dom|oncogene|A;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,69:69:1
chr3	70376595	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	107,0:107:0	72,6:78:0.0769
chr3	70411352	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,70:70:1
chr3	70503812	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,80:80:1
chr3	71860689	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	76,71:147:0.483
chr3	71874711	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,1:128:0.0078	83,71:154:0.461
chr3	71911717	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs1331664667|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,92:92:1
chr3	72332881	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,67:67:1
chr3	72705759	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1019581875||1.31399e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	53,40:93:0.4301
chr3	73878395	.	A	G	.	PASS	CSQ=105377165|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146637.1:n.349-411A>G||MODIFIER||||||LINC02005|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,73:73:1
chr3	73920106	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	48,0:48:0	0,34:34:1
chr3	73932508	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	154,0:154:0	38,42:80:0.525
chr3	73963483	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,86:86:1
chr3	73967482	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,82:82:1
chr3	74354745	.	GA	G	.	PASS	CSQ=5067|protein_coding||intron_variant|||||||NM_020872.2:c.1364+7144del||MODIFIER||||||CNTN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	3,70:73:0.9589
chr3	74709728	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,81:81:1
chr3	74932550	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,73:73:1
chr3	75012671	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,74:74:1
chr3	75268926	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||||6.57479e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	5,68:73:0.9315
chr3	75300834	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	1,79:80:0.9875
chr3	75396002	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	68,0:68:0	0,80:80:1
chr3	75686521	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	386,0:386:0	181,63:244:0.2582
chr3	75706316	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	400,0:400:0	195,82:277:0.296
chr3	75891356	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,60:60:1
chr3	76155033	.	G	A	.	PASS	CSQ=6092|protein_coding||intron_variant|||||||NM_001128929.3:c.109+217431G>A||MODIFIER||||||ROBO2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/ROBO2|y|n|colorectal_adenocarcinoma,melanoma|||E||TSG|F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,71:71:1
chr3	77130454	.	A	T	.	PASS	CSQ=6092|protein_coding||intron_variant|||||||NM_001290040.1:c.388+32114A>T||MODIFIER||||||ROBO2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/ROBO2|y|n|colorectal_adenocarcinoma,melanoma|||E||TSG|F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,1:107:0.0093	0,78:78:1
chr3	77584525	.	G	A	.	PASS	CSQ=6092|protein_coding||intron_variant|||||||NM_001290040.1:c.2513-4226G>A||MODIFIER||||||ROBO2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/ROBO2|y|n|colorectal_adenocarcinoma,melanoma|||E||TSG|F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,69:69:1
chr3	77721022	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	0,70:70:1
chr3	77770585	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,73:73:1
chr3	77784103	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	154,0:154:0	109,33:142:0.2324
chr3	77910095	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1333224280||6.57583e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,80:81:0.9877
chr3	78058389	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1044532577|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	74,5:79:0.0633
chr3	78559690	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1345792421|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,85:85:1
chr3	78626482	.	G	A	.	PASS	CSQ=6091|protein_coding||intron_variant||||rs889578011||6.57774e-06|NM_002941.4:c.3875+839C>T||MODIFIER||||||ROBO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,81:81:1
chr3	78847024	.	G	T	.	PASS	CSQ=6091|protein_coding||intron_variant|||||||NM_002941.4:c.499+91577C>A||MODIFIER||||||ROBO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,67:67:1
chr3	78852829	.	T	A	.	PASS	CSQ=6091|protein_coding||intron_variant|||||||NM_002941.4:c.499+85772A>T||MODIFIER||||||ROBO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:137:0	33,38:71:0.5352
chr3	79320453	.	G	A	.	PASS	CSQ=6091|protein_coding||intron_variant|||||||NM_002941.4:c.89-194914C>T||MODIFIER||||||ROBO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,80:80:1
chr3	79408117	.	G	A	.	PASS	CSQ=6091|protein_coding||intron_variant|||||||NM_002941.4:c.88+181707C>T||MODIFIER||||||ROBO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,93:93:1
chr3	79624714	.	C	A	.	PASS	CSQ=6091|protein_coding||intron_variant|||||||NM_002941.4:c.-50-34753G>T||MODIFIER||||||ROBO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,48:48:1
chr3	81103001	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,65:65:1
chr3	81210879	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,91:91:1
chr3	81661355	.	G	A	.	PASS	CSQ=2632|protein_coding||intron_variant|||||||NM_000158.4:c.429+9483C>T||MODIFIER||||||GBE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:95:0	0,86:86:1
chr3	82025145	.	T	C	.	PASS	CSQ=105377180|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147146.1:n.240+38764T>C||MODIFIER||||||LINC02008|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,58:58:1
chr3	82250042	.	TA	T	.	PASS	CSQ=105377180|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147146.1:n.468+47589del||MODIFIER||||||LINC02008|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,65:65:1
chr3	82250045	.	GT	G	.	PASS	CSQ=105377180|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147146.1:n.468+47595del||MODIFIER||||||LINC02008|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	1,64:65:0.9846
chr3	82491969	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs964736801||3.30408e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	8,59:68:0.8676
chr3	82694647	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,91:91:1
chr3	82892275	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	3,68:71:0.9577
chr3	82923837	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,80:80:1
chr3	83243153	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,64:64:1
chr3	83532911	.	G	GC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	53,13:66:0.197
chr3	83639317	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	58,9:67:0.1343
chr3	83717071	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs530544919||0.000371532|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:85:0	12,41:53:0.7736
chr3	83911237	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,58:58:1
chr3	84100668	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,66:66:1
chr3	84338720	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,68:68:1
chr3	84491192	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,59:59:1
chr3	84581687	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,77:77:1
chr3	84656243	.	T	A	.	PASS	CSQ=440970|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033860.1:n.6427+10157A>T||MODIFIER||||||LINC00971|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	0,81:81:1
chr3	84945018	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	1,62:63:0.9841
chr3	85079603	.	TATAATA	T	.	PASS	CSQ=253559|protein_coding||intron_variant|||||||NM_001167675.1:c.61+119940_61+119945del||MODIFIER||||||CADM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,4:70:0.0571
chr3	85131909	.	G	A	.	PASS	CSQ=253559|protein_coding||intron_variant|||||||NM_001167675.1:c.61+172241G>A||MODIFIER||||||CADM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	0,86:86:1
chr3	85217858	.	G	C	.	PASS	CSQ=253559|protein_coding||intron_variant|||||||NM_001167675.1:c.61+258190G>C||MODIFIER||||||CADM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,74:74:1
chr3	85243774	.	G	A	.	PASS	CSQ=253559|protein_coding||intron_variant||||rs971380375||6.57877e-06|NM_001167675.1:c.61+284106G>A||MODIFIER||||||CADM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,62:62:1
chr3	85317178	.	C	T	.	PASS	CSQ=253559|protein_coding||intron_variant|||||||NM_001167675.1:c.61+357510C>T||MODIFIER||||||CADM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,78:78:1
chr3	86127853	.	GG	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	128,0:128:0	0,61:61:1
chr3	86153927	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,1:132:0.0076	0,76:76:1
chr3	87586618	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,74:74:1
chr3	87771900	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,78:78:1
chr3	88384333	.	C	G	.	PASS	CSQ=111064647|protein_coding||intron_variant|||||||NM_001368168.1:c.-481-15283C>G||MODIFIER||||||CSNKA2IP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,61:61:1
chr3	88462283	.	C	T	.	PASS	CSQ=111064647|protein_coding||intron_variant|||||||NM_001368168.1:c.-270-2805C>T||MODIFIER||||||CSNKA2IP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,75:75:1
chr3	89104147	.	C	T	.	PASS	CSQ=2042|protein_coding||upstream_gene_variant||||rs1052245159||6.57125e-06|||MODIFIER||||||EPHA3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/EPHA3|y|n|lung_cancer,CRC,melanoma|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,64:64:1
chr3	90407838	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1025760944||1.98421e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	39,27:66:0.4091
chr3	90628671	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	110,0:110:0	90,8:98:0.0816
chr3	90659548	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	1,74:75:0.9867
chr3	93818436	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1357946699||1.3152e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,49:119:0.4118
chr3	93820193	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	66,79:145:0.5448
chr3	93955831	.	T	A	.	PASS	CSQ=5627|protein_coding||intron_variant|||||||NM_000313.3:c.76+17843A>T||MODIFIER||||||PROS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	83,87:170:0.5118
chr3	94062994	.	A	T	.	PASS	CSQ=200895|protein_coding||5_prime_UTR_variant|||||||NM_001195643.1:c.-221T>A||MODIFIER||||||DHFR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	123,0:123:0	133,48:181:0.2652
chr3	94174524	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs978547214|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	83,71:154:0.461
chr3	94327532	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	157,8:165:0.0485
chr3	94327886	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1373066780||2.63293e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	100,71:171:0.4152
chr3	94705363	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	76,52:128:0.4062
chr3	94776470	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	78,41:119:0.3445
chr3	94854971	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	92,72:164:0.439
chr3	94908657	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	92,71:163:0.4356
chr3	94910712	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	79,67:146:0.4589
chr3	95000526	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs994721887||5.92784e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	140,5:145:0.0345
chr3	95166531	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	46,53:99:0.5354
chr3	95216206	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,74:153:0.4837
chr3	95372117	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs927582218||2.66752e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	71,43:114:0.3772
chr3	95470645	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	64,70:134:0.5224
chr3	95533938	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1413782300||1.32244e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	63,56:119:0.4706
chr3	95546608	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	89,0:89:0	108,5:113:0.0442
chr3	95825304	.	A	AAAAT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	93,30:123:0.2439
chr3	95864382	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	53,57:110:0.5182
chr3	95939806	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.60049e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,1:116:0.0086	77,63:140:0.45
chr3	95945911	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	76,64:140:0.4571
chr3	96037993	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	77,77:154:0.5
chr3	96695030	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs949939982||6.58935e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	73,74:147:0.5034
chr3	96755625	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	71,90:161:0.559
chr3	96762002	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	85,81:166:0.488
chr3	96834718	.	T	C	.	PASS	CSQ=285220|protein_coding||intron_variant|||||||NM_001080448.3:c.385+19710T>C||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	88,70:158:0.443
chr3	96840186	.	CC	AA	.	PASS	CSQ=285220|protein_coding||intron_variant|||||||NM_001080448.3:c.385+25178_385+25179delinsAA||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	121,0:121:0	95,39:134:0.291
chr3	96928256	.	G	C	.	PASS	CSQ=285220|protein_coding||intron_variant|||||||NM_001080448.3:c.451-59074G>C||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	72,84:156:0.5385
chr3	97021922	.	T	C	.	PASS	CSQ=285220|protein_coding||intron_variant|||||||NM_001080448.3:c.1114+33929T>C||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	144,8:152:0.0526
chr3	97022055	.	A	C	.	PASS	CSQ=285220|protein_coding||intron_variant|||||||NM_001080448.3:c.1114+34062A>C||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	70,74:144:0.5139
chr3	97450492	.	C	G	.	PASS	CSQ=285220|protein_coding||intron_variant||||rs879938927|||NM_001080448.3:c.1894+1762C>G||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	73,76:149:0.5101
chr3	97512856	.	C	T	.	PASS	CSQ=285220|protein_coding||intron_variant||||rs1179794468|||NM_001080448.3:c.2201-19502C>T||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	118,44:162:0.2716
chr3	97566508	.	G	T	.	PASS	CSQ=285220|protein_coding||intron_variant|||||||NM_001080448.3:c.2387-26104G>T||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	89,67:156:0.4295
chr3	97719671	.	A	G	.	PASS	CSQ=285220|protein_coding||intron_variant|||||||NM_001080448.3:c.2785-590A>G||MODIFIER||||||EPHA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	100,58:158:0.3671
chr3	98104276	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	79,79:158:0.5
chr3	98174295	.	G	T	.	PASS	CSQ=403274|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||OR5H15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	76,77:153:0.5033
chr3	98288283	.	G	T	.	PASS	CSQ=79310|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||OR5H2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	75,75:150:0.5
chr3	98442596	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	102,84:186:0.4516
chr3	98678656	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	93,90:183:0.4918
chr3	99015996	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	92,72:164:0.439
chr3	99058505	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1327736373||0.183861|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	74,0:74:0	64,37:101:0.3663
chr3	99061440	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1047670441||1.97389e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	88,75:163:0.4601
chr3	99201912	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	67,80:147:0.5442
chr3	99346527	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	85,77:162:0.4753
chr3	99418764	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	95,85:180:0.4722
chr3	99465544	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	122,0:122:0	87,70:157:0.4459
chr3	99465564	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	123,0:123:0	87,68:155:0.4387
chr3	99465570	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1352014235||2.63082e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	127,0:127:0	88,68:156:0.4359
chr3	99465616	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs34535233|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	136,0:136:0	81,73:154:0.474
chr3	99465628	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs951415113||0.000341876|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	133,0:133:0	76,77:153:0.5033
chr3	99465696	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57402e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	135,0:135:0	72,68:140:0.4857
chr3	99465859	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	89,80:169:0.4734
chr3	99466040	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	82,85:167:0.509
chr3	99466139	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	71,77:148:0.5203
chr3	99466154	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:108:0	70,69:139:0.4964
chr3	99466165	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	107,0:107:0	73,67:140:0.4786
chr3	99466310	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	74,76:150:0.5067
chr3	99494659	COSV60952608	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV60952608|rs764437173||0.00210647|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,1:103:0.0097	95,40:136:0.2941
chr3	99612451	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	102,102:204:0.5
chr3	99664955	.	C	T	.	PASS	CSQ=1295|protein_coding||intron_variant|||||||NM_020351.4:c.-129+26291C>T||MODIFIER||||||COL8A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	59,71:130:0.5462
chr3	99726928	.	G	GT	.	PASS	CSQ=1295|protein_coding||intron_variant||||||6.57609e-06|NM_020351.4:c.-128-17962dup||MODIFIER||||||COL8A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	95,71:166:0.4277
chr3	99918162	.	G	C	.	PASS	CSQ=11259|protein_coding||intron_variant|||||||NM_001042459.2:c.605+6068C>G||MODIFIER||||||FILIP1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	73,73:146:0.5
chr3	100224052	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs940561262|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	80,89:169:0.5266
chr3	100765491	.	A	AT	.	PASS	CSQ=25890|protein_coding||intron_variant|||||||NM_001349331.1:c.3179+349dup||MODIFIER||||||ABI3BP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	83,68:151:0.4503
chr3	100938235	.	C	G	.	PASS	CSQ=25890|protein_coding||intron_variant|||||||NM_001349331.1:c.101-11754G>C||MODIFIER||||||ABI3BP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	85,44:129:0.3411
chr3	101179206	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	164,19:183:0.1038
chr3	101671804	.	A	T	.	PASS	CSQ=100009676|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||ZBTB11-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	137,0:137:0	83,77:160:0.4813
chr3	101689168	.	TC	T	.	PASS	CSQ=6152|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||RPL24|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	77,87:164:0.5305
chr3	101699085	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	149,1:150:0.0067	107,67:174:0.3851
chr3	101699110	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	170,0:170:0	125,68:193:0.3523
chr3	101706643	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	82,0:82:0	84,25:109:0.2294
chr3	101706978	.	A	C	.	PASS	CSQ=|||intergenic_variant||||rs896085174|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	106,71:177:0.4011
chr3	101708636	.	A	G	.	PASS	CSQ=285359|transcribed_pseudogene||upstream_gene_variant||||rs1283010765||6.56883e-06|||MODIFIER||||||PDCL3P4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	100,71:171:0.4152
chr3	101710249	.	G	A	.	PASS	CSQ=285359|transcribed_pseudogene||upstream_gene_variant||||rs983096068|||||MODIFIER||||||PDCL3P4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	81,87:168:0.5179
chr3	101710253	.	G	A	.	PASS	CSQ=285359|transcribed_pseudogene||upstream_gene_variant||||rs560566134||6.5716e-06|||MODIFIER||||||PDCL3P4|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,86:169:0.5089
chr3	102277785	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	69,81:150:0.54
chr3	102302727	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	141,13:154:0.0844
chr3	102517715	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	81,94:175:0.5371
chr3	102934713	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||6.57367e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	68,74:142:0.5211
chr3	103061879	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	104,24:128:0.1875
chr3	103167138	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	89,28:117:0.2393
chr3	103171483	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	150,8:158:0.0506
chr3	103218331	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	71,62:133:0.4662
chr3	103296744	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	72,73:145:0.5034
chr3	103399544	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1267680271||1.31641e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	79,76:155:0.4903
chr3	103426379	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	69,62:131:0.4733
chr3	103787972	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	68,53:121:0.438
chr3	103920553	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1230894050||6.57748e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	144,9:153:0.0588
chr3	104244719	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	65,64:129:0.4961
chr3	104475879	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	59,62:121:0.5124
chr3	104494179	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1458385713|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	69,74:143:0.5175
chr3	104562994	COSV61355927	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV61355927|rs559194390||0.0372913|||MODIFIER||||||||0.0339;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	69,55:126:0.4365
chr3	104944696	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	64,66:130:0.5077
chr3	104966486	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	69,64:133:0.4812
chr3	104966488	COSV55593238	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV55593238||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	66,65:131:0.4962
chr3	105114415	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	125,11:136:0.0809
chr3	105994287	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	65,78:143:0.5455
chr3	106012029	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	74,83:157:0.5287
chr3	106026690	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	90,45:135:0.3333
chr3	106032317	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	81,72:153:0.4706
chr3	106046480	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	80,85:165:0.5152
chr3	106121428	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	66,84:150:0.56
chr3	106543031	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	75,75:150:0.5
chr3	106659516	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	64,62:126:0.4921
chr3	106821126	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs769402446|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,79:159:0.4969
chr3	106850287	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.65283e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	75,78:153:0.5098
chr3	108099379	.	AAACAT	A	.	PASS	CSQ=|||intergenic_variant||||rs1225915308||2.62961e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	86,42:128:0.3281
chr3	109289591	.	C	T	.	PASS	CSQ=151871|protein_coding||downstream_gene_variant||||rs989373097||1.31667e-05|||MODIFIER||||||DPPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	61,54:115:0.4696
chr3	109421519	.	T	TTC	.	PASS	CSQ=401082|lncRNA||intron_variant&non_coding_transcript_variant||||rs200843572|||NR_109841.1:n.378+3635_378+3636dup||MODIFIER||||||LINC01205|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	104,40:145:0.2759
chr3	109446869	.	C	CT	.	PASS	CSQ=401082|lncRNA||intron_variant&non_coding_transcript_variant||||rs1338095153|||NR_109841.1:n.379-13006dup||MODIFIER||||||LINC01205|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	82,61:143:0.4266
chr3	109447518	.	TG	T	.	PASS	CSQ=401082|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109841.1:n.379-12364del||MODIFIER||||||LINC01205|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	60,68:128:0.5312
chr3	109683001	.	TGACTTTA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	79,73:152:0.4803
chr3	110149533	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	74,72:146:0.4932
chr3	110254440	.	ATC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	77,62:139:0.446
chr3	110377043	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	77,80:157:0.5096
chr3	110681963	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	81,88:169:0.5207
chr3	110743371	.	ATTACTTG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	70,60:130:0.4615
chr3	110845219	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	102,7:109:0.0642
chr3	111111174	.	A	G	.	PASS	CSQ=25945|protein_coding||intron_variant|||||||NM_015480.3:c.161-856A>G||MODIFIER||||||NECTIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	83,76:159:0.478
chr3	111125094	.	T	C	.	PASS	CSQ=25945|protein_coding||intron_variant|||||||NM_015480.3:c.918-1090T>C||MODIFIER||||||NECTIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	45,63:108:0.5833
chr3	111267152	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	83,92:175:0.5257
chr3	112016077	.	T	C	.	PASS	CSQ=29114|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TAGLN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	92,81:173:0.4682
chr3	112297315	.	C	CT	.	PASS	CSQ=285335|protein_coding||upstream_gene_variant||||rs572821233||0.00589513|||MODIFIER||||||SLC9C1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	77,69:147:0.4694
chr3	112546403	.	C	T	.	PASS	CSQ=64422|protein_coding||intron_variant|||||||NM_022488.4:c.343+2130G>A||MODIFIER||||||ATG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	89,92:181:0.5083
chr3	112914744	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs970596042||8.55038e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	70,81:151:0.5364
chr3	113122791	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1312543843||6.57004e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	87,90:177:0.5085
chr3	115501073	.	TC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	129,0:129:0	82,73:156:0.4679
chr3	115747868	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	85,81:166:0.488
chr3	116159935	.	G	A	.	PASS	CSQ=4045|protein_coding||intron_variant|||||||NM_002338.5:c.156-73379C>T||MODIFIER||||||LSAMP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	66,71:137:0.5182
chr3	116357504	.	A	G	.	PASS	CSQ=4045|protein_coding||intron_variant|||||||NM_002338.5:c.155+87373T>C||MODIFIER||||||LSAMP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	61,72:133:0.5414
chr3	116727549	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	64,77:141:0.5461
chr3	116796795	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	78,77:155:0.4968
chr3	116816444	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	72,65:137:0.4745
chr3	116889665	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	70,67:138:0.4855
chr3	116921312	.	C	T	.	PASS	CSQ=100506724|lncRNA||upstream_gene_variant||||rs551511418||3.28709e-05|||MODIFIER||||||LINC00901|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	137,0:137:0	71,64:135:0.4741
chr3	116935322	.	C	T	.	PASS	CSQ=100506724|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00901|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	104,8:112:0.0714
chr3	117228245	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	58,55:113:0.4867
chr3	117324591	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	61,60:121:0.4959
chr3	117328896	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	73,66:139:0.4748
chr3	117572395	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	78,75:153:0.4902
chr3	117654088	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1279863296|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	65,63:128:0.4922
chr3	117676678	.	C	CA	.	PASS	CSQ=105374057|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC02024|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	60,50:110:0.4545
chr3	117718643	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	161,12:173:0.0694
chr3	117807001	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs556776986||1.31454e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	51,68:119:0.5714
chr3	117966105	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs989891832|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	80,73:153:0.4771
chr3	118279662	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	119,5:124:0.0403
chr3	118319341	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	66,76:142:0.5352
chr3	118516880	.	G	T	.	PASS	CSQ=105374060|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135547.1:n.314-8188C>A||MODIFIER||||||LOC105374060|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	67,69:136:0.5074
chr3	118680851	.	G	T	.	PASS	CSQ=105374060|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135547.1:n.128-18361C>A||MODIFIER||||||LOC105374060|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	104,33:137:0.2409
chr3	118825708	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	59,75:134:0.5597
chr3	118874681	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1030028135|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	96,43:139:0.3094
chr3	118979533	.	G	T	.	PASS	CSQ=152404|protein_coding||intron_variant|||||||NM_001015887.2:c.53-49258C>A||MODIFIER||||||IGSF11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	138,15:153:0.098
chr3	119064544	.	T	C	.	PASS	CSQ=152404|protein_coding||intron_variant|||||||NM_001353320.1:c.49+40600A>G||MODIFIER||||||IGSF11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:94:0	62,64:126:0.5079
chr3	119152029	.	AC	TA	.	PASS	CSQ=152405|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||C3orf30|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	112,0:113:0	81,66:148:0.4459
chr3	119259331	.	A	C	.	PASS	CSQ=100874201|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046574.1:n.518+24191A>C||MODIFIER||||||B4GALT4-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	94,102:196:0.5204
chr3	119471935	.	G	A	.	PASS	CSQ=56983|protein_coding||intron_variant|||||||NM_152305.3:c.320+483G>A||MODIFIER||||||POGLUT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	80,75:155:0.4839
chr3	119611003	.	G	T	.	PASS	CSQ=51365|protein_coding||intron_variant|||||||NM_015900.4:c.562+1427G>T||MODIFIER||||||PLA1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	76,71:147:0.483
chr3	119939411	.	CC	AG	.	PASS	CSQ=2932|protein_coding||intron_variant|||||||NM_001146156.1:c.366+7856_366+7857delinsCT||MODIFIER||||||GSK3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	131,0:131:0	77,73:150:0.4867
chr3	120174768	.	A	T	.	PASS	CSQ=165829|protein_coding||intron_variant|||||||NM_153002.2:c.934-1298T>A||MODIFIER||||||GPR156|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	55,61:116:0.5259
chr3	120217111	.	C	A	.	PASS	CSQ=165829|protein_coding||intron_variant|||||||NM_153002.2:c.234-23687G>T||MODIFIER||||||GPR156|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	78,80:158:0.5063
chr3	120360198	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	101,82:183:0.4481
chr3	120482351	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	85,69:154:0.4481
chr3	120489464	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	85,88:173:0.5087
chr3	120710986	.	A	C	.	PASS	CSQ=285282|protein_coding||intron_variant|||||||NM_173825.4:c.139-1077T>G||MODIFIER||||||RABL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	73,73:146:0.5
chr3	120750514	.	T	G	.	PASS	CSQ=2960|protein_coding||intron_variant|||||||NM_005513.3:c.-30-9T>G||MODIFIER||||||GTF2E1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	123,0:123:0	84,81:165:0.4909
chr3	121082654	.	G	A	.	PASS	CSQ=9515|protein_coding||intron_variant|||||||NM_001308330.1:c.471-32271G>A||MODIFIER||||||STXBP5L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	71,82:153:0.5359
chr3	122833447	.	G	T	.	PASS	CSQ=84925|protein_coding||splice_donor_variant||||rs1210861146|3.98378e-06||NM_032839.3:c.833+1G>T||HIGH||||||DIRC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	109,0:109:0	74,77:151:0.5099
chr3	123034107	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	70,74:144:0.5139
chr3	123036790	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	112,0:112:0	89,83:172:0.4826
chr3	123070990	.	C	T	.	PASS	CSQ=10954|protein_coding||intron_variant|||||||NM_006810.4:c.42+3784C>T||MODIFIER||||||PDIA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	77,77:154:0.5
chr3	123276871	.	G	A	.	PASS	CSQ=26984|protein_coding||downstream_gene_variant||||rs902059216||3.94353e-05|||MODIFIER||||||SEC22A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	69,94:163:0.5767
chr3	123299432	.	C	G	.	PASS	CSQ=111|protein_coding||intron_variant|||||||NM_183357.2:c.2900+688G>C||MODIFIER||||||ADCY5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	74,67:141:0.4752
chr3	123300837	.	C	A	.	PASS	CSQ=111|protein_coding||intron_variant|||||||NM_183357.2:c.2725-542G>T||MODIFIER||||||ADCY5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	91,74:165:0.4485
chr3	123301119	.	C	G	.	PASS	CSQ=111|protein_coding||intron_variant|||||||NM_183357.2:c.2725-824G>C||MODIFIER||||||ADCY5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	79,93:172:0.5407
chr3	123301494	.	C	A	.	PASS	CSQ=111|protein_coding||intron_variant|||||||NM_183357.2:c.2725-1199G>T||MODIFIER||||||ADCY5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	83,106:189:0.5608
chr3	123302701	.	C	G	.	PASS	CSQ=111|protein_coding||intron_variant|||||||NM_183357.2:c.2724+354G>C||MODIFIER||||||ADCY5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	88,83:171:0.4854
chr3	123425914	.	G	T	.	PASS	CSQ=111|protein_coding||intron_variant|||||||NM_183357.2:c.1134+21498C>A||MODIFIER||||||ADCY5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	88,98:186:0.5269
chr3	124016113	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:103:0	64,94:158:0.5949
chr3	124042023	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	153,6:159:0.0377
chr3	124240196	.	G	A	.	PASS	CSQ=8997|protein_coding||intron_variant|||||||NM_001024660.4:c.257+5253G>A||MODIFIER||||||KALRN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	83,78:161:0.4845
chr3	124301908	.	G	A	.	PASS	CSQ=8997|protein_coding||intron_variant|||||||NM_001024660.4:c.1086+2995G>A||MODIFIER||||||KALRN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	75,82:157:0.5223
chr3	124658799	.	C	T	.	PASS	CSQ=8997|protein_coding||intron_variant|||||||NM_001024660.4:c.6120+282C>T||MODIFIER||||||KALRN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	111,90:201:0.4478
chr3	124757230	.	C	T	.	PASS	CSQ=3693|protein_coding||downstream_gene_variant||||rs1031597072||9.20544e-05|||MODIFIER||||||ITGB5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	80,80:160:0.5
chr3	126357323	.	C	T	.	PASS	CSQ=28999|protein_coding||5_prime_UTR_variant|||||||NM_014079.4:c.-112G>A||MODIFIER||||||KLF15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	96,0:96:0	77,65:142:0.4577
chr3	126554197	.	G	T	.	PASS	CSQ=152065|protein_coding||intron_variant|||||||NM_152533.3:c.-40-767C>A||MODIFIER||||||C3orf22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	78,89:167:0.5329
chr3	126556212	.	G	A	.	PASS	CSQ=152065|protein_coding||intron_variant|||||||NM_152533.3:c.-41+2415C>T||MODIFIER||||||C3orf22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	74,88:162:0.5432
chr3	127043474	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	84,99:183:0.541
chr3	127126490	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	92,71:163:0.4356
chr3	127571612	.	T	C	.	PASS	CSQ=131601|protein_coding||3_prime_UTR_variant|||||||NM_001136053.3:c.*1909A>G||MODIFIER||||||TPRA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	73,62:135:0.4593
chr3	127590636	.	G	C	.	PASS	CSQ=102465857|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR7976|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	80,85:165:0.5152
chr3	127639219	.	A	G	.	PASS	CSQ=50512|protein_coding||intron_variant|||||||NM_015720.4:c.71-26A>G||MODIFIER||||||PODXL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	136,0:136:0	96,95:191:0.4974
chr3	128046294	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	90,72:162:0.4444
chr3	128452557	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	101,72:173:0.4162
chr3	128731335	.	A	T	.	PASS	CSQ=7879|protein_coding||intron_variant|||||||NM_004637.5:c.-9+4976A>T||MODIFIER||||||RAB7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	85,78:164:0.4756
chr3	128817657	.	CT	C	.	PASS	CSQ=7879|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||RAB7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	86,89:175:0.5086
chr3	129535490	.	G	A	.	PASS	CSQ=6010|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||RHO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	86,108:194:0.5567
chr3	129725523	.	C	T	.	PASS	CSQ=23023|protein_coding||intron_variant|||||||NM_001017395.4:c.577-54259G>A||MODIFIER||||||TMCC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	99,97:196:0.4949
chr3	130264410	.	G	A	.	PASS	CSQ=646300|transcribed_pseudogene||non_coding_transcript_exon_variant||||||6.57091e-06|NR_027898.1:n.2197G>A||MODIFIER||||||COL6A4P2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	88,89:177:0.5028
chr3	130463087	.	G	A	.	PASS	CSQ=256076|protein_coding||intron_variant||||rs989804864||6.57479e-06|NM_001278298.1:c.6791-5708G>A||MODIFIER||||||COL6A5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	81,74:155:0.4774
chr3	130745496	.	G	A	.	PASS	CSQ=30849|protein_coding||intron_variant|||||||NM_014602.3:c.-46-232C>T||MODIFIER||||||PIK3R4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	91,85:176:0.483
chr3	130884236	.	C	T	.	PASS	CSQ=27032|protein_coding||intron_variant||||rs771161347||2.62933e-05|NM_001199180.1:c.108+33308C>T||MODIFIER||||||ATP2C1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	62,82:144:0.5694
chr3	130993408	.	A	T	.	PASS	CSQ=27032|protein_coding||intron_variant|||||||NM_001199180.1:c.1992+407A>T||MODIFIER||||||ATP2C1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	76,77:153:0.5033
chr3	131579353	.	A	T	.	PASS	CSQ=131034|protein_coding||intron_variant|||||||NM_130808.2:c.867+2226T>A||MODIFIER||||||CPNE4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	71,79:150:0.5267
chr3	131616312	.	G	A	.	PASS	CSQ=131034|protein_coding||intron_variant|||||||NM_130808.2:c.682-28730C>T||MODIFIER||||||CPNE4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	89,81:170:0.4765
chr3	131751626	.	T	A	.	PASS	CSQ=131034|protein_coding||intron_variant|||||||NM_130808.2:c.181-28001A>T||MODIFIER||||||CPNE4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,1:102:0.0098	71,75:146:0.5137
chr3	131765692	.	G	C	.	PASS	CSQ=131034|protein_coding||intron_variant|||||||NM_130808.2:c.181-42067C>G||MODIFIER||||||CPNE4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	78,102:180:0.5667
chr3	131909432	.	G	A	.	PASS	CSQ=131034|protein_coding||intron_variant|||||||NM_130808.2:c.-1-3988C>T||MODIFIER||||||CPNE4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,1:117:0.0085	81,89:170:0.5235
chr3	131933329	.	G	A	.	PASS	CSQ=131034|protein_coding||intron_variant|||||||NM_130808.2:c.-1-27885C>T||MODIFIER||||||CPNE4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	95,69:164:0.4207
chr3	131950380	.	G	A	.	PASS	CSQ=131034|protein_coding||intron_variant|||||||NM_130808.2:c.-1-44936C>T||MODIFIER||||||CPNE4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	84,69:153:0.451
chr3	132028528	.	G	A	.	PASS	CSQ=131034|protein_coding||intron_variant|||||||NM_130808.2:c.-2+6039C>T||MODIFIER||||||CPNE4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	73,90:163:0.5521
chr3	132226474	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1417699856||6.57177e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	76,72:148:0.4865
chr3	133111672	.	G	C	.	PASS	CSQ=66000|protein_coding||intron_variant|||||||NM_023943.3:c.-47+65652G>C||MODIFIER||||||TMEM108|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	86,83:169:0.4911
chr3	133117882	.	G	T	.	PASS	CSQ=66000|protein_coding||intron_variant|||||||NM_023943.3:c.-47+71862G>T||MODIFIER||||||TMEM108|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	82,80:162:0.4938
chr3	133245125	.	A	T	.	PASS	CSQ=101927455|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||TMEM108-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	77,93:170:0.5471
chr3	133770331	.	TCA	T	.	PASS	CSQ=7018|protein_coding||intron_variant|||||||NM_001063.4:c.1623-176_1623-175del||MODIFIER||||||TF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	108,68:176:0.3864
chr3	134032454	.	G	C	.	PASS	CSQ=6578|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SLCO2A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	70,95:165:0.5758
chr3	134431689	COSV66457215	T	TA	.	PASS	CSQ=|||intergenic_variant|||COSV66457215|rs545647020||0.000503098|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	95,69:164:0.4207
chr3	134701465	.	TAC	T	.	PASS	CSQ=|||intergenic_variant||||rs1160253890||0.000958317|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	59,0:59:0	81,43:124:0.3468
chr3	134884369	.	G	A	.	PASS	CSQ=2047|protein_coding||intron_variant|||||||NM_004441.5:c.59-41447G>A||MODIFIER||||||EPHB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	71,88:159:0.5535
chr3	135012653	.	C	T	.	PASS	CSQ=2047|protein_coding||intron_variant|||||||NM_004441.5:c.805+60601C>T||MODIFIER||||||EPHB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	73,99:173:0.5723
chr3	135419782	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	95,91:186:0.4892
chr3	135490863	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	76,73:149:0.4899
chr3	135493127	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	88,89:177:0.5028
chr3	135507845	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	85,86:171:0.5029
chr3	135604911	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1426015632||1.97086e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	88,84:172:0.4884
chr3	135611543	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	88,85:173:0.4913
chr3	135666095	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	92,77:169:0.4556
chr3	135719837	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	68,93:161:0.5776
chr3	135825681	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,85:161:0.528
chr3	135887823	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	63,68:131:0.5191
chr3	136228562	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	75,70:145:0.4828
chr3	136471670	.	CA	C	.	PASS	CSQ=10274|protein_coding||intron_variant|||||||NM_005862.3:c.1205+742del||MODIFIER||||||STAG1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/STAG1|y|n|colorectal_cancer,AML|||E,L||TSG|Mis,N;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	83,69:152:0.4539
chr3	136542743	.	A	G	.	PASS	CSQ=10274|protein_coding||intron_variant|||||||NM_005862.3:c.395-548T>C||MODIFIER||||||STAG1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/STAG1|y|n|colorectal_cancer,AML|||E,L||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:107:0	155,17:172:0.0988
chr3	136762304	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	90,73:163:0.4479
chr3	137535466	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	83,72:155:0.4645
chr3	137727879	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	117,33:150:0.22
chr3	137896192	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs527776813||0.000105925|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	134,13:147:0.0884
chr3	137910081	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1415316812||6.57203e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	80,74:154:0.4805
chr3	137957204	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	62,67:129:0.5194
chr3	138952993	.	T	TC	.	PASS	CSQ=401089|protein_coding||3_prime_UTR_variant||||rs577879362||0.0220396|NM_001040061.3:c.*2429dup||MODIFIER||||||FOXL2NB|EntrezGene|0.0419;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	62,0:62:0	47,40:88:0.4545
chr3	139156320	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	72,84:156:0.5385
chr3	139222341	.	A	C	.	PASS	CSQ=|||intergenic_variant||||rs1320314605|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,73:147:0.4966
chr3	139323887	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	61,85:146:0.5822
chr3	139675131	.	A	AAC	.	PASS	CSQ=349565|protein_coding||intron_variant||||||3.98438e-05|NM_001320510.2:c.-141+2572_-141+2573dup||MODIFIER||||||NMNAT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	97,0:97:0	103,56:160:0.35
chr3	139735006	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	83,74:157:0.4713
chr3	140281591	.	G	A	.	PASS	CSQ=64084|protein_coding||intron_variant|||||||NM_022131.3:c.232+105518G>A||MODIFIER||||||CLSTN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	128,6:134:0.0448
chr3	140985102	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	70,82:152:0.5395
chr3	141196236	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	85,84:169:0.497
chr3	141263564	.	A	T	.	PASS	CSQ=92370|protein_coding||intron_variant|||||||NM_001037172.3:c.79+3310A>T||MODIFIER||||||PXYLP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	76,85:161:0.528
chr3	141272387	.	G	A	.	PASS	CSQ=92370|protein_coding||intron_variant|||||||NM_001037172.3:c.80-5955G>A||MODIFIER||||||PXYLP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:137:0	83,72:155:0.4645
chr3	141469889	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	87,82:169:0.4852
chr3	141831781	COSV57934136	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV57934136||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	162,7:169:0.0414
chr3	141850819	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.5773e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,76:147:0.517
chr3	142358187	.	C	G	.	PASS	CSQ=54464|protein_coding||intron_variant|||||||NM_001282857.1:c.3465-1068G>C||MODIFIER||||||XRN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	69,82:151:0.543
chr3	142669188	.	C	A	.	PASS	CSQ=5357|protein_coding||intron_variant|||||||NM_001145319.2:c.71-202C>A||MODIFIER||||||PLS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	71,75:146:0.5137
chr3	142827941	.	T	A	.	PASS	CSQ=26577|protein_coding||intron_variant|||||||NM_013363.4:c.865+1751A>T||MODIFIER||||||PCOLCE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	78,82:160:0.5125
chr3	143109329	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	103,36:139:0.259
chr3	143176791	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	88,66:154:0.4286
chr3	143620029	.	C	A	.	PASS	CSQ=285195|protein_coding||intron_variant|||||||NM_173653.4:c.755+32226G>T||MODIFIER||||||SLC9A9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:107:0	84,61:145:0.4207
chr3	144027768	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	66,69:135:0.5111
chr3	144220354	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	66,65:131:0.4962
chr3	144351903	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	53,72:125:0.576
chr3	144418984	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	110,42:152:0.2763
chr3	144743479	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	51,56:107:0.5234
chr3	144829415	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	78,74:152:0.4868
chr3	144896614	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	162,7:169:0.0414
chr3	145022316	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	112,40:152:0.2632
chr3	145109890	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs971666678||6.57419e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	120,7:127:0.0551
chr3	145234789	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1235451021||3.28831e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	80,74:154:0.4805
chr3	145499469	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	73,79:152:0.5197
chr3	145551960	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	80,76:156:0.4872
chr3	145650663	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	126,8:134:0.0597
chr3	145744496	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	74,79:153:0.5163
chr3	145981196	.	T	TG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	69,71:140:0.5071
chr3	146063062	.	GAAAATTTAAT	G	.	PASS	CSQ=109729161|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LNCSRLR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	78,77:155:0.4968
chr3	146546256	.	C	A	.	PASS	CSQ=5359|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PLSCR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	77,66:143:0.4615
chr3	146794277	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	62,63:125:0.504
chr3	147231332	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1441341597||6.5735e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	74,68:142:0.4789
chr3	147336463	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:107:0	65,65:130:0.5
chr3	147340670	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1369268912||5.91483e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	70,91:161:0.5652
chr3	147348443	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	61,64:125:0.512
chr3	147602376	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	67,72:139:0.518
chr3	147739446	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	115,11:126:0.0873
chr3	147781624	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,4:98:0.0408	54,66:120:0.55
chr3	147928238	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	131,6:137:0.0438
chr3	147987625	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs76063957||0.00171722|||MODIFIER||||||||0.1194;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,13:121:0.1074	73,70:143:0.4895
chr3	148056668	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1009689211||6.57704e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	163,11:174:0.0632
chr3	148124284	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	100,77:177:0.435
chr3	148474641	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	131,8:139:0.0576
chr3	148978732	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	95,79:174:0.454
chr3	149210713	.	C	T	.	PASS	CSQ=1356|protein_coding||intron_variant|||||||NM_000096.4:c.395-334G>A||MODIFIER||||||CP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	98,68:166:0.4096
chr3	149652884	.	T	A	.	PASS	CSQ=25937|protein_coding||intron_variant|||||||NM_015472.5:c.431+3992A>T||MODIFIER||||||WWTR1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/WWTR1|y|n|epithelioid_haemangioendothelioma|||M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	144,5:149:0.0336
chr3	149801681	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	61,77:138:0.558
chr3	149850458	.	G	A	.	PASS	CSQ=11342|protein_coding||intron_variant|||||||NM_183381.2:c.115-2058G>A||MODIFIER||||||RNF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	80,68:148:0.4595
chr3	149895393	.	A	G	.	PASS	CSQ=11342|protein_coding||intron_variant|||||||NM_183381.2:c.322-80A>G||MODIFIER||||||RNF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	91,91:182:0.5
chr3	150193464	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	150,10:160:0.0625
chr3	150965414	.	A	G	.	PASS	CSQ=7401|protein_coding||intron_variant|||||||NM_001195794.1:c.253+7042T>C||MODIFIER||||||CLRN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	106,76:182:0.4176
chr3	151451863	.	C	T	.	PASS	CSQ=285313|protein_coding||intron_variant|||||||NM_178822.4:c.715+1521G>A||MODIFIER||||||IGSF10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	166,5:171:0.0292
chr3	151856471	.	C	A	.	PASS	CSQ=101928142|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110203.1:n.319+71386G>T||MODIFIER||||||AADACL2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	79,82:161:0.5093
chr3	152582876	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	79,64:143:0.4476
chr3	152613735	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	70,66:136:0.4853
chr3	153068196	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	65,77:142:0.5423
chr3	153702687	.	C	A	.	PASS	CSQ=105374165|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146713.1:n.77+28068G>T||MODIFIER||||||LINC02006|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	61,81:142:0.5704
chr3	153800491	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	65,67:132:0.5076
chr3	153820749	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	63,70:133:0.5263
chr3	153921200	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	70,65:135:0.4815
chr3	154408865	.	T	A	.	PASS	CSQ=344758|protein_coding||intron_variant|||||||NM_001038705.3:c.1623+12174A>T||MODIFIER||||||GPR149|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	90,81:171:0.4737
chr3	154421286	.	G	A	.	PASS	CSQ=344758|protein_coding||missense_variant||||rs899808921|||NM_001038705.3:c.1376C>T|NP_001033794.1:p.Thr459Met|MODERATE|B||N|T|D|GPR149|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	124,0:124:0	59,69:128:0.5391
chr3	155471261	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	69,81:150:0.54
chr3	155509118	.	C	G	.	PASS	CSQ=23007|protein_coding||intron_variant|||||||NM_014996.3:c.1633-4492G>C||MODIFIER||||||PLCH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	61,0:61:0	2,78:80:0.975
chr3	155509160	.	C	G	.	PASS	CSQ=23007|protein_coding||intron_variant|||||||NM_014996.3:c.1633-4534G>C||MODIFIER||||||PLCH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	56,0:56:0	0,76:76:1
chr3	155532510	.	G	T	.	PASS	CSQ=23007|protein_coding||intron_variant|||||||NM_014996.3:c.1363-8506C>A||MODIFIER||||||PLCH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	98,86:184:0.4674
chr3	155536568	.	G	T	.	PASS	CSQ=23007|protein_coding||intron_variant|||||||NM_014996.3:c.1363-12564C>A||MODIFIER||||||PLCH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	118,30:149:0.2013
chr3	156177755	.	TTTTGCGA	T	.	PASS	CSQ=7881|protein_coding||intron_variant|||||||NM_172160.2:c.275+56870_275+56876del||MODIFIER||||||KCNAB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	66,75:141:0.5319
chr3	156390317	.	A	T	.	PASS	CSQ=7881|protein_coding||intron_variant|||||||NM_172159.3:c.222-31299A>T||MODIFIER||||||KCNAB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	81,67:148:0.4527
chr3	157513089	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	77,85:162:0.5247
chr3	157741468	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	69,69:138:0.5
chr3	157793265	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	77,63:140:0.45
chr3	157839160	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	67,86:153:0.5621
chr3	158574452	.	G	C	.	PASS	CSQ=4291|protein_coding||intron_variant|||||||NM_022443.4:c.47+3105G>C||MODIFIER||||||MLF1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MLF1|y|n|AML|||L|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	78,0:78:0	60,67:127:0.5276
chr3	158633171	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	75,68:143:0.4755
chr3	159040291	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	74,91:165:0.5515
chr3	159139969	.	G	T	.	PASS	CSQ=100505385|protein_coding||intron_variant|||||||NM_001197113.1:c.9+70528G>T||MODIFIER||||||IQCJ-SCHIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	69,64:133:0.4812
chr3	159367421	.	G	A	.	PASS	CSQ=29970|protein_coding||intron_variant|||||||NM_014575.3:c.63+93538G>A||MODIFIER||||||SCHIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	84,79:163:0.4847
chr3	159669251	.	C	G	.	PASS	CSQ=100505385|protein_coding||intron_variant|||||||NM_001197113.1:c.292-95192C>G||MODIFIER||||||IQCJ-SCHIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	86,82:168:0.4881
chr3	160101235	.	G	A	.	PASS	CSQ=101928376|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_108088.1:n.518-75701C>T||MODIFIER||||||IL12A-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	63,77:140:0.55
chr3	160195399	.	C	T	.	PASS	CSQ=101928376|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_108088.1:n.239-6465G>A||MODIFIER||||||IL12A-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,1:129:0.0078	78,85:163:0.5215
chr3	160254068	.	T	C	.	PASS	CSQ=57560|protein_coding||downstream_gene_variant||||rs906303254||0.000164374|||MODIFIER||||||IFT80|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	91,71:162:0.4383
chr3	160597140	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57229e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	74,64:138:0.4638
chr3	160716854	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	133,46:179:0.257
chr3	160727438	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs771943513||0.0188836|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	86,51:137:0.3723
chr3	161246933	COSV63618426;COSV63618426;COSV63618426	G	GTT	.	PASS	CSQ=51068|protein_coding||intron_variant|COSV63618426&COSV63618426&COSV63618426|p.?&p.?&p.?||rs148001688||0.0856235|NM_015938.4:c.1131-316_1131-315dup||MODIFIER||||||NMD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	73,0:127:0	92,60:152:0.3947
chr3	161249200	.	A	G	.	PASS	CSQ=51068|protein_coding||intron_variant|||||||NM_015938.4:c.1204-254A>G||MODIFIER||||||NMD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	66,70:136:0.5147
chr3	161339189	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	74,65:139:0.4676
chr3	161461389	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	103,72:175:0.4114
chr3	161524176	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	84,74:158:0.4684
chr3	161524181	.	AGT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,71:151:0.4702
chr3	161630572	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	68,76:144:0.5278
chr3	161884198	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	84,60:145:0.4138
chr3	162131845	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	61,66:127:0.5197
chr3	162194061	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	67,70:137:0.5109
chr3	162269768	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,72:139:0.518
chr3	162286503	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	113,6:119:0.0504
chr3	162358897	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	67,75:142:0.5282
chr3	162565029	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	68,66:134:0.4925
chr3	162588361	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	73,59:132:0.447
chr3	162624772	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	154,11:165:0.0667
chr3	162797986	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	90,68:158:0.4304
chr3	162800835	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	71,79:150:0.5267
chr3	163016900	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	74,68:142:0.4789
chr3	163267562	.	G	T	.	PASS	CSQ=647107|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033945.1:n.158+10948C>A||MODIFIER||||||LINC01192|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	57,67:124:0.5403
chr3	163337054	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	77,61:138:0.442
chr3	163441180	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	60,79:139:0.5683
chr3	163446439	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,75:145:0.5172
chr3	163453963	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1244729388||6.78647e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	63,86:149:0.5772
chr3	163930271	.	T	TAG	.	PASS	CSQ=|||intergenic_variant||||rs1381684913||0.00765961|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	129,10:139:0.0719
chr3	164009598	.	AAAG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	101,25:126:0.1984
chr3	164009605	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1480983444||0.000157722|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	88,22:110:0.2
chr3	164502746	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	77,70:147:0.4762
chr3	164538215	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	57,65:122:0.5328
chr3	164663532	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	98,0:98:0	84,53:137:0.3869
chr3	164663537	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	99,0:99:0	75,53:128:0.4141
chr3	164663538	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	96,0:96:0	75,54:129:0.4186
chr3	164717162	.	T	G	.	PASS	CSQ=104355289|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126405.1:n.456+410A>C||MODIFIER||||||LINC01324|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	59,62:121:0.5124
chr3	164793868	.	A	T	.	PASS	CSQ=104355289|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126405.1:n.67+37546T>A||MODIFIER||||||LINC01324|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	76,64:140:0.4571
chr3	164917939	.	TATATATATAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	76,58:134:0.4328
chr3	164951469	.	TG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	134,0:134:0	52,65:117:0.5556
chr3	165011063	.	G	C	.	PASS	CSQ=6476|protein_coding||intron_variant|||||||NM_001041.4:c.4063-1668C>G||MODIFIER||||||SI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	135,6:141:0.0426
chr3	165037373	.	G	A	.	PASS	CSQ=6476|protein_coding||intron_variant|||||||NM_001041.4:c.2426+527C>T||MODIFIER||||||SI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	76,77:153:0.5033
chr3	165061556	.	T	A	.	PASS	CSQ=6476|protein_coding||intron_variant|||||||NM_001041.4:c.1020+815A>T||MODIFIER||||||SI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,74:146:0.5068
chr3	165105011	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	129,14:143:0.0979
chr3	165228003	.	C	G	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.200+20844C>G||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	78,63:141:0.4468
chr3	165228073	.	C	G	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.200+20914C>G||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	72,71:143:0.4965
chr3	165228174	.	C	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.200+21015C>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	74,80:154:0.5195
chr3	165228467	.	C	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant||||rs1409463107||6.57402e-06|NR_125764.1:n.200+21308C>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	75,83:158:0.5253
chr3	165228506	.	C	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant||||rs1257803142|||NR_125764.1:n.200+21347C>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,84:158:0.5316
chr3	165228628	.	C	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.200+21469C>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	74,94:168:0.5595
chr3	165228745	.	C	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.200+21586C>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	62,70:132:0.5303
chr3	165228858	.	C	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.200+21699C>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,1:121:0.0083	71,78:149:0.5235
chr3	165228862	.	C	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.200+21703C>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	71,78:149:0.5235
chr3	165228971	.	C	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.200+21812C>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	61,87:148:0.5878
chr3	165238049	.	T	TA	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant||||rs945732111||0.00036992|NR_125764.1:n.200+30899dup||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	64,70:134:0.5224
chr3	165349989	.	G	T	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.201-24270G>T||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	74,62:136:0.4559
chr3	165426560	.	C	CT	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant||||rs564106026||0.00029672|NR_125764.1:n.479+43661dup||MODIFIER||||||LINC01322|EntrezGene|0.0008;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	90,75:165:0.4545
chr3	165428019	.	G	A	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.479+45112G>A||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,67:133:0.5038
chr3	165497062	.	G	A	.	PASS	CSQ=103695433|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125764.1:n.550+5796G>A||MODIFIER||||||LINC01322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,1:92:0.0109	59,75:134:0.5597
chr3	165560989	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	68,49:117:0.4188
chr3	165657013	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	77,60:137:0.438
chr3	165859179	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	74,0:74:0	125,10:135:0.0741
chr3	165944374	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	77,29:106:0.2736
chr3	166158481	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	74,61:135:0.4519
chr3	166306880	COSV57496849	A	G	.	PASS	CSQ=|||intergenic_variant|||COSV57496849||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	84,89:173:0.5145
chr3	166329882	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	150,8:158:0.0506
chr3	166396979	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1046833096||6.57825e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	74,53:127:0.4173
chr3	166499671	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	130,7:137:0.0511
chr3	166555199	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1200168104||1.31492e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	68,78:146:0.5342
chr3	166555251	COSV69623370	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV69623370||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	69,63:132:0.4773
chr3	166584404	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	121,0:121:0	138,8:146:0.0548
chr3	166976754	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	47,79:126:0.627
chr3	166991420	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	59,65:124:0.5242
chr3	167105902	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	74,73:147:0.4966
chr3	167240221	.	A	T	.	PASS	CSQ=79740|protein_coding||downstream_gene_variant||||rs929707277||1.31454e-05|||MODIFIER||||||ZBBX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	151,0:151:0	77,72:149:0.4832
chr3	167952185	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	117,38:155:0.2452
chr3	168082188	.	G	T	.	PASS	CSQ=27333|protein_coding||intron_variant|||||||NM_014498.4:c.187+12911C>A||MODIFIER||||||GOLIM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	72,79:151:0.5232
chr3	168086143	.	A	T	.	PASS	CSQ=27333|protein_coding||intron_variant|||||||NM_014498.4:c.187+8956T>A||MODIFIER||||||GOLIM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	89,72:161:0.4472
chr3	168147760	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	74,88:162:0.5432
chr3	168181064	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1375237718||6.57575e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	162,13:175:0.0743
chr3	168320350	.	C	T	.	PASS	CSQ=93556|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_021485.2:n.747+6174C>T||MODIFIER||||||EGFEM1P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	137,7:144:0.0486
chr3	168388796	.	C	T	.	PASS	CSQ=93556|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_021485.2:n.747+74620C>T||MODIFIER||||||EGFEM1P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	135,12:147:0.0816
chr3	169379494	.	G	A	.	PASS	CSQ=2122|protein_coding||intron_variant||||rs987900970||6.68029e-06|NM_004991.3:c.375+1693C>T||MODIFIER||||||MECOM|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MECOM|y|n|AML,CML,MDS|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	82,58:140:0.4143
chr3	169556909	.	CTA	C	.	PASS	CSQ=2122|protein_coding||intron_variant|||||||NM_004991.3:c.37+106425_37+106426del||MODIFIER||||||MECOM|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MECOM|y|n|AML,CML,MDS|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	100,88:188:0.4681
chr3	170513426	.	AGGGCTATTG	A	.	PASS	CSQ=57709|protein_coding||intron_variant|||||||NM_020949.3:c.305-12090_305-12082del||MODIFIER||||||SLC7A14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	85,64:149:0.4295
chr3	170542502	.	C	G	.	PASS	CSQ=101928583|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135556.1:n.215+65629C>G||MODIFIER||||||LOC101928583|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	75,80:155:0.5161
chr3	170722796	.	C	T	.	PASS	CSQ=101928583|lncRNA||intron_variant&non_coding_transcript_variant||||rs913003579||0.000243469|NR_135556.1:n.367-2764C>T||MODIFIER||||||LOC101928583|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,76:144:0.5278
chr3	171120620	.	C	G	.	PASS	CSQ=23043|protein_coding||intron_variant|||||||NM_015028.4:c.2120+2976G>C||MODIFIER||||||TNIK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	80,85:165:0.5152
chr3	171745811	.	C	T	.	PASS	CSQ=5337|protein_coding||intron_variant|||||||NM_002662.5:c.-31-7729G>A||MODIFIER||||||PLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	86,85:171:0.4971
chr3	171956343	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	132,30:162:0.1852
chr3	172021360	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	84,84:168:0.5
chr3	172200877	.	G	A	.	PASS	CSQ=64778|protein_coding||intron_variant|||||||NM_022763.4:c.188-25994G>A||MODIFIER||||||FNDC3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	71,86:157:0.5478
chr3	172436027	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1269908471||6.57402e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	114,51:165:0.3091
chr3	172849788	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	78,76:154:0.4935
chr3	172958287	.	G	A	.	PASS	CSQ=83893|protein_coding||intron_variant|||||||NM_031955.6:c.934-1463C>T||MODIFIER||||||SPATA16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	66,77:143:0.5385
chr3	173052153	.	A	T	.	PASS	CSQ=83893|protein_coding||intron_variant|||||||NM_031955.6:c.613-3059T>A||MODIFIER||||||SPATA16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	69,78:147:0.5306
chr3	173083903	.	G	T	.	PASS	CSQ=83893|protein_coding||intron_variant|||||||NM_031955.6:c.612+33217C>A||MODIFIER||||||SPATA16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	88,76:164:0.4634
chr3	173098353	.	C	T	.	PASS	CSQ=83893|protein_coding||intron_variant||||rs1249590487||6.5716e-06|NM_031955.6:c.612+18767G>A||MODIFIER||||||SPATA16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	94,78:172:0.4535
chr3	173123899	COSV63534728	C	T	.	PASS	CSQ=83893|protein_coding||intron_variant|COSV63534728|p.?||rs377000525||7.24647e-05|NM_031955.6:c.-18-6150G>A||MODIFIER||||||SPATA16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	88,87:175:0.4971
chr3	173488556	.	T	A	.	PASS	CSQ=22871|protein_coding||intron_variant|||||||NM_001365931.1:c.-321+90493T>A||MODIFIER||||||NLGN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	73,66:139:0.4748
chr3	173529241	.	G	A	.	PASS	CSQ=22871|protein_coding||intron_variant|||||||NM_001365931.1:c.-320-75038G>A||MODIFIER||||||NLGN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	83,84:167:0.503
chr3	174177144	.	G	C	.	PASS	CSQ=22871|protein_coding||intron_variant|||||||NM_001365931.1:c.647-98171G>C||MODIFIER||||||NLGN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	85,82:167:0.491
chr3	174233107	.	A	C	.	PASS	CSQ=22871|protein_coding||intron_variant|||||||NM_001365931.1:c.647-42208A>C||MODIFIER||||||NLGN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	65,85:150:0.5667
chr3	174329493	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs973525184||1.97283e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	76,69:145:0.4759
chr3	174444039	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	50,64:114:0.5614
chr3	174609705	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs554536420|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	147,12:159:0.0755
chr3	174834357	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	73,68:141:0.4823
chr3	174884173	.	G	GA	.	PASS	CSQ=254827|protein_coding||intron_variant|||||||NM_207015.3:c.43+24726dup||MODIFIER||||||NAALADL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	73,54:127:0.4252
chr3	175070279	.	T	A	.	PASS	CSQ=254827|protein_coding||intron_variant|||||||NM_207015.3:c.44-26511T>A||MODIFIER||||||NAALADL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	82,79:161:0.4907
chr3	175141642	.	G	A	.	PASS	CSQ=254827|protein_coding||intron_variant|||||||NM_207015.3:c.545+44351G>A||MODIFIER||||||NAALADL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	66,69:135:0.5111
chr3	175197022	.	A	AT	.	PASS	CSQ=254827|protein_coding||intron_variant||||rs1418054957||2.6329e-05|NM_207015.3:c.546-36902dup||MODIFIER||||||NAALADL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	81,66:147:0.449
chr3	175235640	.	C	T	.	PASS	CSQ=100874244|lncRNA||non_coding_transcript_exon_variant||||rs1049500705||4.59921e-05|NR_046713.1:n.259G>A||MODIFIER||||||NAALADL2-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	88,75:163:0.4601
chr3	175533602	.	G	T	.	PASS	CSQ=254827|protein_coding||intron_variant|||||||NM_207015.3:c.1654-42439G>T||MODIFIER||||||NAALADL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	91,80:171:0.4678
chr3	175968981	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	70,70:140:0.5
chr3	176091171	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||||1.3147e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	91,85:177:0.4802
chr3	176381573	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs185061249||0.000250069|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	59,72:131:0.5496
chr3	176572873	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	63,70:133:0.5263
chr3	176898938	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	99,81:180:0.45
chr3	177105085	.	G	A	.	PASS	CSQ=79718|protein_coding||intron_variant||||||6.57039e-06|NM_001321194.1:c.-240-6544C>T||MODIFIER||||||TBL1XR1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TBL1XR1|y|n|splenic_marginal_zone_lymphoma,primary_central_nervous_system_lymphoma,colorectal_carcinoma,gallbladder_carcinoma|||L,E,M|Rec|oncogene,TSG,fusion|F,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	84,85:169:0.503
chr3	177241003	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	76,69:145:0.4759
chr3	177272529	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	94,77:171:0.4503
chr3	177397191	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	78,86:164:0.5244
chr3	177476178	.	C	T	.	PASS	CSQ=100505566|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047568.1:n.190+34068C>T||MODIFIER||||||LINC00578|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	73,85:158:0.538
chr3	177623333	.	G	A	.	PASS	CSQ=100505566|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047568.1:n.290-6084G>A||MODIFIER||||||LINC00578|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:142:0	89,86:175:0.4914
chr3	177656756	.	G	T	.	PASS	CSQ=100505566|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047568.1:n.428+27201G>T||MODIFIER||||||LINC00578|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	67,71:138:0.5145
chr3	177747888	.	T	C	.	PASS	CSQ=100505566|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047568.1:n.429-4023T>C||MODIFIER||||||LINC00578|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	147,20:167:0.1198
chr3	177810542	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	54,79:133:0.594
chr3	178115340	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:88:0	58,70:128:0.5469
chr3	178984826	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,69:140:0.4929
chr3	179079064	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs923481899||0.0252523|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,0:72:0	67,50:117:0.4274
chr3	179216683	.	T	G	.	PASS	CSQ=5290|protein_coding||intron_variant|||||||NM_006218.4:c.1540-1527T>G||MODIFIER||||||PIK3CA|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PIK3CA|y|n|colorectal,gastric,glioblastoma,breast|||E,O|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	83,80:163:0.4908
chr3	179414995	COSV51709893;COSV51709893;COSV51709893;COSV51709893	G	A	.	PASS	CSQ=59345|protein_coding||missense_variant|COSV51709893&COSV51709893|p.P107L&p.P107L|COSV51709893&COSV51709893|rs267599699&COSM13667|||NM_021629.4:c.320C>T|NP_067642.1:p.Pro107Leu|MODERATE|D&D|T&T|D|D&D|D&D|GNB4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	109,0:109:0	103,84:187:0.4492
chr3	179418921	.	C	G	.	PASS	CSQ=59345|protein_coding||intron_variant||||rs941162389||1.31354e-05|NM_021629.4:c.203+478G>C||MODIFIER||||||GNB4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	90,84:174:0.4828
chr3	179461710	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs937363219||6.59317e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	92,67:159:0.4214
chr3	179528119	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,77:156:0.4936
chr3	179632054	.	TATGA	T	.	PASS	CSQ=4711|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||NDUFB5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,75:152:0.4934
chr3	179905002	.	C	A	.	PASS	CSQ=101928790|lncRNA||intron_variant&non_coding_transcript_variant||||||6.57134e-06|NR_110059.1:n.319+2916C>A||MODIFIER||||||PEX5L-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	89,83:172:0.4826
chr3	179992396	.	C	A	.	PASS	CSQ=51555|protein_coding||intron_variant|||||||NM_016559.3:c.22-20731G>T||MODIFIER||||||PEX5L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	84,67:151:0.4437
chr3	180001493	.	A	T	.	PASS	CSQ=51555|protein_coding||intron_variant||||rs867014236||3.35413e-05|NM_016559.3:c.22-29828T>A||MODIFIER||||||PEX5L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	57,68:125:0.544
chr3	180190868	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	71,80:151:0.5298
chr3	180683766	.	A	G	.	PASS	CSQ=339829|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CCDC39|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,70:138:0.5072
chr3	180692798	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	58,71:129:0.5504
chr3	181165262	.	G	GA	.	PASS	CSQ=347689|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_075091.1:n.149-10246dup||MODIFIER||||||SOX2-OT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	74,80:154:0.5195
chr3	181796860	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	66,81:147:0.551
chr3	181952251	.	G	A	.	PASS	CSQ=100996490|lncRNA||upstream_gene_variant||||rs1001689177||4.60139e-05|||MODIFIER||||||LINC01206|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	62,90:152:0.5921
chr3	182178299	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	88,85:173:0.4913
chr3	182178303	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	85,86:171:0.5029
chr3	182407496	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	66,86:152:0.5658
chr3	182980984	.	C	A	.	PASS	CSQ=54165|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||DCUN1D1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	172,85:257:0.3307
chr3	183147161	.	TGA	T	.	PASS	CSQ=27074|protein_coding||intron_variant|||||||NM_014398.4:c.888+5212_888+5213del||MODIFIER||||||LAMP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	155,70:225:0.3111
chr3	183617672	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs866330432||0.0743299|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,1:88:0.0114	116,94:210:0.4476
chr3	184136537	.	G	A	.	PASS	CSQ=8893|protein_coding||intron_variant|||||||NM_003907.3:c.196-75G>A||MODIFIER||||||EIF2B5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	68,72:140:0.5143
chr3	184295844	.	C	G	.	PASS	CSQ=9718|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ECE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	74,77:151:0.5099
chr3	184580363	.	G	A	.	PASS	CSQ=2049|protein_coding||intron_variant|||||||NM_004443.4:c.2173-39G>A||MODIFIER||||||EPHB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	137,0:137:0	103,75:178:0.4213
chr3	184601843	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57436e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	86,89:175:0.5086
chr3	184947271	.	G	T	.	PASS	CSQ=23355|protein_coding||intron_variant|||||||NM_015303.3:c.3029+7028G>T||MODIFIER||||||VPS8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	87,82:169:0.4852
chr3	185401488	.	G	A	.	PASS	CSQ=9175|protein_coding||intron_variant|||||||NM_004721.5:c.-85-27009G>A||MODIFIER||||||MAP3K13|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MAP3K13|y|n|breast|||E|Rec|oncogene,TSG|F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,71:146:0.4863
chr3	185431033	.	G	A	.	PASS	CSQ=9175|protein_coding||intron_variant|||||||NM_004721.5:c.475+1977G>A||MODIFIER||||||MAP3K13|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MAP3K13|y|n|breast|||E|Rec|oncogene,TSG|F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	72,74:146:0.5068
chr3	185712044	.	TAGAAGGC	T	.	PASS	CSQ=10644|protein_coding||intron_variant|||||||NM_006548.5:c.240-13704_240-13698del||MODIFIER||||||IGF2BP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/IGF2BP2|y|n|lymphoma|||L||TSG|D;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	72,81:153:0.5294
chr3	186029182	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	75,83:158:0.5253
chr3	186278906	.	T	C	.	PASS	CSQ=1608|protein_coding||intron_variant|||||||NM_001346.3:c.792+945A>G||MODIFIER||||||DGKG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	81,73:154:0.474
chr3	186881722	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs945015265||1.97488e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	76,70:146:0.4795
chr3	187702163	COSV100832960;COSV100832960;COSV100832960	C	A	.	PASS	CSQ=344892|protein_coding||5_prime_UTR_variant|COSV100832960|p.?|COSV100832960&COSV100832960||||NM_001004312.2:c.-35G>T||MODIFIER||||||RTP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	132,0:132:0	87,87:174:0.5
chr3	188437370	.	C	T	.	PASS	CSQ=4026|protein_coding||intron_variant|||||||NM_001167671.2:c.193+31057C>T||MODIFIER||||||LPP|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LPP|y|n|lipoma,leukaemia|||L,M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	134,15:149:0.1007
chr3	188684956	.	G	A	.	PASS	CSQ=4026|protein_coding||intron_variant|||||||NM_001167671.2:c.1114-23311G>A||MODIFIER||||||LPP|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/LPP|y|n|lipoma,leukaemia|||L,M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	61,72:133:0.5414
chr3	189140679	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs972875952||5.91389e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,92:92:1
chr3	189457075	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,72:72:1
chr3	189761182	.	C	CT	.	PASS	CSQ=8626|protein_coding||intron_variant|||||||NM_003722.5:c.324+22410dup||MODIFIER||||||TP63|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TP63|y|y|HNSCC,DLBCL|NSCLC||E||oncogene,TSG|Mis,N,T;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	60,3:63:0.0476
chr3	189772893	.	A	T	.	PASS	CSQ=8626|protein_coding||intron_variant|||||||NM_003722.5:c.324+34119A>T||MODIFIER||||||TP63|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TP63|y|y|HNSCC,DLBCL|NSCLC||E||oncogene,TSG|Mis,N,T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,82:82:1
chr3	189811086	.	G	A	.	PASS	CSQ=8626|protein_coding||intron_variant|||||||NM_003722.5:c.579+2560G>A||MODIFIER||||||TP63|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TP63|y|y|HNSCC,DLBCL|NSCLC||E||oncogene,TSG|Mis,N,T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,69:69:1
chr3	190127177	.	A	G	.	PASS	CSQ=55214|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||P3H2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,68:68:1
chr3	190934943	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,85:85:1
chr3	190978435	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,87:87:1
chr3	190993400	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||1.31517e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,86:86:1
chr3	191471236	.	C	G	.	PASS	CSQ=103344926|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120606.1:n.81+45632C>G||MODIFIER||||||LINCR-0002|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,83:83:1
chr3	191610858	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	6,83:89:0.9326
chr3	192538879	.	G	T	.	PASS	CSQ=2257|protein_coding||intron_variant|||||||NM_004113.5:c.14-178341C>A||MODIFIER||||||FGF12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,91:91:1
chr3	193989279	.	T	C	.	PASS	CSQ=647323|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033944.1:n.75+14306A>G||MODIFIER||||||LINC02026|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	77,73:150:0.4867
chr3	194051697	.	C	T	.	PASS	CSQ=285389|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_136179.1:n.149+19125G>A||MODIFIER||||||LINC02028|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	84,78:162:0.4815
chr3	194085694	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	83,74:157:0.4713
chr3	194390829	.	A	G	.	PASS	CSQ=2814|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||GP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	81,73:154:0.474
chr3	194410411	.	A	AAAC	.	PASS	CSQ=79572|protein_coding||intron_variant|||||||NM_001367549.1:c.3573+1785_3573+1787dup||MODIFIER||||||ATP13A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	69,0:69:0	82,46:128:0.3594
chr3	194457835	.	G	A	.	PASS	CSQ=79572|protein_coding||intron_variant|||||||NM_001367549.1:c.480-661C>T||MODIFIER||||||ATP13A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	68,69:137:0.5036
chr3	194680534	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	83,72:155:0.4645
chr3	194687170	COSV61673377	C	T	.	PASS	CSQ=131583|protein_coding||missense_variant|COSV61673377|p.A115V||COSM5355604|||NM_153690.4:c.344C>T|NP_710157.2:p.Ala115Val|MODERATE|P|T|D|T|T|FAM43A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,0:127:0	91,106:197:0.5381
chr3	194690933	.	A	G	.	PASS	CSQ=131583|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FAM43A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	131,50:181:0.2762
chr3	194721324	.	C	T	.	PASS	CSQ=100507391|lncRNA||intron_variant&non_coding_transcript_variant||||rs918078645||1.33415e-05|NR_037891.1:n.727+12177C>T||MODIFIER||||||LINC01968|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	68,100:168:0.5952
chr3	194735076	.	C	A	.	PASS	CSQ=100507391|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037891.1:n.728-9498C>A||MODIFIER||||||LINC01968|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	89,93:182:0.511
chr3	195435400	.	T	C	.	PASS	CSQ=23527|protein_coding||intron_variant|||||||NM_012287.6:c.53+7395A>G||MODIFIER||||||ACAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	71,61:132:0.4621
chr3	196130539	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	90,68:158:0.4304
chr3	197313717	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	69,73:142:0.5141
chr3	197379923	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs918906594||0.000276134|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	72,79:151:0.5232
chr3	197630054	.	G	A	.	PASS	CSQ=220729|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||LOC220729|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	76,77:153:0.5033
chr3	197740628	COSV56376482;COSV56376482;COSV56376482;COSV56376482	C	CT	.	PASS	CSQ=9711|protein_coding||upstream_gene_variant|COSV56376482|p.?|COSV56376482&COSV56376482&COSV56376482|rs1043768402||0.000258208|||MODIFIER||||||RUBCN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	90,61:151:0.404
chr3	197847008	.	C	T	.	PASS	CSQ=84859|protein_coding||intron_variant|||||||NM_001365715.1:c.1329-401C>T||MODIFIER||||||LRCH3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	85,67:152:0.4408
chr3	197874635	.	C	T	.	PASS	CSQ=84859|protein_coding||intron_variant|||||||NM_001365715.1:c.2131-1063C>T||MODIFIER||||||LRCH3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	85,96:181:0.5304
chr4	2451006	.	G	A	.	PASS	CSQ=402160|protein_coding||synonymous_variant|||||||NM_001193282.2:c.855G>A|NP_001180211.2:p.Leu285=|LOW||||||CFAP99|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	140,0:140:0	0,91:91:1
chr4	3725866	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,69:69:1
chr4	3730925	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:141:0	0,90:90:1
chr4	3888404	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	84,12:96:0.125
chr4	4255045	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	0,97:97:1
chr4	4282317	.	G	C	.	PASS	CSQ=55646|protein_coding||intron_variant||||rs1350908538||1.97163e-05|NM_017816.3:c.123-420C>G||MODIFIER||||||LYAR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,77:77:1
chr4	5200673	.	C	T	.	PASS	CSQ=55351|protein_coding||intron_variant|||||||NM_018401.3:c.260+32223C>T||MODIFIER||||||STK32B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,82:82:1
chr4	5860184	.	G	C	.	PASS	CSQ=1400|protein_coding||intron_variant|||||||NM_001014809.2:c.655+842C>G||MODIFIER||||||CRMP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,75:75:1
chr4	5871078	.	G	A	.	PASS	CSQ=1400|protein_coding||intron_variant|||||||NM_001014809.2:c.382-4322C>T||MODIFIER||||||CRMP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	0,75:75:1
chr4	6002793	.	G	T	.	PASS	CSQ=389197|protein_coding||intron_variant|||||||NM_001364689.1:c.963+5203C>A||MODIFIER||||||C4orf50|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,88:88:1
chr4	6281660	.	G	A	.	PASS	CSQ=7466|protein_coding||intron_variant|||||||NM_006005.3:c.232+3973G>A||MODIFIER||||||WFS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,82:82:1
chr4	6906780	.	G	T	.	PASS	CSQ=57533|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TBC1D14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	90,9:99:0.0909
chr4	7180800	.	C	CAT	.	PASS	CSQ=|||intergenic_variant||||rs551910875||0.0108942|||MODIFIER||||||||0.0146;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	16,58:75:0.7733
chr4	7183426	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,68:68:1
chr4	8889643	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,90:90:1
chr4	9580044	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	2,89:91:0.978
chr4	10191013	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.57549e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,59:59:1
chr4	11038628	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs745763611||6.57237e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,73:73:1
chr4	11987026	.	CATTTT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,66:66:1
chr4	12143894	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	0,72:72:1
chr4	12186368	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,64:64:1
chr4	12953959	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,91:91:1
chr4	12984809	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.57722e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,67:67:1
chr4	13311242	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,73:73:1
chr4	13602180	.	G	A	.	PASS	CSQ=259282|protein_coding||missense_variant|||||||NM_148894.3:c.4720C>T|NP_683692.2:p.Leu1574Phe|MODERATE|B|T|N|T|T|BOD1L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	123,0:123:0	0,73:73:1
chr4	13778631	.	G	A	.	PASS	CSQ=101929071|lncRNA||intron_variant&non_coding_transcript_variant||||rs1003861405||6.57384e-06|NR_121681.1:n.282-51149G>A||MODIFIER||||||LINC01182|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,71:71:1
chr4	13967334	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,80:80:1
chr4	14179395	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,80:80:1
chr4	14653985	.	G	T	.	PASS	CSQ=201853|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126435.1:n.225-39569C>A||MODIFIER||||||LINC00504|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,70:70:1
chr4	14763792	.	G	C	.	PASS	CSQ=201853|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126435.1:n.186-63011C>G||MODIFIER||||||LINC00504|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,80:80:1
chr4	14808281	.	C	A	.	PASS	CSQ=201853|lncRNA||intron_variant&non_coding_transcript_variant||||rs1015630430|||NR_126435.1:n.185+51262G>T||MODIFIER||||||LINC00504|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,85:85:1
chr4	15066406	.	C	G	.	PASS	CSQ=101929095|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125911.1:n.155-48525G>C||MODIFIER||||||LOC101929095|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	90,0:90:0	0,90:90:1
chr4	16048649	.	G	T	.	PASS	CSQ=8842|protein_coding||intron_variant|||||||NM_001145848.1:c.221-9648C>A||MODIFIER||||||PROM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,82:82:1
chr4	16298174	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,0:72:0	0,50:50:1
chr4	16394678	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,81:81:1
chr4	16800890	.	TG	GT	.	PASS	CSQ=9079|protein_coding||intron_variant|||||||NM_001290.5:c.133-41631_133-41630delinsAC||MODIFIER||||||LDB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	127,0:127:0	0,84:84:1
chr4	16864074	.	T	TA	.	PASS	CSQ=9079|protein_coding||intron_variant|||||||NM_001290.5:c.132+34279dup||MODIFIER||||||LDB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	4,76:80:0.95
chr4	17082028	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,80:80:1
chr4	18411404	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,87:87:1
chr4	18850185	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,71:71:1
chr4	19108265	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1266752110||6.57281e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	45,32:77:0.4156
chr4	19110868	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	77,12:89:0.1348
chr4	20175180	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,71:71:1
chr4	20249824	.	G	A	.	PASS	CSQ=9353|protein_coding||upstream_gene_variant||||rs1253347282||1.97272e-05|||MODIFIER||||||SLIT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	25,33:58:0.569
chr4	21439782	.	G	A	.	PASS	CSQ=80333|protein_coding||intron_variant||||rs1040708872||3.28601e-05|NM_025221.6:c.61+508789C>T||MODIFIER||||||KCNIP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,71:71:1
chr4	21998031	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,62:62:1
chr4	22471379	.	A	T	.	PASS	CSQ=166647|protein_coding||intron_variant|||||||NM_145290.4:c.329+2393T>A||MODIFIER||||||ADGRA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,70:70:1
chr4	22664037	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,66:66:1
chr4	24090827	.	G	A	.	PASS	CSQ=10891|protein_coding||intron_variant|||||||NM_001330751.1:c.69+641C>T||MODIFIER||||||PPARGC1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,69:69:1
chr4	25303087	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,78:79:0.9873
chr4	25860610	.	C	A	.	PASS	CSQ=23231|protein_coding||intron_variant|||||||NM_015187.5:c.162+2065G>T||MODIFIER||||||SEL1L3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	64,8:72:0.1111
chr4	26045631	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,71:71:1
chr4	26218248	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,61:61:1
chr4	26252614	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,73:73:1
chr4	27291878	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	54,6:60:0.1
chr4	27359609	.	CA	C	.	PASS	CSQ=|||intergenic_variant||||rs1372622352||8.84558e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	9,54:64:0.8438
chr4	27546954	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,1:112:0.0089	1,62:63:0.9841
chr4	27661421	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1456229106||6.57505e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,70:70:1
chr4	28333938	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	114,0:114:0	70,5:75:0.0667
chr4	28596023	.	GC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	4,81:85:0.9529
chr4	28660680	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	0,67:67:1
chr4	28920542	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	5,54:59:0.9153
chr4	29243085	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,74:74:1
chr4	29315666	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs947639912||6.60345e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	1,71:72:0.9861
chr4	29446854	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	0,57:57:1
chr4	29600352	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,72:72:1
chr4	30001904	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,70:70:1
chr4	30120744	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs1245599265||3.29576e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	7,64:71:0.9014
chr4	30300522	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	73,12:85:0.1412
chr4	31014939	.	G	C	.	PASS	CSQ=5099|protein_coding||intron_variant|||||||NM_001173523.1:c.3391+94570G>C||MODIFIER||||||PCDH7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,92:92:1
chr4	31706752	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	0,68:68:1
chr4	31899176	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	59,7:66:0.1061
chr4	32194997	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,65:65:1
chr4	32797048	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.58241e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,74:74:1
chr4	32881155	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,75:75:1
chr4	33012501	.	A	C	.	PASS	CSQ=|||intergenic_variant||||||6.57938e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,69:69:1
chr4	33083778	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,62:62:1
chr4	33394419	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,73:73:1
chr4	33796492	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,69:69:1
chr4	34524240	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,84:84:1
chr4	34607605	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,66:66:1
chr4	34998102	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,1:80:0.0125	55,11:66:0.1667
chr4	35007507	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,98:98:1
chr4	35351223	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,69:69:1
chr4	35687450	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,84:84:1
chr4	36233392	.	A	C	.	PASS	CSQ=116984|protein_coding||intron_variant|||||||NM_015230.4:c.-159-3747T>G||MODIFIER||||||ARAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,68:68:1
chr4	36704926	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,81:81:1
chr4	36816698	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,70:70:1
chr4	36868263	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,75:75:1
chr4	36952611	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	71,17:88:0.1932
chr4	37001257	.	GA	TT	.	PASS	CSQ=100508631|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC100508631|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	76,0:76:0	0,53:53:1
chr4	37066770	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,105:105:1
chr4	37281985	.	A	T	.	PASS	CSQ=57495|protein_coding||intron_variant|||||||NM_001144990.2:c.151+36767A>T||MODIFIER||||||NWD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,81:81:1
chr4	37329422	.	G	A	.	PASS	CSQ=57495|protein_coding||intron_variant||||rs982013894||5.91522e-05|NM_001144990.2:c.240+3398G>A||MODIFIER||||||NWD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,91:91:1
chr4	37442533	.	G	A	.	PASS	CSQ=57495|protein_coding||intron_variant|||||||NM_001144990.2:c.1297-752G>A||MODIFIER||||||NWD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	99,5:104:0.0481
chr4	37846600	.	C	G	.	PASS	CSQ=55276|protein_coding||intron_variant|||||||NM_018290.4:c.1008-331C>G||MODIFIER||||||PGM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,81:81:1
chr4	37860343	.	T	A	.	PASS	CSQ=55276|protein_coding||intron_variant|||||||NM_018290.4:c.1737-1167T>A||MODIFIER||||||PGM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,88:88:1
chr4	38175143	.	CT	TG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	123,0:123:0	0,65:65:1
chr4	38823437	.	G	C	.	PASS	CSQ=10333|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TLR6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,89:89:1
chr4	39878890	.	T	C	.	PASS	CSQ=23244|protein_coding||intron_variant|||||||NM_001100399.2:c.1992+838A>G||MODIFIER||||||PDS5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,68:68:1
chr4	42220176	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,72:72:1
chr4	42479671	.	T	A	.	PASS	CSQ=10396|protein_coding||intron_variant|||||||NM_001105529.1:c.2279+5825A>T||MODIFIER||||||ATP8A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,84:84:1
chr4	42618283	.	T	C	.	PASS	CSQ=10396|protein_coding||intron_variant|||||||NM_001105529.1:c.364-2205A>G||MODIFIER||||||ATP8A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	119,0:119:0	77,5:82:0.061
chr4	42904051	.	A	C	.	PASS	CSQ=389207|protein_coding||intron_variant|||||||NM_001080476.2:c.384+10401A>C||MODIFIER||||||GRXCR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,84:84:1
chr4	42947105	.	C	T	.	PASS	CSQ=389207|protein_coding||intron_variant|||||||NM_001080476.2:c.385-15787C>T||MODIFIER||||||GRXCR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,69:69:1
chr4	43049788	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	24,41:65:0.6308
chr4	43049793	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	23,42:65:0.6462
chr4	43503343	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.57134e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,77:77:1
chr4	44229625	.	T	A	.	PASS	CSQ=386617|protein_coding||intron_variant|||||||NM_198353.3:c.962-54375A>T||MODIFIER||||||KCTD8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,74:74:1
chr4	44355750	.	C	A	.	PASS	CSQ=386617|protein_coding||intron_variant|||||||NM_198353.3:c.961+91813G>T||MODIFIER||||||KCTD8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	0,68:68:1
chr4	44403822	.	C	CA	.	PASS	CSQ=386617|protein_coding||intron_variant||||||6.60764e-06|NM_198353.3:c.961+43740dup||MODIFIER||||||KCTD8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	6,64:70:0.9143
chr4	44727784	.	A	C	.	PASS	CSQ=132789|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GNPDA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	1,70:71:0.9859
chr4	45531932	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1053417307||0.000262912|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:129:0	0,89:89:1
chr4	46758469	.	G	A	.	PASS	CSQ=170712|protein_coding||intron_variant||||rs1245659877|||NM_130902.3:c.-49-23228C>T||MODIFIER||||||COX7B2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,73:73:1
chr4	46965997	.	G	T	.	PASS	CSQ=2557|protein_coding||intron_variant|||||||NM_000809.4:c.875-768C>A||MODIFIER||||||GABRA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,69:69:1
chr4	47247310	.	G	T	.	PASS	CSQ=2560|protein_coding||intron_variant|||||||NM_000812.3:c.462-72817G>T||MODIFIER||||||GABRB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	55,16:71:0.2254
chr4	47405174	.	A	T	.	PASS	CSQ=2560|protein_coding||intron_variant|||||||NM_000812.3:c.835+1463A>T||MODIFIER||||||GABRB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	8,74:82:0.9024
chr4	47474206	.	AAAT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	20,52:72:0.7222
chr4	49208953	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57428e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	28,87:115:0.7565
chr4	49246092	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	277,0:277:0	233,51:284:0.1796
chr4	49643997	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs796838592||0.00013937|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	830,22:852:0.0258	4,16:20:0.8
chr4	49644014	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1408341079||5.7568e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	774,13:846:0.0154	6,13:19:0.6842
chr4	51058168	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	82,68:150:0.4533
chr4	52901725	.	C	A	.	PASS	CSQ=152579|protein_coding||intron_variant|||||||NM_152540.4:c.1842+5732G>T||MODIFIER||||||SCFD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,84:84:1
chr4	53599533	.	T	C	.	PASS	CSQ=100873955|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046827.1:n.118-4004T>C||MODIFIER||||||LNX1-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	156,0:156:0	0,80:80:1
chr4	53867178	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,68:68:1
chr4	54766859	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,88:88:1
chr4	55892248	.	G	C	.	PASS	CSQ=55763|protein_coding||intron_variant|||||||NM_001024924.2:c.1648-387G>C||MODIFIER||||||EXOC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,80:80:1
chr4	56738062	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,85:85:1
chr4	57101700	.	C	T	.	PASS	CSQ=3490|protein_coding||intron_variant|||||||NM_001553.3:c.475+8177G>A||MODIFIER||||||IGFBP7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,84:84:1
chr4	57236203	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	62,6:68:0.0882
chr4	57798593	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,75:75:1
chr4	57890011	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1239890993|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,87:88:0.9886
chr4	57934763	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	1,65:66:0.9848
chr4	57965558	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	0,89:89:1
chr4	58015134	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,76:76:1
chr4	58277001	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,65:65:1
chr4	58474800	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	36,36:72:0.5
chr4	58548697	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,69:69:1
chr4	58650056	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	65,27:92:0.2935
chr4	59167270	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,77:77:1
chr4	59212787	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs939661981||1.31577e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,68:68:1
chr4	59294845	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	57,7:64:0.1094
chr4	59517527	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs565999175||7.23018e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,94:94:1
chr4	59808100	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,72:72:1
chr4	61280107	.	C	CT	.	PASS	CSQ=23284|protein_coding||intron_variant||||rs1372979592||0.0362927|NM_001322402.1:c.-240+78347dup||MODIFIER||||||ADGRL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,1:103:0.0097	20,27:48:0.5625
chr4	61527643	.	A	T	.	PASS	CSQ=23284|protein_coding||intron_variant|||||||NM_001322402.1:c.259+10125A>T||MODIFIER||||||ADGRL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,85:85:1
chr4	61676722	.	AT	A	.	PASS	CSQ=23284|protein_coding||intron_variant|||||||NM_001322402.1:c.474-102del||MODIFIER||||||ADGRL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	130,0:130:0	3,82:85:0.9647
chr4	62251576	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs928425446||1.97272e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,75:75:1
chr4	62571853	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,83:83:1
chr4	63045108	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	6,64:70:0.9143
chr4	63102902	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,78:78:1
chr4	63974666	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,52:53:0.9811
chr4	64220942	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	49,0:49:0	0,80:80:1
chr4	64621249	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1355604957||1.97517e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	6,67:73:0.9178
chr4	64851452	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,93:93:1
chr4	65269857	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,57:57:1
chr4	65554519	.	G	A	.	PASS	CSQ=2044|protein_coding||intron_variant|||||||NM_001281766.2:c.910+47122C>T||MODIFIER||||||EPHA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,59:59:1
chr4	65862966	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	129,0:129:0	64,4:68:0.0588
chr4	65973041	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,1:121:0.0083	0,79:79:1
chr4	66158133	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,61:61:1
chr4	66863974	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	34,31:65:0.4769
chr4	66909545	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs758544844||3.97225e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	77,13:90:0.1444
chr4	67950756	.	G	A	.	PASS	CSQ=339967|protein_coding||intron_variant|||||||NM_001114387.1:c.12-4185C>T||MODIFIER||||||TMPRSS11A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	166,0:166:0	0,82:82:1
chr4	68168992	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,94:94:1
chr4	68290843	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	41,40:81:0.4938
chr4	68646729	.	A	ATT	.	PASS	CSQ=7366|protein_coding||3_prime_UTR_variant||||rs34907656||0.00925085|NM_001076.4:c.*373_*374dup||MODIFIER||||||UGT2B15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	66,1:128:0.0078	12,53:68:0.7794
chr4	68676171	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs4694218|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	67,2:69:0.029	0,13:13:1
chr4	68722676	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1379239934||6.57756e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,67:67:1
chr4	69052545	.	T	TA	.	PASS	CSQ=7364|protein_coding||intron_variant||||rs1232012376||0.000160256|NM_001349568.1:c.-159+952dup||MODIFIER||||||UGT2B7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,0:73:0	7,32:39:0.8205
chr4	69230278	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,58:58:1
chr4	69461503	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||||6.58397e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	44,39:83:0.4699
chr4	69475893	.	C	T	.	PASS	CSQ=7363|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||UGT2B4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	24,41:65:0.6308
chr4	69798488	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,65:65:1
chr4	70019962	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	74,7:81:0.0864
chr4	70076741	.	G	T	.	PASS	CSQ=286828|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||||6.57367e-06|NR_003720.1:n.285-2013G>T||MODIFIER||||||CSN1S2AP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,81:81:1
chr4	70123948	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1485641865||2.64292e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	6,69:75:0.92
chr4	70919750	.	C	T	.	PASS	CSQ=92597|protein_coding||intron_variant||||rs1010227908||3.94223e-05|NM_173468.3:c.14+17200C>T||MODIFIER||||||MOB1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,85:85:1
chr4	71377292	.	G	C	.	PASS	CSQ=8671|protein_coding||intron_variant|||||||NM_001098484.3:c.730+20105G>C||MODIFIER||||||SLC4A4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,64:64:1
chr4	71855659	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs188869745||6.58059e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,87:87:1
chr4	71881373	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1339039598||6.57117e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	0,69:69:1
chr4	71916160	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	35,38:73:0.5205
chr4	71918870	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	59,17:76:0.2237
chr4	72288099	.	CA	C	.	PASS	CSQ=9508|protein_coding||intron_variant|||||||NM_014243.3:c.3049+651del||MODIFIER||||||ADAMTS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	1,82:83:0.988
chr4	72288101	.	G	T	.	PASS	CSQ=9508|protein_coding||intron_variant|||||||NM_014243.3:c.3049+650C>A||MODIFIER||||||ADAMTS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,82:82:1
chr4	72294347	.	C	T	.	PASS	CSQ=9508|protein_coding||intron_variant|||||||NM_014243.3:c.2723+1307G>A||MODIFIER||||||ADAMTS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	72,6:78:0.0769
chr4	72885179	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	79,9:88:0.1023
chr4	73028675	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,85:85:1
chr4	73100955	.	G	A	.	PASS	CSQ=26057|protein_coding||intron_variant|||||||NM_032217.4:c.4573+1421C>T||MODIFIER||||||ANKRD17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,81:81:1
chr4	73328435	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,113:113:1
chr4	73804331	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,84:84:1
chr4	74153531	.	C	T	.	PASS	CSQ=441024|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MTHFD2L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	76,7:83:0.0843
chr4	74646426	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,103:103:1
chr4	75005981	.	A	G	.	PASS	CSQ=25849|protein_coding||intron_variant|||||||NM_015393.4:c.44-6444A>G||MODIFIER||||||PARM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,62:62:1
chr4	75129037	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	3,55:58:0.9483
chr4	75191750	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	0,78:78:1
chr4	75618549	.	C	T	.	PASS	CSQ=8999|protein_coding||intron_variant|||||||NM_001330724.2:c.169-4100G>A||MODIFIER||||||CDKL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,89:89:1
chr4	77335987	.	TATTA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	3,64:67:0.9552
chr4	77462426	.	G	GTT	.	PASS	CSQ=|||intergenic_variant||||rs753901116||0.00554185|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	15,0:114:0	16,75:92:0.8152
chr4	78538798	.	C	CA	.	PASS	CSQ=80144|protein_coding||intron_variant||||rs576736738||0.00132472|NM_025074.7:c.11299-489dup||MODIFIER||||||FRAS1|EntrezGene|0.0016;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	12,67:79:0.8481
chr4	78874659	.	C	G	.	PASS	CSQ=55589|protein_coding||intron_variant|||||||NM_198892.1:c.1793+1861C>G||MODIFIER||||||BMP2K|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,79:79:1
chr4	78988207	.	A	T	.	PASS	CSQ=100505875|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038342.1:n.182+15155A>T||MODIFIER||||||LINC01088|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,81:81:1
chr4	79671577	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,79:79:1
chr4	79960976	.	C	G	.	PASS	CSQ=118429|protein_coding||intron_variant|||||||NM_058172.6:c.1428+16645G>C||MODIFIER||||||ANTXR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,64:64:1
chr4	80731608	.	C	T	.	PASS	CSQ=255119|protein_coding||intron_variant||||rs1005932958||6.57307e-06|NM_152770.2:c.334-138385C>T||MODIFIER||||||CFAP299|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,64:64:1
chr4	81263284	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	74,7:81:0.0864
chr4	82004946	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,90:90:1
chr4	82793817	.	G	A	.	PASS	CSQ=79966|protein_coding||intron_variant|||||||NM_001037582.3:c.232+4489C>T||MODIFIER||||||SCD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	64,14:78:0.1795
chr4	82848755	.	G	A	.	PASS	CSQ=22872|protein_coding||intron_variant|||||||NM_001077207.4:c.2502+49C>T||MODIFIER||||||SEC31A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	101,0:101:0	0,79:79:1
chr4	83896167	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	75,9:84:0.1071
chr4	83919739	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,76:76:1
chr4	83927028	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	66,12:78:0.1538
chr4	85000666	.	G	GT	.	PASS	CSQ=404201|lncRNA||intron_variant&non_coding_transcript_variant||||rs1016309994||0.000206081|NR_152772.1:n.396-16dup||MODIFIER||||||WDFY3-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,1:139:0.0072	18,77:96:0.8021
chr4	85449858	.	CT	C	.	PASS	CSQ=|||intergenic_variant||||rs113571046||0.000403303|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	9,62:72:0.8611
chr4	85711888	.	G	C	.	PASS	CSQ=83478|protein_coding||intron_variant|||||||NM_001025616.3:c.181-9997G>C||MODIFIER||||||ARHGAP24|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,76:76:1
chr4	85804054	.	G	A	.	PASS	CSQ=83478|protein_coding||intron_variant|||||||NM_001025616.3:c.268+82082G>A||MODIFIER||||||ARHGAP24|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	73,10:83:0.1205
chr4	85955817	.	C	G	.	PASS	CSQ=83478|protein_coding||intron_variant|||||||NM_001025616.3:c.599+13544C>G||MODIFIER||||||ARHGAP24|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	68,9:77:0.1169
chr4	86413144	.	C	G	.	PASS	CSQ=5602|protein_coding||intron_variant|||||||NM_002753.4:c.-122+39886G>C||MODIFIER||||||MAPK10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,84:84:1
chr4	86433105	.	C	G	.	PASS	CSQ=5602|protein_coding||intron_variant|||||||NM_002753.4:c.-122+19925G>C||MODIFIER||||||MAPK10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,100:100:1
chr4	87598267	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,74:74:1
chr4	87742717	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs1486453773||1.31787e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	9,80:89:0.8989
chr4	89178986	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,74:74:1
chr4	89199872	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1224538376|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,2:75:0.0267	0,11:11:1
chr4	89199884	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs370187000|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	71,0:71:0	0,6:6:1
chr4	89308664	.	T	A	.	PASS	CSQ=285513|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GPRIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,79:79:1
chr4	89534753	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	45,42:87:0.4828
chr4	89697919	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	116,0:116:0	84,4:88:0.0455
chr4	90048002	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	0,73:73:1
chr4	90285430	.	C	A	.	PASS	CSQ=401145|protein_coding||intron_variant|||||||NM_001145065.1:c.-41-22814C>A||MODIFIER||||||CCSER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	8,87:95:0.9158
chr4	90401620	.	G	A	.	PASS	CSQ=401145|protein_coding||intron_variant||||rs1000986493||6.57886e-06|NM_001145065.1:c.1603+1491G>A||MODIFIER||||||CCSER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:110:0	0,69:69:1
chr4	90699199	.	C	T	.	PASS	CSQ=401145|protein_coding||intron_variant|||||||NM_001145065.1:c.1933-24715C>T||MODIFIER||||||CCSER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,76:76:1
chr4	91049707	.	G	T	.	PASS	CSQ=401145|protein_coding||intron_variant|||||||NM_001145065.1:c.2173-36243G>T||MODIFIER||||||CCSER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	30,52:82:0.6341
chr4	91094026	.	G	A	.	PASS	CSQ=401145|protein_coding||intron_variant||||rs551897807||9.19842e-05|NM_001145065.1:c.2217+8032G>A||MODIFIER||||||CCSER1|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,69:69:1
chr4	91096887	.	C	T	.	PASS	CSQ=401145|protein_coding||intron_variant|||||||NM_001145065.1:c.2217+10893C>T||MODIFIER||||||CCSER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,77:77:1
chr4	92574517	.	T	C	.	PASS	CSQ=2895|protein_coding||intron_variant|||||||NM_001510.4:c.89-15614T>C||MODIFIER||||||GRID2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	0,76:76:1
chr4	92815975	COSV56175922;COSV56175922	C	CA	.	PASS	CSQ=2895|protein_coding||intron_variant|COSV56175922&COSV56175922|p.?&p.?||rs1348802063||0.00111414|NM_001510.4:c.244+225699dup||MODIFIER||||||GRID2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,1:93:0.0108	10,50:62:0.8065
chr4	93243420	.	C	A	.	PASS	CSQ=2895|protein_coding||intron_variant|||||||NM_001510.4:c.1245+4930C>A||MODIFIER||||||GRID2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,69:69:1
chr4	93442611	.	G	A	.	PASS	CSQ=2895|protein_coding||intron_variant||||rs761976237||2.63578e-05|NM_001510.4:c.1546-13051G>A||MODIFIER||||||GRID2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,79:79:1
chr4	93534547	.	G	C	.	PASS	CSQ=2895|protein_coding||intron_variant|||||||NM_001510.4:c.2193+19136G>C||MODIFIER||||||GRID2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,63:63:1
chr4	93705472	.	C	T	.	PASS	CSQ=2895|protein_coding||intron_variant|||||||NM_001510.4:c.2361-63738C>T||MODIFIER||||||GRID2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,9:77:0.1169
chr4	93785368	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,60:60:1
chr4	95244540	.	C	T	.	PASS	CSQ=8633|protein_coding||intron_variant|||||||NM_003728.4:c.943+437G>A||MODIFIER||||||UNC5C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,78:78:1
chr4	95473209	.	T	C	.	PASS	CSQ=8633|protein_coding||intron_variant|||||||NM_003728.4:c.124+75525A>G||MODIFIER||||||UNC5C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,74:74:1
chr4	95707808	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,73:73:1
chr4	96675197	.	C	T	.	PASS	CSQ=105377338|lncRNA||intron_variant&non_coding_transcript_variant||||rs1189678913||1.32088e-05|NR_147149.1:n.228+93403C>T||MODIFIER||||||LINC02267|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,12:80:0.15
chr4	96868310	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,70:70:1
chr4	97038800	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	69,8:77:0.1039
chr4	97264332	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,76:76:1
chr4	97526188	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,63:63:1
chr4	97583993	.	G	T	.	PASS	CSQ=285555|protein_coding||intron_variant|||||||NM_174952.3:c.1321-24876C>A||MODIFIER||||||STPG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,75:75:1
chr4	97616036	.	C	CAA	.	PASS	CSQ=285555|protein_coding||intron_variant||||rs111910700||0.0488888|NM_174952.3:c.1321-56921_1321-56920dup||MODIFIER||||||STPG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	15,0:46:0	13,35:49:0.7143
chr4	97955625	.	G	C	.	PASS	CSQ=285555|protein_coding||intron_variant|||||||NM_174952.3:c.934-11618C>G||MODIFIER||||||STPG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	64,9:73:0.1233
chr4	98955613	.	C	CTT	.	PASS	CSQ=|||intergenic_variant||||rs58374978||0.00250367|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	51,0:79:0	19,46:66:0.697
chr4	99388535	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,64:64:1
chr4	100082127	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,77:77:1
chr4	100750620	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	1,68:69:0.9855
chr4	101179314	.	C	T	.	PASS	CSQ=5530|protein_coding||intron_variant||||rs1276026349|||NM_000944.5:c.259+16602G>A||MODIFIER||||||PPP3CA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,82:82:1
chr4	101652342	.	CC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	118,0:118:0	0,73:73:1
chr4	102007134	.	A	AT	.	PASS	CSQ=55024|protein_coding||intron_variant||||||0.0724965|NM_017935.5:c.1207-14380_1207-14379insT||MODIFIER||||||BANK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	30,0:31:0	18,9:28:0.3214
chr4	103076469	.	G	A	.	PASS	CSQ=56898|protein_coding||downstream_gene_variant||||rs965589230||1.31391e-05|||MODIFIER||||||BDH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	167,0:167:0	0,89:89:1
chr4	104015325	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1311525331||0.00094498|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	10,58:68:0.8529
chr4	104107028	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,76:76:1
chr4	104245324	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,93:93:1
chr4	104251441	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,85:85:1
chr4	104633215	.	A	G	.	PASS	CSQ=101929468|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125926.1:n.97-9796A>G||MODIFIER||||||CXXC4-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,83:83:1
chr4	106928675	.	C	T	.	PASS	CSQ=27123|protein_coding||intron_variant|||||||NM_014421.3:c.223-2726G>A||MODIFIER||||||DKK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,85:85:1
chr4	108036650	.	C	CTT	.	PASS	CSQ=3033|protein_coding||downstream_gene_variant||||rs67422500||0.149647|||MODIFIER||||||HADH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	21,0:95:0	9,47:57:0.8246
chr4	108400772	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1240644639|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,46:46:1
chr4	108428970	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,84:84:1
chr4	109285028	.	G	GT	.	PASS	CSQ=84570|protein_coding||intron_variant|||||||NM_198721.4:c.367+15554dup||MODIFIER||||||COL25A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	10,93:103:0.9029
chr4	109889897	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	0,73:73:1
chr4	110430695	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,63:63:1
chr4	110432390	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,78:78:1
chr4	110514667	.	T	C	.	PASS	CSQ=2028|protein_coding||intron_variant|||||||NM_001977.4:c.1444-710T>C||MODIFIER||||||ENPEP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,84:84:1
chr4	111392888	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,94:94:1
chr4	111791293	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	60,12:72:0.1667
chr4	111868669	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	45,46:91:0.5055
chr4	112074093	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs895361173||0.000118721|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	5,75:80:0.9375
chr4	113187301	.	G	A	.	PASS	CSQ=287|protein_coding||intron_variant|||||||NM_001148.6:c.187-9067G>A||MODIFIER||||||ANK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,85:85:1
chr4	113330869	.	T	A	.	PASS	CSQ=287|protein_coding||intron_variant|||||||NM_001148.6:c.3125+399T>A||MODIFIER||||||ANK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,75:75:1
chr4	113917388	.	C	A	.	PASS	CSQ=79642|protein_coding||intron_variant|||||||NM_024590.4:c.399-13713G>T||MODIFIER||||||ARSJ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	1,83:84:0.9881
chr4	113917390	.	A	C	.	PASS	CSQ=79642|protein_coding||intron_variant|||||||NM_024590.4:c.399-13715T>G||MODIFIER||||||ARSJ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	1,84:85:0.9882
chr4	114431325	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,78:78:1
chr4	115372400	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,74:74:1
chr4	115510577	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1268446838||6.69613e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,80:80:1
chr4	115650889	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1276420324||6.5722e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,69:69:1
chr4	116141745	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,63:63:1
chr4	116187547	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,66:66:1
chr4	116226725	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1026223843||6.57471e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	8,75:83:0.9036
chr4	116496539	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	5,66:71:0.9296
chr4	116551069	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1469500536||0.000332133|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	4,65:69:0.942
chr4	116770468	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,68:68:1
chr4	117014265	COSV71112503	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV71112503|rs562015244||0.00097307|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:138:0	77,8:85:0.0941
chr4	117282594	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,69:69:1
chr4	118237391	.	C	G	.	PASS	CSQ=9348|protein_coding||intron_variant|||||||NM_004784.3:c.2118+171C>G||MODIFIER||||||NDST3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,89:89:1
chr4	120079157	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,90:90:1
chr4	120305594	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	47,18:65:0.2769
chr4	120606260	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.58657e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,97:97:1
chr4	120658636	COSV58216426	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV58216426|rs574442111||0.00035002|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	6,70:77:0.9091
chr4	120947424	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,73:73:1
chr4	121297769	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,1:97:0.0103	0,75:75:1
chr4	121483621	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,85:85:1
chr4	121618222	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	74,12:86:0.1395
chr4	121619314	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	72,6:78:0.0769
chr4	121619619	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	58,13:71:0.1831
chr4	122935728	.	A	C	.	PASS	CSQ=166378|protein_coding||synonymous_variant|||||||NM_145207.3:c.1162A>C|NP_660208.2:p.Arg388=|LOW||||||SPATA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	78,9:87:0.1034
chr4	123219129	.	C	T	.	PASS	CSQ=166378|protein_coding||intron_variant||||rs1410921630||1.97182e-05|NM_145207.3:c.2341-36887C>T||MODIFIER||||||SPATA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	0,93:93:1
chr4	124889746	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	78,13:91:0.1429
chr4	125011493	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	77,11:88:0.125
chr4	125121447	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,72:72:1
chr4	125194621	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,81:81:1
chr4	125258263	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,1:99:0.0101	0,91:91:1
chr4	125534279	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs993559710||5.25659e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,80:80:1
chr4	125911249	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	67,7:74:0.0946
chr4	126237522	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs530783402||1.31453e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,68:68:1
chr4	126266789	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,75:75:1
chr4	126316858	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,65:65:1
chr4	126459616	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	38,25:63:0.3968
chr4	126523774	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,74:74:1
chr4	126529847	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	39,15:54:0.2778
chr4	126533578	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,84:84:1
chr4	126905501	.	CTT	C	.	PASS	CSQ=|||intergenic_variant||||rs1251102562||1.32221e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	1,69:70:0.9857
chr4	129469132	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,62:62:1
chr4	129489104	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,82:82:1
chr4	129631794	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,67:67:1
chr4	129879530	.	C	T	.	PASS	CSQ=107986313|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_151713.1:n.1187+16762C>T||MODIFIER||||||LINC02465|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,70:70:1
chr4	130299956	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,57:57:1
chr4	130727653	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1468874676||6.60014e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,71:71:1
chr4	130907492	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:129:0	0,72:72:1
chr4	130917512	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,65:65:1
chr4	131002320	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,70:70:1
chr4	131343778	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,67:67:1
chr4	131368792	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	64,4:68:0.0588
chr4	131412727	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,58:58:1
chr4	131592775	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1161469350||3.96207e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	6,55:62:0.8871
chr4	131611581	.	ACAT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,55:55:1
chr4	132033531	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,69:69:1
chr4	132199031	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	81,9:90:0.1
chr4	132392144	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,77:77:1
chr4	132416944	COSV70439608	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV70439608|rs181457713||3.9494e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,63:63:1
chr4	132532356	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,66:66:1
chr4	132882555	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,72:72:1
chr4	133076597	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,71:71:1
chr4	133195492	.	C	A	.	PASS	CSQ=57575|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PCDH10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,78:78:1
chr4	133275542	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,66:66:1
chr4	133513320	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,71:71:1
chr4	133575708	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,69:69:1
chr4	133577577	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	5,72:77:0.9351
chr4	133581278	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,76:76:1
chr4	134252034	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	0,73:73:1
chr4	134487037	.	TA	T	.	PASS	CSQ=105377434|lncRNA||intron_variant&non_coding_transcript_variant||||rs1460243935||1.31486e-05|NR_147155.1:n.429+29193del||MODIFIER||||||LINC02462|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	10,62:72:0.8611
chr4	134856767	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	0,68:68:1
chr4	134870492	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1053718982||1.3152e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	0,72:72:1
chr4	135023595	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	62,8:70:0.1143
chr4	135213679	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,85:85:1
chr4	135670100	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,75:75:1
chr4	135835212	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1225966200||6.57964e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	0,72:72:1
chr4	136048792	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs35020193||0.0886981|||MODIFIER||||||||0.1150;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	9,50:59:0.8475
chr4	136078134	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,64:64:1
chr4	136143190	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,61:61:1
chr4	136246570	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs577252658||6.58207e-06|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,77:77:1
chr4	136373036	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1333050037||0.000202252|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	2,59:61:0.9672
chr4	136390554	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	1,52:53:0.9811
chr4	137070825	.	G	T	.	PASS	CSQ=105377441|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149105.1:n.103+18736C>A||MODIFIER||||||LINC02511|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,78:78:1
chr4	137537029	.	C	G	.	PASS	CSQ=54510|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PCDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,77:77:1
chr4	138519289	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,71:71:1
chr4	139548817	.	C	A	.	PASS	CSQ=80854|protein_coding||intron_variant|||||||NM_030648.3:c.41-1768G>T||MODIFIER||||||SETD7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,83:83:1
chr4	140667689	.	C	T	.	PASS	CSQ=23158|protein_coding||intron_variant||||rs1182754692|||NM_015130.3:c.1588+1228G>A||MODIFIER||||||TBC1D9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,77:77:1
chr4	140786598	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1251838950||1.31416e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,68:68:1
chr4	142812701	.	T	TAA	.	PASS	CSQ=8821|protein_coding||intron_variant|||||||NM_001101669.2:c.-254+33506_-254+33507dup||MODIFIER||||||INPP4B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	86,12:98:0.1224
chr4	142857773	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,105:105:1
chr4	143113107	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,96:96:1
chr4	143902871	.	T	C	.	PASS	CSQ=2996|protein_coding||intron_variant|||||||NM_198682.3:c.37+2600A>G||MODIFIER||||||GYPE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,75:75:1
chr4	143970563	.	G	A	.	PASS	CSQ=101927636|lncRNA||intron_variant&non_coding_transcript_variant||||rs10008885|||NR_125886.1:n.389+25G>A||MODIFIER||||||LOC101927636|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	59,2:61:0.0328	0,6:6:1
chr4	143970579	.	A	G	.	PASS	CSQ=101927636|lncRNA||intron_variant&non_coding_transcript_variant||||rs71612467|||NR_125886.1:n.389+41A>G||MODIFIER||||||LOC101927636|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	55,10:65:0.1538	0,14:14:1
chr4	144218426	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,88:88:1
chr4	144439697	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1336731758||9.85947e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,85:85:1
chr4	144701509	.	G	A	.	PASS	CSQ=64399|protein_coding||intron_variant|||||||NM_022475.3:c.832-5022G>A||MODIFIER||||||HHIP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,75:75:1
chr4	145044985	.	A	T	.	PASS	CSQ=10393|protein_coding||intron_variant||||rs888285481||2.63411e-05|NM_001256706.2:c.327+19587T>A||MODIFIER||||||ANAPC10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	71,16:87:0.1839
chr4	145388818	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,80:80:1
chr4	145821570	.	C	CT	.	PASS	CSQ=152485|protein_coding||intron_variant||||rs149432914||0.0128837|NM_001306215.2:c.2383+1851dup||MODIFIER||||||ZNF827|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	109,0:109:0	65,6:71:0.0845
chr4	145848908	.	T	A	.	PASS	CSQ=152485|protein_coding||intron_variant|||||||NM_001306215.2:c.2221+414A>T||MODIFIER||||||ZNF827|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,85:85:1
chr4	146268025	.	G	A	.	PASS	CSQ=84068|protein_coding||intron_variant|||||||NM_001029998.5:c.848-9188C>T||MODIFIER||||||SLC10A7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	76,9:85:0.1059
chr4	146392402	.	C	A	.	PASS	CSQ=84068|protein_coding||intron_variant|||||||NM_001029998.5:c.435+50381G>T||MODIFIER||||||SLC10A7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,73:73:1
chr4	147124052	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,82:82:1
chr4	147428831	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,58:58:1
chr4	148229777	.	G	A	.	PASS	CSQ=4306|protein_coding||intron_variant||||rs1029085298||6.57289e-05|NM_000901.5:c.1897+30201C>T||MODIFIER||||||NR3C2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,97:97:1
chr4	148498635	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,86:86:1
chr4	148519919	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,57:57:1
chr4	149254500	.	T	G	.	PASS	CSQ=101927849|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125887.1:n.1918-1504T>G||MODIFIER||||||LINC02355|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	34,34:68:0.5
chr4	149330666	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	150,14:164:0.0854
chr4	149363794	.	CAT	C	.	PASS	CSQ=285423|protein_coding||intron_variant|||||||NM_001363507.1:c.1391-11730_1391-11729del||MODIFIER||||||IQCM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	84,75:159:0.4717
chr4	149649244	.	G	A	.	PASS	CSQ=285423|protein_coding||intron_variant|||||||NM_001363507.1:c.566-28000C>T||MODIFIER||||||IQCM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,72:72:1
chr4	149649346	.	G	C	.	PASS	CSQ=285423|protein_coding||intron_variant||||rs1427170324||6.57895e-06|NM_001363507.1:c.566-28102C>G||MODIFIER||||||IQCM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	0,52:52:1
chr4	149849023	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	64,22:86:0.2558
chr4	150200779	.	C	G	.	PASS	CSQ=166614|protein_coding||intron_variant|||||||NM_001040260.4:c.961+2676C>G||MODIFIER||||||DCLK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,86:86:1
chr4	150452038	.	G	T	.	PASS	CSQ=987|protein_coding||intron_variant|||||||NM_001364905.1:c.6781-15174C>A||MODIFIER||||||LRBA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,79:79:1
chr4	151106564	.	A	T	.	PASS	CSQ=8944|snoRNA||downstream_gene_variant|||||||||MODIFIER||||||SNORD73A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,90:90:1
chr4	152756741	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,73:73:1
chr4	152847299	.	ATTTTTGTATT	A	.	PASS	CSQ=27236|protein_coding||intron_variant|||||||NM_001025595.3:c.94-16304_94-16295del||MODIFIER||||||ARFIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,62:62:1
chr4	152881698	.	C	A	.	PASS	CSQ=27236|protein_coding||intron_variant|||||||NM_001025595.3:c.633+514C>A||MODIFIER||||||ARFIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,80:80:1
chr4	153180845	.	T	G	.	PASS	CSQ=23321|protein_coding||intron_variant|||||||NM_001351056.1:c.-49+28233T>G||MODIFIER||||||TRIM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,89:89:1
chr4	153247697	.	A	C	.	PASS	CSQ=23321|protein_coding||intron_variant||||rs918402071||3.30596e-05|NM_015271.5:c.31-22638A>C||MODIFIER||||||TRIM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	5,64:69:0.9275
chr4	154289093	.	G	C	.	PASS	CSQ=54798|protein_coding||intron_variant|||||||NM_001358235.1:c.6463+8758C>G||MODIFIER||||||DCHS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,79:79:1
chr4	154763623	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	69,0:69:0	0,55:58:0.9483
chr4	155208849	.	G	A	.	PASS	CSQ=4887|protein_coding||5_prime_UTR_variant|||||||NM_000910.4:c.-269G>A||MODIFIER||||||NPY2R|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	134,0:134:0	0,97:97:1
chr4	155245316	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs753094700||0.000190669|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,76:76:1
chr4	155259184	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,77:77:1
chr4	155295262	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,65:65:1
chr4	156019512	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	9,73:82:0.8902
chr4	156406978	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,68:68:1
chr4	157188372	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,82:82:1
chr4	157838121	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,95:95:1
chr4	158089838	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	76,20:96:0.2083
chr4	158487803	.	GT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,87:87:1
chr4	158622460	.	A	T	.	PASS	CSQ=59350|protein_coding||intron_variant|||||||NM_021634.4:c.756-4360A>T||MODIFIER||||||RXFP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,86:86:1
chr4	158741974	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1254770911||8.59606e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	5,82:87:0.9425
chr4	159129482	.	G	A	.	PASS	CSQ=9693|protein_coding||intron_variant|||||||NM_001351724.1:c.69+25251G>A||MODIFIER||||||RAPGEF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,81:81:1
chr4	159145250	.	T	TA	.	PASS	CSQ=9693|protein_coding||intron_variant||||||6.57203e-06|NM_001351724.1:c.69+41020dup||MODIFIER||||||RAPGEF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	6,78:84:0.9286
chr4	159439603	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,75:75:1
chr4	159606186	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,76:76:1
chr4	160345132	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,67:67:1
chr4	160757097	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,12:84:0.1429
chr4	160757194	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1274583013|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	66,15:81:0.1852
chr4	160757912	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	67,10:77:0.1299
chr4	161519123	.	C	A	.	PASS	CSQ=56884|protein_coding||intron_variant|||||||NM_020116.5:c.1313-8699G>T||MODIFIER||||||FSTL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	2,67:69:0.971
chr4	161694147	.	T	A	.	PASS	CSQ=56884|protein_coding||intron_variant|||||||NM_020116.5:c.728-37653A>T||MODIFIER||||||FSTL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,76:76:1
chr4	161731719	.	A	G	.	PASS	CSQ=56884|protein_coding||intron_variant|||||||NM_020116.5:c.727+27692T>C||MODIFIER||||||FSTL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,73:73:1
chr4	161971682	.	G	A	.	PASS	CSQ=56884|protein_coding||intron_variant|||||||NM_020116.5:c.161-51030C>T||MODIFIER||||||FSTL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,77:77:1
chr4	162074175	.	C	A	.	PASS	CSQ=56884|protein_coding||intron_variant|||||||NM_020116.5:c.126+37096G>T||MODIFIER||||||FSTL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,85:85:1
chr4	162469412	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,87:87:1
chr4	162698556	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs564473551||0.0717263|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	19,0:107:0	12,68:80:0.85
chr4	162819205	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,74:74:1
chr4	163259562	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,64:65:0.9846
chr4	163301287	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,1:81:0.0123	0,75:75:1
chr4	163314335	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	0,70:70:1
chr4	163345763	.	A	G	.	PASS	CSQ=4889|protein_coding||intron_variant|||||||NM_006174.4:c.-81+10A>G||MODIFIER||||||NPY5R|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	105,0:105:0	0,69:69:1
chr4	163822690	.	G	A	.	PASS	CSQ=55016|protein_coding||intron_variant|||||||NM_001166373.1:c.111+31331C>T||MODIFIER||||||MARCH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	50,11:61:0.1803
chr4	165434307	.	A	G	.	PASS	CSQ=1363|protein_coding||intron_variant|||||||NM_001873.4:c.308-30083A>G||MODIFIER||||||CPE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,84:84:1
chr4	165434327	.	C	G	.	PASS	CSQ=1363|protein_coding||intron_variant|||||||NM_001873.4:c.308-30063C>G||MODIFIER||||||CPE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,79:79:1
chr4	165982736	.	TA	T	.	PASS	CSQ=7092|protein_coding||intron_variant||||rs1242401705||0.000791438|NM_012464.5:c.170-6630del||MODIFIER||||||TLL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	55,0:89:0	7,77:86:0.8953
chr4	166545612	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1045201230||0.000256876|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	4,59:64:0.9219
chr4	167283774	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	41,33:74:0.4459
chr4	168547659	.	G	A	.	PASS	CSQ=23022|protein_coding||intron_variant|||||||NM_001166108.2:c.908+35247G>A||MODIFIER||||||PALLD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	89,18:107:0.1682
chr4	168605676	.	C	T	.	PASS	CSQ=23022|protein_coding||intron_variant||||rs1014025774||2.62816e-05|NM_001166108.2:c.909-62514C>T||MODIFIER||||||PALLD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,88:88:1
chr4	168941744	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,80:80:1
chr4	169363725	.	A	AAG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	15,60:75:0.8
chr4	169363726	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	17,61:78:0.7821
chr4	170677539	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs9996914||0.150942|||MODIFIER||||||||0.1591;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,63:63:1
chr4	170691384	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,62:62:1
chr4	170862399	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,62:62:1
chr4	171187045	.	G	A	.	PASS	CSQ=102466953|miRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR6082|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,72:72:1
chr4	171623164	.	T	A	.	PASS	CSQ=105377536|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147157.1:n.198-2589A>T||MODIFIER||||||LINC02174|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,68:68:1
chr4	171771676	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:136:0	0,76:76:1
chr4	171880162	.	A	G	.	PASS	CSQ=442117|protein_coding||intron_variant|||||||NM_001034845.3:c.138+65444A>G||MODIFIER||||||GALNTL6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,70:70:1
chr4	172008459	.	CT	C	.	PASS	CSQ=442117|protein_coding||intron_variant||||rs1186543005||7.39953e-05|NM_001034845.3:c.138+193751del||MODIFIER||||||GALNTL6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	3,60:63:0.9524
chr4	172075582	COSV72491752;COSV72491752	G	A	.	PASS	CSQ=442117|protein_coding||intron_variant|COSV72491752&COSV72491752|p.?&p.?||rs942965310|||NM_001034845.3:c.139-154074G>A||MODIFIER||||||GALNTL6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,83:83:1
chr4	173027750	.	G	A	.	PASS	CSQ=442117|protein_coding||intron_variant|||||||NM_001034845.3:c.1638+6125G>A||MODIFIER||||||GALNTL6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,86:86:1
chr4	173980378	.	G	GAA	.	PASS	CSQ=|||intergenic_variant||||rs35545129||0.000966644|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	13,0:118:0	6,66:73:0.9041
chr4	175082803	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,2:108:0.0185	0,70:70:1
chr4	175472511	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	71,8:79:0.1013
chr4	175519674	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs555963357||9.21987e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,78:78:1
chr4	175621145	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs570897226||0.00143905|||MODIFIER||||||||0.0008;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	9,69:78:0.8846
chr4	175677900	.	C	A	.	PASS	CSQ=2823|protein_coding||intron_variant|||||||NM_201591.2:c.231-4064G>T||MODIFIER||||||GPM6A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	78,4:82:0.0488
chr4	175722510	COSV54550948;COSV54550948;COSV54550948;COSV54550948	C	T	.	PASS	CSQ=2823|protein_coding||intron_variant|COSV54550948&COSV54550948&COSV54550948&COSV54550948|p.?&p.?&p.?&p.?||rs1171759946||4.60199e-05|NM_201591.2:c.38-20743G>A||MODIFIER||||||GPM6A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,72:72:1
chr4	175923576	.	C	A	.	PASS	CSQ=2823|protein_coding||intron_variant|||||||NM_005277.4:c.-23+78733G>T||MODIFIER||||||GPM6A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	31,49:80:0.6125
chr4	176151555	.	TTTTAAA	T	.	PASS	CSQ=116966|protein_coding||intron_variant|||||||NM_181265.3:c.2305-253_2305-248del||MODIFIER||||||WDR17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,77:77:1
chr4	176341110	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs751379007||0.00615136|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	12,66:78:0.8462
chr4	176634054	.	AG	A	.	PASS	CSQ=|||intergenic_variant||||||6.57022e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	2,93:95:0.9789
chr4	176974136	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,78:78:1
chr4	177177841	.	GG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	130,0:130:0	0,78:78:1
chr4	177820985	.	G	A	.	PASS	CSQ=285501|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_028342.1:n.374+88506G>A||MODIFIER||||||LINC01098|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,75:75:1
chr4	177877096	.	T	A	.	PASS	CSQ=285501|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_028342.1:n.375-83666T>A||MODIFIER||||||LINC01098|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,63:63:1
chr4	178177438	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs943504800||0.000138336|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,71:71:1
chr4	178565151	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1450883205|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,92:92:1
chr4	178900254	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.57168e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,74:74:1
chr4	178949120	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,77:77:1
chr4	179275610	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,75:75:1
chr4	179351885	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs754969055||0.000111923|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,72:72:1
chr4	179559094	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs935850138||6.60939e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	55,14:69:0.2029
chr4	179590211	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	8,58:66:0.8788
chr4	179656130	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,65:65:1
chr4	179682730	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,70:70:1
chr4	180251990	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,82:82:1
chr4	180822291	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,74:74:1
chr4	180853614	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,59:59:1
chr4	180905030	COSV63530670	A	AT	.	PASS	CSQ=|||intergenic_variant|||COSV63530670|rs894021041|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	7,51:58:0.8793
chr4	181288875	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	0,68:68:1
chr4	181528669	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,72:72:1
chr4	181696046	.	GC	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	94,0:94:0	0,64:64:1
chr4	181897253	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,85:85:1
chr4	182433290	.	G	A	.	PASS	CSQ=55714|protein_coding||intron_variant|||||||NM_001080477.4:c.511+86361G>A||MODIFIER||||||TENM3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,79:79:1
chr4	182792012	.	A	G	.	PASS	CSQ=55714|protein_coding||intron_variant||||rs1317931018||1.97138e-05|NM_001080477.4:c.5602-262A>G||MODIFIER||||||TENM3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	113,0:113:0	76,6:82:0.0732
chr4	183574726	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,83:83:1
chr4	184788077	.	C	T	.	PASS	CSQ=2180|protein_coding||intron_variant|||||||NM_001995.4:c.310+540G>A||MODIFIER||||||ACSL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,75:75:1
chr4	184979632	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,102:102:1
chr4	186449790	.	A	AT	.	PASS	CSQ=285441|lncRNA||intron_variant&non_coding_transcript_variant||||rs976413083||1.31439e-05|NR_033900.1:n.214+51054dup||MODIFIER||||||F11-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	9,76:85:0.8941
chr4	186813905	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,91:91:1
chr4	187021467	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	0,82:82:1
chr4	187450030	.	T	A	.	PASS	CSQ=339975|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038931.1:n.322+55262A>T||MODIFIER||||||LOC339975|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	61,12:73:0.1644
chr4	187639906	.	C	T	.	PASS	CSQ=100506272|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110436.1:n.157+25856G>A||MODIFIER||||||LINC02492|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,63:63:1
chr4	187747894	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,85:85:1
chr4	187809862	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,69:69:1
chr4	188281365	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	28,20:48:0.4167
chr4	188597396	.	A	T	.	PASS	CSQ=401164|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033869.1:n.343-4372A>T||MODIFIER||||||LINC01060|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	1,68:69:0.9855
chr4	188712289	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1283418392|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,1:107:0.0093	67,7:74:0.0946
chr4	188745056	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs145354630||0.0401361|||MODIFIER||||||||0.0443;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	10,63:73:0.863
chr4	189073627	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	6,88:94:0.9362
chr4	189114594	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs866994339||0.0439044|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	17,56:73:0.7671
chr4	189745254	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,69:69:1
chr4	189752756	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs2337608||0.00547197|||MODIFIER||||||||0.0124;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	45,2:47:0.0426	0,4:4:1
chr4	190008674	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,59:59:1
chr4	190106316	.	GA	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	598,0:599:0	315,60:375:0.16
chr5	94408	.	C	G	.	PASS	CSQ=153478|protein_coding||intron_variant|||||||NM_052909.4:c.45+2132C>G||MODIFIER||||||PLEKHG4B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	79,83:162:0.5123
chr5	249986	.	A	G	.	PASS	CSQ=6389|protein_coding||intron_variant|||||||NM_004168.4:c.1552-1006A>G||MODIFIER||||||SDHA|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/SDHA|y|y|GIST,paraganglioma|paraganglioma|paragangliomas-5_(PGL5)|M,O|Rec|TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	94,80:174:0.4598
chr5	812952	.	C	A	.	PASS	CSQ=79844|protein_coding||intron_variant|||||||NM_024786.2:c.1181+1809G>T||MODIFIER||||||ZDHHC11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	98,105:203:0.5172
chr5	872620	.	G	A	.	PASS	CSQ=65980|protein_coding||intron_variant||||rs1441172606||6.57117e-06|NM_023924.5:c.1384-1056C>T||MODIFIER||||||BRD9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	89,77:166:0.4639
chr5	1141002	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs980391060||2.62805e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	91,89:180:0.4944
chr5	1224416	.	G	A	.	PASS	CSQ=340024|protein_coding||3_prime_UTR_variant|||||||NM_001003841.3:c.*2512G>A||MODIFIER||||||SLC6A19|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	136,0:136:0	107,114:221:0.5158
chr5	1439239	.	C	G	.	PASS	CSQ=6531|protein_coding||intron_variant|||||||NM_001044.5:c.418+2120G>C||MODIFIER||||||SLC6A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	50,70:120:0.5833
chr5	1652590	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1163596542|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	161,0:161:0	99,76:175:0.4343
chr5	1769333	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1305025631||1.31387e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	98,105:203:0.5172
chr5	1797921	.	C	T	.	PASS	CSQ=64979|protein_coding||downstream_gene_variant||||rs567244563|||||MODIFIER||||||MRPL36|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	73,67:140:0.4786
chr5	1816520	.	C	G	.	PASS	CSQ=4726|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||NDUFS6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	80,89:169:0.5266
chr5	2169699	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1191651023||6.57272e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	77,72:149:0.4832
chr5	2234059	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1016247852||6.58493e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	80,60:140:0.4286
chr5	2302518	.	G	A	.	PASS	CSQ=100506858|lncRNA||downstream_gene_variant||||rs928837267||6.57333e-06|||MODIFIER||||||LOC100506858|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	90,66:156:0.4231
chr5	2342083	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,1:121:0.0083	69,81:150:0.54
chr5	2360241	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1238123010||2.62898e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	73,67:140:0.4786
chr5	2384821	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	82,73:155:0.471
chr5	2808269	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	87,76:163:0.4663
chr5	2866956	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	71,79:150:0.5267
chr5	2995217	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	68,67:135:0.4963
chr5	3268235	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	81,78:159:0.4906
chr5	3275547	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1167682553||6.62708e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	62,67:129:0.5194
chr5	3412869	.	T	A	.	PASS	CSQ=285577|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01019|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	74,70:144:0.4861
chr5	3547272	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	62,71:133:0.5338
chr5	3636730	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	81,53:134:0.3955
chr5	3719541	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	72,56:128:0.4375
chr5	3763456	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	75,75:150:0.5
chr5	3820399	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	67,65:132:0.4924
chr5	4171101	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.5703e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	76,86:162:0.5309
chr5	4213695	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	62,62:124:0.5
chr5	4218615	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	70,75:145:0.5172
chr5	4310752	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1327039257||6.57004e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	155,0:155:0	80,80:160:0.5
chr5	4316975	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	61,65:126:0.5159
chr5	4562880	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	78,54:132:0.4091
chr5	4581017	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1034424384||4.0379e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	60,64:124:0.5161
chr5	4615497	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1276385854||7.90868e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	81,82:163:0.5031
chr5	5022024	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	55,81:136:0.5956
chr5	5038253	.	G	T	.	PASS	CSQ=340094|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_026994.1:n.180-417G>T||MODIFIER||||||LINC01020|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	88,66:154:0.4286
chr5	5363263	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs957753835||6.58137e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	57,70:127:0.5512
chr5	5846081	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1213634231||6.57281e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	80,69:149:0.4631
chr5	5916746	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	77,69:146:0.4726
chr5	6042867	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	78,75:153:0.4902
chr5	6453009	.	C	A	.	PASS	CSQ=134111|protein_coding||intron_variant|||||||NM_001145161.3:c.354+3762C>A||MODIFIER||||||UBE2QL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	58,62:120:0.5167
chr5	6676750	.	G	A	.	PASS	CSQ=6715|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SRD5A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	87,79:166:0.4759
chr5	6679103	.	G	C	.	PASS	CSQ=6715|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SRD5A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	84,87:171:0.5088
chr5	6773269	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	85,62:147:0.4218
chr5	7047177	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs547260204||1.31853e-05|||MODIFIER||||||||0.0010;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	69,44:113:0.3894
chr5	7558875	.	G	A	.	PASS	CSQ=108|protein_coding||intron_variant|||||||NM_020546.2:c.570+37976G>A||MODIFIER||||||ADCY2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	71,81:152:0.5329
chr5	7591700	.	C	A	.	PASS	CSQ=108|protein_coding||intron_variant|||||||NM_020546.2:c.571-34467C>A||MODIFIER||||||ADCY2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	58,87:145:0.6
chr5	8158503	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	144,5:149:0.0336
chr5	8328484	.	G	A	.	PASS	CSQ=729506|lncRNA||downstream_gene_variant||||rs1475682217||6.73627e-06|||MODIFIER||||||LINC02226|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	78,61:139:0.4388
chr5	8424477	.	C	G	.	PASS	CSQ=729506|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_039984.1:n.174+27746G>C||MODIFIER||||||LINC02226|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	87,67:155:0.4323
chr5	8528081	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	80,74:154:0.4805
chr5	8604005	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	132,11:143:0.0769
chr5	9080556	.	G	T	.	PASS	CSQ=9037|protein_coding||intron_variant|||||||NM_003966.3:c.2074-13910C>A||MODIFIER||||||SEMA5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	59,101:160:0.6312
chr5	9093491	.	G	A	.	PASS	CSQ=9037|protein_coding||intron_variant||||rs770916138|||NM_003966.3:c.2073+14649C>T||MODIFIER||||||SEMA5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	116,8:124:0.0645
chr5	9196795	.	C	T	.	PASS	CSQ=9037|protein_coding||intron_variant|||||||NM_003966.3:c.1068+373G>A||MODIFIER||||||SEMA5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	88,86:174:0.4943
chr5	9216724	.	C	A	.	PASS	CSQ=9037|protein_coding||intron_variant|||||||NM_003966.3:c.646+7950G>T||MODIFIER||||||SEMA5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	83,79:162:0.4877
chr5	9611763	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	89,81:170:0.4765
chr5	9627494	COSV66778245;COSV66778245;COSV66778245	G	GA	.	PASS	CSQ=50834|protein_coding||downstream_gene_variant|||COSV66778245&COSV66778245&COSV66778245|rs1484470876||5.34381e-05|||MODIFIER||||||TAS2R1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,1:136:0.0074	81,80:161:0.4969
chr5	10018001	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	92,111:203:0.5468
chr5	10038392	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,84:160:0.525
chr5	10116116	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	83,86:169:0.5089
chr5	10134180	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	93,75:168:0.4464
chr5	10162833	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs780994402||4.62694e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	82,84:166:0.506
chr5	10379487	.	G	C	.	PASS	CSQ=10299|protein_coding||intron_variant|||||||NM_005885.4:c.190+655G>C||MODIFIER||||||MARCH6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	83,86:170:0.5059
chr5	11061047	.	C	A	.	PASS	CSQ=1501|protein_coding||intron_variant|||||||NM_001332.4:c.2788+21649G>T||MODIFIER||||||CTNND2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CTNND2|y|n|prostae_adenocarcinoma,GIST|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	90,85:175:0.4857
chr5	11089397	.	C	T	.	PASS	CSQ=1501|protein_coding||intron_variant||||rs538549219||0.000617698|NM_001332.4:c.2638-6551G>A||MODIFIER||||||CTNND2|EntrezGene|0.0004;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CTNND2|y|n|prostae_adenocarcinoma,GIST|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:136:0	65,86:151:0.5695
chr5	11157698	.	C	G	.	PASS	CSQ=1501|protein_coding||intron_variant|||||||NM_001332.4:c.2159+1878G>C||MODIFIER||||||CTNND2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CTNND2|y|n|prostae_adenocarcinoma,GIST|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	103,97:200:0.485
chr5	11265111	.	G	T	.	PASS	CSQ=1501|protein_coding||intron_variant|||||||NM_001332.4:c.1629-28288C>A||MODIFIER||||||CTNND2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CTNND2|y|n|prostae_adenocarcinoma,GIST|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	73,77:150:0.5133
chr5	11283583	.	A	T	.	PASS	CSQ=1501|protein_coding||intron_variant|||||||NM_001332.4:c.1629-46760T>A||MODIFIER||||||CTNND2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CTNND2|y|n|prostae_adenocarcinoma,GIST|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,1:84:0.0119	54,59:113:0.5221
chr5	11355476	.	C	CA	.	PASS	CSQ=1501|protein_coding||intron_variant||||rs909887637||0.00533201|NM_001332.4:c.1373-8850dup||MODIFIER||||||CTNND2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CTNND2|y|n|prostae_adenocarcinoma,GIST|||E||oncogene|Mis;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,1:113:0.0088	101,80:182:0.4396
chr5	11682264	.	C	T	.	PASS	CSQ=1501|protein_coding||intron_variant|||||||NM_001332.4:c.174+49872G>A||MODIFIER||||||CTNND2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CTNND2|y|n|prostae_adenocarcinoma,GIST|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:91:0	99,86:185:0.4649
chr5	11891219	.	C	A	.	PASS	CSQ=1501|protein_coding||intron_variant|||||||NM_001332.4:c.37+12598G>T||MODIFIER||||||CTNND2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CTNND2|y|n|prostae_adenocarcinoma,GIST|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	95,76:171:0.4444
chr5	12068281	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	72,70:142:0.493
chr5	12122148	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,1:118:0.0085	87,76:163:0.4663
chr5	12173520	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	76,83:159:0.522
chr5	12359293	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	66,72:138:0.5217
chr5	12617735	.	G	A	.	PASS	CSQ=404663|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033383.1:n.278+21957G>A||MODIFIER||||||LINC01194|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	80,66:146:0.4521
chr5	12907616	.	T	A	.	PASS	CSQ=105374658|lncRNA||intron_variant&non_coding_transcript_variant||||rs1166613768||1.97262e-05|NR_147005.1:n.275-5522A>T||MODIFIER||||||LINC02220|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	78,95:173:0.5491
chr5	13068976	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1240838760||1.97125e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	84,84:168:0.5
chr5	13473961	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs934736687||6.5716e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	131,11:142:0.0775
chr5	13475095	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	159,12:171:0.0702
chr5	13878222	.	C	T	.	PASS	CSQ=1767|protein_coding||intron_variant|||||||NM_001369.2:c.3263-1405G>A||MODIFIER||||||DNAH5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	78,84:162:0.5185
chr5	14129161	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	87,100:187:0.5348
chr5	14306385	.	T	A	.	PASS	CSQ=7204|protein_coding||intron_variant|||||||NM_007118.4:c.1500+1793T>A||MODIFIER||||||TRIO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	190,5:195:0.0256
chr5	14715636	.	G	A	.	PASS	CSQ=100130744|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046285.1:n.2491+452G>A||MODIFIER||||||LOC100130744|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	154,9:163:0.0552
chr5	15170384	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	75,67:142:0.4718
chr5	15191009	.	G	A	.	PASS	CSQ=101929454|lncRNA||downstream_gene_variant||||rs1162424494||1.32053e-05|||MODIFIER||||||LINC02149|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	84,84:168:0.5
chr5	15461662	.	GG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	83,0:83:0	82,74:156:0.4744
chr5	15848304	.	T	TA	.	PASS	CSQ=23194|protein_coding||intron_variant||||rs148747683||0.0448157|NM_012304.5:c.128-79576dup||MODIFIER||||||FBXL7|EntrezGene|0.0505;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:130:0	86,66:153:0.4314
chr5	16142363	COSV60130587;COSV60130587	C	T	.	PASS	CSQ=441061|protein_coding||intron_variant|COSV60130587|p.?|COSV60130587|rs975938882||0.000118307|NM_001102562.3:c.693+35363G>A||MODIFIER||||||MARCH11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	88,81:169:0.4793
chr5	16198063	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	122,18:140:0.1286
chr5	16264535	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	77,73:150:0.4867
chr5	16268841	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	93,0:93:0	154,8:162:0.0494
chr5	16295815	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	75,86:162:0.5309
chr5	16328772	.	A	C	.	PASS	CSQ=|||intergenic_variant||||rs1377758423||0.000512725|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	82,45:127:0.3543
chr5	16795431	.	C	T	.	PASS	CSQ=4651|protein_coding||intron_variant|||||||NM_012334.3:c.280-598G>A||MODIFIER||||||MYO10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	66,77:143:0.5385
chr5	17467254	.	G	T	.	PASS	CSQ=102723526|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_134270.1:n.226-10361G>T||MODIFIER||||||LINC02218|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	83,70:153:0.4575
chr5	17627881	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	78,82:160:0.5125
chr5	17646943	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1452948556||1.317e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	63,59:122:0.4836
chr5	17646955	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	54,62:116:0.5345
chr5	17706988	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	134,10:144:0.0694
chr5	17950372	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||1.31494e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	73,71:144:0.4931
chr5	18055882	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	77,82:159:0.5157
chr5	18158872	.	GCTACAAT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	153,15:168:0.0893
chr5	18222886	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	65,68:133:0.5113
chr5	18370983	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	78,64:142:0.4507
chr5	18372979	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	159,8:167:0.0479
chr5	18548811	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	70,64:134:0.4776
chr5	18593982	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs530616264||6.57039e-06|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	76,58:134:0.4328
chr5	18671479	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,1:121:0.0083	77,65:142:0.4577
chr5	18974487	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	79,66:145:0.4552
chr5	19055048	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	79,80:159:0.5031
chr5	19189868	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	74,71:145:0.4897
chr5	19254404	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	73,68:141:0.4823
chr5	19335551	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	88,72:160:0.45
chr5	19471931	.	C	T	.	PASS	CSQ=1016|protein_coding||3_prime_UTR_variant|||||||NM_004934.5:c.*1295G>A||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	87,66:153:0.4314
chr5	19477250	.	C	A	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_004934.5:c.1883-3534G>T||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	70,81:151:0.5364
chr5	19568285	.	G	A	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_004934.5:c.1253+3294C>T||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	79,71:150:0.4733
chr5	19589410	.	AG	A	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_004934.5:c.999+1646del||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	71,71:142:0.5
chr5	19635409	.	G	A	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_004934.5:c.644-22808C>T||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	64,88:152:0.5789
chr5	19635419	COSV105091373;COSV105091373;COSV105091373;COSV105091373;COSV105091373;COSV105091373	C	T	.	PASS	CSQ=1016|protein_coding||intron_variant|COSV105091373&COSV105091373&COSV105091373&COSV105091373&COSV105091373&COSV105091373|p.?&p.?&p.?&p.?&p.?&p.?||rs1485626397||6.57402e-06|NM_004934.5:c.644-22818G>A||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	68,87:155:0.5613
chr5	19703073	.	C	T	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_004934.5:c.643+18274G>A||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	69,64:133:0.4812
chr5	19778461	.	A	C	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_004934.5:c.229-31225T>G||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	57,72:129:0.5581
chr5	19897596	.	A	AT	.	PASS	CSQ=1016|protein_coding||intron_variant||||||6.57479e-06|NM_004934.5:c.-256-58355dup||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	78,67:145:0.4621
chr5	20085036	.	C	T	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_001291956.2:c.-517-93022G>A||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	67,73:140:0.5214
chr5	20102821	.	GA	G	.	PASS	CSQ=1016|protein_coding||intron_variant||||rs905511148||0.000592299|NM_001291956.2:c.-517-110808del||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	85,72:157:0.4586
chr5	20208410	.	C	T	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_001291956.2:c.-518+47034G>A||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	56,66:122:0.541
chr5	20225141	.	C	T	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_001291956.2:c.-518+30303G>A||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	60,75:135:0.5556
chr5	20305699	.	C	T	.	PASS	CSQ=1016|protein_coding||intron_variant|||||||NM_001291956.2:c.-579-50194G>A||MODIFIER||||||CDH18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	83,90:173:0.5202
chr5	20670995	.	G	T	.	PASS	CSQ=105374676|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149120.1:n.248+384G>T||MODIFIER||||||LINC02241|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	81,67:148:0.4527
chr5	20882814	.	G	T	.	PASS	CSQ=105374676|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149120.1:n.457-12669G>T||MODIFIER||||||LINC02241|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	130,32:162:0.1975
chr5	20912418	.	G	C	.	PASS	CSQ=105374676|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149120.1:n.541+16851G>C||MODIFIER||||||LINC02241|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	58,66:124:0.5323
chr5	21220312	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	63,85:148:0.5743
chr5	21221027	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:107:0.0093	73,75:148:0.5068
chr5	21402245	.	G	GAATA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	129,7:136:0.0515
chr5	21421979	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	67,65:132:0.4924
chr5	21691558	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	83,66:149:0.443
chr5	21771901	.	C	A	.	PASS	CSQ=1010|protein_coding||intron_variant|||||||NM_004061.4:c.1394-6802G>T||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	97,71:168:0.4226
chr5	21840887	.	C	A	.	PASS	CSQ=1010|protein_coding||intron_variant||||rs1235923213||6.57592e-06|NM_004061.4:c.814+1274G>T||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	84,68:152:0.4474
chr5	21929795	.	AG	TT	.	PASS	CSQ=1010|protein_coding||intron_variant|||||||NM_004061.4:c.526+45295_526+45296delinsAA||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	112,0:112:0	71,70:141:0.4965
chr5	21967157	.	G	A	.	PASS	CSQ=1010|protein_coding||intron_variant|||||||NM_004061.4:c.526+7934C>T||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	73,71:144:0.4931
chr5	22078163	.	CATACTTTAACTTCATGTCTTCAGCAAAGAATGTCAAAAATTGAACGAAATATAT	C	.	PASS	CSQ=1010|protein_coding||intron_variant|||||||NM_004061.4:c.231+229_231+282del||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=mantaSV	AD:DP:AF	169,0:169:0.00599	86,78:164:0.487
chr5	22244937	.	C	T	.	PASS	CSQ=1010|protein_coding||intron_variant||||rs1490577547||1.97433e-05|NM_004061.4:c.-332-32294G>A||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	68,65:133:0.4887
chr5	22454986	.	A	G	.	PASS	CSQ=1010|protein_coding||intron_variant||||rs1010465883||7.22676e-05|NM_004061.4:c.-427-49635T>C||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	133,6:139:0.0432
chr5	22481067	.	C	T	.	PASS	CSQ=1010|protein_coding||intron_variant|||||||NM_004061.4:c.-428+24203G>A||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	73,83:156:0.5321
chr5	22699854	.	G	T	.	PASS	CSQ=1010|protein_coding||intron_variant|||||||NM_004061.4:c.-523+153204C>A||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	63,73:136:0.5368
chr5	22710180	.	G	A	.	PASS	CSQ=1010|protein_coding||intron_variant|||||||NM_004061.4:c.-523+142878C>T||MODIFIER||||||CDH12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:103:0	47,67:114:0.5877
chr5	22873086	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs879657353||0.00126636|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	103,0:103:0	114,31:145:0.2138
chr5	22923940	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs998523098||9.86764e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	65,72:137:0.5255
chr5	22927989	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	60,63:123:0.5122
chr5	22931599	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	61,60:121:0.4959
chr5	23105107	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	59,66:125:0.528
chr5	23181508	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	171,8:179:0.0447
chr5	23317928	.	GGGGTTTCACCAT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	126,0:126:0.007472	128,5:133:0.045
chr5	23360881	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs745765403||0.000184203|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	60,80:140:0.5714
chr5	23412858	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	56,80:136:0.5882
chr5	23454029	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	59,71:130:0.5462
chr5	23571456	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	66,68:134:0.5075
chr5	23743454	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs936178196|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	72,77:149:0.5168
chr5	23762637	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	68,53:121:0.438
chr5	23786815	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	113,0:113:0	128,5:133:0.0376
chr5	23856071	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,1:102:0.0098	105,45:150:0.3
chr5	23979134	.	A	G	.	PASS	CSQ=439936|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_131245.1:n.653-803A>G||MODIFIER||||||C5orf17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,62:129:0.4806
chr5	23993684	.	C	G	.	PASS	CSQ=439936|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_131245.1:n.1557+12843C>G||MODIFIER||||||C5orf17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	72,74:146:0.5068
chr5	24009603	.	A	G	.	PASS	CSQ=439936|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_131245.1:n.1557+28762A>G||MODIFIER||||||C5orf17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	68,71:139:0.5108
chr5	24080023	.	G	C	.	PASS	CSQ=439936|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_131245.1:n.1558-97814G>C||MODIFIER||||||C5orf17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	62,55:117:0.4701
chr5	24368898	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1275350611||6.60537e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	71,71:142:0.5
chr5	24461944	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	63,67:130:0.5154
chr5	24492753	.	T	C	.	PASS	CSQ=1008|protein_coding||intron_variant|||||||NM_006727.5:c.1624+64A>G||MODIFIER||||||CDH10|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CDH10|y|y|melanoma|pancreatic_ductal_adenocarcinoma||E||TSG|Mis,F,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	108,0:108:0	76,82:158:0.519
chr5	24569888	.	G	A	.	PASS	CSQ=1008|protein_coding||intron_variant|||||||NM_006727.5:c.231+23372C>T||MODIFIER||||||CDH10|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CDH10|y|y|melanoma|pancreatic_ductal_adenocarcinoma||E||TSG|Mis,F,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	66,65:131:0.4962
chr5	24641227	.	G	A	.	PASS	CSQ=1008|protein_coding||intron_variant||||rs1205459415||4.60823e-05|NM_006727.5:c.-124+3367C>T||MODIFIER||||||CDH10|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CDH10|y|y|melanoma|pancreatic_ductal_adenocarcinoma||E||TSG|Mis,F,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	67,67:134:0.5
chr5	24886459	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1047077461|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	71,71:142:0.5
chr5	25134702	.	A	G	.	PASS	CSQ=105374694|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147006.1:n.384+1640T>C||MODIFIER||||||LINC02228|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	79,65:144:0.4514
chr5	25321922	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	130,5:135:0.037
chr5	25511077	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	73,72:145:0.4966
chr5	25605512	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	132,5:137:0.0365
chr5	25641595	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	64,70:134:0.5224
chr5	25652817	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs984244331||6.57601e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	141,8:149:0.0537
chr5	25885287	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	74,64:138:0.4638
chr5	26024695	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	68,72:140:0.5143
chr5	26024707	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	65,70:135:0.5185
chr5	26196177	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1385718355||1.31996e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	74,75:149:0.5034
chr5	26319259	.	TC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	120,0:120:0	70,68:138:0.4928
chr5	26598260	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	102,7:109:0.0642
chr5	26666226	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,0:73:0	78,65:143:0.4545
chr5	26697645	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	83,66:149:0.443
chr5	26699552	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	61,68:129:0.5271
chr5	26744268	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	61,68:129:0.5271
chr5	26754701	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	69,72:141:0.5106
chr5	26840030	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs915062477||7.24218e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:133:0	75,70:145:0.4828
chr5	26905234	.	C	A	.	PASS	CSQ=1007|protein_coding||intron_variant||||rs1239840266||2.63099e-05|NM_016279.4:c.811+725G>T||MODIFIER||||||CDH9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	97,32:129:0.2481
chr5	26930400	.	C	G	.	PASS	CSQ=1007|protein_coding||intron_variant|||||||NM_016279.4:c.229-14476G>C||MODIFIER||||||CDH9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	87,79:166:0.4759
chr5	26981561	.	TA	T	.	PASS	CSQ=1007|protein_coding||intron_variant|||||||NM_016279.4:c.228+6544del||MODIFIER||||||CDH9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	66,80:146:0.5479
chr5	27002607	.	C	T	.	PASS	CSQ=1007|protein_coding||intron_variant|||||||NM_016279.4:c.-49-14225G>A||MODIFIER||||||CDH9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	75,82:157:0.5223
chr5	27106307	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,74:144:0.5139
chr5	27120649	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	67,66:133:0.4962
chr5	27249022	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	80,73:153:0.4771
chr5	27363203	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	81,62:143:0.4336
chr5	27437418	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	71,78:149:0.5235
chr5	27499621	.	G	GA	.	PASS	CSQ=643401|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||PURPL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	93,55:148:0.3716
chr5	27688868	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	77,68:145:0.469
chr5	27691988	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	55,49:104:0.4712
chr5	27716268	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs939353194|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	74,61:135:0.4519
chr5	27744674	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1037542541||6.5741e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	68,62:130:0.4769
chr5	27785492	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs767582564||5.92199e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	66,63:129:0.4884
chr5	27833315	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs970530517||0.000138078|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	98,78:176:0.4432
chr5	27929884	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	80,86:166:0.5181
chr5	28019716	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs752666594||0.000184687|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	78,72:150:0.48
chr5	28174598	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	119,32:151:0.2119
chr5	28176367	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	62,77:139:0.554
chr5	28183811	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1204202772||1.31536e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	90,74:164:0.4512
chr5	28302447	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1291077213|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	82,71:153:0.4641
chr5	28324141	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1474529466||2.63352e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	71,68:139:0.4892
chr5	28353731	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	64,69:133:0.5188
chr5	28405361	.	ATT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	79,92:171:0.538
chr5	28405735	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	69,85:154:0.5519
chr5	28414836	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	73,91:164:0.5549
chr5	28439693	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	88,73:161:0.4534
chr5	28485970	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	75,80:155:0.5161
chr5	28514267	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	87,61:148:0.4122
chr5	28720431	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	74,63:137:0.4599
chr5	28720842	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	87,66:153:0.4314
chr5	28860850	.	CT	C	.	PASS	CSQ=|||intergenic_variant||||rs913276877||0.000386794|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	78,64:142:0.4507
chr5	28901246	.	T	TAAA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	102,0:102:0	138,7:145:0.0483
chr5	28930963	COSV69240029;COSV69240029;COSV69240029	AT	A	.	PASS	CSQ=729862|transcribed_pseudogene||downstream_gene_variant|||COSV69240029&COSV69240029&COSV69240029|rs200772545||0.000204731|||MODIFIER||||||LSP1P3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	74,70:144:0.4861
chr5	29359486	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	78,62:141:0.4397
chr5	29483767	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	86,79:165:0.4788
chr5	29493504	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	82,88:170:0.5176
chr5	29521760	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	79,82:161:0.5093
chr5	29574052	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1012822793||2.62933e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	71,77:148:0.5203
chr5	29619038	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	66,69:135:0.5111
chr5	29625970	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs766066740||5.25956e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	66,79:145:0.5448
chr5	29625998	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	62,85:147:0.5782
chr5	29651090	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	107,41:148:0.277
chr5	29725447	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1193541440||0.244296|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	106,38:144:0.2639
chr5	29766358	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs200104913||0.00247377|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	75,61:136:0.4485
chr5	30036389	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	79,65:144:0.4514
chr5	30086093	COSV64341188	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV64341188|rs79384248||0.343165|||MODIFIER||||||||0.2155;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	52,5:57:0.0877	66,65:131:0.4962
chr5	30193328	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs550858746||9.86427e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	59,70:129:0.5426
chr5	30545430	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	161,12:173:0.0694
chr5	30586587	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,69:146:0.4726
chr5	30596226	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	165,9:174:0.0517
chr5	30628159	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	142,5:147:0.034
chr5	30633250	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	68,67:135:0.4963
chr5	30713144	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	62,71:133:0.5338
chr5	30726888	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	128,19:147:0.1293
chr5	30941238	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	71,0:71:0	51,50:101:0.495
chr5	30954307	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1026543954||5.92917e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	53,59:112:0.5268
chr5	31217165	.	C	T	.	PASS	CSQ=1004|protein_coding||intron_variant||||rs1208715253||6.57315e-06|NM_004932.4:c.-129+23279C>T||MODIFIER||||||CDH6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	62,69:131:0.5267
chr5	31283695	.	T	C	.	PASS	CSQ=1004|protein_coding||intron_variant||||rs528740376|||NM_004932.4:c.229-10267T>C||MODIFIER||||||CDH6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	133,0:134:0	159,8:168:0.0476
chr5	31638477	.	G	T	.	PASS	CSQ=23037|protein_coding||upstream_gene_variant||||rs922374620||1.97197e-05|||MODIFIER||||||PDZD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	84,73:157:0.465
chr5	31774255	.	G	A	.	PASS	CSQ=23037|protein_coding||intron_variant|||||||NM_178140.4:c.-360-24634G>A||MODIFIER||||||PDZD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	92,71:163:0.4356
chr5	32026557	.	G	GCA	.	PASS	CSQ=23037|protein_coding||intron_variant||||rs371429453||0.0133654|NM_178140.4:c.1408-10658_1408-10657dup||MODIFIER||||||PDZD2|EntrezGene|0.0148;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	105,74:179:0.4134
chr5	32044113	.	G	A	.	PASS	CSQ=23037|protein_coding||intron_variant|||||||NM_178140.4:c.1520-4426G>A||MODIFIER||||||PDZD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	78,0:78:0	98,6:104:0.0577
chr5	32532072	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	100,102:202:0.505
chr5	32898546	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	93,101:194:0.5206
chr5	33057288	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	84,74:158:0.4684
chr5	33062864	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	81,81:162:0.5
chr5	33264068	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	116,38:154:0.2468
chr5	33301740	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	73,74:147:0.5034
chr5	33642579	.	A	G	.	PASS	CSQ=81792|protein_coding||intron_variant|||||||NM_030955.4:c.1573-624T>C||MODIFIER||||||ADAMTS12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	82,100:182:0.5495
chr5	33699107	.	A	T	.	PASS	CSQ=81792|protein_coding||intron_variant|||||||NM_030955.4:c.635-15052T>A||MODIFIER||||||ADAMTS12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	107,100:207:0.4831
chr5	33845412	.	G	A	.	PASS	CSQ=81792|protein_coding||intron_variant|||||||NM_030955.4:c.489+35707C>T||MODIFIER||||||ADAMTS12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	86,84:170:0.4941
chr5	34081662	.	G	GA	.	PASS	CSQ=114899|misc_RNA||intron_variant&non_coding_transcript_variant||||rs751185215||0.0129192|NR_146599.1:n.895-45905dup||MODIFIER||||||C1QTNF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	84,72:156:0.4615
chr5	34286723	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	85,80:165:0.4848
chr5	34438664	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	81,73:154:0.474
chr5	34540972	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	165,5:170:0.0294
chr5	35181989	.	C	A	.	PASS	CSQ=5618|protein_coding||intron_variant|||||||NM_000949.7:c.-106+48279G>T||MODIFIER||||||PRLR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	80,70:150:0.4667
chr5	35839992	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	98,72:170:0.4235
chr5	35900154	.	T	A	.	PASS	CSQ=133690|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CAPSL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	85,96:181:0.5304
chr5	35942494	.	T	A	.	PASS	CSQ=100506406|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC100506406|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	80,83:163:0.5092
chr5	37440767	.	C	A	.	PASS	CSQ=55100|protein_coding||intron_variant|||||||NM_018034.3:c.553-2472C>A||MODIFIER||||||WDR70|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	85,198:283:0.6996
chr5	37836386	.	C	A	.	PASS	CSQ=2668|protein_coding||intron_variant|||||||NM_000514.4:c.-26-1564G>T||MODIFIER||||||GDNF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	72,145:217:0.6682
chr5	37928972	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	166,84:250:0.336
chr5	37952058	.	C	A	.	PASS	CSQ=105374729|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC02110|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	234,10:244:0.041
chr5	38070499	.	C	G	.	PASS	CSQ=105374731|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147009.1:n.233+41443C>G||MODIFIER||||||LINC02107|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	170,87:258:0.3372
chr5	38284617	.	T	A	.	PASS	CSQ=133584|protein_coding||intron_variant|||||||NM_152403.4:c.97+25766T>A||MODIFIER||||||EGFLAM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	170,86:256:0.3359
chr5	38936065	.	GA	G	.	PASS	CSQ=9180|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||OSMR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	93,164:257:0.6381
chr5	39023168	.	A	C	.	PASS	CSQ=253260|protein_coding||intron_variant|||||||NM_152756.5:c.98-2032T>G||MODIFIER||||||RICTOR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	154,83:237:0.3502
chr5	39201387	.	T	C	.	PASS	CSQ=2533|protein_coding||intron_variant|||||||NM_001465.6:c.1135+439A>G||MODIFIER||||||FYB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	156,98:254:0.3858
chr5	39242855	.	C	T	.	PASS	CSQ=2533|protein_coding||intron_variant|||||||NM_001243093.2:c.3+27714G>A||MODIFIER||||||FYB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	164,85:249:0.3414
chr5	39349294	.	C	A	.	PASS	CSQ=735|protein_coding||intron_variant|||||||NM_001737.5:c.78-7098G>T||MODIFIER||||||C9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	152,85:237:0.3586
chr5	39599204	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	88,98:186:0.5269
chr5	39751698	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	84,76:160:0.475
chr5	39888530	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	90,79:169:0.4675
chr5	40459497	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	68,70:138:0.5072
chr5	40507876	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	87,82:169:0.4852
chr5	40742445	.	G	C	.	PASS	CSQ=23548|protein_coding||intron_variant|||||||NM_012382.3:c.221+4353C>G||MODIFIER||||||TTC33|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	105,83:188:0.4415
chr5	40871916	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	72,87:159:0.5472
chr5	40879061	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	71,72:143:0.5035
chr5	41520965	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	159,20:179:0.1117
chr5	41640422	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs926445200||1.97246e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	111,33:144:0.2292
chr5	41916791	.	C	G	.	PASS	CSQ=285636|protein_coding||intron_variant|||||||NM_175921.6:c.602-225C>G||MODIFIER||||||C5orf51|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	86,71:157:0.4522
chr5	42048246	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	103,86:189:0.455
chr5	42351416	.	GA	G	.	PASS	CSQ=|||intergenic_variant||||rs1051955203||7.93325e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	85,67:152:0.4408
chr5	42405039	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1008824211||1.97717e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	96,81:177:0.4576
chr5	42547476	.	GT	G	.	PASS	CSQ=2690|protein_coding||intron_variant||||rs924330775||0.000194607|NM_000163.5:c.-11-18378del||MODIFIER||||||GHR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:134:0	81,86:168:0.5119
chr5	42663999	.	T	C	.	PASS	CSQ=2690|protein_coding||intron_variant|||||||NM_000163.5:c.137-24891T>C||MODIFIER||||||GHR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	87,76:163:0.4663
chr5	42884699	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,1:122:0.0082	71,82:153:0.5359
chr5	43882574	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	142,8:150:0.0533
chr5	43926992	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	100,90:190:0.4737
chr5	44046090	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	63,82:145:0.5655
chr5	44065242	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	76,77:153:0.5033
chr5	44255183	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	70,81:151:0.5364
chr5	44400963	.	T	C	.	PASS	CSQ=101927075|lncRNA||intron_variant&non_coding_transcript_variant||||||6.57272e-06|NR_108034.1:n.295+5614T>C||MODIFIER||||||FGF10-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:110:0	76,78:154:0.5065
chr5	44551249	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	82,80:162:0.4938
chr5	44683177	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57229e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	80,83:163:0.5092
chr5	44731367	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	79,78:157:0.4968
chr5	45050054	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	78,63:141:0.4468
chr5	45074921	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs890308834||4.6154e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	77,81:158:0.5127
chr5	45198976	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	69,78:147:0.5306
chr5	45242707	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	70,71:141:0.5035
chr5	45401105	.	ACACTCC	A	.	PASS	CSQ=348980|protein_coding||intron_variant|||||||NM_021072.4:c.1012-4401_1012-4396del||MODIFIER||||||HCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	121,8:129:0.062
chr5	45511879	.	A	G	.	PASS	CSQ=348980|protein_coding||intron_variant|||||||NM_021072.4:c.850-49872T>C||MODIFIER||||||HCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	141,5:146:0.0342
chr5	45593983	.	G	A	.	PASS	CSQ=348980|protein_coding||intron_variant||||rs933470627|||NM_021072.4:c.849+51202C>T||MODIFIER||||||HCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	69,69:138:0.5
chr5	45670384	.	T	A	.	PASS	CSQ=348980|protein_coding||intron_variant|||||||NM_021072.4:c.426-24776A>T||MODIFIER||||||HCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,68:144:0.4722
chr5	45857055	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	63,74:137:0.5401
chr5	45859077	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	150,8:158:0.0506
chr5	45894701	.	CTT	C	.	PASS	CSQ=|||intergenic_variant||||rs1328153228||1.31449e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	79,78:157:0.4968
chr5	45952281	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	80,73:153:0.4771
chr5	46086284	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1038823853||2.00342e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	80,56:136:0.4118
chr5	46162506	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	74,78:152:0.5132
chr5	46235133	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1402841129|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	76,86:162:0.5309
chr5	46393123	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	87,69:156:0.4423
chr5	46958776	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	200,0:200:0	141,77:218:0.3532
chr5	49866714	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1423577428|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,2:92:0.0217	0,2:2:1
chr5	50185774	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	69,77:146:0.5274
chr5	50424965	.	G	A	.	PASS	CSQ=133418|protein_coding||intron_variant|||||||NM_198449.3:c.196+3179C>T||MODIFIER||||||EMB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	62,84:146:0.5753
chr5	50486886	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	73,79:152:0.5197
chr5	50905818	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs544444111||0.00490007|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	106,67:173:0.3873
chr5	50936541	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1447394552|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	74,99:173:0.5723
chr5	50976042	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	84,87:171:0.5088
chr5	51521576	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	62,107:169:0.6331
chr5	51763688	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	67,75:142:0.5282
chr5	51763690	COSV68917448	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV68917448|rs1439329696|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	68,74:142:0.5211
chr5	51926279	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	77,86:163:0.5276
chr5	52298989	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	155,15:170:0.0882
chr5	52453325	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	81,83:165:0.503
chr5	52600267	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	77,81:158:0.5127
chr5	52679312	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1457628723||2.63654e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	132,45:177:0.2542
chr5	52679602	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	94,86:180:0.4778
chr5	52788929	.	C	CTT	.	PASS	CSQ=3672|protein_coding||intron_variant|||||||NM_181501.1:c.61+516_61+517dup||MODIFIER||||||ITGA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	3,84:87:0.9655
chr5	53718276	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,80:80:1
chr5	53742087	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	2,87:89:0.9775
chr5	54152678	.	G	A	.	PASS	CSQ=54622|protein_coding||intron_variant||||rs1406888320||1.31423e-05|NM_019087.3:c.253+1902C>T||MODIFIER||||||ARL15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	62,13:75:0.1733
chr5	55057744	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs914638102||6.57497e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,89:89:1
chr5	56522597	.	G	A	.	PASS	CSQ=101928448|protein_coding||intron_variant|||||||NM_001287053.1:c.206-8672C>T||MODIFIER||||||C5orf67|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,74:74:1
chr5	56612916	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,1:112:0.0089	0,78:78:1
chr5	56961056	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,100:100:1
chr5	57431748	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,85:85:1
chr5	57438179	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,88:88:1
chr5	58144019	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,74:74:1
chr5	58144064	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,78:78:1
chr5	58335289	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,80:80:1
chr5	58935244	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs200719100||0.00269439|||MODIFIER||||||||0.0168;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	2,59:61:0.9672
chr5	59353669	.	C	G	.	PASS	CSQ=5144|protein_coding||intron_variant|||||||NM_001104631.2:c.456-137701G>C||MODIFIER||||||PDE4D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,73:73:1
chr5	60880807	.	C	G	.	PASS	CSQ=1161|protein_coding||intron_variant|||||||NM_000082.3:c.1123-6124G>C||MODIFIER||||||ERCC8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	66,10:76:0.1316
chr5	60996626	.	T	A	.	PASS	CSQ=91942|protein_coding||intron_variant|||||||NM_174889.5:c.127+51244T>A||MODIFIER||||||NDUFAF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,89:89:1
chr5	61466710	.	C	T	.	PASS	CSQ=57688|protein_coding||intron_variant|||||||NM_020928.2:c.677-5971C>T||MODIFIER||||||ZSWIM6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,82:82:1
chr5	62196995	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs138293366||0.0266492|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	14,70:84:0.8333
chr5	62896078	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	154,0:154:0	52,12:64:0.1875
chr5	62970860	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,85:85:1
chr5	63223275	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,6:73:0.0822
chr5	63657434	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	63,7:70:0.1
chr5	64253682	.	A	G	.	PASS	CSQ=285671|protein_coding||intron_variant|||||||NM_001113561.2:c.1227+36286A>G||MODIFIER||||||RNF180|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,66:66:1
chr5	64395605	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,76:76:1
chr5	64495083	COSV66165125	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV66165125|rs201408660||0.00569619|||MODIFIER||||||||0.0110;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	7,56:65:0.8615
chr5	65206764	.	C	G	.	PASS	CSQ=11174|protein_coding||intron_variant|||||||NM_197941.4:c.2575+8030G>C||MODIFIER||||||ADAMTS6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	53,10:63:0.1587
chr5	65483576	.	A	ATATG	.	PASS	CSQ=11174|protein_coding||upstream_gene_variant||||rs1010392020|||||MODIFIER||||||ADAMTS6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	11,59:70:0.8429
chr5	66263852	.	GAT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	63,19:82:0.2317
chr5	66484919	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,73:73:1
chr5	66644056	.	C	A	.	PASS	CSQ=375449|protein_coding||intron_variant|||||||NM_001164664.1:c.363+47038C>A||MODIFIER||||||MAST4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,62:62:1
chr5	67792165	.	T	G	.	PASS	CSQ=101928858|lncRNA||upstream_gene_variant||||||6.57125e-06|||MODIFIER||||||LOC101928858|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,78:78:1
chr5	68440643	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,73:73:1
chr5	69520892	.	GG	AC	.	PASS	CSQ=100506658|protein_coding||intron_variant|||||||NM_001205254.2:c.891+6783_891+6784delinsAC||MODIFIER||||||OCLN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	121,0:121:0	0,85:85:1
chr5	69533214	.	A	T	.	PASS	CSQ=100506658|protein_coding||intron_variant|||||||NM_001205254.2:c.892-1480A>T||MODIFIER||||||OCLN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	1,76:77:0.987
chr5	72011592	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,93:93:1
chr5	72422036	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs574872809|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,87:87:1
chr5	72431396	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,89:89:1
chr5	72540313	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1319284896||4.64814e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,71:71:1
chr5	74441591	.	CC	AA	.	PASS	CSQ=104310351|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126354.1:n.422+34746_422+34747delinsTT||MODIFIER||||||LINC01331|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	138,0:138:0	0,92:92:1
chr5	75331492	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,84:84:1
chr5	75437781	.	A	G	.	PASS	CSQ=10087|protein_coding||intron_variant||||rs111688877||6.64929e-05|NM_001130105.1:c.733-11303T>C||MODIFIER||||||COL4A3BP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	1,80:81:0.9877
chr5	75717393	.	A	C	.	PASS	CSQ=441087|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC441087|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	0,85:85:1
chr5	76146585	.	A	T	.	PASS	CSQ=22987|protein_coding||intron_variant|||||||NM_014979.4:c.580+14255A>T||MODIFIER||||||SV2C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,78:78:1
chr5	76902122	.	C	T	.	PASS	CSQ=170591|protein_coding||intron_variant||||||6.57497e-06|NM_130772.4:c.*3-18595C>T||MODIFIER||||||S100Z|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	1,82:83:0.988
chr5	77163787	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	81,9:90:0.1
chr5	77197525	.	G	GT	.	PASS	CSQ=8622|protein_coding||intron_variant||||rs142139764||0.0144764|NM_001349750.1:c.36+17049dup||MODIFIER||||||PDE8B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	9,66:76:0.8684
chr5	77222205	.	AT	A	.	PASS	CSQ=8622|protein_coding||intron_variant|||||||NM_003719.3:c.339+10942del||MODIFIER||||||PDE8B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	2,74:76:0.9737
chr5	77557397	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,81:81:1
chr5	77757519	.	C	CA	.	PASS	CSQ=6902|protein_coding||intron_variant|||||||NM_004607.2:c.53+18685dup||MODIFIER||||||TBCA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	7,71:78:0.9103
chr5	77818647	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1223115279||2.62954e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,80:80:1
chr5	78841162	COSV53727294;COSV53727294	C	A	.	PASS	CSQ=411|protein_coding||intron_variant|COSV53727294&COSV53727294|p.?&p.?||rs58672936||0.125432|NM_000046.5:c.1143-1736G>T||MODIFIER||||||ARSB|EntrezGene|0.1669;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,1:92:0.0109	1,53:54:0.9815
chr5	79179752	.	CCTGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGGGAGGCGGAGGTTGCAGTGAGTCGAG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=mantaSV	AD:DP:AF	153,0:153:0.006863	1,64:65:0.984
chr5	79385459	.	C	G	.	PASS	CSQ=9456|protein_coding||intron_variant|||||||NM_004272.4:c.877-9262G>C||MODIFIER||||||HOMER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,78:78:1
chr5	79396554	.	A	AT	.	PASS	CSQ=9456|protein_coding||intron_variant||||rs768588814||0.00874599|NM_004272.4:c.876+268dup||MODIFIER||||||HOMER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	8,72:80:0.9
chr5	80918048	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,81:81:1
chr5	81841863	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1404401825||1.31489e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,91:91:1
chr5	81899690	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs567594366||9.86868e-05|||MODIFIER||||||||0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,76:76:1
chr5	82096007	.	C	G	.	PASS	CSQ=83734|protein_coding||intron_variant||||rs564007750||6.57091e-06|NM_031482.5:c.216+37405C>G||MODIFIER||||||ATG10|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,74:74:1
chr5	82519324	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,87:87:1
chr5	82800730	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,84:84:1
chr5	83337343	.	A	G	.	PASS	CSQ=7518|protein_coding||intron_variant|||||||NM_022406.3:c.894-15782A>G||MODIFIER||||||XRCC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,77:77:1
chr5	84088296	.	C	T	.	PASS	CSQ=10085|protein_coding||intron_variant|||||||NM_005711.5:c.651+18353G>A||MODIFIER||||||EDIL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,69:69:1
chr5	84400165	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,67:67:1
chr5	84425635	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,83:83:1
chr5	84611013	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,78:78:1
chr5	84821851	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs901246198||6.58146e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,72:73:0.9863
chr5	84858693	COSV65478761	G	GT	.	PASS	CSQ=|||intergenic_variant|||COSV65478761|rs1470004827||0.000152169|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	8,68:76:0.8947
chr5	85004917	.	AGA	TTT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	111,0:112:0	0,66:66:1
chr5	85192854	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,79:79:1
chr5	85233099	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:102:0	0,66:66:1
chr5	85677960	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	80,6:86:0.0698
chr5	85731041	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs767206589|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,71:71:1
chr5	85732279	.	T	TG	.	PASS	CSQ=|||intergenic_variant||||rs1243364181||0.000432755|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,1:89:0.0112	12,19:31:0.6129
chr5	85846899	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,71:71:1
chr5	85869757	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	113,0:113:0	0,75:75:1
chr5	86247398	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,83:83:1
chr5	86289894	.	A	C	.	PASS	CSQ=285622|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003719.2:n.948-933A>C||MODIFIER||||||NBPF22P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,60:60:1
chr5	86289900	.	A	T	.	PASS	CSQ=285622|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003719.2:n.948-927A>T||MODIFIER||||||NBPF22P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,63:63:1
chr5	86295500	.	T	A	.	PASS	CSQ=285622|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003719.2:n.1400-767T>A||MODIFIER||||||NBPF22P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,74:74:1
chr5	86324111	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1169453276||6.5877e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	9,72:81:0.8889
chr5	86789839	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,75:75:1
chr5	86918580	.	T	A	.	PASS	CSQ=|||intergenic_variant||||||6.62357e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:89:0	0,90:90:1
chr5	86998404	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	72,10:82:0.122
chr5	87033123	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:107:0	0,70:70:1
chr5	87550959	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1361721817|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,80:80:1
chr5	87640929	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	121,0:121:0	0,65:65:1
chr5	87680785	.	A	T	.	PASS	CSQ=111082994|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC02488|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,94:94:1
chr5	87796675	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,74:74:1
chr5	88067348	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,74:74:1
chr5	88434640	.	G	A	.	PASS	CSQ=102546226|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_105021.1:n.170+1340C>T||MODIFIER||||||LINC02060|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,73:73:1
chr5	88658950	.	G	A	.	PASS	CSQ=645323|lncRNA||intron_variant&non_coding_transcript_variant||||rs1435940791||2.63373e-05|NR_152235.1:n.218+12086C>T||MODIFIER||||||LINC00461|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:124:0	0,82:82:1
chr5	89006709	.	A	T	.	PASS	CSQ=101929423|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_136218.1:n.400+40794A>T||MODIFIER||||||MEF2C-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,77:77:1
chr5	89104041	.	G	C	.	PASS	CSQ=101929423|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_136218.1:n.471+9012G>C||MODIFIER||||||MEF2C-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,79:79:1
chr5	89574113	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1045090467||1.31773e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	116,0:116:0	94,4:98:0.0408
chr5	89725986	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1415722415||6.60633e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:137:0	0,85:85:1
chr5	89786174	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,1:82:0.0122	0,70:70:1
chr5	90051376	.	C	G	.	PASS	CSQ=|||intergenic_variant||||||6.57635e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,75:75:1
chr5	90261463	.	G	A	.	PASS	CSQ=101929495|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120601.1:n.228+205C>T||MODIFIER||||||LINC01339|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	86,4:90:0.0444
chr5	90515300	.	G	C	.	PASS	CSQ=116068|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LYSMD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	64,17:81:0.2099
chr5	90731039	.	A	T	.	PASS	CSQ=84059|protein_coding||intron_variant|||||||NM_032119.4:c.10549+1275A>T||MODIFIER||||||ADGRV1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,96:96:1
chr5	92173482	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,63:63:1
chr5	92314299	.	GACA	G	.	PASS	CSQ=|||intergenic_variant||||rs1371736628||2.63571e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	2,82:84:0.9762
chr5	92712767	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,77:77:1
chr5	92788174	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	1,68:69:0.9855
chr5	92808017	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,109:109:1
chr5	93427792	.	G	A	.	PASS	CSQ=441094|lncRNA||intron_variant&non_coding_transcript_variant||||rs1016211145||0.000197208|NR_109823.1:n.502-16283C>T||MODIFIER||||||NR2F1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,92:92:1
chr5	93479444	.	G	A	.	PASS	CSQ=441094|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109823.1:n.502-67935C>T||MODIFIER||||||NR2F1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,89:89:1
chr5	93838718	.	TTGAGCAGTATATTGTAATTCTC	T	.	PASS	CSQ=83989|protein_coding||intron_variant|||||||NM_032042.6:c.787-14473_787-14452del||MODIFIER||||||FAM172A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,58:58:1
chr5	93950168	.	G	A	.	PASS	CSQ=83989|protein_coding||intron_variant|||||||NM_032042.6:c.567+8609C>T||MODIFIER||||||FAM172A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,78:78:1
chr5	94223522	.	A	G	.	PASS	CSQ=285600|protein_coding||intron_variant|||||||NM_001145678.1:c.3711-69398T>C||MODIFIER||||||KIAA0825|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	70,7:77:0.0909
chr5	94559286	.	G	A	.	PASS	CSQ=285600|protein_coding||intron_variant|||||||NM_001145678.1:c.-1-22159C>T||MODIFIER||||||KIAA0825|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,87:87:1
chr5	94799532	.	G	A	.	PASS	CSQ=79772|protein_coding||intron_variant|||||||NM_024717.5:c.2437-400C>T||MODIFIER||||||MCTP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,77:77:1
chr5	95271566	.	G	A	.	PASS	CSQ=79772|protein_coding||intron_variant|||||||NM_024717.5:c.720+12290C>T||MODIFIER||||||MCTP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	86,7:93:0.0753
chr5	95456303	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	4,80:84:0.9524
chr5	96684463	.	A	T	.	PASS	CSQ=831|protein_coding||intron_variant|||||||NM_001750.6:c.138+8862A>T||MODIFIER||||||CAST|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,93:93:1
chr5	96879519	.	T	C	.	PASS	CSQ=64167|protein_coding||intron_variant|||||||NM_022350.4:c.-122-45T>C||MODIFIER||||||ERAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,1:129:0.0078	0,74:74:1
chr5	97641547	.	G	A	.	PASS	CSQ=102546227|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_105028.1:n.160-27004G>A||MODIFIER||||||LINC01340|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	64,14:78:0.1795
chr5	97855449	.	G	C	.	PASS	CSQ=109729164|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146299.1:n.243+14449G>C||MODIFIER||||||LINC02234|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,71:71:1
chr5	98047306	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1259947304||3.30675e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	2,77:79:0.9747
chr5	99216466	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,70:70:1
chr5	99288867	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,82:82:1
chr5	100203361	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs199936380||0.000839429|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	34,30:64:0.4688
chr5	100292399	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	1,69:70:0.9857
chr5	100488836	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,57:57:1
chr5	100904033	.	C	G	.	PASS	CSQ=7903|protein_coding||upstream_gene_variant||||rs1200567304||1.31582e-05|||MODIFIER||||||ST8SIA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:131:0	0,69:69:1
chr5	100908347	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,53:53:1
chr5	101150891	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	0,54:54:1
chr5	101166364	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1479516186||5.26725e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	8,54:62:0.871
chr5	101284520	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	67,4:71:0.0563
chr5	101389078	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,90:90:1
chr5	101613250	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,60:60:1
chr5	101761065	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1410245813||1.31404e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	0,81:81:1
chr5	101835141	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,69:69:1
chr5	102006388	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,91:92:0.9891
chr5	102101156	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,86:86:1
chr5	102663611	.	G	A	.	PASS	CSQ=285708|lncRNA||intron_variant&non_coding_transcript_variant||||rs1023542819||0.000105442|NR_103756.1:n.238+7616C>T||MODIFIER||||||LINC00491|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,83:83:1
chr5	102778658	.	C	G	.	PASS	CSQ=5066|protein_coding||intron_variant||||rs989291671||6.57289e-06|NM_001319943.1:c.-374+23310C>G||MODIFIER||||||PAM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,75:75:1
chr5	103142618	.	C	CA	.	PASS	CSQ=23262|protein_coding||intron_variant||||rs570164522||0.00017803|NM_001276277.2:c.488-3901dup||MODIFIER||||||PPIP5K2|EntrezGene|0.0006;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	7,69:76:0.9079
chr5	103823477	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	70,6:76:0.0789
chr5	103913439	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,73:73:1
chr5	104283989	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1227527910||6.59317e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,82:82:1
chr5	104867056	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,56:56:1
chr5	105092183	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,76:76:1
chr5	105147161	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	6,71:77:0.9221
chr5	105147165	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	2,71:73:0.9726
chr5	105225452	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1276303862||6.58822e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	66,4:70:0.0571
chr5	106836291	.	G	A	.	PASS	CSQ=102467213|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104671.1:n.144-17814C>T||MODIFIER||||||LINC01950|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,87:87:1
chr5	107662269	.	C	G	.	PASS	CSQ=1946|protein_coding||intron_variant|||||||NM_001962.3:c.125+8220G>C||MODIFIER||||||EFNA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,78:78:1
chr5	108343964	.	ACCTCTTAAT	A	.	PASS	CSQ=64839|protein_coding||intron_variant|||||||NM_001163315.2:c.1506+4426_1506+4434del||MODIFIER||||||FBXL17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,83:83:1
chr5	108489267	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,79:79:1
chr5	108994681	.	A	C	.	PASS	CSQ=2241|protein_coding||intron_variant|||||||NM_005246.4:c.1656+35334A>C||MODIFIER||||||FER|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,75:75:1
chr5	109293468	.	C	A	.	PASS	CSQ=285638|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149040.1:n.4472+26291G>T||MODIFIER||||||LOC285638|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	44,47:91:0.5165
chr5	109521707	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,61:61:1
chr5	109648860	.	CA	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	115,0:115:0	0,68:68:1
chr5	110175959	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,66:66:1
chr5	110418605	.	TA	T	.	PASS	CSQ=642987|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TMEM232|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	4,81:85:0.9529
chr5	111155783	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:107:0	0,88:88:1
chr5	111360215	.	A	C	.	PASS	CSQ=814|protein_coding||intron_variant|||||||NM_001744.6:c.241-14635A>C||MODIFIER||||||CAMK4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,93:93:1
chr5	111363273	.	G	A	.	PASS	CSQ=814|protein_coding||intron_variant||||rs887122487||5.26177e-05|NM_001744.6:c.241-11577G>A||MODIFIER||||||CAMK4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,74:74:1
chr5	111683176	.	G	A	.	PASS	CSQ=100505678|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_040093.1:n.500+13541G>A||MODIFIER||||||STARD4-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	64,9:73:0.1233
chr5	111816035	.	T	G	.	PASS	CSQ=9315|protein_coding||intron_variant|||||||NM_001142475.1:c.136-80528A>C||MODIFIER||||||NREP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,80:80:1
chr5	112605753	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,63:63:1
chr5	113409359	.	C	CT	.	PASS	CSQ=4163|protein_coding||intron_variant||||rs888344653||0.000941505|NM_001085377.2:c.171-24148dup||MODIFIER||||||MCC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	13,73:86:0.8488
chr5	113469572	.	T	C	.	PASS	CSQ=4163|protein_coding||intron_variant|||||||NM_001085377.2:c.170+18673A>G||MODIFIER||||||MCC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	1,91:92:0.9891
chr5	113811699	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,87:87:1
chr5	113873854	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,88:88:1
chr5	114346272	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs745575572||7.23075e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,75:75:1
chr5	114350435	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs554260268||6.58094e-06|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,76:76:1
chr5	114720044	.	C	T	.	PASS	CSQ=101927078|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_130785.1:n.80-51813G>A||MODIFIER||||||LOC101927078|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,71:71:1
chr5	114983658	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	62,12:74:0.1622
chr5	115102362	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1056796724||0.000105455|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,63:63:1
chr5	115731963	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,64:64:1
chr5	116219033	.	G	T	.	PASS	CSQ=51397|protein_coding||intron_variant|||||||NM_016144.4:c.511-72484G>T||MODIFIER||||||COMMD10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,65:65:1
chr5	116832869	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,54:54:1
chr5	117542800	.	CATATA	C	.	PASS	CSQ=728342|lncRNA||intron_variant&non_coding_transcript_variant||||rs1196517826||0.000113083|NR_046089.1:n.362-3293_362-3289del||MODIFIER||||||LINC00992|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	8,77:85:0.9059
chr5	117872436	.	C	A	.	PASS	CSQ=102467224|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104997.1:n.49-52574C>A||MODIFIER||||||LINC02147|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	157,0:157:0	0,81:81:1
chr5	118220629	.	C	A	.	PASS	CSQ=102467224|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104997.1:n.171-44725C>A||MODIFIER||||||LINC02147|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,61:61:1
chr5	118649710	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	59,17:76:0.2237
chr5	118997463	.	C	CT	.	PASS	CSQ=105379143|lncRNA||intron_variant&non_coding_transcript_variant||||rs201508428||0.0398424|NR_134249.1:n.2207-1091dup||MODIFIER||||||LOC105379143|EntrezGene|0.0198;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	7,59:66:0.8939
chr5	119088490	.	A	T	.	PASS	CSQ=1657|protein_coding||intron_variant|||||||NM_005509.5:c.88-9489A>T||MODIFIER||||||DMXL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:108:0	68,5:73:0.0685
chr5	119167207	.	T	G	.	PASS	CSQ=1657|protein_coding||intron_variant|||||||NM_005509.5:c.5137-396T>G||MODIFIER||||||DMXL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	65,6:71:0.0845
chr5	119167479	.	CCTT	C	.	PASS	CSQ=1657|protein_coding||intron_variant|||||||NM_005509.5:c.5137-120_5137-118del||MODIFIER||||||DMXL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	95,0:95:0	4,77:81:0.9506
chr5	120084443	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,77:77:1
chr5	120108572	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1022804361||6.57652e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,65:65:1
chr5	120157897	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	117,0:117:0	0,65:65:1
chr5	120181839	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,1:136:0.0074	0,91:91:1
chr5	120511241	.	A	T	.	PASS	CSQ=51334|protein_coding||intron_variant|||||||NM_001300783.2:c.159+46596A>T||MODIFIER||||||PRR16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,61:61:1
chr5	120756344	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	62,4:66:0.0606
chr5	120851263	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs201292030||0.000994363|||MODIFIER||||||||0.0020;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,1:132:0.0076	7,64:71:0.9014
chr5	121151811	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs77135705||1.31508e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,88:88:1
chr5	121378718	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,60:60:1
chr5	122677987	.	C	T	.	PASS	CSQ=101927379|lncRNA||intron_variant&non_coding_transcript_variant||||rs182275488||5.28318e-05|NR_109881.1:n.922+19184G>A||MODIFIER||||||LINC02201|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,55:55:1
chr5	123491588	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,82:82:1
chr5	123657515	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	0,95:95:1
chr5	123681186	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	47,38:85:0.4471
chr5	123721201	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,84:84:1
chr5	123756719	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1482301933||0.00116101|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	11,71:84:0.8452
chr5	123833060	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,84:84:1
chr5	123920825	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,96:96:1
chr5	124641022	.	C	A	.	PASS	CSQ=57507|protein_coding||intron_variant|||||||NM_020747.2:c.4450+230G>T||MODIFIER||||||ZNF608|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,55:55:1
chr5	125116529	.	G	A	.	PASS	CSQ=101927421|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109882.1:n.119-42124G>A||MODIFIER||||||LOC101927421|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	3,73:76:0.9605
chr5	125966142	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,66:66:1
chr5	126158079	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,80:80:1
chr5	126173545	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs554860949||0.000401004|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	75,11:86:0.1279
chr5	126598676	.	C	T	.	PASS	CSQ=51808|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PHAX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,79:79:1
chr5	127585535	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,86:86:1
chr5	128269278	.	T	A	.	PASS	CSQ=2201|protein_coding||intron_variant|||||||NM_001999.4:c.7960+2721A>T||MODIFIER||||||FBN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	67,6:73:0.0822
chr5	128538971	.	C	T	.	PASS	CSQ=2201|protein_coding||upstream_gene_variant||||||6.5741e-06|||MODIFIER||||||FBN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,84:84:1
chr5	128634577	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,75:75:1
chr5	129112900	.	C	G	.	PASS	CSQ=51015|protein_coding||missense_variant|||||||NM_016048.2:c.796C>G|NP_057132.2:p.Leu266Val|MODERATE|B||D|T|T|ISOC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	0,77:77:1
chr5	129143534	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	30,36:66:0.5455
chr5	129161862	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	2,68:70:0.9714
chr5	129854919	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,69:69:1
chr5	130206766	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	1,74:75:0.9867
chr5	130408269	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,92:92:1
chr5	130436280	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,72:72:1
chr5	130856105	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,66:66:1
chr5	131066463	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57177e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,75:75:1
chr5	131515610	.	C	CA	.	PASS	CSQ=51735|protein_coding||intron_variant||||rs1366587732|||NM_016340.5:c.628-5120dup||MODIFIER||||||RAPGEF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	6,81:87:0.931
chr5	131739116	.	T	G	.	PASS	CSQ=96459|protein_coding||intron_variant|||||||NM_133372.3:c.219+5448A>C||MODIFIER||||||FNIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,1:132:0.0076	0,82:82:1
chr5	133266494	.	TC	T	.	PASS	CSQ=23105|protein_coding||intron_variant|||||||NM_015082.2:c.728-16919del||MODIFIER||||||FSTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	5,103:108:0.9537
chr5	133376846	.	G	C	.	PASS	CSQ=23105|protein_coding||intron_variant|||||||NM_015082.2:c.409+23892C>G||MODIFIER||||||FSTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,66:66:1
chr5	134123251	.	A	G	.	PASS	CSQ=6932|protein_coding||intron_variant||||rs1326130473||6.58068e-06|NM_003202.5:c.441+7218A>G||MODIFIER||||||TCF7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	0,71:71:1
chr5	134444080	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,75:75:1
chr5	134977594	.	G	A	.	PASS	CSQ=347732|protein_coding||intron_variant||||rs576602554||0.00010528|NM_178019.3:c.252+7502G>A||MODIFIER||||||CATSPER3|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,83:83:1
chr5	135417289	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs962158488||7.23694e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,102:102:1
chr5	135874126	.	C	G	.	PASS	CSQ=153328|protein_coding||missense_variant|||||||NM_001349336.1:c.785C>G|NP_001336265.1:p.Ser262Cys|MODERATE|.&.&.&.||D|.&.&.&.|.&.&.&.|SLC25A48|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	0,71:71:1
chr5	136037219	.	G	A	.	PASS	CSQ=7045|protein_coding||intron_variant|||||||NM_000358.3:c.233+3358G>A||MODIFIER||||||TGFBI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	0,69:69:1
chr5	136774832	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	10,87:97:0.8969
chr5	139176174	.	A	G	.	PASS	CSQ=64374|protein_coding||intron_variant||||||6.57384e-06|NM_022464.5:c.-11+22095T>C||MODIFIER||||||SIL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,83:83:1
chr5	139690972	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1479806395|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	74,12:86:0.1395
chr5	142083508	COSV62149765	T	C	.	PASS	CSQ=|||intergenic_variant|||COSV62149765|rs1454986607|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:93:0	87,6:93:0.0645
chr5	142787063	.	A	G	.	PASS	CSQ=23092|protein_coding||intron_variant|||||||NM_001135608.3:c.154+16148A>G||MODIFIER||||||ARHGAP26|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ARHGAP26|y|n|AML,MDS|||L|Dom|TSG,fusion|T,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,92:92:1
chr5	142939254	.	A	T	.	PASS	CSQ=23092|protein_coding||intron_variant|||||||NM_001135608.3:c.1107+7129A>T||MODIFIER||||||ARHGAP26|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ARHGAP26|y|n|AML,MDS|||L|Dom|TSG,fusion|T,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	0,87:87:1
chr5	143522786	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,60:60:1
chr5	143735715	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1369751542||6.57047e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,82:82:1
chr5	144096675	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,76:76:1
chr5	144249368	.	C	T	.	PASS	CSQ=57528|protein_coding||intron_variant|||||||NM_020768.4:c.832+41822C>T||MODIFIER||||||KCTD16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,77:77:1
chr5	144782727	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,63:63:1
chr5	145056358	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	56,13:69:0.1884
chr5	146740891	.	AG	A	.	PASS	CSQ=5521|protein_coding||intron_variant|||||||NM_001271900.1:c.245-39750del||MODIFIER||||||PPP2R2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,87:87:1
chr5	146868537	.	C	T	.	PASS	CSQ=5521|protein_coding||intron_variant|||||||NM_001271900.1:c.244+9465G>A||MODIFIER||||||PPP2R2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,91:91:1
chr5	147112215	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,86:86:1
chr5	147587257	.	A	T	.	PASS	CSQ=153469|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038902.1:n.145-7103A>T||MODIFIER||||||JAKMIP2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	110,0:110:0	0,86:86:1
chr5	148803288	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	89,5:94:0.0532
chr5	149552828	.	C	CA	.	PASS	CSQ=1452|protein_coding||upstream_gene_variant||||rs1208956860||0.00166534|||MODIFIER||||||CSNK1A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,1:120:0.0083	16,67:84:0.7976
chr5	150167823	.	T	A	.	PASS	CSQ=1044|protein_coding||intron_variant|||||||NM_001804.2:c.445+502T>A||MODIFIER||||||CDX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,70:70:1
chr5	151657265	.	C	A	.	PASS	CSQ=6678|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SPARC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,89:89:1
chr5	152324594	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,72:72:1
chr5	152413151	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||1.3143e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,85:85:1
chr5	152555205	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	0,92:92:1
chr5	152692802	.	C	A	.	PASS	CSQ=101927134|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109877.1:n.235-8017G>T||MODIFIER||||||LINC01470|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	85,4:89:0.0449
chr5	152972132	.	C	T	.	PASS	CSQ=101927134|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109877.1:n.84+134G>A||MODIFIER||||||LINC01470|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	137,0:137:0	1,85:87:0.977
chr5	153265926	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,73:74:0.9865
chr5	153378792	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,80:81:0.9877
chr5	153390656	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,67:67:1
chr5	153673193	.	T	A	.	PASS	CSQ=2890|protein_coding||intron_variant|||||||NM_000827.4:c.700-1307T>A||MODIFIER||||||GRIA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	72,14:86:0.1628
chr5	153673196	.	T	A	.	PASS	CSQ=2890|protein_coding||intron_variant|||||||NM_000827.4:c.700-1304T>A||MODIFIER||||||GRIA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	73,14:87:0.1609
chr5	155145427	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,88:88:1
chr5	155224728	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs188145983||0.000124921|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,77:77:1
chr5	155818477	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,78:78:1
chr5	155884564	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,73:73:1
chr5	155969226	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1305443517||3.28874e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,72:72:1
chr5	156135831	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,61:61:1
chr5	156546653	.	C	T	.	PASS	CSQ=6444|protein_coding||intron_variant|||||||NM_000337.5:c.294+37951C>T||MODIFIER||||||SGCD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	5,74:79:0.9367
chr5	156557336	.	G	A	.	PASS	CSQ=6444|protein_coding||intron_variant|||||||NM_000337.5:c.295-31895G>A||MODIFIER||||||SGCD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,89:89:1
chr5	159488187	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:136:0	0,76:76:1
chr5	159516048	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,84:84:1
chr5	161602314	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	55,11:66:0.1667
chr5	161863598	.	C	A	.	PASS	CSQ=2554|protein_coding||intron_variant|||||||NM_001127644.2:c.188-2123C>A||MODIFIER||||||GABRA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,87:87:1
chr5	162042418	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1419488389||1.97587e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	8,56:64:0.875
chr5	162051315	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,58:58:1
chr5	162090645	.	G	A	.	PASS	CSQ=2566|protein_coding||intron_variant||||||6.57886e-06|NM_198904.2:c.108-3183G>A||MODIFIER||||||GABRG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,4:128:0.0312	0,66:66:1
chr5	162127093	.	T	C	.	PASS	CSQ=2566|protein_coding||intron_variant|||||||NM_198904.2:c.770-15071T>C||MODIFIER||||||GABRG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,84:84:1
chr5	162370190	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	1,75:76:0.9868
chr5	162520893	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,76:76:1
chr5	162601832	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,69:69:1
chr5	162879310	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	89,7:96:0.0729
chr5	163564267	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,94:94:1
chr5	163593783	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	8,64:72:0.8889
chr5	163970874	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	62,16:78:0.2051
chr5	164122814	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,77:77:1
chr5	164334439	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:134:0	35,34:69:0.4928
chr5	164449373	.	G	C	.	PASS	CSQ=101927835|lncRNA||non_coding_transcript_exon_variant|||||||NR_105064.1:n.161C>G||MODIFIER||||||LINC02143|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,0:127:0	0,67:67:1
chr5	164449919	.	G	A	.	PASS	CSQ=101927835|lncRNA||intron_variant&non_coding_transcript_variant||||rs56022916|||NR_105064.1:n.121-506C>T||MODIFIER||||||LINC02143|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,87:87:1
chr5	164608697	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,66:66:1
chr5	164886690	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,66:66:1
chr5	164930399	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,54:54:1
chr5	165083955	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,76:76:1
chr5	165083998	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,84:84:1
chr5	165457676	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	64,9:73:0.1233
chr5	165471945	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,72:72:1
chr5	165910168	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.56927e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,63:63:1
chr5	166052553	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs532146338||0.0863856|||MODIFIER||||||||0.0849;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	2,67:69:0.971
chr5	166076287	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	0,57:57:1
chr5	166094255	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	0,76:76:1
chr5	166237566	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	70,4:74:0.0541
chr5	166307480	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	120,0:120:0	62,7:69:0.1014
chr5	166415369	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,70:70:1
chr5	166451792	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1488601589||1.31695e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,71:71:1
chr5	166538273	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,75:75:1
chr5	167033998	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,76:76:1
chr5	167457659	.	TAA	T	.	PASS	CSQ=57451|protein_coding||intron_variant|||||||NM_001122679.2:c.502+82188_502+82189del||MODIFIER||||||TENM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	1,77:78:0.9872
chr5	167636280	.	G	A	.	PASS	CSQ=57451|protein_coding||intron_variant|||||||NM_001122679.2:c.503-239706G>A||MODIFIER||||||TENM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	109,0:109:0	79,3:82:0.0366
chr5	168907975	.	T	G	.	PASS	CSQ=6586|protein_coding||intron_variant||||rs71589844||0.354795|NM_003062.3:c.414-24639A>C||MODIFIER||||||SLIT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	53,1:54:0.0185	12,37:49:0.7551
chr5	169049985	.	C	G	.	PASS	CSQ=6586|protein_coding||intron_variant|||||||NM_003062.3:c.413+143494G>C||MODIFIER||||||SLIT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,78:78:1
chr5	169056119	.	G	A	.	PASS	CSQ=6586|protein_coding||intron_variant||||rs983086576||0.00014464|NM_003062.3:c.413+137360C>T||MODIFIER||||||SLIT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,69:69:1
chr5	169137447	.	C	T	.	PASS	CSQ=6586|protein_coding||intron_variant|||||||NM_003062.3:c.413+56032G>A||MODIFIER||||||SLIT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,73:73:1
chr5	169386382	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	1,65:66:0.9848
chr5	169887087	COSV56951886;COSV56951886;COSV56951886	G	A	.	PASS	CSQ=1794|protein_coding||intron_variant|COSV56951886&COSV56951886&COSV56951886|p.?&p.?&p.?|||||NM_004946.3:c.2799+46235G>A||MODIFIER||||||DOCK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,60:60:1
chr5	170213611	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	68,0:68:0	0,47:47:1
chr5	170494015	.	GG	CT	.	PASS	CSQ=30820|protein_coding||intron_variant|||||||NM_001034838.2:c.88+140051_88+140052delinsCT||MODIFIER||||||KCNIP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	109,0:109:0	0,82:82:1
chr5	170791864	.	T	C	.	PASS	CSQ=2568|protein_coding||intron_variant|||||||NM_014211.3:c.173-2367T>C||MODIFIER||||||GABRP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,101:101:1
chr5	170862299	.	G	A	.	PASS	CSQ=64901|protein_coding||intron_variant||||rs1346032742||6.57091e-06|NM_022897.5:c.18+248G>A||MODIFIER||||||RANBP17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,113:113:1
chr5	171013974	.	C	T	.	PASS	CSQ=64901|protein_coding||intron_variant|||||||NM_022897.5:c.1710+45597C>T||MODIFIER||||||RANBP17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,81:81:1
chr5	171201983	.	G	A	.	PASS	CSQ=64901|protein_coding||intron_variant||||rs1020775786||4.60314e-05|NM_022897.5:c.2142+2210G>A||MODIFIER||||||RANBP17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,89:89:1
chr5	171552058	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	54,12:66:0.1818
chr5	171933356	.	G	C	.	PASS	CSQ=23291|protein_coding||intron_variant|||||||NM_033644.2:c.46-18951C>G||MODIFIER||||||FBXW11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,76:76:1
chr5	172142846	.	T	A	.	PASS	CSQ=6793|protein_coding||intron_variant|||||||NM_005990.4:c.321+13778A>T||MODIFIER||||||STK10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,84:84:1
chr5	172219940	.	AC	A	.	PASS	CSQ=92181|protein_coding||intron_variant|||||||NM_152277.3:c.308-7714del||MODIFIER||||||UBTD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	1,85:86:0.9884
chr5	172716556	.	TGCTGTGCCCTCA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,60:60:1
chr5	172869464	.	C	T	.	PASS	CSQ=57222|protein_coding||intron_variant||||rs1352043315||3.94156e-05|NM_001031711.3:c.21-19235C>T||MODIFIER||||||ERGIC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	106,0:106:0	0,82:82:1
chr5	172869473	.	C	T	.	PASS	CSQ=57222|protein_coding||intron_variant|||||||NM_001031711.3:c.21-19226C>T||MODIFIER||||||ERGIC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	106,0:106:0	0,80:80:1
chr5	172869555	.	C	T	.	PASS	CSQ=57222|protein_coding||intron_variant|||||||NM_001031711.3:c.21-19144C>T||MODIFIER||||||ERGIC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	130,0:130:0	0,83:83:1
chr5	175189282	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,94:94:1
chr5	176197239	.	A	G	.	PASS	CSQ=643201|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_036494.1:n.60+1997T>C||MODIFIER||||||LOC643201|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,82:82:1
chr5	177133314	.	C	T	.	PASS	CSQ=64324|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NSD1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NSD1|y|n|AML|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,107:107:1
chr5	177335640	.	G	A	.	PASS	CSQ=10960|protein_coding||intron_variant|||||||NM_006816.3:c.791-1237C>T||MODIFIER||||||LMAN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,93:93:1
chr5	178052162	.	C	CA	.	PASS	CSQ=653316|misc_RNA||intron_variant&non_coding_transcript_variant||||rs546158752||0.000321625|NR_149722.1:n.1660-362dup||MODIFIER||||||FAM153C|EntrezGene|0.0008;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	25,81:106:0.7642
chr5	178481863	.	G	T	.	PASS	CSQ=91522|protein_coding||intron_variant|||||||NM_173465.4:c.361+78819C>A||MODIFIER||||||COL23A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	52,0:52:0	0,26:26:1
chr5	179569030	.	G	A	.	PASS	CSQ=80230|protein_coding||intron_variant|||||||NM_025158.5:c.705-272G>A||MODIFIER||||||RUFY1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,88:88:1
chr5	179831183	.	G	T	.	PASS	CSQ=8878|protein_coding||intron_variant||||rs745916315||1.31394e-05|NM_003900.5:c.755-1849G>T||MODIFIER||||||SQSTM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,99:99:1
chr5	180514149	.	C	G	.	PASS	CSQ=57472|protein_coding||intron_variant|||||||NM_001303241.2:c.-2-15126C>G||MODIFIER||||||CNOT6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	0,63:63:1
chr5	180623775	.	A	T	.	PASS	CSQ=2324|protein_coding||intron_variant|||||||NM_182925.5:c.1548+160T>A||MODIFIER||||||FLT4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FLT4|y|n|soft_tissue_sarcoma|||M|Dom|oncogene|A;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,79:79:1
chr5	180822648	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	71,8:79:0.1013
chr6	469822	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	7,50:57:0.8772
chr6	1675659	.	T	A	.	PASS	CSQ=2762|protein_coding||intron_variant|||||||NM_001500.4:c.987+50757A>T||MODIFIER||||||GMDS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	3,72:75:0.96
chr6	1744458	.	A	C	.	PASS	CSQ=2762|protein_coding||intron_variant|||||||NM_001500.4:c.772-1872T>G||MODIFIER||||||GMDS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	68,5:73:0.0685
chr6	2439235	.	GGCTTCCAAAA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	2,85:87:0.977
chr6	2656799	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	90,6:96:0.0625
chr6	2998469	.	C	A	.	PASS	CSQ=4835|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NQO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:140:0	7,77:84:0.9167
chr6	3714581	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:124:0	4,78:82:0.9512
chr6	3847935	.	C	T	.	PASS	CSQ=26240|protein_coding||upstream_gene_variant||||rs985335005|||||MODIFIER||||||FAM50B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	132,0:132:0	74,4:78:0.0513
chr6	3893977	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,1:118:0.0085	6,85:91:0.9341
chr6	3917816	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	3,94:97:0.9691
chr6	4102983	.	C	T	.	PASS	CSQ=404220|protein_coding||intron_variant|||||||NM_001085401.2:c.284+3785C>T||MODIFIER||||||C6orf201|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	2,82:84:0.9762
chr6	4267956	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	4,88:92:0.9565
chr6	4544755	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1386142875||1.97298e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	9,72:81:0.8889
chr6	5368010	.	GCTATGT	G	.	PASS	CSQ=10667|protein_coding||intron_variant|||||||NM_006567.4:c.-21-538_-21-533del||MODIFIER||||||FARS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	2,73:75:0.9733
chr6	5409224	.	G	T	.	PASS	CSQ=10667|protein_coding||intron_variant|||||||NM_006567.4:c.772+4523G>T||MODIFIER||||||FARS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	6,83:89:0.9326
chr6	5490515	.	C	G	.	PASS	CSQ=10667|protein_coding||intron_variant|||||||NM_006567.4:c.905-54665C>G||MODIFIER||||||FARS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	4,82:86:0.9535
chr6	5913349	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	1,57:58:0.9828
chr6	5916147	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	64,7:71:0.0986
chr6	6020748	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	3,64:67:0.9552
chr6	6052063	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	2,85:87:0.977
chr6	6329735	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	4,74:78:0.9487
chr6	6687272	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	3,81:84:0.9643
chr6	6726636	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	77,6:83:0.0723
chr6	7190566	.	TTATTTTC	T	.	PASS	CSQ=6239|protein_coding||intron_variant|||||||NM_001003699.4:c.425+1246_425+1252del||MODIFIER||||||RREB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	5,87:92:0.9457
chr6	7356585	.	C	T	.	PASS	CSQ=285782|protein_coding||intron_variant|||||||NM_001170692.2:c.2194-456G>A||MODIFIER||||||CAGE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	81,10:91:0.1099
chr6	8384570	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	2,56:58:0.9655
chr6	8757808	.	G	A	.	PASS	CSQ=100506207|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038980.1:n.708-26383G>A||MODIFIER||||||LOC100506207|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	2,82:84:0.9762
chr6	8882613	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	31,36:67:0.5373
chr6	9206150	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	3,74:77:0.961
chr6	9514268	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	4,75:79:0.9494
chr6	9628137	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1001683160||0.000348423|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	6,74:80:0.925
chr6	10228527	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	2,66:68:0.9706
chr6	10353214	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	3,103:106:0.9717
chr6	10497022	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	96,4:100:0.04
chr6	10507639	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:130:0	77,5:82:0.061
chr6	10653505	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	86,5:91:0.0549
chr6	11161689	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	7,83:90:0.9222
chr6	11555340	.	G	A	.	PASS	CSQ=100113407|protein_coding||intron_variant||||rs1024785360||1.97636e-05|NM_001100829.3:c.98-10326G>A||MODIFIER||||||TMEM170B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	7,68:75:0.9067
chr6	11677373	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1394609806||1.31401e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	3,87:90:0.9667
chr6	12460719	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	69,6:75:0.08
chr6	12954096	.	A	G	.	PASS	CSQ=221692|protein_coding||intron_variant|||||||NM_001322310.1:c.251-99269A>G||MODIFIER||||||PHACTR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	5,72:77:0.9351
chr6	13108845	.	CT	AA	.	PASS	CSQ=221692|protein_coding||intron_variant|||||||NM_001322314.1:c.419-51359_419-51358delinsAA||MODIFIER||||||PHACTR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	99,0:99:0	6,75:81:0.9259
chr6	13849019	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	74,17:91:0.1868
chr6	13849684	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	2,63:65:0.9692
chr6	14325971	COSV58892370	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV58892370|rs1170290049||0.0025128|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	15,67:82:0.8171
chr6	14368778	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	5,66:71:0.9296
chr6	14863092	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	7,73:80:0.9125
chr6	14967465	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	3,84:87:0.9655
chr6	14995300	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	5,78:83:0.9398
chr6	15605042	.	G	C	.	PASS	CSQ=84062|protein_coding||intron_variant|||||||NM_032122.4:c.488+10225C>G||MODIFIER||||||DTNBP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	1,74:75:0.9867
chr6	15825475	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs950691273||7.85243e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	5,80:85:0.9412
chr6	15952588	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1045083540||4.60066e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	5,64:69:0.9275
chr6	16401246	.	G	A	.	PASS	CSQ=6310|protein_coding||intron_variant||||rs146119470||6.57229e-05|NM_000332.3:c.-160-72776C>T||MODIFIER||||||ATXN1|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	2,59:61:0.9672
chr6	17098890	.	CTTT	C	.	PASS	CSQ=401236|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||STMND1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	78,4:82:0.0488
chr6	19210852	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	75,6:81:0.0741
chr6	19216526	.	TATTGTATGTACAATC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	5,68:73:0.9315
chr6	19613944	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	50,7:57:0.1228
chr6	19977824	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	55,4:59:0.0678
chr6	20377461	.	AAGTCCTC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	3,62:65:0.9538
chr6	21683001	.	A	G	.	PASS	CSQ=401237|lncRNA||intron_variant&non_coding_transcript_variant||||rs1278086357|||NR_015410.2:n.486+14102A>G||MODIFIER||||||CASC15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	6,80:86:0.9302
chr6	21844004	.	A	T	.	PASS	CSQ=401237|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_015410.2:n.647+41264A>T||MODIFIER||||||CASC15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	146,0:146:0	69,4:73:0.0548
chr6	22291371	.	C	T	.	PASS	CSQ=5617|protein_coding||intron_variant||||rs904439771||6.57212e-06|NM_000948.6:c.313-1018G>A||MODIFIER||||||PRL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	3,76:79:0.962
chr6	22354113	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	123,0:123:0	75,6:81:0.0741
chr6	22358876	.	ATTG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	7,69:76:0.9079
chr6	22553138	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,5:79:0.0633
chr6	22813220	.	GT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	54,5:59:0.0847
chr6	23049578	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	2,73:75:0.9733
chr6	23130456	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||||6.57921e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	11,56:67:0.8358
chr6	23662790	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1354152326|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	132,0:132:0	78,5:83:0.0602
chr6	24060011	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	64,5:69:0.0725
chr6	24210946	.	C	A	.	PASS	CSQ=51473|protein_coding||intron_variant|||||||NM_016356.5:c.923-5844G>T||MODIFIER||||||DCDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	128,0:128:0	80,5:85:0.0588
chr6	24215266	.	C	A	.	PASS	CSQ=51473|protein_coding||intron_variant|||||||NM_016356.5:c.923-10164G>T||MODIFIER||||||DCDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	39,50:89:0.5618
chr6	25071632	.	TAATATGAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,79:79:1
chr6	25113343	.	C	T	.	PASS	CSQ=8418|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_002174.2:n.505+249G>A||MODIFIER||||||CMAHP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	62,14:76:0.1842
chr6	25209353	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	32,35:67:0.5224
chr6	26023602	.	G	T	.	PASS	CSQ=8359|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||HIST1H4A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	4,81:85:0.9529
chr6	26055636	.	C	G	.	PASS	CSQ=3006|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||HIST1H1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	86,4:90:0.0444
chr6	26188031	.	C	T	.	PASS	CSQ=8344|protein_coding||downstream_gene_variant||||rs537118995|||||MODIFIER||||||HIST1H2BE|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	1,74:75:0.9867
chr6	26555240	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	124,0:124:0	97,5:102:0.049
chr6	27008400	.	C	T	.	PASS	CSQ=100133205|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_026775.2:n.257-14854C>T||MODIFIER||||||LINC00240|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	6,91:97:0.9381
chr6	27146929	.	T	G	.	PASS	CSQ=85236|protein_coding||upstream_gene_variant||||rs1358259514|||||MODIFIER||||||HIST1H2BK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	5,69:74:0.9324
chr6	27511817	.	GGACCAAAACAA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	135,0:135:0	2,79:81:0.9753
chr6	28275534	.	G	A	.	PASS	CSQ=7741|protein_coding||intron_variant|||||||NM_001023560.3:c.539-661G>A||MODIFIER||||||ZSCAN26|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	2,77:79:0.9747
chr6	28830491	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	8,60:68:0.8824
chr6	29354936	.	G	A	.	PASS	CSQ=81696|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||OR5V1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	4,79:83:0.9518
chr6	29430580	.	C	A	.	PASS	CSQ=26531|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||OR11A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	87,6:93:0.0645
chr6	29988695	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	2,89:91:0.978
chr6	30113216	.	G	A	.	PASS	CSQ=11074|protein_coding||upstream_gene_variant||||rs963054791|||||MODIFIER||||||TRIM31|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	59,12:71:0.169
chr6	30491474	.	C	CT	.	PASS	CSQ=3133|protein_coding||intron_variant|||||||NM_005516.6:c.887-61dup||MODIFIER||||||HLA-E|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	134,0:134:0	15,72:87:0.8276
chr6	30589997	.	G	A	.	PASS	CSQ=23|protein_coding||intron_variant|||||||NM_001025091.2:c.2233+23G>A||MODIFIER||||||ABCF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	2,80:82:0.9756
chr6	30630272	.	G	C	.	PASS	CSQ=28973|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MRPS18B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	87,8:95:0.0842
chr6	32149911	.	T	C	.	PASS	CSQ=100507547|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC100507547|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	3,76:79:0.962
chr6	32304622	.	G	A	.	PASS	CSQ=10665|protein_coding||intron_variant|||||||NM_001286474.1:c.575-1993C>T||MODIFIER||||||C6orf10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,77:77:1
chr6	32467706	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	73,9:82:0.1098
chr6	32551032	.	C	T	.	PASS	CSQ=3128|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||HLA-DRB6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	139,0:139:0	41,67:108:0.6204
chr6	33287789	.	C	T	.	PASS	CSQ=102466754|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR6873|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	4,59:63:0.9365
chr6	33548213	.	TC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:106:0	4,73:77:0.9481
chr6	34058479	.	C	T	.	PASS	CSQ=2914|protein_coding||intron_variant||||||6.57186e-06|NM_000841.3:c.1027+495G>A||MODIFIER||||||GRM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	81,5:86:0.0581
chr6	34534209	.	C	T	.	PASS	CSQ=25803|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SPDEF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	103,0:103:0	81,5:86:0.0581
chr6	35172255	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1340922592||1.31408e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	99,0:99:0	73,7:80:0.0875
chr6	35403082	.	G	A	.	PASS	CSQ=5467|protein_coding||intron_variant|||||||NM_006238.5:c.-101-7905G>A||MODIFIER||||||PPARD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	5,85:90:0.9444
chr6	35491814	.	C	A	.	PASS	CSQ=7005|protein_coding||intron_variant|||||||NM_003214.4:c.-50+5084G>T||MODIFIER||||||TEAD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	100,10:110:0.0909
chr6	36145003	.	C	T	.	PASS	CSQ=5603|protein_coding||downstream_gene_variant||||rs954224078||4.60042e-05|||MODIFIER||||||MAPK13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	78,5:83:0.0602
chr6	36180316	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	135,0:135:0	69,12:81:0.1481
chr6	36899741	.	G	A	.	PASS	CSQ=221477|protein_coding||intron_variant||||rs570219042||0.000591389|NM_001286635.1:c.189+108G>A||MODIFIER||||||C6orf89|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	100,6:106:0.0566
chr6	37827821	.	C	A	.	PASS	CSQ=60685|protein_coding||intron_variant|||||||NM_021943.3:c.71+7805C>A||MODIFIER||||||ZFAND3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	4,93:97:0.9588
chr6	37984455	.	A	G	.	PASS	CSQ=60685|protein_coding||intron_variant||||||6.56901e-06|NM_021943.3:c.112+54456A>G||MODIFIER||||||ZFAND3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	3,92:95:0.9684
chr6	38640120	.	G	T	.	PASS	CSQ=114781|protein_coding||upstream_gene_variant||||||6.57065e-06|||MODIFIER||||||BTBD9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	126,0:126:0	5,71:76:0.9342
chr6	38671692	.	C	T	.	PASS	CSQ=2739|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||GLO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	4,90:94:0.9574
chr6	39078427	.	C	T	.	PASS	CSQ=2740|protein_coding||intron_variant|||||||NM_002062.5:c.884+45C>T||MODIFIER||||||GLP1R|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	71,4:75:0.0533
chr6	39168633	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	87,76:163:0.4663
chr6	39241807	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	77,73:150:0.4867
chr6	39716504	.	T	C	.	PASS	CSQ=221458|protein_coding||intron_variant||||rs754506221||1.97138e-05|NM_145027.6:c.177-1738A>G||MODIFIER||||||KIF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	6,76:82:0.9268
chr6	40341921	.	G	A	.	PASS	CSQ=401260|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00951|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	2,62:64:0.9688
chr6	40431771	COSV57827603	C	T	.	PASS	CSQ=57497|protein_coding||missense_variant|COSV57827603|p.R448Q||rs146724906&COSM272896|7.0025e-05|4.59831e-05|NM_020737.2:c.1343G>A|NP_065788.1:p.Arg448Gln|MODERATE|B|T|D|T|T|LRFN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	6,77:83:0.9277
chr6	40987438	.	G	A	.	PASS	CSQ=101929555|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110873.1:n.135+35708C>T||MODIFIER||||||LOC101929555|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	7,77:84:0.9167
chr6	42825840	.	G	T	.	PASS	CSQ=23506|protein_coding||intron_variant|||||||NM_001318819.1:c.160-2653G>T||MODIFIER||||||BICRAL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	73,10:83:0.1205
chr6	42842051	.	C	G	.	PASS	CSQ=23506|protein_coding||intron_variant||||rs1044823453|||NM_001318819.1:c.1840-10041C>G||MODIFIER||||||BICRAL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	4,99:103:0.9612
chr6	43059987	.	C	A	.	PASS	CSQ=89953|protein_coding||intron_variant|||||||NM_201521.3:c.-26+302C>A||MODIFIER||||||KLC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	102,0:102:0	4,66:70:0.9429
chr6	43236123	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	4,64:68:0.9412
chr6	43266934	.	C	T	.	PASS	CSQ=84630|protein_coding||intron_variant|||||||NM_032538.3:c.1986+3584C>T||MODIFIER||||||TTBK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	69,19:88:0.2159
chr6	43648487	.	G	T	.	PASS	CSQ=221421|protein_coding||intron_variant|||||||NM_152732.5:c.228-1888G>T||MODIFIER||||||RSPH9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	1,74:75:0.9867
chr6	44579790	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	2,82:84:0.9762
chr6	44607297	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs905418149||0.000144606|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	87,6:93:0.0645
chr6	44622666	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	5,79:84:0.9405
chr6	45859986	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57073e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	90,5:95:0.0526
chr6	46335601	.	T	G	.	PASS	CSQ=101926915|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125838.1:n.286-25510T>G||MODIFIER||||||LOC101926915|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	79,5:84:0.0595
chr6	46342874	.	C	A	.	PASS	CSQ=101926915|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125838.1:n.286-18237C>A||MODIFIER||||||LOC101926915|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	4,64:68:0.9412
chr6	46509023	.	G	A	.	PASS	CSQ=101926898|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125837.1:n.76+16896G>A||MODIFIER||||||LOC101926898|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	85,7:92:0.0761
chr6	46674946	.	A	C	.	PASS	CSQ=9481|protein_coding||intron_variant|||||||NM_004277.5:c.901-1437A>C||MODIFIER||||||SLC25A27|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	4,73:77:0.9481
chr6	46959841	.	G	A	.	PASS	CSQ=221395|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ADGRF5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	66,0:66:0	0,45:45:1
chr6	47658200	.	GTGGGAAACAGTCT	G	.	PASS	CSQ=222611|protein_coding||intron_variant|||||||NM_153839.7:c.-207+1542_-207+1554del||MODIFIER||||||ADGRF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	4,67:71:0.9437
chr6	48506813	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	111,0:111:0	68,6:74:0.0811
chr6	48641613	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1010038903||6.58129e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	2,59:61:0.9672
chr6	48671277	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:109:0	6,78:84:0.9286
chr6	48801962	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	99,0:99:0	59,4:63:0.0635
chr6	49007949	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	4,65:69:0.942
chr6	49324916	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	7,65:72:0.9028
chr6	50270952	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	54,5:59:0.0847
chr6	50358953	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	101,0:101:0	59,5:64:0.0781
chr6	50505871	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	126,0:126:0	60,5:65:0.0769
chr6	50699256	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs752771793||8.5451e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	114,0:114:0	75,5:80:0.0625
chr6	50938311	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.58137e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	6,73:79:0.9241
chr6	51357460	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	72,6:78:0.0769
chr6	51450356	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1236883864||0.0148665|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	9,53:62:0.8548
chr6	52929104	.	TTA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	9,78:87:0.8966
chr6	53183953	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	0,150:150:1
chr6	53231871	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	94,63:157:0.4013
chr6	53307638	.	C	G	.	PASS	CSQ=60481|protein_coding||intron_variant|||||||NM_021814.5:c.-8-11931G>C||MODIFIER||||||ELOVL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	8,61:69:0.8841
chr6	54529864	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	63,5:68:0.0735
chr6	54811901	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1216977088||1.31435e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	4,64:68:0.9412
chr6	54988210	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	1,69:70:0.9857
chr6	55084268	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	156,0:156:0	40,39:79:0.4937
chr6	55266377	.	A	T	.	PASS	CSQ=3062|protein_coding||intron_variant|||||||NM_001526.4:c.762+2555A>T||MODIFIER||||||HCRTR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,71:71:1
chr6	55321453	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs938007460|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	3,75:78:0.9615
chr6	55719645	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.58033e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:127:0	4,60:64:0.9375
chr6	56183199	.	T	G	.	PASS	CSQ=81578|protein_coding||intron_variant|||||||NM_030820.4:c.-38-543A>C||MODIFIER||||||COL21A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	5,75:80:0.9375
chr6	57663513	COSV69194130	A	G	.	PASS	CSQ=|||intergenic_variant|||COSV69194130||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	47,49:96:0.5104
chr6	57793354	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	5,81:86:0.9419
chr6	58002728	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	1,88:89:0.9888
chr6	58036115	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs184525527||0.000348528|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	0,73:73:1
chr6	60741306	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	70,66:136:0.4853
chr6	61036329	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	154,0:154:0	69,55:124:0.4435
chr6	61404887	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	71,68:139:0.4892
chr6	61742580	.	T	G	.	PASS	CSQ=202559|protein_coding||intron_variant|||||||NM_152688.4:c.811-9816A>C||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	81,81:162:0.5
chr6	61754094	.	C	T	.	PASS	CSQ=202559|protein_coding||intron_variant||||rs1169768354||1.31574e-05|NM_152688.4:c.811-21330G>A||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,70:140:0.5
chr6	61784197	.	T	A	.	PASS	CSQ=202559|protein_coding||intron_variant|||||||NM_152688.4:c.811-51433A>T||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	74,92:166:0.5542
chr6	61831459	.	T	G	.	PASS	CSQ=202559|protein_coding||intron_variant|||||||NM_152688.4:c.810+63176A>C||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	63,51:114:0.4474
chr6	61876574	.	T	C	.	PASS	CSQ=202559|protein_coding||intron_variant|||||||NM_152688.4:c.810+18061A>G||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	63,77:140:0.55
chr6	61891175	.	TG	T	.	PASS	CSQ=202559|protein_coding||intron_variant|||||||NM_152688.4:c.810+3459del||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	77,75:152:0.4934
chr6	61926888	.	G	GT	.	PASS	CSQ=202559|protein_coding||intron_variant||||rs139821784||0.00424752|NM_152688.4:c.484-25518dup||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	64,42:107:0.3925
chr6	61939454	.	C	T	.	PASS	CSQ=202559|protein_coding||intron_variant|||||||NM_152688.4:c.484-38083G>A||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	70,78:148:0.527
chr6	62248557	.	C	A	.	PASS	CSQ=202559|protein_coding||intron_variant|||||||NM_152688.4:c.91+37301G>T||MODIFIER||||||KHDRBS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	73,54:127:0.4252
chr6	62303098	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	70,61:132:0.4621
chr6	62333866	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	71,87:158:0.5506
chr6	62335483	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1446121249|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,1:104:0.0096	78,62:140:0.4429
chr6	62353629	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1186905384||6.58259e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	62,66:128:0.5156
chr6	62400867	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1329932356||6.57341e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	74,73:147:0.4966
chr6	62658806	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	68,68:136:0.5
chr6	62869809	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1417394831||1.9887e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	76,69:146:0.4726
chr6	62986636	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	79,79:158:0.5
chr6	63152070	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	74,92:166:0.5542
chr6	63219269	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	74,67:141:0.4752
chr6	63446313	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	76,55:131:0.4198
chr6	63845052	.	G	T	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.7228+19134C>A||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	75,76:151:0.5033
chr6	64382358	.	C	G	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.6078+6332G>C||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	58,72:130:0.5538
chr6	64429113	.	C	T	.	PASS	CSQ=346007|protein_coding||intron_variant||||rs918771759||9.86375e-05|NM_001142800.1:c.5927+7061G>A||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	82,70:152:0.4605
chr6	64669323	.	C	G	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.3444-43078G>C||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	70,64:134:0.4776
chr6	64735406	.	CTCCTGTGCACTATCTTATTTATTTAAATTTGGATAGTGACA	C	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.3443+77931_3443+77971del||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	167,0:167:0	172,10:182:0.0549
chr6	64781876	.	C	T	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.3443+31502G>A||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	77,77:154:0.5
chr6	64863568	.	G	A	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2992+23129C>T||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	52,75:127:0.5906
chr6	64905193	.	C	G	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2642-2693G>C||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	84,67:151:0.4437
chr6	64983731	.	AT	A	.	PASS	CSQ=346007|protein_coding||intron_variant||||rs994365800||0.000214782|NM_001142800.1:c.2259+13850del||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:132:0	74,60:134:0.4478
chr6	65023145	.	A	C	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2138-25442T>G||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	129,8:137:0.0584
chr6	65038418	.	C	A	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2137+19196G>T||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	67,67:134:0.5
chr6	65053675	.	G	T	.	PASS	CSQ=346007|protein_coding||intron_variant||||rs1437545687||6.58683e-06|NM_001142800.1:c.2137+3939C>A||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	129,8:137:0.0584
chr6	65082156	.	T	C	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2024-24429A>G||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	123,8:131:0.0611
chr6	65101169	.	A	G	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2024-43442T>C||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	62,67:129:0.5194
chr6	65113306	.	G	T	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2024-55579C>A||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	94,35:129:0.2713
chr6	65134608	.	G	T	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2024-76881C>A||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	60,67:127:0.5276
chr6	65189772	.	C	A	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2023+106091G>T||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	68,76:144:0.5278
chr6	65228055	.	GG	TT	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.2023+67807_2023+67808delinsAA||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	118,0:119:0	61,60:121:0.4959
chr6	65243752	.	G	GA	.	PASS	CSQ=346007|protein_coding||intron_variant||||rs1312943880||1.32036e-05|NM_001142800.1:c.2023+52110dup||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	75,52:127:0.4094
chr6	65298154	.	C	T	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.1767-2035G>A||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	153,9:162:0.0556
chr6	65318527	.	A	G	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.1766+16453T>C||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	69,75:144:0.5208
chr6	65373164	.	C	A	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.1299+11222G>T||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	110,7:117:0.0598
chr6	65436997	.	T	G	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.863-31630A>C||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	125,15:140:0.1071
chr6	65577476	.	G	A	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.-333+62302C>T||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	65,78:143:0.5455
chr6	65636613	.	A	G	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.-333+3165T>C||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	90,63:153:0.4118
chr6	65669132	.	G	C	.	PASS	CSQ=346007|protein_coding||intron_variant|||||||NM_001142800.1:c.-447-29240C>G||MODIFIER||||||EYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	69,67:136:0.4926
chr6	65799512	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	63,72:135:0.5333
chr6	65842805	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs953517153||5.92979e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	75,66:141:0.4681
chr6	65868086	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	84,84:168:0.5
chr6	65920364	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs528718483||0.000206777|||MODIFIER||||||||0.0014;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	95,61:156:0.391
chr6	66123988	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	59,67:126:0.5317
chr6	66488496	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	66,66:132:0.5
chr6	66585520	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:134:0	122,8:130:0.0615
chr6	66607425	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.57142e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	75,63:138:0.4565
chr6	66964050	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	54,66:120:0.55
chr6	67163073	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	56,76:132:0.5758
chr6	67279124	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	59,75:134:0.5597
chr6	67330202	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	65,66:131:0.5038
chr6	67505714	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	70,79:149:0.5302
chr6	67642220	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	139,16:155:0.1032
chr6	67655336	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	124,13:137:0.0949
chr6	67783187	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	64,60:124:0.4839
chr6	67912548	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	70,66:136:0.4853
chr6	67952908	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	67,76:143:0.5315
chr6	68057456	.	C	CT	.	PASS	CSQ=102723883|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125869.1:n.85+2026dup||MODIFIER||||||LOC102723883|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	90,75:165:0.4545
chr6	68149543	.	GT	G	.	PASS	CSQ=|||intergenic_variant||||rs1036786142||0.000200262|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,1:95:0.0105	60,60:121:0.4959
chr6	68280669	.	C	T	.	PASS	CSQ=101928280|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125854.1:n.238-14054G>A||MODIFIER||||||LINC02549|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	90,35:125:0.28
chr6	68380745	COSV62850633	T	A	.	PASS	CSQ=|||intergenic_variant|||COSV62850633||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	81,74:155:0.4774
chr6	68688493	.	A	T	.	PASS	CSQ=577|protein_coding||intron_variant|||||||NM_001704.3:c.757+49061A>T||MODIFIER||||||ADGRB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	96,44:140:0.3143
chr6	68703763	.	C	A	.	PASS	CSQ=577|protein_coding||intron_variant|||||||NM_001704.3:c.757+64331C>A||MODIFIER||||||ADGRB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	104,8:112:0.0714
chr6	68924273	.	G	T	.	PASS	CSQ=577|protein_coding||intron_variant|||||||NM_001704.3:c.758-6286G>T||MODIFIER||||||ADGRB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	114,39:153:0.2549
chr6	68935639	.	A	T	.	PASS	CSQ=577|protein_coding||intron_variant|||||||NM_001704.3:c.869-880A>T||MODIFIER||||||ADGRB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:106:0.0094	67,72:139:0.518
chr6	69234997	.	C	T	.	PASS	CSQ=577|protein_coding||intron_variant|||||||NM_001704.3:c.2608-35C>T||MODIFIER||||||ADGRB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	112,0:112:0	69,67:136:0.4926
chr6	69336807	.	C	A	.	PASS	CSQ=577|protein_coding||intron_variant|||||||NM_001704.3:c.3189-2109C>A||MODIFIER||||||ADGRB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	79,75:154:0.487
chr6	69475543	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	120,14:134:0.1045
chr6	69492159	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	80,56:136:0.4118
chr6	69619124	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	72,70:142:0.493
chr6	69644304	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	77,70:147:0.4762
chr6	69967821	.	G	A	.	PASS	CSQ=1310|protein_coding||intron_variant||||rs998337220||2.63175e-05|NM_001858.6:c.1026+4951G>A||MODIFIER||||||COL19A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	76,74:150:0.4933
chr6	70027463	.	C	A	.	PASS	CSQ=1310|protein_coding||intron_variant|||||||NM_001858.6:c.1080+3783C>A||MODIFIER||||||COL19A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	70,92:162:0.5679
chr6	70215726	.	G	A	.	PASS	CSQ=1297|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||COL9A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	96,69:165:0.4182
chr6	70279803	.	A	T	.	PASS	CSQ=1297|protein_coding||intron_variant|||||||NM_001851.4:c.975+1009T>A||MODIFIER||||||COL9A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	115,78:193:0.4041
chr6	70301165	.	G	A	.	PASS	CSQ=1297|protein_coding||intron_variant|||||||NM_001851.4:c.89-779C>T||MODIFIER||||||COL9A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	73,80:153:0.5229
chr6	70466249	.	C	G	.	PASS	CSQ=57579|protein_coding||intron_variant|||||||NM_001351607.1:c.158-9161C>G||MODIFIER||||||FAM135A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	98,85:183:0.4645
chr6	70466362	.	C	T	.	PASS	CSQ=57579|protein_coding||intron_variant|||||||NM_001351607.1:c.158-9048C>T||MODIFIER||||||FAM135A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	95,75:170:0.4412
chr6	70661902	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	170,69:239:0.2887
chr6	70675852	.	C	A	.	PASS	CSQ=60682|protein_coding||intron_variant|||||||NM_001044305.2:c.118+7711C>A||MODIFIER||||||SMAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	145,74:219:0.3379
chr6	70680401	.	A	G	.	PASS	CSQ=60682|protein_coding||intron_variant|||||||NM_001044305.2:c.118+12260A>G||MODIFIER||||||SMAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	165,96:261:0.3678
chr6	71098547	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	83,77:160:0.4813
chr6	71677029	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1445283545||6.57765e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	88,84:173:0.4855
chr6	72017822	.	C	T	.	PASS	CSQ=22999|protein_coding||intron_variant|||||||NM_014989.5:c.245+48759C>T||MODIFIER||||||RIMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	84,73:157:0.465
chr6	72017943	.	C	G	.	PASS	CSQ=22999|protein_coding||intron_variant|||||||NM_014989.5:c.245+48880C>G||MODIFIER||||||RIMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	87,71:158:0.4494
chr6	72017960	.	C	T	.	PASS	CSQ=22999|protein_coding||intron_variant|||||||NM_014989.5:c.245+48897C>T||MODIFIER||||||RIMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	85,69:154:0.4481
chr6	72018261	.	C	T	.	PASS	CSQ=22999|protein_coding||intron_variant|||||||NM_014989.5:c.245+49198C>T||MODIFIER||||||RIMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	71,49:120:0.4083
chr6	72018298	.	C	G	.	PASS	CSQ=22999|protein_coding||intron_variant||||rs1196125576|||NM_014989.5:c.245+49235C>G||MODIFIER||||||RIMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	138,0:138:0	64,39:103:0.3786
chr6	72081811	.	A	C	.	PASS	CSQ=22999|protein_coding||intron_variant|||||||NM_014989.5:c.246-15138A>C||MODIFIER||||||RIMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,69:69:1
chr6	72397103	.	AAGAGTAAATAGAAAGCTGAAAAAACCTGAGTAGAACTATAACTACCAGTATTTAACATTCTACTTACCAAAAAATGGGGAGAATACACCC	A	.	PASS	CSQ=22999|protein_coding||intron_variant|||||||NM_014989.5:c.4619-1142_4619-1053del||MODIFIER||||||RIMS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=mantaSV	AD:DP:AF	172,1:173:0.006185	101,9:110:0.07
chr6	72571247	.	C	CTT	.	PASS	CSQ=|||intergenic_variant||||rs1189365961||0.000643614|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	47,3:50:0.06	0,4:4:1
chr6	72882009	COSV59664261;COSV59664261;COSV59664261;COSV59664261;COSV59664261;COSV59664261;COSV59664261;COSV59664261;COSV59664261;COSV59664261	G	C	.	PASS	CSQ=56479|protein_coding||intron_variant|COSV59664261&COSV59664261&COSV59664261&COSV59664261&COSV59664261&COSV59664261&COSV59664261&COSV59664261&COSV59664261&COSV59664261|p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?|||||NM_019842.3:c.399-121899G>C||MODIFIER||||||KCNQ5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,94:94:1
chr6	73441034	.	G	A	.	PASS	CSQ=115004|protein_coding||intron_variant|||||||NM_138441.3:c.878-589C>T||MODIFIER||||||CGAS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,81:81:1
chr6	73581281	.	GTATTTGTTTTT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,75:75:1
chr6	73734316	.	C	A	.	PASS	CSQ=135228|protein_coding||intron_variant||||rs553491882||0.000591343|NM_133493.5:c.508-2067C>A||MODIFIER||||||CD109|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:136:0	0,95:95:1
chr6	74123933	.	C	G	.	PASS	CSQ=101928516|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110856.1:n.138+54345C>G||MODIFIER||||||LOC101928516|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,77:77:1
chr6	74139832	.	T	C	.	PASS	CSQ=101928516|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110856.1:n.138+70244T>C||MODIFIER||||||LOC101928516|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	4,104:108:0.963
chr6	74308853	.	A	T	.	PASS	CSQ=101928516|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110856.1:n.139-38222A>T||MODIFIER||||||LOC101928516|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,74:74:1
chr6	74491433	.	C	G	.	PASS	CSQ=101928516|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110856.1:n.193+144304C>G||MODIFIER||||||LOC101928516|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,92:92:1
chr6	75007345	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,77:77:1
chr6	75019152	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	68,14:82:0.1707
chr6	75170355	.	A	G	.	PASS	CSQ=1303|protein_coding||intron_variant|||||||NM_004370.6:c.2711-4576T>C||MODIFIER||||||COL12A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,78:78:1
chr6	75430116	.	G	A	.	PASS	CSQ=101928540|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125859.1:n.208+14920G>A||MODIFIER||||||LOC101928540|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:106:0.0094	0,79:79:1
chr6	77262297	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,70:70:1
chr6	77578459	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,61:61:1
chr6	77735485	.	C	T	.	PASS	CSQ=101928601|protein_coding||intron_variant|||||||NM_001322247.1:c.233-25645C>T||MODIFIER||||||MEI4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,64:64:1
chr6	78450526	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	36,46:82:0.561
chr6	78616102	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,85:85:1
chr6	79722076	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	0,73:73:1
chr6	80905567	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	63,10:73:0.137
chr6	81243578	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,79:79:1
chr6	82477894	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,95:95:1
chr6	82605353	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,64:64:1
chr6	82618201	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1331385259|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,62:62:1
chr6	82735362	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1008328384||5.91553e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:127:0	0,86:86:1
chr6	83294438	.	T	C	.	PASS	CSQ=4199|protein_coding||intron_variant|||||||NM_002395.6:c.704+20872A>G||MODIFIER||||||ME1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	0,70:70:1
chr6	84128163	.	C	A	.	PASS	CSQ=22832|protein_coding||intron_variant|||||||NM_014895.4:c.3871-1651G>T||MODIFIER||||||CEP162|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,84:84:1
chr6	84312826	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	0,84:84:1
chr6	84385727	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs563604557||0.0135815|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	3,71:74:0.9595
chr6	84563740	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	8,69:77:0.8961
chr6	84700760	.	G	C	.	PASS	CSQ=102724201|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125875.1:n.337+5652G>C||MODIFIER||||||TBX18-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	60,8:68:0.1176
chr6	84998406	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,82:82:1
chr6	85150019	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,75:75:1
chr6	85260615	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,72:72:1
chr6	85277465	.	G	GC	.	PASS	CSQ=|||intergenic_variant||||rs1480120447||9.87011e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	7,60:67:0.8955
chr6	85697593	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,86:86:1
chr6	86188070	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	42,45:87:0.5172
chr6	86336728	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,72:72:1
chr6	87003629	.	C	A	.	PASS	CSQ=3354|protein_coding||intron_variant|||||||NM_000865.3:c.-185-11521C>A||MODIFIER||||||HTR1E|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	74,8:82:0.0976
chr6	87691342	.	G	A	.	PASS	CSQ=55122|protein_coding||intron_variant|||||||NM_018064.4:c.236-9579C>T||MODIFIER||||||AKIRIN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,65:65:1
chr6	87868612	.	C	G	.	PASS	CSQ=101928911|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110869.1:n.261-41170C>G||MODIFIER||||||LOC101928911|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,85:85:1
chr6	88085053	COSV69754170	T	A	.	PASS	CSQ=|||intergenic_variant|||COSV69754170||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,66:66:1
chr6	88444210	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,88:88:1
chr6	88516142	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs886613502||8.54487e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,81:81:1
chr6	89488618	.	A	T	.	PASS	CSQ=22881|protein_coding||intron_variant|||||||NM_001242809.2:c.-144+55243A>T||MODIFIER||||||ANKRD6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,91:91:1
chr6	89812279	.	C	A	.	PASS	CSQ=23195|protein_coding||intron_variant|||||||NM_014611.3:c.102+7227G>T||MODIFIER||||||MDN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,97:97:1
chr6	89875701	.	G	C	.	PASS	CSQ=9994|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CASP8AP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,76:76:1
chr6	90007409	.	C	T	.	PASS	CSQ=60468|protein_coding||intron_variant|||||||NM_021813.4:c.243+1193G>A||MODIFIER||||||BACH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,80:80:1
chr6	90322881	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||||1.31961e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	2,83:85:0.9765
chr6	90424010	.	A	AATTTTATTT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	85,79:164:0.4817
chr6	90424049	.	GT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	95,88:183:0.4809
chr6	90424443	.	C	CATCTGTAT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	101,56:157:0.3567
chr6	90808620	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||1.31541e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,78:78:1
chr6	90838914	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	111,0:111:0	91,4:95:0.0421
chr6	91016917	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,69:69:1
chr6	91329203	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,83:83:1
chr6	91973318	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,62:62:1
chr6	92147200	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	4,67:71:0.9437
chr6	92483436	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,79:79:1
chr6	92521048	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,58:58:1
chr6	92681320	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.58545e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	66,10:76:0.1316
chr6	92684651	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	69,13:82:0.1585
chr6	92732077	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,61:61:1
chr6	92858567	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1343790856|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,76:76:1
chr6	93769936	.	C	T	.	PASS	CSQ=643432|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_015362.2:n.4453+1720C>T||MODIFIER||||||TSG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,56:56:1
chr6	93801488	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,58:58:1
chr6	93944022	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	75,4:79:0.0506
chr6	94571893	.	T	A	.	PASS	CSQ=|||intergenic_variant||||||1.31829e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	39,36:75:0.48
chr6	94806858	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs564828394||5.92807e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,67:67:1
chr6	95173976	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,70:70:1
chr6	95324589	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	88,4:92:0.0435
chr6	95548209	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,68:68:1
chr6	95690760	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,75:75:1
chr6	96296582	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,65:65:1
chr6	96512477	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,75:75:1
chr6	96848627	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,71:71:1
chr6	97284656	.	C	CA	.	PASS	CSQ=253714|protein_coding||upstream_gene_variant||||rs1026936274||1.98468e-05|||MODIFIER||||||MMS22L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	7,58:65:0.8923
chr6	97356420	.	C	T	.	PASS	CSQ=101927314|lncRNA||intron_variant&non_coding_transcript_variant||||rs910919655||1.3153e-05|NR_110757.1:n.511+50324C>T||MODIFIER||||||LOC101927314|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	72,15:87:0.1724
chr6	97762749	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,75:75:1
chr6	97903369	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	0,62:62:1
chr6	98277475	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,56:56:1
chr6	98424724	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,64:64:1
chr6	98474499	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1303368808||6.59413e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	0,91:91:1
chr6	99110245	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	54,18:72:0.25
chr6	99178606	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,64:64:1
chr6	99746157	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,159:159:1
chr6	100655631	.	C	G	.	PASS	CSQ=10973|protein_coding||intron_variant|||||||NM_006828.4:c.2823+68G>C||MODIFIER||||||ASCC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	75,0:75:0	0,89:89:1
chr6	101075858	.	A	C	.	PASS	CSQ=|||intergenic_variant||||rs200162744||0.00382162|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	9,54:63:0.8571
chr6	101464367	.	C	CAT	.	PASS	CSQ=2898|protein_coding||intron_variant|||||||NM_021956.4:c.115+64978_115+64979dup||MODIFIER||||||GRIK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	8,68:76:0.8947
chr6	101510220	.	T	C	.	PASS	CSQ=2898|protein_coding||intron_variant|||||||NM_021956.4:c.115+110828T>C||MODIFIER||||||GRIK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,66:66:1
chr6	101574430	.	T	A	.	PASS	CSQ=2898|protein_coding||intron_variant|||||||NM_021956.4:c.116-47519T>A||MODIFIER||||||GRIK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,1:117:0.0085	0,84:84:1
chr6	101790864	.	G	A	.	PASS	CSQ=2898|protein_coding||intron_variant|||||||NM_021956.4:c.952-8784G>A||MODIFIER||||||GRIK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	5,70:75:0.9333
chr6	101874670	.	C	T	.	PASS	CSQ=2898|protein_coding||intron_variant|||||||NM_021956.4:c.1525-14970C>T||MODIFIER||||||GRIK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,60:60:1
chr6	102114301	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs577928393||7.2439e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,80:80:1
chr6	102169645	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs556788228||0.00372|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	102,0:102:0	10,55:65:0.8462
chr6	102326925	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,39:39:1
chr6	102385422	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:135:0	0,80:80:1
chr6	102525821	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,81:81:1
chr6	102690602	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	3,60:63:0.9524
chr6	103169679	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,82:82:1
chr6	103185791	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.60083e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	0,71:71:1
chr6	103405387	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1243609943|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,78:78:1
chr6	103846580	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1483611454||1.97151e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	0,81:81:1
chr6	103948429	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs558901879||1.97275e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,65:65:1
chr6	103999482	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,73:73:1
chr6	104070844	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,71:71:1
chr6	104461560	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,91:91:1
chr6	104662360	.	GAAAAGAAATAACCAAGGCCAGAGCAGAATTAAATGA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,72:72:1
chr6	104695813	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,86:86:1
chr6	105010192	.	C	CA	.	PASS	CSQ=389421|protein_coding||intron_variant||||rs1328721509||0.0096795|NM_001004317.4:c.199-16095dup||MODIFIER||||||LIN28B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	101,0:101:0	8,60:68:0.8824
chr6	105944401	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	81,23:104:0.2212
chr6	106361540	.	CG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	3,69:72:0.9583
chr6	107473681	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	70,13:83:0.1566
chr6	107473778	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	64,10:74:0.1351
chr6	107689844	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,80:80:1
chr6	109771373	.	TA	T	.	PASS	CSQ=9896|protein_coding||intron_variant|||||||NM_014845.5:c.1750+4482del||MODIFIER||||||FIG4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	3,75:78:0.9615
chr6	110035527	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,80:80:1
chr6	110568704	.	CTGTCACCTAGGTTGGAG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	188,0:188:0	0,101:101:1
chr6	111058965	.	CTCTATTACCCAGGCTA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,85:85:1
chr6	112380422	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,86:86:1
chr6	113135588	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	70,13:83:0.1566
chr6	113430726	.	A	AT	.	PASS	CSQ=105377957|lncRNA||intron_variant&non_coding_transcript_variant||||rs983529354||0.000311036|NR_149098.1:n.112-1749dup||MODIFIER||||||LINC02518|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	7,77:84:0.9167
chr6	113950806	.	G	A	.	PASS	CSQ=3066|protein_coding||intron_variant|||||||NM_001527.4:c.640-1546C>T||MODIFIER||||||HDAC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	0,72:72:1
chr6	114482875	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,96:96:1
chr6	114739564	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,85:85:1
chr6	115249274	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1361542649||6.57203e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	72,14:87:0.1609
chr6	115599919	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	1,70:71:0.9859
chr6	115635484	.	T	C	.	PASS	CSQ=105377962|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_134602.1:n.74+738A>G||MODIFIER||||||LINC02534|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	42,28:70:0.4
chr6	117285980	.	G	C	.	PASS	CSQ=6098|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ROS1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ROS1|y|n|glioblastoma,NSCLC,Spitzoid_tumour,cholangiocarcinoma,borderline_ovarian|||O,E|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,86:86:1
chr6	117343098	.	T	A	.	PASS	CSQ=6098|protein_coding||intron_variant|||||||NM_002944.2:c.4525-554A>T||MODIFIER||||||ROS1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ROS1|y|n|glioblastoma,NSCLC,Spitzoid_tumour,cholangiocarcinoma,borderline_ovarian|||O,E|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	1,90:91:0.989
chr6	118221887	.	G	T	.	PASS	CSQ=222553|protein_coding||intron_variant|||||||NM_001029858.4:c.350-13622G>T||MODIFIER||||||SLC35F1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,57:57:1
chr6	119607221	.	G	T	.	PASS	CSQ=105377975|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_134600.1:n.252+56826G>T||MODIFIER||||||LOC105377975|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,78:78:1
chr6	120373911	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,70:70:1
chr6	120736085	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs950419598||0.000164368|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	3,80:83:0.9639
chr6	121082428	.	C	T	.	PASS	CSQ=221322|protein_coding||intron_variant|||||||NM_152730.6:c.3655-1538G>A||MODIFIER||||||TBC1D32|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	0,83:83:1
chr6	121520405	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,72:72:1
chr6	121587331	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,82:82:1
chr6	121761327	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1021743808||1.3261e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,86:86:1
chr6	122009285	COSV61970693	G	GT	.	PASS	CSQ=|||intergenic_variant|||COSV61970693|rs370220906||0.0244667|||MODIFIER||||||||0.0286;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	11,73:84:0.869
chr6	122051801	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,88:88:1
chr6	122072202	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	112,0:112:0	75,4:79:0.0506
chr6	122254222	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	10,66:76:0.8684
chr6	122507066	.	T	G	.	PASS	CSQ=5570|protein_coding||intron_variant||||rs1177823262|||NM_001270394.1:c.-288+29127T>G||MODIFIER||||||PKIB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,91:91:1
chr6	122507164	.	G	T	.	PASS	CSQ=5570|protein_coding||intron_variant|||||||NM_001270394.1:c.-288+29225G>T||MODIFIER||||||PKIB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,68:68:1
chr6	122587785	.	G	A	.	PASS	CSQ=5570|protein_coding||intron_variant||||||6.5716e-06|NM_001270394.1:c.-201+1778G>A||MODIFIER||||||PKIB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,92:92:1
chr6	122774853	.	C	G	.	PASS	CSQ=2173|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||FABP7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,68:69:0.9855
chr6	122839477	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,62:62:1
chr6	123758034	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs929208758||1.32626e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	8,63:71:0.8873
chr6	123775108	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,66:66:1
chr6	123900315	.	C	CA	.	PASS	CSQ=154215|protein_coding||intron_variant|||||||NM_001040214.2:c.54+96067dup||MODIFIER||||||NKAIN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	6,43:49:0.8776
chr6	123972909	.	G	A	.	PASS	CSQ=154215|protein_coding||intron_variant|||||||NM_001040214.2:c.54+168655G>A||MODIFIER||||||NKAIN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,76:76:1
chr6	124217403	.	T	G	.	PASS	CSQ=154215|protein_coding||intron_variant|||||||NM_001040214.2:c.55-65602T>G||MODIFIER||||||NKAIN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,73:73:1
chr6	125374329	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	110,0:110:0	0,69:69:1
chr6	125976878	.	A	T	.	PASS	CSQ=135114|protein_coding||intron_variant|||||||NM_138571.5:c.517-766A>T||MODIFIER||||||HINT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,83:83:1
chr6	126134575	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	48,40:88:0.4545
chr6	126192026	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,87:87:1
chr6	126303546	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,1:126:0.0079	0,73:73:1
chr6	126330668	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,86:86:1
chr6	126590237	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1016175398||0.000786761|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	11,62:73:0.8493
chr6	126740966	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1455105959|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:99:0	63,14:77:0.1818
chr6	127062785	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,90:90:1
chr6	127188730	.	TG	CT	.	PASS	CSQ=84870|protein_coding||intron_variant|||||||NM_032784.5:c.635-7093_635-7092delinsCT||MODIFIER||||||RSPO3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RSPO3|y|n|colorectal|||E|Dom|oncogene,fusion|T;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	123,0:123:0	0,76:76:1
chr6	127526322	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,64:64:1
chr6	127811057	COSV64069496;COSV64069496;COSV64069496;COSV64069496;COSV64069496;COSV64069496	CA	C	.	PASS	CSQ=387357|protein_coding||intron_variant|COSV64069496&COSV64069496&COSV64069496&COSV64069496&COSV64069496|p.?&p.?&p.?&p.?&p.?|COSV64069496|rs535405635||8.57169e-05|NM_001010923.2:c.1758+1825del||MODIFIER||||||THEMIS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	3,68:71:0.9577
chr6	128161539	.	C	G	.	PASS	CSQ=5796|protein_coding||intron_variant||||rs766613616||3.95794e-05|NM_002844.3:c.1162+22893G>C||MODIFIER||||||PTPRK|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRK|y|n|colorectal|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,69:69:1
chr6	128423590	.	G	A	.	PASS	CSQ=5796|protein_coding||intron_variant|||||||NM_002844.3:c.101-25902C>T||MODIFIER||||||PTPRK|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRK|y|n|colorectal|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	76,12:88:0.1364
chr6	128618587	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,70:70:1
chr6	128667303	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs546187803||3.28839e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	62,11:73:0.1507
chr6	129367010	.	G	A	.	PASS	CSQ=3908|protein_coding||intron_variant|||||||NM_000426.3:c.4860+649G>A||MODIFIER||||||LAMA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	0,72:72:1
chr6	129367012	.	TC	T	.	PASS	CSQ=3908|protein_coding||intron_variant|||||||NM_000426.3:c.4860+653del||MODIFIER||||||LAMA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,70:70:1
chr6	130077447	.	C	T	.	PASS	CSQ=84456|protein_coding||intron_variant|||||||NM_032438.3:c.1245-1111C>T||MODIFIER||||||L3MBTL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	128,0:128:0	0,88:88:1
chr6	130666975	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,86:86:1
chr6	130671171	.	C	CAA	.	PASS	CSQ=|||intergenic_variant||||rs11427710||0.00693485|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	56,0:100:0	11,55:66:0.8333
chr6	131362755	.	CA	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	103,0:103:0	0,72:72:1
chr6	131454726	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,85:85:1
chr6	131532554	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs994515795||0.000373145|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	8,75:84:0.8929
chr6	131676176	.	C	T	.	PASS	CSQ=5169|protein_coding||intron_variant|||||||NM_005021.5:c.873-560C>T||MODIFIER||||||ENPP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,75:75:1
chr6	131824571	.	C	T	.	PASS	CSQ=5167|protein_coding||intron_variant|||||||NM_006208.3:c.240+16296C>T||MODIFIER||||||ENPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,86:86:1
chr6	131844303	.	C	T	.	PASS	CSQ=5167|protein_coding||intron_variant|||||||NM_006208.3:c.241-3473C>T||MODIFIER||||||ENPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,91:91:1
chr6	132359654	.	T	G	.	PASS	CSQ=26002|protein_coding||intron_variant|||||||NM_015529.4:c.663+12954A>C||MODIFIER||||||MOXD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,88:88:1
chr6	134207085	.	G	A	.	PASS	CSQ=6446|protein_coding||intron_variant|||||||NM_001143676.1:c.361+271C>T||MODIFIER||||||SGK1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/SGK1|y|n|Nodular_lymphocyte_predominant_Hodgkin_lymphoma|||L||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,73:73:1
chr6	134429144	.	C	CT	.	PASS	CSQ=101928231|lncRNA||non_coding_transcript_exon_variant||||rs1285272241||0.000172094|NR_125852.1:n.1073dup||MODIFIER||||||LOC101928231|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	124,0:124:0	10,66:76:0.8684
chr6	135553525	.	C	T	.	PASS	CSQ=100131814|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_152842.1:n.314+55008C>T||MODIFIER||||||LINC00271|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,91:91:1
chr6	135802326	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,90:90:1
chr6	136168650	.	G	T	.	PASS	CSQ=27115|protein_coding||intron_variant|||||||NM_018945.4:c.712-5147G>T||MODIFIER||||||PDE7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,93:93:1
chr6	136555476	.	G	C	.	PASS	CSQ=4217|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MAP3K5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,82:82:1
chr6	139353663	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,79:79:1
chr6	139529193	COSV69114001	T	A	.	PASS	CSQ=|||intergenic_variant|||COSV69114001||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,81:81:1
chr6	139825020	.	C	T	.	PASS	CSQ=100132735|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038399.2:n.52-31744C>T||MODIFIER||||||FILNC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,71:71:1
chr6	139902276	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,73:73:1
chr6	140565003	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,71:71:1
chr6	140808516	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,79:79:1
chr6	140991898	.	GGCAAAA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,83:83:1
chr6	141509238	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,1:111:0.009	0,55:55:1
chr6	141797988	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1042741438|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	72,7:79:0.0886
chr6	142247656	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs563285738||0.00417634|||MODIFIER||||||||0.0054;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	4,74:79:0.9367
chr6	142322116	.	G	A	.	PASS	CSQ=57211|protein_coding||intron_variant|||||||NM_198569.2:c.103+12472G>A||MODIFIER||||||ADGRG6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,93:93:1
chr6	142719969	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,74:74:1
chr6	142807577	.	C	T	.	PASS	CSQ=3097|protein_coding||intron_variant|||||||NM_006734.4:c.-527-23962G>A||MODIFIER||||||HIVEP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,96:96:1
chr6	142996049	.	G	C	.	PASS	CSQ=100507489|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038987.1:n.882+25617C>G||MODIFIER||||||LINC01277|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,86:86:1
chr6	143747516	.	G	A	.	PASS	CSQ=9749|protein_coding||intron_variant|||||||NM_014721.2:c.182-1469G>A||MODIFIER||||||PHACTR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,84:84:1
chr6	144837392	.	C	T	.	PASS	CSQ=7402|protein_coding||intron_variant|||||||NM_007124.2:c.10065+851C>T||MODIFIER||||||UTRN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	3,84:87:0.9655
chr6	145058457	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	0,95:95:1
chr6	145077401	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,1:117:0.0085	0,79:79:1
chr6	146002698	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	0,74:74:1
chr6	146297825	.	T	C	.	PASS	CSQ=2911|protein_coding||intron_variant|||||||NM_001278064.2:c.951-6786T>C||MODIFIER||||||GRM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,84:84:1
chr6	147769243	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	7,66:73:0.9041
chr6	149132367	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,88:88:1
chr6	149536077	.	AC	A	.	PASS	CSQ=85313|protein_coding||intron_variant|||||||NM_139126.3:c.322-340del||MODIFIER||||||PPIL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	1,98:99:0.9899
chr6	150170956	.	G	C	.	PASS	CSQ=81706|protein_coding||intron_variant|||||||NM_030949.3:c.306+27458G>C||MODIFIER||||||PPP1R14C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,86:86:1
chr6	150231925	.	G	A	.	PASS	CSQ=81706|protein_coding||intron_variant|||||||NM_030949.3:c.423+15069G>A||MODIFIER||||||PPP1R14C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,91:91:1
chr6	150246407	.	C	A	.	PASS	CSQ=81706|protein_coding||intron_variant|||||||NM_030949.3:c.424-2339C>A||MODIFIER||||||PPP1R14C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,100:100:1
chr6	150821444	.	GA	G	.	PASS	CSQ=57480|protein_coding||intron_variant|||||||NM_001029884.2:c.1447+212del||MODIFIER||||||PLEKHG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	4,84:88:0.9545
chr6	150860859	.	T	C	.	PASS	CSQ=25902|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MTHFD1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	0,92:92:1
chr6	151055304	.	C	T	.	PASS	CSQ=25902|protein_coding||intron_variant||||rs894963377||1.97324e-05|NM_015440.4:c.2847+18187C>T||MODIFIER||||||MTHFD1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	30,40:70:0.5714
chr6	152851067	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,70:70:1
chr6	153065003	.	C	T	.	PASS	CSQ=26575|protein_coding||intron_variant|||||||NM_012419.5:c.-25-20960G>A||MODIFIER||||||RGS17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,61:61:1
chr6	153227433	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,77:77:1
chr6	153993385	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,64:64:1
chr6	154144732	.	G	C	.	PASS	CSQ=4988|protein_coding||intron_variant||||rs1190729015|||NM_001008503.2:c.1164+53260G>C||MODIFIER||||||OPRM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	0,44:45:0.9778
chr6	154333239	.	G	A	.	PASS	CSQ=26034|protein_coding||intron_variant|||||||NM_015553.2:c.-62+23433C>T||MODIFIER||||||IPCEF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	72,7:79:0.0886
chr6	154380332	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,98:98:1
chr6	156117388	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	40,34:74:0.4595
chr6	156221272	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,78:78:1
chr6	156232188	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	38,29:67:0.4328
chr6	156506629	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,89:89:1
chr6	156629437	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1407647541||6.58519e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,84:84:1
chr6	156826125	.	A	C	.	PASS	CSQ=57492|protein_coding||intron_variant|||||||NM_001346813.1:c.1543-3102A>C||MODIFIER||||||ARID1B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ARID1B|y|n|breast,hepatocellular_carcinoma,clear_cell_ovarian_carcinoma|||E|Rec|TSG|Mis,F,N,O;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,56:56:1
chr6	157966817	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,85:85:1
chr6	158093463	.	A	C	.	PASS	CSQ=8871|protein_coding||intron_variant|||||||NM_003898.4:c.3744+359A>C||MODIFIER||||||SYNJ2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	118,0:118:0	11,65:76:0.8553
chr6	158781290	.	G	A	.	PASS	CSQ=7430|protein_coding||intron_variant|||||||NM_001111077.2:c.698+2230C>T||MODIFIER||||||EZR|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/EZR|y|n|NSCLC|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,88:88:1
chr6	159546595	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	69,0:69:0	1,50:51:0.9804
chr6	160000758	.	C	A	.	PASS	CSQ=100271873|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||AIRN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	62,1:63:0.0159	0,54:54:1
chr6	160443691	.	C	T	.	PASS	CSQ=6581|protein_coding||synonymous_variant||||COSM3430316|||NM_021977.4:c.1459C>T|NP_068812.1:p.Leu487=|LOW||||||SLC22A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	131,0:131:0	68,10:79:0.1266
chr6	160702495	.	G	C	.	PASS	CSQ=5340|protein_coding||intron_variant|||||||NM_000301.3:c.49+142G>C||MODIFIER||||||PLG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,70:70:1
chr6	160916102	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs368579231||7.98063e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	2,84:86:0.9767
chr6	161545381	.	T	C	.	PASS	CSQ=5071|protein_coding||intron_variant|||||||NM_004562.3:c.1083+3473A>G||MODIFIER||||||PRKN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	0,75:75:1
chr6	161580669	.	G	A	.	PASS	CSQ=5071|protein_coding||intron_variant|||||||NM_004562.3:c.872-11253C>T||MODIFIER||||||PRKN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,56:56:1
chr6	161822673	.	C	CA	.	PASS	CSQ=5071|protein_coding||intron_variant||||rs527779952||0.00303541|NM_004562.3:c.735-36766dup||MODIFIER||||||PRKN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,1:130:0.0077	15,62:77:0.8052
chr6	162131054	.	C	T	.	PASS	CSQ=5071|protein_coding||intron_variant|||||||NM_004562.3:c.534+70077G>A||MODIFIER||||||PRKN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,79:79:1
chr6	162838514	.	G	A	.	PASS	CSQ=135138|protein_coding||intron_variant|||||||NM_001080379.1:c.291+24233G>A||MODIFIER||||||PACRG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,68:68:1
chr6	163176829	.	A	G	.	PASS	CSQ=729658|lncRNA||downstream_gene_variant||||rs1327773588||1.97062e-05|||MODIFIER||||||PACRG-AS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,83:83:1
chr6	163248696	.	T	C	.	PASS	CSQ=135138|protein_coding||intron_variant|||||||NM_001080379.1:c.614-66131T>C||MODIFIER||||||PACRG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	86,4:90:0.0444
chr6	163364577	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,88:88:1
chr6	164865394	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	0,59:59:1
chr6	165053303	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,57:57:1
chr6	165632620	.	C	CA	.	PASS	CSQ=10846|protein_coding||intron_variant|||||||NM_006661.3:c.-92+29326dup||MODIFIER||||||PDE10A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	8,83:91:0.9121
chr6	166136943	COSV51248275	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV51248275|rs963565711||1.9735e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,73:73:1
chr6	166158932	.	G	A	.	PASS	CSQ=6862|protein_coding||intron_variant|||||||NM_001366285.1:c.1038-344C>T||MODIFIER||||||TBXT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,77:77:1
chr6	166582211	.	G	A	.	PASS	CSQ=6196|protein_coding||intron_variant||||rs1410701362||6.57402e-06|NM_021135.6:c.100-43427C>T||MODIFIER||||||RPS6KA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	1,86:87:0.9885
chr6	167109678	.	C	T	.	PASS	CSQ=1235|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CCR6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,72:72:1
chr6	167372137	.	C	A	.	PASS	CSQ=6953|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TCP10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	53,2:55:0.0364	0,2:2:1
chr6	168034401	.	G	A	.	PASS	CSQ=3834|protein_coding||intron_variant|||||||NM_030615.2:c.317+370G>A||MODIFIER||||||KIF25|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,65:65:1
chr6	168103986	.	T	TG	.	PASS	CSQ=|||intergenic_variant||||rs201279433||0.000145617|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,2:131:0.0153	7,55:63:0.873
chr6	168245672	.	T	C	.	PASS	CSQ=101929420|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110870.1:n.138+2597T>C||MODIFIER||||||LOC101929420|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	0,110:110:1
chr6	168545382	.	C	T	.	PASS	CSQ=64094|protein_coding||intron_variant|||||||NM_001166412.1:c.511+1710C>T||MODIFIER||||||SMOC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	66,20:86:0.2326
chr6	168836043	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,78:78:1
chr6	169733478	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,91:91:1
chr6	169900047	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,74:74:1
chr6	170739078	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	81,0:81:0	79,49:128:0.3828
chr7	377791	.	G	A	.	PASS	CSQ=442497|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC442497|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	68,81:149:0.5436
chr7	792568	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	88,87:175:0.4971
chr7	1307896	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,1:125:0.008	85,94:179:0.5251
chr7	1318750	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	76,90:166:0.5422
chr7	1439381	.	T	C	.	PASS	CSQ=79778|protein_coding||intron_variant|||||||NM_182924.4:c.1967-386A>G||MODIFIER||||||MICALL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	174,0:174:0	98,97:195:0.4974
chr7	1568053	.	C	A	.	PASS	CSQ=114796|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||PSMG3-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	72,60:132:0.4545
chr7	1586589	.	G	A	.	PASS	CSQ=114796|lncRNA||intron_variant&non_coding_transcript_variant||||||1.97057e-05|NR_021487.2:n.2054+972G>A||MODIFIER||||||PSMG3-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	160,0:160:0	100,104:204:0.5098
chr7	1827164	.	G	C	.	PASS	CSQ=8379|protein_coding||intron_variant|||||||NM_001013836.1:c.1999-10936C>G||MODIFIER||||||MAD1L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	90,87:177:0.4915
chr7	2164004	.	G	C	.	PASS	CSQ=8379|protein_coding||intron_variant||||rs750291442||6.57687e-06|NM_001013836.1:c.987-14766C>G||MODIFIER||||||MAD1L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	72,51:123:0.4146
chr7	2625090	.	TC	CG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	119,0:119:0	98,110:208:0.5288
chr7	2783654	.	A	T	.	PASS	CSQ=2768|protein_coding||intron_variant|||||||NM_007353.3:c.525+11274T>A||MODIFIER||||||GNA12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	65,0:65:0	27,78:105:0.7429
chr7	3008682	.	G	A	.	PASS	CSQ=84433|protein_coding||intron_variant|||||||NM_001324281.1:c.-186-28102C>T||MODIFIER||||||CARD11|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/CARD11|y|n|DLBCL|||L|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	59,0:59:0	41,30:71:0.4225
chr7	3642589	.	G	T	.	PASS	CSQ=221935|protein_coding||intron_variant|||||||NM_152744.4:c.713+484G>T||MODIFIER||||||SDK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	69,76:145:0.5241
chr7	3915833	.	A	G	.	PASS	CSQ=221935|protein_coding||intron_variant|||||||NM_152744.4:c.848-35090A>G||MODIFIER||||||SDK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	75,77:152:0.5066
chr7	3990795	.	G	C	.	PASS	CSQ=221935|protein_coding||intron_variant||||rs1442978902||3.28489e-05|NM_152744.4:c.2131+3473G>C||MODIFIER||||||SDK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	87,71:158:0.4494
chr7	4096842	.	C	T	.	PASS	CSQ=221935|protein_coding||intron_variant||||rs969491726|||NM_152744.4:c.3325-13821C>T||MODIFIER||||||SDK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	90,59:149:0.396
chr7	4124090	.	T	C	.	PASS	CSQ=221935|protein_coding||intron_variant||||rs1307316204||6.57073e-06|NM_152744.4:c.3824-3291T>C||MODIFIER||||||SDK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	91,87:178:0.4888
chr7	4147674	.	G	C	.	PASS	CSQ=221935|protein_coding||intron_variant|||||||NM_152744.4:c.4424-1588G>C||MODIFIER||||||SDK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	66,70:136:0.5147
chr7	4224500	.	C	T	.	PASS	CSQ=221935|protein_coding||intron_variant|||||||NM_152744.4:c.5827+3136C>T||MODIFIER||||||SDK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	69,83:153:0.5425
chr7	5068254	.	T	TA	.	PASS	CSQ=57786|protein_coding||3_prime_UTR_variant||||rs898251984||0.000582438|NM_021163.4:c.*2663dup||MODIFIER||||||RBAK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	181,56:238:0.2353
chr7	5429209	.	A	T	.	PASS	CSQ=100129484|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||LOC100129484|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	182,95:277:0.343
chr7	5522868	.	C	CA	.	PASS	CSQ=60|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ACTB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	90,157:247:0.6356
chr7	5599256	.	G	A	.	PASS	CSQ=6624|protein_coding||intron_variant||||rs1364872442||6.57272e-06|NM_003088.4:c.833-4001G>A||MODIFIER||||||FSCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	197,73:270:0.2704
chr7	5600977	.	G	C	.	PASS	CSQ=6624|protein_coding||intron_variant|||||||NM_003088.4:c.833-2280G>C||MODIFIER||||||FSCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	156,65:221:0.2941
chr7	6037318	.	C	G	.	PASS	CSQ=27102|protein_coding||intron_variant|||||||NM_014413.4:c.1332+106G>C||MODIFIER||||||EIF2AK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	97,0:97:0	145,78:223:0.3498
chr7	6338116	.	C	T	.	PASS	CSQ=84792|protein_coding||intron_variant|||||||NM_001037163.2:c.-81-6881G>A||MODIFIER||||||FAM220A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	186,87:273:0.3187
chr7	6338127	.	C	G	.	PASS	CSQ=84792|protein_coding||intron_variant|||||||NM_001037163.2:c.-81-6892G>C||MODIFIER||||||FAM220A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	185,89:274:0.3248
chr7	6403152	.	G	A	.	PASS	CSQ=5879|protein_coding||3_prime_UTR_variant||||rs760010477||1.97257e-05|NM_006908.5:c.*706G>A||MODIFIER||||||RAC1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RAC1|y|n|melanoma,carcinoma|||E|Dom|oncogene|Mis,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	187,83:270:0.3074
chr7	6704315	.	T	TA	.	PASS	CSQ=7559|protein_coding||intron_variant||||rs1369889752||0.00375827|NM_016265.4:c.15+843dup||MODIFIER||||||ZNF12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	173,67:240:0.2792
chr7	6810390	.	C	G	.	PASS	CSQ=221960|protein_coding||intron_variant||||rs905158713|||NM_198097.3:c.954+1562G>C||MODIFIER||||||CCZ1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	184,83:267:0.3109
chr7	6960772	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	146,62:208:0.2981
chr7	7163874	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	145,89:234:0.3803
chr7	7229328	.	G	C	.	PASS	CSQ=56913|protein_coding||intron_variant|||||||NM_020156.4:c.-17-4975G>C||MODIFIER||||||C1GALT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	162,84:246:0.3415
chr7	7538244	.	G	C	.	PASS	CSQ=340267|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||COL28A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	187,87:274:0.3175
chr7	8157393	.	C	T	.	PASS	CSQ=3382|protein_coding||intron_variant||||||6.57134e-06|NM_001136020.3:c.706-179G>A||MODIFIER||||||ICA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	53,83:136:0.6103
chr7	8508300	.	G	T	.	PASS	CSQ=30010|protein_coding||intron_variant|||||||NM_152745.3:c.54+72533G>T||MODIFIER||||||NXPH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	91,77:168:0.4583
chr7	8536286	.	C	T	.	PASS	CSQ=30010|protein_coding||intron_variant||||rs892623386||5.9202e-05|NM_152745.3:c.54+100519C>T||MODIFIER||||||NXPH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	82,86:168:0.5119
chr7	8627399	.	A	C	.	PASS	CSQ=30010|protein_coding||intron_variant|||||||NM_152745.3:c.55-123609A>C||MODIFIER||||||NXPH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	86,72:158:0.4557
chr7	8647325	.	G	C	.	PASS	CSQ=30010|protein_coding||intron_variant|||||||NM_152745.3:c.55-103683G>C||MODIFIER||||||NXPH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	70,55:125:0.44
chr7	9092170	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	77,68:145:0.469
chr7	9164346	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs199531184||0.0717494|||MODIFIER||||||||0.0799;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	80,63:143:0.4406
chr7	9172264	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs974609383||3.29017e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	55,61:116:0.5259
chr7	9172660	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	65,63:128:0.4922
chr7	9188492	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs567268945||0.00030782|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	107,0:107:0	59,74:133:0.5564
chr7	9264033	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:104:0	67,62:129:0.4806
chr7	9436150	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	69,65:134:0.4851
chr7	9508717	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	54,63:117:0.5385
chr7	9517472	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1361080619||6.58363e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	67,66:133:0.4962
chr7	9587386	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	58,70:128:0.5469
chr7	9624156	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	82,62:144:0.4306
chr7	9634732	.	C	CT	.	PASS	CSQ=168741|transcribed_pseudogene||non_coding_transcript_exon_variant||||rs1209285692||3.97388e-05|NR_002790.3:n.472dup||MODIFIER||||||PER4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	107,70:177:0.3955
chr7	9829047	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	78,67:145:0.4621
chr7	9919888	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||||0.0131934|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	66,65:131:0.4962
chr7	10063421	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	79,94:173:0.5434
chr7	10225074	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	82,53:135:0.3926
chr7	10319998	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	68,49:117:0.4188
chr7	10398485	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	76,77:153:0.5033
chr7	10503573	.	C	T	.	PASS	CSQ=79150|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147499.1:n.160-50795G>A||MODIFIER||||||MGC4859|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:108:0	61,65:126:0.5159
chr7	10566230	.	C	A	.	PASS	CSQ=79150|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147499.1:n.64-4653G>T||MODIFIER||||||MGC4859|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	118,4:122:0.0328
chr7	10636509	.	GC	G	.	PASS	CSQ=79150|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147499.1:n.64-74933del||MODIFIER||||||MGC4859|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	135,6:141:0.0426
chr7	10764608	.	C	A	.	PASS	CSQ=79150|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147499.1:n.63+15274G>T||MODIFIER||||||MGC4859|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	65,84:149:0.5638
chr7	10979428	.	G	A	.	PASS	CSQ=9678|protein_coding||intron_variant|||||||NM_001007157.2:c.113-2944G>A||MODIFIER||||||PHF14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	63,73:136:0.5368
chr7	11097175	.	C	T	.	PASS	CSQ=9678|protein_coding||intron_variant|||||||NM_001007157.2:c.2655-14175C>T||MODIFIER||||||PHF14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	74,58:132:0.4394
chr7	11233255	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:125:0	79,86:165:0.5212
chr7	11274930	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	89,82:171:0.4795
chr7	11304856	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	89,80:169:0.4734
chr7	11374738	.	G	A	.	PASS	CSQ=221981|protein_coding||3_prime_UTR_variant|||||||NM_015204.3:c.*1056C>T||MODIFIER||||||THSD7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,0:127:0	63,78:141:0.5532
chr7	11572691	.	G	C	.	PASS	CSQ=221981|protein_coding||intron_variant|||||||NM_015204.3:c.1453+17769C>G||MODIFIER||||||THSD7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	61,58:119:0.4874
chr7	11700547	.	A	G	.	PASS	CSQ=221981|protein_coding||intron_variant|||||||NM_015204.3:c.191-63586T>C||MODIFIER||||||THSD7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	86,74:160:0.4625
chr7	11712633	.	G	A	.	PASS	CSQ=221981|protein_coding||intron_variant|||||||NM_015204.3:c.191-75672C>T||MODIFIER||||||THSD7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	85,74:159:0.4654
chr7	11886261	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	77,92:169:0.5444
chr7	11926563	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	91,70:161:0.4348
chr7	12132182	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	134,7:141:0.0496
chr7	12195655	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	71,83:154:0.539
chr7	12374520	.	C	CA	.	PASS	CSQ=221806|protein_coding||intron_variant||||rs370469427||6.5838e-06|NM_001135924.3:c.1316+168dup||MODIFIER||||||VWDE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	76,75:151:0.4967
chr7	12393011	.	C	T	.	PASS	CSQ=221806|protein_coding||intron_variant||||rs1340253453||1.31496e-05|NM_001135924.3:c.243+583G>A||MODIFIER||||||VWDE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	86,83:169:0.4911
chr7	12426990	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs536631719||1.31394e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	77,64:141:0.4539
chr7	12440934	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	76,67:143:0.4685
chr7	12457346	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs145542457||0.0591415|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	66,49:115:0.4261
chr7	12537813	.	G	C	.	PASS	CSQ=102725191|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_136261.1:n.520-497G>C||MODIFIER||||||LOC102725191|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	68,88:156:0.5641
chr7	12565347	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	158,1:159:0.0063	89,114:203:0.5616
chr7	12878831	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	75,85:160:0.5312
chr7	13015467	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	88,65:154:0.4221
chr7	13087697	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	85,64:149:0.4295
chr7	13186764	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,83:165:0.503
chr7	13662867	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,70:141:0.4965
chr7	13703707	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	78,71:149:0.4765
chr7	13741069	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	93,85:178:0.4775
chr7	14107297	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs529000956||1.327e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	79,65:144:0.4514
chr7	14166985	.	G	A	.	PASS	CSQ=1607|protein_coding||intron_variant||||rs546961054||5.91965e-05|NM_001350708.1:c.2304+9854C>T||MODIFIER||||||DGKB|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	57,77:134:0.5746
chr7	14531705	.	G	A	.	PASS	CSQ=1607|protein_coding||intron_variant|||||||NM_001350708.1:c.1770+42507C>T||MODIFIER||||||DGKB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	71,68:139:0.4892
chr7	14570445	.	A	C	.	PASS	CSQ=1607|protein_coding||intron_variant|||||||NM_001350708.1:c.1770+3767T>G||MODIFIER||||||DGKB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	76,82:158:0.519
chr7	14756334	.	C	T	.	PASS	CSQ=1607|protein_coding||intron_variant|||||||NM_001350708.1:c.147+1321G>A||MODIFIER||||||DGKB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	70,56:126:0.4444
chr7	14803490	.	T	C	.	PASS	CSQ=1607|protein_coding||intron_variant|||||||NM_001350708.1:c.70+37704A>G||MODIFIER||||||DGKB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	94,64:158:0.4051
chr7	14964912	.	C	T	.	PASS	CSQ=1607|protein_coding||intron_variant|||||||NM_001350707.1:c.-188+9784G>A||MODIFIER||||||DGKB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	81,65:146:0.4452
chr7	15087134	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs959938193|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	88,69:157:0.4395
chr7	15404436	.	T	C	.	PASS	CSQ=392636|protein_coding||intron_variant|||||||NM_001004320.2:c.610-10257A>G||MODIFIER||||||AGMO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	80,81:161:0.5031
chr7	15430644	.	A	C	.	PASS	CSQ=392636|protein_coding||intron_variant||||rs73068531||0.202932|NM_001004320.2:c.513+361T>G||MODIFIER||||||AGMO|EntrezGene|0.2592;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	92,18:110:0.1636	78,79:157:0.5032
chr7	15627283	.	A	T	.	PASS	CSQ=4223|protein_coding||intron_variant|||||||NM_005924.5:c.518-365T>A||MODIFIER||||||MEOX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	68,61:129:0.4729
chr7	15720935	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	64,100:164:0.6098
chr7	15980689	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	67,86:153:0.5621
chr7	16109790	.	G	C	.	PASS	CSQ=729920|protein_coding||intron_variant|||||||NM_001101426.4:c.1252-17991C>G||MODIFIER||||||ISPD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	74,80:154:0.5195
chr7	16942595	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	78,89:167:0.5329
chr7	16985368	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	79,60:139:0.4317
chr7	17630881	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1189180468||6.57255e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	110,0:110:0	79,65:144:0.4514
chr7	17630937	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	104,0:104:0	80,68:148:0.4595
chr7	17630964	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	103,0:103:0	78,66:144:0.4583
chr7	17631003	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	82,80:162:0.4938
chr7	17631039	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	111,0:111:0	85,84:169:0.497
chr7	17631058	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1411962219||6.57203e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	110,0:110:0	82,88:170:0.5176
chr7	17685851	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	79,70:149:0.4698
chr7	17690245	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs903975876||1.31709e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	78,75:153:0.4902
chr7	18348772	.	C	T	.	PASS	CSQ=9734|protein_coding||intron_variant|||||||NM_001321868.1:c.26-147490C>T||MODIFIER||||||HDAC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	145,11:156:0.0705
chr7	18817534	COSV67787348;COSV67787348;COSV67787348;COSV67787348	C	T	.	PASS	CSQ=9734|protein_coding||intron_variant|COSV67787348&COSV67787348&COSV67787348&COSV67787348|p.?&p.?&p.?&p.?|||||NM_178425.3:c.2323-11627C>T||MODIFIER||||||HDAC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	89,83:172:0.4826
chr7	18938610	.	TA	T	.	PASS	CSQ=9734|protein_coding||intron_variant||||rs1053395664||0.000125696|NM_178425.3:c.2937+2677del||MODIFIER||||||HDAC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,1:96:0.0104	90,81:171:0.4737
chr7	19261101	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	73,79:152:0.5197
chr7	19387783	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	76,80:156:0.5128
chr7	20347144	.	C	G	.	PASS	CSQ=3696|protein_coding||intron_variant|||||||NM_002214.3:c.127+15211C>G||MODIFIER||||||ITGB8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	83,68:151:0.4503
chr7	21128621	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	73,73:146:0.5
chr7	21323549	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.56892e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	75,100:175:0.5714
chr7	21863495	.	T	G	.	PASS	CSQ=8701|protein_coding||intron_variant|||||||NM_001277115.2:c.11374-1040T>G||MODIFIER||||||DNAH11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	69,81:150:0.54
chr7	22023806	.	AT	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	118,0:119:0	72,85:159:0.5346
chr7	22164607	.	G	A	.	PASS	CSQ=9771|protein_coding||intron_variant|||||||NM_012294.4:c.1284-2066C>T||MODIFIER||||||RAPGEF5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	83,69:152:0.4539
chr7	22384717	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	79,85:165:0.5152
chr7	22547289	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	86,79:165:0.4788
chr7	22656939	.	G	A	.	PASS	CSQ=401312|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_122075.1:n.1025-3525C>T||MODIFIER||||||LOC401312|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	97,69:166:0.4157
chr7	22932731	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	136,38:174:0.2184
chr7	23062996	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs377562569||0.00232348|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,1:88:0.0114	115,69:184:0.375
chr7	24185536	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	98,77:176:0.4375
chr7	24690561	.	T	A	.	PASS	CSQ=51678|protein_coding||3_prime_UTR_variant||||||6.57454e-06|NM_016447.3:c.*2947T>A||MODIFIER||||||MPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	94,88:182:0.4835
chr7	25269733	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	83,80:163:0.4908
chr7	25628601	.	G	T	.	PASS	CSQ=646588|other||intron_variant&non_coding_transcript_variant|||||||NR_157829.1:n.591+29359C>A||MODIFIER||||||LOC646588|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	113,43:156:0.2756
chr7	26044171	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	68,75:143:0.5245
chr7	26145583	.	ACAAGC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	60,57:117:0.4872
chr7	26220670	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	91,84:175:0.48
chr7	26228067	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	90,77:167:0.4611
chr7	26252510	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	97,73:170:0.4294
chr7	26391925	.	C	T	.	PASS	CSQ=105375304|lncRNA||intron_variant&non_coding_transcript_variant||||rs1321482973||5.91397e-05|NR_136272.1:n.78+7416G>A||MODIFIER||||||LOC105375304|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:127:0	84,75:159:0.4717
chr7	26545810	.	C	T	.	PASS	CSQ=441204|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC441204|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	66,90:156:0.5769
chr7	26823491	.	G	C	.	PASS	CSQ=8935|protein_coding||intron_variant|||||||NM_003930.5:c.307+20539C>G||MODIFIER||||||SKAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	72,78:150:0.52
chr7	26823611	.	G	A	.	PASS	CSQ=8935|protein_coding||intron_variant||||rs1222733547|||NM_003930.5:c.307+20419C>T||MODIFIER||||||SKAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:104:0	66,82:148:0.5541
chr7	26957532	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	84,102:186:0.5484
chr7	27284934	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	90,91:181:0.5028
chr7	27458386	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	92,99:191:0.5183
chr7	28026042	.	G	T	.	PASS	CSQ=221895|protein_coding||intron_variant|||||||NM_175061.4:c.116-34061C>A||MODIFIER||||||JAZF1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/JAZF1|y|n|endometrial_stromal_tumour|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,1:115:0.0087	73,82:155:0.529
chr7	28269512	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	69,69:138:0.5
chr7	28667133	.	A	G	.	PASS	CSQ=9586|protein_coding||intron_variant|||||||NM_182898.4:c.465-51620A>G||MODIFIER||||||CREB5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	83,75:158:0.4747
chr7	28796376	.	TACGG	T	.	PASS	CSQ=9586|protein_coding||intron_variant|||||||NM_182898.4:c.703-7820_703-7817del||MODIFIER||||||CREB5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	82,73:155:0.471
chr7	28816622	.	A	C	.	PASS	CSQ=9586|protein_coding||intron_variant|||||||NM_182898.4:c.1255-1449A>C||MODIFIER||||||CREB5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	72,102:174:0.5862
chr7	29283295	.	T	C	.	PASS	CSQ=1124|protein_coding||intron_variant|||||||NM_004067.3:c.50-71330T>C||MODIFIER||||||CHN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	78,75:153:0.4902
chr7	29332600	.	C	G	.	PASS	CSQ=1124|protein_coding||intron_variant|||||||NM_004067.3:c.50-22025C>G||MODIFIER||||||CHN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	78,86:164:0.5244
chr7	29452806	.	C	G	.	PASS	CSQ=1124|protein_coding||intron_variant|||||||NM_004067.3:c.577-27473C>G||MODIFIER||||||CHN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,87:166:0.5241
chr7	29902754	.	T	G	.	PASS	CSQ=644150|protein_coding||intron_variant|||||||NM_001080529.2:c.1352-1532T>G||MODIFIER||||||WIPF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	140,12:152:0.0789
chr7	30107295	.	T	C	.	PASS	CSQ=84725|protein_coding||intron_variant|||||||NM_001197027.1:c.1363-10675T>C||MODIFIER||||||PLEKHA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	148,14:162:0.0864
chr7	30156776	.	G	C	.	PASS	CSQ=222166|protein_coding||intron_variant|||||||NM_152793.3:c.286-662G>C||MODIFIER||||||MTURN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	81,78:159:0.4906
chr7	30293169	.	A	G	.	PASS	CSQ=100500883|miRNA||upstream_gene_variant||||||6.58519e-06|||MODIFIER||||||MIR550B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	74,91:165:0.5515
chr7	30447732	.	T	A	.	PASS	CSQ=10392|protein_coding||intron_variant|||||||NM_006092.4:c.2285+566A>T||MODIFIER||||||NOD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	67,82:149:0.5503
chr7	30879535	.	C	T	.	PASS	CSQ=100526825|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037598.1:n.2501-2646C>T||MODIFIER||||||INMT-MINDY4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	101,86:187:0.4599
chr7	31387694	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	80,77:157:0.4904
chr7	31434734	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	70,71:141:0.5035
chr7	31760312	.	C	T	.	PASS	CSQ=5137|protein_coding||intron_variant|||||||NM_001191057.4:c.1961-6759G>A||MODIFIER||||||PDE1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	144,16:160:0.1
chr7	31761198	.	C	A	.	PASS	CSQ=5137|protein_coding||intron_variant|||||||NM_001191057.4:c.1961-7645G>T||MODIFIER||||||PDE1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	120,9:129:0.0698
chr7	31824547	COSV58512109;COSV58512109;COSV58512109;COSV58512109;COSV58512109;COSV58512109	C	A	.	PASS	CSQ=5137|protein_coding||intron_variant|COSV58512109&COSV58512109&COSV58512109&COSV58512109&COSV58512109|p.?&p.?&p.?&p.?&p.?|COSV58512109||||NM_001191057.4:c.1406+320G>T||MODIFIER||||||PDE1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	107,32:139:0.2302
chr7	32124803	.	T	A	.	PASS	CSQ=5137|protein_coding||intron_variant|||||||NM_001191058.3:c.308+44982A>T||MODIFIER||||||PDE1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	87,72:159:0.4528
chr7	32379102	.	C	T	.	PASS	CSQ=5137|protein_coding||intron_variant|||||||NM_001322059.1:c.310+48720G>A||MODIFIER||||||PDE1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	86,78:164:0.4756
chr7	32416866	.	T	A	.	PASS	CSQ=5137|protein_coding||intron_variant|||||||NM_001322059.1:c.310+10956A>T||MODIFIER||||||PDE1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	58,87:145:0.6
chr7	32831091	.	G	C	.	PASS	CSQ=102724668|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_132360.1:n.296-1917G>C||MODIFIER||||||DPY19L1P2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	75,82:157:0.5223
chr7	33041175	.	C	G	.	PASS	CSQ=51251|protein_coding||intron_variant|||||||NM_001002010.3:c.139-14260G>C||MODIFIER||||||NT5C3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	112,0:112:0	77,93:170:0.5471
chr7	33442963	.	A	T	.	PASS	CSQ=27241|protein_coding||intron_variant|||||||NM_198428.2:c.2115+54819A>T||MODIFIER||||||BBS9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	155,81:236:0.3432
chr7	33479208	.	A	C	.	PASS	CSQ=27241|protein_coding||intron_variant|||||||NM_198428.2:c.2116-26255A>C||MODIFIER||||||BBS9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	85,163:248:0.6573
chr7	33481454	.	G	GA	.	PASS	CSQ=27241|protein_coding||intron_variant|||||||NM_198428.2:c.2116-24005dup||MODIFIER||||||BBS9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	152,85:237:0.3586
chr7	33549516	.	G	T	.	PASS	CSQ=27241|protein_coding||intron_variant|||||||NM_198428.2:c.2521+15340G>T||MODIFIER||||||BBS9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,1:99:0.0101	85,58:143:0.4056
chr7	33555788	.	C	A	.	PASS	CSQ=27241|protein_coding||intron_variant|||||||NM_198428.2:c.2521+21612C>A||MODIFIER||||||BBS9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	73,77:150:0.5133
chr7	33684785	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	72,79:151:0.5232
chr7	33751955	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	87,85:172:0.4942
chr7	34045537	.	G	T	.	PASS	CSQ=168667|protein_coding||intron_variant|||||||NM_001365308.1:c.577-769G>T||MODIFIER||||||BMPER|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	68,77:145:0.531
chr7	34134191	.	G	GT	.	PASS	CSQ=168667|protein_coding||intron_variant|||||||NM_001365308.1:c.1746-9035dup||MODIFIER||||||BMPER|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	71,64:135:0.4741
chr7	34264807	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	89,80:169:0.4734
chr7	34274410	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	67,80:147:0.5442
chr7	34562707	.	C	T	.	PASS	CSQ=404744|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033665.1:n.280-145035G>A||MODIFIER||||||NPSR1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,74:150:0.4933
chr7	34587073	.	A	G	.	PASS	CSQ=404744|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033665.1:n.279+141664T>C||MODIFIER||||||NPSR1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	80,77:157:0.4904
chr7	34820719	.	G	A	.	PASS	CSQ=387129|protein_coding||intron_variant|||||||NM_207172.1:c.479-6682G>A||MODIFIER||||||NPSR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	59,85:144:0.5903
chr7	34867702	.	G	A	.	PASS	CSQ=387129|protein_coding||intron_variant||||rs1458421377|||NM_207173.1:c.1026-10374G>A||MODIFIER||||||NPSR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	92,75:167:0.4491
chr7	35230012	COSV68782853;COSV68782853	G	A	.	PASS	CSQ=57057|protein_coding||intron_variant|COSV68782853|p.?|COSV68782853|rs1350528987||3.95424e-05|NM_001077653.2:c.890+1492C>T||MODIFIER||||||TBX20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	66,69:135:0.5111
chr7	35310655	.	C	T	.	PASS	CSQ=401324|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC401324|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	96,102:199:0.5126
chr7	35349230	.	G	A	.	PASS	CSQ=401324|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038864.1:n.87-3061G>A||MODIFIER||||||LOC401324|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	73,79:152:0.5197
chr7	35614822	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	70,65:135:0.4815
chr7	35835198	.	G	T	.	PASS	CSQ=989|protein_coding||intron_variant|||||||NM_001788.5:c.169+2298G>T||MODIFIER||||||SEPT7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	85,100:185:0.5405
chr7	36244571	.	C	T	.	PASS	CSQ=80820|protein_coding||intron_variant|||||||NM_030636.3:c.930+5535C>T||MODIFIER||||||EEPD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	67,55:122:0.4508
chr7	36244880	.	C	T	.	PASS	CSQ=80820|protein_coding||intron_variant|||||||NM_030636.3:c.930+5844C>T||MODIFIER||||||EEPD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	51,56:107:0.5234
chr7	36539370	.	AG	A	.	PASS	CSQ=313|protein_coding||intron_variant|||||||NM_001637.3:c.1306+948del||MODIFIER||||||AOAH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	75,71:146:0.4863
chr7	36598227	.	G	A	.	PASS	CSQ=313|protein_coding||intron_variant|||||||NM_001637.3:c.847-3797C>T||MODIFIER||||||AOAH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	88,90:178:0.5056
chr7	36603881	.	A	AT	.	PASS	CSQ=313|protein_coding||intron_variant|||||||NM_001637.3:c.847-9452dup||MODIFIER||||||AOAH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	96,78:174:0.4483
chr7	37042559	.	T	G	.	PASS	CSQ=9844|protein_coding||intron_variant|||||||NM_001206480.2:c.1301-29124A>C||MODIFIER||||||ELMO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	55,63:118:0.5339
chr7	37154935	.	G	T	.	PASS	CSQ=9844|protein_coding||intron_variant|||||||NM_001206480.2:c.1087-21701C>A||MODIFIER||||||ELMO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	72,86:158:0.5443
chr7	37804236	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	73,58:131:0.4427
chr7	38333304	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1303849562||6.59291e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	74,79:153:0.5163
chr7	38393567	.	G	A	.	PASS	CSQ=273|protein_coding||intron_variant|||||||NM_001635.4:c.1608+438C>T||MODIFIER||||||AMPH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	74,70:144:0.4861
chr7	38463291	.	A	G	.	PASS	CSQ=273|protein_coding||intron_variant|||||||NM_001635.4:c.750-178T>C||MODIFIER||||||AMPH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	84,84:168:0.5
chr7	38552192	.	CA	C	.	PASS	CSQ=273|protein_coding||intron_variant|||||||NM_001635.4:c.70-17182del||MODIFIER||||||AMPH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	76,53:129:0.4109
chr7	38552195	.	G	T	.	PASS	CSQ=273|protein_coding||intron_variant|||||||NM_001635.4:c.70-17184C>A||MODIFIER||||||AMPH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	75,53:128:0.4141
chr7	38632130	.	G	T	.	PASS	CSQ=273|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||AMPH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	74,70:144:0.4861
chr7	38634880	.	T	C	.	PASS	CSQ=273|protein_coding||upstream_gene_variant||||||2.62871e-05|||MODIFIER||||||AMPH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	67,91:158:0.5759
chr7	39018042	.	C	G	.	PASS	CSQ=100689074|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||POU6F2-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	87,60:147:0.4082
chr7	39126156	.	G	A	.	PASS	CSQ=11281|protein_coding||intron_variant|||||||NM_007252.3:c.190+40125G>A||MODIFIER||||||POU6F2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	64,79:143:0.5524
chr7	39166699	.	C	T	.	PASS	CSQ=11281|protein_coding||intron_variant|||||||NM_007252.3:c.191-37536C>T||MODIFIER||||||POU6F2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	85,58:143:0.4056
chr7	39264019	.	G	A	.	PASS	CSQ=11281|protein_coding||intron_variant|||||||NM_007252.3:c.511+56399G>A||MODIFIER||||||POU6F2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	75,76:151:0.5033
chr7	39462499	.	G	GA	.	PASS	CSQ=11281|protein_coding||intron_variant|||||||NM_007252.3:c.1572-1677dup||MODIFIER||||||POU6F2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	75,69:144:0.4792
chr7	40046619	.	C	T	.	PASS	CSQ=8621|protein_coding||intron_variant|||||||NM_003718.5:c.2543+594C>T||MODIFIER||||||CDK13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	64,78:143:0.5455
chr7	40143866	.	G	A	.	PASS	CSQ=79783|protein_coding||intron_variant|||||||NM_001193313.1:c.121+8746G>A||MODIFIER||||||SUGCT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	78,79:157:0.5032
chr7	40172637	.	C	G	.	PASS	CSQ=79783|protein_coding||intron_variant|||||||NM_001193313.1:c.122-8310C>G||MODIFIER||||||SUGCT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	94,76:170:0.4471
chr7	40451841	.	AT	A	.	PASS	CSQ=79783|protein_coding||intron_variant||||rs1009267043||9.92182e-05|NM_001193313.1:c.909+2492del||MODIFIER||||||SUGCT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	100,65:165:0.3939
chr7	40596424	.	T	C	.	PASS	CSQ=79783|protein_coding||intron_variant|||||||NM_001193313.1:c.1110+100038T>C||MODIFIER||||||SUGCT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	153,9:162:0.0556
chr7	41063550	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	90,81:171:0.4737
chr7	41284147	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	82,83:165:0.503
chr7	41388553	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs368291826||0.000131679|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,1:117:0.0085	68,80:148:0.5405
chr7	41454311	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	107,44:151:0.2914
chr7	41562828	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs556570574||6.64902e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	70,72:142:0.507
chr7	41896665	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	58,79:137:0.5766
chr7	41939971	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:151:0	76,103:179:0.5754
chr7	42098496	.	AGTTCCCCAGAATAACCTT	A	.	PASS	CSQ=2737|protein_coding||intron_variant|||||||NM_000168.6:c.368-21657_368-21640del||MODIFIER||||||GLI3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	84,67:151:0.4437
chr7	42201666	.	C	A	.	PASS	CSQ=2737|protein_coding||intron_variant|||||||NM_000168.6:c.124+21464G>T||MODIFIER||||||GLI3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	148,10:158:0.0633
chr7	43233864	.	G	A	.	PASS	CSQ=23072|protein_coding||intron_variant|||||||NM_015052.5:c.-31-10011G>A||MODIFIER||||||HECW1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	149,8:157:0.051
chr7	43445562	COSV106565875;COSV106565875;COSV106565875	G	A	.	PASS	CSQ=23072|protein_coding||missense_variant|COSV106565875&COSV106565875|p.R797Q&p.R797Q|COSV106565875|rs777676600|||NM_015052.5:c.2390G>A|NP_055867.3:p.Arg797Gln|MODERATE|B&.|T&T|D|T&T|T&D|HECW1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	80,91:171:0.5322
chr7	44107406	.	C	T	.	PASS	CSQ=100616346|miRNA||upstream_gene_variant||||rs375925458|1.60852e-05|5.91444e-05|||MODIFIER||||||MIR4649|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,1:133:0.0075	88,104:192:0.5417
chr7	44136059	.	C	T	.	PASS	CSQ=58498|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MYL7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	87,101:188:0.5372
chr7	44596286	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1380045320|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	91,75:166:0.4518
chr7	44724433	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	76,77:153:0.5033
chr7	44844603	.	C	T	.	PASS	CSQ=94239|protein_coding||intron_variant|||||||NM_012412.4:c.4-1249G>A||MODIFIER||||||H2AFV|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	73,67:140:0.4786
chr7	45056858	.	C	T	.	PASS	CSQ=83605|protein_coding||intron_variant||||rs1306511802||6.57428e-06|NM_031443.3:c.205-7060C>T||MODIFIER||||||CCM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	94,86:180:0.4778
chr7	45279948	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	78,96:174:0.5517
chr7	45421383	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	172,6:178:0.0337
chr7	45427892	.	GAAA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	72,72:144:0.5
chr7	45525087	.	TAATGA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	80,72:152:0.4737
chr7	45616918	.	G	A	.	PASS	CSQ=107|protein_coding||intron_variant|||||||NM_021116.4:c.909-5714G>A||MODIFIER||||||ADCY1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	132,6:138:0.0435
chr7	46150131	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	102,75:177:0.4237
chr7	46247298	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs371847642||0.139435|||MODIFIER||||||||0.1312;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	69,51:120:0.425
chr7	46344430	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	118,35:153:0.2288
chr7	46595790	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1222478490||6.57142e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	63,67:130:0.5154
chr7	46788393	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs542115707||9.20471e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	64,86:150:0.5733
chr7	46807553	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:107:0.0093	73,83:156:0.5321
chr7	48697153	.	CTT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	77,57:134:0.4254
chr7	48723752	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	73,75:148:0.5068
chr7	48802079	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs928893185||0.000108804|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:107:0.0093	87,67:154:0.4351
chr7	49052303	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.57999e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	75,80:155:0.5161
chr7	49535158	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	135,42:177:0.2373
chr7	49556855	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	80,68:148:0.4595
chr7	49712671	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	81,74:155:0.4774
chr7	49725740	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	87,66:153:0.4314
chr7	49806713	.	C	T	.	PASS	CSQ=375567|protein_coding||intron_variant||||rs1259238217||4.62052e-05|NM_198570.5:c.826+3873C>T||MODIFIER||||||VWC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	78,73:151:0.4834
chr7	49837707	.	C	A	.	PASS	CSQ=375567|protein_coding||intron_variant|||||||NM_198570.5:c.826+34867C>A||MODIFIER||||||VWC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	83,77:160:0.4813
chr7	50026307	.	G	A	.	PASS	CSQ=11055|protein_coding||intron_variant||||rs1346424819||7.24943e-05|NM_007009.3:c.706+4785C>T||MODIFIER||||||ZPBP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	131,9:140:0.0643
chr7	51276092	.	G	A	.	PASS	CSQ=23242|protein_coding||intron_variant|||||||NM_015198.5:c.41+40501C>T||MODIFIER||||||COBL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	81,77:159:0.4843
chr7	51586941	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,1:128:0.0078	91,85:176:0.483
chr7	51755150	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1010468329||8.54892e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	104,40:144:0.2778
chr7	52261290	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||1.31401e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	77,65:142:0.4577
chr7	52307934	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	83,78:161:0.4845
chr7	52389057	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	137,11:148:0.0743
chr7	52490866	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs922997444||1.31522e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	78,70:148:0.473
chr7	52602379	.	TTTTC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	75,73:148:0.4932
chr7	52638537	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	74,77:151:0.5099
chr7	52753477	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	64,76:140:0.5429
chr7	52918908	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1259563565||6.57384e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	44,64:108:0.5926
chr7	53355652	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	78,61:139:0.4388
chr7	53440045	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs561101586||0.00226361|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	79,63:142:0.4437
chr7	53450935	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	81,74:155:0.4774
chr7	53526242	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1473638972|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	167,9:176:0.0511
chr7	53678002	.	T	G	.	PASS	CSQ=401337|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038371.1:n.1544+13925A>C||MODIFIER||||||LINC01446|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	78,74:152:0.4868
chr7	53806786	.	G	T	.	PASS	CSQ=401337|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038371.1:n.424+4722C>A||MODIFIER||||||LINC01446|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	74,49:123:0.3984
chr7	54482451	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,84:154:0.5455
chr7	54488200	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	81,81:162:0.5
chr7	54777958	.	G	A	.	PASS	CSQ=100996654|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110040.1:n.213-5150G>A||MODIFIER||||||LOC100996654|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	81,80:161:0.4969
chr7	55379784	.	A	C	.	PASS	CSQ=55915|protein_coding||intron_variant|||||||NM_018697.3:c.205-12009A>C||MODIFIER||||||LANCL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	131,45:176:0.2557
chr7	55618958	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	170,6:177:0.0339
chr7	55748592	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	56,37:93:0.3978
chr7	55874432	.	TG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	108,0:108:0	66,74:140:0.5286
chr7	56286073	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	100,0:100:0	64,59:123:0.4797
chr7	56347925	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs180784124||5.93801e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	73,85:158:0.538
chr7	56496776	.	C	T	.	PASS	CSQ=222029|lncRNA||non_coding_transcript_exon_variant||||rs1442020678||5.25838e-05|NR_026929.1:n.554C>T||MODIFIER||||||DKFZp434L192|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	103,0:103:0	84,71:155:0.4581
chr7	56737255	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	75,93:168:0.5536
chr7	57061235	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	161,0:161:0	76,96:173:0.5549
chr7	57251006	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	63,64:127:0.5039
chr7	57348183	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	64,72:136:0.5294
chr7	57360311	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	67,76:143:0.5315
chr7	57385613	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	143,10:153:0.0654
chr7	57461107	.	TA	T	.	PASS	CSQ=441234|protein_coding||intron_variant||||rs1288984066||0.00162442|NM_001159279.1:c.40-1340del||MODIFIER||||||ZNF716|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	61,43:105:0.4095
chr7	57523851	.	C	G	.	PASS	CSQ=|||intergenic_variant||||||6.57748e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	70,62:132:0.4697
chr7	57550883	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	142,14:156:0.0897
chr7	57899970	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	129,0:129:0	100,11:111:0.0991
chr7	58032060	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1306206962||6.61726e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,1:119:0.0084	104,23:127:0.1811
chr7	60952767	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	52,84:136:0.6176
chr7	62402396	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	237,0:237:0	228,71:299:0.2375
chr7	62645436	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	4,74:78:0.9487
chr7	62650662	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.65318e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	2,63:65:0.9692
chr7	62865763	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	3,68:71:0.9577
chr7	62900109	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	6,70:76:0.9211
chr7	63113407	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	5,83:88:0.9432
chr7	63243263	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	3,71:74:0.9595
chr7	63499370	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1334751218||3.38776e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	19,0:19:0	3,21:24:0.875
chr7	63664920	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,63:63:1
chr7	63947904	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	83,6:89:0.0674
chr7	64353843	.	C	T	.	PASS	CSQ=728927|protein_coding||3_prime_UTR_variant|||||||NM_001170905.3:c.*4696C>T||MODIFIER||||||ZNF736|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	112,0:112:0	87,5:92:0.0543
chr7	64666375	.	AGTC	A	.	PASS	CSQ=51427|protein_coding||intron_variant|||||||NM_001282359.1:c.3+91_3+93del||MODIFIER||||||ZNF107|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	6,73:79:0.9241
chr7	64666379	.	C	A	.	PASS	CSQ=51427|protein_coding||intron_variant|||||||NM_001282359.1:c.3+94C>A||MODIFIER||||||ZNF107|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	7,73:80:0.9125
chr7	64756487	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs947464557||5.91778e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	7,76:83:0.9157
chr7	64884804	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	160,0:160:0	7,87:94:0.9255
chr7	64966734	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	68,12:80:0.15
chr7	65024700	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1197641320|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	2,80:82:0.9756
chr7	65281890	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	81,7:88:0.0795
chr7	65454650	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||6.5767e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	61,11:72:0.1528
chr7	65816946	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	6,75:81:0.9259
chr7	65834354	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	1,94:96:0.9792
chr7	65834518	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	4,70:75:0.9333
chr7	66188530	COSV66879653	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV66879653|rs576003166||1.31737e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	4,82:86:0.9535
chr7	66585554	.	C	T	.	PASS	CSQ=493754|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_111973.1:n.221-1088G>A||MODIFIER||||||GS1-124K5.11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,14:93:0.1505
chr7	67109184	.	G	T	.	PASS	CSQ=55253|protein_coding||intron_variant|||||||NM_018264.4:c.1563-8299G>T||MODIFIER||||||TYW1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	6,77:83:0.9277
chr7	67380729	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs758784473||4.60763e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	10,124:134:0.9254
chr7	67414517	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57367e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,1:111:0.009	2,82:84:0.9762
chr7	67686792	COSV69301839	T	TA	.	PASS	CSQ=|||intergenic_variant|||COSV69301839||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	13,68:81:0.8395
chr7	67748929	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	73,5:78:0.0641
chr7	68100718	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	1,70:71:0.9859
chr7	68664248	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	4,74:78:0.9487
chr7	68701082	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	66,5:71:0.0704
chr7	68804809	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	2,67:69:0.971
chr7	68935799	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	2,67:70:0.9571
chr7	68991743	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	2,85:87:0.977
chr7	69061342	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	2,81:83:0.9759
chr7	69406476	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs777291522||3.29134e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	69,5:74:0.0676
chr7	69441601	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1456050969||4.61979e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	83,5:88:0.0568
chr7	70618311	.	G	A	.	PASS	CSQ=26053|protein_coding||intron_variant|||||||NM_015570.3:c.691-80258G>A||MODIFIER||||||AUTS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	5,69:74:0.9324
chr7	71083898	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	69,5:74:0.0676
chr7	71401106	.	T	C	.	PASS	CSQ=64409|protein_coding||intron_variant|||||||NM_022479.3:c.589+12705T>C||MODIFIER||||||GALNT17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	59,5:64:0.0781
chr7	71533718	.	C	A	.	PASS	CSQ=64409|protein_coding||intron_variant|||||||NM_022479.3:c.963-37567C>A||MODIFIER||||||GALNT17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	4,84:88:0.9545
chr7	71825681	.	G	A	.	PASS	CSQ=83698|protein_coding||intron_variant|||||||NM_031468.4:c.502-15189C>T||MODIFIER||||||CALN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	70,5:75:0.0667
chr7	71971235	.	C	T	.	PASS	CSQ=83698|protein_coding||intron_variant||||rs999096225||5.92261e-05|NM_031468.4:c.501+52422G>A||MODIFIER||||||CALN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	68,7:75:0.0933
chr7	72076302	.	TA	T	.	PASS	CSQ=83698|protein_coding||intron_variant||||rs1208552635||0.000666487|NM_031468.4:c.388+29848del||MODIFIER||||||CALN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,1:89:0.0112	12,60:72:0.8333
chr7	72534040	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1429857921||1.97439e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	77,6:83:0.0723
chr7	73359541	.	G	A	.	PASS	CSQ=8468|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FKBP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	4,99:104:0.9519
chr7	74045733	.	C	T	.	PASS	CSQ=2006|protein_coding||intron_variant||||rs782371212||9.88794e-05|NM_000501.4:c.541+440C>T||MODIFIER||||||ELN|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/ELN|y|n|B-ALL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	1,92:93:0.9892
chr7	74446655	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,87:87:1
chr7	74624245	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:104:0	0,94:94:1
chr7	76211040	.	C	T	.	PASS	CSQ=222183|protein_coding||intron_variant|||||||NM_001110199.3:c.-40+8973C>T||MODIFIER||||||SRRM3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,82:82:1
chr7	76544053	.	G	A	.	PASS	CSQ=102723555|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SPDYE16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,78:78:1
chr7	76911089	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	1,70:71:0.9859
chr7	78187379	.	A	G	.	PASS	CSQ=9863|protein_coding||intron_variant|||||||NM_012301.4:c.2270-1709T>C||MODIFIER||||||MAGI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,63:63:1
chr7	78202929	.	T	TA	.	PASS	CSQ=9863|protein_coding||intron_variant|||||||NM_012301.4:c.2048-1737dup||MODIFIER||||||MAGI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	65,9:74:0.1216
chr7	78315511	.	T	A	.	PASS	CSQ=9863|protein_coding||intron_variant|||||||NM_012301.4:c.1408+28267A>T||MODIFIER||||||MAGI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,65:65:1
chr7	78546625	.	C	T	.	PASS	CSQ=9863|protein_coding||intron_variant|||||||NM_012301.4:c.539-24980G>A||MODIFIER||||||MAGI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,85:85:1
chr7	78597024	.	GA	G	.	PASS	CSQ=9863|protein_coding||intron_variant||||rs1184712364||1.31541e-05|NM_012301.4:c.538+30095del||MODIFIER||||||MAGI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	4,75:79:0.9494
chr7	78955941	COSV62701242;COSV62701242;COSV62701242;COSV62701242	CT	C	.	PASS	CSQ=9863|protein_coding||intron_variant|COSV62701242&COSV62701242&COSV62701242&COSV62701242|p.?&p.?&p.?&p.?||rs529960629||7.31694e-05|NM_012301.4:c.418+51148del||MODIFIER||||||MAGI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	6,64:70:0.9143
chr7	79166035	.	C	T	.	PASS	CSQ=9863|protein_coding||intron_variant|||||||NM_012301.4:c.302-158829G>A||MODIFIER||||||MAGI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,76:76:1
chr7	79607627	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,81:81:1
chr7	79641470	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,90:90:1
chr7	79658253	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1361077845|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	71,11:82:0.1341
chr7	80020636	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.57151e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,1:132:0.0076	4,79:83:0.9518
chr7	80322252	.	C	CTA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	56,6:62:0.0968
chr7	80796747	.	C	A	.	PASS	CSQ=10512|protein_coding||intron_variant||||rs1159310709||6.57419e-06|NM_006379.5:c.1131+1345G>T||MODIFIER||||||SEMA3C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	83,4:87:0.046
chr7	80796777	.	A	G	.	PASS	CSQ=10512|protein_coding||intron_variant||||rs984861589|||NM_006379.5:c.1131+1315T>C||MODIFIER||||||SEMA3C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	85,6:91:0.0659
chr7	81038157	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1056221138||6.5741e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,86:86:1
chr7	82136216	.	C	T	.	PASS	CSQ=781|protein_coding||intron_variant|||||||NM_000722.4:c.396+419G>A||MODIFIER||||||CACNA2D1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,82:82:1
chr7	83279816	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs983523217||6.57333e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,84:85:0.9882
chr7	83717300	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:96:0	0,90:90:1
chr7	83924271	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs905620685||0.000147277|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	6,86:93:0.9247
chr7	84550297	.	C	A	.	PASS	CSQ=101927378|lncRNA||intron_variant&non_coding_transcript_variant||||rs912921407||1.31544e-05|NR_110080.1:n.239+1044C>A||MODIFIER||||||LOC101927378|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,78:78:1
chr7	84630043	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,71:71:1
chr7	85186215	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	0,77:77:1
chr7	85243045	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,58:58:1
chr7	85326283	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,71:71:1
chr7	85382925	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,64:64:1
chr7	85453129	.	G	A	.	PASS	CSQ=105375380|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_134240.1:n.267+3140G>A||MODIFIER||||||LINC00972|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,79:79:1
chr7	85500161	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	65,7:72:0.0972
chr7	85950616	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,62:62:1
chr7	85979295	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,72:72:1
chr7	86208129	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,77:77:1
chr7	86496583	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,76:76:1
chr7	86655073	.	G	T	.	PASS	CSQ=2913|protein_coding||intron_variant|||||||NM_000840.2:c.-141+10201G>T||MODIFIER||||||GRM3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GRM3|y|n|melanoma,oral_SCC|||E||oncogene|Mis,A;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,79:79:1
chr7	86757931	.	G	T	.	PASS	CSQ=2913|protein_coding||intron_variant|||||||NM_000840.2:c.-140-7075G>T||MODIFIER||||||GRM3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GRM3|y|n|melanoma,oral_SCC|||E||oncogene|Mis,A;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	46,12:58:0.2069
chr7	87053469	.	C	A	.	PASS	CSQ=222223|protein_coding||intron_variant|||||||NM_001142749.3:c.189+5856G>T||MODIFIER||||||KIAA1324L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,66:66:1
chr7	87071675	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,65:65:1
chr7	87490600	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,100:100:1
chr7	87798479	.	GC	G	.	PASS	CSQ=154661|protein_coding||intron_variant|||||||NM_001134405.1:c.957-8890del||MODIFIER||||||RUNDC3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	4,77:81:0.9506
chr7	87955596	.	G	A	.	PASS	CSQ=53616|protein_coding||intron_variant|||||||NM_001324418.1:c.246+20410G>A||MODIFIER||||||ADAM22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,96:96:1
chr7	88656049	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,63:63:1
chr7	88699507	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,67:67:1
chr7	89226507	.	G	A	.	PASS	CSQ=219578|protein_coding||intron_variant|||||||NM_181646.4:c.249+8212G>A||MODIFIER||||||ZNF804B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,64:64:1
chr7	89312390	.	A	T	.	PASS	CSQ=219578|protein_coding||intron_variant|||||||NM_181646.4:c.250-14954A>T||MODIFIER||||||ZNF804B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,60:60:1
chr7	89315522	.	G	T	.	PASS	CSQ=219578|protein_coding||intron_variant|||||||NM_181646.4:c.250-11822G>T||MODIFIER||||||ZNF804B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,78:78:1
chr7	89530472	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs933082851||0.000523914|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	7,56:63:0.8889
chr7	89590397	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,74:74:1
chr7	89670748	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,79:79:1
chr7	90084553	.	G	C	.	PASS	CSQ=100874100|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110029.2:n.424+125298C>G||MODIFIER||||||STEAP2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,80:80:1
chr7	90423339	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	0,74:74:1
chr7	90913142	.	G	T	.	PASS	CSQ=5218|protein_coding||intron_variant|||||||NM_001287135.2:c.703-4459G>T||MODIFIER||||||CDK14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,72:72:1
chr7	91889882	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,99:99:1
chr7	92317737	.	G	A	.	PASS	CSQ=54467|protein_coding||intron_variant|||||||NM_019004.2:c.487-1593G>A||MODIFIER||||||ANKIB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,70:70:1
chr7	92999806	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs984926854||1.97324e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,75:75:1
chr7	93591746	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	132,0:132:0	1,101:102:0.9902
chr7	94027469	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.60773e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,78:79:0.9873
chr7	94496205	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,85:85:1
chr7	94685274	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,85:85:1
chr7	95580439	.	C	T	.	PASS	CSQ=5166|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PDK4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,76:76:1
chr7	97203690	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,85:85:1
chr7	97608490	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,78:78:1
chr7	98183033	.	C	A	.	PASS	CSQ=22853|protein_coding||intron_variant|||||||NM_014916.4:c.792-2018C>A||MODIFIER||||||LMTK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,80:80:1
chr7	98714640	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,76:76:1
chr7	99324451	.	T	A	.	PASS	CSQ=10552|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ARPC1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,1:103:0.0097	0,74:74:1
chr7	99613886	.	C	A	.	PASS	CSQ=221785|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ZSCAN25|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,77:77:1
chr7	100296438	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1426829893|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,1:97:0.0103	6,76:82:0.9268
chr7	101361724	.	C	T	.	PASS	CSQ=136227|protein_coding||upstream_gene_variant||||rs1243671168|||||MODIFIER||||||COL26A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,55:56:0.9821
chr7	102412330	.	G	A	.	PASS	CSQ=100630923|lncRNA||intron_variant&non_coding_transcript_variant||||rs1180141402||6.57298e-06|NR_038967.1:n.1242+4832G>A||MODIFIER||||||LOC100630923|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,79:79:1
chr7	102928526	.	C	A	.	PASS	CSQ=222235|protein_coding||intron_variant|||||||NM_145032.3:c.778-2152G>T||MODIFIER||||||FBXL13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,62:63:0.9841
chr7	103295025	.	C	T	.	PASS	CSQ=9512|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PMPCB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,91:91:1
chr7	104241580	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1052780275||1.97285e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,82:82:1
chr7	104780681	.	G	T	.	PASS	CSQ=375612|protein_coding||intron_variant|||||||NM_199000.2:c.682+43770G>T||MODIFIER||||||LHFPL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	49,32:81:0.3951
chr7	108364728	.	C	CA	.	PASS	CSQ=4897|protein_coding||intron_variant||||rs34574826||0.315576|NM_001193582.1:c.-174+34707dup||MODIFIER||||||NRCAM|EntrezGene|0.3373;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,1:92:0.0109	9,68:78:0.8718
chr7	108487621	.	TG	T	.	PASS	CSQ=50640|protein_coding||intron_variant|||||||NM_001256007.3:c.1878+137del||MODIFIER||||||PNPLA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	0,101:101:1
chr7	108691534	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,84:85:0.9882
chr7	108899824	COSV74097339	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV74097339||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,74:74:1
chr7	109169566	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,72:72:1
chr7	109509516	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:87:0	0,59:59:1
chr7	109995813	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,63:63:1
chr7	110809651	.	C	A	.	PASS	CSQ=83943|protein_coding||intron_variant|||||||NM_032549.3:c.408+76942G>T||MODIFIER||||||IMMP2L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	7,71:78:0.9103
chr7	111234981	.	T	G	.	PASS	CSQ=83943|protein_coding||intron_variant|||||||NM_032549.3:c.239+252257A>C||MODIFIER||||||IMMP2L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,67:67:1
chr7	113210102	.	GA	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	124,0:124:0	0,81:81:1
chr7	114112933	.	G	C	.	PASS	CSQ=93986|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_033766.1:n.302+26322G>C||MODIFIER||||||FOXP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,75:75:1
chr7	114152601	.	G	C	.	PASS	CSQ=93986|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_033766.1:n.302+65990G>C||MODIFIER||||||FOXP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,81:81:1
chr7	114327060	.	AG	A	.	PASS	CSQ=93986|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_033766.1:n.393+38952del||MODIFIER||||||FOXP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,82:82:1
chr7	115208583	.	C	T	.	PASS	CSQ=104355291|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126407.1:n.173+22600G>A||MODIFIER||||||LINC01392|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,87:87:1
chr7	115450101	.	TTTGGAGTTGAG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	0,87:87:1
chr7	115997477	COSV55396964;COSV55396964;COSV55396964;COSV55396964	C	T	.	PASS	CSQ=22797|protein_coding||intron_variant|COSV55396964&COSV55396964&COSV55396964&COSV55396964|p.?&p.?&p.?&p.?||rs1011835487||2.66898e-05|NM_012252.4:c.-72-12964G>A||MODIFIER||||||TFEC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:107:0	0,69:70:0.9857
chr7	116040842	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	79,13:92:0.1413
chr7	116793558	.	T	C	.	PASS	CSQ=4233|protein_coding||intron_variant|||||||NM_001127500.3:c.3853-2097T>C||MODIFIER||||||MET|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MET|y|n|papillary_renal,head-neck_squamous_cell|papillary_renal|familial_papillary_renal_cancer|E|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	92,0:92:0	67,8:75:0.1067
chr7	117140241	.	A	T	.	PASS	CSQ=93654|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_002331.3:n.284+3926T>A||MODIFIER||||||ST7-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	0,75:75:1
chr7	118238886	COSV54555891;COSV54555891;COSV54555891;COSV54555891;COSV54555891;COSV54555891	G	A	.	PASS	CSQ=56311|protein_coding||intron_variant|COSV54555891&COSV54555891&COSV54555891|p.?&p.?&p.?|COSV54555891&COSV54555891&COSV54555891|rs186781278||9.85766e-05|NM_019644.4:c.713-1023G>A||MODIFIER||||||ANKRD7|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,88:88:1
chr7	118452685	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	1,49:50:0.98
chr7	118950969	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,1:126:0.0079	5,77:82:0.939
chr7	119008415	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	65,12:77:0.1558
chr7	119018218	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,67:67:1
chr7	119037891	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs910616659||6.57471e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,77:77:1
chr7	119287960	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,61:61:1
chr7	119321272	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.58016e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,66:66:1
chr7	119325801	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,81:81:1
chr7	119468956	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,53:53:1
chr7	119801003	.	T	A	.	PASS	CSQ=105375475|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_131960.1:n.167-129A>T||MODIFIER||||||LINC02476|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,77:77:1
chr7	119828024	.	G	A	.	PASS	CSQ=105375475|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_131960.1:n.84-11444C>T||MODIFIER||||||LINC02476|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	58,7:65:0.1077
chr7	120181370	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs756877645|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,66:66:1
chr7	120200982	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,71:71:1
chr7	121057750	.	T	A	.	PASS	CSQ=79974|protein_coding||intron_variant|||||||NM_024913.5:c.541-6488T>A||MODIFIER||||||CPED1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,77:77:1
chr7	121524491	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1420489101|8.60674e-06||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	161,0:161:0	0,83:83:1
chr7	122064826	.	C	T	.	PASS	CSQ=5803|protein_coding||downstream_gene_variant||||rs1019793268|||||MODIFIER||||||PTPRZ1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,83:83:1
chr7	122632109	.	T	G	.	PASS	CSQ=93664|protein_coding||intron_variant|||||||NM_017954.11:c.787-2781A>C||MODIFIER||||||CADPS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,85:85:1
chr7	122668524	.	T	A	.	PASS	CSQ=93664|protein_coding||intron_variant||||rs1358025628||6.57428e-06|NM_017954.11:c.454-4955A>T||MODIFIER||||||CADPS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,89:89:1
chr7	123237761	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,77:77:1
chr7	123310209	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1193412782||1.32314e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	5,71:76:0.9342
chr7	123438704	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	0,48:48:1
chr7	124253439	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1298650079||2.62909e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:108:0	0,73:73:1
chr7	124285214	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,65:65:1
chr7	125154702	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs368516824||0.000382616|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,85:85:1
chr7	125393613	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	36,36:72:0.5
chr7	125858793	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,71:72:0.9861
chr7	125901420	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,56:56:1
chr7	125965572	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,68:68:1
chr7	126208986	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,1:104:0.0096	0,87:87:1
chr7	126309821	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,65:65:1
chr7	126343232	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	120,0:120:0	49,9:58:0.1552
chr7	126587685	.	G	C	.	PASS	CSQ=2918|protein_coding||intron_variant||||rs375716421|||NM_000845.2:c.1494+21677C>G||MODIFIER||||||GRM8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	64,0:64:0	22,6:28:0.2143
chr7	126914298	COSV58867625;COSV58867625	G	C	.	PASS	CSQ=2918|protein_coding||intron_variant|COSV58867625&COSV58867625|p.?&p.?|||||NM_000845.2:c.728-9615C>G||MODIFIER||||||GRM8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,79:79:1
chr7	129081898	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1411518782||6.58241e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,76:76:1
chr7	129256468	.	T	G	.	PASS	CSQ=23382|protein_coding||intron_variant|||||||NM_001130720.2:c.363+31029T>G||MODIFIER||||||AHCYL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,47:47:1
chr7	129500256	.	G	C	.	PASS	CSQ=100287482|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SMKR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,91:91:1
chr7	129593566	COSV63248122	A	C	.	PASS	CSQ=|||intergenic_variant|||COSV63248122|rs868263909||7.93701e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	103,0:103:0	0,77:77:1
chr7	129817559	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,92:92:1
chr7	129818137	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,92:92:1
chr7	131230159	.	T	C	.	PASS	CSQ=4289|protein_coding||intron_variant|||||||NM_001145354.1:c.29+87218T>C||MODIFIER||||||MKLN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,69:69:1
chr7	131805116	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1216941641||6.5825e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,98:98:1
chr7	131845422	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,80:80:1
chr7	132105531	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,82:82:1
chr7	132332527	.	A	C	.	PASS	CSQ=91584|protein_coding||intron_variant|||||||NM_020911.1:c.1372-34305T>G||MODIFIER||||||PLXNA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,70:70:1
chr7	132822418	.	C	CT	.	PASS	CSQ=54927|protein_coding||intron_variant||||rs961312048||3.30142e-05|NM_017812.4:c.524+15980dup||MODIFIER||||||CHCHD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	11,77:89:0.8652
chr7	133528899	.	G	T	.	PASS	CSQ=60412|protein_coding||intron_variant||||||6.57825e-06|NM_021807.4:c.1417+48761G>T||MODIFIER||||||EXOC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	79,9:88:0.1023
chr7	133606519	.	T	TA	.	PASS	CSQ=60412|protein_coding||intron_variant||||rs1356063575||0.00857166|NM_021807.4:c.1418-23526_1418-23525insA||MODIFIER||||||EXOC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	12,56:68:0.8235
chr7	134480904	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1306990033|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	76,5:81:0.0617
chr7	134610183	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,82:82:1
chr7	135243075	.	G	A	.	PASS	CSQ=346673|protein_coding||intron_variant|||||||NM_182489.2:c.268+219G>A||MODIFIER||||||STRA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,75:75:1
chr7	135903551	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,80:80:1
chr7	136112873	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,57:57:1
chr7	136603513	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1405654495|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,97:97:1
chr7	136807086	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,66:66:1
chr7	136836436	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	0,76:76:1
chr7	137494249	.	C	A	.	PASS	CSQ=9162|protein_coding||intron_variant|||||||NM_001321708.1:c.2249-6560G>T||MODIFIER||||||DGKI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	1,65:66:0.9848
chr7	137768853	.	G	T	.	PASS	CSQ=9162|protein_coding||intron_variant|||||||NM_001321708.1:c.401+77609C>A||MODIFIER||||||DGKI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,73:73:1
chr7	138409611	COSV68652780	T	TC	.	PASS	CSQ=|||intergenic_variant|||COSV68652780|rs112970698||0.0371023|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	105,0:105:0	20,49:69:0.7101
chr7	138454813	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,75:75:1
chr7	140147141	.	AG	A	.	PASS	CSQ=80853|protein_coding||intron_variant|||||||NM_030647.2:c.195-7952del||MODIFIER||||||KDM7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	5,61:66:0.9242
chr7	142445058	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,71:71:1
chr7	142482209	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.70655e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,82:82:1
chr7	144229844	.	G	A	.	PASS	CSQ=101928605|lncRNA||intron_variant&non_coding_transcript_variant||||rs1167673819||1.98145e-05|NR_126022.1:n.493+22040G>A||MODIFIER||||||LOC101928605|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	265,0:265:0	97,52:149:0.349
chr7	144787450	COSV100765217;COSV100765217;COSV100765217	G	A	.	PASS	CSQ=27010|protein_coding||intron_variant|COSV100765217&COSV100765217&COSV100765217|p.?&p.?&p.?||rs576330153||0.000230109|NM_022445.4:c.44-21499C>T||MODIFIER||||||TPK1|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,76:76:1
chr7	145177060	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs893103247|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	68,5:73:0.0685
chr7	145496609	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,58:58:1
chr7	145630943	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,74:74:1
chr7	145735704	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,59:59:1
chr7	145736450	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,57:57:1
chr7	145831531	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,77:77:1
chr7	146274400	.	A	C	.	PASS	CSQ=26047|protein_coding||intron_variant|||||||NM_014141.6:c.97+157427A>C||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,66:66:1
chr7	146486630	.	TC	CA	.	PASS	CSQ=26047|protein_coding||intron_variant|||||||NM_014141.6:c.98-287641_98-287640delinsCA||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	88,0:88:0	0,56:56:1
chr7	146501143	.	T	G	.	PASS	CSQ=26047|protein_coding||intron_variant|||||||NM_014141.6:c.98-273128T>G||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	126,0:126:0	71,4:75:0.0533
chr7	146931350	.	G	A	.	PASS	CSQ=26047|protein_coding||intron_variant||||rs1304226110||6.65407e-06|NM_014141.6:c.402+91446G>A||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,64:64:1
chr7	147639639	.	T	A	.	PASS	CSQ=26047|protein_coding||intron_variant|||||||NM_014141.6:c.2098+333T>A||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,77:77:1
chr7	147657063	.	C	T	.	PASS	CSQ=26047|protein_coding||intron_variant|||||||NM_014141.6:c.2098+17757C>T||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,59:59:1
chr7	148199115	.	G	C	.	PASS	CSQ=26047|protein_coding||intron_variant|||||||NM_014141.6:c.3011-18173G>C||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,76:76:1
chr7	148330721	.	G	A	.	PASS	CSQ=26047|protein_coding||intron_variant||||rs1374947059||6.79625e-06|NM_014141.6:c.3476-52928G>A||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	38,12:50:0.24
chr7	148332255	.	G	C	.	PASS	CSQ=26047|protein_coding||intron_variant||||rs929218817||6.59674e-06|NM_014141.6:c.3476-51394G>C||MODIFIER||||||CNTNAP2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNTNAP2|y|n|glioma,melanoma|||E,O||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	56,8:64:0.125
chr7	148482192	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	0,76:76:1
chr7	148665766	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,62:62:1
chr7	149968219	.	T	G	.	PASS	CSQ=653857|protein_coding||intron_variant|||||||NM_001351027.1:c.54-58514A>C||MODIFIER||||||ACTR3C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:133:0	0,73:73:1
chr7	150691126	.	C	T	.	PASS	CSQ=26157|protein_coding||intron_variant|||||||NM_015660.3:c.29-1189C>T||MODIFIER||||||GIMAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,81:81:1
chr7	150749445	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,1:99:0.0101	0,73:73:1
chr7	150825027	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,89:89:1
chr7	151398602	.	T	G	.	PASS	CSQ=349136|protein_coding||intron_variant|||||||NM_198285.2:c.305+1498A>C||MODIFIER||||||WDR86|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	144,0:144:0	0,100:100:1
chr7	153005232	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,76:76:1
chr7	153207013	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,74:74:1
chr7	153368750	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,84:84:1
chr7	153542510	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,75:75:1
chr7	153542512	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,72:72:1
chr7	153597643	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs751096257||3.94436e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,63:63:1
chr7	153830142	.	TA	T	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_001364497.1:c.60+81137del||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	1,70:71:0.9859
chr7	153923258	.	T	A	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_001364497.1:c.60+174250T>A||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	129,0:129:0	74,5:79:0.0633
chr7	153924552	.	A	G	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_001364497.1:c.60+175544A>G||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,61:61:1
chr7	154018469	.	G	A	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_001364497.1:c.60+269461G>A||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	74,12:86:0.1395
chr7	154018786	.	G	A	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_001364497.1:c.60+269778G>A||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	57,10:67:0.1493
chr7	154019256	.	G	A	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_001364497.1:c.60+270248G>A||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	65,11:76:0.1447
chr7	154316617	.	G	C	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_130797.4:c.244-129597G>C||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,67:67:1
chr7	154470863	.	T	A	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_130797.4:c.359-4076T>A||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,75:75:1
chr7	154526508	.	G	A	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_130797.4:c.458-14024G>A||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	70,13:83:0.1566
chr7	154632375	.	G	T	.	PASS	CSQ=1804|protein_coding||intron_variant|||||||NM_130797.4:c.628-5446G>T||MODIFIER||||||DPP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	75,12:87:0.1379
chr7	155092178	.	C	T	.	PASS	CSQ=3361|protein_coding||downstream_gene_variant||||rs541358203||8.54667e-05|||MODIFIER||||||HTR5A|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:111:0	0,79:79:1
chr7	155742386	.	A	T	.	PASS	CSQ=155435|protein_coding||intron_variant|||||||NM_053043.3:c.2337+280A>T||MODIFIER||||||RBM33|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,79:79:1
chr7	156204925	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,83:83:1
chr7	156816224	.	G	C	.	PASS	CSQ=64327|protein_coding||intron_variant|||||||NM_022458.3:c.319+10381C>G||MODIFIER||||||LMBR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,87:87:1
chr7	157119348	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,80:80:1
chr7	157962455	.	A	C	.	PASS	CSQ=5799|protein_coding||intron_variant|||||||NM_002847.5:c.1724-63718T>G||MODIFIER||||||PTPRN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,91:91:1
chr7	158473276	.	CAGA	C	.	PASS	CSQ=5799|protein_coding||intron_variant|||||||NM_002847.5:c.163+16456_163+16458del||MODIFIER||||||PTPRN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,69:69:1
chr7	159020369	.	A	G	.	PASS	CSQ=154822|lncRNA||non_coding_transcript_exon_variant|||||||NR_024394.1:n.2337A>G||MODIFIER||||||LINC00689|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	0,67:67:1
chr7	159276319	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	116,0:116:0	72,5:77:0.0649
chr8	1336304	.	T	C	.	PASS	CSQ=9228|protein_coding||intron_variant||||||1.31411e-05|NM_001346810.1:c.106+77421T>C||MODIFIER||||||DLGAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	0,74:74:1
chr8	1586706	.	TGTCACTGGA	T	.	PASS	CSQ=9228|protein_coding||intron_variant|||||||NM_001346810.1:c.1442+20813_1442+20821del||MODIFIER||||||DLGAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,62:62:1
chr8	2224636	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,74:74:1
chr8	2920539	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,63:63:1
chr8	3438429	.	C	T	.	PASS	CSQ=64478|protein_coding||intron_variant|||||||NM_033225.6:c.1562-28824G>A||MODIFIER||||||CSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,65:65:1
chr8	3685023	.	G	T	.	PASS	CSQ=64478|protein_coding||intron_variant|||||||NM_033225.6:c.1009+23391C>A||MODIFIER||||||CSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	27,36:63:0.5714
chr8	3736965	.	T	G	.	PASS	CSQ=64478|protein_coding||intron_variant|||||||NM_033225.6:c.931+16965A>C||MODIFIER||||||CSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,81:81:1
chr8	4055184	.	G	A	.	PASS	CSQ=64478|protein_coding||intron_variant||||rs574436313||1.97179e-05|NM_033225.6:c.416-23085C>T||MODIFIER||||||CSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	4,54:58:0.931
chr8	4156352	.	T	C	.	PASS	CSQ=64478|protein_coding||intron_variant||||rs540119115||6.57142e-06|NM_033225.6:c.416-124253A>G||MODIFIER||||||CSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	113,0:113:0	75,4:79:0.0506
chr8	4245553	.	G	T	.	PASS	CSQ=64478|protein_coding||intron_variant|||||||NM_033225.6:c.415+174400C>A||MODIFIER||||||CSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,1:118:0.0085	4,62:66:0.9394
chr8	4772640	.	G	A	.	PASS	CSQ=64478|protein_coding||intron_variant|||||||NM_033225.6:c.86-135082C>T||MODIFIER||||||CSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,57:57:1
chr8	4814567	.	G	T	.	PASS	CSQ=64478|protein_coding||intron_variant|||||||NM_033225.6:c.86-177009C>A||MODIFIER||||||CSMD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	67,6:73:0.0822
chr8	5198323	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	5,69:74:0.9324
chr8	5395711	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs981032678||0.000105373|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,72:72:1
chr8	5418627	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.58926e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,57:57:1
chr8	5468545	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1202721127||7.90826e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	6,76:82:0.9268
chr8	5597303	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	2,72:74:0.973
chr8	5879103	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,63:63:1
chr8	6485324	.	C	CA	.	PASS	CSQ=79648|protein_coding||intron_variant||||rs1391661728||0.00103062|NM_024596.5:c.2136+4460dup||MODIFIER||||||MCPH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:94:0	14,60:74:0.8108
chr8	8760657	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,93:93:1
chr8	9565856	.	C	CA	.	PASS	CSQ=8658|protein_coding||intron_variant||||||1.32307e-05|NM_003747.3:c.673+9252dup||MODIFIER||||||TNKS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	11,79:90:0.8778
chr8	10180591	.	G	C	.	PASS	CSQ=4482|protein_coding||intron_variant||||rs1247314966|||NM_012331.5:c.143-27242G>C||MODIFIER||||||MSRA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,83:83:1
chr8	10881119	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,67:67:1
chr8	11106314	.	G	A	.	PASS	CSQ=286046|protein_coding||intron_variant|||||||NM_173683.3:c.764+94262C>T||MODIFIER||||||XKR6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,100:100:1
chr8	11572902	.	T	A	.	PASS	CSQ=83655|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC00208|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,88:88:1
chr8	11643047	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,80:80:1
chr8	11910948	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs150523645||0.0052948|||MODIFIER||||||||0.3752;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	61,2:63:0.0317	0,8:8:1
chr8	11910950	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs139581114||0.00700491|||MODIFIER||||||||0.3752;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	62,3:65:0.0462	0,9:9:1
chr8	12422015	.	G	A	.	PASS	CSQ=653333|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FAM86B2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	1,63:64:0.9844
chr8	12556960	.	A	T	.	PASS	CSQ=729732|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047662.2:n.1996-17895T>A||MODIFIER||||||LOC729732|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	331,0:331:0	187,41:228:0.1798
chr8	12577565	.	C	A	.	PASS	CSQ=729732|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047662.2:n.1995+3263G>T||MODIFIER||||||LOC729732|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	348,0:348:0	139,89:228:0.3904
chr8	13304360	.	G	A	.	PASS	CSQ=10395|protein_coding||intron_variant||||rs979709795||4.60375e-05|NM_182643.3:c.1348+909C>T||MODIFIER||||||DLC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,83:83:1
chr8	13315710	.	C	T	.	PASS	CSQ=10395|protein_coding||intron_variant|||||||NM_182643.3:c.1315-10408G>A||MODIFIER||||||DLC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,96:96:1
chr8	13383903	.	C	T	.	PASS	CSQ=10395|protein_coding||intron_variant||||rs1036127658||2.62905e-05|NM_182643.3:c.1314+9650G>A||MODIFIER||||||DLC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,70:70:1
chr8	13627391	.	C	G	.	PASS	CSQ=102725080|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC102725080|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,80:80:1
chr8	13685037	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	37,39:76:0.5132
chr8	13736606	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1388345322||6.57376e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,66:66:1
chr8	13747058	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,73:73:1
chr8	13903743	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,66:66:1
chr8	14118257	.	C	G	.	PASS	CSQ=137868|protein_coding||intron_variant||||rs1275193200|||NM_139167.4:c.548-10022G>C||MODIFIER||||||SGCZ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,76:76:1
chr8	14306729	.	TTATTTGTGGTCAA	T	.	PASS	CSQ=137868|protein_coding||intron_variant|||||||NM_139167.4:c.336+17361_336+17373del||MODIFIER||||||SGCZ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,74:74:1
chr8	14834110	.	A	AT	.	PASS	CSQ=137868|protein_coding||intron_variant||||rs1034110535||0.000164934|NM_139167.4:c.40-279185dup||MODIFIER||||||SGCZ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	4,76:80:0.95
chr8	14971153	.	T	A	.	PASS	CSQ=137868|protein_coding||intron_variant|||||||NM_139167.4:c.39+266432A>T||MODIFIER||||||SGCZ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,68:68:1
chr8	15301599	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,56:56:1
chr8	15301622	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,60:60:1
chr8	15821584	COSV64933996	GT	G	.	PASS	CSQ=|||intergenic_variant|||COSV64933996|rs796894711||0.00039057|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	4,63:67:0.9403
chr8	17939260	.	GTTT	G	.	PASS	CSQ=5108|protein_coding||intron_variant|||||||NM_001352632.1:c.612+254_612+256del||MODIFIER||||||PCM1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PCM1|y|n|papillary_thyroid,CML,MPN|||E,L|Dom|fusion|T;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,73:73:1
chr8	20044548	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	44,39:83:0.4699
chr8	20273203	.	G	A	.	PASS	CSQ=11178|protein_coding||intron_variant|||||||NM_021020.5:c.-134-17888C>T||MODIFIER||||||LZTS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,90:90:1
chr8	20789730	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs948045494||6.57333e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,80:80:1
chr8	21679356	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	0,114:114:1
chr8	22244705	.	G	A	.	PASS	CSQ=407037|miRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR320A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,85:85:1
chr8	22736955	.	G	A	.	PASS	CSQ=157310|protein_coding||intron_variant|||||||NM_144962.3:c.358-9735C>T||MODIFIER||||||PEBP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,84:84:1
chr8	22736957	.	TGCCA	T	.	PASS	CSQ=157310|protein_coding||intron_variant|||||||NM_144962.3:c.358-9741_358-9738del||MODIFIER||||||PEBP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,82:82:1
chr8	22739439	.	CTGGG	C	.	PASS	CSQ=157310|protein_coding||intron_variant|||||||NM_144962.3:c.358-12223_358-12220del||MODIFIER||||||PEBP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	3,85:88:0.9659
chr8	23393919	.	C	T	.	PASS	CSQ=4017|protein_coding||intron_variant|||||||NM_002318.2:c.-84+10035G>A||MODIFIER||||||LOXL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:136:0	0,75:75:1
chr8	23837785	.	G	T	.	PASS	CSQ=6781|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||STC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,1:132:0.0076	0,74:74:1
chr8	25594430	.	C	CTT	.	PASS	CSQ=|||intergenic_variant||||rs10665931||0.00459384|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	22,0:91:0	20,60:81:0.7407
chr8	26556285	.	A	ATACT	.	PASS	CSQ=1808|protein_coding||intron_variant||||rs1261734787||0.00487329|NM_001197293.3:c.355-25684_355-25683insTACT||MODIFIER||||||DPYSL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	9,0:9:0	12,9:21:0.4286
chr8	26805825	.	C	T	.	PASS	CSQ=148|protein_coding||intron_variant|||||||NM_000680.3:c.884-35159G>A||MODIFIER||||||ADRA1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	59,8:67:0.1194
chr8	27386721	.	C	T	.	PASS	CSQ=2185|protein_coding||intron_variant||||rs367694622|||NM_173176.3:c.-37-10827C>T||MODIFIER||||||PTK2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,73:73:1
chr8	27994351	.	T	TAA	.	PASS	CSQ=286133|protein_coding||upstream_gene_variant||||rs113838020||0.000113918|||MODIFIER||||||SCARA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	54,0:103:0	7,74:83:0.8916
chr8	28110722	.	A	T	.	PASS	CSQ=55140|protein_coding||intron_variant||||rs1207253851||6.57194e-06|NM_018091.6:c.462+284A>T||MODIFIER||||||ELP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	81,30:111:0.2703
chr8	29051918	.	AC	A	.	PASS	CSQ=79618|protein_coding||3_prime_UTR_variant||||rs1483581524|||NM_001135726.3:c.*766del||MODIFIER||||||HMBOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	17,44:61:0.7213
chr8	29761024	.	G	A	.	PASS	CSQ=101929450|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125815.1:n.271+12445G>A||MODIFIER||||||LINC02099|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,96:96:1
chr8	30744381	.	G	A	.	PASS	CSQ=7993|protein_coding||intron_variant|||||||NM_005671.4:c.88+104G>A||MODIFIER||||||UBXN8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	0,100:100:1
chr8	31547102	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,75:75:1
chr8	31658642	.	T	C	.	PASS	CSQ=3084|protein_coding||intron_variant||||rs1198746783|||NM_001159999.2:c.37+19211T>C||MODIFIER||||||NRG1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NRG1|y|n|NSCLC|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	59,9:68:0.1324
chr8	32281047	.	C	T	.	PASS	CSQ=3084|protein_coding||intron_variant|||||||NM_001159999.2:c.38-314781C>T||MODIFIER||||||NRG1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NRG1|y|n|NSCLC|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	56,7:63:0.1111
chr8	32555162	COSV55178764;COSV55178764;COSV55178764;COSV55178764;COSV55178764;COSV55178764;COSV55178764	C	A	.	PASS	CSQ=3084|protein_coding||intron_variant|COSV55178764&COSV55178764&COSV55178764&COSV55178764&COSV55178764&COSV55178764&COSV55178764|p.?&p.?&p.?&p.?&p.?&p.?&p.?||rs1333781209||6.57307e-06|NM_013956.4:c.100+6336C>A||MODIFIER||||||NRG1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NRG1|y|n|NSCLC|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,65:65:1
chr8	32608101	COSV55167724;COSV55167724;COSV55167724;COSV55167724;COSV55167724;COSV55167724;COSV55167724	T	TG	.	PASS	CSQ=3084|protein_coding||intron_variant|COSV55167724&COSV55167724&COSV55167724&COSV55167724&COSV55167724&COSV55167724&COSV55167724|p.?&p.?&p.?&p.?&p.?&p.?&p.?||rs796560560||0.0265713|NM_013956.4:c.400+2418_400+2419insG||MODIFIER||||||NRG1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NRG1|y|n|NSCLC|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	22,39:62:0.629
chr8	32746337	.	C	T	.	PASS	CSQ=3084|protein_coding||intron_variant||||rs539897432||0.000111789|NM_001322205.1:c.857-3224C>T||MODIFIER||||||NRG1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NRG1|y|n|NSCLC|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,85:85:1
chr8	32754576	COSV55173594;COSV55173594;COSV55173594;COSV55173594;COSV55173594;COSV55173594;COSV55173594;COSV55173594;COSV55173594	TA	T	.	PASS	CSQ=3084|protein_coding||intron_variant|COSV55173594&COSV55173594&COSV55173594&COSV55173594&COSV55173594&COSV55173594&COSV55173594|p.?&p.?&p.?&p.?&p.?&p.?&p.?|COSV55173594&COSV55173594|rs913106624||0.00024108|NM_001322205.1:c.983+112del||MODIFIER||||||NRG1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NRG1|y|n|NSCLC|||E|Dom|TSG,fusion|T;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,1:117:0.0085	7,77:84:0.9167
chr8	33246558	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	6,86:92:0.9348
chr8	33677160	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1191710977||1.972e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,74:74:1
chr8	34009203	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs949130115||6.57289e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	40,18:58:0.3103
chr8	34078540	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,1:102:0.0098	0,66:66:1
chr8	34229500	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,84:84:1
chr8	34709575	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1006082617|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,79:79:1
chr8	34745103	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,70:70:1
chr8	35092440	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	0,53:53:1
chr8	35092478	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,63:63:1
chr8	35584987	.	G	A	.	PASS	CSQ=137970|protein_coding||intron_variant||||rs892723326|||NM_080872.4:c.467-10567G>A||MODIFIER||||||UNC5D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,59:59:1
chr8	35647850	.	C	T	.	PASS	CSQ=137970|protein_coding||intron_variant|||||||NM_080872.4:c.571-35697C>T||MODIFIER||||||UNC5D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,58:58:1
chr8	35874022	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,77:77:1
chr8	35915503	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	6,65:71:0.9155
chr8	36468766	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	2,88:90:0.9778
chr8	36639716	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,73:73:1
chr8	36644067	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs964776798||3.29324e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,72:72:1
chr8	38423075	.	CCAA	C	.	PASS	CSQ=2260|protein_coding||intron_variant|||||||NM_023110.2:c.937-1137_937-1135del||MODIFIER||||||FGFR1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FGFR1|y|n|MPN,NHL,salivary_adenoma|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	99,0:99:0	0,76:76:1
chr8	39114462	.	G	A	.	PASS	CSQ=203102|protein_coding||intron_variant||||rs1455913688||1.97153e-05|NM_145004.7:c.59-3624G>A||MODIFIER||||||ADAM32|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,77:77:1
chr8	39307193	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,92:92:1
chr8	39387503	.	T	C	.	PASS	CSQ=255926|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_001448.1:n.1290-5071T>C||MODIFIER||||||ADAM5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,92:92:1
chr8	39531285	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1441648234||3.29233e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,64:64:1
chr8	39669120	.	G	A	.	PASS	CSQ=8749|protein_coding||intron_variant|||||||NM_014237.3:c.1525+924G>A||MODIFIER||||||ADAM18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,82:82:1
chr8	40148956	.	G	A	.	PASS	CSQ=56892|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TCIM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,83:83:1
chr8	40412255	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,82:82:1
chr8	40748743	.	AT	A	.	PASS	CSQ=79698|protein_coding||intron_variant||||rs1186449312||2.6448e-05|NM_024645.3:c.192+18897del||MODIFIER||||||ZMAT4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	5,80:85:0.9412
chr8	41301623	.	G	C	.	PASS	CSQ=6422|protein_coding||intron_variant|||||||NM_003012.5:c.622+1838C>G||MODIFIER||||||SFRP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,77:77:1
chr8	41327345	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,97:97:1
chr8	43014107	.	G	A	.	PASS	CSQ=84376|protein_coding||intron_variant|||||||NM_032410.4:c.2016+707G>A||MODIFIER||||||HOOK3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/HOOK3|y|n|papillary_thyroid|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	0,72:72:1
chr8	43096155	.	C	T	.	PASS	CSQ=84197|protein_coding||intron_variant||||rs940854479|||NM_032237.4:c.-209-1369C>T||MODIFIER||||||POMK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,96:96:1
chr8	43673709	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	56,13:69:0.1884
chr8	43723219	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,87:87:1
chr8	46052949	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	96,65:161:0.4037
chr8	46221724	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	77,87:164:0.5305
chr8	46222221	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	157,11:168:0.0655
chr8	46240618	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,64:134:0.4776
chr8	46312072	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	78,65:143:0.4545
chr8	46464399	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	60,76:136:0.5588
chr8	46605869	.	A	G	.	PASS	CSQ=389652|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||rs1173268711|||NR_146077.1:n.390+8408T>C||MODIFIER||||||ASNSP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	66,88:154:0.5714
chr8	46758715	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	72,65:137:0.4745
chr8	47018365	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	86,71:157:0.4522
chr8	47121702	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1309235215||7.89297e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	75,68:143:0.4755
chr8	47207546	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	64,77:141:0.5461
chr8	47412040	.	G	C	.	PASS	CSQ=23514|protein_coding||intron_variant||||rs202042190||4.60369e-05|NM_001080394.3:c.877+4079G>C||MODIFIER||||||SPIDR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	73,96:169:0.568
chr8	47725615	.	C	G	.	PASS	CSQ=23514|protein_coding||intron_variant|||||||NM_001080394.3:c.2342-1585C>G||MODIFIER||||||SPIDR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	101,80:181:0.442
chr8	47726110	.	C	T	.	PASS	CSQ=23514|protein_coding||intron_variant|||||||NM_001080394.3:c.2342-1090C>T||MODIFIER||||||SPIDR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	99,94:193:0.487
chr8	47729844	.	G	A	.	PASS	CSQ=23514|protein_coding||intron_variant||||rs141581951||1.97288e-05|NM_001080394.3:c.2604+379G>A||MODIFIER||||||SPIDR|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	93,76:169:0.4497
chr8	47838383	.	A	G	.	PASS	CSQ=5591|protein_coding||intron_variant|||||||NM_006904.6:c.7553+765T>C||MODIFIER||||||PRKDC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	74,86:160:0.5375
chr8	47889922	.	T	C	.	PASS	CSQ=5591|protein_coding||intron_variant|||||||NM_006904.6:c.4071+335A>G||MODIFIER||||||PRKDC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	60,76:136:0.5588
chr8	48228114	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	70,83:153:0.5425
chr8	48442769	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	78,75:153:0.4902
chr8	48443132	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	72,67:139:0.482
chr8	48604810	.	T	G	.	PASS	CSQ=101929268|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_105002.1:n.356+52738T>G||MODIFIER||||||LOC101929268|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	73,73:146:0.5
chr8	48612312	.	C	G	.	PASS	CSQ=101929268|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_105002.1:n.356+60240C>G||MODIFIER||||||LOC101929268|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	72,82:154:0.5325
chr8	48743490	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	147,7:154:0.0455
chr8	48780436	.	CT	AG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	114,0:114:0	78,74:152:0.4868
chr8	48847918	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	73,79:152:0.5197
chr8	48915528	.	G	A	.	PASS	CSQ=6591|protein_coding||downstream_gene_variant||||rs1048784652||7.2279e-05|||MODIFIER||||||SNAI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	71,81:152:0.5329
chr8	48981409	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	69,75:144:0.5208
chr8	49144935	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	76,77:153:0.5033
chr8	49231525	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs912674335||8.55252e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	139,7:146:0.0479
chr8	49688525	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	105,0:105:0	73,88:161:0.5466
chr8	49688532	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	101,0:101:0	72,95:168:0.5655
chr8	49688541	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	100,0:100:0	71,100:171:0.5848
chr8	49807760	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	86,70:156:0.4487
chr8	50459476	.	T	C	.	PASS	CSQ=54212|protein_coding||intron_variant|||||||NM_018967.5:c.363+8747T>C||MODIFIER||||||SNTG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,69:149:0.4631
chr8	50778859	.	C	G	.	PASS	CSQ=54212|protein_coding||intron_variant||||rs1178650305|||NM_018967.5:c.1396-13812C>G||MODIFIER||||||SNTG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	88,57:145:0.3931
chr8	51088322	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs931310588|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	81,76:157:0.4841
chr8	51179640	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	68,77:145:0.531
chr8	51205044	COSV66520630	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV66520630|rs768450021||0.000171008|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	100,0:100:0	142,11:153:0.0719
chr8	51263236	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	91,82:173:0.474
chr8	51396021	.	C	A	.	PASS	CSQ=137902|protein_coding||intron_variant|||||||NM_144651.5:c.3557+12046G>T||MODIFIER||||||PXDNL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	79,83:162:0.5123
chr8	51434618	.	G	T	.	PASS	CSQ=137902|protein_coding||intron_variant|||||||NM_144651.5:c.1526-7860C>A||MODIFIER||||||PXDNL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	88,85:173:0.4913
chr8	51461528	.	G	A	.	PASS	CSQ=137902|protein_coding||intron_variant||||rs372787938|||NM_144651.5:c.813-3861C>T||MODIFIER||||||PXDNL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	70,74:144:0.5139
chr8	51551108	.	A	G	.	PASS	CSQ=137902|protein_coding||intron_variant|||||||NM_144651.5:c.380+5732T>C||MODIFIER||||||PXDNL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	99,68:167:0.4072
chr8	51656984	.	C	A	.	PASS	CSQ=137902|protein_coding||intron_variant|||||||NM_144651.5:c.165-2224G>T||MODIFIER||||||PXDNL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,71:141:0.5035
chr8	51931796	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	78,88:166:0.5301
chr8	52566516	.	C	T	.	PASS	CSQ=389658|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ALKAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	77,83:160:0.5188
chr8	52796983	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	74,68:142:0.4789
chr8	52847465	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1188807525||1.97062e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	80,91:171:0.5322
chr8	52873686	COSV50142918	T	G	.	PASS	CSQ=|||intergenic_variant|||COSV50142918|rs373314091||0.000289337|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	81,75:156:0.4808
chr8	53249188	.	GT	G	.	PASS	CSQ=4986|protein_coding||intron_variant|||||||NM_000912.5:c.257+1592del||MODIFIER||||||OPRK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	70,74:144:0.5139
chr8	53462518	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,54:131:0.4122
chr8	53519089	.	T	C	.	PASS	CSQ=100507516|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149032.1:n.638-2135A>G||MODIFIER||||||LOC100507516|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	70,86:156:0.5513
chr8	54005646	.	A	C	.	PASS	CSQ=6917|protein_coding||intron_variant|||||||NM_006756.4:c.126+4784T>G||MODIFIER||||||TCEA1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TCEA1|y|n|salivary_adenoma|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	92,79:171:0.462
chr8	54131487	COSV52637064;COSV52637064;COSV52637064	C	CT	.	PASS	CSQ=29088|protein_coding||upstream_gene_variant|||COSV52637064&COSV52637064&COSV52637064|rs533330292||0.126152|||MODIFIER||||||MRPL15|EntrezGene|0.2047;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	92,67:161:0.4161
chr8	54516886	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	100,67:167:0.4012
chr8	54519193	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	159,0:159:0	104,82:186:0.4409
chr8	54811137	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	84,64:148:0.4324
chr8	54820357	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	55,82:137:0.5985
chr8	54893044	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,1:117:0.0085	75,68:144:0.4722
chr8	54992563	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	157,6:163:0.0368
chr8	55166986	.	G	T	.	PASS	CSQ=114786|protein_coding||intron_variant|||||||NM_052898.1:c.806+63692G>T||MODIFIER||||||XKR4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	84,80:164:0.4878
chr8	55221792	.	A	G	.	PASS	CSQ=114786|protein_coding||intron_variant|||||||NM_052898.1:c.806+118498A>G||MODIFIER||||||XKR4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	76,63:139:0.4532
chr8	55260470	.	G	A	.	PASS	CSQ=114786|protein_coding||intron_variant||||rs1262229286||1.97151e-05|NM_052898.1:c.807-97208G>A||MODIFIER||||||XKR4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	78,73:151:0.4834
chr8	55916752	.	C	T	.	PASS	CSQ=4067|protein_coding||intron_variant|||||||NM_002350.4:c.-5-25103C>T||MODIFIER||||||LYN|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LYN|y|n|DLBCL,B-ALL,MPN|||L||oncogene,fusion|Mis,T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	90,92:182:0.5055
chr8	56014104	.	C	T	.	PASS	CSQ=4067|protein_coding||3_prime_UTR_variant|||||||NM_002350.4:c.*3994C>T||MODIFIER||||||LYN|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LYN|y|n|DLBCL,B-ALL,MPN|||L||oncogene,fusion|Mis,T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	82,65:147:0.4422
chr8	56253646	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	72,95:167:0.5689
chr8	56403218	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	81,70:151:0.4636
chr8	56429471	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs548115670||4.60024e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	86,76:162:0.4691
chr8	56453128	.	T	A	.	PASS	CSQ=101929415|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125813.1:n.694+6628T>A||MODIFIER||||||LOC101929415|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	131,40:171:0.2339
chr8	56472310	.	C	G	.	PASS	CSQ=101929415|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125813.1:n.695-23913C>G||MODIFIER||||||LOC101929415|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	78,81:159:0.5094
chr8	56672758	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1299899096||6.57471e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	69,76:145:0.5241
chr8	56809506	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	62,80:142:0.5634
chr8	57702052	.	TTGTGTCCACA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	84,77:161:0.4783
chr8	57989803	.	C	T	.	PASS	CSQ=90362|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||FAM110B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	88,87:175:0.4971
chr8	58015531	.	T	A	.	PASS	CSQ=90362|protein_coding||intron_variant|||||||NM_147189.2:c.-627-16075T>A||MODIFIER||||||FAM110B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	61,76:137:0.5547
chr8	58037471	.	C	CA	.	PASS	CSQ=90362|protein_coding||intron_variant||||rs537506310||0.068847|NM_147189.2:c.-529-5702dup||MODIFIER||||||FAM110B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	67,50:119:0.4202
chr8	58073767	.	C	G	.	PASS	CSQ=90362|protein_coding||intron_variant|||||||NM_147189.2:c.-413-1768C>G||MODIFIER||||||FAM110B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	84,86:170:0.5059
chr8	58184275	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	102,81:183:0.4426
chr8	58501455	.	C	CACAAACACAT	.	PASS	CSQ=1581|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CYP7A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	130,0:130:0	95,73:168:0.4345
chr8	58501460	.	A	C	.	PASS	CSQ=1581|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CYP7A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	128,0:128:0	120,45:165:0.2727
chr8	58663609	.	G	A	.	PASS	CSQ=8439|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NSMAF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	87,95:182:0.522
chr8	58702415	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	153,14:167:0.0838
chr8	58907010	.	C	T	.	PASS	CSQ=9760|protein_coding||intron_variant|||||||NM_014729.3:c.411+32292G>A||MODIFIER||||||TOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	71,81:152:0.5329
chr8	58990216	.	A	T	.	PASS	CSQ=9760|protein_coding||intron_variant|||||||NM_014729.3:c.103-30208T>A||MODIFIER||||||TOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	72,69:141:0.4894
chr8	59115466	.	T	A	.	PASS	CSQ=9760|protein_coding||intron_variant|||||||NM_014729.3:c.102+3420A>T||MODIFIER||||||TOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	81,96:177:0.5424
chr8	59122210	.	C	A	.	PASS	CSQ=100505501|lncRNA||non_coding_transcript_exon_variant|||||||NR_149031.1:n.2066C>A||MODIFIER||||||LOC100505501|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,1:113:0.0088	81,69:150:0.46
chr8	59209232	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	82,81:163:0.4969
chr8	59388609	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	67,90:157:0.5732
chr8	59546975	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	83,75:158:0.4747
chr8	59961925	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	74,67:141:0.4752
chr8	60215449	.	A	G	.	PASS	CSQ=767|protein_coding||intron_variant|||||||NM_004056.6:c.739-6530T>C||MODIFIER||||||CA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	68,0:68:0	59,53:112:0.4732
chr8	60311467	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	79,74:153:0.4837
chr8	60440964	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	81,79:160:0.4938
chr8	60895972	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs993549758|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	72,89:161:0.5528
chr8	60989297	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	95,99:194:0.5103
chr8	61084101	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	80,73:153:0.4771
chr8	61166881	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1219328139||0.0435473|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	95,59:155:0.3806
chr8	62453049	.	T	G	.	PASS	CSQ=286183|protein_coding||intron_variant|||||||NM_001304533.1:c.55-126490T>G||MODIFIER||||||NKAIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	52,71:123:0.5772
chr8	62499708	.	C	A	.	PASS	CSQ=286183|protein_coding||intron_variant|||||||NM_001304533.1:c.55-79831C>A||MODIFIER||||||NKAIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	76,82:158:0.519
chr8	62880971	.	G	A	.	PASS	CSQ=286183|protein_coding||intron_variant|||||||NM_001304533.1:c.472-37482G>A||MODIFIER||||||NKAIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	101,104:205:0.5073
chr8	63236691	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	78,61:139:0.4388
chr8	63409938	COSV72943683;COSV72943683	AG	A	.	PASS	CSQ=|||intergenic_variant|||COSV72943683&COSV72943683|rs199821138|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	91,87:178:0.4888
chr8	63498516	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	89,77:166:0.4639
chr8	63504032	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs957348911||0.094668|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	114,28:142:0.1972
chr8	63632466	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	127,11:138:0.0797
chr8	63680654	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	65,76:141:0.539
chr8	63780170	.	G	T	.	PASS	CSQ=286184|lncRNA||non_coding_transcript_exon_variant|||||||NR_038875.2:n.2138G>T||MODIFIER||||||LINC01289|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,1:128:0.0078	73,71:144:0.4931
chr8	63819021	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	76,72:148:0.4865
chr8	64114791	.	G	A	.	PASS	CSQ=102724623|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125826.1:n.410+18657C>T||MODIFIER||||||LOC102724623|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	64,108:172:0.6279
chr8	64307150	.	G	GA	.	PASS	CSQ=102724623|lncRNA||intron_variant&non_coding_transcript_variant||||rs1335563113||6.60546e-06|NR_125826.1:n.218+61190dup||MODIFIER||||||LOC102724623|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	78,90:168:0.5357
chr8	64557351	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57402e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	72,77:149:0.5168
chr8	64646096	.	C	A	.	PASS	CSQ=9420|protein_coding||intron_variant|||||||NM_004820.5:c.123-21557G>T||MODIFIER||||||CYP7B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	70,81:151:0.5364
chr8	64929524	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1490382036||6.57263e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	81,69:150:0.46
chr8	65003782	.	GCA	G	.	PASS	CSQ=|||intergenic_variant||||rs1183426673|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	76,83:159:0.522
chr8	65158221	.	A	AT	.	PASS	CSQ=552859|lncRNA||downstream_gene_variant||||rs1300626297|||||MODIFIER||||||LINC00251|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	90,76:166:0.4578
chr8	65305083	COSV63743611	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV63743611|rs937805942||0.000119035|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	69,87:156:0.5577
chr8	65351175	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	78,73:151:0.4834
chr8	65571116	.	TGCCTGG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	86,71:157:0.4522
chr8	65755137	.	C	G	.	PASS	CSQ=5150|protein_coding||intron_variant|||||||NM_001242318.2:c.284-7334G>C||MODIFIER||||||PDE7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	53,70:123:0.5691
chr8	65920471	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	69,79:148:0.5338
chr8	66444203	.	G	A	.	PASS	CSQ=137872|protein_coding||intron_variant||||rs138503583||2.62912e-05|NM_144650.3:c.145-164G>A||MODIFIER||||||ADHFE1|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	74,83:157:0.5287
chr8	67062196	.	C	A	.	PASS	CSQ=79848|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CSPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,1:140:0.0071	92,97:189:0.5132
chr8	67099925	.	T	TA	.	PASS	CSQ=79848|protein_coding||intron_variant||||||6.5812e-06|NM_024790.6:c.951-3104dup||MODIFIER||||||CSPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	104,80:184:0.4348
chr8	67154367	.	AT	A	.	PASS	CSQ=79848|protein_coding||intron_variant||||rs1416625603||1.97774e-05|NM_024790.6:c.2226+239del||MODIFIER||||||CSPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	93,75:168:0.4464
chr8	67154377	.	T	A	.	PASS	CSQ=79848|protein_coding||intron_variant|||||||NM_024790.6:c.2226+241T>A||MODIFIER||||||CSPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	95,86:181:0.4751
chr8	67457351	.	AATTCTCATTTTTTTCCTGTCTATTAAGATTCTTTGGTTTTTGGTCAAAGCCCTTTAACTGGATATATGGGGGACTTATTTTTTTGGCTGAAGATCTTGGAGTCTTCAGCTCC	A	.	PASS	CSQ=57094|protein_coding||intron_variant|||||||NM_020361.4:c.839-23223_839-23112del||MODIFIER||||||CPA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=mantaSV	AD:DP:AF	212,2:214:0.004819	143,48:191:0.222
chr8	67546662	.	AG	A	.	PASS	CSQ=57094|protein_coding||intron_variant|||||||NM_020361.4:c.193-28616del||MODIFIER||||||CPA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	82,69:151:0.457
chr8	67567654	.	G	A	.	PASS	CSQ=57094|protein_coding||intron_variant|||||||NM_020361.4:c.193-49607C>T||MODIFIER||||||CPA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	169,17:186:0.0914
chr8	67614351	.	CATGG	C	.	PASS	CSQ=57094|protein_coding||intron_variant|||||||NM_020361.4:c.192+9821_192+9824del||MODIFIER||||||CPA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	81,69:150:0.46
chr8	67728456	.	C	T	.	PASS	CSQ=57094|protein_coding||intron_variant||||rs901579869||5.26427e-05|NM_020361.4:c.116+17558G>A||MODIFIER||||||CPA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	106,48:154:0.3117
chr8	67848597	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	73,69:142:0.4859
chr8	67940329	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	160,12:172:0.0698
chr8	68328564	.	C	G	.	PASS	CSQ=116328|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||C8orf34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	57,57:114:0.5
chr8	68416009	.	A	G	.	PASS	CSQ=116328|protein_coding||intron_variant|||||||NM_052958.4:c.328-23490A>G||MODIFIER||||||C8orf34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	84,91:176:0.517
chr8	68595844	.	A	T	.	PASS	CSQ=116328|protein_coding||intron_variant|||||||NM_052958.4:c.1106-44532A>T||MODIFIER||||||C8orf34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	86,69:155:0.4452
chr8	68743815	.	C	T	.	PASS	CSQ=116328|protein_coding||intron_variant||||rs1163421866||8.54094e-05|NM_052958.4:c.1404+22378C>T||MODIFIER||||||C8orf34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	87,67:154:0.4351
chr8	68911655	.	C	T	.	PASS	CSQ=100505718|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01592|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	64,65:129:0.5039
chr8	68952257	.	A	T	.	PASS	CSQ=100505718|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_039986.1:n.520+1801T>A||MODIFIER||||||LINC01592|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,60:126:0.4762
chr8	69015234	.	C	T	.	PASS	CSQ=100505718|lncRNA||intron_variant&non_coding_transcript_variant||||rs1019230387||6.57843e-06|NR_039986.1:n.415+53094G>A||MODIFIER||||||LINC01592|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	81,84:165:0.5091
chr8	69027369	.	G	GA	.	PASS	CSQ=100505718|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_039986.1:n.415+40958dup||MODIFIER||||||LINC01592|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	63,65:128:0.5078
chr8	69177518	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	60,77:137:0.562
chr8	69179123	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57428e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	69,70:139:0.5036
chr8	69385204	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs895936065|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	80,76:156:0.4872
chr8	69566060	.	C	T	.	PASS	CSQ=23213|protein_coding||intron_variant||||rs1233924432||6.57722e-06|NM_001128205.2:c.172+1913C>T||MODIFIER||||||SULF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	83,49:132:0.3712
chr8	69856890	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	90,78:168:0.4643
chr8	70046312	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs763665718||0.305783|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	128,8:137:0.0584
chr8	70069402	COSV52575510;COSV52575510	G	A	.	PASS	CSQ=63978|protein_coding||synonymous_variant|COSV52575510|p.P153|COSV52575510|COSM5409824|||NM_024504.3:c.459C>T|NP_078780.1:p.Pro153=|LOW||||||PRDM14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	89,92:181:0.5083
chr8	70192968	.	G	A	.	PASS	CSQ=10499|protein_coding||intron_variant|||||||NM_006540.4:c.260-18109C>T||MODIFIER||||||NCOA2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NCOA2|y|n|AML,chondrosarcoma,rhabdomyosarcoma|||L,M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	64,66:130:0.5077
chr8	70247727	.	C	T	.	PASS	CSQ=10499|protein_coding||intron_variant|||||||NM_006540.4:c.-19-30963G>A||MODIFIER||||||NCOA2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NCOA2|y|n|AML,chondrosarcoma,rhabdomyosarcoma|||L,M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	84,73:157:0.465
chr8	70422717	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs529950833||1.97226e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	88,88:176:0.5
chr8	70477770	.	C	T	.	PASS	CSQ=101926892|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110653.1:n.713-323C>T||MODIFIER||||||LOC101926892|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	77,86:163:0.5276
chr8	70874283	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1019939227||3.94789e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	78,65:143:0.4545
chr8	70912695	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs984649034||1.31723e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	76,70:146:0.4795
chr8	70986205	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	73,75:148:0.5068
chr8	70987657	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	70,84:154:0.5455
chr8	71108772	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	73,66:139:0.4748
chr8	71992235	.	C	T	.	PASS	CSQ=100132891|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033652.1:n.1028+26701C>T||MODIFIER||||||MSC-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	78,62:140:0.4429
chr8	72349654	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,1:95:0.0105	87,69:156:0.4423
chr8	72362069	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs550265602||0.00125161|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	104,51:155:0.329
chr8	72643782	.	A	T	.	PASS	CSQ=9312|protein_coding||intron_variant|||||||NM_004770.3:c.579+75469A>T||MODIFIER||||||KCNB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	110,35:145:0.2414
chr8	73419161	.	A	G	.	PASS	CSQ=100128126|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||STAU2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	78,87:165:0.5273
chr8	73451004	.	A	T	.	PASS	CSQ=27067|protein_coding||intron_variant|||||||NM_001164380.2:c.1531-28302T>A||MODIFIER||||||STAU2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	75,67:142:0.4718
chr8	73748889	.	C	G	.	PASS	CSQ=27067|protein_coding||upstream_gene_variant||||rs1266408616||0.00329955|||MODIFIER||||||STAU2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	55,0:55:0	35,29:64:0.4531
chr8	74186812	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1380250692||6.57324e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	79,74:153:0.4837
chr8	74319872	COSV60612301;COSV60612301;COSV60612301	C	A	.	PASS	CSQ=56704|protein_coding||intron_variant|COSV60612301|p.?|COSV60612301&COSV60612301|rs916027204||1.31406e-05|NM_020647.4:c.379+1037G>T||MODIFIER||||||JPH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	89,87:176:0.4943
chr8	74574273	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	81,64:145:0.4414
chr8	74600277	COSV72886185	C	CT	.	PASS	CSQ=441355|lncRNA||intron_variant&non_coding_transcript_variant|||COSV72886185|rs781650557||0.0345351|NR_033830.1:n.43+381dup||MODIFIER||||||MIR2052HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	71,52:125:0.416
chr8	74762180	.	C	G	.	PASS	CSQ=441355|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR2052HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	57,81:138:0.587
chr8	74903392	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	60,70:130:0.5385
chr8	74981208	.	TCCCTG	T	.	PASS	CSQ=83690|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CRISPLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	80,53:133:0.3985
chr8	75019591	.	A	AT	.	PASS	CSQ=83690|protein_coding||intron_variant||||||1.97631e-05|NM_031461.6:c.1128-273dup||MODIFIER||||||CRISPLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	91,68:159:0.4277
chr8	75407059	.	C	T	.	PASS	CSQ=3174|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||HNF4G|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	130,9:139:0.0647
chr8	75578387	.	ACCATGATGTCTTTGAGAGTGTG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	62,78:140:0.5571
chr8	75592484	.	TGCAGTG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	50,64:114:0.5614
chr8	75604783	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	71,81:153:0.5294
chr8	75646579	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	132,11:143:0.0769
chr8	75831948	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	64,57:121:0.4711
chr8	76566316	.	CC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	125,0:125:0	77,67:144:0.4653
chr8	76850543	.	C	T	.	PASS	CSQ=79776|protein_coding||intron_variant|||||||NM_024721.4:c.3964+181C>T||MODIFIER||||||ZFHX4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	61,82:143:0.5734
chr8	77020278	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs996183341||2.63016e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	94,74:168:0.4405
chr8	77032123	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs942766564|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	83,78:161:0.4845
chr8	77191183	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	72,77:150:0.5133
chr8	77328399	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	119,28:147:0.1905
chr8	77429311	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	55,56:111:0.5045
chr8	77718630	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	77,61:138:0.442
chr8	77778197	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	77,66:143:0.4615
chr8	77904345	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1351090705||6.58033e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	142,10:152:0.0658
chr8	78089082	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	80,73:153:0.4771
chr8	78137207	.	TG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	104,0:104:0	80,81:161:0.5031
chr8	78262693	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	82,54:136:0.3971
chr8	78517608	.	G	A	.	PASS	CSQ=5569|protein_coding||intron_variant|||||||NM_006823.4:c.-157+1140G>A||MODIFIER||||||PKIA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	80,66:146:0.4521
chr8	78521455	.	G	T	.	PASS	CSQ=5569|protein_coding||intron_variant||||||6.58319e-06|NM_006823.4:c.-157+4987G>T||MODIFIER||||||PKIA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	80,61:141:0.4326
chr8	78603799	.	G	A	.	PASS	CSQ=5569|protein_coding||3_prime_UTR_variant|||||||NM_006823.4:c.*1978G>A||MODIFIER||||||PKIA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	139,0:139:0	147,8:155:0.0516
chr8	78646664	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	151,8:159:0.0503
chr8	79019497	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	85,79:164:0.4817
chr8	79141260	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	65,61:126:0.4841
chr8	79909394	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	82,92:174:0.5287
chr8	80262815	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	66,95:161:0.5901
chr8	80838322	.	G	A	.	PASS	CSQ=619279|protein_coding||intron_variant|||||||NM_001033723.3:c.-21-16707C>T||MODIFIER||||||ZNF704|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	99,94:193:0.487
chr8	81336163	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,78:158:0.4937
chr8	81597476	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	78,69:147:0.4694
chr8	81701484	.	T	G	.	PASS	CSQ=79752|protein_coding||3_prime_UTR_variant|||||||NM_024699.3:c.*1211A>C||MODIFIER||||||ZFAND1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	138,13:151:0.0861
chr8	81924391	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	83,64:147:0.4354
chr8	82094076	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||6.578e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	72,74:146:0.5068
chr8	82201277	.	C	G	.	PASS	CSQ=|||intergenic_variant||||||6.57402e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,1:133:0.0075	69,53:122:0.4344
chr8	83063718	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	163,0:163:0	99,83:182:0.456
chr8	83089657	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	58,70:128:0.5469
chr8	83109452	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	82,66:148:0.4459
chr8	83391068	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	124,8:132:0.0606
chr8	83416405	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1237745733||0.00148516|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	71,52:124:0.4194
chr8	83519040	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	50,68:118:0.5763
chr8	83536389	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,1:102:0.0098	57,67:124:0.5403
chr8	83761489	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	68,62:130:0.4769
chr8	83823962	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	73,63:136:0.4632
chr8	83864340	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	68,75:143:0.5245
chr8	83980059	.	TCTAGAGTTAAG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	78,67:145:0.4621
chr8	84174556	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	79,75:154:0.487
chr8	84189178	.	G	A	.	PASS	CSQ=138046|protein_coding||intron_variant|||||||NM_173848.7:c.-24+4754G>A||MODIFIER||||||RALYL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	80,69:149:0.4631
chr8	84379861	.	C	CA	.	PASS	CSQ=138046|protein_coding||intron_variant||||rs745791236||0.00637038|NM_173848.7:c.-23-149426dup||MODIFIER||||||RALYL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	94,0:94:0	80,68:148:0.4595
chr8	84408503	.	C	A	.	PASS	CSQ=138046|protein_coding||intron_variant|||||||NM_173848.7:c.-23-120796C>A||MODIFIER||||||RALYL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	86,69:155:0.4452
chr8	84457602	COSV72826732;COSV72826732;COSV72826732;COSV72826732;COSV72826732	C	A	.	PASS	CSQ=138046|protein_coding||intron_variant|COSV72826732&COSV72826732&COSV72826732&COSV72826732&COSV72826732|p.?&p.?&p.?&p.?&p.?||||6.58831e-06|NM_173848.7:c.-23-71697C>A||MODIFIER||||||RALYL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	84,82:166:0.494
chr8	84516585	.	C	T	.	PASS	CSQ=138046|protein_coding||intron_variant|||||||NM_173848.7:c.-23-12714C>T||MODIFIER||||||RALYL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	71,61:132:0.4621
chr8	84684197	.	A	T	.	PASS	CSQ=138046|protein_coding||intron_variant|||||||NM_173848.7:c.257-90382A>T||MODIFIER||||||RALYL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	80,83:163:0.5092
chr8	84866856	.	G	T	.	PASS	CSQ=138046|protein_coding||intron_variant||||rs900684973||1.9728e-05|NM_173848.7:c.571+4403G>T||MODIFIER||||||RALYL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	72,79:151:0.5232
chr8	84911246	.	G	T	.	PASS	CSQ=138046|protein_coding||intron_variant|||||||NM_173848.7:c.859-9648G>T||MODIFIER||||||RALYL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	70,71:141:0.5035
chr8	85045152	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	68,65:133:0.4887
chr8	85388724	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs979137624||6.59118e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	66,69:136:0.5074
chr8	85513725	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	61,75:136:0.5515
chr8	86657485	.	GG	CA	.	PASS	CSQ=54714|protein_coding||intron_variant|||||||NM_019098.4:c.853-3424_853-3423delinsTG||MODIFIER||||||CNGB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	136,0:136:0	81,63:145:0.4345
chr8	87140577	.	A	G	.	PASS	CSQ=168975|protein_coding||intron_variant||||rs1298138323||6.57315e-06|NM_173538.2:c.432-65416A>G||MODIFIER||||||CNBD1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CNBD1|y|n|gastric_cancer,colon_cancer|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	72,85:157:0.5414
chr8	87440290	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1219504414||6.5957e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	71,71:142:0.5
chr8	87523100	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs192059617||0.00034971|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	73,84:157:0.535
chr8	87579015	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	122,7:129:0.0543
chr8	87655096	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	129,11:140:0.0786
chr8	87808668	.	CA	AG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	103,0:103:0	56,58:114:0.5088
chr8	87824728	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1188660869||2.63387e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	73,72:145:0.4966
chr8	87852437	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	69,68:138:0.4928
chr8	87949700	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	76,77:153:0.5033
chr8	87995141	.	CA	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	123,0:123:0	67,85:152:0.5592
chr8	88167142	.	G	A	.	PASS	CSQ=4325|protein_coding||intron_variant|||||||NM_005941.5:c.709+527C>T||MODIFIER||||||MMP16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	76,57:133:0.4286
chr8	88168444	.	C	T	.	PASS	CSQ=4325|protein_coding||intron_variant|||||||NM_005941.5:c.405-471G>A||MODIFIER||||||MMP16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	87,74:162:0.4568
chr8	88318842	.	GTGTTCAAATGGTATTTCCA	G	.	PASS	CSQ=4325|protein_coding||intron_variant|||||||NM_005941.5:c.132+8214_132+8232del||MODIFIER||||||MMP16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	115,41:156:0.2628
chr8	88338076	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	62,81:143:0.5664
chr8	88465072	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	84,76:160:0.475
chr8	88739292	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	64,79:143:0.5524
chr8	88764330	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	84,72:156:0.4615
chr8	88778084	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	81,72:153:0.4706
chr8	88890714	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs1459287082||1.98093e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	83,80:163:0.4908
chr8	89105639	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	69,69:138:0.5
chr8	89166608	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	73,86:159:0.5409
chr8	89362435	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57341e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	78,77:155:0.4968
chr8	90259336	.	C	T	.	PASS	CSQ=100874052|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_051989.1:n.350+13066C>T||MODIFIER||||||LINC00534|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	61,77:138:0.558
chr8	90429741	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	163,5:168:0.0298
chr8	90548672	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	101,70:171:0.4094
chr8	90968873	.	G	A	.	PASS	CSQ=100127983|protein_coding||intron_variant||||rs1458798977|||NM_001190972.2:c.223+2193C>T||MODIFIER||||||C8orf88|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	78,67:145:0.4621
chr8	91587315	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	68,66:134:0.4925
chr8	91766327	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	139,12:151:0.0795
chr8	92106005	.	A	G	.	PASS	CSQ=862|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||RUNX1T1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RUNX1T1|y|n|AML|||L|Dom|oncogene,TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	87,70:157:0.4459
chr8	92147607	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	70,76:146:0.5205
chr8	92209997	COSV70015949	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV70015949|rs956422873||1.34041e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:99:0	81,66:147:0.449
chr8	92571159	.	G	C	.	PASS	CSQ=102724710|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125827.1:n.396-2093C>G||MODIFIER||||||LOC102724710|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	80,69:149:0.4631
chr8	92647233	.	G	A	.	PASS	CSQ=102724710|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125827.1:n.272+6709C>T||MODIFIER||||||LOC102724710|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	67,66:133:0.4962
chr8	92784823	.	G	A	.	PASS	CSQ=441369|lncRNA||intron_variant&non_coding_transcript_variant||||rs574896828||0.00021714|NR_046114.1:n.85+1153C>T||MODIFIER||||||FLJ46284|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	86,81:167:0.485
chr8	93296435	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	68,76:144:0.5278
chr8	94594149	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	148,8:156:0.0513
chr8	95040892	.	G	A	.	PASS	CSQ=137682|protein_coding||intron_variant|||||||NM_152416.4:c.421-678G>A||MODIFIER||||||NDUFAF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	150,0:150:0	90,101:191:0.5288
chr8	95059836	.	G	A	.	PASS	CSQ=137682|protein_coding||downstream_gene_variant||||rs1306381739|||||MODIFIER||||||NDUFAF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	166,13:179:0.0726
chr8	95154765	.	G	A	.	PASS	CSQ=79666|protein_coding||missense_variant|||||||NM_024613.4:c.721G>A|NP_078889.1:p.Asp241Asn|MODERATE|P&P|D&D|D|T&T|T&T|PLEKHF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	157,8:165:0.0485
chr8	95763651	.	C	A	.	PASS	CSQ=100616530|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038201.1:n.316-36845C>A||MODIFIER||||||C8orf37-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	131,14:145:0.0966
chr8	95764095	.	G	A	.	PASS	CSQ=100616530|lncRNA||intron_variant&non_coding_transcript_variant||||rs898211986||1.31422e-05|NR_038201.1:n.316-36401G>A||MODIFIER||||||C8orf37-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	81,67:148:0.4527
chr8	95979330	.	CA	C	.	PASS	CSQ=|||intergenic_variant||||rs1277565123||6.61175e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	77,60:137:0.438
chr8	96095695	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	80,77:157:0.4904
chr8	96183724	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	74,79:153:0.5163
chr8	96198058	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	93,74:167:0.4431
chr8	96273017	.	A	T	.	PASS	CSQ=9791|protein_coding||intron_variant|||||||NM_014754.2:c.180-282A>T||MODIFIER||||||PTDSS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	79,86:165:0.5212
chr8	96346659	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	138,15:153:0.098
chr8	96532079	.	TGAA	T	.	PASS	CSQ=6383|protein_coding||intron_variant|||||||NM_002998.4:c.60+37750_60+37752del||MODIFIER||||||SDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	155,6:161:0.0373
chr8	96559818	.	TACTACTG	T	.	PASS	CSQ=6383|protein_coding||intron_variant|||||||NM_002998.4:c.61-33660_61-33654del||MODIFIER||||||SDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	70,68:138:0.4928
chr8	96593181	.	G	T	.	PASS	CSQ=6383|protein_coding||intron_variant|||||||NM_002998.4:c.61-299G>T||MODIFIER||||||SDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	94,80:174:0.4598
chr8	96601904	.	G	A	.	PASS	CSQ=6383|protein_coding||intron_variant||||rs577701446||0.000158303|NM_002998.4:c.173-491G>A||MODIFIER||||||SDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	78,61:139:0.4388
chr8	96886156	.	C	G	.	PASS	CSQ=10404|protein_coding||intron_variant||||rs1246614107||6.57168e-06|NM_016134.4:c.849+6151C>G||MODIFIER||||||CPQ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	134,11:145:0.0759
chr8	97083816	.	G	A	.	PASS	CSQ=10404|protein_coding||intron_variant|||||||NM_016134.4:c.1255+17606G>A||MODIFIER||||||CPQ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	77,76:153:0.4967
chr8	97385625	.	A	C	.	PASS	CSQ=101927066|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125390.1:n.471+33445T>G||MODIFIER||||||LOC101927066|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	91,86:177:0.4859
chr8	97735689	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1271119890||1.97223e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	81,84:165:0.5091
chr8	98041217	.	C	A	.	PASS	CSQ=4147|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MATN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	69,82:151:0.543
chr8	98488163	.	C	G	.	PASS	CSQ=6788|protein_coding||intron_variant|||||||NM_006281.4:c.1318-32163G>C||MODIFIER||||||STK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	167,6:173:0.0347
chr8	98509758	.	C	A	.	PASS	CSQ=6788|protein_coding||intron_variant|||||||NM_006281.4:c.1317+16984G>T||MODIFIER||||||STK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	84,85:169:0.503
chr8	99032926	.	C	T	.	PASS	CSQ=157680|protein_coding||intron_variant|||||||NM_152564.4:c.148-5497C>T||MODIFIER||||||VPS13B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	84,87:172:0.5058
chr8	99556553	.	C	T	.	PASS	CSQ=157680|protein_coding||missense_variant||||rs1212741771||6.57696e-06|NM_152564.4:c.4849C>T|NP_689777.3:p.His1617Tyr|MODERATE|B&B|T&T|D|D&D|T&T|VPS13B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	108,0:108:0	70,74:144:0.5139
chr8	100237335	.	C	G	.	PASS	CSQ=6674|protein_coding||intron_variant|||||||NM_172218.2:c.2116-1905C>G||MODIFIER||||||SPAG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	73,72:145:0.4966
chr8	100263482	.	G	A	.	PASS	CSQ=25897|protein_coding||intron_variant|||||||NM_183419.4:c.1468+552C>T||MODIFIER||||||RNF19A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	77,83:160:0.5188
chr8	100389767	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs193212232||1.97156e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	95,92:187:0.492
chr8	101013797	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	65,64:129:0.4961
chr8	101415902	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	83,85:168:0.506
chr8	102812111	.	A	G	.	PASS	CSQ=401472|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||GASAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	111,94:205:0.4585
chr8	103722149	.	C	T	.	PASS	CSQ=9699|protein_coding||intron_variant|||||||NM_001348484.1:c.519+5829C>T||MODIFIER||||||RIMS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	68,72:140:0.5143
chr8	103814910	.	C	T	.	PASS	CSQ=9699|protein_coding||intron_variant|||||||NM_001348484.1:c.830+48373C>T||MODIFIER||||||RIMS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	83,84:167:0.503
chr8	103910672	.	C	A	.	PASS	CSQ=9699|protein_coding||intron_variant|||||||NM_001348484.1:c.1965+143C>A||MODIFIER||||||RIMS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	77,104:182:0.5714
chr8	104099174	.	C	G	.	PASS	CSQ=9699|protein_coding||intron_variant|||||||NM_001348484.1:c.3866+5531C>G||MODIFIER||||||RIMS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	85,91:176:0.517
chr8	104267875	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	74,72:146:0.4932
chr8	104456874	.	T	C	.	PASS	CSQ=1807|protein_coding||intron_variant|||||||NM_001385.3:c.265-5470A>G||MODIFIER||||||DPYS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	84,78:162:0.4815
chr8	104488504	.	T	TA	.	PASS	CSQ=693127|miRNA||upstream_gene_variant||||rs993250037||7.91724e-05|||MODIFIER||||||MIR548A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	94,82:176:0.4659
chr8	104513571	.	C	A	.	PASS	CSQ=29967|protein_coding||intron_variant|||||||NM_013437.4:c.137-4497G>T||MODIFIER||||||LRP12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	77,71:148:0.4797
chr8	104621794	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs183793754||0.000479941|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	82,79:161:0.4907
chr8	105050227	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs569376657||0.000355034|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	85,87:172:0.5058
chr8	105113605	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	77,72:149:0.4832
chr8	105297316	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs866034101||0.000164236|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	95,84:179:0.4693
chr8	105564510	.	T	G	.	PASS	CSQ=23414|protein_coding||intron_variant|||||||NM_012082.4:c.420+3029T>G||MODIFIER||||||ZFPM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	96,79:175:0.4514
chr8	105597859	.	A	C	.	PASS	CSQ=23414|protein_coding||intron_variant|||||||NM_012082.4:c.420+36378A>C||MODIFIER||||||ZFPM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	58,68:126:0.5397
chr8	105896846	.	C	T	.	PASS	CSQ=102723356|lncRNA||intron_variant&non_coding_transcript_variant||||rs566285895||6.57678e-05|NR_125797.1:n.190+30805G>A||MODIFIER||||||ZFPM2-AS1|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	77,86:163:0.5276
chr8	106131532	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	161,16:177:0.0904
chr8	106425658	.	G	GT	.	PASS	CSQ=55074|protein_coding||intron_variant||||||1.3151e-05|NM_001198533.1:c.23+66029dup||MODIFIER||||||OXR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	80,62:142:0.4366
chr8	106554374	.	A	C	.	PASS	CSQ=55074|protein_coding||intron_variant|||||||NM_001198533.1:c.220+35235A>C||MODIFIER||||||OXR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	95,74:169:0.4379
chr8	106750745	.	A	G	.	PASS	CSQ=55074|protein_coding||intron_variant|||||||NM_001198533.1:c.2487-61A>G||MODIFIER||||||OXR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	119,0:119:0	86,96:182:0.5275
chr8	107171846	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	73,67:140:0.4786
chr8	107183937	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	78,76:154:0.4935
chr8	107197681	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	66,77:143:0.5385
chr8	107373129	.	T	A	.	PASS	CSQ=284|protein_coding||intron_variant|||||||NM_001146.5:c.298-26032A>T||MODIFIER||||||ANGPT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	59,57:116:0.4914
chr8	107388579	.	C	T	.	PASS	CSQ=284|protein_coding||intron_variant||||rs1403423300||6.57384e-06|NM_001146.5:c.298-41482G>A||MODIFIER||||||ANGPT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	74,62:136:0.4559
chr8	107754825	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	79,69:148:0.4662
chr8	107834960	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	77,76:153:0.4967
chr8	108097527	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	63,68:131:0.5191
chr8	108543461	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	78,78:156:0.5
chr8	108957832	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1183834962||6.57246e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,1:111:0.009	57,67:124:0.5403
chr8	108960887	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	73,79:152:0.5197
chr8	109360740	.	G	GT	.	PASS	CSQ=93035|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PKHD1L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	92,70:162:0.4321
chr8	109535203	.	C	CA	.	PASS	CSQ=9166|protein_coding||upstream_gene_variant||||rs755357158||0.00427297|||MODIFIER||||||EBAG9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	86,64:151:0.4238
chr8	109752771	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	64,68:132:0.5152
chr8	109973976	.	TGGATCTCCTGCA	T	.	PASS	CSQ=27012|protein_coding||inframe_deletion|||||||NM_014379.4:c.401_412del|NP_055194.1:p.Leu134_Ile137del|MODERATE||||||KCNV1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	151,0:151:0	84,95:179:0.5307
chr8	110155001	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	100,98:198:0.4949
chr8	110353448	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	81,81:162:0.5
chr8	110404571	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	146,7:153:0.0458
chr8	110711111	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1274558894||1.32053e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	119,38:157:0.242
chr8	110749478	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	73,75:148:0.5068
chr8	110832207	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	117,0:118:0	72,70:142:0.493
chr8	110888466	.	T	TATATATA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	63,0:63:0	69,50:119:0.4202
chr8	110947419	.	C	G	.	PASS	CSQ=101927459|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125417.1:n.524-9692G>C||MODIFIER||||||LINC01608|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	78,75:153:0.4902
chr8	111185765	.	G	T	.	PASS	CSQ=101927487|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125418.1:n.122+50317C>A||MODIFIER||||||LINC01609|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	66,67:133:0.5038
chr8	111213293	.	T	A	.	PASS	CSQ=101927487|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125418.1:n.122+22789A>T||MODIFIER||||||LINC01609|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	70,86:156:0.5513
chr8	111572259	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	67,70:137:0.5109
chr8	111650807	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1433486734||6.58363e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	58,60:118:0.5085
chr8	111678771	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	79,64:143:0.4476
chr8	111702902	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	70,78:148:0.527
chr8	111781156	.	C	G	.	PASS	CSQ=|||intergenic_variant||||||6.57817e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,67:136:0.4926
chr8	111799868	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,62:139:0.446
chr8	111829551	COSV101098025	T	A	.	PASS	CSQ=|||intergenic_variant|||COSV101098025|rs868730875||0.000203805|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,1:136:0.0074	77,82:159:0.5157
chr8	111846361	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	68,54:122:0.4426
chr8	111853570	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	77,80:157:0.5096
chr8	111866845	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	71,83:154:0.539
chr8	112133750	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	112,0:112:0	65,61:126:0.4841
chr8	112187906	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	62,59:121:0.4876
chr8	112363992	.	C	A	.	PASS	CSQ=114788|protein_coding||intron_variant|||||||NM_198123.2:c.6137-11458G>T||MODIFIER||||||CSMD3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CSMD3|y|n|ovarian_cancer,oral_SCC,lung_cancer|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	125,14:139:0.1007
chr8	112471573	.	C	G	.	PASS	CSQ=114788|protein_coding||intron_variant||||rs191213626||1.97254e-05|NM_198123.2:c.5395+1018G>C||MODIFIER||||||CSMD3|EntrezGene|0.0002;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CSMD3|y|n|ovarian_cancer,oral_SCC,lung_cancer|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	74,58:132:0.4394
chr8	112505680	.	G	GT	.	PASS	CSQ=114788|protein_coding||intron_variant||||rs141045960||0.0174324|NM_198123.2:c.4895+1010dup||MODIFIER||||||CSMD3|EntrezGene|0.0214;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CSMD3|y|n|ovarian_cancer,oral_SCC,lung_cancer|||E||TSG|Mis,N;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	68,57:126:0.4524
chr8	112560264	.	C	A	.	PASS	CSQ=114788|protein_coding||intron_variant|||||||NM_198123.2:c.4043-3310G>T||MODIFIER||||||CSMD3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CSMD3|y|n|ovarian_cancer,oral_SCC,lung_cancer|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	70,78:148:0.527
chr8	113132881	.	C	A	.	PASS	CSQ=114788|protein_coding||intron_variant||||rs1188079799||1.3152e-05|NM_198123.2:c.710-33918G>T||MODIFIER||||||CSMD3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CSMD3|y|n|ovarian_cancer,oral_SCC,lung_cancer|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	65,74:139:0.5324
chr8	113187659	.	C	A	.	PASS	CSQ=114788|protein_coding||intron_variant|||||||NM_198123.2:c.515-13743G>T||MODIFIER||||||CSMD3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CSMD3|y|n|ovarian_cancer,oral_SCC,lung_cancer|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	69,53:122:0.4344
chr8	113453741	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	67,72:139:0.518
chr8	113740159	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	69,70:139:0.5036
chr8	113816308	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,64:140:0.4571
chr8	113859386	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	124,0:124:0	128,10:138:0.0725
chr8	113915089	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	62,74:136:0.5441
chr8	113940926	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	66,72:138:0.5217
chr8	113964572	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs760909786|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	66,69:135:0.5111
chr8	114035215	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	94,32:126:0.254
chr8	114161331	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1308459198||6.56858e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	89,77:166:0.4639
chr8	114281749	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs190298395||0.000229973|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	66,57:123:0.4634
chr8	114370095	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs371699822||1.37382e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	70,69:139:0.4964
chr8	114543750	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	70,57:127:0.4488
chr8	114873457	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	69,84:153:0.549
chr8	114893290	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	67,72:139:0.518
chr8	115211945	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	54,74:128:0.5781
chr8	115298311	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	76,74:150:0.4933
chr8	115484570	.	T	C	.	PASS	CSQ=7227|protein_coding||intron_variant|||||||NM_001330599.1:c.2662-66118A>G||MODIFIER||||||TRPS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	81,67:148:0.4527
chr8	115704638	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	69,89:158:0.5633
chr8	115868335	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,1:137:0.0073	75,81:156:0.5192
chr8	115946346	.	C	G	.	PASS	CSQ=100859921|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	74,83:157:0.5287
chr8	115953499	.	C	A	.	PASS	CSQ=100859921|lncRNA||intron_variant&non_coding_transcript_variant||||rs368375121||1.97939e-05|NR_046215.1:n.2355+1430G>T||MODIFIER||||||LINC00536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	61,77:138:0.558
chr8	115992635	.	G	A	.	PASS	CSQ=100859921|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046215.1:n.1559-15199C>T||MODIFIER||||||LINC00536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	70,70:140:0.5
chr8	116134146	.	C	A	.	PASS	CSQ=100859921|lncRNA||intron_variant&non_coding_transcript_variant||||rs1006480759||3.94311e-05|NR_046215.1:n.1334-3866G>T||MODIFIER||||||LINC00536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	83,80:163:0.4908
chr8	116235766	.	G	GA	.	PASS	CSQ=100859921|lncRNA||intron_variant&non_coding_transcript_variant||||rs377573040|||NR_046215.1:n.1333+23725dup||MODIFIER||||||LINC00536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	81,74:156:0.4744
chr8	116297556	.	G	T	.	PASS	CSQ=100859921|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046215.1:n.231-23844C>A||MODIFIER||||||LINC00536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	67,52:119:0.437
chr8	116324132	.	G	A	.	PASS	CSQ=100859921|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046215.1:n.230+698C>T||MODIFIER||||||LINC00536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	62,72:134:0.5373
chr8	116486568	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	68,82:150:0.5467
chr8	116618092	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	79,84:163:0.5153
chr8	116876088	.	A	C	.	PASS	CSQ=644660|lncRNA||non_coding_transcript_exon_variant|||||||NR_033886.1:n.1230A>C||MODIFIER||||||RAD21-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	93,0:93:0	60,79:139:0.5683
chr8	116901862	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57549e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	72,58:130:0.4462
chr8	117029368	.	T	G	.	PASS	CSQ=169026|protein_coding||intron_variant|||||||NM_001172811.1:c.-107+78249T>G||MODIFIER||||||SLC30A8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	84,92:176:0.5227
chr8	117079358	.	T	C	.	PASS	CSQ=169026|protein_coding||intron_variant|||||||NM_001172811.1:c.-106-67461T>C||MODIFIER||||||SLC30A8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,95:177:0.5367
chr8	117605272	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	83,74:157:0.4713
chr8	117854561	.	T	TA	.	PASS	CSQ=2131|protein_coding||intron_variant|||||||NM_000127.2:c.963-17361dup||MODIFIER||||||EXT1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/EXT1|n|y||exostoses,osteosarcoma|multiple_exostoses_type_1|M|Rec|TSG,fusion|Mis,N,F,S;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	95,69:164:0.4207
chr8	117956451	.	TA	T	.	PASS	CSQ=2131|protein_coding||intron_variant||||rs1329933134||0.000261254|NM_000127.2:c.963-119251del||MODIFIER||||||EXT1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/EXT1|n|y||exostoses,osteosarcoma|multiple_exostoses_type_1|M|Rec|TSG,fusion|Mis,N,F,S;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	97,55:153:0.3595
chr8	117989383	.	C	T	.	PASS	CSQ=2131|protein_coding||intron_variant||||||6.57419e-06|NM_000127.2:c.962+120702G>A||MODIFIER||||||EXT1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/EXT1|n|y||exostoses,osteosarcoma|multiple_exostoses_type_1|M|Rec|TSG,fusion|Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	86,67:153:0.4379
chr8	118016072	.	T	A	.	PASS	CSQ=2131|protein_coding||intron_variant|||||||NM_000127.2:c.962+94013A>T||MODIFIER||||||EXT1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/EXT1|n|y||exostoses,osteosarcoma|multiple_exostoses_type_1|M|Rec|TSG,fusion|Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,1:121:0.0083	85,80:165:0.4848
chr8	118208107	.	A	C	.	PASS	CSQ=401474|protein_coding||intron_variant|||||||NM_001101676.1:c.464-10375T>G||MODIFIER||||||SAMD12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	73,82:155:0.529
chr8	118208115	.	G	GGT	.	PASS	CSQ=401474|protein_coding||intron_variant|||||||NM_001101676.1:c.464-10385_464-10384dup||MODIFIER||||||SAMD12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	89,71:160:0.4437
chr8	118516988	.	G	A	.	PASS	CSQ=401474|protein_coding||intron_variant|||||||NM_207506.2:c.192+63727C>T||MODIFIER||||||SAMD12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	156,6:162:0.037
chr8	118955956	.	TACAACAAACTATCATA	T	.	PASS	CSQ=4982|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TNFRSF11B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	76,64:140:0.4571
chr8	119063153	.	C	A	.	PASS	CSQ=10584|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||COLEC10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	92,69:161:0.4286
chr8	119810253	.	G	T	.	PASS	CSQ=6873|protein_coding||intron_variant|||||||NM_003184.4:c.300-3852C>A||MODIFIER||||||TAF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	97,79:176:0.4489
chr8	119943338	.	T	C	.	PASS	CSQ=64798|protein_coding||intron_variant|||||||NM_022783.4:c.425+13400T>C||MODIFIER||||||DEPTOR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	76,79:155:0.5097
chr8	120100964	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	74,84:158:0.5316
chr8	120167637	.	C	CT	.	PASS	CSQ=7373|protein_coding||intron_variant||||||1.31461e-05|NM_021110.4:c.350-517dup||MODIFIER||||||COL14A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	89,76:165:0.4606
chr8	120300448	.	G	A	.	PASS	CSQ=7373|protein_coding||intron_variant|||||||NM_021110.4:c.4315-284G>A||MODIFIER||||||COL14A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	50,66:116:0.569
chr8	120337512	.	G	A	.	PASS	CSQ=7373|protein_coding||intron_variant|||||||NM_021110.4:c.4786-3813G>A||MODIFIER||||||COL14A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,90:170:0.5294
chr8	120826624	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs756361900||6.57099e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	89,82:171:0.4795
chr8	120827224	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	65,72:137:0.5255
chr8	121905584	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:139:0	72,81:153:0.5294
chr8	122017090	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	69,78:147:0.5306
chr8	122326669	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	54,57:111:0.5135
chr8	124202510	.	C	G	.	PASS	CSQ=101927588|lncRNA||intron_variant&non_coding_transcript_variant||||rs997928474||6.57125e-06|NR_125420.1:n.321+5606G>C||MODIFIER||||||LOC101927588|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	81,79:160:0.4938
chr8	124710195	.	C	T	.	PASS	CSQ=9788|protein_coding||intron_variant||||rs1358681374|||NM_014751.5:c.73-6004G>A||MODIFIER||||||MTSS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	74,77:151:0.5099
chr8	124807142	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	97,104:201:0.5174
chr8	125419273	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	85,90:175:0.5143
chr8	125570871	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	92,87:179:0.486
chr8	125693447	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs919036194||3.28649e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	115,51:166:0.3072
chr8	125841746	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	85,86:171:0.5029
chr8	127193945	.	A	AAG	.	PASS	CSQ=103021165|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120364.1:n.153+3529_153+3530insCT||MODIFIER||||||CASC19|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	78,74:152:0.4868
chr8	127474614	.	A	AT	.	PASS	CSQ=727677|lncRNA||intron_variant&non_coding_transcript_variant||||rs570495542||0.0458523|NR_117100.1:n.1041+4468dup||MODIFIER||||||CASC8|EntrezGene|0.0497;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	86,55:142:0.3873
chr8	127617804	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	87,81:168:0.4821
chr8	127668480	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	160,16:176:0.0909
chr8	127953381	.	G	C	.	PASS	CSQ=5820|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_003367.3:n.781+13705G>C||MODIFIER||||||PVT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	89,89:178:0.5
chr8	128246997	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	74,86:160:0.5375
chr8	128936472	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	72,67:139:0.482
chr8	129886318	.	C	T	.	PASS	CSQ=51571|protein_coding||intron_variant|||||||NM_001353258.1:c.-10-6847G>A||MODIFIER||||||FAM49B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	157,13:170:0.0765
chr8	130097992	.	G	A	.	PASS	CSQ=50807|protein_coding||intron_variant|||||||NM_018482.4:c.2402-5849C>T||MODIFIER||||||ASAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	80,91:171:0.5322
chr8	130755413	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	95,94:189:0.4974
chr8	130766592	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	73,72:145:0.4966
chr8	131183509	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	71,61:132:0.4621
chr8	131204075	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1234152944||1.31572e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	62,89:151:0.5894
chr8	131539789	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	152,13:165:0.0788
chr8	132060770	.	C	T	.	PASS	CSQ=10086|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||HHLA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	73,67:140:0.4786
chr8	132171919	.	GCC	G	.	PASS	CSQ=3786|protein_coding||intron_variant|||||||NM_004519.4:c.1140+677_1140+678del||MODIFIER||||||KCNQ3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	76,84:160:0.525
chr8	132296025	.	C	A	.	PASS	CSQ=3786|protein_coding||intron_variant|||||||NM_004519.4:c.387-109844G>T||MODIFIER||||||KCNQ3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	167,10:177:0.0565
chr8	132328366	.	G	A	.	PASS	CSQ=3786|protein_coding||intron_variant|||||||NM_004519.4:c.387-142185C>T||MODIFIER||||||KCNQ3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	54,66:120:0.55
chr8	132360020	.	C	A	.	PASS	CSQ=3786|protein_coding||intron_variant|||||||NM_004519.4:c.386+120127G>T||MODIFIER||||||KCNQ3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	75,82:157:0.5223
chr8	132524889	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	125,0:125:0	132,6:138:0.0435
chr8	132612899	.	C	G	.	PASS	CSQ=23639|protein_coding||intron_variant|||||||NM_012472.6:c.975-1536G>C||MODIFIER||||||LRRC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	72,108:180:0.6
chr8	132707056	.	T	G	.	PASS	CSQ=137835|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TMEM71|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	78,77:155:0.4968
chr8	133787855	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	66,79:145:0.5448
chr8	133909440	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	141,29:170:0.1706
chr8	134199586	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	78,70:148:0.473
chr8	134408095	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	79,83:162:0.5123
chr8	134470751	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	88,56:144:0.3889
chr8	134661829	.	G	A	.	PASS	CSQ=57623|protein_coding||intron_variant|||||||NM_020863.4:c.20-4092C>T||MODIFIER||||||ZFAT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	71,77:148:0.5203
chr8	134751080	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs887618660||0.000845443|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	101,69:170:0.4059
chr8	134832031	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs932931724||6.67022e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	84,95:179:0.5307
chr8	135237987	.	T	C	.	PASS	CSQ=286094|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_026706.2:n.384+3473T>C||MODIFIER||||||LINC01591|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	63,75:138:0.5435
chr8	135440834	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	126,7:133:0.0526
chr8	135525756	.	C	T	.	PASS	CSQ=10656|protein_coding||intron_variant|||||||NM_006558.3:c.207+4401C>T||MODIFIER||||||KHDRBS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	85,75:160:0.4688
chr8	135598824	.	C	T	.	PASS	CSQ=10656|protein_coding||intron_variant||||rs563602711||0.000111804|NM_006558.3:c.808-8131C>T||MODIFIER||||||KHDRBS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	82,77:159:0.4843
chr8	135649089	.	A	G	.	PASS	CSQ=10656|protein_coding||downstream_gene_variant||||rs1207765365||6.56918e-06|||MODIFIER||||||KHDRBS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	70,71:141:0.5035
chr8	135672659	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1238585337||6.56953e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	86,80:167:0.479
chr8	135680687	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	92,80:172:0.4651
chr8	135755851	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	79,76:155:0.4903
chr8	135950885	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	74,64:138:0.4638
chr8	136019619	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	82,82:164:0.5
chr8	136193160	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs1174281256||1.34515e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	75,51:126:0.4048
chr8	136426262	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	73,69:142:0.4859
chr8	136750472	.	A	C	.	PASS	CSQ=107986980|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147196.1:n.292-39363A>C||MODIFIER||||||LINC02055|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	60,67:127:0.5276
chr8	136952245	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	65,62:127:0.4882
chr8	136983670	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	76,61:137:0.4453
chr8	137030963	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	83,75:158:0.4747
chr8	137110390	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	93,33:126:0.2619
chr8	137124457	.	CA	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	113,0:113:0	60,77:137:0.562
chr8	137301406	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,70:146:0.4795
chr8	137309209	.	AAATTC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	118,6:124:0.0484
chr8	137386274	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	73,86:159:0.5409
chr8	137408968	.	C	A	.	PASS	CSQ=101927915|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125428.1:n.254-1816G>T||MODIFIER||||||LOC101927915|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	61,62:123:0.5041
chr8	137470368	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs957648797|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	133,12:145:0.0828
chr8	137624502	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	72,75:147:0.5102
chr8	137727758	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	68,69:137:0.5036
chr8	137794780	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	142,11:153:0.0719
chr8	138075700	.	G	T	.	PASS	CSQ=401478|protein_coding||intron_variant|||||||NM_001354876.1:c.249+7357C>A||MODIFIER||||||LOC401478|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	147,8:155:0.0516
chr8	138382994	.	TG	T	.	PASS	CSQ=51059|protein_coding||intron_variant|||||||NM_015912.4:c.-19-14993del||MODIFIER||||||FAM135B|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FAM135B|y|n|SCLC|||E|||Mis;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	82,63:145:0.4345
chr8	138495940	.	G	A	.	PASS	CSQ=51059|protein_coding||intron_variant||||rs752328902||4.59988e-05|NM_015912.4:c.-20+731C>T||MODIFIER||||||FAM135B|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FAM135B|y|n|SCLC|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,81:145:0.5586
chr8	138722791	.	G	A	.	PASS	CSQ=169044|protein_coding||intron_variant|||||||NM_152888.3:c.2248-702C>T||MODIFIER||||||COL22A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	63,45:108:0.4167
chr8	138910847	.	C	T	.	PASS	CSQ=169044|protein_coding||intron_variant||||rs984091365|||NM_152888.3:c.-73+2772G>A||MODIFIER||||||COL22A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	90,80:170:0.4706
chr8	138999091	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1367083026||6.5697e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	75,87:162:0.537
chr8	139307012	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	78,68:146:0.4658
chr8	139506027	.	CAAAAAGTCAAGT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	62,65:127:0.5118
chr8	139602867	.	G	A	.	PASS	CSQ=51305|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_104210.1:n.2528-1266C>T||MODIFIER||||||KCNK9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	77,57:134:0.4254
chr8	139611943	.	C	T	.	PASS	CSQ=51305|misc_RNA||non_coding_transcript_exon_variant||||rs1253979073||6.56961e-06|NR_104210.1:n.1921G>A||MODIFIER||||||KCNK9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,0:127:0	76,86:162:0.5309
chr8	140125198	.	G	A	.	PASS	CSQ=83696|protein_coding||intron_variant||||rs922052889||0.000111711|NM_001160372.3:c.2556+96261C>T||MODIFIER||||||TRAPPC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	142,44:187:0.2353
chr8	140205037	.	AAAC	A	.	PASS	CSQ=83696|protein_coding||intron_variant|||||||NM_001160372.3:c.2556+16419_2556+16421del||MODIFIER||||||TRAPPC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	69,78:147:0.5306
chr8	140833496	.	T	A	.	PASS	CSQ=5747|protein_coding||intron_variant|||||||NM_001352701.1:c.594-2970A>T||MODIFIER||||||PTK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	87,93:180:0.5167
chr8	141130950	.	G	A	.	PASS	CSQ=22898|protein_coding||intron_variant|||||||NM_014957.4:c.-51+2141G>A||MODIFIER||||||DENND3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	87,86:173:0.4971
chr8	141361539	.	A	T	.	PASS	CSQ=2843|protein_coding||intron_variant|||||||NM_005293.2:c.-24-3592T>A||MODIFIER||||||GPR20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:142:0	85,82:167:0.491
chr8	141411124	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	142,59:201:0.2935
chr8	141614781	.	A	AG	.	PASS	CSQ=|||intergenic_variant||||rs529198861||0.00169543|||MODIFIER||||||||0.0012;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	89,80:169:0.4734
chr8	141724679	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs542490813||3.28697e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	71,100:171:0.5848
chr8	142437568	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	62,85:147:0.5782
chr8	142517229	.	G	T	.	PASS	CSQ=575|protein_coding||intron_variant|||||||NM_001702.2:c.2818-909G>T||MODIFIER||||||ADGRB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	89,95:184:0.5163
chr8	142517520	.	G	C	.	PASS	CSQ=575|protein_coding||intron_variant|||||||NM_001702.2:c.2818-618G>C||MODIFIER||||||ADGRB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	80,86:166:0.5181
chr8	142635915	.	C	T	.	PASS	CSQ=101928087|lncRNA||upstream_gene_variant||||rs141491617||0.00117579|||MODIFIER||||||LOC101928087|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	83,95:178:0.5337
chr8	143426865	.	C	T	.	PASS	CSQ=389692|protein_coding||downstream_gene_variant||||rs374603888|||||MODIFIER||||||MAFA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	75,83:158:0.5253
chr8	143654097	.	C	G	.	PASS	CSQ=9831|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZNF623|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	85,65:150:0.4333
chr8	143858176	.	G	A	.	PASS	CSQ=83481|protein_coding||synonymous_variant||||rs782513372||4.60211e-05|NM_031308.3:c.15078C>T|NP_112598.3:p.Pro5026=|LOW||||||EPPK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	112,72:184:0.3913
chr8	144142498	.	G	C	.	PASS	CSQ=51236|protein_coding||downstream_gene_variant||||||6.57186e-06|||MODIFIER||||||HGH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	82,93:175:0.5314
chr8	144272820	.	G	GT	.	PASS	CSQ=23246|protein_coding||intron_variant|||||||NM_015201.5:c.390+3403dup||MODIFIER||||||BOP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	182,21:203:0.1034
chr9	303173	.	A	T	.	PASS	CSQ=81704|protein_coding||intron_variant|||||||NM_203447.3:c.405-1408A>T||MODIFIER||||||DOCK8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	27,34:61:0.5574
chr9	760290	.	TC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	138,0:138:0	0,84:85:0.9882
chr9	1701995	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs922065997|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,75:75:1
chr9	1992697	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,77:77:1
chr9	2196439	.	G	A	.	PASS	CSQ=6595|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SMARCA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,88:88:1
chr9	2411349	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,67:67:1
chr9	3705732	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,91:91:1
chr9	5110520	.	G	A	.	PASS	CSQ=3717|protein_coding||intron_variant|||||||NM_004972.3:c.3060-12484G>A||MODIFIER||||||JAK2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/JAK2|y|n|ALL,AML,MPN,_CML|||L|Dom|oncogene,fusion|T,Mis,O;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,84:84:1
chr9	5186561	.	G	A	.	PASS	CSQ=11172|protein_coding||upstream_gene_variant||||rs1029799010||6.57004e-06|||MODIFIER||||||INSL6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	67,5:72:0.0694
chr9	5189659	.	C	T	.	PASS	CSQ=11172|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||INSL6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,79:79:1
chr9	5566730	.	T	A	.	PASS	CSQ=80380|protein_coding||intron_variant|||||||NM_025239.3:c.817-3224T>A||MODIFIER||||||PDCD1LG2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PDCD1LG2|y|n|PMBL,Hodgkin_lymphoma|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,85:85:1
chr9	7047294	.	C	A	.	PASS	CSQ=23081|protein_coding||intron_variant|||||||NM_015061.4:c.2315+377C>A||MODIFIER||||||KDM4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,82:82:1
chr9	7061017	.	G	A	.	PASS	CSQ=23081|protein_coding||intron_variant|||||||NM_015061.4:c.2424+11817G>A||MODIFIER||||||KDM4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	69,12:81:0.1481
chr9	7688800	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,62:62:1
chr9	8007074	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,69:69:1
chr9	8209925	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	59,4:63:0.0635
chr9	8464007	.	C	T	.	PASS	CSQ=5789|protein_coding||intron_variant||||rs566474369||6.5838e-06|NM_002839.3:c.3714+1459G>A||MODIFIER||||||PTPRD|EntrezGene|0.0002;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRD|y|n|lung_cancer,kidney_cancer,HNSCC,glioblastoma|||E,O||TSG|D,N,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	5,71:76:0.9342
chr9	8520608	COSV61973272;COSV61973272;COSV61973272;COSV61973272;COSV61973272;COSV61973272;COSV61973272;COSV61973272;COSV61973272;COSV61973272	G	GA	.	PASS	CSQ=5789|protein_coding||intron_variant|COSV61973272&COSV61973272&COSV61973272&COSV61973272&COSV61973272&COSV61973272&COSV61973272&COSV61973272&COSV61973272|p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?|COSV61973272|rs888724276||0.000141641|NM_002839.3:c.961+668dup||MODIFIER||||||PTPRD|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRD|y|n|lung_cancer,kidney_cancer,HNSCC,glioblastoma|||E,O||TSG|D,N,Mis;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	7,47:54:0.8704
chr9	8947123	.	C	T	.	PASS	CSQ=5789|protein_coding||intron_variant|||||||NM_002839.3:c.-104+71574G>A||MODIFIER||||||PTPRD|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRD|y|n|lung_cancer,kidney_cancer,HNSCC,glioblastoma|||E,O||TSG|D,N,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,76:76:1
chr9	9381274	.	C	T	.	PASS	CSQ=5789|protein_coding||intron_variant|||||||NM_002839.3:c.-203+16175G>A||MODIFIER||||||PTPRD|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRD|y|n|lung_cancer,kidney_cancer,HNSCC,glioblastoma|||E,O||TSG|D,N,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,89:89:1
chr9	9720981	.	G	A	.	PASS	CSQ=5789|protein_coding||intron_variant|||||||NM_002839.3:c.-287+13552C>T||MODIFIER||||||PTPRD|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRD|y|n|lung_cancer,kidney_cancer,HNSCC,glioblastoma|||E,O||TSG|D,N,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	48,15:63:0.2381
chr9	9885884	.	G	T	.	PASS	CSQ=5789|protein_coding||intron_variant|||||||NM_002839.3:c.-368+52623C>A||MODIFIER||||||PTPRD|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRD|y|n|lung_cancer,kidney_cancer,HNSCC,glioblastoma|||E,O||TSG|D,N,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,67:67:1
chr9	10193559	.	C	T	.	PASS	CSQ=5789|protein_coding||intron_variant||||rs1178313062||1.97389e-05|NM_002839.3:c.-545+147404G>A||MODIFIER||||||PTPRD|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRD|y|n|lung_cancer,kidney_cancer,HNSCC,glioblastoma|||E,O||TSG|D,N,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	67,7:74:0.0946
chr9	10572237	.	C	A	.	PASS	CSQ=5789|protein_coding||intron_variant|||||||NM_002839.3:c.-600+40161G>T||MODIFIER||||||PTPRD|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRD|y|n|lung_cancer,kidney_cancer,HNSCC,glioblastoma|||E,O||TSG|D,N,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,49:49:1
chr9	10938978	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	1,69:70:0.9857
chr9	11380923	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs563745407||0.2929|||MODIFIER||||||||0.3301;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	5,63:68:0.9265
chr9	11614356	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,75:75:1
chr9	11736842	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	0,75:75:1
chr9	11795854	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,63:63:1
chr9	15071592	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,77:77:1
chr9	15130330	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1405699950||6.57644e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,75:75:1
chr9	15949194	.	G	T	.	PASS	CSQ=203238|protein_coding||intron_variant|||||||NM_173550.4:c.3754-22415G>T||MODIFIER||||||CCDC171|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,73:73:1
chr9	16105599	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,96:96:1
chr9	16323576	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,66:66:1
chr9	17139659	.	C	CA	.	PASS	CSQ=54875|protein_coding||intron_variant||||rs1346164855||0.000981102|NM_017738.4:c.361-3617dup||MODIFIER||||||CNTLN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:92:0	19,57:77:0.7403
chr9	17338020	.	A	T	.	PASS	CSQ=54875|protein_coding||intron_variant|||||||NM_017738.4:c.1645-2807A>T||MODIFIER||||||CNTLN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	3,62:65:0.9538
chr9	17998945	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs570828485||0.000789567|||MODIFIER||||||||0.0012;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	9,84:93:0.9032
chr9	18243836	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	56,9:65:0.1385
chr9	18450534	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,85:85:1
chr9	19135140	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	71,0:71:0	2,41:43:0.9535
chr9	19752068	.	G	T	.	PASS	CSQ=25769|protein_coding||intron_variant|||||||NM_020344.3:c.930+33869C>A||MODIFIER||||||SLC24A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	67,4:71:0.0563
chr9	20141916	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,69:69:1
chr9	21337859	.	T	A	.	PASS	CSQ=55958|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||KLHL9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,62:62:1
chr9	21557826	.	C	T	.	PASS	CSQ=554202|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_152878.1:n.51+1922G>A||MODIFIER||||||MIR31HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,78:78:1
chr9	21691910	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,85:85:1
chr9	22056202	.	A	ATG	.	PASS	CSQ=100048912|lncRNA||intron_variant&non_coding_transcript_variant||||rs368722026||0.0648893|NR_003529.3:n.1253-40_1253-39dup||MODIFIER||||||CDKN2B-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2,lancet;num_callers=2	AD:DP:AF	74,0:74:0	34,19:53:0.3585
chr9	22664931	.	T	G	.	PASS	CSQ=441389|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038977.1:n.98-9512T>G||MODIFIER||||||LINC01239|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	86,57:143:0.3986
chr9	22994847	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,87:87:1
chr9	23403095	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,67:67:1
chr9	23789730	.	C	T	.	PASS	CSQ=1993|protein_coding||intron_variant|||||||NM_004432.5:c.-15-27481G>A||MODIFIER||||||ELAVL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,94:94:1
chr9	23876231	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,85:85:1
chr9	24273082	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,71:71:1
chr9	24334590	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	3,67:70:0.9571
chr9	24407105	.	GAACTTTATAGTGAGAGGAT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	130,0:130:0.00757	87,4:91:0.054
chr9	24493229	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,61:61:1
chr9	24621342	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,63:63:1
chr9	25316799	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,84:84:1
chr9	25557683	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	46,41:87:0.4713
chr9	25831238	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs796154182||0.0175147|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	5,58:63:0.9206
chr9	25963885	.	A	AAAC	.	PASS	CSQ=|||intergenic_variant||||rs780970482||0.0109558|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	10,50:60:0.8333
chr9	25966514	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,57:57:1
chr9	26015887	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	5,78:83:0.9398
chr9	26168217	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	5,71:76:0.9342
chr9	26168219	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,71:71:1
chr9	26430220	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||||6.60362e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	7,73:82:0.8902
chr9	26569502	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1444989113||0.000690821|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,1:77:0.013	9,23:32:0.7188
chr9	26594517	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs979398645||0.000106457|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	0,69:69:1
chr9	27892265	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1418589771||2.6303e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	0,72:72:1
chr9	27894047	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs56760164||0.0191564|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	12,63:76:0.8289
chr9	28416461	.	A	G	.	PASS	CSQ=158038|protein_coding||intron_variant||||rs1303767448|||NM_001258282.2:c.-227-43593T>C||MODIFIER||||||LINGO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	39,48:87:0.5517
chr9	28577157	COSV66153122;COSV66153122;COSV66153122	C	T	.	PASS	CSQ=158038|protein_coding||intron_variant|COSV66153122&COSV66153122&COSV66153122|p.?&p.?&p.?||rs371610122||0.000230133|NM_001258282.2:c.-314+93043G>A||MODIFIER||||||LINGO2|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,83:83:1
chr9	28585963	.	C	T	.	PASS	CSQ=158038|protein_coding||intron_variant|||||||NM_001258282.2:c.-314+84237G>A||MODIFIER||||||LINGO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,87:87:1
chr9	28592084	.	GA	G	.	PASS	CSQ=158038|protein_coding||intron_variant|||||||NM_001258282.2:c.-314+78115del||MODIFIER||||||LINGO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	68,4:72:0.0556
chr9	29007489	.	C	A	.	PASS	CSQ=158038|protein_coding||intron_variant|||||||NM_001258282.2:c.-491-59575G>T||MODIFIER||||||LINGO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,74:74:1
chr9	29640648	COSV72008612	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV72008612||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,75:75:1
chr9	30085966	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,81:81:1
chr9	30133493	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,74:74:1
chr9	30646055	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	9,84:93:0.9032
chr9	31185782	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,82:82:1
chr9	33166634	.	T	G	.	PASS	CSQ=101929639|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||B4GALT1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	0,92:92:1
chr9	33183990	.	G	A	.	PASS	CSQ=101929639|lncRNA||downstream_gene_variant||||rs1407584661|||||MODIFIER||||||B4GALT1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	0,60:60:1
chr9	33705125	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,71:71:1
chr9	35209490	.	G	T	.	PASS	CSQ=10497|protein_coding||intron_variant|||||||NM_006377.3:c.23-18525G>T||MODIFIER||||||UNC13B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,91:91:1
chr9	36132593	.	C	T	.	PASS	CSQ=152007|protein_coding||upstream_gene_variant||||rs746546656|||||MODIFIER||||||GLIPR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,90:90:1
chr9	36260824	.	G	A	.	PASS	CSQ=10020|protein_coding||upstream_gene_variant||||rs1051007017||2.98887e-05|||MODIFIER||||||GNE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,72:72:1
chr9	36601024	COSV53201106;COSV53201106;COSV53201106;COSV53201106;COSV53201106;COSV53201106;COSV53201106	G	GT	.	PASS	CSQ=9833|protein_coding||intron_variant|COSV53201106&COSV53201106&COSV53201106&COSV53201106&COSV53201106&COSV53201106&COSV53201106|p.?&p.?&p.?&p.?&p.?&p.?&p.?||rs1397752096||0.000192755|NM_014791.4:c.567+1547dup||MODIFIER||||||MELK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	11,85:96:0.8854
chr9	37099207	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1343688379||0.000797645|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	101,0:101:0	19,47:67:0.7015
chr9	38350059	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,93:93:1
chr9	39842603	.	G	T	.	PASS	CSQ=654466|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003670.1:n.658-23679C>A||MODIFIER||||||FGF7P3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	240,0:240:0	88,45:133:0.3383
chr9	41401422	.	C	T	.	PASS	CSQ=107984035|lncRNA||intron_variant&non_coding_transcript_variant||||||6.79348e-06|NR_148348.1:n.291+42270C>T||MODIFIER||||||LOC107984035|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,66:66:1
chr9	42170768	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	0,68:68:1
chr9	42250136	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	256,0:256:0	83,68:151:0.4503
chr9	42767461	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1039357370||1.97278e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,71:71:1
chr9	43039879	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	12,42:54:0.7778
chr9	43082473	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1470546737||1.97589e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,1:102:0.0098	0,74:74:1
chr9	63629197	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,1:130:0.0077	5,50:55:0.9091
chr9	63881742	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	241,0:241:0	155,35:190:0.1842
chr9	64487565	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	50,9:59:0.1525
chr9	64902922	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	32,35:67:0.5224
chr9	65481495	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,74:74:1
chr9	68392730	.	A	AT	.	PASS	CSQ=5239|protein_coding||intron_variant|||||||NM_021965.4:c.1043+258dup||MODIFIER||||||PGM5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	5,74:79:0.9367
chr9	68613571	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,80:80:1
chr9	69004570	.	C	T	.	PASS	CSQ=8395|protein_coding||intron_variant|||||||NM_003558.4:c.1621-3877C>T||MODIFIER||||||PIP5K1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,68:69:0.9855
chr9	70555045	.	T	G	.	PASS	CSQ=80036|protein_coding||intron_variant|||||||NM_001366145.1:c.3224-1735A>C||MODIFIER||||||TRPM3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	69,5:74:0.0676
chr9	71529814	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,77:77:1
chr9	72940148	.	C	A	.	PASS	CSQ=216|protein_coding||missense_variant&splice_region_variant|||||||NM_000689.5:c.171G>T|NP_000680.2:p.Lys57Asn|MODERATE|P&.&.&.|T&T&T&T|D|D&D&.&D|D&D&D&D|ALDH1A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	103,0:103:0	0,78:78:1
chr9	73146751	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,82:82:1
chr9	73201161	.	CTA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	58,9:67:0.1343
chr9	73370113	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,88:88:1
chr9	73592280	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	5,71:76:0.9342
chr9	74092809	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,79:79:1
chr9	74267426	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	34,46:80:0.575
chr9	74873866	.	GA	G	.	PASS	CSQ=140803|protein_coding||intron_variant||||rs1037223195||6.1747e-05|NM_017662.5:c.33+13957del||MODIFIER||||||TRPM6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	10,79:89:0.8876
chr9	75460800	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	38,42:80:0.525
chr9	75544384	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,66:66:1
chr9	75546566	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,63:63:1
chr9	75724639	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	2,73:75:0.9733
chr9	75807341	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs906217067||1.31468e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	3,65:68:0.9559
chr9	75834204	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,99:99:1
chr9	76366460	.	G	A	.	PASS	CSQ=5125|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PCSK5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,89:89:1
chr9	76606896	.	C	A	.	PASS	CSQ=158471|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PRUNE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,70:70:1
chr9	77459040	.	G	A	.	PASS	CSQ=9630|protein_coding||intron_variant||||rs536438061||6.57609e-06|NM_004297.4:c.310-24518C>T||MODIFIER||||||GNA14|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,70:70:1
chr9	77679413	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,79:79:1
chr9	78263858	.	T	G	.	PASS	CSQ=84131|protein_coding||intron_variant|||||||NM_001330691.2:c.1459-292T>G||MODIFIER||||||CEP78|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,70:70:1
chr9	78485782	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,69:69:1
chr9	78956596	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,80:80:1
chr9	79309206	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,64:64:1
chr9	79829517	.	G	A	.	PASS	CSQ=101927477|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_121213.1:n.97+4891G>A||MODIFIER||||||LINC01507|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,72:72:1
chr9	80009366	.	C	T	.	PASS	CSQ=101927477|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_121213.1:n.98-21218C>T||MODIFIER||||||LINC01507|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,73:73:1
chr9	80192085	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,77:77:1
chr9	80340060	COSV57116195	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV57116195||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,51:51:1
chr9	80435900	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,66:66:1
chr9	80529994	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,68:68:1
chr9	80543438	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,81:81:1
chr9	80736386	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	0,70:70:1
chr9	80805234	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,78:78:1
chr9	81510560	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1196226250||0.0114582|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	88,0:88:0	18,45:64:0.7031
chr9	82913034	COSV66692379	C	G	.	PASS	CSQ=|||intergenic_variant|||COSV66692379||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	0,84:84:1
chr9	83016056	.	C	A	.	PASS	CSQ=158158|protein_coding||intron_variant|||||||NM_152573.4:c.670-156G>T||MODIFIER||||||RASEF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	0,73:73:1
chr9	84083692	.	A	AT	.	PASS	CSQ=101927575|lncRNA||intron_variant&non_coding_transcript_variant||||rs1037504178||0.000185261|NR_110995.1:n.1202-251dup||MODIFIER||||||LOC101927575|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	14,74:88:0.8409
chr9	84345820	.	C	G	.	PASS	CSQ=64078|protein_coding||intron_variant|||||||NM_022127.2:c.-45-5142G>C||MODIFIER||||||SLC28A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,77:77:1
chr9	84416634	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,104:104:1
chr9	84418322	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	74,5:79:0.0633
chr9	84902137	.	A	T	.	PASS	CSQ=4915|protein_coding||intron_variant|||||||NM_001018064.2:c.1586-32025A>T||MODIFIER||||||NTRK2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NTRK2|y|n|colorectal_cancer,ganglioglioma,glioma,HNSCC,lung_adenocarcinoma|||E,O||oncogene,fusion|T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,93:93:1
chr9	85006314	.	C	G	.	PASS	CSQ=4915|protein_coding||intron_variant|||||||NM_001018064.2:c.2125-13892C>G||MODIFIER||||||NTRK2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NTRK2|y|n|colorectal_cancer,ganglioglioma,glioma,HNSCC,lung_adenocarcinoma|||E,O||oncogene,fusion|T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,77:77:1
chr9	85110984	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs1015863608||6.56918e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,83:83:1
chr9	85149577	.	CC	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	119,0:119:0	0,68:68:1
chr9	85249169	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,91:91:1
chr9	87060497	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,73:73:1
chr9	87268365	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,89:89:1
chr9	88593204	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,72:72:1
chr9	89290509	.	ACC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,56:56:1
chr9	90003180	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,74:74:1
chr9	93359466	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,81:81:1
chr9	93388273	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,77:77:1
chr9	93457237	.	C	T	.	PASS	CSQ=158293|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||FAM120AOS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,83:83:1
chr9	94931135	.	C	T	.	PASS	CSQ=84909|protein_coding||intron_variant|||||||NM_001193329.1:c.1661+2604C>T||MODIFIER||||||C9orf3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,73:73:1
chr9	94935147	.	T	C	.	PASS	CSQ=84909|protein_coding||intron_variant|||||||NM_001193329.1:c.1661+6616T>C||MODIFIER||||||C9orf3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,83:83:1
chr9	95183712	.	C	G	.	PASS	CSQ=2176|protein_coding||intron_variant|||||||NM_000136.2:c.346-11565G>C||MODIFIER||||||FANCC|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FANCC|n|y||AML,leukaemia|Fanconi_anaemia_C|L|Rec|TSG|D,Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,88:88:1
chr9	95906138	.	G	T	.	PASS	CSQ=375748|protein_coding||intron_variant|||||||NM_020207.4:c.628-940G>T||MODIFIER||||||ERCC6L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	79,6:85:0.0706
chr9	95940108	.	C	T	.	PASS	CSQ=375748|protein_coding||intron_variant|||||||NM_020207.4:c.1785-1346C>T||MODIFIER||||||ERCC6L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	74,11:85:0.1294
chr9	96233594	.	G	C	.	PASS	CSQ=3293|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||HSD17B3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,84:84:1
chr9	97807538	.	T	C	.	PASS	CSQ=101928337|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_147055.1:n.311-1514A>G||MODIFIER||||||PTCSC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,89:89:1
chr9	97848259	.	G	A	.	PASS	CSQ=101928337|lncRNA||intron_variant&non_coding_transcript_variant||||rs930373070|||NR_147055.1:n.165+4657C>T||MODIFIER||||||PTCSC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,94:94:1
chr9	98363384	.	C	T	.	PASS	CSQ=9568|protein_coding||intron_variant|||||||NM_005458.8:c.1771-547G>A||MODIFIER||||||GABBR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,89:89:1
chr9	98363392	.	C	A	.	PASS	CSQ=9568|protein_coding||intron_variant|||||||NM_005458.8:c.1771-555G>T||MODIFIER||||||GABBR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,87:87:1
chr9	98386450	.	G	A	.	PASS	CSQ=9568|protein_coding||intron_variant||||rs1330968496||1.31473e-05|NM_005458.8:c.1530-678C>T||MODIFIER||||||GABBR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,91:91:1
chr9	99192534	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1239188635||1.31437e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,111:111:1
chr9	99273593	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,79:79:1
chr9	99273597	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.57039e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,87:87:1
chr9	99693926	.	CTTATAG	C	.	PASS	CSQ=101928438|lncRNA||intron_variant&non_coding_transcript_variant||||rs966751250||0.000131508|NR_109802.1:n.319+24227_319+24232del||MODIFIER||||||LOC101928438|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,74:74:1
chr9	99705284	.	T	A	.	PASS	CSQ=101928438|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109802.1:n.319+12875A>T||MODIFIER||||||LOC101928438|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	155,0:155:0	0,84:84:1
chr9	100752071	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	54,4:58:0.069
chr9	101083271	.	GC	TA	.	PASS	CSQ=54886|protein_coding||intron_variant|||||||NM_207299.2:c.-46+54169_-46+54170delinsTA||MODIFIER||||||PLPPR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	100,0:100:0	0,58:58:1
chr9	101600169	.	G	A	.	PASS	CSQ=116443|protein_coding||intron_variant||||rs1015600164||1.31432e-05|NM_133445.2:c.2766+13207C>T||MODIFIER||||||GRIN3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,72:72:1
chr9	101638172	.	C	T	.	PASS	CSQ=116443|protein_coding||intron_variant|||||||NM_133445.2:c.2353-9771G>A||MODIFIER||||||GRIN3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,95:95:1
chr9	101698431	.	C	T	.	PASS	CSQ=116443|protein_coding||intron_variant||||rs928210944||1.31518e-05|NM_133445.2:c.700-11231G>A||MODIFIER||||||GRIN3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,77:77:1
chr9	101768831	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs999633505||1.32006e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	70,17:87:0.1954
chr9	102251909	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	67,7:74:0.0946
chr9	102531192	.	G	A	.	PASS	CSQ=414319|lncRNA||intron_variant&non_coding_transcript_variant||||rs984349953|||NR_103830.1:n.72+11484G>A||MODIFIER||||||LINC00587|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,55:55:1
chr9	102713206	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,66:66:1
chr9	103212974	.	C	G	.	PASS	CSQ=101928496|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_121578.1:n.869+14740G>C||MODIFIER||||||LINC01492|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,71:71:1
chr9	103275396	.	A	G	.	PASS	CSQ=101928496|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_121578.1:n.644+635T>C||MODIFIER||||||LINC01492|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	79,7:86:0.0814
chr9	103614653	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,71:71:1
chr9	104023927	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,91:91:1
chr9	104825898	.	C	T	.	PASS	CSQ=19|protein_coding||intron_variant|||||||NM_005502.4:c.2338-11G>A||MODIFIER||||||ABCA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	129,0:129:0	0,91:91:1
chr9	105841737	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,83:83:1
chr9	106175044	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	34,41:75:0.5467
chr9	106765837	.	A	AAAAG	.	PASS	CSQ=|||intergenic_variant||||rs1373567359||0.000278157|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	30,57:94:0.6064
chr9	107084509	.	A	G	.	PASS	CSQ=340512|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126029.1:n.380+12666T>C||MODIFIER||||||LOC340512|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,72:72:1
chr9	107084514	.	A	T	.	PASS	CSQ=340512|lncRNA||intron_variant&non_coding_transcript_variant||||rs1041509466||8.54285e-05|NR_126029.1:n.380+12661T>A||MODIFIER||||||LOC340512|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	1,71:72:0.9861
chr9	107988251	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	75,6:81:0.0741
chr9	108875471	.	C	A	.	PASS	CSQ=8518|protein_coding||intron_variant|||||||NM_003640.5:c.3856-501G>T||MODIFIER||||||ELP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	90,6:96:0.0625
chr9	110406256	.	G	T	.	PASS	CSQ=79987|protein_coding||missense_variant||||COSM3169410|||NM_153366.4:c.9344C>A|NP_699197.3:p.Pro3115Gln|MODERATE|.&D||D|D&D|.&.|SVEP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	41,50:91:0.5495
chr9	111282238	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	1,79:80:0.9875
chr9	111306278	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,82:82:1
chr9	112052147	.	C	T	.	PASS	CSQ=64420|protein_coding||intron_variant|||||||NM_022486.4:c.2149+252G>A||MODIFIER||||||SUSD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,94:94:1
chr9	112221005	.	C	G	.	PASS	CSQ=9991|protein_coding||3_prime_UTR_variant||||rs890364862|||NM_001163788.2:c.*2846G>C||MODIFIER||||||PTBP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	109,0:109:0	0,93:93:1
chr9	112296544	.	C	T	.	PASS	CSQ=9991|protein_coding||intron_variant|||||||NM_001163788.2:c.34+1288G>A||MODIFIER||||||PTBP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	0,73:73:1
chr9	114555818	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,92:92:1
chr9	114909742	.	C	A	.	PASS	CSQ=944|protein_coding||intron_variant|||||||NM_001244.3:c.239-3843G>T||MODIFIER||||||TNFSF8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,96:96:1
chr9	115010757	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,76:76:1
chr9	115988957	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1165991326||2.63505e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	7,56:63:0.8889
chr9	116185769	.	T	C	.	PASS	CSQ=5069|protein_coding||intron_variant|||||||NM_002581.5:c.416-1385T>C||MODIFIER||||||PAPPA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,75:75:1
chr9	116368984	.	T	A	.	PASS	CSQ=5069|protein_coding||intron_variant|||||||NM_002581.5:c.4605+1230T>A||MODIFIER||||||PAPPA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,82:82:1
chr9	116659881	.	CTATT	C	.	PASS	CSQ=23245|protein_coding||intron_variant|||||||NM_001365068.1:c.2807-8092_2807-8089del||MODIFIER||||||ASTN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,75:75:1
chr9	118789545	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,56:56:1
chr9	119012572	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,61:61:1
chr9	119549510	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,66:66:1
chr9	119631171	COSV68715684	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV68715684|rs919301771||1.97215e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,67:67:1
chr9	119681260	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:133:0	1,84:85:0.9882
chr9	119844080	.	TCTG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,63:63:1
chr9	120041375	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,68:68:1
chr9	120041384	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,70:70:1
chr9	120353199	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,77:77:1
chr9	120825490	.	G	A	.	PASS	CSQ=5711|protein_coding||intron_variant|||||||NM_005047.4:c.815-805C>T||MODIFIER||||||PSMD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,83:83:1
chr9	121340965	.	A	T	.	PASS	CSQ=2040|protein_coding||3_prime_UTR_variant|||||||NM_004099.5:c.*237T>A||MODIFIER||||||STOM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	107,0:107:0	0,77:77:1
chr9	121505478	.	GTCTCTCA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,88:88:1
chr9	121792901	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1317350604||6.57549e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	0,73:73:1
chr9	122717742	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1216889493||6.57289e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,68:68:1
chr9	122863219	.	C	T	.	PASS	CSQ=54542|protein_coding||intron_variant|||||||NM_001100588.3:c.1634+2130G>A||MODIFIER||||||RC3H2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	0,84:84:1
chr9	122933931	.	TG	T	.	PASS	CSQ=57684|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ZBTB26|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	9,50:59:0.8475
chr9	123366394	.	C	T	.	PASS	CSQ=286204|protein_coding||intron_variant||||rs372736931|0.000292899|0.000395424|NM_173689.7:c.754+28C>T||MODIFIER||||||CRB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	132,0:132:0	1,83:84:0.9881
chr9	125217052	.	T	C	.	PASS	CSQ=10244|protein_coding||intron_variant|||||||NM_001174152.1:c.365-3487T>C||MODIFIER||||||RABEPK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,97:97:1
chr9	125759400	.	C	G	.	PASS	CSQ=5090|protein_coding||intron_variant|||||||NM_006195.6:c.274+10777C>G||MODIFIER||||||PBX3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,98:98:1
chr9	126277324	COSV69539581	A	G	.	PASS	CSQ=101929116|lncRNA||upstream_gene_variant|||COSV69539581||||||MODIFIER||||||LOC101929116|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,91:91:1
chr9	126441526	.	G	A	.	PASS	CSQ=89853|protein_coding||intron_variant|||||||NM_033446.3:c.757+19578G>A||MODIFIER||||||MVB12B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	0,106:106:1
chr9	126940290	.	G	T	.	PASS	CSQ=9649|protein_coding||intron_variant|||||||NM_014636.3:c.-65-21935G>T||MODIFIER||||||RALGPS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,85:85:1
chr9	127279359	.	G	GT	.	PASS	CSQ=84253|protein_coding||intron_variant||||rs1210775008||6.58025e-06|NM_032293.5:c.145-11803dup||MODIFIER||||||GARNL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	7,82:89:0.9213
chr9	128736903	.	GGAGGCT	G	.	PASS	CSQ=100506100|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC100506100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	0,71:71:1
chr9	129065320	.	A	C	.	PASS	CSQ=84895|protein_coding||intron_variant|||||||NM_001329990.1:c.1170+1689A>C||MODIFIER||||||MIGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,77:77:1
chr9	129557940	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,96:96:1
chr9	129718709	.	G	T	.	PASS	CSQ=101929437|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||PRRX2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	1,77:78:0.9872
chr9	129846838	.	G	T	.	PASS	CSQ=10868|protein_coding||intron_variant|||||||NM_006676.7:c.-128-2975G>T||MODIFIER||||||USP20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,80:80:1
chr9	129916627	.	C	CA	.	PASS	CSQ=23048|protein_coding||intron_variant||||rs1456144756||0.00358098|NM_015033.3:c.1171-648dup||MODIFIER||||||FNBP1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FNBP1|y|n|AML|||L|Dom|fusion|T;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	7,68:75:0.9067
chr9	130800524	.	T	C	.	PASS	CSQ=25|protein_coding||intron_variant|||||||NM_007313.2:c.137-53540T>C||MODIFIER||||||ABL1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ABL1|y|n|CML,ALL,T-ALL|||L|Dom|oncogene,fusion|T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,61:61:1
chr9	131144766	.	C	T	.	PASS	CSQ=8021|protein_coding||intron_variant||||rs766111648|4.61911e-06||NM_005085.4:c.1769+12C>T||MODIFIER||||||NUP214|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NUP214|y|n|AML,T-ALL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	0,88:88:1
chr9	131842089	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1016260132||6.5703e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,80:80:1
chr9	132083784	.	C	A	.	PASS	CSQ=9442|protein_coding||upstream_gene_variant||||rs1020844142|||||MODIFIER||||||MED27|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,2:126:0.0159	80,5:86:0.0581
chr9	133736594	.	C	A	.	PASS	CSQ=1757|protein_coding||intron_variant|||||||NM_001134707.2:c.-31+1660G>T||MODIFIER||||||SARDH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,85:85:1
chr9	134625462	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	97,5:102:0.049
chr9	134652672	.	GA	TT	.	PASS	CSQ=1289|protein_coding||intron_variant|||||||NM_000093.4:c.109+10376_109+10377delinsTT||MODIFIER||||||COL5A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	120,0:120:0	0,85:85:1
chr9	135158385	.	CA	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	122,0:122:0	0,51:51:1
chr9	135283668	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,77:77:1
chr9	135401176	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1170618394||6.57808e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,74:74:1
chr9	135546954	.	C	A	.	PASS	CSQ=29991|protein_coding||intron_variant|||||||NM_014582.2:c.206+43C>A||MODIFIER||||||OBP2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,95:95:1
chr9	136066560	.	T	C	.	PASS	CSQ=138151|protein_coding||intron_variant|||||||NM_144653.5:c.-59-15980A>G||MODIFIER||||||NACC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	0,91:91:1
chr9	136788948	.	T	C	.	PASS	CSQ=85014|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TMEM141|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	4,92:96:0.9583
chr9	136792245	.	CC	TT	.	PASS	CSQ=84960|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CCDC183|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2,lancet;num_callers=2;supported_by=strelka2_SNVs	AD:DP:AF	141,0:141:0	0,75:75:1
chr9	136794194	.	C	T	.	PASS	CSQ=84960|protein_coding||upstream_gene_variant||||rs1423343551||5.25735e-05|||MODIFIER||||||CCDC183|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,102:102:1
chr9	136801901	.	C	A	.	PASS	CSQ=100131193|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||CCDC183-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,82:82:1
chr9	137305868	.	G	C	.	PASS	CSQ=441478|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NRARP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	0,107:107:1
chr9	137430108	.	TCTCCC	T	.	PASS	CSQ=377841|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ENTPD8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,0:72:0	1,55:56:0.9821
chr10	1758683	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	62,37:99:0.3737
chr10	2100367	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,26:90:0.2889
chr10	2181991	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	33,73:106:0.6887
chr10	2259457	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	58,37:95:0.3895
chr10	2424265	.	TG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	111,0:112:0	31,69:100:0.69
chr10	2500693	.	C	A	.	PASS	CSQ=105376351|lncRNA||intron_variant&non_coding_transcript_variant||||rs1406672146|||NR_136146.1:n.89+681G>T||MODIFIER||||||LOC105376351|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	56,36:92:0.3913
chr10	2549905	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1307785235||1.97171e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	36,61:97:0.6289
chr10	2597782	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	30,75:105:0.7143
chr10	3420687	.	C	T	.	PASS	CSQ=105376360|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_131187.1:n.162+101831C>T||MODIFIER||||||LOC105376360|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	50,33:83:0.3976
chr10	3470644	.	G	A	.	PASS	CSQ=105376360|lncRNA||intron_variant&non_coding_transcript_variant||||rs896648554||2.63186e-05|NR_131187.1:n.162+151788G>A||MODIFIER||||||LOC105376360|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	55,21:76:0.2763
chr10	3816606	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	33,53:86:0.6163
chr10	3971424	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	33,45:78:0.5769
chr10	4064952	.	C	T	.	PASS	CSQ=101927964|lncRNA||intron_variant&non_coding_transcript_variant||||rs1178805295||3.94301e-05|NR_120632.1:n.432+12795C>T||MODIFIER||||||LOC101927964|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	38,59:97:0.6082
chr10	4252307	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	77,36:113:0.3186
chr10	4837880	.	C	T	.	PASS	CSQ=83592|protein_coding||intron_variant|||||||NM_001040177.3:c.582+299C>T||MODIFIER||||||AKR1E2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	56,42:98:0.4286
chr10	5102077	.	C	T	.	PASS	CSQ=8644|protein_coding||intron_variant||||rs781910878|4.13227e-06||NM_003739.6:c.571-24C>T||MODIFIER||||||AKR1C3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	24,73:97:0.7526
chr10	5163588	.	T	A	.	PASS	CSQ=340811|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_027916.2:n.177-568A>T||MODIFIER||||||AKR1C8P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	35,60:95:0.6316
chr10	5176117	.	C	T	.	PASS	CSQ=340811|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||rs1417406494||3.29303e-05|NR_027916.2:n.176+8895G>A||MODIFIER||||||AKR1C8P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	34,56:90:0.6222
chr10	5573325	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	68,43:111:0.3874
chr10	5665551	.	C	T	.	PASS	CSQ=79754|protein_coding||intron_variant||||rs528879108||0.000315387|NM_024701.4:c.43+958G>A||MODIFIER||||||ASB13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	98,70:168:0.4167
chr10	5794906	.	C	A	.	PASS	CSQ=2665|protein_coding||stop_gained|||||||NM_001494.4:c.367G>T|NP_001485.2:p.Glu123Ter|HIGH|.&.&.&.&.||D|.&.&.&.&.|.&.&.&.&.|GDI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	102,62:164:0.378
chr10	5824844	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1034797377|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,1:121:0.0083	76,41:117:0.3504
chr10	6776957	.	G	A	.	PASS	CSQ=100507127|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC00707|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	58,26:84:0.3095
chr10	6790705	.	G	A	.	PASS	CSQ=100507127|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038291.1:n.473+9219G>A||MODIFIER||||||LINC00707|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	94,5:99:0.0505
chr10	6876950	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	68,32:100:0.32
chr10	7049296	.	GTGCGAGACTCTGTC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	64,27:91:0.2967
chr10	7068862	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	38,55:93:0.5914
chr10	7204604	.	C	T	.	PASS	CSQ=57713|protein_coding||intron_variant||||rs1309355825||3.94317e-05|NM_001029880.2:c.1444+1211G>A||MODIFIER||||||SFMBT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	63,32:95:0.3368
chr10	7293404	.	A	AT	.	PASS	CSQ=57713|protein_coding||intron_variant||||rs532526512||0.000178836|NM_001029880.2:c.437-7451dup||MODIFIER||||||SFMBT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	79,38:117:0.3248
chr10	7566563	.	TA	T	.	PASS	CSQ=80760|protein_coding||intron_variant|||||||NM_030569.7:c.2150-157del||MODIFIER||||||ITIH5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	30,43:73:0.589
chr10	7615763	.	G	T	.	PASS	CSQ=80760|protein_coding||intron_variant||||rs1199048535|||NM_030569.7:c.939+219C>A||MODIFIER||||||ITIH5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	57,36:93:0.3871
chr10	7923582	COSV60208862	C	CA	.	PASS	CSQ=83860|protein_coding||intron_variant|COSV60208862|p.?||rs139803422||0.029353|NM_031923.4:c.410-40331dup||MODIFIER||||||TAF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,2:85:0.0235	42,58:101:0.5743
chr10	8653222	.	GATTT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	35,61:96:0.6354
chr10	8761131	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	34,58:92:0.6304
chr10	9183747	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1007675483|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	69,39:108:0.3611
chr10	9291527	.	CA	C	.	PASS	CSQ=101928272|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120635.1:n.192+2822del||MODIFIER||||||LOC101928272|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	34,52:86:0.6047
chr10	9381833	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	95,4:99:0.0404
chr10	9575202	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs760225369||1.31641e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	41,36:77:0.4675
chr10	9646227	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	31,57:88:0.6477
chr10	9755161	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	31,63:94:0.6702
chr10	9785559	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	41,70:111:0.6306
chr10	9876663	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	64,34:98:0.3469
chr10	10078965	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	39,59:98:0.602
chr10	10089947	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:120:0	73,27:100:0.27
chr10	10221357	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	38,54:92:0.587
chr10	10296029	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	61,53:114:0.4649
chr10	10849167	COSV50151337;COSV50151337;COSV50151337	C	T	.	PASS	CSQ=10659|protein_coding||intron_variant|COSV50151337&COSV50151337&COSV50151337|p.?&p.?&p.?||rs1322734252||3.30802e-05|NM_001326325.1:c.110+3011C>T||MODIFIER||||||CELF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	68,36:104:0.3462
chr10	10977090	.	C	A	.	PASS	CSQ=10659|protein_coding||intron_variant|||||||NM_001326325.1:c.146+57091C>A||MODIFIER||||||CELF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	65,30:95:0.3158
chr10	11102247	.	G	C	.	PASS	CSQ=10659|protein_coding||intron_variant|||||||NM_001326332.1:c.54-63239G>C||MODIFIER||||||CELF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	51,34:85:0.4
chr10	11136411	.	G	T	.	PASS	CSQ=10659|protein_coding||intron_variant|||||||NM_001326332.1:c.54-29075G>T||MODIFIER||||||CELF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	82,4:86:0.0465
chr10	11175086	.	G	A	.	PASS	CSQ=10659|protein_coding||intron_variant||||rs938363702|||NM_001326332.1:c.250+9404G>A||MODIFIER||||||CELF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	59,40:99:0.404
chr10	11622442	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs141842985||0.0876418|||MODIFIER||||||||0.1030;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	46,62:108:0.5741
chr10	11679381	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	37,71:108:0.6574
chr10	12264199	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	46,82:128:0.6406
chr10	12675263	.	C	T	.	PASS	CSQ=57118|protein_coding||intron_variant|||||||NM_153498.3:c.299+8453C>T||MODIFIER||||||CAMK1D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	27,58:85:0.6824
chr10	12684439	.	C	T	.	PASS	CSQ=57118|protein_coding||intron_variant|||||||NM_153498.3:c.299+17629C>T||MODIFIER||||||CAMK1D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	29,48:77:0.6234
chr10	12714227	COSV66606059;COSV66606059	G	A	.	PASS	CSQ=57118|protein_coding||intron_variant|COSV66606059&COSV66606059|p.?&p.?||rs374097872||0.000237505|NM_153498.3:c.300-46721G>A||MODIFIER||||||CAMK1D|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	69,38:107:0.3551
chr10	13192105	.	G	T	.	PASS	CSQ=55388|protein_coding||intron_variant|||||||NM_018518.4:c.1517-150G>T||MODIFIER||||||MCM10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	46,58:104:0.5577
chr10	13241527	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,0:72:0	37,15:52:0.2885
chr10	13461094	.	C	T	.	PASS	CSQ=222389|protein_coding||intron_variant|||||||NM_001100912.1:c.947-8436G>A||MODIFIER||||||BEND7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	42,70:112:0.625
chr10	13577443	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57523e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	42,51:93:0.5484
chr10	13983316	.	G	A	.	PASS	CSQ=55691|protein_coding||intron_variant|||||||NM_018027.5:c.46-124404C>T||MODIFIER||||||FRMD4A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	53,32:85:0.3765
chr10	14057198	.	C	G	.	PASS	CSQ=55691|protein_coding||intron_variant||||rs1458135936||3.94244e-05|NM_018027.5:c.46-198286G>C||MODIFIER||||||FRMD4A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	36,67:103:0.6505
chr10	14451017	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	67,37:104:0.3558
chr10	14974447	.	G	T	.	PASS	CSQ=644890|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MEIG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	29,65:94:0.6915
chr10	15204140	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	52,32:84:0.381
chr10	15582238	.	C	CA	.	PASS	CSQ=8516|protein_coding||intron_variant||||rs938112820||1.32097e-05|NM_003638.3:c.2372+4345dup||MODIFIER||||||ITGA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	64,32:96:0.3333
chr10	15622752	.	T	C	.	PASS	CSQ=8516|protein_coding||intron_variant|||||||NM_003638.3:c.1400-6193A>G||MODIFIER||||||ITGA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	65,29:94:0.3085
chr10	15721652	.	G	A	.	PASS	CSQ=8516|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ITGA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	38,47:86:0.5465
chr10	15809521	.	C	A	.	PASS	CSQ=80013|protein_coding||intron_variant|||||||NM_024948.4:c.882+7314G>T||MODIFIER||||||MINDY3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	50,31:81:0.3827
chr10	15932565	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	36,80:116:0.6897
chr10	15957422	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	59,30:89:0.3371
chr10	15997043	.	GG	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	105,0:105:0	23,63:86:0.7326
chr10	16296951	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.59257e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	41,62:103:0.6019
chr10	16407357	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	60,43:103:0.4175
chr10	16418348	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	47,66:113:0.5841
chr10	16501619	.	C	T	.	PASS	CSQ=9317|protein_coding||intron_variant|||||||NM_030664.4:c.699-3401C>T||MODIFIER||||||PTER|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	54,39:93:0.4194
chr10	16699584	.	G	C	.	PASS	CSQ=6251|protein_coding||intron_variant|||||||NM_012425.4:c.599-4429C>G||MODIFIER||||||RSU1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	72,41:113:0.3628
chr10	16858570	.	C	A	.	PASS	CSQ=8029|protein_coding||intron_variant|||||||NM_001081.3:c.9455-7127G>T||MODIFIER||||||CUBN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	36,73:109:0.6697
chr10	16908402	.	C	T	.	PASS	CSQ=8029|protein_coding||intron_variant|||||||NM_001081.3:c.7534-723G>A||MODIFIER||||||CUBN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	56,37:93:0.3978
chr10	17126350	.	G	A	.	PASS	CSQ=8029|protein_coding||intron_variant||||rs562660153||0.000124885|NM_001081.3:c.387+411C>T||MODIFIER||||||CUBN|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	38,64:102:0.6275
chr10	17194742	.	G	C	.	PASS	CSQ=1787|protein_coding||intron_variant|||||||NM_004412.7:c.64+6829C>G||MODIFIER||||||TRDMT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	27,74:101:0.7327
chr10	17240071	.	G	A	.	PASS	CSQ=7431|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||VIM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	31,76:107:0.7103
chr10	17476770	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	60,42:102:0.4118
chr10	17957079	.	C	A	.	PASS	CSQ=221074|protein_coding||intron_variant|||||||NM_001145195.2:c.261+3542C>A||MODIFIER||||||SLC39A12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:134:0	47,65:112:0.5804
chr10	17993608	.	T	A	.	PASS	CSQ=221074|protein_coding||intron_variant|||||||NM_001145195.2:c.1533+317T>A||MODIFIER||||||SLC39A12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	62,39:101:0.3861
chr10	18024584	.	G	C	.	PASS	CSQ=221074|protein_coding||intron_variant|||||||NM_001145195.2:c.1948-18121G>C||MODIFIER||||||SLC39A12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	35,63:98:0.6429
chr10	18049462	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	71,34:105:0.3238
chr10	18378850	.	A	G	.	PASS	CSQ=783|protein_coding||intron_variant|||||||NM_201596.2:c.214-23074A>G||MODIFIER||||||CACNB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	37,60:97:0.6186
chr10	18423280	.	T	C	.	PASS	CSQ=783|protein_coding||intron_variant|||||||NM_201596.2:c.333+21237T>C||MODIFIER||||||CACNB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	62,31:93:0.3333
chr10	18818893	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	30,62:92:0.6739
chr10	18883844	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs529213528||9.26281e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	72,29:101:0.2871
chr10	19159060	.	C	T	.	PASS	CSQ=340895|protein_coding||intron_variant|||||||NM_001142308.3:c.1656+3888C>T||MODIFIER||||||MALRD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	21,60:81:0.7407
chr10	19603285	.	T	G	.	PASS	CSQ=340895|protein_coding||intron_variant|||||||NM_001142308.3:c.5945-4492T>G||MODIFIER||||||MALRD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	31,58:89:0.6517
chr10	19633304	.	C	A	.	PASS	CSQ=340895|protein_coding||intron_variant|||||||NM_001142308.3:c.6137+17381C>A||MODIFIER||||||MALRD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	40,49:89:0.5506
chr10	19637781	.	G	A	.	PASS	CSQ=340895|protein_coding||intron_variant|||||||NM_001142308.3:c.6137+21858G>A||MODIFIER||||||MALRD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	20,60:80:0.75
chr10	19788314	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	35,54:89:0.6067
chr10	19929125	.	TC	T	.	PASS	CSQ=84898|protein_coding||intron_variant|||||||NM_032812.9:c.113-72647del||MODIFIER||||||PLXDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	36,56:92:0.6087
chr10	19952585	.	T	C	.	PASS	CSQ=84898|protein_coding||intron_variant|||||||NM_032812.9:c.113-49190T>C||MODIFIER||||||PLXDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	69,43:112:0.3839
chr10	20146179	.	G	T	.	PASS	CSQ=84898|protein_coding||intron_variant|||||||NM_032812.9:c.665-1605G>T||MODIFIER||||||PLXDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	25,56:81:0.6914
chr10	20206572	.	AATGGGTTGTAGAGC	A	.	PASS	CSQ=84898|protein_coding||intron_variant|||||||NM_032812.9:c.1062-5091_1062-5078del||MODIFIER||||||PLXDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	34,55:89:0.618
chr10	20207663	.	G	A	.	PASS	CSQ=84898|protein_coding||intron_variant|||||||NM_032812.9:c.1062-4006G>A||MODIFIER||||||PLXDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	38,55:93:0.5914
chr10	20226317	.	C	A	.	PASS	CSQ=84898|protein_coding||intron_variant|||||||NM_032812.9:c.1312+7215C>A||MODIFIER||||||PLXDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	39,54:93:0.5806
chr10	20519626	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	35,78:113:0.6903
chr10	20575982	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	62,22:84:0.2619
chr10	20584695	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1192881820|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	29,79:108:0.7315
chr10	20648205	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	81,37:118:0.3136
chr10	20665077	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	81,11:92:0.1196
chr10	21883449	.	T	A	.	PASS	CSQ=64215|protein_coding||intron_variant|||||||NM_022365.4:c.821-1010A>T||MODIFIER||||||DNAJC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	51,73:124:0.5887
chr10	22462214	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	82,37:119:0.3109
chr10	22482229	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	100,5:105:0.0476
chr10	22788260	COSV67642354	T	A	.	PASS	CSQ=|||intergenic_variant|||COSV67642354||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	69,26:95:0.2737
chr10	23163608	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	67,50:117:0.4274
chr10	23183589	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1439804105||0.00202388|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	49,64:113:0.5664
chr10	23270546	.	G	T	.	PASS	CSQ=256815|protein_coding||intron_variant|||||||NM_001365862.1:c.979-3292C>A||MODIFIER||||||C10orf67|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	44,63:107:0.5888
chr10	23469791	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	27,63:90:0.7
chr10	23987249	.	C	T	.	PASS	CSQ=56243|protein_coding||intron_variant||||rs561995793|||NM_001098500.2:c.-320-19976C>T||MODIFIER||||||KIAA1217|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	30,50:81:0.6173
chr10	24231749	.	G	A	.	PASS	CSQ=56243|protein_coding||intron_variant|||||||NM_019590.5:c.354+11840G>A||MODIFIER||||||KIAA1217|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	45,82:127:0.6457
chr10	24448250	.	G	GA	.	PASS	CSQ=56243|protein_coding||intron_variant|||||||NM_019590.5:c.846+9771_846+9772insA||MODIFIER||||||KIAA1217|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	69,42:111:0.3784
chr10	24862569	.	T	A	.	PASS	CSQ=56952|protein_coding||intron_variant|||||||NM_020200.7:c.406-4160A>T||MODIFIER||||||PRTFDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	37,58:95:0.6105
chr10	24926897	.	C	A	.	PASS	CSQ=56952|protein_coding||intron_variant|||||||NM_020200.7:c.339+10287G>T||MODIFIER||||||PRTFDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	68,44:112:0.3929
chr10	24997654	.	G	T	.	PASS	CSQ=219670|protein_coding||intron_variant|||||||NM_145010.4:c.223+1747C>A||MODIFIER||||||ENKUR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	64,46:110:0.4182
chr10	25755978	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	54,29:83:0.3494
chr10	26581549	.	AA	TC	.	PASS	CSQ=101929117|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC101929117|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	138,0:138:0	82,41:123:0.3333
chr10	26581553	.	G	T	.	PASS	CSQ=101929117|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC101929117|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,1:133:0.0075	82,43:125:0.344
chr10	26791466	.	ACTGATCTACAGCTTCAATGCATTCCAATAAAAATGC	A	.	PASS	CSQ=10006|protein_coding||intron_variant|||||||NM_001012750.2:c.286-14261_286-14226del||MODIFIER||||||ABI1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ABI1|y|n|AML|||L|Dom|TSG,fusion|T;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	76,36:112:0.3214
chr10	27216952	.	C	A	.	PASS	CSQ=91452|protein_coding||intron_variant|||||||NM_145698.5:c.829+1028G>T||MODIFIER||||||ACBD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	29,42:71:0.5915
chr10	27378973	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	84,41:125:0.328
chr10	27680490	.	A	T	.	PASS	CSQ=283078|protein_coding||intron_variant|||||||NM_173576.3:c.839-4936T>A||MODIFIER||||||MKX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	72,28:100:0.28
chr10	27877364	.	G	C	.	PASS	CSQ=55130|protein_coding||intron_variant|||||||NM_001290020.1:c.2611-14742C>G||MODIFIER||||||ARMC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	59,35:94:0.3723
chr10	28291285	.	G	A	.	PASS	CSQ=143098|protein_coding||intron_variant|||||||NM_001318170.1:c.-132+11576C>T||MODIFIER||||||MPP7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	85,45:130:0.3462
chr10	28702873	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	40,75:115:0.6522
chr10	28797712	.	A	AAT	.	PASS	CSQ=100507605|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC00837|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	40,46:87:0.5287
chr10	29185957	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	31,61:92:0.663
chr10	30118323	.	G	A	.	PASS	CSQ=57608|protein_coding||upstream_gene_variant||||rs546605879||1.97151e-05|||MODIFIER||||||JCAD|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	77,43:120:0.3583
chr10	30404185	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	37,53:90:0.5889
chr10	30404187	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	39,50:89:0.5618
chr10	30508487	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	83,28:111:0.2523
chr10	30591959	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	47,52:100:0.52
chr10	31285084	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	104,0:106:0	87,6:93:0.0645
chr10	31357935	.	C	A	.	PASS	CSQ=100505502|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LOC100505502|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	63,25:88:0.2841
chr10	32064471	.	CCCAGGCTGGA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	42,72:114:0.6316
chr10	32291669	.	A	C	.	PASS	CSQ=80314|protein_coding||intron_variant|||||||NM_001272004.1:c.816-347T>G||MODIFIER||||||EPC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	96,7:103:0.068
chr10	32303916	.	C	G	.	PASS	CSQ=80314|protein_coding||intron_variant|||||||NM_001272004.1:c.313+1856G>C||MODIFIER||||||EPC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	45,79:124:0.6371
chr10	32547903	.	T	C	.	PASS	CSQ=79741|protein_coding||intron_variant||||rs1020185535||5.25645e-05|NM_001321115.1:c.1134+3602T>C||MODIFIER||||||CCDC7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	24,69:93:0.7419
chr10	32565520	.	C	G	.	PASS	CSQ=79741|protein_coding||intron_variant|||||||NM_001321115.1:c.1135-38C>G||MODIFIER||||||CCDC7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	92,0:92:0	31,65:96:0.6771
chr10	32764703	.	C	T	.	PASS	CSQ=79741|protein_coding||intron_variant|||||||NM_001321115.1:c.2906-14274C>T||MODIFIER||||||CCDC7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	80,35:115:0.3043
chr10	33725039	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1262939337||1.31458e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	23,52:75:0.6933
chr10	33987056	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	37,55:92:0.5978
chr10	34456413	.	C	T	.	PASS	CSQ=56288|protein_coding||intron_variant|||||||NM_001184785.2:c.583-5965G>A||MODIFIER||||||PARD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	63,34:97:0.3505
chr10	34920343	.	TTTC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	111,51:162:0.3148
chr10	35304277	.	G	C	.	PASS	CSQ=219771|protein_coding||intron_variant|||||||NM_181698.3:c.-9+53651G>C||MODIFIER||||||CCNY|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	121,0:121:0	70,20:90:0.2222
chr10	35565921	.	G	A	.	PASS	CSQ=219771|protein_coding||intron_variant||||||6.56883e-06|NM_145012.6:c.747-102G>A||MODIFIER||||||CCNY|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	152,0:152:0	45,69:114:0.6053
chr10	36037469	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	53,29:82:0.3537
chr10	36208161	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	60,35:95:0.3684
chr10	36417745	.	CCTCCAGACT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	61,31:92:0.337
chr10	36430105	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	66,32:98:0.3265
chr10	36484881	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	28,52:80:0.65
chr10	36644830	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs890891894||1.31577e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	33,65:98:0.6633
chr10	36765504	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1274824794||6.56944e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	60,40:100:0.4
chr10	36963490	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	159,0:160:0	31,56:87:0.6437
chr10	37006476	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1351485668||2.00438e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	29,58:88:0.6591
chr10	37240178	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	37,72:109:0.6606
chr10	37249303	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1297504653||1.31437e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	85,6:91:0.0659
chr10	37486263	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	39,33:72:0.4583
chr10	37660200	COSV50314892	GA	G	.	PASS	CSQ=|||intergenic_variant|||COSV50314892|rs954702432||0.000183653|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:99:0	60,24:85:0.2824
chr10	37766395	.	T	G	.	PASS	CSQ=57209|misc_RNA||intron_variant&non_coding_transcript_variant||||||6.5722e-06|NR_147995.1:n.1501-6330A>C||MODIFIER||||||ZNF248|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	70,36:106:0.3396
chr10	37825043	.	G	A	.	PASS	CSQ=57209|protein_coding||downstream_gene_variant||||rs1174869692||1.31794e-05|||MODIFIER||||||ZNF248|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	82,8:90:0.0889
chr10	38362434	.	G	T	.	PASS	CSQ=158160|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003086.1:n.413+96G>T||MODIFIER||||||HSD17B7P2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	37,70:107:0.6542
chr10	38377207	.	C	T	.	PASS	CSQ=158160|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||rs1295246037||3.28459e-05|NR_003086.1:n.881-778C>T||MODIFIER||||||HSD17B7P2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	92,17:109:0.156
chr10	38613695	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1219829345||6.60563e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	63,0:63:0	0,58:58:1
chr10	39012606	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	24,64:88:0.7273
chr10	39265327	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1410648183||0.000131211|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	74,0:74:0	48,16:64:0.25
chr10	39534858	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	37,63:100:0.63
chr10	42163678	.	AGGTAGAGACT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	488,0:488:0.00202	461,32:493:0.067
chr10	42494487	.	C	T	.	PASS	CSQ=84856|lncRNA||non_coding_transcript_exon_variant|||||||NR_026827.1:n.1456C>T||MODIFIER||||||LINC00839|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	112,0:112:0	98,4:102:0.0392
chr10	42495541	.	C	T	.	PASS	CSQ=84856|lncRNA||downstream_gene_variant||||rs1454556310||1.31498e-05|||MODIFIER||||||LINC00839|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:109:0	94,4:98:0.0408
chr10	43031568	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	33,66:99:0.6667
chr10	43467693	.	T	C	.	PASS	CSQ=642819|protein_coding||intron_variant|||||||NM_001355444.1:c.-90-8028T>C||MODIFIER||||||ZNF487|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	27,46:73:0.6301
chr10	43479625	.	C	CT	.	PASS	CSQ=642819|protein_coding||intron_variant||||rs1015500442||0.000125198|NM_001355444.1:c.134-1796dup||MODIFIER||||||ZNF487|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	58,30:88:0.3409
chr10	43535254	.	AA	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	133,0:134:0	33,54:87:0.6207
chr10	43581210	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	44,42:86:0.4884
chr10	43666667	.	C	T	.	PASS	CSQ=414201|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038867.1:n.163-4454C>T||MODIFIER||||||ZNF32-AS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	30,56:86:0.6512
chr10	43932733	.	C	T	.	PASS	CSQ=283033|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_136147.1:n.192-10459C>T||MODIFIER||||||LINC00841|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	44,34:78:0.4359
chr10	43974434	.	G	A	.	PASS	CSQ=283033|lncRNA||intron_variant&non_coding_transcript_variant||||||1.31425e-05|NR_136147.1:n.398-6020G>A||MODIFIER||||||LINC00841|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	54,37:91:0.4066
chr10	44204742	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	25,56:81:0.6914
chr10	44498225	COSV51315217	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV51315217|rs552173715||0.0865538|||MODIFIER||||||||0.0713;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	44,39:83:0.4699
chr10	45107297	.	G	A	.	PASS	CSQ=100133308|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_024472.1:n.623-214C>T||MODIFIER||||||RSU1P2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	45,56:101:0.5545
chr10	45120697	.	C	A	.	PASS	CSQ=100133308|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_024472.1:n.520-4657G>T||MODIFIER||||||RSU1P2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	60,39:99:0.3939
chr10	46747403	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	80,26:106:0.2453
chr10	47102670	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	38,80:118:0.678
chr10	47159033	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	74,37:111:0.3333
chr10	47208881	.	C	CAGAT	.	PASS	CSQ=|||intergenic_variant||||rs1297824410||1.31641e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	76,35:111:0.3153
chr10	47691421	.	C	A	.	PASS	CSQ=439965|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_027634.1:n.1530+192C>A||MODIFIER||||||FAM35DP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	74,0:74:0	24,42:66:0.6364
chr10	48495793	.	C	T	.	PASS	CSQ=58504|protein_coding||intron_variant|||||||NM_021226.3:c.323-16029G>A||MODIFIER||||||ARHGAP22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	64,51:115:0.4435
chr10	48539489	.	C	A	.	PASS	CSQ=58504|protein_coding||intron_variant|||||||NM_021226.3:c.322+15974G>T||MODIFIER||||||ARHGAP22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	35,61:96:0.6354
chr10	48707136	.	G	C	.	PASS	CSQ=57705|protein_coding||intron_variant|||||||NM_020945.1:c.-17-2580G>C||MODIFIER||||||WDFY4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	65,46:111:0.4144
chr10	48807970	.	C	G	.	PASS	CSQ=57705|protein_coding||intron_variant|||||||NM_020945.1:c.4838+12C>G||MODIFIER||||||WDFY4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	130,0:130:0	29,69:98:0.7041
chr10	48988845	.	G	T	.	PASS	CSQ=100422895|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR4294|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	73,39:112:0.3482
chr10	49704974	.	A	T	.	PASS	CSQ=282966|protein_coding||intron_variant|||||||NM_182554.3:c.218-3387A>T||MODIFIER||||||C10orf53|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	61,32:93:0.3441
chr10	50086128	.	G	A	.	PASS	CSQ=387680|protein_coding||intron_variant|||||||NM_001005751.3:c.684+570G>A||MODIFIER||||||WASHC2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	34,66:100:0.66
chr10	50258588	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57099e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	40,69:109:0.633
chr10	51211336	.	A	T	.	PASS	CSQ=5592|protein_coding||intron_variant|||||||NM_006258.4:c.478+58006A>T||MODIFIER||||||PRKG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	55,27:82:0.3293
chr10	51280626	.	C	T	.	PASS	CSQ=5592|protein_coding||intron_variant|||||||NM_006258.4:c.478+127296C>T||MODIFIER||||||PRKG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	62,29:91:0.3187
chr10	51396811	.	T	C	.	PASS	CSQ=5592|protein_coding||intron_variant|||||||NM_006258.4:c.479-70912T>C||MODIFIER||||||PRKG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	85,6:91:0.0659
chr10	51564695	.	G	T	.	PASS	CSQ=5592|protein_coding||intron_variant|||||||NM_006258.4:c.592+96859G>T||MODIFIER||||||PRKG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	58,34:92:0.3696
chr10	51630008	.	C	A	.	PASS	CSQ=5592|protein_coding||intron_variant|||||||NM_006258.4:c.592+162172C>A||MODIFIER||||||PRKG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	39,61:100:0.61
chr10	51715521	.	C	G	.	PASS	CSQ=5592|protein_coding||intron_variant|||||||NM_006258.4:c.593-89064C>G||MODIFIER||||||PRKG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	51,28:79:0.3544
chr10	51891944	.	G	T	.	PASS	CSQ=5592|protein_coding||intron_variant|||||||NM_006258.4:c.699-15563G>T||MODIFIER||||||PRKG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	30,50:80:0.625
chr10	52732848	.	G	C	.	PASS	CSQ=105378305|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_155748.1:n.95+22462C>G||MODIFIER||||||LOC105378305|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	50,27:77:0.3506
chr10	52751481	.	G	T	.	PASS	CSQ=105378305|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_155748.1:n.95+3829C>A||MODIFIER||||||LOC105378305|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	57,39:96:0.4062
chr10	52768877	.	C	CA	.	PASS	CSQ=4153|protein_coding||intron_variant|||||||NM_000242.2:c.374-368dup||MODIFIER||||||MBL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	52,22:74:0.2973
chr10	53084498	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	46,66:112:0.5893
chr10	53393387	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	43,49:92:0.5326
chr10	53465418	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	48,27:75:0.36
chr10	53528000	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	35,24:59:0.4068
chr10	53634503	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	66,9:75:0.12
chr10	53641929	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1249265700||0.400769|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	54,0:54:0	47,13:60:0.2167
chr10	53915498	.	C	T	.	PASS	CSQ=65217|protein_coding||intron_variant||||rs745956842|||NM_001142769.2:c.3410-12128G>A||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	86,6:92:0.0652
chr10	54088812	.	T	A	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001142769.2:c.2033+1172A>T||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	51,42:93:0.4516
chr10	54117494	.	G	A	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001142769.2:c.1953+15381C>T||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	29,44:73:0.6027
chr10	54181189	.	C	T	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001142769.2:c.1626+2255G>A||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	63,27:90:0.3
chr10	54355848	.	C	A	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001142769.2:c.490-9364G>T||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	39,53:92:0.5761
chr10	54506937	COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063;COSV57275063	A	AT	.	PASS	CSQ=65217|protein_coding||intron_variant|COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063&COSV57275063|p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?||rs920085966||0.000330085|NM_001142769.2:c.172+20874dup||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	73,49:122:0.4016
chr10	54578636	.	CT	C	.	PASS	CSQ=105378311|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_134503.1:n.198+9962del||MODIFIER||||||LOC105378311|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	26,48:74:0.6486
chr10	54661542	COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460;COSV57274460	T	TA	.	PASS	CSQ=65217|protein_coding||intron_variant|COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460&COSV57274460|p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?||rs1025988437||6.62445e-05|NM_001142769.2:c.91+2629dup||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	52,25:77:0.3247
chr10	54701952	.	G	T	.	PASS	CSQ=65217|protein_coding||intron_variant||||rs1048014184||6.58267e-06|NM_001142769.2:c.-28-37662C>A||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	43,21:64:0.3281
chr10	54772683	.	C	T	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001142769.2:c.-29+28242G>A||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	49,34:83:0.4096
chr10	54906083	.	C	T	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001354404.1:c.-79-8583G>A||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	55,24:79:0.3038
chr10	55154944	.	A	G	.	PASS	CSQ=65217|protein_coding||intron_variant||||rs1457718583|||NM_001354404.1:c.-80+11632T>C||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	33,55:88:0.625
chr10	55250718	.	G	T	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001354404.1:c.-155-84067C>A||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	41,33:74:0.4459
chr10	55339935	.	GA	G	.	PASS	CSQ=65217|protein_coding||intron_variant||||rs919696340||0.00015613|NM_001354404.1:c.-155-173285del||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	38,23:61:0.377
chr10	55467416	.	G	C	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001354404.1:c.-156+160209C>G||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	48,26:74:0.3514
chr10	55482395	.	C	T	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001354404.1:c.-156+145230G>A||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	50,30:80:0.375
chr10	55563124	.	C	G	.	PASS	CSQ=65217|protein_coding||intron_variant|||||||NM_001354404.1:c.-156+64501G>C||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	65,6:71:0.0845
chr10	55578471	.	C	T	.	PASS	CSQ=65217|protein_coding||intron_variant||||rs751269943||3.29017e-05|NM_001354404.1:c.-156+49154G>A||MODIFIER||||||PCDH15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	46,55:101:0.5446
chr10	55640063	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:135:0	78,5:83:0.0602
chr10	55764525	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:137:0	42,50:92:0.5435
chr10	55803869	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	36,50:86:0.5814
chr10	55910844	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	33,66:99:0.6667
chr10	56004104	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	62,27:89:0.3034
chr10	56014990	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	43,26:69:0.3768
chr10	56019243	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	47,35:82:0.4268
chr10	56076716	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	33,37:70:0.5286
chr10	56098138	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	39,43:82:0.5244
chr10	56261562	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	31,66:97:0.6804
chr10	56333270	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs370792129|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	81,15:96:0.1562
chr10	56563215	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	60,30:90:0.3333
chr10	56649988	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:84:0	46,27:73:0.3699
chr10	56666486	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	41,54:95:0.5684
chr10	57109782	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs996532451||0.00018449|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	55,39:94:0.4149
chr10	57261755	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	60,32:92:0.3478
chr10	57261757	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1039232676|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	59,31:90:0.3444
chr10	57604157	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	46,30:76:0.3947
chr10	58043726	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	41,54:95:0.5684
chr10	58075144	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	79,15:94:0.1596
chr10	58364678	.	G	C	.	PASS	CSQ=7321|protein_coding||intron_variant|||||||NM_003338.5:c.199-93G>C||MODIFIER||||||UBE2D1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:111:0	83,17:100:0.17
chr10	58383647	.	CT	C	.	PASS	CSQ=7019|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TFAM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	34,47:81:0.5802
chr10	58533024	.	G	A	.	PASS	CSQ=80114|protein_coding||intron_variant|||||||NM_001080512.2:c.190+19691G>A||MODIFIER||||||BICC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	32,56:88:0.6364
chr10	59639365	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	30,54:84:0.6429
chr10	59958674	COSV71309115	C	CT	.	PASS	CSQ=283025|lncRNA||non_coding_transcript_exon_variant|||COSV71309115|rs764064272|0.00059851|0.000243588|NR_024340.1:n.1357dup||MODIFIER||||||LINC01553|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	98,0:98:0	46,51:97:0.5258
chr10	60227159	.	AT	A	.	PASS	CSQ=288|protein_coding||intron_variant|||||||NM_020987.5:c.897+7528del||MODIFIER||||||ANK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	39,62:101:0.6139
chr10	60506984	.	C	A	.	PASS	CSQ=288|protein_coding||intron_variant|||||||NM_001204404.1:c.63+65481G>T||MODIFIER||||||ANK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	36,51:87:0.5862
chr10	61356979	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	54,43:97:0.4433
chr10	61564003	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	64,29:93:0.3118
chr10	61883849	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	46,57:103:0.5534
chr10	62047636	.	AG	TT	.	PASS	CSQ=84159|protein_coding||intron_variant|||||||NM_032199.3:c.734-3252_734-3251delinsTT||MODIFIER||||||ARID5B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	110,0:111:0	29,64:93:0.6882
chr10	62351939	.	G	A	.	PASS	CSQ=283045|lncRNA||intron_variant&non_coding_transcript_variant||||rs1051892550||1.31435e-05|NR_104162.1:n.539+999C>T||MODIFIER||||||LOC283045|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	80,18:98:0.1837
chr10	62353495	.	A	T	.	PASS	CSQ=283045|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104162.1:n.456-474T>A||MODIFIER||||||LOC283045|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	52,54:106:0.5094
chr10	62697162	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	64,40:104:0.3846
chr10	62766515	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	63,39:102:0.3824
chr10	62834433	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	69,28:97:0.2887
chr10	62979975	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	40,53:93:0.5699
chr10	63614566	.	G	A	.	PASS	CSQ=221035|protein_coding||intron_variant|||||||NM_001001330.3:c.565+4232G>A||MODIFIER||||||REEP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:95:0	83,38:121:0.314
chr10	63657093	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	49,76:125:0.608
chr10	63956610	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	78,47:125:0.376
chr10	64049437	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	104,8:112:0.0714
chr10	64060883	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	39,56:95:0.5895
chr10	64323741	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	43,54:97:0.5567
chr10	64468321	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	35,45:80:0.5625
chr10	64481748	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	20,48:68:0.7059
chr10	64586764	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,12:88:0.1364
chr10	64626407	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	32,58:90:0.6444
chr10	64798003	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	49,24:73:0.3288
chr10	64829017	.	C	CT	.	PASS	CSQ=305|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||ANXA2P3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	26,45:71:0.6338
chr10	65012274	.	T	G	.	PASS	CSQ=|||intergenic_variant||||||6.57298e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	41,35:76:0.4605
chr10	65013510	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57514e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	59,45:104:0.4327
chr10	65089637	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	28,59:87:0.6782
chr10	65093033	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	32,45:77:0.5844
chr10	65132656	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	68,50:118:0.4237
chr10	65370551	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	76,16:92:0.1739
chr10	65455259	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	38,64:102:0.6275
chr10	65677787	.	G	GA	.	PASS	CSQ=101928913|lncRNA||intron_variant&non_coding_transcript_variant||||rs1377350845||6.61131e-06|NR_120647.1:n.404-11709dup||MODIFIER||||||LINC01515|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	45,74:119:0.6218
chr10	65909997	.	C	A	.	PASS	CSQ=29119|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	29,46:75:0.6133
chr10	66322676	.	G	A	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.1733-42055C>T||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	28,57:85:0.6706
chr10	66364612	.	C	A	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.1732+14540G>T||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	33,44:77:0.5714
chr10	66475472	.	T	G	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.1531+45145A>C||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	53,27:80:0.3375
chr10	66486705	.	A	G	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.1531+33912T>C||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	92,5:97:0.0515
chr10	66547415	.	T	C	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.1375-26642A>G||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	71,0:71:0	33,25:58:0.431
chr10	66657616	.	T	C	.	PASS	CSQ=29119|protein_coding||intron_variant||||rs1387653485|||NM_013266.4:c.1282-35832A>G||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	33,42:75:0.56
chr10	66743513	.	A	T	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.1281+22751T>A||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	34,51:85:0.6
chr10	67245791	.	G	T	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.580-25921C>A||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	28,53:81:0.6543
chr10	67316529	.	G	A	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.580-96659C>T||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	37,60:97:0.6186
chr10	67430338	.	G	T	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.579+91504C>A||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	26,54:80:0.675
chr10	67442170	.	T	C	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.579+79672A>G||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	59,38:97:0.3918
chr10	67476402	.	C	A	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.579+45440G>T||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	88,55:143:0.3846
chr10	67482032	.	C	A	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.579+39810G>T||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	92,44:136:0.3235
chr10	67499334	.	C	G	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.579+22508G>C||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	112,51:163:0.3129
chr10	67499356	.	T	G	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.579+22486A>C||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	101,53:154:0.3442
chr10	67639484	.	G	T	.	PASS	CSQ=29119|protein_coding||intron_variant|||||||NM_013266.4:c.99+7931C>A||MODIFIER||||||CTNNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	122,37:159:0.2327
chr10	68870775	.	C	G	.	PASS	CSQ=219736|protein_coding||intron_variant|||||||NM_152709.5:c.311-11183C>G||MODIFIER||||||STOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	39,61:100:0.61
chr10	68963035	.	G	A	.	PASS	CSQ=9188|protein_coding||intron_variant|||||||NM_004728.4:c.608-256G>A||MODIFIER||||||DDX21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	61,34:95:0.3579
chr10	69110950	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1437306897|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	38,64:102:0.6275
chr10	69117198	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	69,36:105:0.3429
chr10	69411590	.	C	G	.	PASS	CSQ=6865|protein_coding||intron_variant|||||||NM_001057.2:c.588-2515G>C||MODIFIER||||||TACR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	36,69:105:0.6571
chr10	70248068	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	44,59:103:0.5728
chr10	70248087	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	48,53:101:0.5248
chr10	70384163	.	T	C	.	PASS	CSQ=55222|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||LRRC20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	52,35:87:0.4023
chr10	70407176	.	G	A	.	PASS	CSQ=1979|protein_coding||intron_variant|||||||NM_004096.5:c.145+2630G>A||MODIFIER||||||EIF4EBP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	35,76:111:0.6847
chr10	71200492	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	77,38:115:0.3304
chr10	71310402	.	TAAAGGTAATTCTCCTTGTGGGA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	47,73:120:0.6083
chr10	71538499	.	C	T	.	PASS	CSQ=64072|protein_coding||intron_variant||||rs1217676285||1.31456e-05|NM_022124.5:c.429+27287C>T||MODIFIER||||||CDH23|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	40,60:100:0.6
chr10	71542716	.	G	A	.	PASS	CSQ=64072|protein_coding||intron_variant|||||||NM_022124.5:c.430-24026G>A||MODIFIER||||||CDH23|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	37,62:99:0.6263
chr10	71633885	.	G	A	.	PASS	CSQ=64072|protein_coding||intron_variant||||rs532929433||5.25693e-05|NM_022124.5:c.1135-9976G>A||MODIFIER||||||CDH23|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	60,43:103:0.4175
chr10	71634038	.	G	A	.	PASS	CSQ=64072|protein_coding||intron_variant||||rs563389412||2.62722e-05|NM_022124.5:c.1135-9823G>A||MODIFIER||||||CDH23|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	50,45:95:0.4737
chr10	71831956	.	G	C	.	PASS	CSQ=5660|protein_coding||intron_variant||||rs761481248|7.97448e-06|2.63009e-05|NM_002778.4:c.175-36C>G||MODIFIER||||||PSAP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	65,26:91:0.2857
chr10	72056111	.	C	G	.	PASS	CSQ=9806|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SPOCK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	38,61:99:0.6162
chr10	72056297	.	C	G	.	PASS	CSQ=9806|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SPOCK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	44,51:95:0.5368
chr10	72352884	.	TTACTCCCCCTGGGGAGGC	T	.	PASS	CSQ=54788|protein_coding||intron_variant|||||||NM_001002762.3:c.133+1863_133+1880del||MODIFIER||||||DNAJB12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	66,41:107:0.3832
chr10	72419365	.	C	T	.	PASS	CSQ=10367|protein_coding||intron_variant|||||||NM_001195518.2:c.1071+3869G>A||MODIFIER||||||MICU1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	100,6:106:0.0566
chr10	73199915	.	G	A	.	PASS	CSQ=317662|protein_coding||intron_variant|||||||NM_173348.1:c.542+6322G>A||MODIFIER||||||FAM149B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	52,60:112:0.5357
chr10	73314942	.	G	A	.	PASS	CSQ=118491|protein_coding||intron_variant||||rs1037603053||1.98533e-05|NM_001350933.1:c.913-2299C>T||MODIFIER||||||CFAP70|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	41,42:84:0.5
chr10	73722936	.	T	C	.	PASS	CSQ=729096|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||rs1428764670|||NR_026592.2:n.556-359A>G||MODIFIER||||||BMS1P4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	82,41:123:0.3333
chr10	73804624	.	G	C	.	PASS	CSQ=23053|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZSWIM8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	60,50:110:0.4545
chr10	74356824	.	TAAGGAG	T	.	PASS	CSQ=132|protein_coding||intron_variant|||||||NM_006721.3:c.274-37315_274-37310del||MODIFIER||||||ADK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	38,54:92:0.587
chr10	74424531	.	G	A	.	PASS	CSQ=132|protein_coding||intron_variant||||rs146555246||0.000323508|NM_006721.3:c.555+25952G>A||MODIFIER||||||ADK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	64,0:64:0	39,15:54:0.2778
chr10	75116275	.	A	T	.	PASS	CSQ=142891|protein_coding||intron_variant|||||||NM_001174156.2:c.-16+4553A>T||MODIFIER||||||SAMD8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	37,57:94:0.6064
chr10	75165786	.	G	A	.	PASS	CSQ=142891|protein_coding||intron_variant|||||||NM_001174156.2:c.674+1046G>A||MODIFIER||||||SAMD8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	61,39:100:0.39
chr10	75266895	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	34,65:99:0.6566
chr10	75884558	.	A	T	.	PASS	CSQ=83938|protein_coding||intron_variant|||||||NM_001305581.2:c.132-151450A>T||MODIFIER||||||LRMDA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	63,46:109:0.422
chr10	75900506	.	TG	T	.	PASS	CSQ=83938|protein_coding||intron_variant|||||||NM_001305581.2:c.132-135500del||MODIFIER||||||LRMDA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	46,35:81:0.4321
chr10	75956323	.	G	T	.	PASS	CSQ=83938|protein_coding||intron_variant||||||6.57531e-06|NM_001305581.2:c.132-79685G>T||MODIFIER||||||LRMDA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	66,48:114:0.4211
chr10	76238567	.	G	A	.	PASS	CSQ=83938|protein_coding||intron_variant||||rs924265854||1.32345e-05|NM_001305581.2:c.517-85834G>A||MODIFIER||||||LRMDA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	37,32:69:0.4638
chr10	76811260	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	35,58:93:0.6237
chr10	76875456	.	G	T	.	PASS	CSQ=3778|protein_coding||3_prime_UTR_variant|||||||NM_001322830.1:c.*2413C>A||MODIFIER||||||KCNMA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	94,6:100:0.06
chr10	77079553	.	G	GA	.	PASS	CSQ=3778|protein_coding||splice_region_variant&intron_variant||||rs758818645|3.97858e-06||NM_001161352.2:c.1524-4dup||LOW||||||KCNMA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	43,56:99:0.5657
chr10	77426128	.	G	A	.	PASS	CSQ=3778|protein_coding||intron_variant|||||||NM_001161352.2:c.379-22105C>T||MODIFIER||||||KCNMA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	28,60:88:0.6818
chr10	77427821	.	CT	C	.	PASS	CSQ=3778|protein_coding||intron_variant|||||||NM_001161352.2:c.379-23799del||MODIFIER||||||KCNMA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	49,37:86:0.4302
chr10	77891958	.	G	A	.	PASS	CSQ=9231|protein_coding||intron_variant|||||||NM_004747.4:c.305-22761C>T||MODIFIER||||||DLG5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	75,33:108:0.3056
chr10	78067106	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||1.31391e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:135:0	38,70:108:0.6481
chr10	78148708	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	45,60:105:0.5714
chr10	78458789	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	46,58:104:0.5577
chr10	78519138	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	34,61:95:0.6421
chr10	78638626	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	65,38:103:0.3689
chr10	79289677	.	G	A	.	PASS	CSQ=57178|protein_coding||intron_variant|||||||NM_020338.4:c.426-98G>A||MODIFIER||||||ZMIZ1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	136,0:136:0	88,40:128:0.3125
chr10	79911096	.	C	A	.	PASS	CSQ=100288974|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_033857.1:n.550+3240C>A||MODIFIER||||||BMS1P21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	45,46:91:0.5055
chr10	79988819	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	43,84:127:0.6614
chr10	80004534	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	76,47:123:0.3821
chr10	80031894	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	58,33:91:0.3626
chr10	80099273	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs567107423||0.000427986|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	69,44:113:0.3894
chr10	80548306	.	G	A	.	PASS	CSQ=387694|protein_coding||intron_variant|||||||NM_207372.2:c.184+9791G>A||MODIFIER||||||SH2D4B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	75,35:110:0.3182
chr10	80672184	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	41,46:87:0.5287
chr10	80980994	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	46,42:88:0.4773
chr10	81295132	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.57748e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,1:122:0.0082	33,67:100:0.67
chr10	81375931	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,34:100:0.34
chr10	81485926	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs544339123||2.63044e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	66,30:96:0.3125
chr10	81650194	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs78034427||0.215905|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	34,49:83:0.5904
chr10	82076325	.	C	T	.	PASS	CSQ=10718|protein_coding||intron_variant||||rs538074976||5.91452e-05|NM_001010848.4:c.823+200162C>T||MODIFIER||||||NRG3|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	34,71:105:0.6762
chr10	82348937	.	C	T	.	PASS	CSQ=10718|protein_coding||intron_variant|||||||NM_001010848.4:c.824-9802C>T||MODIFIER||||||NRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	31,34:65:0.5231
chr10	82588503	COSV64546779;COSV64546779;COSV64546779;COSV64546779;COSV64546779	C	CT	.	PASS	CSQ=10718|protein_coding||intron_variant|COSV64546779&COSV64546779&COSV64546779&COSV64546779&COSV64546779|p.?&p.?&p.?&p.?&p.?||rs1311508891||0.00292437|NM_001010848.4:c.954-150064dup||MODIFIER||||||NRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	46,48:94:0.5106
chr10	82786849	.	G	T	.	PASS	CSQ=10718|protein_coding||intron_variant|||||||NM_001010848.4:c.1027+48199G>T||MODIFIER||||||NRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	58,38:96:0.3958
chr10	83089338	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	38,49:87:0.5632
chr10	83092163	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:108:0	48,21:69:0.3043
chr10	83186780	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	51,30:81:0.3704
chr10	83269851	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	37,61:98:0.6224
chr10	83323004	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	99,5:104:0.0481
chr10	83381504	COSV101214251	A	T	.	PASS	CSQ=|||intergenic_variant|||COSV101214251|rs189947015||0.000881347|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	49,24:73:0.3288
chr10	83723752	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	40,34:74:0.4595
chr10	83764882	.	ACT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	60,32:92:0.3478
chr10	83798762	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	39,58:97:0.5979
chr10	84230749	.	G	C	.	PASS	CSQ=26103|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LRIT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	33,61:94:0.6489
chr10	84236997	.	C	T	.	PASS	CSQ=26103|protein_coding||intron_variant|||||||NM_015613.2:c.589+223G>A||MODIFIER||||||LRIT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	35,47:82:0.5732
chr10	84321830	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	78,49:127:0.3858
chr10	84533459	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs932151928||0.000161188|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	65,34:100:0.34
chr10	84699155	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	39,60:99:0.6061
chr10	85134976	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	95,7:103:0.068
chr10	85320618	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1362747194||2.62943e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	62,50:112:0.4464
chr10	85390462	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	51,38:89:0.427
chr10	85533918	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	40,29:69:0.4203
chr10	85642457	.	C	G	.	PASS	CSQ=2894|protein_coding||intron_variant|||||||NM_017551.3:c.2193+4745G>C||MODIFIER||||||GRID1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	25,62:87:0.7126
chr10	86209187	.	G	C	.	PASS	CSQ=2894|protein_coding||intron_variant|||||||NM_017551.3:c.236-2539C>G||MODIFIER||||||GRID1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	57,36:93:0.3871
chr10	86564051	.	CAAGG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	41,35:76:0.4605
chr10	86596603	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	51,36:87:0.4138
chr10	86658048	.	ACAC	A	.	PASS	CSQ=94233|protein_coding||inframe_deletion|||||||NM_033282.4:c.309_311del|NP_150598.1:p.Pro104del|MODERATE||||||OPN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	125,0:125:0	66,45:111:0.4054
chr10	86659524	.	C	T	.	PASS	CSQ=94233|protein_coding||intron_variant||||rs1335552306||1.97039e-05|NM_033282.4:c.800+56C>T||MODIFIER||||||OPN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	160,0:160:0	68,38:106:0.3585
chr10	86975786	.	GC	G	.	PASS	CSQ=119385|protein_coding||intron_variant|||||||NM_133447.1:c.-1030+4873del||MODIFIER||||||AGAP11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	74,47:121:0.3884
chr10	87005948	.	C	G	.	PASS	CSQ=119385|protein_coding||intron_variant|||||||NM_133447.1:c.50+1588C>G||MODIFIER||||||AGAP11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	61,32:93:0.3441
chr10	87401768	.	C	A	.	PASS	CSQ=728218|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046091.1:n.199-3568G>T||MODIFIER||||||LINC00864|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	40,51:91:0.5604
chr10	88074790	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	49,35:84:0.4167
chr10	88331703	.	C	G	.	PASS	CSQ=55328|protein_coding||intron_variant|||||||NM_001031709.3:c.701-17062G>C||MODIFIER||||||RNLS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	63,27:90:0.3
chr10	88687658	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	49,66:115:0.5739
chr10	88886035	.	A	G	.	PASS	CSQ=57559|protein_coding||intron_variant|||||||NM_020799.4:c.-54+5397A>G||MODIFIER||||||STAMBPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	136,0:136:0	55,73:128:0.5703
chr10	89338376	.	G	T	.	PASS	CSQ=3437|protein_coding||intron_variant|||||||NM_001549.6:c.6-285G>T||MODIFIER||||||IFIT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	45,29:74:0.3919
chr10	89513220	.	C	T	.	PASS	CSQ=387700|protein_coding||intron_variant|||||||NM_213606.4:c.-47+21281G>A||MODIFIER||||||SLC16A12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	85,19:104:0.1827
chr10	89763789	.	C	G	.	PASS	CSQ=9585|protein_coding||intron_variant|||||||NM_016195.3:c.4869+954C>G||MODIFIER||||||KIF20B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	38,55:93:0.5914
chr10	89875416	.	TC	AT	.	PASS	CSQ=105378425|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149080.1:n.102+21409_102+21410delinsAT||MODIFIER||||||LINC01374|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	113,0:114:0	65,35:100:0.35
chr10	89928057	.	CAT	C	.	PASS	CSQ=101926924|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110655.1:n.578-11288_578-11287del||MODIFIER||||||LINC01375|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	84,21:105:0.2
chr10	89997703	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	33,100:133:0.7519
chr10	90207195	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs771089887||3.29385e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	31,41:72:0.5694
chr10	90526853	.	C	A	.	PASS	CSQ=101926942|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110657.1:n.240+421G>T||MODIFIER||||||LOC101926942|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	40,55:95:0.5789
chr10	90550085	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	38,52:90:0.5778
chr10	90589943	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||6.5722e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	73,54:127:0.4252
chr10	90697168	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	35,58:93:0.6237
chr10	90776032	.	T	A	.	PASS	CSQ=3363|protein_coding||intron_variant|||||||NM_019859.4:c.540-26438A>T||MODIFIER||||||HTR7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	43,59:102:0.5784
chr10	91196149	.	G	C	.	PASS	CSQ=84333|protein_coding||intron_variant|||||||NM_001257101.1:c.-183-26540G>C||MODIFIER||||||PCGF5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	40,62:102:0.6078
chr10	91701007	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	65,43:108:0.3981
chr10	91701009	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	66,43:109:0.3945
chr10	91755746	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	53,67:120:0.5583
chr10	91756652	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	31,59:90:0.6556
chr10	91872933	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	54,42:96:0.4375
chr10	93289854	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	94,40:134:0.2985
chr10	93633480	.	AT	A	.	PASS	CSQ=5146|protein_coding||intron_variant||||rs200659189||0.00037511|NM_006204.3:c.1120-1277del||MODIFIER||||||PDE6C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	104,0:104:0	105,27:132:0.2045
chr10	94278616	.	TTTAA	T	.	PASS	CSQ=51196|protein_coding||intron_variant|||||||NM_016341.3:c.4666-1165_4666-1162del||MODIFIER||||||PLCE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	109,34:143:0.2378
chr10	94673357	COSV55037394	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV55037394|rs1328892063|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,2:93:0.0215	89,31:120:0.2583
chr10	94683832	.	G	T	.	PASS	CSQ=1562|protein_coding||missense_variant|||||||NM_000772.3:c.13G>T|NP_000763.1:p.Val5Leu|MODERATE|B&.|T&T|N|T&T|T&T|CYP2C18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	109,0:109:0	88,34:122:0.2787
chr10	95313064	.	TTC	T	.	PASS	CSQ=10580|protein_coding||3_prime_UTR_variant|||||||NM_001290294.1:c.*1993_*1994del||MODIFIER||||||SORBS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	126,0:126:0	60,30:90:0.3333
chr10	95929668	.	C	A	.	PASS	CSQ=387707|protein_coding||intron_variant|||||||NM_001349008.2:c.336+2336C>A||MODIFIER||||||CC2D2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	42,61:103:0.5922
chr10	96055336	.	GATGGTTTTAAACCTTAAATCT	G	.	PASS	CSQ=728558|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038444.1:n.296+33909_296+33929del||MODIFIER||||||ENTPD1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	50,61:111:0.5495
chr10	96208823	.	G	A	.	PASS	CSQ=9849|misc_RNA||downstream_gene_variant|||||||||MODIFIER||||||ZNF518A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	63,28:91:0.3077
chr10	96679552	.	C	T	.	PASS	CSQ=118788|protein_coding||intron_variant|||||||NM_152309.3:c.431-22618G>A||MODIFIER||||||PIK3AP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	37,66:103:0.6408
chr10	96832553	.	G	C	.	PASS	CSQ=102723665|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC102723665|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	58,0:58:0	41,20:61:0.3279
chr10	97348000	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	59,44:103:0.4272
chr10	97662060	.	G	T	.	PASS	CSQ=55361|protein_coding||intron_variant|||||||NM_018425.3:c.923-847G>T||MODIFIER||||||PI4K2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	46,60:106:0.566
chr10	98195374	.	A	G	.	PASS	CSQ=27291|protein_coding||intron_variant||||rs534371801||1.3146e-05|NM_001351010.1:c.-14-12727A>G||MODIFIER||||||R3HCC1L|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	65,40:105:0.381
chr10	99208510	.	C	A	.	PASS	CSQ=60495|protein_coding||intron_variant|||||||NM_021828.4:c.448+23838G>T||MODIFIER||||||HPSE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	52,24:76:0.3158
chr10	99212538	.	G	T	.	PASS	CSQ=60495|protein_coding||intron_variant|||||||NM_021828.4:c.448+19810C>A||MODIFIER||||||HPSE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	62,38:100:0.38
chr10	99536508	.	G	T	.	PASS	CSQ=159296|protein_coding||3_prime_UTR_variant|||||||NM_145285.3:c.*787G>T||MODIFIER||||||NKX2-3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	123,0:123:0	41,51:92:0.5543
chr10	100081033	.	C	T	.	PASS	CSQ=1369|protein_coding||intron_variant||||rs1184706658|||NM_001308.2:c.223+370G>A||MODIFIER||||||CPN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	101,9:110:0.0818
chr10	100119990	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	58,33:91:0.3626
chr10	100445846	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:104:0	77,13:90:0.1444
chr10	100951765	.	C	T	.	PASS	CSQ=55719|protein_coding||intron_variant||||||6.56866e-06|NM_018121.4:c.3330+1012C>T||MODIFIER||||||SLF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	64,48:112:0.4286
chr10	101210891	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	69,54:123:0.439
chr10	101253431	.	C	T	.	PASS	CSQ=101927419|lncRNA||non_coding_transcript_exon_variant||||rs1038693028|||NR_120621.1:n.1612G>A||MODIFIER||||||LOC101927419|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	104,0:104:0	66,38:104:0.3654
chr10	101414945	.	G	A	.	PASS	CSQ=8945|protein_coding||intron_variant|||||||NM_033637.4:c.49-15400G>A||MODIFIER||||||BTRC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	39,58:97:0.5979
chr10	101485326	.	A	G	.	PASS	CSQ=8945|protein_coding||intron_variant|||||||NM_033637.4:c.324+5869A>G||MODIFIER||||||BTRC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,1:127:0.0079	65,42:107:0.3925
chr10	102430160	.	T	TTTAG	.	PASS	CSQ=79004|protein_coding||intron_variant|||||||NM_024040.3:c.-11+2365_-11+2366insCTAA||MODIFIER||||||CUEDC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	56,39:95:0.4105
chr10	102795910	.	G	A	.	PASS	CSQ=54838|protein_coding||intron_variant|||||||NM_001083913.2:c.91-2083G>A||MODIFIER||||||WBP1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	61,36:97:0.3711
chr10	102839118	.	G	C	.	PASS	CSQ=1586|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CYP17A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	62,38:100:0.38
chr10	102839804	.	G	A	.	PASS	CSQ=1586|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CYP17A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	58,53:111:0.4775
chr10	102908814	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||6.57013e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	43,67:110:0.6091
chr10	103533543	.	A	AT	.	PASS	CSQ=9148|protein_coding||intron_variant||||rs1245619011||0.0298789|NM_004210.4:c.86-37318dup||MODIFIER||||||NEURL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	36,45:82:0.5488
chr10	103564138	.	C	A	.	PASS	CSQ=9148|protein_coding||intron_variant|||||||NM_004210.4:c.86-6734C>A||MODIFIER||||||NEURL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	66,38:104:0.3654
chr10	103573752	.	G	C	.	PASS	CSQ=9148|protein_coding||intron_variant|||||||NM_004210.4:c.649+1930G>C||MODIFIER||||||NEURL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	63,43:107:0.4019
chr10	104207171	.	T	C	.	PASS	CSQ=80217|protein_coding||intron_variant|||||||NM_025145.6:c.895+494A>G||MODIFIER||||||CFAP43|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	74,26:100:0.26
chr10	104491913	.	C	CTT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	65,0:65:0	58,11:72:0.1528
chr10	104672658	.	C	T	.	PASS	CSQ=22986|protein_coding||intron_variant||||rs1303349128|||NM_014978.3:c.627+30704C>T||MODIFIER||||||SORCS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	58,39:97:0.4021
chr10	104968636	.	A	T	.	PASS	CSQ=22986|protein_coding||intron_variant|||||||NM_014978.3:c.796-8699A>T||MODIFIER||||||SORCS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	45,61:106:0.5755
chr10	104992346	.	A	C	.	PASS	CSQ=22986|protein_coding||intron_variant|||||||NM_014978.3:c.954+14853A>C||MODIFIER||||||SORCS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	64,40:104:0.3846
chr10	105233369	.	A	T	.	PASS	CSQ=22986|protein_coding||intron_variant||||rs542136013||3.3604e-05|NM_014978.3:c.2868+10120A>T||MODIFIER||||||SORCS3|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,9:140:0.0643	68,44:112:0.3929
chr10	105296822	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	36,48:84:0.5714
chr10	105437501	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1036814484||0.000305006|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,1:93:0.0108	44,26:70:0.3714
chr10	105517853	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	130,0:131:0	39,50:89:0.5618
chr10	105533084	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	44,41:85:0.4824
chr10	105664598	.	GG	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	128,0:129:0	64,35:99:0.3535
chr10	105747487	.	C	T	.	PASS	CSQ=101927549|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120625.1:n.430+70431G>A||MODIFIER||||||LOC101927549|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	34,60:94:0.6383
chr10	105973590	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs557846306||1.31505e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	32,47:79:0.5949
chr10	106127978	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	38,35:73:0.4795
chr10	106167980	.	A	C	.	PASS	CSQ=105378470|lncRNA||intron_variant&non_coding_transcript_variant||||rs1343296210||0.000454283|NR_134330.1:n.163-15806A>C||MODIFIER||||||LOC105378470|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	37,37:74:0.5
chr10	106306997	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	35,40:75:0.5333
chr10	106454478	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	26,57:83:0.6867
chr10	106480143	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	29,52:81:0.642
chr10	106501542	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	57,26:83:0.3133
chr10	106798791	.	G	T	.	PASS	CSQ=114815|protein_coding||intron_variant|||||||NM_001206572.1:c.727-22099C>A||MODIFIER||||||SORCS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	72,16:88:0.1818
chr10	106955245	.	T	G	.	PASS	CSQ=114815|protein_coding||intron_variant|||||||NM_001206572.1:c.626+1268A>C||MODIFIER||||||SORCS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	156,0:156:0	34,67:101:0.6634
chr10	107061243	.	C	G	.	PASS	CSQ=114815|protein_coding||intron_variant|||||||NM_001206572.1:c.558+102726G>C||MODIFIER||||||SORCS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	34,45:79:0.5696
chr10	107281912	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	26,60:86:0.6977
chr10	107558618	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	36,56:92:0.6087
chr10	107807958	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	47,53:100:0.53
chr10	107893517	.	A	AT	.	PASS	CSQ=103695365|lncRNA||intron_variant&non_coding_transcript_variant||||rs201429467||0.000283897|NR_125760.1:n.544-21765dup||MODIFIER||||||LINC01435|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	27,52:79:0.6582
chr10	107933808	.	TA	T	.	PASS	CSQ=103695365|lncRNA||intron_variant&non_coding_transcript_variant||||rs569009669||9.21902e-05|NR_125760.1:n.544-62056del||MODIFIER||||||LINC01435|EntrezGene|0.0008;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	32,33:65:0.5077
chr10	108431579	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	56,35:91:0.3846
chr10	108580156	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1259733777|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	53,37:90:0.4111
chr10	108986461	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	35,64:99:0.6465
chr10	109097077	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	46,35:81:0.4321
chr10	109304773	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	26,44:70:0.6286
chr10	109319158	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	42,47:89:0.5281
chr10	109357080	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	33,48:81:0.5926
chr10	110521855	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	38,55:93:0.5914
chr10	110894394	.	C	G	.	PASS	CSQ=27250|protein_coding||intron_variant|||||||NM_014456.5:c.1099-18C>G||MODIFIER||||||PDCD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	94,0:94:0	64,19:83:0.2289
chr10	110932303	.	G	A	.	PASS	CSQ=8036|protein_coding||intron_variant|||||||NM_007373.3:c.-235+12646G>A||MODIFIER||||||SHOC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	58,38:96:0.3958
chr10	111197581	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	61,29:90:0.3222
chr10	111330052	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	36,57:93:0.6129
chr10	111724020	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	48,29:77:0.3766
chr10	111888334	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	59,23:82:0.2805
chr10	111950167	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	52,34:86:0.3953
chr10	112023477	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	44,74:118:0.6271
chr10	112182008	COSV62082190;COSV62082190	G	GA	.	PASS	CSQ=57678|protein_coding||intron_variant|COSV62082190&COSV62082190|p.?&p.?||rs1458726359|||NM_001244949.2:c.-29-196dup||MODIFIER||||||GPAM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	47,46:93:0.4946
chr10	113504376	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	37,57:94:0.6064
chr10	113727482	.	A	G	.	PASS	CSQ=840|protein_coding||intron_variant|||||||NM_001227.4:c.682+1048A>G||MODIFIER||||||CASP7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	65,24:89:0.2697
chr10	114396201	.	G	A	.	PASS	CSQ=84632|protein_coding||intron_variant|||||||NM_001001936.3:c.16+8239C>T||MODIFIER||||||AFAP1L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	104,5:109:0.0459
chr10	114891685	.	C	G	.	PASS	CSQ=57700|protein_coding||intron_variant|||||||NM_001135051.1:c.2193-7805C>G||MODIFIER||||||FAM160B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	44,43:87:0.4943
chr10	114916687	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	42,66:108:0.6111
chr10	115003175	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	71,33:104:0.3173
chr10	115350348	.	A	C	.	PASS	CSQ=26033|protein_coding||intron_variant||||rs74593534||0.000716881|NM_207303.4:c.3175+15929A>C||MODIFIER||||||ATRNL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	44,27:71:0.3803
chr10	115512670	.	G	T	.	PASS	CSQ=26033|protein_coding||intron_variant|||||||NM_207303.4:c.3655-6593G>T||MODIFIER||||||ATRNL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	53,45:98:0.4592
chr10	116071857	.	A	AT	.	PASS	CSQ=2674|protein_coding||intron_variant||||rs997636243|||NM_145793.4:c.1183-6232dup||MODIFIER||||||GFRA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	67,33:101:0.3267
chr10	116155008	.	A	G	.	PASS	CSQ=2674|protein_coding||intron_variant|||||||NM_145793.4:c.419-29451T>C||MODIFIER||||||GFRA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	55,37:92:0.4022
chr10	116346034	.	G	A	.	PASS	CSQ=374355|protein_coding||intron_variant||||rs1008499915||3.94643e-05|NM_198515.3:c.448+3833G>A||MODIFIER||||||CCDC172|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	40,64:104:0.6154
chr10	116538228	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	40,63:103:0.6117
chr10	117089252	.	C	A	.	PASS	CSQ=57698|protein_coding||intron_variant|||||||NM_001258300.1:c.-189+37055G>T||MODIFIER||||||SHTN1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/SHTN1|y|n|Spitzoid_tumour|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	62,36:98:0.3673
chr10	117417388	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	63,42:105:0.4
chr10	118271164	COSV71512080	A	T	.	PASS	CSQ=|||intergenic_variant|||COSV71512080|rs1031066353||6.58614e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	69,32:101:0.3168
chr10	118391177	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	25,38:63:0.6032
chr10	119070012	.	T	TTA	.	PASS	CSQ=8661|protein_coding||intron_variant|||||||NM_003750.4:c.742-360_742-359dup||MODIFIER||||||EIF3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	40,54:94:0.5745
chr10	119093966	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	40,64:104:0.6154
chr10	120076674	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	51,40:91:0.4396
chr10	120287860	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	40,57:97:0.5876
chr10	120397487	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	38,60:98:0.6122
chr10	120996898	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:94:0	33,48:81:0.5926
chr10	121917907	.	G	C	.	PASS	CSQ=11101|protein_coding||intron_variant|||||||NM_007041.3:c.234-4014C>G||MODIFIER||||||ATE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	67,43:110:0.3909
chr10	122008246	.	G	GTTATTATTA	.	PASS	CSQ=10579|protein_coding||intron_variant||||rs111866182||0.0455847|NM_206862.4:c.-45-13679_-45-13671dup||MODIFIER||||||TACC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	68,17:85:0.2
chr10	122212259	.	T	A	.	PASS	CSQ=10579|protein_coding||intron_variant|||||||NM_206862.4:c.7283+551T>A||MODIFIER||||||TACC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	59,32:91:0.3516
chr10	122231715	.	C	T	.	PASS	CSQ=10579|protein_coding||intron_variant||||rs1358250506||1.97112e-05|NM_206862.4:c.8127+1275C>T||MODIFIER||||||TACC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	36,64:100:0.64
chr10	122496776	.	T	A	.	PASS	CSQ=5654|protein_coding||intron_variant|||||||NM_002775.5:c.777+7150T>A||MODIFIER||||||HTRA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	28,44:72:0.6111
chr10	122496777	.	GC	G	.	PASS	CSQ=5654|protein_coding||intron_variant|||||||NM_002775.5:c.777+7152del||MODIFIER||||||HTRA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	28,41:69:0.5942
chr10	122678798	.	G	C	.	PASS	CSQ=112577516|protein_coding||intron_variant|||||||NM_001364461.1:c.213-49G>C||MODIFIER||||||LOC112577516|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	48,60:108:0.5556
chr10	122720619	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	63,42:105:0.4
chr10	123535183	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	36,68:104:0.6538
chr10	123536728	.	GGAGGATGTGATCGGCC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	33,56:89:0.6292
chr10	123547102	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	32,62:94:0.6596
chr10	123626384	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	29,57:86:0.6628
chr10	123702412	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	87,20:107:0.1869
chr10	123720949	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	62,27:89:0.3034
chr10	123761038	.	G	A	.	PASS	CSQ=119587|protein_coding||intron_variant||||rs1294903396||1.31437e-05|NM_198148.3:c.1777+834C>T||MODIFIER||||||CPXM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	64,42:106:0.3962
chr10	123878305	.	T	C	.	PASS	CSQ=119587|protein_coding||intron_variant||||rs1336010932||0.00186784|NM_198148.3:c.403+1906A>G||MODIFIER||||||CPXM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	57,23:80:0.2875
chr10	123928491	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	64,32:96:0.3333
chr10	123976060	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	38,59:97:0.6082
chr10	124035135	.	G	A	.	PASS	CSQ=51363|protein_coding||intron_variant||||rs1404878764||2.19758e-05|NM_001270764.2:c.1190+3380C>T||MODIFIER||||||CHST15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	35,32:67:0.4776
chr10	124122112	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	53,35:88:0.3977
chr10	124388799	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	160,0:160:0	66,53:119:0.4454
chr10	125328009	.	A	C	.	PASS	CSQ=|||intergenic_variant||||rs1470531370||6.57194e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	35,68:103:0.6602
chr10	125672766	.	C	G	.	PASS	CSQ=387718|protein_coding||intron_variant|||||||NM_001128202.2:c.51+10173G>C||MODIFIER||||||TEX36|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	58,31:89:0.3483
chr10	126248936	.	C	A	.	PASS	CSQ=8038|protein_coding||intron_variant|||||||NM_001288973.1:c.260+29979G>T||MODIFIER||||||ADAM12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	40,24:64:0.375
chr10	126389228	.	G	C	.	PASS	CSQ=8038|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ADAM12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	54,30:84:0.3571
chr10	126885017	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	54,34:88:0.3864
chr10	127076345	.	C	CA	.	PASS	CSQ=1793|protein_coding||intron_variant||||rs557461138||3.28727e-05|NM_001380.4:c.2382+14575dup||MODIFIER||||||DOCK1|EntrezGene|0.0006;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	60,31:91:0.3407
chr10	127158832	.	TAGCTTGGAAAACATCGCATTCAGC	T	.	PASS	CSQ=642938|protein_coding||intron_variant|||||||NM_001039762.3:c.1185-4933_1185-4910del||MODIFIER||||||FAM196A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	154,0:154:0	64,41:105:0.3905
chr10	127499028	COSV57510928	G	C	.	PASS	CSQ=|||intergenic_variant|||COSV57510928||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	47,45:92:0.4891
chr10	127511194	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	62,33:95:0.3474
chr10	127774175	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1309387068||1.31508e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	67,39:106:0.3679
chr10	127893169	.	G	A	.	PASS	CSQ=119467|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CLRN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	66,38:104:0.3654
chr10	128057871	.	G	C	.	PASS	CSQ=5791|protein_coding||intron_variant||||rs896412895||6.57073e-06|NM_001323354.1:c.511+1658G>C||MODIFIER||||||PTPRE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	43,68:111:0.6126
chr10	128136308	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	40,63:103:0.6117
chr10	128172364	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	42,36:78:0.4615
chr10	128654321	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	35,57:92:0.6196
chr10	129169004	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	34,55:89:0.618
chr10	129412102	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	33,64:97:0.6598
chr10	129538553	.	C	CT	.	PASS	CSQ=4255|protein_coding||intron_variant|||||||NM_002412.5:c.125+2179dup||MODIFIER||||||MGMT|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/MGMT|y|n|glioma|||O||TSG|D;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	80,32:112:0.2857
chr10	129538557	.	G	C	.	PASS	CSQ=4255|protein_coding||intron_variant|||||||NM_002412.5:c.125+2180G>C||MODIFIER||||||MGMT|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/MGMT|y|n|glioma|||O||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	78,33:112:0.2946
chr10	129670271	.	TTTTGCTTCACACAA	T	.	PASS	CSQ=4255|protein_coding||intron_variant|||||||NM_002412.5:c.126-37620_126-37607del||MODIFIER||||||MGMT|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/MGMT|y|n|glioma|||O||TSG|D;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	37,63:100:0.63
chr10	130226264	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.56978e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	43,65:109:0.5963
chr10	130241441	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	83,7:90:0.0778
chr10	130330301	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	94,13:107:0.1215
chr10	130331273	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	91,10:101:0.099
chr10	130362018	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	58,31:89:0.3483
chr10	130393918	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs534175318||0.000321924|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	30,44:74:0.5946
chr10	130558355	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	27,46:73:0.6301
chr10	130710475	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	53,45:98:0.4592
chr10	130719687	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	57,33:90:0.3667
chr10	130847468	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs933629591||3.28835e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	56,33:89:0.3708
chr10	130894806	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs10652310||0.353306|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	43,30:73:0.411
chr10	130949644	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1466174054|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	59,38:97:0.3918
chr10	131084107	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs778756131||1.31396e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:131:0	51,36:87:0.4138
chr10	131226020	.	C	T	.	PASS	CSQ=256536|protein_coding||intron_variant|||||||NM_174937.4:c.856+34239G>A||MODIFIER||||||TCERG1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	56,34:90:0.3778
chr10	131353487	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1214899591||6.57471e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	53,30:83:0.3614
chr10	131364758	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	49,50:99:0.5051
chr10	131376671	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	53,38:91:0.4176
chr10	131397440	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	52,34:86:0.3953
chr10	132861385	.	G	A	.	PASS	CSQ=54777|protein_coding||intron_variant|||||||NM_001200049.3:c.4891-403C>T||MODIFIER||||||CFAP46|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	77,48:125:0.384
chr10	133166961	.	C	T	.	PASS	CSQ=85442|protein_coding||intron_variant||||rs1351628370||1.97148e-05|NM_152643.8:c.103-420C>T||MODIFIER||||||KNDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	102,5:107:0.0467
chr10	133637466	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	62,0:62:0	12,32:44:0.7273
chr11	228385	.	A	G	.	PASS	CSQ=23410|protein_coding||intron_variant||||||6.56849e-06|NM_012239.6:c.807+2067T>C||MODIFIER||||||SIRT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	76,82:158:0.519
chr11	905913	.	T	A	.	PASS	CSQ=66005|protein_coding||intron_variant|||||||NM_023947.3:c.-43-1054A>T||MODIFIER||||||CHID1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	91,75:166:0.4518
chr11	1107974	COSV64216749	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV64216749|rs774999469|7.89939e-05|4.59957e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:111:0	80,103:183:0.5628
chr11	1160424	.	C	CTGA	.	PASS	CSQ=4586|protein_coding||intron_variant|||||||NM_001304359.2:c.74-187_74-186insGAT||MODIFIER||||||MUC5AC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	85,80:165:0.4848
chr11	1727288	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	58,74:132:0.5606
chr11	1750438	.	C	A	.	PASS	CSQ=1509|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CTSD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	144,0:145:0	89,68:157:0.4331
chr11	1750445	.	C	T	.	PASS	CSQ=1509|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CTSD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	144,0:144:0	95,71:166:0.4277
chr11	1878299	.	C	T	.	PASS	CSQ=102465993|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR7847|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	77,87:164:0.5305
chr11	1931466	.	C	A	.	PASS	CSQ=7140|protein_coding||intron_variant|||||||NM_006757.4:c.126-1003C>A||MODIFIER||||||TNNT3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	76,80:156:0.5128
chr11	1980380	.	G	A	.	PASS	CSQ=100133545|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||MRPL23-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	92,81:173:0.4682
chr11	2016065	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	88,105:193:0.544
chr11	2266660	.	C	T	.	PASS	CSQ=430|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ASCL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	76,96:172:0.5581
chr11	2280077	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	109,0:110:0	89,78:167:0.4671
chr11	2461800	.	G	A	.	PASS	CSQ=3784|protein_coding||intron_variant||||rs1157507277||1.31491e-05|NM_000218.2:c.386+16316G>A||MODIFIER||||||KCNQ1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	78,65:143:0.4545
chr11	2814678	.	G	A	.	PASS	CSQ=3784|protein_coding||intron_variant|||||||NM_000218.2:c.1795-33089G>A||MODIFIER||||||KCNQ1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	73,68:141:0.4823
chr11	3528141	.	C	G	.	PASS	CSQ=101927708|lncRNA||intron_variant&non_coding_transcript_variant||||rs1461605491||6.57583e-06|NR_126335.1:n.54-12943G>C||MODIFIER||||||LOC101927708|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	76,73:149:0.4899
chr11	3609174	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	82,70:152:0.4605
chr11	3764704	.	G	C	.	PASS	CSQ=4928|protein_coding||intron_variant|||||||NM_016320.5:c.949-1665C>G||MODIFIER||||||NUP98|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NUP98|y|n|AML|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	66,106:172:0.6163
chr11	4030126	.	C	G	.	PASS	CSQ=6786|protein_coding||intron_variant|||||||NM_003156.3:c.385+6139C>G||MODIFIER||||||STIM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	80,75:155:0.4839
chr11	4422034	.	TCAAGGACTTTAGGTTCCAAAGGGAAGATC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	79,95:174:0.546
chr11	4961793	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1278909172|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,69:149:0.4631
chr11	5144191	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs1275055808||0.000100231|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,2:135:0.0148	86,83:169:0.4911
chr11	5208905	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1488128062|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	73,51:125:0.408
chr11	5213710	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	63,69:132:0.5227
chr11	5323819	COSV60917322;COSV60917322;COSV60917322;COSV60917322	C	T	.	PASS	CSQ=79345|protein_coding||missense_variant|COSV60917322&COSV60917322&COSV60917322&COSV60917322|p.?&p.?&p.?&p.R160H||rs138700784&COSM3787992|0.000131664|7.89879e-05|NM_033180.4:c.479G>A|NP_149420.4:p.Arg160His|MODERATE|B||N|||OR51B2|EntrezGene|0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	65,73:138:0.529
chr11	5324309	.	C	T	.	PASS	CSQ=79345|protein_coding||5_prime_UTR_variant||||rs745726815|0.000162628|2.62874e-05|NM_033180.4:c.-12G>A||MODIFIER||||||OR51B2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	140,0:140:0	68,84:152:0.5526
chr11	5527175	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs570699129||4.59927e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	71,78:149:0.5235
chr11	5755533	COSV100421594;COSV100421594;COSV100421594	C	T	.	PASS	CSQ=390072|protein_coding||missense_variant|COSV100421594&COSV100421594&COSV100421594|p.?&p.R265C&p.R265C||rs774937620|4.01506e-06|1.97195e-05|NM_001005175.3:c.793C>T|NP_001005175.3:p.Arg265Cys|MODERATE|B&B|.&T|N|.&D|.&D|OR52N4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	131,0:132:0	83,83:166:0.5
chr11	5759176	.	A	T	.	PASS	CSQ=390072|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||OR52N4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	77,69:146:0.4726
chr11	5763776	.	A	C	.	PASS	CSQ=|||intergenic_variant||||rs1035198434|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	74,90:164:0.5488
chr11	6040395	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	67,76:143:0.5315
chr11	6593415	.	TCAG	T	.	PASS	CSQ=23378|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||RRP8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	80,62:142:0.4366
chr11	7244177	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	73,71:144:0.4931
chr11	7914345	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1014929487||0.000269705|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	81,64:145:0.4414
chr11	8063138	.	C	T	.	PASS	CSQ=7275|protein_coding||intron_variant|||||||NM_003320.4:c.203+23446C>T||MODIFIER||||||TUB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	64,55:119:0.4622
chr11	8503532	.	G	C	.	PASS	CSQ=65975|protein_coding||intron_variant||||rs1233276367|||NM_001352389.1:c.-465-22918C>G||MODIFIER||||||STK33|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	76,74:150:0.4933
chr11	8874317	.	T	C	.	PASS	CSQ=6764|protein_coding||intron_variant|||||||NM_005418.3:c.-156+6693A>G||MODIFIER||||||ST5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	83,83:166:0.5
chr11	9221269	.	AAAAATACAAAAATTAGCCGGGCAT	A	.	PASS	CSQ=23258|protein_coding||intron_variant|||||||NM_015213.4:c.110-13661_110-13638del||MODIFIER||||||DENND5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	77,46:123:0.374
chr11	9491419	.	G	A	.	PASS	CSQ=7702|protein_coding||intron_variant||||rs1171010620||1.31721e-05|NM_003442.6:c.646-3227G>A||MODIFIER||||||ZNF143|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:100:0	88,76:164:0.4634
chr11	9609139	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	59,72:131:0.5496
chr11	9683906	.	T	A	.	PASS	CSQ=23075|protein_coding||intron_variant|||||||NM_015055.4:c.100-10240T>A||MODIFIER||||||SWAP70|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,92:172:0.5349
chr11	9958082	.	C	G	.	PASS	CSQ=81846|protein_coding||intron_variant|||||||NM_030962.3:c.1860+3875G>C||MODIFIER||||||SBF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	108,0:108:0	70,57:127:0.4488
chr11	10541638	.	G	C	.	PASS	CSQ=100129827|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046374.1:n.307+96G>C||MODIFIER||||||MRVI1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	149,0:149:0	100,90:190:0.4737
chr11	10954534	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	91,80:171:0.4678
chr11	11166768	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	79,64:143:0.4476
chr11	11337071	.	CC	AG	.	PASS	CSQ=374378|protein_coding||intron_variant|||||||NM_198516.3:c.1278+3747_1278+3748delinsCT||MODIFIER||||||GALNT18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	126,0:126:0	87,84:171:0.4912
chr11	11591462	.	C	T	.	PASS	CSQ=374378|protein_coding||intron_variant||||rs12417137|||NM_198516.3:c.235+29897G>A||MODIFIER||||||GALNT18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	77,67:144:0.4653
chr11	11813992	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	111,0:111:0	167,8:175:0.0457
chr11	11815122	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	89,74:163:0.454
chr11	12894428	.	T	TA	.	PASS	CSQ=7003|protein_coding||intron_variant||||rs1316954251||3.29177e-05|NM_021961.6:c.700-7504dup||MODIFIER||||||TEAD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	109,63:172:0.3663
chr11	13586913	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	67,62:129:0.4806
chr11	13923606	.	G	A	.	PASS	CSQ=101928132|lncRNA||intron_variant&non_coding_transcript_variant||||rs1227963996||1.31468e-05|NR_135052.1:n.172+1086C>T||MODIFIER||||||LOC101928132|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	73,80:153:0.5229
chr11	13923720	.	C	A	.	PASS	CSQ=101928132|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135052.1:n.172+972G>T||MODIFIER||||||LOC101928132|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	74,88:162:0.5432
chr11	14682954	.	T	G	.	PASS	CSQ=5140|protein_coding||intron_variant|||||||NM_000922.4:c.978+37901T>G||MODIFIER||||||PDE3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	94,78:172:0.4535
chr11	14692694	.	G	T	.	PASS	CSQ=5140|protein_coding||intron_variant||||rs1177808809||6.57523e-06|NM_000922.4:c.978+47641G>T||MODIFIER||||||PDE3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	78,73:151:0.4834
chr11	15245132	.	GC	G	.	PASS	CSQ=387755|protein_coding||intron_variant|||||||NM_001042536.2:c.1471-779del||MODIFIER||||||INSC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	64,75:139:0.5396
chr11	15388000	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	85,59:144:0.4097
chr11	15585282	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	75,79:154:0.513
chr11	16276219	.	CA	AG	.	PASS	CSQ=55553|protein_coding||intron_variant|||||||NM_001145819.2:c.446-41549_446-41548delinsCT||MODIFIER||||||SOX6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	111,0:111:0	77,64:141:0.4539
chr11	16440793	.	G	C	.	PASS	CSQ=55553|protein_coding||intron_variant|||||||NM_033326.3:c.-5+35522C>G||MODIFIER||||||SOX6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	78,91:169:0.5385
chr11	16531988	.	AGAGTTAAGC	A	.	PASS	CSQ=55553|protein_coding||intron_variant|||||||NM_001367872.1:c.-5+80084_-5+80092del||MODIFIER||||||SOX6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	76,71:147:0.483
chr11	17434220	.	C	T	.	PASS	CSQ=6833|protein_coding||intron_variant||||rs1324263456|||NM_000352.4:c.1631-1976G>A||MODIFIER||||||ABCC8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	71,78:150:0.52
chr11	17454445	.	G	A	.	PASS	CSQ=6833|protein_coding||intron_variant||||||6.57117e-06|NM_000352.4:c.1012-1162C>T||MODIFIER||||||ABCC8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	59,81:140:0.5786
chr11	17505775	.	G	A	.	PASS	CSQ=10083|protein_coding||intron_variant||||rs1003272817||7.88374e-05|NM_153676.4:c.2133+55C>T||MODIFIER||||||USH1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	93,78:171:0.4561
chr11	17689114	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	78,72:150:0.48
chr11	18420881	.	T	A	.	PASS	CSQ=3948|protein_coding||intron_variant|||||||NM_017448.4:c.244+5580T>A||MODIFIER||||||LDHC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	72,79:152:0.5197
chr11	19077233	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs992168405|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	75,74:149:0.4966
chr11	19888404	.	C	T	.	PASS	CSQ=89797|protein_coding||intron_variant|||||||NM_182964.6:c.771-4030C>T||MODIFIER||||||NAV2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	74,78:152:0.5132
chr11	20081990	.	C	T	.	PASS	CSQ=89797|protein_coding||intron_variant|||||||NM_182964.6:c.5326-602C>T||MODIFIER||||||NAV2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	71,85:156:0.5449
chr11	20790847	.	G	A	.	PASS	CSQ=4745|protein_coding||intron_variant|||||||NM_006157.4:c.335+7017G>A||MODIFIER||||||NELL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:143:0	91,56:148:0.3784
chr11	21288779	.	C	T	.	PASS	CSQ=4745|protein_coding||intron_variant|||||||NM_006157.4:c.1549+59325C>T||MODIFIER||||||NELL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	126,10:136:0.0735
chr11	21298319	.	C	T	.	PASS	CSQ=4745|protein_coding||intron_variant||||||6.58137e-06|NM_006157.4:c.1549+68865C>T||MODIFIER||||||NELL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	87,65:152:0.4276
chr11	21487801	.	G	A	.	PASS	CSQ=4745|protein_coding||intron_variant|||||||NM_006157.4:c.1646-46573G>A||MODIFIER||||||NELL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	61,61:122:0.5
chr11	21613957	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	133,6:139:0.0432
chr11	21665768	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	78,65:143:0.4545
chr11	21756591	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs771598427||0.0011195|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	75,74:149:0.4966
chr11	21760201	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1311060608||1.31539e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	57,72:129:0.5581
chr11	22087638	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	62,64:126:0.5079
chr11	22104668	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	69,66:135:0.4889
chr11	22124848	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	108,46:154:0.2987
chr11	22142097	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	70,78:148:0.527
chr11	22483517	.	AACTGACATGCAGTT	A	.	PASS	CSQ=102723378|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120583.1:n.106-3322_106-3309del||MODIFIER||||||LINC01495|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	84,70:154:0.4545
chr11	22553312	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	86,78:164:0.4756
chr11	22607044	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1023726644||3.28891e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	79,62:141:0.4397
chr11	22761975	.	A	G	.	PASS	CSQ=2620|protein_coding||intron_variant|||||||NM_005256.3:c.723+6022A>G||MODIFIER||||||GAS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	105,48:153:0.3137
chr11	22780737	.	C	T	.	PASS	CSQ=2620|protein_coding||intron_variant|||||||NM_005256.3:c.723+24784C>T||MODIFIER||||||GAS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	45,39:84:0.4643
chr11	22919323	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	87,72:159:0.4528
chr11	22927455	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	83,70:153:0.4575
chr11	23031142	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	73,60:133:0.4511
chr11	23264737	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	119,0:119:0	119,8:127:0.063
chr11	23448642	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	71,63:134:0.4701
chr11	23706664	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	84,67:151:0.4437
chr11	23866358	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	144,10:154:0.0649
chr11	23997295	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	94,33:128:0.2578
chr11	24098275	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	64,54:118:0.4576
chr11	24131659	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	63,70:133:0.5263
chr11	24213648	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,64:128:0.5
chr11	24343278	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs909770692||6.57583e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	63,71:134:0.5299
chr11	24422453	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:127:0	62,57:119:0.479
chr11	24465163	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	70,60:130:0.4615
chr11	25110031	.	CTGA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	83,72:155:0.4645
chr11	25366752	COSV64702526	G	GA	.	PASS	CSQ=|||intergenic_variant|||COSV64702526|rs1461946492||6.72088e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	72,53:126:0.4206
chr11	25443221	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	60,68:128:0.5312
chr11	25443928	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	81,76:157:0.4841
chr11	25548711	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	83,72:155:0.4645
chr11	25778077	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	53,56:109:0.5138
chr11	26159247	COSV50265510	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV50265510|rs754515286||0.0271176|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	70,52:122:0.4262
chr11	26169891	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	71,63:134:0.4701
chr11	26424868	.	C	A	.	PASS	CSQ=63982|protein_coding||intron_variant|||||||NM_031418.4:c.47-17050C>A||MODIFIER||||||ANO3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	76,86:162:0.5309
chr11	26884057	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	65,64:129:0.4961
chr11	28108220	.	C	A	.	PASS	CSQ=81930|protein_coding||upstream_gene_variant||||rs1201791142|||||MODIFIER||||||KIF18A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,1:141:0.0071	87,86:173:0.4971
chr11	28270221	.	A	AT	.	PASS	CSQ=196074|protein_coding||intron_variant||||rs1201386740||3.2896e-05|NM_001113528.2:c.408-19978dup||MODIFIER||||||METTL15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	83,68:151:0.4503
chr11	28322326	.	G	A	.	PASS	CSQ=196074|protein_coding||intron_variant|||||||NM_001113528.2:c.779-8070G>A||MODIFIER||||||METTL15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	74,71:145:0.4897
chr11	28359370	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	90,93:183:0.5082
chr11	28924449	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	145,6:151:0.0397
chr11	29255159	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	84,68:152:0.4474
chr11	29339117	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	84,63:147:0.4286
chr11	29398504	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.58796e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	91,70:161:0.4348
chr11	29504366	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	52,66:118:0.5593
chr11	29633971	.	G	A	.	PASS	CSQ=105376606|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC02546|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	93,71:164:0.4329
chr11	29688986	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	146,8:154:0.0519
chr11	29697187	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	80,74:154:0.4805
chr11	30308887	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1371297430||6.57618e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	67,65:132:0.4924
chr11	30916569	.	C	A	.	PASS	CSQ=341019|protein_coding||intron_variant|||||||NM_001367979.1:c.3452+301G>T||MODIFIER||||||DCDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,69:141:0.4894
chr11	30992029	.	T	C	.	PASS	CSQ=341019|protein_coding||intron_variant|||||||NM_001367979.1:c.2592-39461A>G||MODIFIER||||||DCDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	111,36:147:0.2449
chr11	31145590	.	C	T	.	PASS	CSQ=341019|protein_coding||intron_variant|||||||NM_001367979.1:c.1222-7806G>A||MODIFIER||||||DCDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,68:151:0.4503
chr11	31285072	.	C	CT	.	PASS	CSQ=341019|protein_coding||intron_variant|||||||NM_001367979.1:c.960+5574dup||MODIFIER||||||DCDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	85,72:157:0.4586
chr11	31529262	.	CT	AC	.	PASS	CSQ=26610|protein_coding||intron_variant|||||||NM_019040.5:c.259+9171_259+9172delinsAC||MODIFIER||||||ELP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	121,0:121:0	70,71:141:0.5035
chr11	31982871	.	ATG	A	.	PASS	CSQ=|||intergenic_variant||||rs1383372750|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	82,69:151:0.457
chr11	32025564	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	85,67:152:0.4408
chr11	32129844	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	70,73:143:0.5105
chr11	32250702	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs964039747||1.97075e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	88,79:167:0.4731
chr11	32298925	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	70,72:142:0.507
chr11	33100308	.	T	G	.	PASS	CSQ=1479|protein_coding||intron_variant|||||||NM_001326.3:c.827-591A>C||MODIFIER||||||CSTF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	57,81:138:0.587
chr11	33163543	.	T	C	.	PASS	CSQ=338739|lncRNA||intron_variant&non_coding_transcript_variant||||rs1331200606||6.63887e-06|NR_034027.1:n.125+1762T>C||MODIFIER||||||CSTF3-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	79,58:137:0.4234
chr11	33443505	.	C	T	.	PASS	CSQ=25758|protein_coding||intron_variant|||||||NM_012194.3:c.238+66616C>T||MODIFIER||||||KIAA1549L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	79,97:176:0.5511
chr11	33444902	.	C	G	.	PASS	CSQ=25758|protein_coding||intron_variant|||||||NM_012194.3:c.238+68013C>G||MODIFIER||||||KIAA1549L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	70,66:136:0.4853
chr11	33743561	.	G	T	.	PASS	CSQ=26273|protein_coding||intron_variant|||||||NM_012175.4:c.1240-1477C>A||MODIFIER||||||FBXO3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	158,74:232:0.319
chr11	33817780	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	68,147:215:0.6837
chr11	33925769	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	78,144:222:0.6486
chr11	34127087	.	G	T	.	PASS	CSQ=55226|protein_coding||intron_variant|||||||NM_024662.3:c.1108-376G>T||MODIFIER||||||NAT10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	64,166:230:0.7217
chr11	34838609	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	230,7:237:0.0295
chr11	35055844	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	177,94:271:0.3469
chr11	35081080	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	175,81:256:0.3164
chr11	35207078	.	A	G	.	PASS	CSQ=960|protein_coding||intron_variant|||||||NM_001001391.1:c.668-7774A>G||MODIFIER||||||CD44|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	192,8:200:0.04
chr11	35945116	.	C	T	.	PASS	CSQ=143458|protein_coding||intron_variant|||||||NM_174902.4:c.46+972C>T||MODIFIER||||||LDLRAD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	91,88:179:0.4916
chr11	36222790	.	G	C	.	PASS	CSQ=143458|protein_coding||intron_variant|||||||NM_174902.4:c.455-4295G>C||MODIFIER||||||LDLRAD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	89,74:163:0.454
chr11	36288382	.	G	T	.	PASS	CSQ=29099|protein_coding||intron_variant|||||||NM_014186.4:c.51+980C>A||MODIFIER||||||COMMD9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	88,96:184:0.5217
chr11	37352914	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1264139710||1.31491e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	70,74:144:0.5139
chr11	37413932	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	81,80:161:0.4969
chr11	37530095	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:131:0	135,4:139:0.0288
chr11	37557030	COSV51698315	T	A	.	PASS	CSQ=|||intergenic_variant|||COSV51698315|rs894671132||0.000131556|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,2:136:0.0147	79,84:163:0.5153
chr11	38030355	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	132,15:147:0.102
chr11	38138334	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	122,5:127:0.0394
chr11	38323229	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	67,69:136:0.5074
chr11	38482803	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1357530236||6.57272e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	65,62:127:0.4882
chr11	38623238	.	C	T	.	PASS	CSQ=103312105|lncRNA||intron_variant&non_coding_transcript_variant||||rs928735158||5.91685e-05|NR_120555.1:n.222-3368G>A||MODIFIER||||||LOC103312105|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	73,64:137:0.4672
chr11	38881996	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	62,68:130:0.5231
chr11	39016212	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs894231569||3.28757e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,59:133:0.4436
chr11	39243734	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	75,61:136:0.4485
chr11	39438217	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	70,0:70:0	36,76:112:0.6786
chr11	39653717	.	ACGTATATATATATATACATATATATTTTTT	A	.	PASS	CSQ=|||intergenic_variant||||||1.00806e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	86,0:86:0.011	68,42:110:0.42
chr11	39677524	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	64,75:139:0.5396
chr11	40154441	.	A	T	.	PASS	CSQ=57689|protein_coding||intron_variant|||||||NM_001258419.2:c.-95-13588T>A||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	80,68:148:0.4595
chr11	40238495	.	ATT	A	.	PASS	CSQ=57689|protein_coding||intron_variant|||||||NM_001258419.2:c.-96+3022_-96+3023del||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	75,74:149:0.4966
chr11	40381894	.	G	A	.	PASS	CSQ=57689|protein_coding||intron_variant|||||||NM_001258419.2:c.-269-62173C>T||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	102,74:176:0.4205
chr11	40440864	.	GA	G	.	PASS	CSQ=57689|protein_coding||intron_variant||||rs1045252465||9.83091e-05|NM_001258419.2:c.-269-121144del||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,1:130:0.0077	63,53:116:0.4569
chr11	40514234	.	T	G	.	PASS	CSQ=57689|protein_coding||intron_variant|||||||NM_001258419.2:c.-270+133908A>C||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	65,72:137:0.5255
chr11	40801817	.	C	T	.	PASS	CSQ=57689|protein_coding||intron_variant||||rs1039280855||6.58198e-06|NM_001258419.2:c.-407+131818G>A||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	63,65:128:0.5078
chr11	40810357	.	G	A	.	PASS	CSQ=57689|protein_coding||intron_variant||||rs1010049503||6.57324e-06|NM_001258419.2:c.-407+123278C>T||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	62,84:146:0.5753
chr11	40963030	.	A	T	.	PASS	CSQ=57689|protein_coding||intron_variant|||||||NM_001258419.2:c.-495-29307T>A||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	62,55:117:0.4701
chr11	41031573	.	C	T	.	PASS	CSQ=57689|protein_coding||intron_variant|||||||NM_001258419.2:c.-495-97850G>A||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	89,80:169:0.4734
chr11	41146896	.	G	T	.	PASS	CSQ=57689|protein_coding||intron_variant|||||||NM_001258419.2:c.-495-213173C>A||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	111,5:116:0.0431
chr11	41167762	.	G	A	.	PASS	CSQ=57689|protein_coding||intron_variant||||rs1213262856||6.57549e-06|NM_001258419.2:c.-495-234039C>T||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	74,64:138:0.4638
chr11	41388431	.	G	A	.	PASS	CSQ=57689|protein_coding||intron_variant||||rs1243073707||6.58675e-06|NM_001258419.2:c.-496+71000C>T||MODIFIER||||||LRRC4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	138,12:151:0.0795
chr11	41485427	COSV101151010	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV101151010|rs967614864||3.95387e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	67,68:135:0.5037
chr11	41547211	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	96,26:122:0.2131
chr11	41708519	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57678e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	58,58:116:0.5
chr11	41712733	.	G	A	.	PASS	CSQ=102723644|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01499|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	73,69:142:0.4859
chr11	42048854	.	G	A	.	PASS	CSQ=101928591|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135065.1:n.868-9729C>T||MODIFIER||||||LOC101928591|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	60,59:119:0.4958
chr11	42112039	.	G	GATTT	.	PASS	CSQ=|||intergenic_variant||||rs141131010||0.00666347|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:98:0	101,29:130:0.2231
chr11	42150729	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	64,69:133:0.5188
chr11	42258714	.	ATGCTTTGTAACAGAATC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	103,6:109:0.055
chr11	42352175	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	60,67:127:0.5276
chr11	42374835	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	80,76:156:0.4872
chr11	42406798	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	138,9:147:0.0612
chr11	42684826	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	139,22:161:0.1366
chr11	42742196	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	59,58:117:0.4957
chr11	42748458	.	AAGGTT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,55:130:0.4231
chr11	42974477	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	89,79:168:0.4702
chr11	43027972	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1478133547|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	58,68:126:0.5397
chr11	43265942	.	T	A	.	PASS	CSQ=399881|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_033868.1:n.106-2662A>T||MODIFIER||||||HNRNPKP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	80,89:169:0.5266
chr11	43272896	.	T	G	.	PASS	CSQ=399881|transcribed_pseudogene||upstream_gene_variant||||rs1231079701|||||MODIFIER||||||HNRNPKP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	113,2:115:0.0174	81,86:167:0.515
chr11	44401864	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	88,94:182:0.5165
chr11	44985148	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	78,67:145:0.4621
chr11	44985246	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1002790254||1.3143e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	99,103:202:0.5099
chr11	45691562	.	G	A	.	PASS	CSQ=102465691|miRNA||downstream_gene_variant||||rs1399244210||6.78767e-06|||MODIFIER||||||MIR7154|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	76,74:151:0.4901
chr11	46552348	.	G	A	.	PASS	CSQ=55626|protein_coding||intron_variant||||rs1431888259|||NM_001367471.1:c.-120-3848C>T||MODIFIER||||||AMBRA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	64,0:65:0	50,43:93:0.4624
chr11	46858136	.	T	A	.	PASS	CSQ=4038|protein_coding||3_prime_UTR_variant|||||||NM_002334.4:c.*847A>T||MODIFIER||||||LRP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	88,88:176:0.5
chr11	46916904	.	C	A	.	PASS	CSQ=4038|protein_coding||intron_variant|||||||NM_002334.4:c.52+1424G>T||MODIFIER||||||LRP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,1:117:0.0085	70,94:164:0.5732
chr11	47255104	.	G	T	.	PASS	CSQ=10062|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NR1H3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	97,86:183:0.4699
chr11	47897620	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	88,85:173:0.4913
chr11	48212397	.	AGGAC	A	.	PASS	CSQ=119765|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||OR4B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	69,66:135:0.4889
chr11	48998935	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	75,85:160:0.5312
chr11	49308140	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57272e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	75,80:155:0.5161
chr11	49312685	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1174928647||0.0801238|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	73,71:144:0.4931
chr11	49378671	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	113,45:159:0.283
chr11	49487097	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	143,10:153:0.0654
chr11	49562541	.	C	T	.	PASS	CSQ=440040|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_027044.1:n.188+3826C>T||MODIFIER||||||LOC440040|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	68,66:134:0.4925
chr11	49679254	.	C	A	.	PASS	CSQ=440040|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_027044.1:n.1049+102348C>A||MODIFIER||||||LOC440040|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	110,10:120:0.0833
chr11	49828469	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	67,63:130:0.4846
chr11	49970094	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	52,64:116:0.5517
chr11	50371121	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	112,0:112:0	79,60:139:0.4317
chr11	50532770	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	55,64:119:0.5378
chr11	50766896	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1249885659|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	104,1:105:0.0095	152,10:162:0.0617
chr11	50768988	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	63,72:135:0.5333
chr11	54593214	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1350136510||1.31473e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	66,83:150:0.5533
chr11	54646012	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	72,61:133:0.4586
chr11	54751610	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	74,69:143:0.4825
chr11	54791295	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs552639707||3.95304e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	128,16:144:0.1111
chr11	54856204	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1253338260||6.57557e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:110:0	62,78:140:0.5571
chr11	55095643	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	75,87:162:0.537
chr11	55329432	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs187588864||6.5825e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	115,5:120:0.0417
chr11	55413035	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||6.57367e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	79,55:134:0.4104
chr11	55489214	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	62,62:124:0.5
chr11	55593101	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	76,59:135:0.437
chr11	55622264	COSV66251394	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV66251394|rs991546989||0.000145144|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	63,62:125:0.496
chr11	55665162	.	G	A	.	PASS	CSQ=219432|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||OR4C6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	110,0:110:0	70,60:130:0.4615
chr11	55671259	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1000188552|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	136,5:141:0.0355
chr11	55723382	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs558092006||0.00017138|||MODIFIER||||||||0.0018;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	80,81:161:0.5031
chr11	55927721	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	76,74:150:0.4933
chr11	55968213	COSV100400066;COSV100400066	G	T	.	PASS	CSQ=282770|protein_coding||missense_variant|COSV100400066&COSV100400066|p.S84Y&p.S104Y||COSM5920188|||NM_001005491.1:c.251C>A|NP_001005491.1:p.Ser84Tyr|MODERATE|.&B|.&T|D|.&D|.&D|OR10AG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	139,0:139:0	68,71:139:0.5108
chr11	56165625	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	139,16:155:0.1032
chr11	56270004	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	71,64:135:0.4741
chr11	56606438	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	59,76:135:0.563
chr11	56802363	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	137,0:137:0	135,7:142:0.0493
chr11	56981042	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1011203856||6.57091e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	98,89:187:0.4759
chr11	57807553	.	C	T	.	PASS	CSQ=100528016|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037646.1:n.2522+570C>T||MODIFIER||||||TMX2-CTNND1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	89,25:114:0.2193
chr11	58062446	.	C	T	.	PASS	CSQ=219956|protein_coding||intron_variant|||||||NM_001005212.3:c.-15+6499C>T||MODIFIER||||||OR9Q1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	73,85:158:0.538
chr11	58467817	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:124:0	84,61:145:0.4207
chr11	59494773	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	79,61:140:0.4357
chr11	59494774	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	77,58:135:0.4296
chr11	59644781	.	T	C	.	PASS	CSQ=219988|protein_coding||intron_variant|||||||NM_152716.3:c.1894-1746A>G||MODIFIER||||||PATL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	81,70:151:0.4636
chr11	59656218	.	G	T	.	PASS	CSQ=219988|protein_coding||intron_variant|||||||NM_152716.3:c.724-173C>A||MODIFIER||||||PATL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	62,57:119:0.479
chr11	59817755	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs542742917||0.00189452|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	92,47:139:0.3381
chr11	59876339	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	76,68:144:0.4722
chr11	59949479	.	CTT	C	.	PASS	CSQ=255649|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_130719.1:n.378+1618_378+1619del||MODIFIER||||||OOSP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	66,82:148:0.5541
chr11	60148039	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:138:0	66,71:137:0.5182
chr11	60239140	.	G	A	.	PASS	CSQ=643680|protein_coding||intron_variant||||rs571930883||4.60163e-05|NM_001351235.1:c.-90+3818C>T||MODIFIER||||||MS4A4E|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	74,73:148:0.4932
chr11	60268902	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	84,68:152:0.4474
chr11	60545920	.	A	T	.	PASS	CSQ=503497|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MS4A13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	79,78:157:0.4968
chr11	60724508	.	G	C	.	PASS	CSQ=728588|protein_coding||5_prime_UTR_variant|||||||NM_001354471.1:c.-299G>C||MODIFIER||||||MS4A18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	72,73:145:0.5034
chr11	61254509	.	G	C	.	PASS	CSQ=220001|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||VWCE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	76,72:148:0.4865
chr11	61630383	.	G	T	.	PASS	CSQ=113157|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_002775.2:n.434+1344G>T||MODIFIER||||||RPLP0P2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	79,73:152:0.4803
chr11	62068528	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs201960405||0.00614616|||MODIFIER||||||||0.0056;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	85,70:155:0.4516
chr11	62156994	.	C	T	.	PASS	CSQ=3619|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||INCENP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	133,9:142:0.0634
chr11	62870867	COSV64933512;COSV64933512;COSV64933512;COSV64933512	T	A	.	PASS	CSQ=6520|protein_coding||intron_variant|COSV64933512&COSV64933512&COSV64933512&COSV64933512|p.?&p.?&p.?&p.?||rs201005789|0.0197402|0.0144137|NM_001012662.2:c.113-710T>A||MODIFIER||||||SLC3A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	64,0:64:0	73,57:130:0.4385
chr11	62873391	.	A	G	.	PASS	CSQ=6520|protein_coding||intron_variant|||||||NM_001012662.2:c.205+1722A>G||MODIFIER||||||SLC3A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	86,87:173:0.5029
chr11	63101307	.	G	GT	.	PASS	CSQ=283238|protein_coding||intron_variant||||rs1414141898||0.00197607|NM_001136506.2:c.954+2867dup||MODIFIER||||||SLC22A24|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,2:121:0.0165	87,75:164:0.4573
chr11	63131805	.	C	T	.	PASS	CSQ=283238|protein_coding||intron_variant||||||6.57471e-06|NM_001136506.2:c.506+2860G>A||MODIFIER||||||SLC22A24|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	90,81:171:0.4737
chr11	64446283	.	C	G	.	PASS	CSQ=100996455|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC100996455|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	90,77:167:0.4611
chr11	64751645	.	C	T	.	PASS	CSQ=5837|protein_coding||synonymous_variant|||||||NM_005609.4:c.1779G>A|NP_005600.1:p.Arg593=|LOW||||||PYGM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	102,97:199:0.4874
chr11	65376778	.	C	T	.	PASS	CSQ=283130|protein_coding||intron_variant|||||||NM_182556.3:c.598+40G>A||MODIFIER||||||SLC25A45|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	123,0:123:0	120,105:225:0.4667
chr11	65393970	.	T	TG	.	PASS	CSQ=83786|protein_coding||intron_variant|||||||NM_031904.5:c.356-68dup||MODIFIER||||||FRMD8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	142,0:142:0	188,25:213:0.1174
chr11	65601429	.	C	A	.	PASS	CSQ=4296|protein_coding||intron_variant|||||||NM_002419.4:c.1832-1661G>T||MODIFIER||||||MAP3K11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	86,88:174:0.5057
chr11	65731141	.	ATTTATTTTAT	A	.	PASS	CSQ=|||intergenic_variant||||rs1334825210||2.64299e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	134,46:180:0.2556
chr11	65733752	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1228491869||6.63359e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	98,69:167:0.4132
chr11	65781284	.	C	T	.	PASS	CSQ=91056|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||AP5B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	102,101:203:0.4975
chr11	65818491	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	83,100:183:0.5464
chr11	66278729	.	G	A	.	PASS	CSQ=254263|protein_coding||intron_variant|||||||NM_182553.3:c.81+192G>A||MODIFIER||||||CNIH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:94:0	72,41:113:0.3628
chr11	67023922	.	G	T	.	PASS	CSQ=91683|protein_coding||intron_variant|||||||NM_177963.4:c.-24+462G>T||MODIFIER||||||SYT12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	199,16:215:0.0744
chr11	67502866	.	C	T	.	PASS	CSQ=9600|protein_coding||intron_variant|||||||NM_004910.3:c.79-148G>A||MODIFIER||||||PITPNM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	95,83:178:0.4663
chr11	67783788	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	59,91:150:0.6067
chr11	67970382	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	87,86:173:0.4971
chr11	67979073	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	125,0:125:0	105,95:200:0.475
chr11	68742552	.	C	G	.	PASS	CSQ=9633|protein_coding||intron_variant|||||||NM_004923.3:c.752-158G>C||MODIFIER||||||TESMIN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	86,91:177:0.5141
chr11	68768211	.	G	T	.	PASS	CSQ=1374|protein_coding||intron_variant|||||||NM_001876.4:c.1740+5054C>A||MODIFIER||||||CPT1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	78,73:151:0.4834
chr11	68822645	.	G	A	.	PASS	CSQ=1374|protein_coding||intron_variant||||rs1474531902||1.97433e-05|NM_001876.4:c.-13-7158C>T||MODIFIER||||||CPT1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	102,95:198:0.4798
chr11	69569226	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs900803517|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	176,85:261:0.3257
chr11	69816808	.	G	A	.	PASS	CSQ=2248|protein_coding||intron_variant||||||6.5703e-06|NM_005247.3:c.221-385C>T||MODIFIER||||||FGF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	97,100:197:0.5076
chr11	69872576	.	CA	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	112,0:112:0	87,59:149:0.396
chr11	69920832	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs894762035||1.97122e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	110,73:183:0.3989
chr11	69957448	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	95,94:189:0.4974
chr11	70032615	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	82,86:168:0.5119
chr11	70374522	.	GC	AT	.	PASS	CSQ=8500|protein_coding||intron_variant|||||||NM_003626.3:c.3140-396_3140-395delinsAT||MODIFIER||||||PPFIA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2,lancet;num_callers=2;supported_by=strelka2_SNVs	AD:DP:AF	134,0:134:0	99,104:203:0.5123
chr11	70419650	.	G	A	.	PASS	CSQ=2017|protein_coding||intron_variant|||||||NM_005231.4:c.569-96G>A||MODIFIER||||||CTTN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	113,0:113:0	71,80:151:0.5298
chr11	70858960	.	GTCCAC	G	.	PASS	CSQ=22941|protein_coding||intron_variant|||||||NM_012309.4:c.1174+37536_1174+37540del||MODIFIER||||||SHANK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	77,54:131:0.4122
chr11	71095826	.	C	T	.	PASS	CSQ=22941|protein_coding||intron_variant||||rs1490007131||1.97057e-05|NM_012309.4:c.593-1138G>A||MODIFIER||||||SHANK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	90,78:168:0.4643
chr11	71283297	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	79,92:171:0.538
chr11	71364283	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	90,90:180:0.5
chr11	71794104	.	A	C	.	PASS	CSQ=285407|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||ALG1L9P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	107,94:201:0.4677
chr11	71804551	.	G	A	.	PASS	CSQ=55199|protein_coding||downstream_gene_variant||||rs1262175631||2.62881e-05|||MODIFIER||||||FAM86C1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	90,95:185:0.5135
chr11	71915045	.	A	C	.	PASS	CSQ=100133315|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_029192.1:n.899+1029T>G||MODIFIER||||||LOC100133315|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	83,84:167:0.503
chr11	72022674	.	C	A	.	PASS	CSQ=100128494|lncRNA||downstream_gene_variant||||rs1159357284||6.58961e-06|||MODIFIER||||||LOC100128494|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	76,72:148:0.4865
chr11	72445143	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	87,90:177:0.5085
chr11	72582728	.	T	C	.	PASS	CSQ=5138|protein_coding||intron_variant|||||||NM_002599.5:c.1729-162A>G||MODIFIER||||||PDE2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	79,90:169:0.5325
chr11	73144524	.	T	A	.	PASS	CSQ=9873|protein_coding||upstream_gene_variant||||rs944779709||2.64072e-05|||MODIFIER||||||FCHSD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	104,86:190:0.4526
chr11	73502188	.	C	CA	.	PASS	CSQ=23201|protein_coding||intron_variant||||rs112282375||0.0861333|NM_015159.2:c.-18-33697dup||MODIFIER||||||FAM168A|EntrezGene|0.0575;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	99,77:176:0.4375
chr11	73698172	.	G	C	.	PASS	CSQ=5870|protein_coding||intron_variant|||||||NM_198896.1:c.495+9248C>G||MODIFIER||||||RAB6A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	108,96:204:0.4706
chr11	73698339	.	G	T	.	PASS	CSQ=5870|protein_coding||intron_variant|||||||NM_198896.1:c.495+9081C>A||MODIFIER||||||RAB6A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	95,104:199:0.5226
chr11	74206699	.	T	A	.	PASS	CSQ=51400|protein_coding||intron_variant|||||||NM_016147.3:c.288+2254T>A||MODIFIER||||||PPME1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	70,75:145:0.5172
chr11	74286311	.	C	T	.	PASS	CSQ=283208|protein_coding||missense_variant|||||||NM_182904.5:c.850G>A|NP_878907.1:p.Glu284Lys|MODERATE|B&.|T&T|N|T&T|T&T|P4HA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	129,0:129:0	164,21:185:0.1135
chr11	74287725	.	C	G	.	PASS	CSQ=283208|protein_coding||intron_variant|||||||NM_182904.5:c.770-1334G>C||MODIFIER||||||P4HA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	163,8:171:0.0468
chr11	74288423	.	C	T	.	PASS	CSQ=283208|protein_coding||intron_variant|||||||NM_182904.5:c.769+656G>A||MODIFIER||||||P4HA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	163,8:171:0.0468
chr11	74288436	.	C	G	.	PASS	CSQ=283208|protein_coding||intron_variant|||||||NM_182904.5:c.769+643G>C||MODIFIER||||||P4HA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	151,9:160:0.0563
chr11	74487257	.	A	T	.	PASS	CSQ=387787|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LIPT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	92,83:175:0.4743
chr11	75925944	.	CATTATATT	C	.	PASS	CSQ=7405|protein_coding||intron_variant|||||||NM_003369.4:c.593+13906_593+13913del||MODIFIER||||||UVRAG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	132,40:172:0.2326
chr11	75925953	.	T	C	.	PASS	CSQ=7405|protein_coding||intron_variant|||||||NM_003369.4:c.593+13914T>C||MODIFIER||||||UVRAG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	139,41:180:0.2278
chr11	76249551	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	90,72:162:0.4444
chr11	76269920	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	92,94:186:0.5054
chr11	76374687	.	C	T	.	PASS	CSQ=5612|protein_coding||intron_variant|||||||NM_004705.4:c.89+6061G>A||MODIFIER||||||THAP12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	81,80:161:0.4969
chr11	77678324	.	C	T	.	PASS	CSQ=51773|protein_coding||intron_variant|||||||NM_016578.3:c.3066-171G>A||MODIFIER||||||RSF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	78,71:149:0.4765
chr11	77678705	.	C	A	.	PASS	CSQ=51773|protein_coding||intron_variant|||||||NM_016578.3:c.3066-552G>T||MODIFIER||||||RSF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	65,83:148:0.5608
chr11	77678792	.	C	T	.	PASS	CSQ=51773|protein_coding||intron_variant|||||||NM_016578.3:c.3066-639G>A||MODIFIER||||||RSF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	72,79:151:0.5232
chr11	77678902	.	C	T	.	PASS	CSQ=51773|protein_coding||intron_variant|||||||NM_016578.3:c.3066-749G>A||MODIFIER||||||RSF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	67,104:171:0.6082
chr11	78360033	.	G	A	.	PASS	CSQ=9846|protein_coding||intron_variant|||||||NM_080491.3:c.75+57613C>T||MODIFIER||||||GAB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	78,81:159:0.5094
chr11	79065162	.	C	G	.	PASS	CSQ=26011|protein_coding||intron_variant|||||||NM_001098816.2:c.224-155G>C||MODIFIER||||||TENM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	88,72:160:0.45
chr11	79287656	.	A	T	.	PASS	CSQ=26011|protein_coding||intron_variant|||||||NM_001098816.2:c.-265+9832T>A||MODIFIER||||||TENM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	66,86:152:0.5658
chr11	79494855	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	75,74:149:0.4966
chr11	79564347	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	66,63:129:0.4884
chr11	79597094	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	118,0:118:0	86,88:174:0.5057
chr11	79677120	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	83,86:169:0.5089
chr11	80189398	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	79,83:162:0.5123
chr11	80270120	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	74,83:157:0.5287
chr11	80289995	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	96,72:168:0.4286
chr11	80709085	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1198052626||0.00473571|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	69,48:118:0.4068
chr11	80750727	.	T	A	.	PASS	CSQ=101928944|lncRNA||downstream_gene_variant||||rs1185798697||6.57462e-06|||MODIFIER||||||LOC101928944|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	72,59:131:0.4504
chr11	80968560	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	88,60:148:0.4054
chr11	81416456	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:110:0	56,82:138:0.5942
chr11	81420274	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	143,14:157:0.0892
chr11	81447306	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	73,84:157:0.535
chr11	81532439	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs199516471||0.0140708|||MODIFIER||||||||0.0112;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	94,51:145:0.3517
chr11	81672694	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,72:152:0.4737
chr11	81732718	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	87,71:158:0.4494
chr11	81748922	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	65,50:115:0.4348
chr11	81753901	.	TTATATGG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	107,16:123:0.1301
chr11	81904667	.	TA	T	.	PASS	CSQ=101928989|lncRNA||intron_variant&non_coding_transcript_variant||||rs1451505623||2.63498e-05|NR_120571.1:n.941-22372del||MODIFIER||||||MIR4300HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	66,54:120:0.45
chr11	81937873	.	G	A	.	PASS	CSQ=101928989|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120571.1:n.941-55577C>T||MODIFIER||||||MIR4300HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	89,33:122:0.2705
chr11	82036241	.	G	T	.	PASS	CSQ=101928989|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120571.1:n.814-20507C>A||MODIFIER||||||MIR4300HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	85,70:155:0.4516
chr11	82062424	.	G	A	.	PASS	CSQ=101928989|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120571.1:n.813+34037C>T||MODIFIER||||||MIR4300HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	65,70:135:0.5185
chr11	82446764	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	87,82:169:0.4852
chr11	82501019	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1020273022||1.97151e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	74,78:152:0.5132
chr11	82612304	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	80,79:159:0.4969
chr11	82616506	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	83,78:161:0.4845
chr11	82672624	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	69,90:159:0.566
chr11	82721553	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	96,82:178:0.4607
chr11	83106574	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1232060738|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	81,84:165:0.5091
chr11	83153412	.	G	A	.	PASS	CSQ=51585|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PCF11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	75,74:149:0.4966
chr11	83600514	.	G	A	.	PASS	CSQ=1740|protein_coding||intron_variant||||rs773724300||0.000190679|NM_001142699.1:c.1940+32697C>T||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	85,84:169:0.497
chr11	83663204	.	G	C	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.1826-29879C>G||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	80,81:161:0.5031
chr11	84280403	.	G	A	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.520-29112C>T||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	59,64:123:0.5203
chr11	84307205	.	G	T	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.520-55914C>A||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	56,64:120:0.5333
chr11	84355679	.	G	A	.	PASS	CSQ=1740|protein_coding||intron_variant||||rs1014753149||6.57505e-06|NM_001142699.1:c.520-104388C>T||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	74,99:173:0.5723
chr11	84524717	.	G	A	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.519+9853C>T||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:129:0	68,68:136:0.5
chr11	84582259	.	G	C	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.358-47528C>G||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	67,71:138:0.5145
chr11	84675771	.	C	A	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.358-141040G>T||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	157,6:163:0.0368
chr11	84901403	.	C	T	.	PASS	CSQ=1740|protein_coding||intron_variant||||rs773807104||1.31511e-05|NM_001142699.1:c.357+210258G>A||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	76,76:152:0.5
chr11	84933205	.	C	G	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.357+178456G>C||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	133,14:147:0.0952
chr11	85388444	.	T	A	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.41-103079A>T||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	73,81:155:0.5226
chr11	85554726	.	G	A	.	PASS	CSQ=1740|protein_coding||intron_variant||||rs549644007||2.66244e-05|NM_001142699.1:c.40+43931C>T||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	76,89:165:0.5394
chr11	85588572	.	C	T	.	PASS	CSQ=1740|protein_coding||intron_variant|||||||NM_001142699.1:c.40+10085G>A||MODIFIER||||||DLG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	90,78:168:0.4643
chr11	86048570	.	A	C	.	PASS	CSQ=8301|protein_coding||intron_variant||||rs1245287660||6.59692e-06|NM_007166.4:c.131-16959T>G||MODIFIER||||||PICALM|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PICALM|y|n|T-ALL,AML|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	170,4:175:0.0229
chr11	86263822	.	G	C	.	PASS	CSQ=8726|protein_coding||intron_variant|||||||NM_003797.5:c.635-350G>C||MODIFIER||||||EED|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/EED|y|n|malignant_peripheral_nerve_sheath_tumours,MDS_and_related,lung_adenocarcinoma|||E,L||TSG|Mis,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	70,79:149:0.5302
chr11	86273122	.	C	T	.	PASS	CSQ=8726|protein_coding||intron_variant||||rs1308697301|||NM_003797.5:c.967-3858C>T||MODIFIER||||||EED|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/EED|y|n|malignant_peripheral_nerve_sheath_tumours,MDS_and_related,lung_adenocarcinoma|||E,L||TSG|Mis,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	97,84:181:0.4641
chr11	86281165	.	C	T	.	PASS	CSQ=8726|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||EED|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/EED|y|n|malignant_peripheral_nerve_sheath_tumours,MDS_and_related,lung_adenocarcinoma|||E,L||TSG|Mis,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	84,98:182:0.5385
chr11	86559746	.	G	A	.	PASS	CSQ=10873|protein_coding||synonymous_variant||||rs140957290|3.97788e-05|3.94213e-05|NM_001161586.1:c.261C>T|NP_001155058.1:p.Asp87=|LOW||||||ME3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	64,94:158:0.5949
chr11	86964715	.	C	CT	.	PASS	CSQ=100506368|lncRNA||intron_variant&non_coding_transcript_variant||||rs1389938666||1.31692e-05|NR_038905.1:n.137+6697dup||MODIFIER||||||LOC100506368|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,1:105:0.0095	88,86:174:0.4943
chr11	86989125	.	C	T	.	PASS	CSQ=100506368|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038905.1:n.138-10751C>T||MODIFIER||||||LOC100506368|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	75,98:173:0.5665
chr11	87061799	.	G	A	.	PASS	CSQ=65084|protein_coding||intron_variant||||rs770811850||0.000249685|NM_022918.4:c.142-5895G>A||MODIFIER||||||TMEM135|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	94,73:167:0.4371
chr11	87110656	.	T	A	.	PASS	CSQ=65084|protein_coding||intron_variant|||||||NM_022918.4:c.396+19261T>A||MODIFIER||||||TMEM135|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	86,83:169:0.4911
chr11	87360912	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1437578948||6.57151e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	149,8:157:0.051
chr11	87425062	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	72,72:144:0.5
chr11	87559427	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	140,15:155:0.0968
chr11	88082321	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1026941881||0.00024604|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	79,66:145:0.4552
chr11	88118930	.	G	C	.	PASS	CSQ=23682|protein_coding||intron_variant||||||6.57557e-06|NM_022337.3:c.484-4790C>G||MODIFIER||||||RAB38|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	79,83:162:0.5123
chr11	88495112	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1278847926|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	66,70:136:0.5147
chr11	88812911	.	TC	AA	.	PASS	CSQ=2915|protein_coding||intron_variant|||||||NM_001143831.2:c.911+36994_911+36995delinsTT||MODIFIER||||||GRM5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	114,0:115:0	107,39:146:0.2671
chr11	88928990	.	T	C	.	PASS	CSQ=2915|protein_coding||intron_variant|||||||NM_001143831.2:c.662-78835A>G||MODIFIER||||||GRM5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	68,79:147:0.5374
chr11	89265610	.	C	T	.	PASS	CSQ=7299|protein_coding||intron_variant|||||||NM_000372.5:c.1185-19163C>T||MODIFIER||||||TYR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	84,76:160:0.475
chr11	89320193	.	G	GA	.	PASS	CSQ=50507|protein_coding||downstream_gene_variant||||rs772372670||5.96769e-05|||MODIFIER||||||NOX4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	129,0:129:0	105,20:125:0.16
chr11	89467376	.	AAT	A	.	PASS	CSQ=50507|protein_coding||intron_variant|||||||NM_016931.5:c.154-15483_154-15482del||MODIFIER||||||NOX4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	156,21:177:0.1186
chr11	89814491	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	64,81:145:0.5586
chr11	90339386	.	C	T	.	PASS	CSQ=101929222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104190.1:n.86+88069C>T||MODIFIER||||||DISC1FP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	65,61:126:0.4841
chr11	90339845	.	G	A	.	PASS	CSQ=101929222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104190.1:n.86+88528G>A||MODIFIER||||||DISC1FP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	80,74:154:0.4805
chr11	90440501	.	T	A	.	PASS	CSQ=101929222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104190.1:n.87-106253T>A||MODIFIER||||||DISC1FP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	93,72:165:0.4364
chr11	90760547	.	C	G	.	PASS	CSQ=101929222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104190.1:n.333-41219C>G||MODIFIER||||||DISC1FP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	67,66:133:0.4962
chr11	90783707	.	C	G	.	PASS	CSQ=101929222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104190.1:n.333-18059C>G||MODIFIER||||||DISC1FP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,1:109:0.0092	59,72:131:0.5496
chr11	90787647	.	A	C	.	PASS	CSQ=101929222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104190.1:n.333-14119A>C||MODIFIER||||||DISC1FP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	72,62:134:0.4627
chr11	90801581	.	G	C	.	PASS	CSQ=101929222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104190.1:n.333-185G>C||MODIFIER||||||DISC1FP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	70,79:149:0.5302
chr11	90966094	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	64,66:130:0.5077
chr11	91282408	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1042184643|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	82,68:150:0.4533
chr11	91487195	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	83,62:145:0.4276
chr11	91533442	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	103,0:103:0	72,69:141:0.4894
chr11	91686750	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs889842517||6.57479e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	144,9:153:0.0588
chr11	91934027	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	61,74:135:0.5481
chr11	92176216	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	83,79:162:0.4877
chr11	92226876	.	G	A	.	PASS	CSQ=120114|protein_coding||intron_variant|||||||NM_001367949.1:c.-18+1702G>A||MODIFIER||||||FAT3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FAT3|y|n|SCC,colon_adenocarcinoma,gastric_adenocarcinoma|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	90,74:164:0.4512
chr11	92305565	.	C	T	.	PASS	CSQ=120114|protein_coding||intron_variant|||||||NM_001367949.1:c.-17-46531C>T||MODIFIER||||||FAT3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FAT3|y|n|SCC,colon_adenocarcinoma,gastric_adenocarcinoma|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	131,11:142:0.0775
chr11	92524131	COSV53116094;COSV53116094	C	CA	.	PASS	CSQ=120114|protein_coding||intron_variant|COSV53116094&COSV53116094|p.?&p.?||rs1169480651||1.97714e-05|NM_001367949.1:c.3293-496dup||MODIFIER||||||FAT3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FAT3|y|n|SCC,colon_adenocarcinoma,gastric_adenocarcinoma|||E|||Mis;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	82,66:148:0.4459
chr11	92700979	.	C	A	.	PASS	CSQ=120114|protein_coding||intron_variant|||||||NM_001367949.1:c.3669+3534C>A||MODIFIER||||||FAT3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FAT3|y|n|SCC,colon_adenocarcinoma,gastric_adenocarcinoma|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	90,71:161:0.441
chr11	92781281	.	C	T	.	PASS	CSQ=120114|protein_coding||intron_variant|||||||NM_001367949.1:c.4335+7101C>T||MODIFIER||||||FAT3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FAT3|y|n|SCC,colon_adenocarcinoma,gastric_adenocarcinoma|||E|||Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	58,69:127:0.5433
chr11	93172145	.	G	GA	.	PASS	CSQ=120103|protein_coding||intron_variant||||rs771057659|||NM_152313.4:c.541-3975dup||MODIFIER||||||SLC36A4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	161,16:177:0.0904
chr11	93577357	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	91,77:168:0.4583
chr11	93639753	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs1210919268||6.57013e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	87,84:171:0.4912
chr11	93813351	.	T	G	.	PASS	CSQ=9440|protein_coding||3_prime_UTR_variant|||||||NM_004268.5:c.*1287T>G||MODIFIER||||||MED17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	113,0:113:0	80,70:150:0.4667
chr11	94120205	.	TTACATCTCA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	71,69:140:0.4929
chr11	94418945	.	C	T	.	PASS	CSQ=4361|protein_coding||3_prime_UTR_variant|||||||NM_005591.3:c.*1180G>A||MODIFIER||||||MRE11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	96,0:96:0	65,75:140:0.5357
chr11	94589792	.	C	CCCT	.	PASS	CSQ=105369438|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135093.1:n.524-43949_524-43947dup||MODIFIER||||||LOC105369438|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	84,70:154:0.4545
chr11	95386393	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	73,67:140:0.4786
chr11	95737261	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	96,88:184:0.4783
chr11	95754526	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	83,72:155:0.4645
chr11	95761061	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	98,81:179:0.4525
chr11	96008242	.	C	G	.	PASS	CSQ=84441|protein_coding||intron_variant|||||||NM_032427.4:c.2140-16519G>C||MODIFIER||||||MAML2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MAML2|y|n|salivary_gland_mucoepidermoid|||E|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	84,70:154:0.4545
chr11	96178129	.	T	G	.	PASS	CSQ=84441|protein_coding||intron_variant|||||||NM_032427.4:c.514-84612A>C||MODIFIER||||||MAML2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MAML2|y|n|salivary_gland_mucoepidermoid|||E|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	70,79:149:0.5302
chr11	96624896	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1039685048||5.99912e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	68,76:144:0.5278
chr11	97404900	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	84,68:152:0.4474
chr11	97580695	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	65,68:133:0.5113
chr11	97685521	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,1:121:0.0083	68,76:144:0.5278
chr11	97807171	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	53,74:127:0.5827
chr11	97813840	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	132,6:138:0.0435
chr11	98302148	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	70,59:129:0.4574
chr11	98335527	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1325827060|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	61,72:133:0.5414
chr11	98423503	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	161,0:161:0	117,62:179:0.3464
chr11	98438216	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,0:73:0	59,49:108:0.4537
chr11	98470965	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	87,42:129:0.3256
chr11	98580987	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	61,76:137:0.5547
chr11	98591393	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	79,68:147:0.4626
chr11	98603641	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	75,64:139:0.4604
chr11	98675139	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:100:0	81,74:155:0.4774
chr11	98680433	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	90,73:163:0.4479
chr11	98973871	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	75,69:144:0.4792
chr11	99037575	.	TC	T	.	PASS	CSQ=53942|protein_coding||intron_variant||||rs376083635|||NM_014361.4:c.-210+16306del||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	103,34:137:0.2482
chr11	99116989	.	TA	AC	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-210+95719_-210+95720delinsAC||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	122,0:122:0	70,59:129:0.4574
chr11	99132336	.	A	C	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-210+111066A>C||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	110,30:140:0.2143
chr11	99161593	.	C	T	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-210+140323C>T||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	76,56:132:0.4242
chr11	99181053	.	G	T	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-209-144293G>T||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	118,21:139:0.1511
chr11	99186269	.	G	A	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-209-139077G>A||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	80,67:147:0.4558
chr11	99191257	.	G	GT	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-209-134082dup||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	92,55:147:0.3741
chr11	99272690	.	T	C	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-209-52656T>C||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	80,63:143:0.4406
chr11	99298085	.	G	C	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-209-27261G>C||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	65,61:126:0.4841
chr11	99399252	.	G	C	.	PASS	CSQ=53942|protein_coding||intron_variant||||rs553306581||0.00045609|NM_014361.4:c.-71+73768G>C||MODIFIER||||||CNTN5|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	77,73:150:0.4867
chr11	99416286	COSV73158947;COSV73158947;COSV73158947	CT	C	.	PASS	CSQ=53942|protein_coding||intron_variant|COSV73158947&COSV73158947&COSV73158947|p.?&p.?&p.?||rs570548103||3.98904e-05|NM_014361.4:c.-71+90811del||MODIFIER||||||CNTN5|EntrezGene|0.0008;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	79,51:131:0.3893
chr11	99533613	.	C	A	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.-70-22532C>A||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	76,78:154:0.5065
chr11	99635070	.	G	C	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.55+78801G>C||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	81,78:159:0.4906
chr11	99742078	.	G	T	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.56-77466G>T||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	70,85:155:0.5484
chr11	99980976	.	C	CT	.	PASS	CSQ=53942|protein_coding||intron_variant||||rs913470054|||NM_014361.4:c.878-21051dup||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	56,52:109:0.4771
chr11	100152366	.	G	A	.	PASS	CSQ=53942|protein_coding||intron_variant|||||||NM_014361.4:c.1581-38760G>A||MODIFIER||||||CNTN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	74,54:128:0.4219
chr11	100750167	.	A	C	.	PASS	CSQ=143872|protein_coding||intron_variant|||||||NM_152432.4:c.155-20176A>C||MODIFIER||||||ARHGAP42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	71,81:152:0.5329
chr11	100827111	.	C	T	.	PASS	CSQ=143872|protein_coding||intron_variant|||||||NM_152432.4:c.312+31945C>T||MODIFIER||||||ARHGAP42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	57,61:118:0.5169
chr11	100879199	.	C	G	.	PASS	CSQ=143872|protein_coding||intron_variant|||||||NM_152432.4:c.384+19574C>G||MODIFIER||||||ARHGAP42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	54,80:134:0.597
chr11	100962985	.	G	A	.	PASS	CSQ=143872|protein_coding||intron_variant|||||||NM_152432.4:c.1444+518G>A||MODIFIER||||||ARHGAP42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	84,102:186:0.5484
chr11	101504553	.	A	C	.	PASS	CSQ=7225|protein_coding||missense_variant|||||||NM_004621.6:c.416T>G|NP_004612.2:p.Leu139Trp|MODERATE|D&.&D&D|T&T&T&T|D|D&D&D&D|D&D&D&D|TRPC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	81,62:143:0.4336
chr11	101650796	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs949075061||1.97278e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	89,74:163:0.454
chr11	102327664	.	T	A	.	PASS	CSQ=330|protein_coding||intron_variant|||||||NM_001165.4:c.954-388T>A||MODIFIER||||||BIRC3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/BIRC3|y|n|CLL,MALT,MCL,MM|||L|Dom|oncogene,TSG,fusion|D,F,N,T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	86,87:173:0.5029
chr11	102460483	.	G	A	.	PASS	CSQ=101928424|lncRNA||intron_variant&non_coding_transcript_variant||||rs962912293||6.57255e-05|NR_135053.1:n.132-965G>A||MODIFIER||||||LOC101928424|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	79,89:168:0.5298
chr11	102923902	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	88,81:169:0.4793
chr11	102943316	.	A	G	.	PASS	CSQ=4322|protein_coding||3_prime_UTR_variant|||||||NM_002427.4:c.*950T>C||MODIFIER||||||MMP13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	78,86:164:0.5244
chr11	103185561	.	A	T	.	PASS	CSQ=79659|protein_coding||intron_variant|||||||NM_001377.3:c.6633+510A>T||MODIFIER||||||DYNC2H1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	84,94:178:0.5281
chr11	103258751	.	C	T	.	PASS	CSQ=79659|protein_coding||intron_variant|||||||NM_001377.3:c.10605+1000C>T||MODIFIER||||||DYNC2H1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:150:0	70,98:168:0.5833
chr11	103818785	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	64,77:141:0.5461
chr11	104223823	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs559656089||0.00374037|||MODIFIER||||||||0.0050;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	86,68:154:0.4416
chr11	104469633	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	133,7:140:0.05
chr11	104481589	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	65,71:136:0.5221
chr11	104536522	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1485362363||6.59248e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	88,55:143:0.3846
chr11	104804725	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	80,82:162:0.5062
chr11	105047165	.	G	A	.	PASS	CSQ=114769|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CARD16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	61,69:130:0.5308
chr11	105392771	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	73,75:148:0.5068
chr11	105422054	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	72,79:151:0.5232
chr11	105674467	.	G	A	.	PASS	CSQ=2893|protein_coding||intron_variant||||||1.31947e-05|NM_000829.3:c.247+62033G>A||MODIFIER||||||GRIA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	71,68:139:0.4892
chr11	105688015	.	A	G	.	PASS	CSQ=2893|protein_coding||intron_variant|||||||NM_000829.3:c.248-64966A>G||MODIFIER||||||GRIA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	93,64:157:0.4076
chr11	105801960	.	G	T	.	PASS	CSQ=2893|protein_coding||intron_variant|||||||NM_000829.3:c.487+48740G>T||MODIFIER||||||GRIA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	96,70:166:0.4217
chr11	105892661	.	C	A	.	PASS	CSQ=2893|protein_coding||intron_variant|||||||NM_000829.3:c.726+5089C>A||MODIFIER||||||GRIA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	78,73:151:0.4834
chr11	106216812	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:130:0	0,64:64:1
chr11	106387322	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,60:60:1
chr11	106691735	.	A	AT	.	PASS	CSQ=2977|protein_coding||intron_variant|||||||NM_000855.2:c.1992-3980dup||MODIFIER||||||GUCY1A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	2,56:58:0.9655
chr11	106691737	.	G	A	.	PASS	CSQ=2977|protein_coding||intron_variant|||||||NM_000855.2:c.1992-3981C>T||MODIFIER||||||GUCY1A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,59:60:0.9833
chr11	106775960	.	A	G	.	PASS	CSQ=2977|protein_coding||intron_variant||||||6.57229e-06|NM_000855.2:c.1836+479T>C||MODIFIER||||||GUCY1A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	55,7:62:0.1129
chr11	106802642	.	G	A	.	PASS	CSQ=2977|protein_coding||intron_variant|||||||NM_000855.2:c.1692+7351C>T||MODIFIER||||||GUCY1A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,64:64:1
chr11	107406735	.	G	C	.	PASS	CSQ=143884|protein_coding||intron_variant|||||||NM_152434.2:c.1617+9474C>G||MODIFIER||||||CWF19L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,72:72:1
chr11	108761569	.	G	C	.	PASS	CSQ=1662|protein_coding||intron_variant|||||||NM_004398.4:c.1965+38107G>C||MODIFIER||||||DDX10|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/DDX10|y|n|AML*|||L|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	78,6:84:0.0714
chr11	109093168	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:107:0	0,85:85:1
chr11	110726024	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs562987012||0.227373|||MODIFIER||||||||0.2512;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	6,75:81:0.9259
chr11	110822722	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,99:99:1
chr11	111007920	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,67:67:1
chr11	112135889	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	1,79:80:0.9875
chr11	112816213	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,78:78:1
chr11	113632377	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	80,7:87:0.0805
chr11	113892014	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,77:77:1
chr11	113893984	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,85:85:1
chr11	114557184	.	G	A	.	PASS	CSQ=120400|protein_coding||intron_variant||||||1.97309e-05|NM_001367953.1:c.-99+2614C>T||MODIFIER||||||NXPE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,88:89:0.9888
chr11	114680153	.	C	T	.	PASS	CSQ=120406|protein_coding||intron_variant||||rs1398536917||6.57557e-06|NM_182495.5:c.132+391C>T||MODIFIER||||||NXPE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	55,12:67:0.1791
chr11	114702854	.	A	G	.	PASS	CSQ=120406|protein_coding||intron_variant|||||||NM_182495.5:c.867-1137A>G||MODIFIER||||||NXPE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,84:84:1
chr11	114726997	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,89:89:1
chr11	115461821	.	CA	C	.	PASS	CSQ=23705|protein_coding||intron_variant|||||||NM_001301043.1:c.124+42449del||MODIFIER||||||CADM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	4,73:77:0.9481
chr11	115883216	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs1161367325||1.97866e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	1,82:83:0.988
chr11	116130852	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	6,54:60:0.9
chr11	116795806	.	C	CTATTA	.	PASS	CSQ=116519|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||APOA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	1,69:70:0.9857
chr11	116853935	.	G	A	.	PASS	CSQ=104326055|antisense_RNA||intron_variant&non_coding_transcript_variant|||||||NR_126362.1:n.124-1355G>A||MODIFIER||||||APOA1-AS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,84:84:1
chr11	117303423	.	C	T	.	PASS	CSQ=23621|protein_coding||intron_variant|||||||NM_012104.4:c.262-6462G>A||MODIFIER||||||BACE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,100:100:1
chr11	117796162	.	C	T	.	PASS	CSQ=57453|protein_coding||intron_variant|||||||NM_020693.4:c.46+872G>A||MODIFIER||||||DSCAML1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,80:80:1
chr11	118194354	.	C	T	.	PASS	CSQ=120425|protein_coding||missense_variant|||||||NM_001098526.1:c.1156G>A|NP_001091996.1:p.Gly386Arg|MODERATE|B&B&B&.|D&D&D&D|N|T&T&T&T|T&T&T&T|JAML|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	0,79:79:1
chr11	119594798	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,96:96:1
chr11	119897607	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,68:68:1
chr11	120617391	.	A	T	.	PASS	CSQ=2900|protein_coding||intron_variant|||||||NM_014619.4:c.-158-36294A>T||MODIFIER||||||GRIK4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,85:85:1
chr11	120822374	.	G	A	.	PASS	CSQ=105369532|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LOC105369532|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,94:94:1
chr11	120938816	.	T	C	.	PASS	CSQ=2900|protein_coding||intron_variant||||rs895587753||1.97086e-05|NM_014619.4:c.1477-1531T>C||MODIFIER||||||GRIK4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,93:93:1
chr11	121088528	.	A	T	.	PASS	CSQ=219899|protein_coding||3_prime_UTR_variant|||||||NM_001363644.1:c.*1432A>T||MODIFIER||||||TBCEL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	124,0:124:0	0,76:76:1
chr11	122337969	.	C	A	.	PASS	CSQ=399959|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_137192.1:n.493+29527G>T||MODIFIER||||||MIR100HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,88:88:1
chr11	122746092	.	G	A	.	PASS	CSQ=84959|protein_coding||intron_variant||||rs991668077|||NM_032873.5:c.162-30127G>A||MODIFIER||||||UBASH3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	0,82:82:1
chr11	122910604	.	A	T	.	PASS	CSQ=79864|protein_coding||intron_variant|||||||NM_024806.3:c.864+6160A>T||MODIFIER||||||JHY|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,101:101:1
chr11	123470637	.	C	T	.	PASS	CSQ=57476|protein_coding||intron_variant|||||||NM_001367421.1:c.243-10179C>T||MODIFIER||||||GRAMD1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,71:71:1
chr11	123745428	.	T	C	.	PASS	CSQ=7753|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ZNF202|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	75,12:87:0.1379
chr11	123849125	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,76:76:1
chr11	126149422	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	84,73:157:0.465
chr11	127021454	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	98,63:161:0.3913
chr11	127323315	.	G	A	.	PASS	CSQ=101929497|lncRNA||intron_variant&non_coding_transcript_variant||||rs1041138419||3.94555e-05|NR_120580.1:n.105-11709G>A||MODIFIER||||||LOC101929497|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:120:0	72,80:152:0.5263
chr11	127340529	.	G	T	.	PASS	CSQ=101929497|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC101929497|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	62,63:125:0.504
chr11	127593436	.	TAC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	77,72:149:0.4832
chr11	127677484	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	73,59:132:0.447
chr11	127840685	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs973382758||3.94706e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	78,79:157:0.5032
chr11	127981168	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	76,81:157:0.5159
chr11	128045208	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	140,18:158:0.1139
chr11	128063735	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs926466067|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	85,71:156:0.4551
chr11	128238285	.	G	T	.	PASS	CSQ=105369564|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146647.1:n.375-2993G>T||MODIFIER||||||LINC02098|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	83,84:167:0.503
chr11	128764211	.	C	T	.	PASS	CSQ=2313|protein_coding||intron_variant||||rs971435104|||NM_002017.5:c.231-3907C>T||MODIFIER||||||FLI1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FLI1|y|n|Ewing_sarcoma|||M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	89,88:177:0.4972
chr11	129442319	.	G	T	.	PASS	CSQ=8538|protein_coding||intron_variant||||||6.57428e-06|NM_003658.4:c.489-516G>T||MODIFIER||||||BARX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	73,81:154:0.526
chr11	129449525	.	C	G	.	PASS	CSQ=8538|protein_coding||intron_variant|||||||NM_003658.4:c.574-1611C>G||MODIFIER||||||BARX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	84,85:169:0.503
chr11	129639508	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	92,84:176:0.4773
chr11	129656979	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	79,53:132:0.4015
chr11	130046454	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	88,93:181:0.5138
chr11	130153492	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	99,97:196:0.4949
chr11	130416955	.	GGGTGTGGGCCGCCTGGA	G	.	PASS	CSQ=11095|protein_coding||frameshift_variant|||||||NM_007037.6:c.1064_1080del|NP_008968.4:p.Leu355ProfsTer4|HIGH||||||ADAMTS8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	179,0:179:0	78,89:167:0.5329
chr11	130695791	.	G	A	.	PASS	CSQ=283171|protein_coding||intron_variant|||||||NM_001271983.1:c.211-17403G>A||MODIFIER||||||C11orf44|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	83,87:170:0.5118
chr11	130718910	.	G	GT	.	PASS	CSQ=283171|protein_coding||downstream_gene_variant||||rs568467817||0.0293109|||MODIFIER||||||C11orf44|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:98:0	90,52:143:0.3636
chr11	130855041	.	C	T	.	PASS	CSQ=100507431|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125383.1:n.199-149G>A||MODIFIER||||||LINC02551|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	79,73:152:0.4803
chr11	131095383	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	83,81:164:0.4939
chr11	131374190	.	T	A	.	PASS	CSQ=50863|protein_coding||intron_variant||||rs996366675||0.000111673|NM_001352001.1:c.82+3302T>A||MODIFIER||||||NTM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	72,85:158:0.538
chr11	131922180	.	G	T	.	PASS	CSQ=50863|protein_coding||intron_variant|||||||NM_001352001.1:c.167+10532G>T||MODIFIER||||||NTM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	87,67:154:0.4351
chr11	132031600	.	T	A	.	PASS	CSQ=50863|protein_coding||intron_variant|||||||NM_001352001.1:c.168-114682T>A||MODIFIER||||||NTM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	61,55:116:0.4741
chr11	132077017	.	C	A	.	PASS	CSQ=50863|protein_coding||intron_variant|||||||NM_001352001.1:c.168-69265C>A||MODIFIER||||||NTM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	73,69:142:0.4859
chr11	132081658	.	G	A	.	PASS	CSQ=50863|protein_coding||intron_variant|||||||NM_001352001.1:c.168-64624G>A||MODIFIER||||||NTM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	58,82:140:0.5857
chr11	132306631	.	C	A	.	PASS	CSQ=50863|protein_coding||intron_variant|||||||NM_001352001.1:c.527-1058C>A||MODIFIER||||||NTM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	81,79:160:0.4938
chr11	132514083	.	T	A	.	PASS	CSQ=4978|protein_coding||intron_variant|||||||NM_002545.4:c.526+14978A>T||MODIFIER||||||OPCML|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	74,67:141:0.4752
chr11	133381255	.	G	A	.	PASS	CSQ=4978|protein_coding||intron_variant|||||||NM_001012393.2:c.61+151009C>T||MODIFIER||||||OPCML|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	130,39:169:0.2308
chr11	133385851	.	GC	AA	.	PASS	CSQ=4978|protein_coding||intron_variant|||||||NM_001012393.2:c.61+146412_61+146413delinsTT||MODIFIER||||||OPCML|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	136,0:136:0	72,69:142:0.4859
chr11	133572554	.	TCA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	77,68:145:0.469
chr11	133642954	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	79,54:133:0.406
chr11	133691782	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	84,86:170:0.5059
chr11	134035314	.	G	A	.	PASS	CSQ=100128239|lncRNA||intron_variant&non_coding_transcript_variant||||rs998489220|||NR_027276.1:n.590-2198G>A||MODIFIER||||||LOC100128239|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	94,94:188:0.5
chr11	134459894	.	G	A	.	PASS	CSQ=283177|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033852.1:n.304-6446G>A||MODIFIER||||||LOC283177|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	83,91:174:0.523
chr11	134543540	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	139,8:147:0.0544
chr11	134556064	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	75,78:153:0.5098
chr11	134604251	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	88,63:151:0.4172
chr11	134738536	.	C	CA	.	PASS	CSQ=729305|lncRNA||intron_variant&non_coding_transcript_variant||||rs919571928||7.9041e-05|NR_147836.1:n.598+2002dup||MODIFIER||||||LOC729305|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	81,67:148:0.4527
chr11	134769213	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	79,75:154:0.487
chr11	134827542	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	79,56:135:0.4148
chr12	94894	.	T	C	.	PASS	CSQ=440073|protein_coding||intron_variant|||||||NM_001170738.1:c.555-4252T>C||MODIFIER||||||IQSEC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	74,90:164:0.5488
chr12	216351	.	C	T	.	PASS	CSQ=6540|protein_coding||downstream_gene_variant||||rs558776659|||||MODIFIER||||||SLC6A13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	57,0:57:0	42,56:98:0.5714
chr12	1029855	.	C	G	.	PASS	CSQ=23085|protein_coding||intron_variant|||||||NM_178040.4:c.669+1283C>G||MODIFIER||||||ERC1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERC1|y|n|papillary_thyroid,Spitzoid_tumour|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	104,0:104:0	125,9:136:0.0662
chr12	1029981	.	C	T	.	PASS	CSQ=23085|protein_coding||intron_variant|||||||NM_178040.4:c.669+1409C>T||MODIFIER||||||ERC1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERC1|y|n|papillary_thyroid,Spitzoid_tumour|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	160,11:171:0.0643
chr12	1506519	.	C	T	.	PASS	CSQ=100292680|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00942|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	101,96:197:0.4873
chr12	1761323	.	C	T	.	PASS	CSQ=79602|protein_coding||intron_variant|||||||NM_024551.3:c.171+6809C>T||MODIFIER||||||ADIPOR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	73,86:159:0.5409
chr12	2087069	.	G	GT	.	PASS	CSQ=775|protein_coding||intron_variant||||rs199558545||0.0101968|NM_001129827.1:c.50-28148dup||MODIFIER||||||CACNA1C|EntrezGene|0.0120;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	72,66:138:0.4783
chr12	2195649	.	G	T	.	PASS	CSQ=775|protein_coding||intron_variant|||||||NM_001129827.1:c.477+75219G>T||MODIFIER||||||CACNA1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	84,70:154:0.4545
chr12	2307599	.	G	A	.	PASS	CSQ=775|protein_coding||intron_variant|||||||NM_001129827.1:c.478-141377G>A||MODIFIER||||||CACNA1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	69,79:149:0.5302
chr12	2484557	COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186;COSV59751186	G	A	.	PASS	CSQ=775|protein_coding||intron_variant|COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186&COSV59751186|p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?&p.?||rs574108347||0.000394348|NM_001129827.1:c.758-1547G>A||MODIFIER||||||CACNA1C|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:84:0	59,68:127:0.5354
chr12	2776768	.	C	T	.	PASS	CSQ=283440|lncRNA||intron_variant&non_coding_transcript_variant||||rs895492468||5.25749e-05|NR_146317.1:n.434-4861G>A||MODIFIER||||||ITFG2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:148:0	86,90:176:0.5114
chr12	3517748	.	C	T	.	PASS	CSQ=56341|protein_coding||intron_variant|||||||NM_019854.4:c.76-22858C>T||MODIFIER||||||PRMT8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	64,73:137:0.5328
chr12	3535110	.	C	T	.	PASS	CSQ=56341|protein_coding||intron_variant|||||||NM_019854.4:c.76-5496C>T||MODIFIER||||||PRMT8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	81,85:166:0.512
chr12	3787134	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	103,78:181:0.4309
chr12	3941463	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	70,81:151:0.5364
chr12	3956032	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs959281902|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	137,13:150:0.0867
chr12	4031147	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	88,98:186:0.5269
chr12	4255379	.	GAGTGC	G	.	PASS	CSQ=103752584|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125790.1:n.127-6191_127-6187del||MODIFIER||||||CCND2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	99,72:171:0.4211
chr12	4370506	COSV52975564	C	T	.	PASS	CSQ=8074|protein_coding||missense_variant|COSV52975564|p.R198Q||rs1297215936&COSM244515|4.06894e-06|1.31593e-05|NM_020638.2:c.593G>A|NP_065689.1:p.Arg198Gln|MODERATE|P|D|N|T|T|FGF23|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	76,86:162:0.5309
chr12	4709572	.	T	C	.	PASS	CSQ=101929549|lncRNA||intron_variant&non_coding_transcript_variant||||rs1043082872|||NR_110112.1:n.239-5275A>G||MODIFIER||||||LOC101929549|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	64,71:135:0.5259
chr12	5473941	.	G	A	.	PASS	CSQ=4908|protein_coding||intron_variant||||rs550022165||1.31477e-05|NM_001102654.2:c.19-20253G>A||MODIFIER||||||NTF3|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	90,81:171:0.4737
chr12	5705053	.	G	C	.	PASS	CSQ=57101|protein_coding||intron_variant|||||||NM_001278596.3:c.1560+27467C>G||MODIFIER||||||ANO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	88,84:172:0.4884
chr12	5925989	.	C	T	.	PASS	CSQ=57101|protein_coding||intron_variant|||||||NM_001278596.3:c.23-3185G>A||MODIFIER||||||ANO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	87,101:188:0.5372
chr12	6010203	.	G	T	.	PASS	CSQ=7450|protein_coding||intron_variant||||rs563237692||6.58172e-06|NM_000552.4:c.5842+1414C>A||MODIFIER||||||VWF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	80,83:163:0.5092
chr12	6095889	.	C	A	.	PASS	CSQ=7450|protein_coding||intron_variant|||||||NM_000552.4:c.533-305G>T||MODIFIER||||||VWF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	100,0:100:0	75,95:170:0.5588
chr12	6975065	.	C	G	.	PASS	CSQ=10436|protein_coding||intron_variant|||||||NM_006331.8:c.413-25C>G||MODIFIER||||||EMG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	75,83:158:0.5253
chr12	7061608	.	G	T	.	PASS	CSQ=716|protein_coding||intron_variant|||||||NM_001734.5:c.-74-231G>T||MODIFIER||||||C1S|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	81,79:160:0.4938
chr12	7714012	.	C	A	.	PASS	CSQ=359787|protein_coding||intron_variant|||||||NM_199286.4:c.83-1171C>A||MODIFIER||||||DPPA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	82,79:161:0.4907
chr12	7986090	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	70,71:141:0.5035
chr12	8331878	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs771686907||0.0348154|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	99,56:157:0.3567
chr12	8927061	.	C	T	.	PASS	CSQ=1911|protein_coding||intron_variant|||||||NM_004426.3:c.613-3374C>T||MODIFIER||||||PHC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	99,91:190:0.4789
chr12	8957723	.	GG	TA	.	PASS	CSQ=10219|protein_coding||intron_variant|||||||NM_001329101.1:c.-156+7487_-156+7488delinsTA||MODIFIER||||||KLRG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	118,0:118:0	88,73:161:0.4534
chr12	9098874	.	A	G	.	PASS	CSQ=2|protein_coding||intron_variant|||||||NM_000014.5:c.1702-118T>C||MODIFIER||||||A2M|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	119,0:119:0	70,86:156:0.5513
chr12	9118975	.	G	A	.	PASS	CSQ=2|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||A2M|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	67,84:151:0.5563
chr12	9416752	.	TCA	T	.	PASS	CSQ=440081|transcribed_pseudogene||downstream_gene_variant||||rs1485794564||1.31323e-05|||MODIFIER||||||DDX12P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	175,0:175:0	178,67:245:0.2735
chr12	9448064	.	C	T	.	PASS	CSQ=440081|transcribed_pseudogene||non_coding_transcript_exon_variant|||||||NR_033399.1:n.109G>A||MODIFIER||||||DDX12P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	156,0:156:0	148,83:232:0.3578
chr12	9616000	.	G	A	.	PASS	CSQ=374443|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||LOC374443|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	79,72:151:0.4768
chr12	10109267	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	77,66:143:0.4615
chr12	10446876	COSV61726185;COSV61726185;COSV61726185;COSV61726185;COSV61726185;COSV61726185;COSV61726185;COSV61726185	C	T	.	PASS	CSQ=3821|protein_coding||intron_variant|COSV61726185&COSV61726185&COSV61726185&COSV61726185&COSV61726185|p.?&p.?&p.?&p.?&p.?|COSV61726185&COSV61726185&COSV61726185|rs34285268|||NM_002259.4:c.591-214G>A||MODIFIER||||||KLRC1|EntrezGene|0.0006;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	87,93:180:0.5167
chr12	10573735	.	A	C	.	PASS	CSQ=101060038|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146456.1:n.216-1089A>C||MODIFIER||||||LINC02446|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	92,96:188:0.5106
chr12	10613053	.	C	T	.	PASS	CSQ=55110|protein_coding||intron_variant||||rs997520847|||NM_018048.5:c.94+386G>A||MODIFIER||||||MAGOHB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	64,84:148:0.5676
chr12	10857481	.	G	C	.	PASS	CSQ=100533464|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037918.2:n.1185-9074C>G||MODIFIER||||||PRH1-PRR4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	79,77:156:0.4936
chr12	11070408	.	C	A	.	PASS	CSQ=100533464|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037918.2:n.205-23220G>T||MODIFIER||||||PRH1-PRR4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	151,0:151:0	206,12:218:0.055
chr12	11239105	.	ATTTGATGGAGATAGTT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	91,80:171:0.4678
chr12	11279199	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	69,60:129:0.4651
chr12	11331792	.	TATATATATGCTCACATATATATGTGAGCATATATATATACACAC	T	.	PASS	CSQ=|||intergenic_variant||||rs1231061260||0.000652057|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	91,29:120:0.2417
chr12	12018274	.	AG	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	114,0:114:0	73,76:149:0.5101
chr12	12067877	.	A	G	.	PASS	CSQ=79370|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||BCL2L14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	88,74:162:0.4568
chr12	12767333	.	AT	A	.	PASS	CSQ=693198|miRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR613|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	102,83:185:0.4486
chr12	12829315	.	G	C	.	PASS	CSQ=51202|protein_coding||intron_variant|||||||NM_016355.4:c.1237-108G>C||MODIFIER||||||DDX47|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	151,16:167:0.0958
chr12	12849622	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	203,20:223:0.0897
chr12	13139849	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	75,68:143:0.4755
chr12	13368380	.	C	T	.	PASS	CSQ=283422|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01559|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	94,80:174:0.4598
chr12	14766837	.	G	C	.	PASS	CSQ=121504|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||HIST4H4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	95,81:176:0.4602
chr12	14997750	.	C	G	.	PASS	CSQ=101928340|lncRNA||upstream_gene_variant||||rs910262166||1.3314e-05|||MODIFIER||||||LINC01489|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	90,100:190:0.5263
chr12	15091967	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	88,93:181:0.5138
chr12	15133503	.	CTTAGTTGCTTCCAAGATTTGGCAATTATGAATAAAAGTTCTACAAATA	C	.	PASS	CSQ=85004|protein_coding||intron_variant|||||||NM_032918.3:c.62-12432_62-12385del||MODIFIER||||||RERG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	104,54:158:0.3418
chr12	15236483	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	84,66:150:0.44
chr12	15456539	.	G	T	.	PASS	CSQ=5800|protein_coding||intron_variant|||||||NM_030667.3:c.76-27435G>T||MODIFIER||||||PTPRO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	84,86:170:0.5059
chr12	15685482	.	G	GA	.	PASS	CSQ=2059|protein_coding||intron_variant|||||||NM_004447.6:c.-21-2511dup||MODIFIER||||||EPS8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	82,73:155:0.471
chr12	15793823	.	T	G	.	PASS	CSQ=2059|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||EPS8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	88,70:158:0.443
chr12	16261052	.	G	GT	.	PASS	CSQ=729025|protein_coding||intron_variant||||rs1056002440||0.000365391|NM_001170798.1:c.585-3183dup||MODIFIER||||||SLC15A5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	89,69:158:0.4367
chr12	16324697	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	82,74:156:0.4744
chr12	16346696	.	C	G	.	PASS	CSQ=4257|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MGST1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	88,68:156:0.4359
chr12	16347136	.	G	A	.	PASS	CSQ=4257|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MGST1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	97,0:97:0	109,8:117:0.0684
chr12	16759747	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	141,12:153:0.0784
chr12	16866743	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.57981e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	141,14:155:0.0903
chr12	16920241	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	119,11:130:0.0846
chr12	17098406	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	150,12:162:0.0741
chr12	17536909	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	67,71:138:0.5145
chr12	17730427	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	112,40:152:0.2632
chr12	17782698	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	128,10:138:0.0725
chr12	17857154	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	58,52:110:0.4727
chr12	19190889	.	G	A	.	PASS	CSQ=54477|protein_coding||intron_variant|||||||NM_001256470.1:c.227+58439G>A||MODIFIER||||||PLEKHA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	92,68:160:0.425
chr12	19350324	.	G	C	.	PASS	CSQ=54477|protein_coding||intron_variant|||||||NM_001256470.1:c.3019+1805G>C||MODIFIER||||||PLEKHA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	93,95:189:0.5026
chr12	19396552	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	69,83:152:0.5461
chr12	19568065	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	93,57:150:0.38
chr12	19749411	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	135,14:149:0.094
chr12	20006055	.	ACAAT	A	.	PASS	CSQ=|||intergenic_variant||||||1.31425e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:108:0	112,30:142:0.2113
chr12	20086121	.	C	G	.	PASS	CSQ=100506393|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_040098.1:n.410-12631C>G||MODIFIER||||||LINC02398|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	90,78:168:0.4643
chr12	20378252	.	GA	G	.	PASS	CSQ=5139|protein_coding||intron_variant|||||||NM_000921.4:c.960+8013del||MODIFIER||||||PDE3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	68,70:138:0.5072
chr12	20444459	.	C	T	.	PASS	CSQ=5139|protein_coding||intron_variant||||rs1363851104||6.57168e-06|NM_000921.4:c.960+74215C>T||MODIFIER||||||PDE3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	80,64:144:0.4444
chr12	20542624	.	T	A	.	PASS	CSQ=5139|protein_coding||intron_variant|||||||NM_000921.4:c.961-14036T>A||MODIFIER||||||PDE3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	79,75:154:0.487
chr12	20677668	.	C	G	.	PASS	CSQ=5139|protein_coding||intron_variant|||||||NM_000921.4:c.3185-2362C>G||MODIFIER||||||PDE3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:102:0	53,83:136:0.6103
chr12	20678737	.	C	T	.	PASS	CSQ=5139|protein_coding||intron_variant||||rs193181751||0.000216888|NM_000921.4:c.3185-1293C>T||MODIFIER||||||PDE3A|EntrezGene|0.0006;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	73,79:152:0.5197
chr12	21051263	COSV67443762;COSV67443762;COSV67443762;COSV67443762;COSV67443762;COSV67443762;COSV67443762	C	T	.	PASS	CSQ=338821|protein_coding||intron_variant|COSV67443762&COSV67443762&COSV67443762|p.?&p.?&p.?|COSV67443762&COSV67443762&COSV67443762&COSV67443762|rs994085731||6.60467e-06|NM_001009562.4:c.1191-833C>T||MODIFIER||||||SLCO1B7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	65,66:131:0.5038
chr12	21117400	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	59,80:139:0.5755
chr12	21144744	.	G	C	.	PASS	CSQ=10599|protein_coding||intron_variant|||||||NM_006446.4:c.84+3086G>C||MODIFIER||||||SLCO1B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	140,6:146:0.0411
chr12	21171400	.	G	A	.	PASS	CSQ=10599|protein_coding||intron_variant|||||||NM_006446.4:c.85-1250G>A||MODIFIER||||||SLCO1B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	96,76:172:0.4419
chr12	21255071	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	71,53:124:0.4274
chr12	21367850	.	C	CA	.	PASS	CSQ=6579|protein_coding||intron_variant||||rs1353597085||6.59465e-06|NM_134431.3:c.-63+6548dup||MODIFIER||||||SLCO1A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	82,56:139:0.4029
chr12	21548817	.	C	T	.	PASS	CSQ=2998|protein_coding||intron_variant||||rs746130580||6.57592e-05|NM_021957.4:c.1423-2347G>A||MODIFIER||||||GYS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	74,89:163:0.546
chr12	21900695	.	GAGGAA	G	.	PASS	CSQ=10060|protein_coding||intron_variant|||||||NM_005691.3:c.1619-5385_1619-5381del||MODIFIER||||||ABCC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	73,60:133:0.4511
chr12	21944116	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	79,75:154:0.487
chr12	21948882	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	69,76:145:0.5241
chr12	22041929	.	G	C	.	PASS	CSQ=55907|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CMAS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	67,54:123:0.439
chr12	22317890	.	C	T	.	PASS	CSQ=6489|protein_coding||intron_variant|||||||NM_003034.3:c.236+16107G>A||MODIFIER||||||ST8SIA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	72,73:145:0.5034
chr12	22380997	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,80:160:0.5
chr12	22415498	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	69,69:138:0.5
chr12	22415500	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	66,69:135:0.5111
chr12	22527426	.	C	T	.	PASS	CSQ=9847|protein_coding||intron_variant|||||||NM_001286174.1:c.349+295G>A||MODIFIER||||||C2CD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	63,69:132:0.5227
chr12	22581453	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	136,11:147:0.0748
chr12	22781191	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	86,68:154:0.4416
chr12	23099027	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	69,79:148:0.5338
chr12	23249508	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs10842145|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,19:118:0.161	61,75:136:0.5515
chr12	23566350	.	C	T	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_006940.6:c.1343-2947G>A||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,102:182:0.5604
chr12	23588068	.	G	A	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_006940.6:c.1165-12230C>T||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	96,77:173:0.4451
chr12	23658689	COSV58650787;COSV58650787;COSV58650787;COSV58650787;COSV58650787;COSV58650787;COSV58650787	G	A	.	PASS	CSQ=6660|protein_coding||intron_variant|COSV58650787&COSV58650787&COSV58650787&COSV58650787&COSV58650787&COSV58650787&COSV58650787|p.?&p.?&p.?&p.?&p.?&p.?&p.?||rs566988014||4.60242e-05|NM_006940.6:c.931+6755C>T||MODIFIER||||||SOX5|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	80,77:157:0.4904
chr12	24002031	.	G	A	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_152989.4:c.-1-106007C>T||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	67,80:147:0.5442
chr12	24045999	.	C	T	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_152989.4:c.-1-149975G>A||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	84,73:157:0.465
chr12	24047790	.	AT	A	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_152989.4:c.-1-151767del||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	94,75:169:0.4438
chr12	24175325	.	C	A	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_152989.4:c.-2+101891G>T||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	72,72:144:0.5
chr12	24215594	.	T	A	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_152989.4:c.-2+61622A>T||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	68,97:165:0.5879
chr12	24325371	.	A	T	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_152989.4:c.-99+43192T>A||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	89,72:161:0.4472
chr12	24374154	.	GG	CA	.	PASS	CSQ=6660|protein_coding||intron_variant|||||||NM_152989.4:c.-175-5516_-175-5515delinsTG||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	117,0:117:0	91,66:157:0.4204
chr12	24398902	.	C	T	.	PASS	CSQ=6660|protein_coding||intron_variant||||rs1004621005||4.60217e-05|NM_152989.4:c.-176+8583G>A||MODIFIER||||||SOX5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	80,55:135:0.4074
chr12	24623544	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	63,74:137:0.5401
chr12	24654674	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1358243472|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	183,5:188:0.0266
chr12	24763309	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1023052749|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	157,84:241:0.3485
chr12	24812507	.	A	T	.	PASS	CSQ=586|protein_coding||3_prime_UTR_variant|||||||NM_005504.7:c.*5501T>A||MODIFIER||||||BCAT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	155,83:238:0.3487
chr12	24813761	.	G	T	.	PASS	CSQ=586|protein_coding||3_prime_UTR_variant|||||||NM_005504.7:c.*4247C>A||MODIFIER||||||BCAT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	169,81:250:0.324
chr12	24917823	.	C	T	.	PASS	CSQ=586|protein_coding||intron_variant|||||||NM_005504.7:c.7-15938G>A||MODIFIER||||||BCAT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	158,71:229:0.31
chr12	24963087	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1312299677||1.97267e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	88,175:263:0.6654
chr12	25034882	.	C	A	.	PASS	CSQ=645177|protein_coding||intron_variant|||||||NM_001321724.2:c.1717-771C>A||MODIFIER||||||LOC645177|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	81,156:237:0.6582
chr12	25245350	COSV55497419;COSV55497419;COSV55497419;COSV55497419	C	A	.	PASS	CSQ=3845|protein_coding|not_provided&likely_pathogenic&pathogenic|missense_variant|COSV55497419&COSV55497419&COSV55497419&COSV55497419|p.G12V&p.G12V&p.G12V&p.G12V||rs121913529&COSM1135366&COSM1140133&COSM1140134&COSM12657&COSM49168&COSM520&COSM521&COSM522|||NM_004985.4:c.35G>T|NP_004976.2:p.Gly12Val|MODERATE|D&.&D&.|T&T&T&T|D|D&D&D&D|D&D&D&D|KRAS|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/KRAS|y|n|pancreatic,colorectal,lung,thyroid,AML,other_tumour_types|||L,E,M,O|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:113:0	69,173:242:0.7149
chr12	25406888	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	171,81:252:0.3214
chr12	25519532	.	G	A	.	PASS	CSQ=160492|protein_coding||intron_variant||||rs1166294022||2.80454e-05|NM_152590.3:c.953+326C>T||MODIFIER||||||LMNTD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,1:134:0.0075	146,83:229:0.3624
chr12	25537650	.	C	T	.	PASS	CSQ=160492|protein_coding||intron_variant|||||||NM_152590.3:c.428+8724G>A||MODIFIER||||||LMNTD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	157,35:192:0.1823
chr12	25537651	.	TAAAAATCAGAGCGCCTCTCC	T	.	PASS	CSQ=160492|protein_coding||intron_variant|||||||NM_152590.3:c.428+8703_428+8722del||MODIFIER||||||LMNTD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	165,52:217:0.2396
chr12	25574486	.	C	A	.	PASS	CSQ=160492|protein_coding||intron_variant|||||||NM_001352232.1:c.-50+7936G>T||MODIFIER||||||LMNTD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	184,68:252:0.2698
chr12	25750501	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	145,65:210:0.3095
chr12	25960958	.	G	C	.	PASS	CSQ=100506451|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||RASSF8-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	155,82:237:0.346
chr12	26267527	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	192,96:288:0.3333
chr12	26521740	.	G	A	.	PASS	CSQ=3709|protein_coding||intron_variant|||||||NM_002223.4:c.5074-26480C>T||MODIFIER||||||ITPR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	180,102:282:0.3617
chr12	27247425	.	C	T	.	PASS	CSQ=23012|protein_coding||intron_variant|||||||NM_015000.4:c.-12+3093C>T||MODIFIER||||||STK38L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	86,91:177:0.5141
chr12	27299247	.	G	C	.	PASS	CSQ=23012|protein_coding||intron_variant|||||||NM_015000.4:c.134+1393G>C||MODIFIER||||||STK38L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	77,100:177:0.565
chr12	27779961	.	C	G	.	PASS	CSQ=57542|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||KLHL42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	85,76:161:0.472
chr12	27780207	.	C	T	.	PASS	CSQ=57542|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||KLHL42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	119,0:119:0	91,87:178:0.4888
chr12	27781235	.	C	G	.	PASS	CSQ=57542|protein_coding||intron_variant|||||||NM_020782.2:c.872+33C>G||MODIFIER||||||KLHL42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	95,93:188:0.4947
chr12	27781259	.	C	G	.	PASS	CSQ=57542|protein_coding||intron_variant|||||||NM_020782.2:c.872+57C>G||MODIFIER||||||KLHL42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	89,98:187:0.5241
chr12	27951319	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	91,68:159:0.4277
chr12	27999754	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	78,82:160:0.5125
chr12	28319912	.	C	A	.	PASS	CSQ=55297|protein_coding||intron_variant|||||||NM_001352081.1:c.576+12163C>A||MODIFIER||||||CCDC91|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	66,60:126:0.4762
chr12	28323012	.	C	A	.	PASS	CSQ=55297|protein_coding||intron_variant||||rs765104611||6.6424e-06|NM_001352081.1:c.576+15263C>A||MODIFIER||||||CCDC91|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	88,84:172:0.4884
chr12	28664100	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	82,86:168:0.5119
chr12	28701500	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	84,72:156:0.4615
chr12	28745940	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	67,90:157:0.5732
chr12	28784547	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	89,67:156:0.4295
chr12	29580604	.	C	T	.	PASS	CSQ=83857|protein_coding||intron_variant|||||||NM_001193451.2:c.1418+2803G>A||MODIFIER||||||TMTC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	93,70:163:0.4294
chr12	29652403	.	G	A	.	PASS	CSQ=83857|protein_coding||intron_variant|||||||NM_001193451.2:c.939-19067C>T||MODIFIER||||||TMTC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	77,89:166:0.5361
chr12	30185513	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1340335264||1.31427e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	71,70:141:0.4965
chr12	30317888	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs900891482||6.57601e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	61,72:133:0.5414
chr12	30335694	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs780207732||6.57125e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	77,67:144:0.4653
chr12	30346482	.	G	GC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	89,72:161:0.4472
chr12	31027224	.	G	A	.	PASS	CSQ=100506660|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038927.2:n.765-5195C>T||MODIFIER||||||DDX11-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	82,89:171:0.5205
chr12	31111602	.	C	G	.	PASS	CSQ=144203|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||OVOS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	67,85:152:0.5592
chr12	31814832	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57851e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	71,52:123:0.4228
chr12	33550063	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs996752370|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	83,94:177:0.5311
chr12	33609160	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57263e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	75,90:165:0.5455
chr12	33887410	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	116,38:154:0.2468
chr12	33968149	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	68,67:135:0.4963
chr12	34144466	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	110,37:147:0.2517
chr12	34192234	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1269757864||6.56901e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,68:137:0.4964
chr12	37301455	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	1,90:91:0.989
chr12	37469526	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	4,71:75:0.9467
chr12	37586126	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs369834017||0.143493|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,1:98:0.0102	11,40:51:0.7843
chr12	38315101	.	G	T	.	PASS	CSQ=144245|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ALG10B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,88:88:1
chr12	38886335	.	G	A	.	PASS	CSQ=144402|protein_coding||intron_variant||||rs1187862744||6.56961e-06|NM_153634.3:c.99-11824C>T||MODIFIER||||||CPNE8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	66,9:75:0.12
chr12	38966146	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,65:65:1
chr12	38985394	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	1,77:78:0.9872
chr12	39057571	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,48:48:1
chr12	40493871	.	G	A	.	PASS	CSQ=283463|protein_coding||intron_variant|||||||NM_173600.2:c.18353-76G>A||MODIFIER||||||MUC19|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	0,78:78:1
chr12	40511602	.	G	A	.	PASS	CSQ=283463|protein_coding||intron_variant|||||||NM_173600.2:c.19655-566G>A||MODIFIER||||||MUC19|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,90:90:1
chr12	40668214	.	ATTGCAGTGCAATAAATGCACTGAAGTGGGGAAGAGAAAGCTGCCCTTTTACCCCTCTTGTTGTGTCCTATGTAGC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=mantaSV	AD:DP:AF	169,0:169:0.0062	0,68:68:0.986
chr12	40843641	.	A	C	.	PASS	CSQ=1272|protein_coding||intron_variant|||||||NM_001843.4:c.-76-64716A>C||MODIFIER||||||CNTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,64:64:1
chr12	41039434	.	T	A	.	PASS	CSQ=1272|protein_coding||intron_variant|||||||NM_001843.4:c.2980+10215T>A||MODIFIER||||||CNTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,62:62:1
chr12	41039439	.	A	G	.	PASS	CSQ=1272|protein_coding||intron_variant|||||||NM_001843.4:c.2980+10220A>G||MODIFIER||||||CNTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,65:65:1
chr12	41112236	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	32,39:71:0.5493
chr12	41257256	.	T	C	.	PASS	CSQ=29951|protein_coding||intron_variant|||||||NM_001164595.1:c.843+63068T>C||MODIFIER||||||PDZRN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,72:72:1
chr12	41540398	.	G	T	.	PASS	CSQ=29951|protein_coding||intron_variant|||||||NM_001164595.1:c.1204-12258G>T||MODIFIER||||||PDZRN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	69,19:88:0.2159
chr12	42374872	.	A	G	.	PASS	CSQ=51535|protein_coding||synonymous_variant||||rs777838122|4.05085e-06||NM_201439.1:c.309A>G|NP_958847.1:p.Arg103=|LOW||||||PPHLN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	109,0:109:0	0,51:51:1
chr12	43120678	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,86:86:1
chr12	43210522	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,75:75:1
chr12	43464959	.	C	G	.	PASS	CSQ=80070|protein_coding||intron_variant|||||||NM_025003.4:c.1368-227G>C||MODIFIER||||||ADAMTS20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,79:79:1
chr12	43587870	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	109,0:109:0	72,14:86:0.1628
chr12	44261381	.	C	G	.	PASS	CSQ=84216|protein_coding||intron_variant|||||||NM_032256.3:c.609-38199C>G||MODIFIER||||||TMEM117|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	85,71:156:0.4551
chr12	44322330	.	G	T	.	PASS	CSQ=84216|protein_coding||intron_variant|||||||NM_032256.3:c.768+22591G>T||MODIFIER||||||TMEM117|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	76,64:140:0.4571
chr12	45190079	.	C	T	.	PASS	CSQ=51054|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_037144.1:n.68-13646G>A||MODIFIER||||||PLEKHA8P1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	75,0:75:0	0,53:53:1
chr12	45391514	.	CAATAAATGTTAAAGTCTTACTTTA	C	.	PASS	CSQ=196527|protein_coding||intron_variant|||||||NM_001025356.3:c.1386+1019_1386+1042del||MODIFIER||||||ANO6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	163,0:163:0	0,84:84:1
chr12	47038704	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1362740199||6.57376e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,1:88:0.0114	0,81:82:0.9878
chr12	47457590	.	CT	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	145,0:145:0	0,91:91:1
chr12	48075055	.	T	TA	.	PASS	CSQ=29843|protein_coding||intron_variant||||rs369422900||0.0957819|NM_001267594.2:c.553-263dup||MODIFIER||||||SENP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	11,60:72:0.8333
chr12	50643941	.	G	A	.	PASS	CSQ=57609|protein_coding||intron_variant|||||||NM_173602.3:c.301+3089G>A||MODIFIER||||||DIP2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,98:98:1
chr12	50963386	.	A	G	.	PASS	CSQ=613227|protein_coding||intron_variant||||rs1343871684||1.32401e-05|NM_001109619.2:c.229+2284A>G||MODIFIER||||||HIGD1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	3,68:72:0.9444
chr12	51079312	.	T	C	.	PASS	CSQ=81566|protein_coding||intron_variant|||||||NM_030809.2:c.-86-2665A>G||MODIFIER||||||CSRNP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,78:78:1
chr12	52402805	.	C	T	.	PASS	CSQ=3888|protein_coding||intron_variant|||||||NM_033033.3:c.620+896G>A||MODIFIER||||||KRT82|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,86:86:1
chr12	52442186	.	GG	TC	.	PASS	CSQ=3854|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||KRT6B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	132,0:132:0	0,83:83:1
chr12	52615832	.	G	A	.	PASS	CSQ=319101|protein_coding||intron_variant|||||||NM_175068.2:c.662+334C>T||MODIFIER||||||KRT73|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,91:91:1
chr12	52978897	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,69:69:1
chr12	53200310	.	C	A	.	PASS	CSQ=3695|protein_coding||missense_variant|||||||NM_000889.3:c.134G>T|NP_000880.1:p.Cys45Phe|MODERATE|D&D&.&.&.&.|D&D&D&D&D&D|D|D&D&D&.&.&.|D&D&.&D&D&D|ITGB7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	146,0:146:0	78,4:82:0.0488
chr12	54372726	.	G	A	.	PASS	CSQ=25946|protein_coding||intron_variant|||||||NM_015481.2:c.362-1011C>T||MODIFIER||||||ZNF385A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,82:82:1
chr12	54654747	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,73:73:1
chr12	55198138	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs369967371||0.000512868|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,80:81:0.9877
chr12	55264863	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1227031085||0.00422722|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	13,68:82:0.8293
chr12	55828593	.	G	C	.	PASS	CSQ=85406|protein_coding||synonymous_variant||||COSM293452|||NM_032364.5:c.66C>G|NP_115740.5:p.Leu22=|LOW||||||DNAJC14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:111:0	0,79:79:1
chr12	58283071	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1036576363||5.92526e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,93:93:1
chr12	58443302	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,68:68:1
chr12	58839643	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,81:81:1
chr12	58839972	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,66:66:1
chr12	59050281	.	T	TTC	.	PASS	CSQ=|||intergenic_variant||||rs775709705|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	40,27:69:0.3913
chr12	59074666	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,74:74:1
chr12	59297208	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,77:77:1
chr12	60411756	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,63:63:1
chr12	60691360	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1037354553||0.000160169|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	135,0:135:0	64,10:74:0.1351
chr12	60780767	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,79:79:1
chr12	60811620	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,58:58:1
chr12	61241265	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,63:63:1
chr12	61551816	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,73:73:1
chr12	61784957	.	G	T	.	PASS	CSQ=338811|protein_coding||intron_variant||||rs1471529719|||NM_178539.4:c.107-29933C>A||MODIFIER||||||FAM19A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	0,87:87:1
chr12	61948089	.	T	A	.	PASS	CSQ=338811|protein_coding||intron_variant|||||||NM_178539.4:c.-1-80663A>T||MODIFIER||||||FAM19A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,83:83:1
chr12	62440039	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	1,87:88:0.9886
chr12	63120522	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	6,88:94:0.9362
chr12	63122470	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	0,86:86:1
chr12	63983852	.	A	T	.	PASS	CSQ=57522|protein_coding||intron_variant||||rs1231501200||0.00850358|NM_020762.4:c.68-95A>T||MODIFIER||||||SRGAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	54,0:54:0	15,40:55:0.7273
chr12	64401875	.	C	A	.	PASS	CSQ=11260|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||XPOT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,85:85:1
chr12	64958458	.	AT	A	.	PASS	CSQ=109729131|lncRNA||intron_variant&non_coding_transcript_variant||||rs879704813||0.00011223|NR_146276.1:n.131-602del||MODIFIER||||||LINC02231|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	5,85:91:0.9341
chr12	64974227	.	G	A	.	PASS	CSQ=109729131|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146276.1:n.130+8181C>T||MODIFIER||||||LINC02231|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,87:87:1
chr12	65828627	.	C	T	.	PASS	CSQ=204010|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||RPSAP52|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	1,82:83:0.988
chr12	67207378	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	0,91:91:1
chr12	67365981	.	CTGT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	7,68:75:0.9067
chr12	67391949	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,72:72:1
chr12	67953002	.	C	A	.	PASS	CSQ=101927922|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120456.1:n.267-16810C>A||MODIFIER||||||LINC01479|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,88:88:1
chr12	68012731	.	A	G	.	PASS	CSQ=100885789|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104124.1:n.326-800A>G||MODIFIER||||||IFNG-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,89:89:1
chr12	68078085	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,92:92:1
chr12	68081851	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs920356712||6.63896e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,80:80:1
chr12	68247328	.	G	C	.	PASS	CSQ=50616|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||IL22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,81:81:1
chr12	68341270	.	A	C	.	PASS	CSQ=|||intergenic_variant||||||2.63835e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,74:74:1
chr12	69201083	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,74:74:1
chr12	70407742	.	C	A	.	PASS	CSQ=27345|protein_coding||intron_variant|||||||NM_014505.6:c.464+7406C>A||MODIFIER||||||KCNMB4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,85:85:1
chr12	70516787	.	G	C	.	PASS	CSQ=5787|protein_coding||3_prime_UTR_variant|||||||NM_001109754.3:c.*4702C>G||MODIFIER||||||PTPRB|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRB|y|n|angiosarcoma|||E|Rec|TSG|N,Mis,S,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	124,0:124:0	0,91:91:1
chr12	71001501	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,1:141:0.0071	0,80:80:1
chr12	71116410	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,67:67:1
chr12	71120033	.	CAAGCAAAAT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	36,0:36:0	7,29:36:0.8056
chr12	71479358	.	G	A	.	PASS	CSQ=8549|protein_coding||intron_variant||||rs992095725||0.000111705|NM_003667.4:c.213-25256G>A||MODIFIER||||||LGR5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,72:72:1
chr12	71518450	.	A	G	.	PASS	CSQ=8549|protein_coding||intron_variant|||||||NM_003667.4:c.285-5956A>G||MODIFIER||||||LGR5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	3,89:92:0.9674
chr12	71594588	.	GATCTC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,77:77:1
chr12	71819402	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||2.72257e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	1,95:96:0.9896
chr12	71965244	.	T	A	.	PASS	CSQ=121278|protein_coding||intron_variant|||||||NM_173353.4:c.609-7275T>A||MODIFIER||||||TPH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,81:81:1
chr12	71991213	.	C	T	.	PASS	CSQ=121278|protein_coding||intron_variant||||rs1225110012||2.62854e-05|NM_173353.4:c.942-3226C>T||MODIFIER||||||TPH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,67:67:1
chr12	72376876	.	T	A	.	PASS	CSQ=29953|protein_coding||intron_variant||||rs1028099272|||NM_013381.2:c.1054-1119T>A||MODIFIER||||||TRHDE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	12,61:73:0.8356
chr12	72898048	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,78:78:1
chr12	73250869	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,1:129:0.0078	0,63:63:1
chr12	73548152	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,77:77:1
chr12	73686737	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,80:80:1
chr12	74247234	.	C	T	.	PASS	CSQ=100507377|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038300.1:n.473+37791G>A||MODIFIER||||||LOC100507377|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,83:83:1
chr12	74288472	.	A	G	.	PASS	CSQ=100507377|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038300.1:n.318-2526T>C||MODIFIER||||||LOC100507377|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	77,11:88:0.125
chr12	74552402	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,59:59:1
chr12	74654661	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,68:68:1
chr12	74745717	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,77:77:1
chr12	74848880	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs970602550||0.000177746|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	3,72:75:0.96
chr12	74892217	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,75:75:1
chr12	75601212	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1327725005||6.57566e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,76:76:1
chr12	76433462	.	C	CA	.	PASS	CSQ=114882|protein_coding||intron_variant||||rs1029710604||0.000214732|NM_020841.5:c.217+17388dup||MODIFIER||||||OSBPL8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	7,72:80:0.9
chr12	76883706	.	CT	C	.	PASS	CSQ=1466|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CSRP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	4,62:66:0.9394
chr12	78062185	.	T	C	.	PASS	CSQ=89795|protein_coding||intron_variant|||||||NM_001024383.2:c.2636+3070T>C||MODIFIER||||||NAV3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	89,6:95:0.0632
chr12	78374180	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,74:74:1
chr12	78394181	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,78:78:1
chr12	78864249	.	C	A	.	PASS	CSQ=6857|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SYT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	108,0:108:0	0,75:75:1
chr12	78866063	.	G	A	.	PASS	CSQ=6857|protein_coding||intron_variant|||||||NM_005639.3:c.-217+954G>A||MODIFIER||||||SYT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,87:87:1
chr12	78940556	.	A	AT	.	PASS	CSQ=6857|protein_coding||intron_variant||||rs540879064||0.000537288|NM_005639.3:c.-216-37233dup||MODIFIER||||||SYT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	9,59:68:0.8676
chr12	78970472	.	G	A	.	PASS	CSQ=6857|protein_coding||intron_variant|||||||NM_005639.3:c.-216-7327G>A||MODIFIER||||||SYT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,60:60:1
chr12	80223443	.	C	T	.	PASS	CSQ=283310|protein_coding||intron_variant|||||||NM_173591.3:c.462+1198C>T||MODIFIER||||||OTOGL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,65:65:1
chr12	80262561	.	C	T	.	PASS	CSQ=283310|protein_coding||intron_variant||||||1.31567e-05|NM_173591.3:c.1987+468C>T||MODIFIER||||||OTOGL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,79:79:1
chr12	80454598	.	G	A	.	PASS	CSQ=374462|protein_coding||intron_variant||||rs1401984512|7.85139e-06||NM_001145026.2:c.391-2977G>A||MODIFIER||||||PTPRQ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,1:94:0.0106	0,60:60:1
chr12	80666817	.	A	G	.	PASS	CSQ=374462|protein_coding||intron_variant||||rs909082819||7.89567e-05|NM_001145026.2:c.6193-2190A>G||MODIFIER||||||PTPRQ|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,49:49:1
chr12	80807306	.	G	A	.	PASS	CSQ=8825|protein_coding||intron_variant|||||||NM_004664.3:c.*4159C>T||MODIFIER||||||LIN7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	72,5:77:0.0649
chr12	80961630	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,83:83:1
chr12	80977976	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,69:69:1
chr12	81739705	.	A	C	.	PASS	CSQ=8499|protein_coding||intron_variant|||||||NM_003625.4:c.249+14268T>G||MODIFIER||||||PPFIA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,72:72:1
chr12	81977320	.	TC	T	.	PASS	CSQ=101928449|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110089.1:n.671-15111del||MODIFIER||||||LINC02426|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,1:109:0.0092	2,85:87:0.977
chr12	81978904	.	T	A	.	PASS	CSQ=101928449|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110089.1:n.671-13528T>A||MODIFIER||||||LINC02426|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,1:117:0.0085	0,63:63:1
chr12	82540936	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,96:96:1
chr12	83374455	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs761082923|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,76:76:1
chr12	84337653	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,72:72:1
chr12	84355528	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	0,64:64:1
chr12	84695289	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1018509825||6.578e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	82,5:87:0.0575
chr12	84757068	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,50:50:1
chr12	85712728	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,87:87:1
chr12	86124273	.	T	C	.	PASS	CSQ=25834|protein_coding||intron_variant|||||||NM_001351286.1:c.-56-74550A>G||MODIFIER||||||MGAT4C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,80:80:1
chr12	86974279	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs570331433||1.97249e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,73:73:1
chr12	87020391	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,83:83:1
chr12	87725681	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,68:68:1
chr12	87893432	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,65:65:1
chr12	88891962	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,82:82:1
chr12	89966794	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1032871060||6.57117e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,87:87:1
chr12	90256559	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs992902674||1.31479e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,68:68:1
chr12	91227682	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,74:74:1
chr12	91249826	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,68:68:1
chr12	91438583	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs893745953||9.34579e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	6,56:62:0.9032
chr12	92202185	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	118,0:118:0	75,6:81:0.0741
chr12	93670514	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,75:75:1
chr12	93808496	.	G	T	.	PASS	CSQ=8738|protein_coding||intron_variant|||||||NM_003805.5:c.299-41474G>T||MODIFIER||||||CRADD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,64:64:1
chr12	94501641	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,89:89:1
chr12	94590598	.	T	G	.	PASS	CSQ=57458|protein_coding||intron_variant|||||||NM_020698.4:c.79-8060A>C||MODIFIER||||||TMCC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,78:78:1
chr12	94785406	.	AAATATTCATGTCC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	70,6:76:0.0789
chr12	95288777	.	ATT	A	.	PASS	CSQ=55591|protein_coding||intron_variant|||||||NM_017599.4:c.1522+925_1522+926del||MODIFIER||||||VEZT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	1,97:98:0.9898
chr12	96725561	.	T	C	.	PASS	CSQ=144535|protein_coding||intron_variant|||||||NM_001306084.2:c.6965+4996T>C||MODIFIER||||||CFAP54|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	2,71:73:0.9726
chr12	97573498	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,85:85:1
chr12	97653488	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	31,30:61:0.4918
chr12	98093821	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1403593293||1.97099e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,76:76:1
chr12	98297873	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,73:73:1
chr12	99120112	.	AG	TT	.	PASS	CSQ=56899|protein_coding||intron_variant|||||||NM_001352187.1:c.2526+34176_2526+34177delinsAA||MODIFIER||||||ANKS1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	99,0:99:0	0,84:84:1
chr12	99153214	.	C	G	.	PASS	CSQ=56899|protein_coding||intron_variant|||||||NM_001352187.1:c.2526+1075G>C||MODIFIER||||||ANKS1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,81:81:1
chr12	99296787	.	G	A	.	PASS	CSQ=56899|protein_coding||intron_variant||||rs562135075||0.00155911|NM_001352187.1:c.1757-49923C>T||MODIFIER||||||ANKS1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,61:61:1
chr12	99340817	.	G	T	.	PASS	CSQ=56899|protein_coding||intron_variant|||||||NM_001352187.1:c.1756+58814C>A||MODIFIER||||||ANKS1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	85,7:92:0.0761
chr12	99601716	.	GA	G	.	PASS	CSQ=56899|protein_coding||intron_variant|||||||NM_001352187.1:c.1272+53350del||MODIFIER||||||ANKS1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	5,68:73:0.9315
chr12	99995844	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:110:0	0,79:80:0.9875
chr12	100716740	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	1,82:83:0.988
chr12	100808200	.	T	C	.	PASS	CSQ=121601|protein_coding||intron_variant|||||||NM_001286615.2:c.-141+13173T>C||MODIFIER||||||ANO4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,66:66:1
chr12	101605034	.	G	C	.	PASS	CSQ=4604|protein_coding||intron_variant|||||||NM_002465.3:c.26-9462G>C||MODIFIER||||||MYBPC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,66:66:1
chr12	101688406	.	G	A	.	PASS	CSQ=4604|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MYBPC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:130:0	0,64:64:1
chr12	102651371	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs922671428||0.000105309|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	8,67:75:0.8933
chr12	102786092	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,89:89:1
chr12	102803668	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||6.58146e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,79:79:1
chr12	103038927	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,81:81:1
chr12	103388420	.	G	A	.	PASS	CSQ=374470|protein_coding||intron_variant||||rs879523952||0.000124939|NM_001099336.2:c.147+13187C>T||MODIFIER||||||C12orf42|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,1:126:0.0079	0,87:87:1
chr12	104158627	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,84:84:1
chr12	105115502	.	G	T	.	PASS	CSQ=23325|protein_coding||intron_variant|||||||NM_015275.2:c.368-159G>T||MODIFIER||||||WASHC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,97:97:1
chr12	105571235	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:149:0	0,85:85:1
chr12	107324077	.	G	C	.	PASS	CSQ=121551|protein_coding||intron_variant|||||||NM_001018072.2:c.1135+4002G>C||MODIFIER||||||BTBD11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,88:88:1
chr12	107493030	.	C	T	.	PASS	CSQ=121551|protein_coding||intron_variant||||rs1353168615|||NM_001018072.2:c.1136-27457C>T||MODIFIER||||||BTBD11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	117,0:117:0	82,10:92:0.1087
chr12	108064262	.	GG	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	125,0:126:0	0,79:79:1
chr12	108647393	.	G	A	.	PASS	CSQ=23603|protein_coding||3_prime_UTR_variant|||||||NM_014325.3:c.*10C>T||MODIFIER||||||CORO1C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	96,0:96:0	0,75:75:1
chr12	108881605	.	T	TTC	.	PASS	CSQ=1610|protein_coding||intron_variant||||rs1312609427||0.00523512|NM_001917.5:c.-10+1382_-10+1383insCT||MODIFIER||||||DAO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,2:114:0.0175	23,48:74:0.6486
chr12	108946418	.	AT	A	.	PASS	CSQ=55530|protein_coding||intron_variant|||||||NM_018711.4:c.579-1253del||MODIFIER||||||SVOP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	78,7:85:0.0824
chr12	109007898	.	C	T	.	PASS	CSQ=55530|protein_coding||intron_variant||||rs1050621077||6.57999e-06|NM_018711.4:c.35+12936G>A||MODIFIER||||||SVOP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,89:89:1
chr12	109049005	.	G	A	.	PASS	CSQ=84749|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||USP30|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,83:83:1
chr12	110693419	.	C	T	.	PASS	CSQ=84329|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||HVCN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	1,62:63:0.9841
chr12	110905451	.	C	G	.	PASS	CSQ=160762|protein_coding||intron_variant||||rs980814842||1.31499e-05|NM_152591.2:c.1546+660C>G||MODIFIER||||||CCDC63|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,85:85:1
chr12	111020865	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,90:90:1
chr12	112059312	.	A	T	.	PASS	CSQ=80018|protein_coding||intron_variant|||||||NM_024953.4:c.1447+958T>A||MODIFIER||||||NAA25|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	0,76:76:1
chr12	112124228	.	G	C	.	PASS	CSQ=10906|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TRAFD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,80:80:1
chr12	112988176	.	C	T	.	PASS	CSQ=4939|protein_coding||intron_variant|||||||NM_002535.2:c.448+868C>T||MODIFIER||||||OAS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	135,0:135:0	0,66:66:1
chr12	113050771	.	T	TCCGCACCCCC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,72:72:1
chr12	113577859	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,67:67:1
chr12	113579921	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	79,4:83:0.0482
chr12	113734607	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs748503645||0.000197138|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,101:101:1
chr12	114087026	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,80:80:1
chr12	114298927	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,78:78:1
chr12	114324073	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,82:82:1
chr12	114516281	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,70:70:1
chr12	114894385	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs981647065||3.957e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	5,62:67:0.9254
chr12	115132285	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1173443524||6.57523e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,1:112:0.0089	0,69:69:1
chr12	115961996	.	G	C	.	PASS	CSQ=23389|protein_coding||intron_variant|||||||NM_015335.4:c.6501-598C>G||MODIFIER||||||MED13L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,89:89:1
chr12	116044558	.	A	C	.	PASS	CSQ=23389|protein_coding||intron_variant|||||||NM_015335.4:c.480-21957T>G||MODIFIER||||||MED13L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,75:75:1
chr12	116124593	.	C	T	.	PASS	CSQ=23389|protein_coding||intron_variant|||||||NM_015335.4:c.311-13081G>A||MODIFIER||||||MED13L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	90,7:97:0.0722
chr12	116294947	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1230524868||6.57013e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,87:87:1
chr12	116540334	.	C	T	.	PASS	CSQ=100287569|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00173|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	67,5:72:0.0694
chr12	117237377	.	C	T	.	PASS	CSQ=4842|protein_coding||intron_variant||||rs984599153||6.59204e-06|NM_000620.5:c.3042-2619G>A||MODIFIER||||||NOS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,69:69:1
chr12	117356615	.	C	T	.	PASS	CSQ=4842|protein_coding||intron_variant||||rs930357847||2.62733e-05|NM_000620.5:c.-421+4897G>A||MODIFIER||||||NOS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,83:83:1
chr12	117715781	.	C	A	.	PASS	CSQ=283455|protein_coding||intron_variant|||||||NM_173598.5:c.986+45230G>T||MODIFIER||||||KSR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,87:87:1
chr12	117819459	.	G	A	.	PASS	CSQ=283455|protein_coding||intron_variant|||||||NM_173598.5:c.472+35969C>T||MODIFIER||||||KSR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,84:84:1
chr12	117819498	.	G	C	.	PASS	CSQ=283455|protein_coding||intron_variant|||||||NM_173598.5:c.472+35930C>G||MODIFIER||||||KSR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,78:78:1
chr12	118365520	.	T	A	.	PASS	CSQ=51347|protein_coding||intron_variant|||||||NM_016281.4:c.-194+7128A>T||MODIFIER||||||TAOK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,99:99:1
chr12	118564744	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,74:74:1
chr12	119126275	.	C	T	.	PASS	CSQ=84530|protein_coding||intron_variant||||rs567783254||6.57929e-06|NM_194286.4:c.614+796C>T||MODIFIER||||||SRRM4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,71:71:1
chr12	119736604	.	G	A	.	PASS	CSQ=11113|protein_coding||intron_variant|||||||NM_001206999.2:c.2959-1247C>T||MODIFIER||||||CIT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,80:80:1
chr12	120336731	.	C	T	.	PASS	CSQ=4440|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MSI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,75:75:1
chr12	120778137	.	G	C	.	PASS	CSQ=121665|protein_coding||intron_variant|||||||NM_139015.5:c.502+4518C>G||MODIFIER||||||SPPL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	65,0:65:0	0,47:48:0.9792
chr12	120779224	.	G	C	.	PASS	CSQ=121665|protein_coding||intron_variant||||||6.57004e-06|NM_139015.5:c.502+3431C>G||MODIFIER||||||SPPL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,67:67:1
chr12	121804519	.	G	A	.	PASS	CSQ=338799|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01089|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,70:71:0.9859
chr12	122908107	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,59:59:1
chr12	122981740	.	G	C	.	PASS	CSQ=79676|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||OGFOD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	0,105:105:1
chr12	124109056	.	G	A	.	PASS	CSQ=100533183|protein_coding||intron_variant|||||||NM_001204299.2:c.-233-40539G>A||MODIFIER||||||ZNF664-RFLNA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,77:77:1
chr12	124282247	.	G	A	.	PASS	CSQ=100533183|protein_coding||intron_variant|||||||NM_001204299.2:c.-36-29571G>A||MODIFIER||||||ZNF664-RFLNA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,82:82:1
chr12	125464810	.	T	G	.	PASS	CSQ=114795|protein_coding||intron_variant|||||||NM_001366854.1:c.1106+49133T>G||MODIFIER||||||TMEM132B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	62,4:66:0.0606
chr12	125854874	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1051481531||6.5838e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	47,9:56:0.1607
chr12	125941005	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,70:70:1
chr12	126381783	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,76:76:1
chr12	126386842	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,76:76:1
chr12	126473305	.	C	A	.	PASS	CSQ=100128554|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC02347|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	51,9:60:0.15
chr12	127308396	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	7,56:63:0.8889
chr12	127427116	.	CT	C	.	PASS	CSQ=|||intergenic_variant||||rs1174628303||3.29047e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	6,71:77:0.9221
chr12	127478597	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1298850518||6.59578e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,66:66:1
chr12	127643815	.	A	ATTTTTTT	.	PASS	CSQ=|||intergenic_variant||||rs368643541||0.0212874|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	13,0:82:0	13,37:52:0.7115
chr12	127842434	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1397849398||0.00231776|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	10,40:50:0.8
chr12	127898440	.	G	T	.	PASS	CSQ=104472718|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126452.2:n.312-13335C>A||MODIFIER||||||LINC00508|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	0,59:59:1
chr12	128049640	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,71:71:1
chr12	128099030	.	GG	AT	.	PASS	CSQ=100996679|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104647.1:n.253-11175_253-11174delinsAT||MODIFIER||||||LINC02369|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	105,0:105:0	0,61:66:0.9242
chr12	128154145	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,66:66:1
chr12	128159869	.	C	CTATA	.	PASS	CSQ=|||intergenic_variant||||rs1265542692||0.0378392|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,1:84:0.0119	68,35:104:0.3365
chr12	128273326	.	C	A	.	PASS	CSQ=92293|protein_coding||intron_variant|||||||NM_001136103.2:c.85+5839C>A||MODIFIER||||||TMEM132C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	130,13:143:0.0909
chr12	128342170	.	G	T	.	PASS	CSQ=92293|protein_coding||intron_variant|||||||NM_001136103.2:c.86-72562G>T||MODIFIER||||||TMEM132C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	6,63:69:0.913
chr12	128540736	.	G	A	.	PASS	CSQ=92293|protein_coding||intron_variant|||||||NM_001136103.2:c.975-3221G>A||MODIFIER||||||TMEM132C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,74:75:0.9867
chr12	128829271	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,79:79:1
chr12	128853235	.	T	G	.	PASS	CSQ=144423|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GLT1D1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,83:83:1
chr12	128899551	.	T	G	.	PASS	CSQ=144423|protein_coding||intron_variant||||rs60243683||0.00131998|NM_144669.3:c.375+264T>G||MODIFIER||||||GLT1D1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	32,33:65:0.5077
chr12	128947937	.	C	T	.	PASS	CSQ=144423|protein_coding||intron_variant|||||||NM_144669.3:c.540+479C>T||MODIFIER||||||GLT1D1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	0,69:69:1
chr12	129042517	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1250789106||6.57376e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,59:59:1
chr12	129150399	.	T	C	.	PASS	CSQ=121256|protein_coding||intron_variant|||||||NM_133448.3:c.1443+59121A>G||MODIFIER||||||TMEM132D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	159,0:159:0	0,93:93:1
chr12	129150468	.	T	C	.	PASS	CSQ=121256|protein_coding||intron_variant||||||6.57013e-06|NM_133448.3:c.1443+59052A>G||MODIFIER||||||TMEM132D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,73:73:1
chr12	129179318	.	C	CT	.	PASS	CSQ=121256|protein_coding||intron_variant||||rs113121442||0.000194493|NM_133448.3:c.1443+30201dup||MODIFIER||||||TMEM132D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:100:0	17,45:65:0.6923
chr12	129199600	.	G	A	.	PASS	CSQ=121256|protein_coding||intron_variant|||||||NM_133448.3:c.1443+9920C>T||MODIFIER||||||TMEM132D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	0,82:82:1
chr12	130142588	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,65:65:1
chr12	130307806	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,82:82:1
chr12	130499637	.	C	G	.	PASS	CSQ=23504|protein_coding||intron_variant|||||||NM_001351226.1:c.-4+7011G>C||MODIFIER||||||RIMBP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,54:54:1
chr12	130670123	.	G	A	.	PASS	CSQ=23504|protein_coding||intron_variant|||||||NM_001351226.1:c.-351-41667C>T||MODIFIER||||||RIMBP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,86:86:1
chr12	131002423	.	CC	TT	.	PASS	CSQ=283383|protein_coding||intron_variant|||||||NM_198827.5:c.1027-762_1027-761delinsTT||MODIFIER||||||ADGRD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	116,0:116:0	0,72:72:1
chr12	131097436	.	A	T	.	PASS	CSQ=283383|protein_coding||intron_variant|||||||NM_198827.5:c.1672-7395A>T||MODIFIER||||||ADGRD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,85:85:1
chr12	131697827	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,75:75:1
chr12	133243206	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	66,7:73:0.0959
chr13	17034509	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1189399678|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	45,0:45:0	23,27:50:0.54
chr13	18241923	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	66,0:66:0	0,75:75:1
chr13	18562811	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	105,0:105:0	61,61:122:0.5
chr13	18640455	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs563127548||0.000138094|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	67,69:136:0.5074
chr13	18745440	.	CTATTCCCTGGCCTCCTCCATCCTGTGCAGCCCA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	142,0:142:0	90,61:151:0.404
chr13	18827457	.	A	T	.	PASS	CSQ=284232|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_138091.1:n.2227-662T>A||MODIFIER||||||ANKRD20A9P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	91,74:165:0.4485
chr13	18893748	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	87,74:161:0.4596
chr13	19097663	.	C	T	.	PASS	CSQ=107984132|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146902.1:n.501-8357G>A||MODIFIER||||||LOC107984132|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	72,61:133:0.4586
chr13	19119824	COSV56121529	C	T	.	PASS	CSQ=107984132|lncRNA||upstream_gene_variant|||COSV56121529|rs1004790476||2.13554e-05|||MODIFIER||||||LOC107984132|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	72,49:121:0.405
chr13	19473739	.	G	T	.	PASS	CSQ=93492|protein_coding||intron_variant|||||||NM_199254.2:c.392+175C>A||MODIFIER||||||TPTE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	71,85:156:0.5449
chr13	19484957	.	G	T	.	PASS	CSQ=93492|protein_coding||intron_variant||||rs1165067245|||NM_199254.2:c.120-2410C>A||MODIFIER||||||TPTE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	93,69:162:0.4259
chr13	19920667	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1401107224||6.57981e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	76,92:168:0.5476
chr13	19937149	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	90,92:182:0.5055
chr13	19937530	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1387295537||1.37502e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	99,0:99:0	74,70:145:0.4828
chr13	19937532	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	103,0:103:0	75,66:141:0.4681
chr13	19937539	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	106,1:108:0.0093	78,64:142:0.4507
chr13	20214785	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	181,6:187:0.0321
chr13	20450082	.	G	GA	.	PASS	CSQ=51084|protein_coding||intron_variant|||||||NM_015974.3:c.277-10329dup||MODIFIER||||||CRYL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	91,77:168:0.4583
chr13	21092538	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs939437225|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	88,69:157:0.4395
chr13	22235348	.	C	T	.	PASS	CSQ=100506622|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_103810.1:n.144+24920C>T||MODIFIER||||||LINC00540|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	57,79:136:0.5809
chr13	22383374	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1456616089||1.97246e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	82,67:149:0.4497
chr13	22620410	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	64,79:143:0.5524
chr13	22704226	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs532697144||0.000144645|||MODIFIER||||||||0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,1:111:0.009	68,63:131:0.4809
chr13	22894858	.	C	A	.	PASS	CSQ=646201|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||BASP1P1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	83,85:168:0.506
chr13	22948992	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1053545608||2.62874e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	90,90:180:0.5
chr13	22998442	.	G	GAA	.	PASS	CSQ=|||intergenic_variant||||rs71719556||6.60162e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	57,0:101:0	76,75:152:0.4934
chr13	23205257	.	T	C	.	PASS	CSQ=6445|protein_coding||intron_variant|||||||NM_000231.2:c.195+1368T>C||MODIFIER||||||SGCG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	83,81:164:0.4939
chr13	23490630	.	A	T	.	PASS	CSQ=100506697|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00327|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	75,86:161:0.5342
chr13	23656419	.	A	C	.	PASS	CSQ=55504|protein_coding||intron_variant|||||||NM_148957.3:c.446-2631A>C||MODIFIER||||||TNFRSF19|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	64,80:144:0.5556
chr13	23755837	.	C	T	.	PASS	CSQ=4285|protein_coding||intron_variant|||||||NM_005932.4:c.2044+708G>A||MODIFIER||||||MIPEP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	96,88:184:0.4783
chr13	23763737	.	T	C	.	PASS	CSQ=4285|protein_coding||intron_variant|||||||NM_005932.4:c.1849-3520A>G||MODIFIER||||||MIPEP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	84,86:170:0.5059
chr13	24490058	.	C	T	.	PASS	CSQ=143|protein_coding||intron_variant|||||||NM_006437.4:c.1214+610G>A||MODIFIER||||||PARP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	77,62:139:0.446
chr13	24792533	.	C	G	.	PASS	CSQ=56163|protein_coding||intron_variant|||||||NM_031277.3:c.936-509C>G||MODIFIER||||||RNF17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	87,86:173:0.4971
chr13	25120874	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	67,86:153:0.5621
chr13	25337097	.	T	TA	.	PASS	CSQ=9818|protein_coding||intron_variant|||||||NM_014089.4:c.1534+72dup||MODIFIER||||||NUP58|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	81,57:138:0.413
chr13	25589600	.	GA	G	.	PASS	CSQ=51761|protein_coding||intron_variant|||||||NM_016529.6:c.2147-34del||MODIFIER||||||ATP8A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	101,0:101:0	85,75:160:0.4688
chr13	25966342	.	G	C	.	PASS	CSQ=51761|protein_coding||intron_variant|||||||NM_016529.6:c.3273-2233G>C||MODIFIER||||||ATP8A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	83,93:176:0.5284
chr13	26174496	.	C	CA	.	PASS	CSQ=6049|protein_coding||intron_variant||||rs3981341||0.0124516|NM_183045.1:c.408+40977dup||MODIFIER||||||RNF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	90,68:159:0.4277
chr13	26322250	.	A	T	.	PASS	CSQ=1024|protein_coding||intron_variant||||rs1338003031|||NM_001260.3:c.129-15317A>T||MODIFIER||||||CDK8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	140,28:169:0.1657
chr13	26480315	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	78,100:178:0.5618
chr13	26504405	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	70,65:135:0.4815
chr13	26583426	.	T	A	.	PASS	CSQ=10810|protein_coding||intron_variant|||||||NM_006646.5:c.-109+25607T>A||MODIFIER||||||WASF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	151,6:157:0.0382
chr13	26967300	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	99,93:192:0.4844
chr13	27950722	.	C	T	.	PASS	CSQ=100132234|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC00543|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	69,69:138:0.5
chr13	28047452	.	G	A	.	PASS	CSQ=2322|protein_coding||intron_variant|||||||NM_004119.2:c.1205+823C>T||MODIFIER||||||FLT3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/FLT3|y|n|AML,ALL|||L|Dom|oncogene|Mis,O;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	69,63:132:0.4773
chr13	28790833	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	146,8:154:0.0519
chr13	28980636	.	C	T	.	PASS	CSQ=23281|protein_coding||intron_variant||||||6.57333e-06|NM_001366650.1:c.-242-43821C>T||MODIFIER||||||MTUS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	69,75:144:0.5208
chr13	29004007	.	G	A	.	PASS	CSQ=23281|protein_coding||intron_variant|||||||NM_001366650.1:c.-242-20450G>A||MODIFIER||||||MTUS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	102,78:180:0.4333
chr13	29024980	.	C	T	.	PASS	CSQ=23281|protein_coding||synonymous_variant|||||||NM_001033602.3:c.282C>T|NP_001028774.3:p.Ser94=|LOW||||||MTUS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	97,0:97:0	62,61:123:0.4959
chr13	29446244	.	G	T	.	PASS	CSQ=23281|protein_coding||intron_variant|||||||NM_001033602.3:c.3184+6195G>T||MODIFIER||||||MTUS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	73,69:142:0.4859
chr13	29948843	.	C	T	.	PASS	CSQ=440131|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033889.1:n.524+1072C>T||MODIFIER||||||LINC00544|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	65,70:135:0.5185
chr13	29948852	.	A	T	.	PASS	CSQ=440131|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033889.1:n.524+1081A>T||MODIFIER||||||LINC00544|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	64,69:133:0.5188
chr13	30397095	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	64,81:145:0.5586
chr13	30492165	.	T	TA	.	PASS	CSQ=3146|protein_coding||intron_variant||||rs1310850250||0.00386478|NM_001313893.1:c.-14-28472dup||MODIFIER||||||HMGB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	91,57:150:0.38
chr13	30758008	.	C	A	.	PASS	CSQ=241|protein_coding||intron_variant|||||||NM_001629.3:c.323+1983C>A||MODIFIER||||||ALOX5AP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	78,84:163:0.5153
chr13	30785219	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1203925114||0.000267083|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	104,59:164:0.3598
chr13	30873957	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	94,93:187:0.4973
chr13	30911764	.	G	A	.	PASS	CSQ=100507064|lncRNA||intron_variant&non_coding_transcript_variant||||rs748579397||6.57523e-06|NR_038287.1:n.1437+19037C>T||MODIFIER||||||TEX26-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	59,80:139:0.5755
chr13	30930954	.	A	G	.	PASS	CSQ=122046|protein_coding||upstream_gene_variant||||rs1237661998||6.56961e-06|||MODIFIER||||||TEX26|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	158,8:166:0.0482
chr13	31064329	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	158,7:165:0.0424
chr13	31117610	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||6.57082e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	70,64:134:0.4776
chr13	31117612	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs919225640||4.59921e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	70,64:134:0.4776
chr13	31150080	.	TG	AT	.	PASS	CSQ=10808|protein_coding||missense_variant|||||||NM_006644.3:c.1010_1011delinsAT|NP_006635.2:p.Ala337Asp|MODERATE||||||HSPH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2,lancet;num_callers=2;supported_by=strelka2_SNVs	AD:DP:AF	127,0:127:0	68,72:141:0.5106
chr13	31433581	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	69,62:131:0.4733
chr13	31445287	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	94,68:162:0.4198
chr13	31535695	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs1333756813||0.000111697|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	79,74:153:0.4837
chr13	31960345	.	G	A	.	PASS	CSQ=196549|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||EEF1DP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	79,75:154:0.487
chr13	32043182	.	G	A	.	PASS	CSQ=10129|protein_coding||intron_variant||||rs942874240||1.31442e-05|NM_023037.2:c.70+11317G>A||MODIFIER||||||FRY|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	61,73:134:0.5448
chr13	32808223	.	C	T	.	PASS	CSQ=100874167|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00423|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	81,71:152:0.4671
chr13	33116006	.	TG	T	.	PASS	CSQ=90627|protein_coding||intron_variant|||||||NM_178006.4:c.2281+2058del||MODIFIER||||||STARD13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	76,68:144:0.4722
chr13	33596014	.	C	T	.	PASS	CSQ=90627|protein_coding||intron_variant|||||||NM_001243476.2:c.-106+65263G>A||MODIFIER||||||STARD13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	86,79:165:0.4788
chr13	33618674	.	A	C	.	PASS	CSQ=90627|protein_coding||intron_variant|||||||NM_001243476.2:c.-106+42603T>G||MODIFIER||||||STARD13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	143,10:153:0.0654
chr13	33751527	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	74,76:150:0.5067
chr13	33899446	.	A	T	.	PASS	CSQ=5983|protein_coding||intron_variant|||||||NM_181558.2:c.879+64229A>T||MODIFIER||||||RFC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	77,63:140:0.45
chr13	34045824	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	123,51:174:0.2931
chr13	34049287	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1374535001|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	101,35:136:0.2574
chr13	34062897	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	71,75:147:0.5102
chr13	34141843	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	90,88:178:0.4944
chr13	34388892	.	C	G	.	PASS	CSQ=105370158|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146542.1:n.83-40575C>G||MODIFIER||||||LINC02343|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	68,70:138:0.5072
chr13	35469990	.	AGT	A	.	PASS	CSQ=4081|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MAB21L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	77,89:166:0.5361
chr13	35621860	.	C	T	.	PASS	CSQ=26960|protein_coding||intron_variant|||||||NM_015678.4:c.7450-6221C>T||MODIFIER||||||NBEA|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/NBEA|y|n|large_intestine_carcinoma,multiple_myeloma|||E,L|||F,T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	97,84:181:0.4641
chr13	35911700	.	G	A	.	PASS	CSQ=9201|protein_coding||intron_variant|||||||NM_001330071.1:c.823+35658C>T||MODIFIER||||||DCLK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	85,83:168:0.494
chr13	35987438	.	G	A	.	PASS	CSQ=9201|protein_coding||intron_variant||||rs902310164||1.97283e-05|NM_001330071.1:c.724-39981C>T||MODIFIER||||||DCLK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	59,69:128:0.5391
chr13	36079098	.	A	T	.	PASS	CSQ=9201|protein_coding||intron_variant|||||||NM_001330071.1:c.723+32771T>A||MODIFIER||||||DCLK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	116,35:151:0.2318
chr13	36426834	.	G	A	.	PASS	CSQ=8900|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CCNA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	76,73:149:0.4899
chr13	36966498	.	C	T	.	PASS	CSQ=29880|protein_coding||intron_variant|||||||NM_013338.5:c.622-772G>A||MODIFIER||||||ALG5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	86,77:163:0.4724
chr13	37051741	.	C	A	.	PASS	CSQ=55578|protein_coding||intron_variant||||rs1269326298||6.57618e-06|NM_001014286.3:c.-93-158G>T||MODIFIER||||||SUPT20H|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	74,65:139:0.4676
chr13	37312951	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	76,71:147:0.483
chr13	37658053	.	C	T	.	PASS	CSQ=7223|protein_coding||intron_variant||||rs1396214101|||NM_016179.3:c.1689-2770G>A||MODIFIER||||||TRPC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	80,77:157:0.4904
chr13	37720327	.	G	A	.	PASS	CSQ=7223|protein_coding||intron_variant||||||6.57523e-06|NM_016179.3:c.897+25610C>T||MODIFIER||||||TRPC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	73,56:129:0.4341
chr13	37848545	.	A	C	.	PASS	CSQ=7223|protein_coding||intron_variant|||||||NM_016179.3:c.-28+21050T>G||MODIFIER||||||TRPC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	72,76:148:0.5135
chr13	37862513	.	C	T	.	PASS	CSQ=7223|protein_coding||intron_variant|||||||NM_016179.3:c.-28+7082G>A||MODIFIER||||||TRPC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	52,68:120:0.5667
chr13	39028886	.	C	T	.	PASS	CSQ=80209|protein_coding||intron_variant|||||||NM_025138.5:c.275+395G>A||MODIFIER||||||PROSER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	67,61:128:0.4766
chr13	39045157	.	G	A	.	PASS	CSQ=387921|protein_coding||intron_variant|||||||NM_001012754.4:c.678+976G>A||MODIFIER||||||NHLRC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	68,79:147:0.5374
chr13	39126350	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	79,74:153:0.4837
chr13	39226270	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	96,84:180:0.4667
chr13	39457706	.	G	A	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.386-79180C>T||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	95,79:174:0.454
chr13	39534827	.	C	T	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+66005G>A||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	71,73:144:0.5069
chr13	39534854	.	C	T	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+65978G>A||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:133:0	71,76:147:0.517
chr13	39534992	.	C	T	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+65840G>A||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	65,83:148:0.5608
chr13	39535781	.	C	T	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+65051G>A||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	68,77:145:0.531
chr13	39535798	.	C	G	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+65034G>C||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	73,81:154:0.526
chr13	39536041	.	C	T	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+64791G>A||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	75,81:156:0.5192
chr13	39538573	.	G	C	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+62259C>G||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	75,70:145:0.4828
chr13	39538611	.	G	A	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+62221C>T||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	77,81:158:0.5127
chr13	39539075	.	G	A	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+61757C>T||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	71,84:155:0.5419
chr13	39539725	.	G	A	.	PASS	CSQ=10186|protein_coding||intron_variant||||rs936921950||1.97163e-05|NM_005780.3:c.385+61107C>T||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	53,65:118:0.5508
chr13	39540139	.	G	T	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+60693C>A||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	75,87:162:0.537
chr13	39541909	.	G	A	.	PASS	CSQ=10186|protein_coding||intron_variant||||rs923163529|||NM_005780.3:c.385+58923C>T||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	48,72:120:0.6
chr13	39542305	.	G	A	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+58527C>T||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	65,69:134:0.5149
chr13	39544242	.	G	T	.	PASS	CSQ=10186|protein_coding||intron_variant|||||||NM_005780.3:c.385+56590C>A||MODIFIER||||||LHFPL6|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LHFPL6|y|n|lipoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	78,75:153:0.4902
chr13	39692190	.	G	A	.	PASS	CSQ=57511|protein_coding||intron_variant||||rs1450513866|||NM_020751.3:c.1074+2366G>A||MODIFIER||||||COG6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,69:135:0.5111
chr13	40022725	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	80,77:157:0.4904
chr13	40937467	.	G	A	.	PASS	CSQ=1997|protein_coding||intron_variant|||||||NM_172373.4:c.1257-3439C>T||MODIFIER||||||ELF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	68,88:156:0.5641
chr13	41071559	.	G	T	.	PASS	CSQ=11193|protein_coding||stop_gained|||||||NM_007187.5:c.472G>T|NP_009118.1:p.Gly158Ter|HIGH|||D|||WBP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	93,0:93:0	89,88:177:0.4972
chr13	41179532	.	T	G	.	PASS	CSQ=101929140|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120423.1:n.350+17129T>G||MODIFIER||||||LOC101929140|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	91,64:155:0.4129
chr13	41224333	.	C	A	.	PASS	CSQ=9617|protein_coding||intron_variant|||||||NM_004294.4:c.1126-979G>T||MODIFIER||||||MTRF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	74,66:140:0.4714
chr13	41662447	.	C	T	.	PASS	CSQ=23078|protein_coding||intron_variant|||||||NM_015058.1:c.4611+8499G>A||MODIFIER||||||VWA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	85,101:186:0.543
chr13	41896250	.	T	A	.	PASS	CSQ=23078|protein_coding||intron_variant|||||||NM_015058.1:c.484-4663A>T||MODIFIER||||||VWA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	86,92:178:0.5169
chr13	42135133	.	G	A	.	PASS	CSQ=160851|protein_coding||intron_variant|||||||NM_178009.4:c.384+5501G>A||MODIFIER||||||DGKH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	90,95:185:0.5135
chr13	42169780	.	A	C	.	PASS	CSQ=160851|protein_coding||intron_variant|||||||NM_178009.4:c.1367+962A>C||MODIFIER||||||DGKH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	100,97:197:0.4924
chr13	42442115	.	C	CTTATTA	.	PASS	CSQ=105370177|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135319.1:n.336+4648_336+4649insATTATT||MODIFIER||||||LINC02341|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	83,60:143:0.4196
chr13	42704624	.	TAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	73,82:155:0.529
chr13	42888516	.	AAAAC	A	.	PASS	CSQ=94240|protein_coding||intron_variant|||||||NM_033255.4:c.916-18_916-15del||MODIFIER||||||EPSTI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	97,63:160:0.3937
chr13	43334825	.	CT	C	.	PASS	CSQ=55068|protein_coding||intron_variant||||rs1299593770|||NM_001347969.1:c.1037-8301del||MODIFIER||||||ENOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	84,80:164:0.4878
chr13	43443366	.	C	G	.	PASS	CSQ=55068|protein_coding||intron_variant|||||||NM_001347969.1:c.-74-30378G>C||MODIFIER||||||ENOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	158,7:165:0.0424
chr13	43595281	.	C	T	.	PASS	CSQ=55068|protein_coding||intron_variant||||rs1002827905||6.58077e-06|NM_001347969.1:c.-219+72198G>A||MODIFIER||||||ENOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	93,79:172:0.4593
chr13	43645801	.	T	A	.	PASS	CSQ=55068|protein_coding||intron_variant|||||||NM_001347969.1:c.-219+21678A>T||MODIFIER||||||ENOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	94,66:160:0.4125
chr13	44003493	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	58,85:143:0.5944
chr13	45335321	.	GG	AA	.	PASS	CSQ=677814|snoRNA||downstream_gene_variant|||||||||MODIFIER||||||SNORA31|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2,lancet;num_callers=2;supported_by=strelka2_SNVs	AD:DP:AF	114,0:114:0	92,71:163:0.4356
chr13	45832140	.	G	A	.	PASS	CSQ=283514|protein_coding||intron_variant||||rs964343945||6.56987e-06|NM_198849.3:c.135+19355C>T||MODIFIER||||||SIAH3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	85,92:177:0.5198
chr13	46085991	.	G	A	.	PASS	CSQ=1361|protein_coding||intron_variant|||||||NM_001872.5:c.151-1648C>T||MODIFIER||||||CPB2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	65,84:149:0.5638
chr13	46184348	.	C	T	.	PASS	CSQ=3936|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||LCP1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/LCP1|y|n|NHL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	53,82:135:0.6074
chr13	46299573	.	AC	A	.	PASS	CSQ=100861554|lncRNA||upstream_gene_variant||||rs1291026001||3.29099e-05|||MODIFIER||||||LINC00563|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	97,66:163:0.4049
chr13	46503209	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	72,70:142:0.493
chr13	47049829	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	76,73:149:0.4899
chr13	47267655	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	82,75:157:0.4777
chr13	47575361	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	61,67:128:0.5234
chr13	47737965	COSV51322264	A	T	.	PASS	CSQ=|||intergenic_variant|||COSV51322264||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	83,87:170:0.5118
chr13	48472548	.	TG	AT	.	PASS	CSQ=5925|protein_coding||intron_variant|||||||NM_000321.2:c.2490-812_2490-811delinsAT||MODIFIER||||||RB1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RB1|y|y|retinoblastoma,sarcoma,breast,small_cell_lung_carcinoma|retinoblastoma,sarcoma,breast,small_cell_lung_carcinoma|familial_retinoblastoma|L,E,M,O|Rec|TSG|D,Mis,N,F,S;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	108,0:108:0	80,81:161:0.5031
chr13	48601365	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	61,80:141:0.5674
chr13	48789402	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	73,96:169:0.568
chr13	48842525	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	91,64:155:0.4129
chr13	48884811	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs879679611||7.2437e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	73,62:135:0.4593
chr13	49207535	.	C	CT	.	PASS	CSQ=22862|protein_coding||3_prime_UTR_variant|||||||NM_001079673.2:c.*142dup||MODIFIER||||||FNDC3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	113,0:113:0	77,92:169:0.5444
chr13	49313522	.	CCA	C	.	PASS	CSQ=81617|protein_coding||intron_variant|||||||NM_001079670.3:c.835-2531_835-2530del||MODIFIER||||||CAB39L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	89,62:151:0.4106
chr13	50462892	.	C	G	.	PASS	CSQ=10301|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109974.1:n.674+29342C>G||MODIFIER||||||DLEU1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	75,82:157:0.5223
chr13	51709570	.	C	G	.	PASS	CSQ=115825|protein_coding||intron_variant|||||||NM_052950.4:c.334+5920C>G||MODIFIER||||||WDFY2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	89,78:167:0.4671
chr13	52081390	.	C	T	.	PASS	CSQ=341676|protein_coding||intron_variant|||||||NM_001365552.1:c.1572+1870G>A||MODIFIER||||||NEK5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	65,82:147:0.5578
chr13	52199655	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1341386052||6.57255e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	93,83:176:0.4716
chr13	52582552	.	G	T	.	PASS	CSQ=220115|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_002793.1:n.2169-544G>T||MODIFIER||||||TPTE2P3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	67,63:130:0.4846
chr13	52725223	.	A	AG	.	PASS	CSQ=11061|protein_coding||intron_variant|||||||NM_007015.3:c.355-1114dup||MODIFIER||||||CNMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	137,12:149:0.0805
chr13	52822295	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	61,71:132:0.5379
chr13	53435117	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	58,71:129:0.5504
chr13	53556815	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	80,90:170:0.5294
chr13	53585637	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	73,59:132:0.447
chr13	53680181	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	75,69:144:0.4792
chr13	53967721	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	63,53:116:0.4569
chr13	53969175	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs572020317||0.230121|||MODIFIER||||||||0.2304;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	88,42:130:0.3231
chr13	54168629	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,1:116:0.0086	59,94:153:0.6144
chr13	54420389	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	134,0:134:0	70,80:151:0.5298
chr13	54429597	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	81,57:138:0.413
chr13	54556478	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	58,61:119:0.5126
chr13	54806002	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1271758444||1.31494e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	66,69:135:0.5111
chr13	54808133	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	66,66:133:0.4962
chr13	54825823	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs755516277||9.20266e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	79,71:151:0.4702
chr13	54986844	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	65,75:140:0.5357
chr13	55061694	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1157688406||2.6645e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	64,68:132:0.5152
chr13	55156491	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,1:136:0.0074	63,54:117:0.4615
chr13	55193064	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	66,66:132:0.5
chr13	55331291	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	79,70:149:0.4698
chr13	55539018	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,67:147:0.4558
chr13	55667479	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	69,69:138:0.5
chr13	55686528	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1410750723||2.65544e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	60,70:130:0.5385
chr13	55705415	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	73,68:141:0.4823
chr13	55766412	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	75,65:140:0.4643
chr13	55890934	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	128,16:144:0.1111
chr13	55971941	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1180526651|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	73,48:121:0.3967
chr13	55978188	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1301701503||2.63068e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,1:130:0.0077	69,76:145:0.5241
chr13	56058444	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	70,59:129:0.4574
chr13	56150958	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	75,89:164:0.5427
chr13	56234535	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1262853242||2.63992e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	75,75:150:0.5
chr13	56265581	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1249584181||1.31491e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	82,75:157:0.4777
chr13	56325813	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs910307221||1.32052e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,1:113:0.0088	64,62:126:0.4921
chr13	56396994	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	60,66:126:0.5238
chr13	56696493	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	71,68:139:0.4892
chr13	56726060	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	48,69:117:0.5897
chr13	57039643	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	52,58:110:0.5273
chr13	57072368	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	57,66:123:0.5366
chr13	57119550	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs750076820||5.91685e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	153,11:164:0.0671
chr13	57324472	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs888183322|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	62,64:126:0.5079
chr13	57360711	COSV63301626	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV63301626|rs993389594||5.32205e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:90:0	54,58:112:0.5179
chr13	57405625	COSV65617000	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV65617000|rs763466206||6.59109e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	58,55:113:0.4867
chr13	57417971	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	52,75:127:0.5906
chr13	57425137	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1361527517|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	93,70:163:0.4294
chr13	57469401	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	65,72:137:0.5255
chr13	57645654	.	C	T	.	PASS	CSQ=27253|protein_coding||intron_variant||||rs1041931599|||NM_001040429.3:c.2565+10543C>T||MODIFIER||||||PCDH17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	103,0:103:0	146,13:159:0.0818
chr13	57702106	.	C	T	.	PASS	CSQ=27253|protein_coding||intron_variant||||rs1273944655||1.31692e-05|NM_001040429.3:c.2798-22506C>T||MODIFIER||||||PCDH17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	58,57:115:0.4957
chr13	57763396	COSV51341998	T	TA	.	PASS	CSQ=|||intergenic_variant|||COSV51341998|rs796462444||0.0010515|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:91:0	72,54:128:0.4219
chr13	57875608	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	131,0:131:0	84,82:167:0.491
chr13	58023080	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	63,78:141:0.5532
chr13	58332845	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	68,71:139:0.5108
chr13	58414387	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	156,5:161:0.0311
chr13	58480684	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	66,76:142:0.5352
chr13	58482926	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	71,79:150:0.5267
chr13	58653015	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	76,75:151:0.4967
chr13	58824666	.	AATATAT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	70,75:145:0.5172
chr13	59048001	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	68,58:126:0.4603
chr13	59091726	.	CTTA	C	.	PASS	CSQ=|||intergenic_variant||||rs1376633054||1.31511e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	76,67:143:0.4685
chr13	59422927	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,62:130:0.4769
chr13	60219758	.	G	A	.	PASS	CSQ=100874169|lncRNA||intron_variant&non_coding_transcript_variant||||rs750105678||2.6321e-05|NR_047022.1:n.365-4816C>T||MODIFIER||||||LINC00434|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	69,69:138:0.5
chr13	60327066	.	ATTTTTTAC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	86,62:148:0.4189
chr13	60636642	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	88,62:150:0.4133
chr13	60689190	.	TC	T	.	PASS	CSQ=101926930|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047003.1:n.243-1581del||MODIFIER||||||LINC00378|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	61,57:118:0.4831
chr13	60689194	.	A	T	.	PASS	CSQ=101926930|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047003.1:n.243-1579A>T||MODIFIER||||||LINC00378|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	49,57:106:0.5377
chr13	60789514	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	70,64:134:0.4776
chr13	60815326	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	88,88:176:0.5
chr13	60951522	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs781279514||3.29415e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	73,56:129:0.4341
chr13	60954993	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	88,65:153:0.4248
chr13	61222225	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs527372840||0.000136784|||MODIFIER||||||||0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	57,57:114:0.5
chr13	61353733	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	130,7:137:0.0511
chr13	61509750	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs967351207||4.60375e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	78,80:158:0.5063
chr13	61750797	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs934406337||3.29594e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	66,78:144:0.5417
chr13	61823331	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	49,60:109:0.5505
chr13	61879373	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	69,72:141:0.5106
chr13	62175769	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	67,52:119:0.437
chr13	62188138	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	88,80:168:0.4762
chr13	62417566	COSV69083675	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV69083675|rs1405240752|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	65,70:135:0.5185
chr13	62496104	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	86,67:153:0.4379
chr13	62542177	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	126,0:126:0	129,8:137:0.0584
chr13	62628574	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	74,64:138:0.4638
chr13	62726306	.	G	A	.	PASS	CSQ=100874176|lncRNA||intron_variant&non_coding_transcript_variant||||rs1297142670|||NR_047029.1:n.452+5788C>T||MODIFIER||||||LINC00448|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	75,66:141:0.4681
chr13	62775077	.	A	T	.	PASS	CSQ=100874176|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047029.1:n.209+19419T>A||MODIFIER||||||LINC00448|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	63,78:141:0.5532
chr13	62869976	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs1227799695||1.97774e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	83,68:151:0.4503
chr13	62883428	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	77,65:142:0.4577
chr13	63030263	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1229598893||6.5884e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	101,0:101:0	68,56:124:0.4516
chr13	63148838	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	71,78:149:0.5235
chr13	63163663	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	70,47:117:0.4017
chr13	63249348	.	G	A	.	PASS	CSQ=104355293|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126409.1:n.214+14863C>T||MODIFIER||||||LINC00376|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	67,77:144:0.5347
chr13	63294251	.	G	A	.	PASS	CSQ=104355293|lncRNA||intron_variant&non_coding_transcript_variant||||rs1023877923||0.000152459|NR_126409.1:n.150-29976C>T||MODIFIER||||||LINC00376|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	80,79:159:0.4969
chr13	63388436	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	79,64:143:0.4476
chr13	63555531	.	T	TC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	72,75:147:0.5102
chr13	63773880	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	75,77:152:0.5066
chr13	63807054	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	97,34:131:0.2595
chr13	64097765	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	64,53:117:0.453
chr13	64156886	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1383456640||1.31883e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	76,78:154:0.5065
chr13	64221686	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs997164595||0.000889305|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	84,55:139:0.3957
chr13	64223031	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs915021632|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	80,73:153:0.4771
chr13	64240414	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	66,75:141:0.5319
chr13	64332447	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	73,102:175:0.5829
chr13	64451329	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	135,9:144:0.0625
chr13	64472897	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	65,57:122:0.4672
chr13	64570544	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,53:117:0.453
chr13	64585998	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	78,69:147:0.4694
chr13	64586018	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	80,76:156:0.4872
chr13	64638455	.	CA	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	124,0:125:0	72,82:154:0.5325
chr13	64723540	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	76,69:145:0.4759
chr13	65064940	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	81,52:133:0.391
chr13	65300159	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	72,71:143:0.4965
chr13	65588867	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs71439078||1.97423e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	80,41:121:0.3388
chr13	65670130	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	83,64:147:0.4354
chr13	65731770	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	75,84:159:0.5283
chr13	65858477	COSV60280285	GA	G	.	PASS	CSQ=|||intergenic_variant|||COSV60280285|rs1167652922||2.03095e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	65,56:121:0.4628
chr13	66346976	.	C	A	.	PASS	CSQ=5101|protein_coding||intron_variant|||||||NM_203487.3:c.3341-41948G>T||MODIFIER||||||PCDH9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	113,41:154:0.2662
chr13	66654841	.	TG	AT	.	PASS	CSQ=5101|protein_coding||intron_variant|||||||NM_203487.3:c.3139-23431_3139-23430delinsAT||MODIFIER||||||PCDH9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	87,0:87:0	70,50:120:0.4167
chr13	67042600	.	T	C	.	PASS	CSQ=5101|protein_coding||intron_variant|||||||NM_203487.3:c.3037-138995A>G||MODIFIER||||||PCDH9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,77:77:1
chr13	67361527	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,84:84:1
chr13	67905000	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,55:55:1
chr13	67984278	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	33,42:75:0.56
chr13	68020422	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,75:75:1
chr13	68715448	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,78:78:1
chr13	69849204	.	C	G	.	PASS	CSQ=57626|protein_coding||intron_variant|||||||NM_020866.3:c.1228-10042G>C||MODIFIER||||||KLHL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	0,74:74:1
chr13	69942188	.	A	AT	.	PASS	CSQ=57626|protein_coding||intron_variant|||||||NM_020866.3:c.818-1953dup||MODIFIER||||||KLHL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	11,79:90:0.8778
chr13	69964117	.	C	T	.	PASS	CSQ=57626|protein_coding||intron_variant||||||1.31513e-05|NM_020866.3:c.681-2673G>A||MODIFIER||||||KLHL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	62,6:68:0.0882
chr13	70114996	.	T	A	.	PASS	CSQ=6315|antisense_RNA||intron_variant&non_coding_transcript_variant|||||||NR_002717.2:n.530-145T>A||MODIFIER||||||ATXN8OS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,77:77:1
chr13	70139320	.	C	CA	.	PASS	CSQ=6315|antisense_RNA||non_coding_transcript_exon_variant|||||||NR_002717.2:n.1039_1040insA||MODIFIER||||||ATXN8OS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:111:0	0,44:45:0.9778
chr13	70185927	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,67:67:1
chr13	70293871	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	61,5:66:0.0758
chr13	70372453	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs947348854||6.57428e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,79:79:1
chr13	70751195	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.57791e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,58:58:1
chr13	71207798	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs530920781||3.28684e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,76:76:1
chr13	71935159	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,74:74:1
chr13	72475689	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,72:72:1
chr13	72822569	.	CTAAGATCA	C	.	PASS	CSQ=10464|protein_coding||intron_variant|||||||NM_006346.4:c.806+588_806+595del||MODIFIER||||||PIBF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,62:62:1
chr13	73617938	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	68,75:143:0.5245
chr13	74191807	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	82,82:164:0.5
chr13	74609337	.	ACT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	74,70:144:0.4861
chr13	74684022	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	71,66:137:0.4818
chr13	74694886	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	72,73:145:0.5034
chr13	74838608	.	CA	C	.	PASS	CSQ=|||intergenic_variant||||rs1199955401||0.000726513|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,1:112:0.0089	83,53:136:0.3897
chr13	75278238	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	97,78:175:0.4457
chr13	75660679	.	G	A	.	PASS	CSQ=4008|protein_coding||intron_variant|||||||NM_001306080.2:c.69+23953G>A||MODIFIER||||||LMO7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	86,84:170:0.4941
chr13	76012462	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	77,79:156:0.5064
chr13	76602009	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	76,74:150:0.4933
chr13	76924442	.	G	A	.	PASS	CSQ=690|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||BTF3P11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	51,73:124:0.5887
chr13	77125957	.	G	A	.	PASS	CSQ=23077|protein_coding||intron_variant|||||||NM_015057.4:c.7884+361C>T||MODIFIER||||||MYCBP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	133,11:144:0.0764
chr13	78017730	.	G	A	.	PASS	CSQ=100874175|lncRNA||intron_variant&non_coding_transcript_variant||||rs1044662744||2.63664e-05|NR_047028.1:n.154+3967G>A||MODIFIER||||||LINC00446|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	87,78:165:0.4727
chr13	78093611	.	C	G	.	PASS	CSQ=100874222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047001.1:n.210+38547C>G||MODIFIER||||||RNF219-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	62,76:138:0.5507
chr13	78205026	.	C	T	.	PASS	CSQ=100874222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047001.1:n.299+15330C>T||MODIFIER||||||RNF219-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	59,65:124:0.5242
chr13	78207430	.	G	A	.	PASS	CSQ=100874222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047001.1:n.299+17734G>A||MODIFIER||||||RNF219-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	77,83:161:0.5155
chr13	78223018	.	T	C	.	PASS	CSQ=100874222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047001.1:n.299+33322T>C||MODIFIER||||||RNF219-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	89,70:159:0.4403
chr13	78404399	.	GA	G	.	PASS	CSQ=100874222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047001.1:n.384+130063del||MODIFIER||||||RNF219-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	75,83:158:0.5253
chr13	78546317	.	C	T	.	PASS	CSQ=100874222|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047001.1:n.385-58984C>T||MODIFIER||||||RNF219-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	66,70:136:0.5147
chr13	78659130	.	C	G	.	PASS	CSQ=79596|protein_coding||5_prime_UTR_variant||||rs1462782879||6.64328e-06|NM_024546.4:c.-10G>C||MODIFIER||||||RNF219|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	61,0:61:0	37,36:73:0.4932
chr13	78835551	.	G	A	.	PASS	CSQ=100874126|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046869.2:n.111+4389C>T||MODIFIER||||||LINC00331|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	75,67:142:0.4718
chr13	78953367	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1008068728||1.31451e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	62,73:135:0.5407
chr13	79119473	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,97:167:0.5808
chr13	79248050	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	78,71:149:0.4765
chr13	79622659	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	100,77:177:0.435
chr13	79622983	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	86,83:170:0.4882
chr13	79741787	.	TTTAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	71,78:149:0.5235
chr13	80396729	.	GA	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:106:0	71,57:128:0.4453
chr13	80932701	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	76,69:145:0.4759
chr13	81138193	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	71,77:148:0.5203
chr13	81231688	.	G	A	.	PASS	CSQ=100861546|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC00564|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	68,53:121:0.438
chr13	81267509	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	70,65:135:0.4815
chr13	81432203	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1191875085|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	58,70:128:0.5469
chr13	81540442	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	68,76:144:0.5278
chr13	81620619	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	98,32:130:0.2462
chr13	82000536	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	61,81:142:0.5704
chr13	82141464	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1402331014|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	64,60:124:0.4839
chr13	82246729	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	53,62:115:0.5391
chr13	82260705	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	81,68:149:0.4564
chr13	82298648	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	65,80:145:0.5517
chr13	82345198	COSV106181535	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV106181535|rs1490916875|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	60,66:126:0.5238
chr13	82424479	COSV51049142	A	AT	.	PASS	CSQ=|||intergenic_variant|||COSV51049142|||6.58709e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	76,65:141:0.461
chr13	82535549	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	121,14:135:0.1037
chr13	82691468	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	60,60:120:0.5
chr13	82725072	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	76,82:158:0.519
chr13	82737181	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1017913706|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	97,0:97:0	115,6:121:0.0496
chr13	82776593	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	135,9:144:0.0625
chr13	82861756	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs953804123||5.25728e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	69,64:133:0.4812
chr13	83100157	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	85,79:164:0.4817
chr13	83270303	.	T	A	.	PASS	CSQ=|||intergenic_variant||||||6.57203e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	69,65:134:0.4851
chr13	83512328	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	118,9:127:0.0709
chr13	83617042	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	75,63:138:0.4565
chr13	83766875	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	71,81:152:0.5329
chr13	83803489	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	48,78:126:0.619
chr13	83823670	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	93,83:176:0.4716
chr13	83829766	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	88,74:162:0.4568
chr13	83916899	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	100,0:100:0	136,6:142:0.0423
chr13	83927338	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	70,73:143:0.5105
chr13	83934021	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	72,67:139:0.482
chr13	83953386	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1332019906||4.62596e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	70,49:119:0.4118
chr13	83973590	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	95,39:134:0.291
chr13	83976808	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	58,71:129:0.5504
chr13	84079743	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	73,74:147:0.5034
chr13	84108697	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,1:90:0.0111	84,65:149:0.4362
chr13	84327648	.	ATTGATC	A	.	PASS	CSQ=100874128|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046871.1:n.138+85555_138+85560del||MODIFIER||||||LINC00333|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	52,39:91:0.4286
chr13	84328670	.	G	A	.	PASS	CSQ=100874128|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046871.1:n.138+86573G>A||MODIFIER||||||LINC00333|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	75,80:155:0.5161
chr13	84441333	.	C	A	.	PASS	CSQ=100874128|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046871.1:n.139-121031C>A||MODIFIER||||||LINC00333|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	58,83:141:0.5887
chr13	84443521	.	C	A	.	PASS	CSQ=100874128|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046871.1:n.139-118843C>A||MODIFIER||||||LINC00333|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	67,72:139:0.518
chr13	84451075	.	C	T	.	PASS	CSQ=100874128|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046871.1:n.139-111289C>T||MODIFIER||||||LINC00333|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	70,85:155:0.5484
chr13	84466494	.	CT	C	.	PASS	CSQ=100874128|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046871.1:n.139-95865del||MODIFIER||||||LINC00333|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	74,59:133:0.4436
chr13	84557927	.	G	A	.	PASS	CSQ=100874128|lncRNA||intron_variant&non_coding_transcript_variant||||rs748288034||1.97213e-05|NR_046871.1:n.139-4437G>A||MODIFIER||||||LINC00333|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	54,81:135:0.6
chr13	84795630	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	81,60:141:0.4255
chr13	84854018	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1284214485||1.97709e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	63,71:134:0.5299
chr13	85088364	.	ATGGTC	A	.	PASS	CSQ=104355140|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126383.1:n.31-9449_31-9445del||MODIFIER||||||LINC00375|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	63,60:123:0.4878
chr13	85626922	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	64,63:127:0.4961
chr13	85629854	.	TGTTTTGA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	74,65:139:0.4676
chr13	85648516	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs922000193||3.29082e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	89,73:162:0.4506
chr13	85754920	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	81,68:149:0.4564
chr13	85850861	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	55,69:125:0.552
chr13	85954320	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	79,73:152:0.4803
chr13	86286633	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	81,73:154:0.474
chr13	86484956	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1228785466|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	61,50:111:0.4505
chr13	86526915	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	73,89:162:0.5494
chr13	86553621	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs76834576|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	61,72:133:0.5414
chr13	86655769	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	76,58:134:0.4328
chr13	86727876	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	57,80:137:0.5839
chr13	86803106	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	75,86:161:0.5342
chr13	86964828	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	151,16:167:0.0958
chr13	87219257	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	78,79:157:0.5032
chr13	87326509	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	75,74:149:0.4966
chr13	87609418	.	G	GT	.	PASS	CSQ=642345|lncRNA||intron_variant&non_coding_transcript_variant||||rs1295223327||0.000115508|NR_033829.1:n.128+61417dup||MODIFIER||||||MIR4500HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	68,33:101:0.3267
chr13	87631548	.	TTTA	T	.	PASS	CSQ=642345|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033829.1:n.128+39285_128+39287del||MODIFIER||||||MIR4500HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	76,0:76:0	73,28:101:0.2772
chr13	87642794	.	C	A	.	PASS	CSQ=642345|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033829.1:n.128+28042G>T||MODIFIER||||||MIR4500HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	62,78:140:0.5571
chr13	87645644	.	G	A	.	PASS	CSQ=642345|lncRNA||intron_variant&non_coding_transcript_variant||||rs547557801||6.58016e-05|NR_033829.1:n.128+25192C>T||MODIFIER||||||MIR4500HG|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	74,69:143:0.4825
chr13	88110078	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	70,62:132:0.4697
chr13	88173164	.	TA	T	.	PASS	CSQ=105370306|lncRNA||intron_variant&non_coding_transcript_variant||||rs1204346448||0.000992164|NR_131919.1:n.234+30077del||MODIFIER||||||LOC105370306|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	62,49:112:0.4375
chr13	88259743	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	77,58:135:0.4296
chr13	88560392	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	78,62:140:0.4429
chr13	88726880	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1037636884||3.33218e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	84,0:84:0	73,54:127:0.4252
chr13	88768115	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	65,67:132:0.5076
chr13	88931591	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	118,0:118:0	77,57:134:0.4254
chr13	89089785	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	74,73:147:0.4966
chr13	89113937	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	66,77:143:0.5385
chr13	89148134	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	89,28:117:0.2393
chr13	89261942	.	G	T	.	PASS	CSQ=100874172|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047025.1:n.69-7690G>T||MODIFIER||||||LINC00440|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	75,79:154:0.513
chr13	89318482	.	C	CAAAA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	94,47:141:0.3333
chr13	89421011	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	70,73:143:0.5105
chr13	89567684	.	G	A	.	PASS	CSQ=100874139|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC00353|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	76,68:144:0.4722
chr13	89769958	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	68,74:142:0.5211
chr13	89888645	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	71,49:120:0.4083
chr13	90142398	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	128,7:135:0.0519
chr13	90160640	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	67,89:156:0.5705
chr13	90273105	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:106:0.0094	53,63:116:0.5431
chr13	90342397	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	66,73:139:0.5252
chr13	90570399	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	68,58:126:0.4603
chr13	90578528	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	68,57:125:0.456
chr13	90660266	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	73,96:169:0.568
chr13	90716978	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	78,71:149:0.4765
chr13	90791010	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	81,77:158:0.4873
chr13	90882097	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	71,85:156:0.5449
chr13	90896871	.	T	C	.	PASS	CSQ=144776|lncRNA||intron_variant&non_coding_transcript_variant||||rs980108463|||NR_027039.1:n.377-3331A>G||MODIFIER||||||LINC00410|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,68:141:0.4823
chr13	91331667	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs951665865||1.31525e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	75,56:131:0.4275
chr13	91416789	.	T	A	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.163+17580T>A||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	69,76:145:0.5241
chr13	91742607	.	G	A	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.1155-13688G>A||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	71,74:145:0.5103
chr13	91968248	.	G	GT	.	PASS	CSQ=2262|protein_coding||intron_variant||||rs199921840||0.00023892|NM_004466.6:c.1401+60200dup||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	87,55:142:0.3873
chr13	92030156	.	G	A	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.1402-114674G>A||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	71,80:151:0.5298
chr13	92228084	.	G	A	.	PASS	CSQ=2262|protein_coding||intron_variant||||rs1374874168||5.93887e-05|NM_004466.6:c.1561+83095G>A||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	75,67:142:0.4718
chr13	92236315	.	G	A	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.1561+91326G>A||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	69,77:146:0.5274
chr13	92335590	.	C	G	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.1561+190601C>G||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	81,65:146:0.4452
chr13	92341981	.	C	T	.	PASS	CSQ=100873970|lncRNA||intron_variant&non_coding_transcript_variant||||||6.57583e-06|NR_120382.1:n.221+591G>A||MODIFIER||||||GPC5-AS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	86,61:147:0.415
chr13	92385500	.	A	G	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.1561+240511A>G||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	109,29:138:0.2101
chr13	92551575	.	G	T	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.1562-314707G>T||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	135,5:140:0.0357
chr13	92590659	.	T	G	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.1562-275623T>G||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	100,40:140:0.2857
chr13	92745726	.	C	T	.	PASS	CSQ=2262|protein_coding||intron_variant|||||||NM_004466.6:c.1562-120556C>T||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	68,69:137:0.5036
chr13	92818791	.	G	C	.	PASS	CSQ=2262|protein_coding||intron_variant||||rs1036870751||6.58337e-06|NM_004466.6:c.1562-47491G>C||MODIFIER||||||GPC5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/GPC5|y|n|lung_adenocarcinoma|||E||TSG|D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	73,69:142:0.4859
chr13	92875932	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	74,67:141:0.4752
chr13	92884098	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1199261108||3.94716e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	85,70:155:0.4516
chr13	92908186	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1357397350|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	82,51:133:0.3835
chr13	93026734	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	59,62:121:0.5124
chr13	93132950	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	70,79:149:0.5302
chr13	93283370	.	C	T	.	PASS	CSQ=10082|protein_coding||intron_variant|||||||NM_005708.5:c.160+55754C>T||MODIFIER||||||GPC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	143,8:151:0.053
chr13	93341709	.	C	CT	.	PASS	CSQ=10082|protein_coding||intron_variant||||rs941080744||0.000367428|NM_005708.5:c.160+114101dup||MODIFIER||||||GPC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	69,40:110:0.3636
chr13	94048558	.	T	A	.	PASS	CSQ=10082|protein_coding||intron_variant|||||||NM_005708.5:c.877+20664T>A||MODIFIER||||||GPC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	75,52:127:0.4094
chr13	94121664	.	G	A	.	PASS	CSQ=10082|protein_coding||intron_variant|||||||NM_005708.5:c.877+93770G>A||MODIFIER||||||GPC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	69,87:156:0.5577
chr13	94475434	.	A	G	.	PASS	CSQ=1638|protein_coding||intron_variant|||||||NM_001922.5:c.295+3527T>C||MODIFIER||||||DCT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	69,67:136:0.4926
chr13	95104889	.	C	G	.	PASS	CSQ=10257|protein_coding||intron_variant|||||||NM_005845.4:c.2535+11033G>C||MODIFIER||||||ABCC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	86,75:161:0.4658
chr13	95106121	.	C	T	.	PASS	CSQ=10257|protein_coding||intron_variant|||||||NM_005845.4:c.2535+9801G>A||MODIFIER||||||ABCC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	85,73:158:0.462
chr13	95106298	.	C	G	.	PASS	CSQ=10257|protein_coding||intron_variant|||||||NM_005845.4:c.2535+9624G>C||MODIFIER||||||ABCC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	73,71:144:0.4931
chr13	95106422	.	C	G	.	PASS	CSQ=10257|protein_coding||intron_variant|||||||NM_005845.4:c.2535+9500G>C||MODIFIER||||||ABCC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	76,78:154:0.5065
chr13	95167124	.	C	A	.	PASS	CSQ=10257|protein_coding||intron_variant|||||||NM_005845.4:c.1825-757G>T||MODIFIER||||||ABCC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	67,77:144:0.5347
chr13	95213207	.	C	T	.	PASS	CSQ=109616987|snoRNA||downstream_gene_variant|||||||||MODIFIER||||||SNORD13G|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	86,71:157:0.4522
chr13	96571212	.	C	G	.	PASS	CSQ=266722|protein_coding||intron_variant|||||||NM_153456.3:c.708-261278C>G||MODIFIER||||||HS6ST3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	93,72:165:0.4364
chr13	96772803	.	C	A	.	PASS	CSQ=266722|protein_coding||intron_variant|||||||NM_153456.3:c.708-59687C>A||MODIFIER||||||HS6ST3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	72,91:163:0.5583
chr13	96847131	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	85,77:162:0.4753
chr13	97170539	.	G	A	.	PASS	CSQ=103625683|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00456|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	76,74:150:0.4933
chr13	97823016	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1054711369||5.32836e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	88,69:157:0.4395
chr13	97946172	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	82,91:173:0.526
chr13	98073345	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,1:137:0.0073	81,84:165:0.5091
chr13	99015664	.	C	G	.	PASS	CSQ=23348|protein_coding||5_prime_UTR_variant|||||||NM_001366677.1:c.-56G>C||MODIFIER||||||DOCK9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	87,69:156:0.4423
chr13	99164859	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	97,96:193:0.4974
chr13	99555271	.	G	A	.	PASS	CSQ=9375|protein_coding||intron_variant|||||||NM_004800.2:c.1641-265G>A||MODIFIER||||||TM9SF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	79,70:149:0.4698
chr13	99658530	.	C	G	.	PASS	CSQ=171425|protein_coding||intron_variant|||||||NM_206808.3:c.62+51773C>G||MODIFIER||||||CLYBL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	79,76:155:0.4903
chr13	99660578	.	C	T	.	PASS	CSQ=171425|protein_coding||intron_variant|||||||NM_206808.3:c.62+53821C>T||MODIFIER||||||CLYBL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	155,10:166:0.0602
chr13	99686906	.	G	T	.	PASS	CSQ=171425|protein_coding||intron_variant||||rs1162849918||6.57065e-06|NM_206808.3:c.62+80149G>T||MODIFIER||||||CLYBL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	81,81:162:0.5
chr13	99780390	.	C	CT	.	PASS	CSQ=101927437|lncRNA||intron_variant&non_coding_transcript_variant||||rs915656356||0.000184346|NR_120421.1:n.84-5043dup||MODIFIER||||||LOC101927437|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	89,67:156:0.4295
chr13	100313591	.	TGA	T	.	PASS	CSQ=5095|protein_coding||intron_variant|||||||NM_000282.4:c.1429+3685_1429+3686del||MODIFIER||||||PCCA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	77,61:138:0.442
chr13	100506249	.	G	T	.	PASS	CSQ=5095|protein_coding||intron_variant|||||||NM_000282.4:c.1900-9178G>T||MODIFIER||||||PCCA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,70:141:0.4965
chr13	100830298	.	C	T	.	PASS	CSQ=100885778|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047687.1:n.141+89670C>T||MODIFIER||||||NALCN-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	83,71:154:0.461
chr13	100852278	.	C	G	.	PASS	CSQ=100885778|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_047687.1:n.141+111650C>G||MODIFIER||||||NALCN-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	90,93:183:0.5082
chr13	101220639	.	C	T	.	PASS	CSQ=259232|protein_coding||intron_variant||||rs868612044||1.31536e-05|NM_052867.4:c.1626+8754G>A||MODIFIER||||||NALCN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	81,83:164:0.5061
chr13	101332457	.	A	G	.	PASS	CSQ=259232|protein_coding||intron_variant|||||||NM_052867.4:c.799+12809T>C||MODIFIER||||||NALCN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	78,79:159:0.4969
chr13	101526170	.	A	T	.	PASS	CSQ=9358|protein_coding||intron_variant||||rs1321933196||0.000164755|NM_004791.3:c.317-41529A>T||MODIFIER||||||ITGBL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,2:91:0.022	70,58:128:0.4531
chr13	101585674	.	C	A	.	PASS	CSQ=9358|protein_coding||intron_variant|||||||NM_004791.3:c.868+2318C>A||MODIFIER||||||ITGBL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	72,77:149:0.5168
chr13	101692211	.	C	A	.	PASS	CSQ=9358|protein_coding||intron_variant|||||||NM_004791.3:c.1016-374C>A||MODIFIER||||||ITGBL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	93,79:172:0.4593
chr13	101733598	.	A	C	.	PASS	CSQ=2259|protein_coding||intron_variant|||||||NM_175929.2:c.424-6788T>G||MODIFIER||||||FGF14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	59,71:130:0.5462
chr13	102060418	.	C	T	.	PASS	CSQ=2259|protein_coding||intron_variant||||rs1037076214||2.63345e-05|NM_175929.2:c.209-185122G>A||MODIFIER||||||FGF14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	63,85:148:0.5743
chr13	102102642	.	GG	TA	.	PASS	CSQ=2259|protein_coding||intron_variant|||||||NM_175929.2:c.209-227347_209-227346delinsTA||MODIFIER||||||FGF14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	120,0:122:0	71,74:145:0.5103
chr13	102795529	.	C	A	.	PASS	CSQ=79070|protein_coding||intron_variant|||||||NM_024089.3:c.388+1275G>T||MODIFIER||||||KDELC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	70,76:146:0.5205
chr13	102909810	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	93,86:179:0.4804
chr13	103118635	.	GG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	115,0:116:0	78,67:146:0.4589
chr13	103270742	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	79,94:173:0.5434
chr13	103503422	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	82,85:167:0.509
chr13	103593811	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	86,74:160:0.4625
chr13	103769020	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	85,62:147:0.4218
chr13	104104563	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	82,85:167:0.509
chr13	104132191	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs768177550||5.94012e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	63,70:133:0.5263
chr13	104769765	COSV68572510	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV68572510||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	69,63:132:0.4773
chr13	104950952	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	66,74:140:0.5286
chr13	105046010	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	78,68:146:0.4658
chr13	105119312	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	72,68:140:0.4857
chr13	105226833	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	70,71:141:0.5035
chr13	105318180	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	79,76:155:0.4903
chr13	105480078	.	C	CA	.	PASS	CSQ=267012|protein_coding||intron_variant|||||||NM_172370.4:c.281+7397dup||MODIFIER||||||DAOA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	85,74:159:0.4654
chr13	105737913	.	C	A	.	PASS	CSQ=144920|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046391.2:n.743-23350C>A||MODIFIER||||||LINC00343|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	88,78:166:0.4699
chr13	105802783	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	77,59:136:0.4338
chr13	106049247	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	76,69:145:0.4759
chr13	106233441	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	134,15:149:0.1007
chr13	106292126	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	73,66:139:0.4748
chr13	106593580	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	63,90:153:0.5882
chr13	106786122	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	102,76:178:0.427
chr13	106824180	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs573956153||6.57289e-06|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	65,79:144:0.5486
chr13	106967936	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	80,83:163:0.5092
chr13	107019053	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	88,66:154:0.4286
chr13	107045325	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	136,14:150:0.0933
chr13	107073812	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	79,66:145:0.4552
chr13	107384498	.	GTTTT	G	.	PASS	CSQ=728215|protein_coding||intron_variant|||||||NM_001080396.2:c.916-173747_916-173744del||MODIFIER||||||FAM155A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	62,71:134:0.5299
chr13	107514434	.	T	TATCA	.	PASS	CSQ=728215|protein_coding||intron_variant|||||||NM_001080396.2:c.916-303680_916-303679insTGAT||MODIFIER||||||FAM155A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	85,56:141:0.3972
chr13	107881794	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	72,77:149:0.5168
chr13	108114983	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	141,9:150:0.06
chr13	108258870	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1315861173||6.6912e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	78,72:150:0.48
chr13	108561007	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	68,76:144:0.5278
chr13	108567149	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1171822470||6.57402e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	81,64:145:0.4414
chr13	108628890	.	C	CA	.	PASS	CSQ=23026|protein_coding||upstream_gene_variant||||rs748598535||0.000125396|||MODIFIER||||||MYO16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	82,76:158:0.481
chr13	108701824	.	G	A	.	PASS	CSQ=23026|protein_coding||intron_variant|||||||NM_001198950.3:c.293-10837G>A||MODIFIER||||||MYO16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	88,83:171:0.4854
chr13	109004390	.	C	A	.	PASS	CSQ=23026|protein_coding||intron_variant|||||||NM_001198950.3:c.2443-4507C>A||MODIFIER||||||MYO16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,79:154:0.513
chr13	109276164	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	80,77:157:0.4904
chr13	109424331	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,84:159:0.5283
chr13	109466035	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	58,59:117:0.5043
chr13	109701216	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	158,0:158:0	101,81:182:0.4451
chr13	109733172	.	G	A	.	PASS	CSQ=101409253|lncRNA||downstream_gene_variant||||rs1027947153||5.25562e-05|||MODIFIER||||||LINC00676|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	94,91:185:0.4919
chr13	110124555	.	G	A	.	PASS	CSQ=105370361|lncRNA||non_coding_transcript_exon_variant|||||||NR_148221.1:n.2513G>A||MODIFIER||||||LOC105370361|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	80,84:164:0.5122
chr13	110657701	.	C	A	.	PASS	CSQ=79587|protein_coding||intron_variant|||||||NM_024537.4:c.987+5750G>T||MODIFIER||||||CARS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	102,97:199:0.4874
chr13	110899745	.	A	G	.	PASS	CSQ=55608|protein_coding||intron_variant||||rs1308388854||6.57609e-06|NM_017664.4:c.455+6288T>C||MODIFIER||||||ANKRD10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	119,0:119:0	89,87:176:0.4943
chr13	111353569	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	80,78:158:0.4937
chr13	111935917	.	T	TG	.	PASS	CSQ=|||intergenic_variant||||rs113985127||0.0852256|||MODIFIER||||||||0.1092;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	85,56:141:0.3972
chr13	111959399	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	87,65:152:0.4276
chr13	112038227	.	G	A	.	PASS	CSQ=100505996|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120392.1:n.85-57248G>A||MODIFIER||||||SOX1-OT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	117,0:117:0	121,11:133:0.0827
chr13	112044780	.	C	A	.	PASS	CSQ=100505996|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120392.1:n.85-50695C>A||MODIFIER||||||SOX1-OT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	75,93:168:0.5536
chr13	112076215	.	C	G	.	PASS	CSQ=100505996|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120392.1:n.85-19260C>G||MODIFIER||||||SOX1-OT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	87,86:173:0.4971
chr13	112397354	.	G	A	.	PASS	CSQ=122258|protein_coding||intron_variant|||||||NM_145248.5:c.152-695G>A||MODIFIER||||||SPACA7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:149:0	127,10:137:0.073
chr13	113747634	.	C	T	.	PASS	CSQ=100130386|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00552|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	97,92:189:0.4868
chr13	113876874	.	TCACTCTCA	T	.	PASS	CSQ=100874178|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00454|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	91,83:174:0.477
chr13	114344110	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	75,83:158:0.5253
chr14	18996263	.	T	A	.	PASS	CSQ=641455|protein_coding||intron_variant|||||||NM_001145442.1:c.1410-778T>A||MODIFIER||||||POTEM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	227,0:227:0	202,42:244:0.1721
chr14	19157725	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	127,42:169:0.2485
chr14	19169845	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	184,0:184:0	185,34:219:0.1553
chr14	19374218	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1229410106||2.70376e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	334,0:335:0	328,52:380:0.1368
chr14	19669557	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs770692459|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	296,0:296:0	307,82:389:0.2108
chr14	19953643	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	169,0:169:0	138,64:202:0.3168
chr14	20322837	.	G	C	.	PASS	CSQ=100113391|snoRNA||downstream_gene_variant|||||||||MODIFIER||||||SNORD126|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	68,74:142:0.5211
chr14	21522645	.	C	T	.	PASS	CSQ=6297|protein_coding||3_prime_UTR_variant|||||||NM_001364564.1:c.*59G>A||MODIFIER||||||SALL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	124,0:124:0	73,85:158:0.538
chr14	21610196	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,70:147:0.4762
chr14	21647827	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,87:156:0.5577
chr14	21760180	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	78,84:162:0.5185
chr14	21908711	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	73,70:143:0.4895
chr14	22078036	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	83,68:151:0.4503
chr14	22207558	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	83,82:165:0.497
chr14	22858451	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	78,75:153:0.4902
chr14	23091775	.	C	G	.	PASS	CSQ=55017|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||C14orf119|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	75,83:158:0.5253
chr14	23129708	COSV57554849;COSV57554849;COSV57554849;COSV57554849;COSV57554849;COSV57554849	G	A	.	PASS	CSQ=23428|protein_coding||missense_variant|COSV57554849&COSV57554849&COSV57554849&COSV57554849&COSV57554849&COSV57554849|p.T297M&p.T402M&p.T199M&p.T178M&p.?&p.H198||rs758342760&COSM6140232|1.9884e-05|3.9413e-05|NM_012244.4:c.1205C>T|NP_036376.2:p.Thr402Met|MODERATE|D&.&.&.|D&D&D&D|D|D&D&D&D|D&D&D&D|SLC7A8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	92,89:181:0.4917
chr14	24615014	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	89,89:178:0.5
chr14	25037901	.	T	C	.	PASS	CSQ=29091|protein_coding||intron_variant|||||||NM_001351943.1:c.-109+11306A>G||MODIFIER||||||STXBP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	72,80:152:0.5263
chr14	25064006	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	99,76:175:0.4343
chr14	25120814	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs559809828||0.0526516|||MODIFIER||||||||0.0911;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	93,60:153:0.3922
chr14	25252656	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	70,0:70:0	44,62:107:0.5794
chr14	25377710	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	78,70:148:0.473
chr14	25431837	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||1.31435e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	60,80:140:0.5714
chr14	25743985	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	123,10:133:0.0752
chr14	25761271	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	57,55:112:0.4911
chr14	25857577	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs928468885||2.6293e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	84,85:169:0.503
chr14	26296841	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	58,43:101:0.4257
chr14	26593506	.	G	GT	.	PASS	CSQ=4857|protein_coding||intron_variant|||||||NM_002515.3:c.280+1903dup||MODIFIER||||||NOVA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	86,66:152:0.4342
chr14	26744322	.	T	G	.	PASS	CSQ=102725045|lncRNA||intron_variant&non_coding_transcript_variant||||||6.58085e-06|NR_147061.1:n.1727+19528T>G||MODIFIER||||||NOVA1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	68,84:152:0.5526
chr14	27056431	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	69,73:142:0.5141
chr14	27094007	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	87,24:111:0.2162
chr14	27194080	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	97,63:160:0.3937
chr14	27456150	.	G	A	.	PASS	CSQ=728755|lncRNA||intron_variant&non_coding_transcript_variant||||rs898726619||6.58354e-06|NR_148991.1:n.254-134009C>T||MODIFIER||||||LOC728755|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	143,5:148:0.0338
chr14	27497939	.	A	G	.	PASS	CSQ=728755|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_148991.1:n.253+158504T>C||MODIFIER||||||LOC728755|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	77,73:150:0.4867
chr14	27581801	.	C	T	.	PASS	CSQ=728755|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_148991.1:n.253+74642G>A||MODIFIER||||||LOC728755|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	83,83:166:0.5
chr14	27610831	.	T	G	.	PASS	CSQ=100505967|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC00645|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	67,68:135:0.5037
chr14	27677599	.	C	CA	.	PASS	CSQ=728755|lncRNA||upstream_gene_variant||||rs1392847449||0.050944|||MODIFIER||||||LOC728755|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	48,51:99:0.5152
chr14	27881985	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1037823205||5.9209e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	80,47:128:0.3672
chr14	27893701	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	60,68:128:0.5312
chr14	27982130	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	90,76:166:0.4578
chr14	28067431	COSV62108525	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV62108525|rs531306845||5.91763e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	69,67:136:0.4926
chr14	28082104	.	TG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	134,0:134:0	61,62:123:0.5041
chr14	28236595	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	79,81:160:0.5062
chr14	28280765	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	96,28:124:0.2258
chr14	28317024	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1293842933||0.000112071|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:98:0	58,65:123:0.5285
chr14	28320028	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	63,77:140:0.55
chr14	28345409	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	65,76:141:0.539
chr14	28756296	.	C	G	.	PASS	CSQ=103695363|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125758.1:n.303+6036G>C||MODIFIER||||||FOXG1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	62,91:153:0.5948
chr14	28769796	.	T	A	.	PASS	CSQ=103695363|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||FOXG1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	86,0:86:0	77,88:165:0.5333
chr14	28860024	COSV73430723	C	A	.	PASS	CSQ=|||intergenic_variant|||COSV73430723||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	58,79:137:0.5766
chr14	29209057	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	78,83:161:0.5155
chr14	29263541	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	83,84:167:0.503
chr14	29447229	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs535543076||0.000157785|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	89,74:163:0.454
chr14	29488163	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	57,62:119:0.521
chr14	29631192	.	C	A	.	PASS	CSQ=5587|protein_coding||intron_variant|||||||NM_002742.2:c.1393-171G>T||MODIFIER||||||PRKD1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PRKD1|y|n|cribriform_adenocarcinoma_of_the_minor_salivary_glands,polymorphous_adenocarcinoma_of_the_minor_salivary_glands|||E||fusion|T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	73,62:135:0.4593
chr14	29647872	.	T	A	.	PASS	CSQ=5587|protein_coding||intron_variant|||||||NM_002742.2:c.697-8968A>T||MODIFIER||||||PRKD1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PRKD1|y|n|cribriform_adenocarcinoma_of_the_minor_salivary_glands,polymorphous_adenocarcinoma_of_the_minor_salivary_glands|||E||fusion|T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	77,68:145:0.469
chr14	29759584	.	G	T	.	PASS	CSQ=5587|protein_coding||intron_variant|||||||NM_002742.2:c.265-33910C>A||MODIFIER||||||PRKD1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PRKD1|y|n|cribriform_adenocarcinoma_of_the_minor_salivary_glands,polymorphous_adenocarcinoma_of_the_minor_salivary_glands|||E||fusion|T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	84,64:148:0.4324
chr14	29858084	.	G	A	.	PASS	CSQ=5587|protein_coding||intron_variant|||||||NM_002742.2:c.264+69165C>T||MODIFIER||||||PRKD1|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PRKD1|y|n|cribriform_adenocarcinoma_of_the_minor_salivary_glands,polymorphous_adenocarcinoma_of_the_minor_salivary_glands|||E||fusion|T,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	77,91:168:0.5417
chr14	30067557	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	85,71:156:0.4551
chr14	30871590	.	A	G	.	PASS	CSQ=100506071|lncRNA||downstream_gene_variant||||rs1048333760||2.62719e-05|||MODIFIER||||||LOC100506071|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	157,14:171:0.0819
chr14	30947810	.	C	G	.	PASS	CSQ=29966|protein_coding||intron_variant|||||||NM_001083893.2:c.543-547G>C||MODIFIER||||||STRN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	132,73:205:0.3561
chr14	31044193	.	C	G	.	PASS	CSQ=11154|protein_coding||intron_variant|||||||NM_001128126.2:c.-72+18406C>G||MODIFIER||||||AP4S1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	159,80:239:0.3347
chr14	31270109	.	TCCAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	63,56:119:0.4706
chr14	31288673	.	T	A	.	PASS	CSQ=25938|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||HEATR5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	87,91:178:0.5112
chr14	31378180	.	G	C	.	PASS	CSQ=25938|protein_coding||intron_variant|||||||NM_015473.4:c.1708+2287C>G||MODIFIER||||||HEATR5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	66,63:129:0.4884
chr14	31484287	.	A	AT	.	PASS	CSQ=2856|protein_coding||intron_variant||||rs200398426||0.0154464|NM_001197184.2:c.-6-317dup||MODIFIER||||||GPR33|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	103,59:162:0.3642
chr14	31804278	.	G	A	.	PASS	CSQ=80224|protein_coding||intron_variant||||rs887037691||1.31444e-05|NM_025152.3:c.607+16405G>A||MODIFIER||||||NUBPL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	83,80:163:0.4908
chr14	31805073	.	C	CA	.	PASS	CSQ=80224|protein_coding||intron_variant||||rs138333095||0.36227|NM_025152.3:c.607+17209dup||MODIFIER||||||NUBPL|EntrezGene|0.3788;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,1:104:0.0096	95,70:165:0.4242
chr14	32095656	.	A	T	.	PASS	CSQ=394|protein_coding||intron_variant|||||||NM_001030055.2:c.3717+1270A>T||MODIFIER||||||ARHGAP5|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/ARHGAP5|y|n|colon_cancer,glioma|||E,O||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	67,78:145:0.5379
chr14	32930762	COSV73438890;COSV73438890	G	GA	.	PASS	CSQ=|||intergenic_variant|||COSV73438890&COSV73438890|rs567761829||7.26715e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	78,69:147:0.4694
chr14	32943174	COSV58120459;COSV58120459;COSV58120459;COSV58120459;COSV58120459	C	CT	.	PASS	CSQ=64067|protein_coding||intron_variant|COSV58120459&COSV58120459&COSV58120459&COSV58120459&COSV58120459|p.?&p.?&p.?&p.?&p.?||rs965753312||0.000211734|NM_001165893.1:c.50+3820dup||MODIFIER||||||NPAS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	97,57:157:0.3631
chr14	33025645	.	G	A	.	PASS	CSQ=64067|protein_coding||intron_variant|||||||NM_001165893.1:c.50+86279G>A||MODIFIER||||||NPAS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	93,86:179:0.4804
chr14	33077351	.	T	C	.	PASS	CSQ=64067|protein_coding||intron_variant|||||||NM_001165893.1:c.51-137831T>C||MODIFIER||||||NPAS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	63,59:122:0.4836
chr14	33167827	.	C	T	.	PASS	CSQ=64067|protein_coding||intron_variant||||rs1329437161|||NM_001165893.1:c.51-47355C>T||MODIFIER||||||NPAS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	81,68:149:0.4564
chr14	33193379	.	G	T	.	PASS	CSQ=64067|protein_coding||intron_variant|||||||NM_001165893.1:c.51-21803G>T||MODIFIER||||||NPAS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,74:156:0.4744
chr14	33617906	.	A	G	.	PASS	CSQ=64067|protein_coding||intron_variant|||||||NM_001165893.1:c.468+57696A>G||MODIFIER||||||NPAS3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	59,80:139:0.5755
chr14	34562775	.	G	C	.	PASS	CSQ=58533|protein_coding||3_prime_UTR_variant|||||||NM_152233.4:c.*347C>G||MODIFIER||||||SNX6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	95,98:193:0.5078
chr14	34566516	.	AT	A	.	PASS	CSQ=58533|protein_coding||intron_variant|||||||NM_152233.4:c.1167+1169del||MODIFIER||||||SNX6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	109,73:182:0.4011
chr14	35181041	.	G	A	.	PASS	CSQ=9692|protein_coding||intron_variant|||||||NM_014672.3:c.1275+264G>A||MODIFIER||||||KIAA0391|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,1:116:0.0086	70,76:147:0.517
chr14	35259103	.	C	G	.	PASS	CSQ=9692|protein_coding||intron_variant|||||||NM_014672.3:c.1276-7624C>G||MODIFIER||||||KIAA0391|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	76,81:157:0.5159
chr14	35259116	.	C	T	.	PASS	CSQ=9692|protein_coding||intron_variant|||||||NM_014672.3:c.1276-7611C>T||MODIFIER||||||KIAA0391|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	83,76:159:0.478
chr14	35362824	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	98,96:194:0.4948
chr14	35590389	.	C	T	.	PASS	CSQ=253959|protein_coding||intron_variant|||||||NM_001346248.1:c.7068+5245G>A||MODIFIER||||||RALGAPA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	81,91:172:0.5291
chr14	35815749	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,2:104:0.0192	84,61:145:0.4207
chr14	35919413	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	90,76:166:0.4578
chr14	36384392	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	79,76:155:0.4903
chr14	36579093	.	C	T	.	PASS	CSQ=26257|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||NKX2-8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	75,58:133:0.4361
chr14	36666376	.	C	A	.	PASS	CSQ=5083|protein_coding||intron_variant|||||||NM_006194.3:c.632-86C>A||MODIFIER||||||PAX9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	77,79:156:0.5064
chr14	37503489	.	CAT	C	.	PASS	CSQ=145282|protein_coding||intron_variant|||||||NM_001195296.1:c.1262+3354_1262+3355del||MODIFIER||||||MIPOL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	107,0:107:0	81,65:146:0.4452
chr14	37635926	.	C	T	.	PASS	CSQ=319089|protein_coding||intron_variant|||||||NM_001310135.2:c.987+12923C>T||MODIFIER||||||TTC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	68,63:131:0.4809
chr14	37821197	.	AG	GT	.	PASS	CSQ=319089|protein_coding||intron_variant|||||||NM_001310135.2:c.4812-2550_4812-2549delinsGT||MODIFIER||||||TTC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	107,0:107:0	80,58:138:0.4203
chr14	37844750	.	C	A	.	PASS	CSQ=319089|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TTC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	103,41:144:0.2847
chr14	37961007	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	116,39:155:0.2516
chr14	38037336	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	71,71:142:0.5
chr14	38287678	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs116966641|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,3:77:0.039	55,71:126:0.5635
chr14	38534046	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	69,69:138:0.5
chr14	38616176	.	ATG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	67,74:141:0.5248
chr14	38660004	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	112,19:131:0.145
chr14	38714731	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	83,80:163:0.4908
chr14	38915115	.	T	A	.	PASS	CSQ=105370457|lncRNA||intron_variant&non_coding_transcript_variant||||rs756786572||0.000554104|NR_135256.1:n.167-3883T>A||MODIFIER||||||LOC105370457|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,76:155:0.4903
chr14	39375600	.	GG	TT	.	PASS	CSQ=4253|protein_coding||intron_variant|||||||NM_001354154.1:c.2249-11285_2249-11284delinsTT||MODIFIER||||||MIA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	122,0:122:0	85,81:166:0.488
chr14	39380008	.	AAAACTAATGAGAAGGATACTTAAATAGAAGG	A	.	PASS	CSQ=4253|protein_coding||intron_variant|||||||NM_001354154.1:c.2249-6874_2249-6844del||MODIFIER||||||MIA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	105,89:194:0.4588
chr14	40092580	.	GT	G	.	PASS	CSQ=|||intergenic_variant||||rs759522997||0.000351257|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,2:126:0.0159	73,48:122:0.3934
chr14	40098389	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	127,15:142:0.1056
chr14	40696744	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	120,14:134:0.1045
chr14	40717917	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	76,63:139:0.4532
chr14	41324976	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,58:126:0.4603
chr14	41584772	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	70,48:118:0.4068
chr14	41600074	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	78,66:144:0.4583
chr14	41691081	.	T	C	.	PASS	CSQ=145581|protein_coding||intron_variant|||||||NM_152447.4:c.-196-75773T>C||MODIFIER||||||LRFN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	43,68:111:0.6126
chr14	41832657	.	G	A	.	PASS	CSQ=145581|protein_coding||intron_variant|||||||NM_152447.4:c.-20-53949G>A||MODIFIER||||||LRFN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	35,67:102:0.6569
chr14	41903362	.	A	T	.	PASS	CSQ=145581|protein_coding||intron_variant|||||||NM_152447.4:c.2143-796A>T||MODIFIER||||||LRFN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:102:0	57,65:122:0.5328
chr14	41948903	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	59,59:118:0.5
chr14	41966445	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	67,49:116:0.4224
chr14	42043083	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	61,55:116:0.4741
chr14	42232520	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	124,5:129:0.0388
chr14	42310767	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	118,8:126:0.0635
chr14	42481332	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	66,57:123:0.4634
chr14	42652459	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	75,68:143:0.4755
chr14	42660772	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	60,63:123:0.5122
chr14	42858626	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	76,82:158:0.519
chr14	42938432	COSV61066961	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV61066961|rs923877637||1.31991e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	52,59:111:0.5315
chr14	43012783	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	81,73:155:0.471
chr14	43303297	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:99:0	59,67:126:0.5317
chr14	43391618	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	55,54:109:0.4954
chr14	43452601	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	69,79:148:0.5338
chr14	43457106	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	75,71:146:0.4863
chr14	43467053	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	75,60:135:0.4444
chr14	43673078	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	66,67:133:0.5038
chr14	43775991	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	75,58:133:0.4361
chr14	43813077	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	74,50:124:0.4032
chr14	43849811	.	T	TGA	.	PASS	CSQ=|||intergenic_variant||||rs1033920294||0.000547904|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	64,55:120:0.4583
chr14	43994800	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	58,68:126:0.5397
chr14	44379301	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	73,74:147:0.5034
chr14	44410903	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	142,12:154:0.0779
chr14	44418572	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	69,92:161:0.5714
chr14	44872332	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	61,68:129:0.5271
chr14	45245489	.	C	A	.	PASS	CSQ=55320|protein_coding||intron_variant|||||||NM_018353.5:c.544+1254G>T||MODIFIER||||||MIS18BP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	82,85:168:0.506
chr14	45471167	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1331127153||1.31914e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	71,81:152:0.5329
chr14	45501899	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	159,9:168:0.0536
chr14	45649579	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1380683915|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	81,66:148:0.4459
chr14	46151135	.	A	C	.	PASS	CSQ=100506412|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_102701.1:n.59-59689A>C||MODIFIER||||||LINC00871|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	83,67:150:0.4467
chr14	46598514	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs766656995||7.24151e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	54,71:125:0.568
chr14	46674107	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	109,43:152:0.2829
chr14	46681649	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	55,63:118:0.5339
chr14	46681732	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	66,60:126:0.4762
chr14	47032626	.	CAATTTAAA	C	.	PASS	CSQ=161357|protein_coding||intron_variant|||||||NM_001113498.2:c.1612+2377_1612+2384del||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	136,0:136:0	54,40:94:0.4255
chr14	47032640	.	TATCTGAA	T	.	PASS	CSQ=161357|protein_coding||intron_variant|||||||NM_001113498.2:c.1612+2364_1612+2370del||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	129,0:129:0	65,40:105:0.381
chr14	47032649	.	T	TAC	.	PASS	CSQ=161357|protein_coding||intron_variant|||||||NM_001113498.2:c.1612+2361_1612+2362insGT||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	137,0:137:0	69,40:109:0.367
chr14	47137083	.	G	A	.	PASS	CSQ=161357|protein_coding||intron_variant|||||||NM_001113498.2:c.586-5237C>T||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	63,64:127:0.5039
chr14	47174810	.	G	A	.	PASS	CSQ=161357|protein_coding||intron_variant|||||||NM_001113498.2:c.389-30536C>T||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	79,71:150:0.4733
chr14	47444785	.	T	C	.	PASS	CSQ=161357|protein_coding||intron_variant|||||||NM_001113498.2:c.74-143235A>G||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	118,4:122:0.0328
chr14	47474775	.	A	T	.	PASS	CSQ=161357|protein_coding||intron_variant|||||||NM_001113498.2:c.74-173225T>A||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	111,11:122:0.0902
chr14	47520910	.	G	A	.	PASS	CSQ=161357|protein_coding||intron_variant||||rs1025830619||0.000184099|NM_001113498.2:c.73+153607C>T||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	85,58:143:0.4056
chr14	47557933	.	A	AT	.	PASS	CSQ=161357|protein_coding||intron_variant|||||||NM_001113498.2:c.73+116583dup||MODIFIER||||||MDGA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	64,65:129:0.5039
chr14	47680587	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	74,80:154:0.5195
chr14	47727951	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	55,64:119:0.5378
chr14	47955876	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	56,61:117:0.5214
chr14	48258515	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	72,69:141:0.4894
chr14	48306463	.	T	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	73,76:149:0.5101
chr14	48531795	.	TTTC	T	.	PASS	CSQ=|||intergenic_variant||||rs771532552||0.000327601|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	81,53:134:0.3955
chr14	48550695	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	71,88:159:0.5535
chr14	48624980	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs532543903||3.94451e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	74,71:145:0.4897
chr14	48689158	.	ACAACAACAACAACAT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	58,56:114:0.4912
chr14	48747420	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	80,62:142:0.4366
chr14	48858446	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1271652014|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	83,73:156:0.4679
chr14	48858972	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	68,66:134:0.4925
chr14	49721699	.	G	C	.	PASS	CSQ=122773|protein_coding||intron_variant|||||||NM_172193.3:c.405-2175G>C||MODIFIER||||||KLHDC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	91,74:165:0.4485
chr14	49956270	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	106,83:189:0.4392
chr14	50155841	.	C	T	.	PASS	CSQ=6655|protein_coding||intron_variant|||||||NM_006939.4:c.2057+1158G>A||MODIFIER||||||SOS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	98,0:98:0	61,96:157:0.6115
chr14	50400145	.	T	C	.	PASS	CSQ=8814|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CDKL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	73,74:147:0.5034
chr14	50956541	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	87,68:155:0.4387
chr14	51128443	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	90,94:184:0.5109
chr14	51224486	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	79,83:162:0.5123
chr14	51407295	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	78,87:165:0.5273
chr14	51508318	.	G	C	.	PASS	CSQ=122786|protein_coding||intron_variant|||||||NM_001042481.2:c.-210+18898G>C||MODIFIER||||||FRMD6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	62,86:148:0.5811
chr14	51633765	.	C	T	.	PASS	CSQ=122786|protein_coding||intron_variant|||||||NM_001042481.2:c.-146-55926C>T||MODIFIER||||||FRMD6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,87:162:0.537
chr14	51868614	.	C	T	.	PASS	CSQ=54331|protein_coding||intron_variant||||rs879332523||9.2115e-05|NM_053064.4:c.-71+7824C>T||MODIFIER||||||GNG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	65,83:148:0.5608
chr14	51970320	.	G	A	.	PASS	CSQ=54331|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||GNG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	74,93:167:0.5569
chr14	52081898	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	78,85:163:0.5215
chr14	52458546	.	C	CA	.	PASS	CSQ=57544|protein_coding||intron_variant||||rs201655887||0.0866276|NM_020784.3:c.1619-1373dup||MODIFIER||||||TXNDC16|EntrezGene|0.0968;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	96,74:170:0.4353
chr14	52487213	.	C	A	.	PASS	CSQ=57544|protein_coding||intron_variant|||||||NM_020784.3:c.1108+1150G>T||MODIFIER||||||TXNDC16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	79,80:159:0.5031
chr14	53279502	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1429939863||2.62957e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	75,74:149:0.4966
chr14	53597185	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	64,76:140:0.5429
chr14	53834295	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	66,73:139:0.5252
chr14	54235078	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	77,77:154:0.5
chr14	54397267	.	G	T	.	PASS	CSQ=1033|protein_coding||intron_variant|||||||NM_005192.4:c.9+190G>T||MODIFIER||||||CDKN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	110,113:223:0.5067
chr14	54750208	.	C	T	.	PASS	CSQ=23034|protein_coding||intron_variant|||||||NM_015589.5:c.1090-1243C>T||MODIFIER||||||SAMD4A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	82,70:152:0.4605
chr14	54804021	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	89,88:177:0.4972
chr14	54954513	.	G	A	.	PASS	CSQ=11169|protein_coding||intron_variant|||||||NM_007086.4:c.3050+1048C>T||MODIFIER||||||WDHD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	79,85:164:0.5183
chr14	55346839	.	C	T	.	PASS	CSQ=55030|protein_coding||intron_variant|||||||NM_017943.4:c.-10-3542C>T||MODIFIER||||||FBXO34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	70,68:138:0.4928
chr14	55966262	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs532235050||6.57367e-06|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	78,81:159:0.5094
chr14	56128503	.	C	T	.	PASS	CSQ=57161|protein_coding||intron_variant|||||||NM_021255.3:c.77+9766C>T||MODIFIER||||||PELI2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	132,13:145:0.0897
chr14	56382309	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	93,66:159:0.4151
chr14	56403051	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,1:118:0.0085	76,81:157:0.5159
chr14	56426412	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	66,70:136:0.5147
chr14	56921125	.	T	A	.	PASS	CSQ=100309464|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||OTX2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,1:127:0.0079	66,78:144:0.5417
chr14	57005437	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs979929850||5.26815e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	66,69:135:0.5111
chr14	57148532	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	76,73:149:0.4899
chr14	57185410	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs1180682429|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	68,76:144:0.5278
chr14	57903864	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	66,75:141:0.5319
chr14	57922556	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	101,39:140:0.2786
chr14	58219137	.	T	A	.	PASS	CSQ=55860|protein_coding||intron_variant|||||||NM_018477.3:c.599-557T>A||MODIFIER||||||ACTR10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	87,63:150:0.42
chr14	58512628	.	G	A	.	PASS	CSQ=9786|protein_coding||splice_donor_variant|||||||NM_001329943.2:c.4429+1G>A||HIGH||||||KIAA0586|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	131,0:131:0	86,79:165:0.4788
chr14	58753957	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	136,38:174:0.2184
chr14	58833593	.	C	T	.	PASS	CSQ=102723742|lncRNA||intron_variant&non_coding_transcript_variant||||rs1236200995||1.97104e-05|NR_110547.1:n.268+5038C>T||MODIFIER||||||LINC01500|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	79,94:173:0.5434
chr14	59145905	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	77,67:144:0.4653
chr14	59410610	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	80,71:151:0.4702
chr14	59550527	.	G	A	.	PASS	CSQ=729665|protein_coding||intron_variant|||||||NM_001164399.2:c.1035+828C>T||MODIFIER||||||CCDC175|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	67,76:143:0.5315
chr14	59683538	.	G	C	.	PASS	CSQ=6252|protein_coding||intron_variant|||||||NM_021136.3:c.1765+43381C>G||MODIFIER||||||RTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	71,89:160:0.5563
chr14	59715841	.	T	A	.	PASS	CSQ=6252|protein_coding||intron_variant||||rs919787701|||NM_021136.3:c.1765+11078A>T||MODIFIER||||||RTN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	72,80:152:0.5263
chr14	60005633	.	G	A	.	PASS	CSQ=341883|protein_coding||intron_variant|||||||NM_001355272.2:c.2843-764G>A||MODIFIER||||||LRRC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	72,89:161:0.5528
chr14	60041741	.	C	T	.	PASS	CSQ=341883|protein_coding||intron_variant|||||||NM_001355272.2:c.3990+9678C>T||MODIFIER||||||LRRC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	131,20:151:0.1325
chr14	60325694	.	G	T	.	PASS	CSQ=101927729|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC02322|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	76,90:166:0.5422
chr14	60465818	.	A	T	.	PASS	CSQ=317761|protein_coding||intron_variant|||||||NM_174978.3:c.972+161T>A||MODIFIER||||||C14orf39|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	61,76:137:0.5547
chr14	60600407	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs571809145||0.000197125|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,84:164:0.5122
chr14	60775140	.	GAGAA	G	.	PASS	CSQ=4331|protein_coding||intron_variant||||rs1410383814||6.57134e-06|NM_002431.4:c.90-21073_90-21070del||MODIFIER||||||MNAT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	72,73:145:0.5034
chr14	60918508	.	AATTGTTCATTTTTACATGATTTTCTCCCTTCCAAATACCTTTATGTGGACACTTGCCAATATC	A	.	PASS	CSQ=4331|protein_coding||intron_variant|||||||NM_002431.4:c.809+38677_809+38739del||MODIFIER||||||MNAT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=mantaSV	AD:DP:AF	163,0:163:0.006159	112,65:177:0.393
chr14	61366165	.	A	G	.	PASS	CSQ=5583|protein_coding||intron_variant|||||||NM_006255.4:c.364-25060A>G||MODIFIER||||||PRKCH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	87,76:163:0.4663
chr14	61539768	.	G	C	.	PASS	CSQ=5583|protein_coding||intron_variant|||||||NM_006255.4:c.1762-7975G>C||MODIFIER||||||PRKCH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	98,86:184:0.4674
chr14	61587196	.	C	T	.	PASS	CSQ=400221|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_039985.1:n.221+16436C>T||MODIFIER||||||FLJ22447|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	69,81:150:0.54
chr14	61625097	.	C	G	.	PASS	CSQ=400221|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_039985.1:n.222-25865C>G||MODIFIER||||||FLJ22447|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	80,73:153:0.4771
chr14	61945810	.	C	T	.	PASS	CSQ=83851|protein_coding||intron_variant||||rs1273329083|||NM_001367661.1:c.-324-24322C>T||MODIFIER||||||SYT16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	94,85:179:0.4749
chr14	62483517	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,1:146:0.0068	141,10:151:0.0662
chr14	62727642	.	C	G	.	PASS	CSQ=27133|protein_coding||intron_variant|||||||NM_139318.5:c.2020-19187G>C||MODIFIER||||||KCNH5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	72,64:136:0.4706
chr14	62744004	.	G	C	.	PASS	CSQ=27133|protein_coding||intron_variant|||||||NM_139318.5:c.2020-35549C>G||MODIFIER||||||KCNH5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	73,79:152:0.5197
chr14	62803057	.	G	T	.	PASS	CSQ=27133|protein_coding||intron_variant|||||||NM_139318.5:c.1570-476C>A||MODIFIER||||||KCNH5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	128,29:157:0.1847
chr14	63169123	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	75,89:164:0.5427
chr14	63173531	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs111852920||0.0025565|||MODIFIER||||||||0.0036;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:132:0	65,95:160:0.5938
chr14	63433838	.	G	A	.	PASS	CSQ=5529|protein_coding||intron_variant||||rs1458776043||6.57212e-06|NM_006246.5:c.355-11744C>T||MODIFIER||||||PPP2R5E|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	107,11:118:0.0932
chr14	63566483	.	GT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	89,69:158:0.4367
chr14	63717063	.	A	G	.	PASS	CSQ=81537|protein_coding||intron_variant|||||||NM_030791.4:c.684+10198T>C||MODIFIER||||||SGPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	84,78:162:0.4815
chr14	63851672	COSV58359889;COSV58359889;COSV58359889;COSV58359889;COSV58359889	G	T	.	PASS	CSQ=23224|protein_coding||upstream_gene_variant|||COSV58359889&COSV58359889&COSV58359889&COSV58359889&COSV58359889||||||MODIFIER||||||SYNE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	56,67:123:0.5447
chr14	64455700	.	A	G	.	PASS	CSQ=4522|protein_coding||intron_variant||||rs1213533465||1.97052e-05|NM_005956.4:c.2718+825A>G||MODIFIER||||||MTHFD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	83,101:184:0.5489
chr14	64922052	.	G	A	.	PASS	CSQ=91612|protein_coding||intron_variant||||rs1284539404||6.5722e-06|NM_001204063.1:c.121-1939G>A||MODIFIER||||||CHURC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	72,72:145:0.4966
chr14	65229372	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	70,77:147:0.5238
chr14	65314170	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	67,69:136:0.5074
chr14	66111695	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	78,30:108:0.2778
chr14	66179680	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	71,58:129:0.4496
chr14	66254114	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs780197242||0.000203738|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	78,80:159:0.5031
chr14	66383364	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	79,68:147:0.4626
chr14	66545254	.	G	A	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.64+36663G>A||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	77,52:130:0.4
chr14	66618967	.	C	T	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.65-62140C>T||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	79,78:157:0.4968
chr14	66888054	.	G	A	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+8021G>A||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	75,73:148:0.4932
chr14	66890113	.	G	C	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+10080G>C||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	89,70:160:0.4375
chr14	66890398	.	G	C	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+10365G>C||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	59,51:111:0.4595
chr14	66891100	.	G	C	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+11067G>C||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	67,79:146:0.5411
chr14	66891105	.	G	A	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+11072G>A||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	72,77:149:0.5168
chr14	66891702	.	G	T	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+11669G>T||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	75,94:169:0.5562
chr14	66892682	.	G	A	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+12649G>A||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	94,81:175:0.4629
chr14	66893532	.	G	C	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+13499G>C||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:138:0	69,84:153:0.549
chr14	66893817	.	G	A	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.389+13784G>A||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	81,64:145:0.4414
chr14	66996651	.	A	T	.	PASS	CSQ=10243|protein_coding||intron_variant|||||||NM_020806.4:c.964-26982A>T||MODIFIER||||||GPHN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPHN|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	89,88:177:0.4972
chr14	67304019	.	C	T	.	PASS	CSQ=64398|protein_coding||intron_variant||||rs1159770742||6.58614e-06|NM_022474.3:c.1041+420C>T||MODIFIER||||||MPP5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	81,79:160:0.4938
chr14	67508349	.	C	T	.	PASS	CSQ=161145|protein_coding||intron_variant|||||||NM_001348544.1:c.-256-4798G>A||MODIFIER||||||TMEM229B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	62,72:134:0.5373
chr14	68073227	.	A	G	.	PASS	CSQ=5890|protein_coding||intron_variant|||||||NM_001321814.1:c.756+186023A>G||MODIFIER||||||RAD51B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RAD51B|y|n|lipoma,uterine_leiomyoma|||M|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	83,92:175:0.5257
chr14	68362848	.	C	CA	.	PASS	CSQ=5890|protein_coding||intron_variant||||rs796123570||0.00917335|NM_001321814.1:c.854-48566dup||MODIFIER||||||RAD51B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RAD51B|y|n|lipoma,uterine_leiomyoma|||M|Dom|TSG,fusion|T;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	99,72:171:0.4211
chr14	68373952	.	T	C	.	PASS	CSQ=5890|protein_coding||intron_variant|||||||NM_001321814.1:c.854-37472T>C||MODIFIER||||||RAD51B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RAD51B|y|n|lipoma,uterine_leiomyoma|||M|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	65,85:150:0.5667
chr14	68489606	.	A	T	.	PASS	CSQ=5890|protein_coding||intron_variant|||||||NM_001321814.1:c.1036+21356A>T||MODIFIER||||||RAD51B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RAD51B|y|n|lipoma,uterine_leiomyoma|||M|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	73,91:164:0.5549
chr14	68857259	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	68,66:134:0.4925
chr14	68986629	.	C	T	.	PASS	CSQ=161159|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_073422.1:n.481-716C>T||MODIFIER||||||ACTN1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	80,96:176:0.5455
chr14	69365783	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs147678983||0.140963|||MODIFIER||||||||0.1262;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	96,60:156:0.3846
chr14	69448001	.	C	T	.	PASS	CSQ=55334|protein_coding||intron_variant|||||||NM_018375.5:c.404-5240C>T||MODIFIER||||||SLC39A9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	79,91:170:0.5353
chr14	69519274	.	A	T	.	PASS	CSQ=400224|protein_coding||intron_variant|||||||NM_001161498.2:c.556-3009A>T||MODIFIER||||||PLEKHD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	62,81:143:0.5664
chr14	69578794	.	A	T	.	PASS	CSQ=56936|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CCDC177|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	83,77:160:0.4813
chr14	69859969	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	84,94:178:0.5281
chr14	70280487	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	65,63:128:0.4922
chr14	70586766	.	CA	C	.	PASS	CSQ=10001|protein_coding||intron_variant|||||||NM_005466.3:c.583-984del||MODIFIER||||||MED6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	74,84:158:0.5316
chr14	70676344	.	CTAAGAGACTTGGGTCAG	C	.	PASS	CSQ=23508|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TTC9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	87,82:169:0.4852
chr14	71012987	.	C	T	.	PASS	CSQ=22990|protein_coding||splice_region_variant&synonymous_variant||||rs766745613|3.97785e-06||NM_014982.2:c.2781C>T|NP_055797.2:p.Leu927=|LOW||||||PCNX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	89,91:180:0.5056
chr14	71344058	.	AT	A	.	PASS	CSQ=26037|protein_coding||intron_variant||||||6.5767e-06|NM_001284245.2:c.-574+22885del||MODIFIER||||||SIPA1L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	87,82:169:0.4852
chr14	71380393	.	C	T	.	PASS	CSQ=26037|protein_coding||intron_variant|||||||NM_001284245.2:c.-573-33555C>T||MODIFIER||||||SIPA1L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	65,77:142:0.5423
chr14	72117664	.	G	A	.	PASS	CSQ=9628|protein_coding||intron_variant|||||||NM_001204424.2:c.84+152789G>A||MODIFIER||||||RGS6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:120:0	88,90:178:0.5056
chr14	72146660	.	G	A	.	PASS	CSQ=9628|protein_coding||intron_variant|||||||NM_001204424.2:c.84+181785G>A||MODIFIER||||||RGS6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	80,72:152:0.4737
chr14	72361954	.	G	A	.	PASS	CSQ=9628|protein_coding||intron_variant|||||||NM_001204424.2:c.184+9760G>A||MODIFIER||||||RGS6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	78,88:166:0.5301
chr14	72380600	.	T	C	.	PASS	CSQ=9628|protein_coding||intron_variant|||||||NM_001204424.2:c.184+28406T>C||MODIFIER||||||RGS6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,82:159:0.5157
chr14	72387076	.	C	A	.	PASS	CSQ=9628|protein_coding||intron_variant|||||||NM_001204424.2:c.184+34882C>A||MODIFIER||||||RGS6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	121,41:162:0.2531
chr14	73033201	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	69,94:163:0.5767
chr14	73218003	.	C	G	.	PASS	CSQ=5663|protein_coding||intron_variant|||||||NM_000021.4:c.1248+759C>G||MODIFIER||||||PSEN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	72,63:135:0.4667
chr14	73311191	.	G	T	.	PASS	CSQ=8650|protein_coding||intron_variant|||||||NM_001005744.1:c.234+5199C>A||MODIFIER||||||NUMB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	121,35:156:0.2244
chr14	73589412	.	C	A	.	PASS	CSQ=122970|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ACOT4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	81,78:159:0.4906
chr14	73800705	.	C	T	.	PASS	CSQ=100506476|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109995.1:n.241-2180C>T||MODIFIER||||||LOC100506476|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,74:153:0.4837
chr14	73900054	.	G	T	.	PASS	CSQ=57862|protein_coding||intron_variant|||||||NM_021188.2:c.580+1792G>T||MODIFIER||||||ZNF410|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	114,32:146:0.2192
chr14	74485093	.	G	A	.	PASS	CSQ=100616211|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR4709|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	78,59:137:0.4307
chr14	74485196	.	G	A	.	PASS	CSQ=100616211|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR4709|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	70,74:144:0.5139
chr14	74512186	.	G	C	.	PASS	CSQ=4053|protein_coding||intron_variant|||||||NM_000428.3:c.2909-822C>G||MODIFIER||||||LTBP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	81,88:169:0.5207
chr14	75271411	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	66,71:137:0.5182
chr14	76720481	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	69,89:158:0.5633
chr14	77204874	.	G	A	.	PASS	CSQ=57156|protein_coding||intron_variant|||||||NM_020431.4:c.-76-8572G>A||MODIFIER||||||TMEM63C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	81,78:159:0.4906
chr14	77496765	.	C	A	.	PASS	CSQ=145501|protein_coding||intron_variant|||||||NM_199296.3:c.141+1888G>T||MODIFIER||||||ISM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	75,0:75:0	49,43:92:0.4674
chr14	77691217	.	T	A	.	PASS	CSQ=8846|protein_coding||intron_variant|||||||NM_006020.3:c.455+3521A>T||MODIFIER||||||ALKBH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	83,84:167:0.503
chr14	77898601	.	TGGACACAGGGAGGGGAACAACACACCTGGG	T	.	PASS	CSQ=57143|protein_coding||intron_variant|||||||NM_020421.4:c.583-497_583-468del||MODIFIER||||||ADCK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	99,55:154:0.3571
chr14	77898661	.	G	A	.	PASS	CSQ=57143|protein_coding||intron_variant||||rs1159500908|||NM_020421.4:c.583-439G>A||MODIFIER||||||ADCK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	89,63:152:0.4145
chr14	78298476	.	C	G	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.757+616C>G||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	84,87:171:0.5088
chr14	78370198	.	C	A	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.757+72338C>A||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	67,74:141:0.5248
chr14	78472826	.	G	C	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.758-172294G>C||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	71,79:150:0.5267
chr14	79147369	.	C	G	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.3262+159228C>G||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	74,71:145:0.4897
chr14	79148684	.	C	A	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.3262+160543C>A||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	135,5:140:0.0357
chr14	79322942	.	A	T	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.3263-144279A>T||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	89,82:171:0.4795
chr14	79495173	.	C	T	.	PASS	CSQ=9369|protein_coding||intron_variant||||rs1006227317||0.000124896|NM_001330195.1:c.3444+27771C>T||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	65,80:145:0.5517
chr14	79505203	.	G	A	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.3444+37801G>A||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:88:0	60,68:128:0.5312
chr14	79526368	.	A	T	.	PASS	CSQ=9369|protein_coding||intron_variant||||rs536936646||2.63296e-05|NM_001330195.1:c.3444+58966A>T||MODIFIER||||||NRXN3|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	56,74:130:0.5692
chr14	79578852	.	T	A	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.3445-84926T>A||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	120,7:127:0.0551
chr14	79772092	.	G	T	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.4015-33020G>T||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	79,55:134:0.4104
chr14	79799439	.	G	A	.	PASS	CSQ=9369|protein_coding||intron_variant|||||||NM_001330195.1:c.4015-5673G>A||MODIFIER||||||NRXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	81,57:138:0.413
chr14	80076104	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	62,55:117:0.4701
chr14	80185044	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1224406895||0.0104682|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	71,64:136:0.4706
chr14	81057697	.	G	A	.	PASS	CSQ=7253|protein_coding||intron_variant|||||||NM_000369.2:c.171-4451G>A||MODIFIER||||||TSHR|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TSHR|y|y|toxic_thyroid_adenoma|thyroid_adenoma||E|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	66,77:143:0.5385
chr14	81113563	.	G	A	.	PASS	CSQ=7253|protein_coding||intron_variant|||||||NM_000369.2:c.692+5111G>A||MODIFIER||||||TSHR|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TSHR|y|y|toxic_thyroid_adenoma|thyroid_adenoma||E|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	110,45:155:0.2903
chr14	81114372	.	G	A	.	PASS	CSQ=7253|protein_coding||intron_variant||||rs1039765272||7.22619e-05|NM_000369.2:c.692+5920G>A||MODIFIER||||||TSHR|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TSHR|y|y|toxic_thyroid_adenoma|thyroid_adenoma||E|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	159,0:159:0	98,75:173:0.4335
chr14	81619144	.	G	T	.	PASS	CSQ=101928559|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110074.1:n.409+3509C>A||MODIFIER||||||LINC01467|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	66,93:159:0.5849
chr14	81686410	.	A	AAC	.	PASS	CSQ=|||intergenic_variant||||rs1024185313||0.000225297|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	113,0:113:0	68,64:132:0.4848
chr14	81788160	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs67010075||0.0812614|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	69,60:131:0.458
chr14	81916743	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	127,9:136:0.0662
chr14	82064159	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1480893407||6.57324e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	69,94:163:0.5767
chr14	82199009	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs578109533||5.91358e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	75,77:152:0.5066
chr14	82225847	COSV50267789	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV50267789|rs1394350411||0.00235345|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	70,63:136:0.4632
chr14	82318544	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1301131075||9.27582e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	72,49:121:0.405
chr14	82371125	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	83,65:148:0.4392
chr14	82449185	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	92,70:162:0.4321
chr14	82483597	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,52:116:0.4483
chr14	82573340	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	61,74:135:0.5481
chr14	82742827	.	T	TTATTAG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	83,0:83:0	80,29:109:0.2661
chr14	82974656	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	67,79:146:0.5411
chr14	82984248	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	62,60:122:0.4918
chr14	83097374	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	61,76:137:0.5547
chr14	83103494	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1409933139||3.95278e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	54,47:101:0.4653
chr14	83127267	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	114,0:114:0	85,46:131:0.3511
chr14	83141974	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	68,76:144:0.5278
chr14	83261484	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	80,85:165:0.5152
chr14	83455825	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	73,48:121:0.3967
chr14	83508261	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	69,72:142:0.507
chr14	83665789	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	65,80:145:0.5517
chr14	83708269	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	79,59:138:0.4275
chr14	83789922	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	59,61:120:0.5083
chr14	83803294	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	53,69:122:0.5656
chr14	83925075	.	GTAACCTAC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	79,58:137:0.4234
chr14	83935581	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	67,58:125:0.464
chr14	84002398	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	69,81:150:0.54
chr14	84070024	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	61,56:117:0.4786
chr14	84141492	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1435862841||3.31227e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	68,74:143:0.5175
chr14	84206520	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	76,66:142:0.4648
chr14	84356386	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs200839060||0.00164015|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	72,59:131:0.4504
chr14	84653249	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	70,65:135:0.4815
chr14	84704963	.	CT	AG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	110,0:110:0	131,17:148:0.1149
chr14	84762415	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs991658032||6.58016e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	117,49:166:0.2952
chr14	84817915	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57134e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	88,82:170:0.4824
chr14	84817916	.	TGTG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	85,83:168:0.494
chr14	84941650	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,1:144:0.0069	83,78:161:0.4845
chr14	84945478	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	144,8:152:0.0526
chr14	85110720	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	75,74:149:0.4966
chr14	85232452	.	CTTTCCCTTATGATCTTG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	156,10:166:0.0602
chr14	85236028	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	62,67:129:0.5194
chr14	85258912	.	TCAGAGAAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	67,55:122:0.4508
chr14	85348058	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	67,80:147:0.5442
chr14	85483417	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	67,59:126:0.4683
chr14	85699807	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	75,71:146:0.4863
chr14	85722085	.	TG	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	104,0:104:0	76,67:143:0.4685
chr14	85759331	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	65,85:150:0.5667
chr14	85883397	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	71,67:138:0.4855
chr14	86004338	.	T	C	.	PASS	CSQ=101928767|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110155.1:n.185-66525T>C||MODIFIER||||||LINC02328|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	65,64:129:0.4961
chr14	86293727	.	AATGG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	66,66:132:0.5
chr14	86397788	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	55,57:112:0.5089
chr14	86502149	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	73,68:141:0.4823
chr14	86789859	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	80,64:144:0.4444
chr14	87063716	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	72,51:123:0.4146
chr14	87082328	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1041851949||6.56944e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	81,58:139:0.4173
chr14	87131606	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	46,67:113:0.5929
chr14	87135329	COSV61204584	G	GT	.	PASS	CSQ=|||intergenic_variant|||COSV61204584|rs373539553||0.000292452|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,61:138:0.442
chr14	87169908	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1008107484||3.94415e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	68,63:131:0.4809
chr14	87288020	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	80,65:145:0.4483
chr14	87594332	.	CC	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	122,0:122:0	70,61:131:0.4656
chr14	87606155	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	74,58:132:0.4394
chr14	87650526	.	G	T	.	PASS	CSQ=105370611|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146551.1:n.164+4605C>A||MODIFIER||||||LINC02330|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	73,64:137:0.4672
chr14	87872475	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	63,56:119:0.4706
chr14	88378850	.	CA	C	.	PASS	CSQ=|||intergenic_variant||||||2.00631e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	74,83:157:0.5287
chr14	88454294	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1022500517||0.000124972|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	126,5:131:0.0382
chr14	88694000	.	T	A	.	PASS	CSQ=161436|protein_coding||intron_variant|||||||NM_183387.3:c.2539+307A>T||MODIFIER||||||EML5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	80,66:146:0.4521
chr14	88877785	.	G	A	.	PASS	CSQ=123016|protein_coding||3_prime_UTR_variant|||||||NM_198309.3:c.*375G>A||MODIFIER||||||TTC8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:111:0	74,84:158:0.5316
chr14	88900395	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs925583591||0.000240903|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,1:131:0.0076	85,73:158:0.462
chr14	89083400	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	83,68:151:0.4503
chr14	89200421	.	G	C	.	PASS	CSQ=1112|protein_coding||intron_variant|||||||NM_005197.3:c.746-19615C>G||MODIFIER||||||FOXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	58,69:127:0.5433
chr14	89448187	.	G	C	.	PASS	CSQ=1112|protein_coding||intron_variant|||||||NM_001085471.1:c.-14-35697C>G||MODIFIER||||||FOXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	75,79:154:0.513
chr14	89641891	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,1:137:0.0073	77,68:145:0.469
chr14	89998026	.	A	T	.	PASS	CSQ=55775|protein_coding||intron_variant|||||||NM_018319.3:c.1541+4543A>T||MODIFIER||||||TDP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	76,58:134:0.4328
chr14	90155232	.	G	A	.	PASS	CSQ=56659|protein_coding||intron_variant||||rs891740274||6.57367e-06|NM_022054.4:c.335-28879G>A||MODIFIER||||||KCNK13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	81,75:156:0.4808
chr14	90405321	.	G	C	.	PASS	CSQ=801|protein_coding||3_prime_UTR_variant||||rs927021519||6.57056e-06|NM_006888.6:c.*604G>C||MODIFIER||||||CALM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	81,68:149:0.4564
chr14	90530094	.	C	G	.	PASS	CSQ=145567|protein_coding||3_prime_UTR_variant|||||||NM_001010854.2:c.*11274G>C||MODIFIER||||||TTC7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	67,66:133:0.4962
chr14	90649724	.	C	G	.	PASS	CSQ=145567|protein_coding||intron_variant|||||||NM_001010854.2:c.1518-2701G>C||MODIFIER||||||TTC7B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	61,97:158:0.6139
chr14	91438748	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	83,90:173:0.5202
chr14	91522204	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	70,82:152:0.5395
chr14	91541654	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs915452581||0.00027529|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	91,54:145:0.3724
chr14	91750942	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	62,74:136:0.5441
chr14	91801150	.	TCA	T	.	PASS	CSQ=123036|protein_coding||intron_variant||||rs918208243||0.000118555|NM_001128596.3:c.470-780_470-779del||MODIFIER||||||TC2N|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	89,74:163:0.454
chr14	92073292	.	C	T	.	PASS	CSQ=4287|protein_coding||intron_variant|||||||NM_004993.5:c.873-2239G>A||MODIFIER||||||ATXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	98,93:191:0.4869
chr14	92663850	.	T	C	.	PASS	CSQ=79890|protein_coding||intron_variant|||||||NM_024832.5:c.2335+4381T>C||MODIFIER||||||RIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:129:0	79,85:164:0.5183
chr14	92994037	.	G	T	.	PASS	CSQ=3705|protein_coding||intron_variant|||||||NM_014216.6:c.247-40C>A||MODIFIER||||||ITPK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	150,0:150:0	97,79:176:0.4489
chr14	93287050	.	G	C	.	PASS	CSQ=55727|protein_coding||intron_variant|||||||NM_001002860.4:c.1162+6808C>G||MODIFIER||||||BTBD7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	76,75:151:0.4967
chr14	93406250	.	G	T	.	PASS	CSQ=57578|protein_coding||intron_variant|||||||NM_020818.4:c.-350-61421G>T||MODIFIER||||||UNC79|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	83,89:172:0.5174
chr14	93424956	.	C	T	.	PASS	CSQ=57578|protein_coding||intron_variant||||rs562179287||4.60302e-05|NM_020818.4:c.-350-42715C>T||MODIFIER||||||UNC79|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	158,11:169:0.0651
chr14	93466147	.	G	C	.	PASS	CSQ=57578|protein_coding||intron_variant|||||||NM_001346218.1:c.23-1524G>C||MODIFIER||||||UNC79|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	90,81:171:0.4737
chr14	93598199	.	C	G	.	PASS	CSQ=57578|protein_coding||intron_variant|||||||NM_001346218.1:c.3372+659C>G||MODIFIER||||||UNC79|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	83,80:163:0.4908
chr14	93777312	.	CC	AA	.	PASS	CSQ=145270|protein_coding||intron_variant|||||||NM_178013.4:c.229+1863_229+1864delinsTT||MODIFIER||||||PRIMA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	101,0:101:0	73,73:146:0.5
chr14	94008902	.	G	A	.	PASS	CSQ=256369|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CCDC197|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,0:127:0	75,83:158:0.5253
chr14	94398568	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1216337439||1.97104e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	94,96:190:0.5053
chr14	94610364	.	A	C	.	PASS	CSQ=12|protein_coding||upstream_gene_variant||||rs371474872||0.0755307|||MODIFIER||||||SERPINA3|EntrezGene|0.0563;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	69,0:69:0	71,34:105:0.3238
chr14	94882585	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	164,8:172:0.0465
chr14	94954451	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1025148677||6.57203e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,1:143:0.007	73,76:149:0.5101
chr14	95138978	.	A	T	.	PASS	CSQ=23405|protein_coding||intron_variant||||rs867908273||0.0388926|NM_177438.2:c.-45-5475T>A||MODIFIER||||||DICER1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/DICER1|y|y|sex_cord-stromal_tumour,TGCT,embryonal_rhabdomyosarcoma,pleuropulmonary_blastoma,pituitary_blastoma,Wilms_tumour,thyroid_cancer,other_tumour_types|pleuropulmonary_blastoma|familial_pleuropulmonary_blastoma_or_DICER1_syndrome|E,M,O|Rec|TSG|Mis,F,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	83,67:150:0.4467
chr14	95165219	.	A	G	.	PASS	CSQ=400242|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_015415.1:n.373+6184A>G||MODIFIER||||||DICER1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	75,84:159:0.5283
chr14	95456335	.	A	G	.	PASS	CSQ=161176|protein_coding||intron_variant|||||||NM_001363692.1:c.790-611T>C||MODIFIER||||||SYNE3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	76,58:134:0.4328
chr14	95588531	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	70,68:138:0.4928
chr14	95925097	.	C	T	.	PASS	CSQ=100507043|lncRNA||non_coding_transcript_exon_variant|||||||NR_132399.1:n.2465C>T||MODIFIER||||||TUNAR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	134,0:134:0	95,73:168:0.4345
chr14	95930193	.	G	T	.	PASS	CSQ=100507043|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||TUNAR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	78,81:159:0.5094
chr14	96609541	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	63,84:148:0.5676
chr14	96623030	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	77,66:143:0.4615
chr14	96658041	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	92,73:165:0.4424
chr14	96659471	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs566521193||0.00469089|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	83,61:145:0.4207
chr14	96961762	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1278069986||5.98221e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	96,64:160:0.4
chr14	97033798	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	79,74:153:0.4837
chr14	97080300	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	71,66:137:0.4818
chr14	97125587	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs764459677||7.23532e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	67,67:134:0.5
chr14	97419736	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	74,48:122:0.3934
chr14	97420684	.	GCTTAGGGCTTTCTCAGTTTTAATACTGAAAGTCTGAA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	86,76:162:0.4691
chr14	97675606	.	G	GA	.	PASS	CSQ=100129345|lncRNA||intron_variant&non_coding_transcript_variant||||rs200606710||0.00154243|NR_033943.1:n.301-2165dup||MODIFIER||||||LINC02291|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	82,55:137:0.4015
chr14	97777692	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	70,77:147:0.5238
chr14	97889556	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	54,49:103:0.4757
chr14	98190716	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	57,63:120:0.525
chr14	98313277	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	138,5:143:0.035
chr14	98372402	COSV65723482	G	GA	.	PASS	CSQ=|||intergenic_variant|||COSV65723482|rs566264136||0.000449894|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	61,49:110:0.4455
chr14	98526550	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs369410593||8.54566e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	49,62:111:0.5586
chr14	98575811	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	88,64:152:0.4211
chr14	98576718	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57722e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	69,68:137:0.4964
chr14	98590790	.	TAAAAAATTAATTAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	78,61:139:0.4388
chr14	98610303	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	65,55:120:0.4583
chr14	98652769	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	81,73:154:0.474
chr14	99157512	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	73,97:170:0.5706
chr14	99211966	.	C	A	.	PASS	CSQ=64919|protein_coding||intron_variant||||rs1360323915||6.57583e-06|NM_138576.4:c.640+19379G>T||MODIFIER||||||BCL11B|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/BCL11B|y|n|T-ALL|||L|Dom|oncogene,TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	73,71:144:0.4931
chr14	99439686	.	TTATATGTATTTATATTTTTATACATATAAA	T	.	PASS	CSQ=84193|protein_coding||intron_variant||||rs1485252500||0.00010835|NM_032233.3:c.675+18563_675+18592del||MODIFIER||||||SETD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	90,71:161:0.441
chr14	100578720	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	78,75:153:0.4902
chr14	100729863	.	C	T	.	PASS	CSQ=8788|protein_coding||intron_variant|||||||NM_003836.6:c.262+797C>T||MODIFIER||||||DLK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	72,68:140:0.4857
chr14	100965478	.	GGTGGCTCATGCCT	G	.	PASS	CSQ=767589|snoRNA||upstream_gene_variant|||||||||MODIFIER||||||SNORD114-11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	96,54:150:0.36
chr14	101150287	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1020279226||3.28571e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	159,0:160:0	91,78:169:0.4615
chr14	101259692	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	84,82:166:0.494
chr14	101352114	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	72,67:139:0.482
chr14	101369813	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	76,75:151:0.4967
chr14	102147815	.	C	G	.	PASS	CSQ=91833|protein_coding||intron_variant|||||||NM_144574.3:c.249+7643C>G||MODIFIER||||||WDR20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	97,82:179:0.4581
chr14	102500092	.	T	C	.	PASS	CSQ=122416|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ANKRD9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	129,0:129:0	200,43:243:0.177
chr14	102709061	.	A	C	.	PASS	CSQ=23186|protein_coding||intron_variant|||||||NM_015156.4:c.779+478A>C||MODIFIER||||||RCOR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:106:0.0094	150,81:232:0.3491
chr14	102784000	.	C	T	.	PASS	CSQ=7187|protein_coding||intron_variant|||||||NM_145725.2:c.-157+6325C>T||MODIFIER||||||TRAF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	82,77:159:0.4843
chr14	103296845	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	100,75:175:0.4286
chr14	103507736	.	G	T	.	PASS	CSQ=4140|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MARK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	89,95:184:0.5163
chr14	104450820	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57194e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	153,10:163:0.0613
chr14	104488905	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	79,80:159:0.5031
chr14	105302267	.	G	C	.	PASS	CSQ=23241|protein_coding||intron_variant|||||||NM_001243127.2:c.-83+1288G>C||MODIFIER||||||PACS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	64,0:64:0	105,15:121:0.124
chr14	105302956	.	G	A	.	PASS	CSQ=2972|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||BRF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	157,16:173:0.0925
chr14	105380146	.	G	A	.	PASS	CSQ=23241|protein_coding||missense_variant|||||||NM_015197.3:c.1117G>A|NP_056012.2:p.Val373Met|MODERATE|.&B&B&.|T&T&T&T|N|T&T&T&T|T&T&T&T|PACS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	71,97:168:0.5774
chr14	105605347	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	97,71:168:0.4226
chr14	105729466	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1343452410||6.59274e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	80,70:150:0.4667
chr14	105778020	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	60,77:137:0.562
chr14	106156481	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	70,67:138:0.4855
chr14	106157551	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	75,66:141:0.4681
chr14	106375450	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	126,6:132:0.0455
chr14	106671677	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	66,64:130:0.4923
chr15	19835348	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs374289619|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	59,75:134:0.5597
chr15	20065501	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	263,0:263:0	254,49:303:0.1617
chr15	20065516	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	238,0:238:0	223,41:265:0.1547
chr15	20243485	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	372,1:373:0.0027	362,54:416:0.1298
chr15	20256951	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	370,2:372:0.0054	398,60:458:0.131
chr15	20270831	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	412,1:414:0.0024	398,74:472:0.1568
chr15	20360662	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1479762961|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	428,0:428:0	419,74:493:0.1501
chr15	20413904	.	A	T	.	PASS	CSQ=283755|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_036432.1:n.3946-5175T>A||MODIFIER||||||HERC2P3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	446,0:446:0	408,81:489:0.1656
chr15	20643813	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	413,0:413:0	446,53:499:0.1062
chr15	20656416	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	345,0:345:0	377,77:454:0.1696
chr15	21275954	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	222,0:222:0	177,37:214:0.1729
chr15	21291164	.	T	TA	.	PASS	CSQ=646214|transcribed_pseudogene||non_coding_transcript_exon_variant||||rs1317290496||0.000209849|NR_027053.2:n.6665dup||MODIFIER||||||LOC646214|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	68,80:148:0.5405
chr15	21325382	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1426368902||1.37076e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	162,0:162:0	145,36:181:0.1989
chr15	21921660	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	187,0:188:0	187,39:226:0.1726
chr15	22259035	.	G	A	.	PASS	CSQ=646396|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_033735.1:n.265+157G>A||MODIFIER||||||REREP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	216,0:217:0	221,39:262:0.1489
chr15	22607514	.	G	C	.	PASS	CSQ=283796|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||GOLGA8IP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	183,0:183:0	141,100:241:0.4149
chr15	23611317	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	145,12:157:0.0764
chr15	23646663	.	C	T	.	PASS	CSQ=54551|protein_coding||synonymous_variant||||rs1191799957|8.98456e-06|1.97353e-05|NM_019066.5:c.1080G>A|NP_061939.3:p.Ala360=|LOW||||||MAGEL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	124,0:124:0	101,69:170:0.4059
chr15	23757309	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	64,66:130:0.5077
chr15	23805091	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	72,57:129:0.4419
chr15	23864596	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	61,66:127:0.5197
chr15	24348368	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1048340327||5.2633e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	82,50:132:0.3788
chr15	24411446	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	74,56:130:0.4308
chr15	24429474	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	82,65:147:0.4422
chr15	24491716	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	57,72:129:0.5581
chr15	24869629	.	C	T	.	PASS	CSQ=104472715|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146177.1:n.325-16887C>T||MODIFIER||||||SNHG14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	68,70:138:0.5072
chr15	25020987	.	C	A	.	PASS	CSQ=104472715|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146177.1:n.4840+226C>A||MODIFIER||||||SNHG14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	81,59:140:0.4214
chr15	25040643	.	G	A	.	PASS	CSQ=104472715|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146177.1:n.4841-10459G>A||MODIFIER||||||SNHG14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	64,82:146:0.5616
chr15	25659440	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	60,73:133:0.5489
chr15	25659444	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	62,73:136:0.5368
chr15	25663448	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	67,54:121:0.4463
chr15	25731656	.	C	A	.	PASS	CSQ=57194|protein_coding||intron_variant|||||||NM_024490.3:c.741-4390G>T||MODIFIER||||||ATP10A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	60,60:120:0.5
chr15	25867000	.	G	A	.	PASS	CSQ=57194|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ATP10A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	60,65:125:0.52
chr15	26030211	.	A	T	.	PASS	CSQ=100128714|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_040082.1:n.895+14190A>T||MODIFIER||||||LINC02346|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	62,82:144:0.5694
chr15	26062616	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	48,59:107:0.5514
chr15	26133838	.	G	T	.	PASS	CSQ=503519|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00929|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	60,84:144:0.5833
chr15	26183468	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs771055874||6.57281e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	120,9:129:0.0698
chr15	26324780	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	62,51:113:0.4513
chr15	26397724	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	81,61:142:0.4296
chr15	27134547	.	A	G	.	PASS	CSQ=2567|protein_coding||intron_variant|||||||NM_033223.5:c.270+107726A>G||MODIFIER||||||GABRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	59,55:114:0.4825
chr15	27430585	.	G	T	.	PASS	CSQ=2567|protein_coding||intron_variant|||||||NM_033223.5:c.575-50065G>T||MODIFIER||||||GABRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	75,54:129:0.4186
chr15	27468880	.	G	A	.	PASS	CSQ=2567|protein_coding||intron_variant||||rs935368852||6.57065e-06|NM_033223.5:c.575-11770G>A||MODIFIER||||||GABRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	61,69:131:0.5267
chr15	27482683	.	C	T	.	PASS	CSQ=2567|protein_coding||intron_variant|||||||NM_033223.5:c.712+1896C>T||MODIFIER||||||GABRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	152,5:157:0.0318
chr15	27502476	.	G	A	.	PASS	CSQ=2567|protein_coding||intron_variant||||||6.57255e-06|NM_033223.5:c.713-17496G>A||MODIFIER||||||GABRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	70,62:132:0.4697
chr15	27528611	.	C	T	.	PASS	CSQ=2567|protein_coding||intron_variant|||||||NM_033223.5:c.1122+619C>T||MODIFIER||||||GABRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	70,67:137:0.4891
chr15	27733964	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	60,66:126:0.5238
chr15	27739672	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	68,64:132:0.4848
chr15	27763444	.	G	A	.	PASS	CSQ=4948|protein_coding||intron_variant|||||||NM_000275.3:c.2433-7972C>T||MODIFIER||||||OCA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	79,89:168:0.5298
chr15	27814040	.	A	T	.	PASS	CSQ=4948|protein_coding||intron_variant|||||||NM_000275.3:c.2432+30919T>A||MODIFIER||||||OCA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	78,67:145:0.4621
chr15	27881111	.	A	T	.	PASS	CSQ=4948|protein_coding||intron_variant|||||||NM_000275.3:c.2080-9189T>A||MODIFIER||||||OCA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	65,67:132:0.5076
chr15	27954754	.	C	T	.	PASS	CSQ=4948|protein_coding||intron_variant|||||||NM_000275.3:c.1842+404G>A||MODIFIER||||||OCA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	81,69:150:0.46
chr15	27954756	.	G	T	.	PASS	CSQ=4948|protein_coding||intron_variant|||||||NM_000275.3:c.1842+402C>A||MODIFIER||||||OCA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	77,68:145:0.469
chr15	27982635	.	G	A	.	PASS	CSQ=4948|protein_coding||intron_variant||||rs189181619||9.86206e-05|NM_000275.3:c.1503+710C>T||MODIFIER||||||OCA2|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	73,76:149:0.5101
chr15	28255993	.	G	A	.	PASS	CSQ=8924|protein_coding||missense_variant|||||||NM_004667.5:c.2750C>T|NP_004658.3:p.Ser917Leu|MODERATE|B|T|D||D|HERC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	111,0:111:0	85,57:142:0.4014
chr15	28537058	.	G	T	.	PASS	CSQ=283768|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GOLGA8G|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	70,63:133:0.4737
chr15	28545167	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	75,0:75:0	83,20:103:0.1942
chr15	28679939	.	T	C	.	PASS	CSQ=440248|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_036443.1:n.1764-1857T>C||MODIFIER||||||HERC2P9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	75,0:75:0	28,31:59:0.5254
chr15	29103260	.	G	A	.	PASS	CSQ=321|protein_coding||intron_variant|||||||NM_001353788.1:c.1524+1476G>A||MODIFIER||||||APBA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	72,72:144:0.5
chr15	29107847	.	A	T	.	PASS	CSQ=321|protein_coding||intron_variant|||||||NM_001353788.1:c.1918-423A>T||MODIFIER||||||APBA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	100,101:201:0.5025
chr15	29182377	.	G	A	.	PASS	CSQ=23359|protein_coding||intron_variant||||rs1235236417|||NM_015307.1:c.522+14053C>T||MODIFIER||||||FAM189A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	57,75:132:0.5682
chr15	29360251	.	C	T	.	PASS	CSQ=23359|protein_coding||intron_variant||||rs549314605||0.000151192|NM_015307.1:c.276+21524G>A||MODIFIER||||||FAM189A1|EntrezGene|0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	78,79:157:0.5032
chr15	29548747	.	G	C	.	PASS	CSQ=23359|protein_coding||intron_variant|||||||NM_015307.1:c.219+21758C>G||MODIFIER||||||FAM189A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	65,75:140:0.5357
chr15	29577074	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	83,83:166:0.5
chr15	29858105	.	G	T	.	PASS	CSQ=7082|protein_coding||intron_variant|||||||NM_001301025.2:c.307-57403C>A||MODIFIER||||||TJP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	90,98:188:0.5213
chr15	30031089	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	73,68:141:0.4823
chr15	30065451	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs928305845||6.57134e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	88,84:172:0.4884
chr15	30560303	.	GG	AT	.	PASS	CSQ=727909|protein_coding||intron_variant|||||||NM_001355476.1:c.1201-233_1201-232delinsAT||MODIFIER||||||GOLGA8Q|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	59,0:59:0	0,69:70:0.9857
chr15	30669161	.	G	A	.	PASS	CSQ=100288637|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_038253.1:n.228+21447G>A||MODIFIER||||||LOC100288637|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	80,82:162:0.5062
chr15	31004436	.	G	GT	.	PASS	CSQ=4308|protein_coding||intron_variant||||rs889834241||0.0291972|NM_001252024.1:c.3630-1367dup||MODIFIER||||||TRPM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,2:117:0.0171	93,54:148:0.3649
chr15	31199493	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	76,68:145:0.469
chr15	31326050	.	C	A	.	PASS	CSQ=51621|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||KLF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	80,86:166:0.5181
chr15	31364237	.	G	C	.	PASS	CSQ=51621|protein_coding||intron_variant|||||||NM_015995.4:c.578-7773G>C||MODIFIER||||||KLF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	76,86:162:0.5309
chr15	31457758	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	85,68:153:0.4444
chr15	31509431	.	T	C	.	PASS	CSQ=161725|protein_coding||intron_variant|||||||NM_130901.2:c.873-5613A>G||MODIFIER||||||OTUD7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	164,59:223:0.2646
chr15	31838792	.	TC	AT	.	PASS	CSQ=161725|protein_coding||intron_variant|||||||NM_130901.2:c.-223+31714_-223+31715delinsAT||MODIFIER||||||OTUD7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	110,0:110:0	57,61:120:0.5083
chr15	31852698	.	G	C	.	PASS	CSQ=161725|protein_coding||intron_variant|||||||NM_130901.2:c.-223+17809C>G||MODIFIER||||||OTUD7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	85,64:149:0.4295
chr15	32003287	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	70,84:154:0.5455
chr15	32033189	.	GTGGC	G	.	PASS	CSQ=1139|protein_coding||intron_variant|||||||NM_000746.5:c.195+2153_195+2156del||MODIFIER||||||CHRNA7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	62,61:123:0.4959
chr15	32282166	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	65,0:65:0	70,17:87:0.1954
chr15	32619763	.	GGTAAAT	G	.	PASS	CSQ=9824|protein_coding||intron_variant|||||||NM_014783.6:c.130-342_130-337del||MODIFIER||||||ARHGAP11A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	81,54:135:0.4
chr15	33157170	.	C	T	.	PASS	CSQ=342184|protein_coding||intron_variant|||||||NM_001277313.1:c.-131-2125G>A||MODIFIER||||||FMN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	65,88:153:0.5752
chr15	33516264	.	G	GC	.	PASS	CSQ=6263|protein_coding||intron_variant||||rs944444272||0.000730926|NM_001036.4:c.279+12534dup||MODIFIER||||||RYR3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	93,47:141:0.3333
chr15	33516627	.	C	T	.	PASS	CSQ=6263|protein_coding||intron_variant|||||||NM_001036.4:c.279+12889C>T||MODIFIER||||||RYR3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	85,94:179:0.5251
chr15	34847140	.	CAAA	C	.	PASS	CSQ=9716|protein_coding||downstream_gene_variant||||rs1049160152||0.00017716|||MODIFIER||||||AQR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	101,68:169:0.4024
chr15	35011012	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	62,79:141:0.5603
chr15	35807835	.	T	G	.	PASS	CSQ=100507466|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038251.1:n.463-50152T>G||MODIFIER||||||DPH6-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	77,70:147:0.4762
chr15	35832122	.	G	A	.	PASS	CSQ=100507466|lncRNA||intron_variant&non_coding_transcript_variant||||rs1398625260||5.99992e-05|NR_038251.1:n.463-25865G>A||MODIFIER||||||DPH6-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	67,68:135:0.5037
chr15	36036298	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	61,79:140:0.5643
chr15	36158831	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,66:136:0.4853
chr15	36454006	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	73,94:167:0.5629
chr15	36844612	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	83,63:146:0.4315
chr15	37144347	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	90,63:153:0.4118
chr15	37466502	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	65,58:123:0.4715
chr15	37495982	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	73,84:157:0.535
chr15	37532551	.	T	TACA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	88,51:139:0.3669
chr15	37555397	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	71,70:141:0.4965
chr15	37717817	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	97,83:180:0.4611
chr15	37818993	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	81,58:139:0.4173
chr15	38354922	.	TATC	T	.	PASS	CSQ=161742|protein_coding||3_prime_UTR_variant|||||||NM_152594.3:c.*3261_*3263del||MODIFIER||||||SPRED1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	135,0:135:0	142,10:152:0.0658
chr15	38448255	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	71,61:132:0.4621
chr15	38574770	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	137,12:149:0.0805
chr15	38660796	.	AGTCTG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	59,60:119:0.5042
chr15	38662436	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs190264389||5.93401e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	91,83:175:0.4743
chr15	38889854	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	86,81:167:0.485
chr15	38936493	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	71,71:142:0.5
chr15	38995739	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	90,71:161:0.441
chr15	40363204	.	C	G	.	PASS	CSQ=85455|protein_coding||intron_variant|||||||NM_033510.3:c.120-421C>G||MODIFIER||||||DISP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	69,70:139:0.5036
chr15	40660244	.	G	A	.	PASS	CSQ=57082|protein_coding||intron_variant|||||||NM_144508.4:c.6836+783G>A||MODIFIER||||||KNL1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/KNL1|y|n|AML|||L|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	71,89:160:0.5563
chr15	40892204	.	G	A	.	PASS	CSQ=57617|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||VPS18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	117,45:162:0.2778
chr15	41581284	.	G	A	.	PASS	CSQ=7301|protein_coding||3_prime_UTR_variant|||||||NM_006293.4:c.*3008G>A||MODIFIER||||||TYRO3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	82,58:140:0.4143
chr15	42185163	.	A	G	.	PASS	CSQ=23339|protein_coding||intron_variant|||||||NM_015289.3:c.535-463T>C||MODIFIER||||||VPS39|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	98,71:169:0.4201
chr15	42552129	.	T	A	.	PASS	CSQ=255252|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||LRRC57|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	91,80:171:0.4678
chr15	42579191	.	A	G	.	PASS	CSQ=57519|protein_coding||intron_variant|||||||NM_020759.3:c.47+3429A>G||MODIFIER||||||STARD9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	78,72:150:0.48
chr15	43815637	COSV51038310	A	AT	.	PASS	CSQ=4236|protein_coding||intron_variant|COSV51038310|p.?||rs796773976||0.000624532|NM_005926.3:c.300-564dup||MODIFIER||||||MFAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,1:115:0.0087	116,51:168:0.3036
chr15	45013363	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	69,81:150:0.54
chr15	45200035	.	G	A	.	PASS	CSQ=90525|protein_coding||intron_variant|||||||NM_138356.2:c.-47+692C>T||MODIFIER||||||SHF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	76,76:152:0.5
chr15	45305244	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1432195583||6.57436e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	105,0:105:0	138,7:145:0.0483
chr15	45707163	.	T	C	.	PASS	CSQ=105370802|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135680.1:n.95+1874T>C||MODIFIER||||||LOC105370802|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	71,77:148:0.5203
chr15	45741866	.	G	T	.	PASS	CSQ=105370802|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135680.1:n.95+36577G>T||MODIFIER||||||LOC105370802|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	73,65:138:0.471
chr15	45742937	.	TG	T	.	PASS	CSQ=105370802|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135680.1:n.95+37650del||MODIFIER||||||LOC105370802|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	63,67:130:0.5154
chr15	45790587	.	T	G	.	PASS	CSQ=105370802|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135680.1:n.96-57994T>G||MODIFIER||||||LOC105370802|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	76,65:141:0.461
chr15	45831340	.	G	A	.	PASS	CSQ=105370802|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135680.1:n.96-17241G>A||MODIFIER||||||LOC105370802|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:131:0	75,80:155:0.5161
chr15	46061654	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	77,63:140:0.45
chr15	46154613	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	71,86:157:0.5478
chr15	46175752	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1327911713||6.57263e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	119,16:135:0.1185
chr15	46179585	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1466837283||1.97709e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	67,61:129:0.4729
chr15	46476549	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	53,84:137:0.6131
chr15	46636655	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	83,49:132:0.3712
chr15	46675992	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs187039545||6.57073e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	83,31:114:0.2719
chr15	46969200	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	78,68:146:0.4658
chr15	47025677	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	56,86:142:0.6056
chr15	47025699	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	55,80:135:0.5926
chr15	47044797	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	88,64:152:0.4211
chr15	47170133	.	TA	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	97,0:98:0	54,68:122:0.5574
chr15	47236965	.	A	G	.	PASS	CSQ=80031|protein_coding||intron_variant|||||||NM_001198999.1:c.-239+52547A>G||MODIFIER||||||SEMA6D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	73,59:132:0.447
chr15	47272829	.	G	T	.	PASS	CSQ=80031|protein_coding||intron_variant|||||||NM_001198999.1:c.-239+88411G>T||MODIFIER||||||SEMA6D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	60,70:130:0.5385
chr15	47333098	.	G	A	.	PASS	CSQ=80031|protein_coding||intron_variant|||||||NM_001198999.1:c.-238-79295G>A||MODIFIER||||||SEMA6D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	80,68:148:0.4595
chr15	47434905	.	T	A	.	PASS	CSQ=80031|protein_coding||intron_variant|||||||NM_001198999.1:c.-159+22433T>A||MODIFIER||||||SEMA6D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,71:143:0.4965
chr15	47689861	.	GC	G	.	PASS	CSQ=80031|protein_coding||intron_variant|||||||NM_001198999.1:c.-54-69883del||MODIFIER||||||SEMA6D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	95,72:167:0.4311
chr15	47846656	.	G	A	.	PASS	CSQ=101928442|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01491|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	59,68:127:0.5354
chr15	47895007	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	74,63:137:0.4599
chr15	47945286	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:109:0	94,36:130:0.2769
chr15	48127292	.	A	T	.	PASS	CSQ=283652|protein_coding||intron_variant|||||||NM_205850.2:c.301+5256A>T||MODIFIER||||||SLC24A5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	75,67:142:0.4718
chr15	48515864	.	G	C	.	PASS	CSQ=2200|protein_coding||intron_variant|||||||NM_000138.4:c.1327+319C>G||MODIFIER||||||FBN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	93,64:157:0.4076
chr15	48551745	.	C	T	.	PASS	CSQ=2200|protein_coding||intron_variant|||||||NM_000138.4:c.539-13937G>A||MODIFIER||||||FBN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	74,80:154:0.5195
chr15	48572148	COSV57330711	T	TA	.	PASS	CSQ=2200|protein_coding||intron_variant|COSV57330711|p.?||rs552667841||0.000566259|NM_000138.4:c.538+24134dup||MODIFIER||||||FBN1|EntrezGene|0.0008;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	83,76:159:0.478
chr15	48861646	.	C	A	.	PASS	CSQ=399694|protein_coding||intron_variant|||||||NM_203349.4:c.947-3831G>T||MODIFIER||||||SHC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	85,81:166:0.488
chr15	48903747	.	G	A	.	PASS	CSQ=399694|protein_coding||intron_variant||||rs1448375316|||NM_203349.4:c.657-12936C>T||MODIFIER||||||SHC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	63,62:125:0.496
chr15	49512166	.	AT	A	.	PASS	CSQ=196951|protein_coding||intron_variant|||||||NM_152647.2:c.875-3819del||MODIFIER||||||FAM227B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	70,80:150:0.5333
chr15	49635714	.	T	A	.	PASS	CSQ=56986|protein_coding||intron_variant|||||||NM_001144955.2:c.667+920T>A||MODIFIER||||||DTWD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	139,1:140:0.0071	148,6:154:0.039
chr15	49778963	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1326267193||6.59144e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	68,38:106:0.3585
chr15	49873058	.	C	T	.	PASS	CSQ=79895|protein_coding||intron_variant|||||||NM_024837.3:c.3027+3220G>A||MODIFIER||||||ATP8B4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	72,81:153:0.5294
chr15	50024285	COSV52720826;COSV52720826	G	GA	.	PASS	CSQ=79895|protein_coding||intron_variant|COSV52720826&COSV52720826|p.?&p.?||rs747136134||0.00389326|NM_024837.3:c.363-13369dup||MODIFIER||||||ATP8B4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	74,59:134:0.4403
chr15	50063502	.	A	G	.	PASS	CSQ=79895|protein_coding||intron_variant|||||||NM_024837.3:c.87+10625T>C||MODIFIER||||||ATP8B4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	77,80:157:0.5096
chr15	50336172	.	G	A	.	PASS	CSQ=2553|protein_coding||intron_variant||||rs1019924880||7.91713e-05|NM_016654.4:c.-1+18813C>T||MODIFIER||||||GABPB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	150,9:159:0.0566
chr15	50715822	.	A	G	.	PASS	CSQ=84888|protein_coding||intron_variant|||||||NM_032802.4:c.1488+4118T>C||MODIFIER||||||SPPL2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,79:161:0.4907
chr15	51979138	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	56,0:56:0	46,66:112:0.5893
chr15	52404407	.	C	A	.	PASS	CSQ=4644|protein_coding||intron_variant|||||||NM_000259.3:c.1053+880G>T||MODIFIER||||||MYO5A|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MYO5A|y|n|Spitzoid_tumour|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	94,88:182:0.4835
chr15	52975605	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1360079465||2.62802e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	90,92:182:0.5055
chr15	53323917	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	152,11:163:0.0675
chr15	53724309	.	C	A	.	PASS	CSQ=256764|protein_coding||intron_variant||||rs921393603||2.63037e-05|NM_182758.4:c.154-1401G>T||MODIFIER||||||WDR72|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	78,77:155:0.4968
chr15	53758970	.	C	T	.	PASS	CSQ=256764|protein_coding||intron_variant||||rs1348715314|||NM_182758.4:c.-13+663G>A||MODIFIER||||||WDR72|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	65,72:137:0.5255
chr15	53813138	.	AATAATTAAGTGTG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	81,69:150:0.46
chr15	53855091	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	136,10:146:0.0685
chr15	54169953	.	G	T	.	PASS	CSQ=440279|protein_coding||intron_variant|||||||NM_001080534.2:c.3071+26269G>T||MODIFIER||||||UNC13C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:124:0.0081	84,102:186:0.5484
chr15	54254021	.	T	A	.	PASS	CSQ=440279|protein_coding||intron_variant|||||||NM_001080534.2:c.3448+3577T>A||MODIFIER||||||UNC13C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	71,74:145:0.5103
chr15	54466377	.	T	C	.	PASS	CSQ=440279|protein_coding||intron_variant|||||||NM_001080534.2:c.4934-28231T>C||MODIFIER||||||UNC13C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	80,83:163:0.5092
chr15	54819467	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1348323176||6.57082e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	110,14:124:0.1129
chr15	55343014	.	C	A	.	PASS	CSQ=9488|protein_coding||intron_variant|||||||NM_004855.5:c.1123+1212C>A||MODIFIER||||||PIGB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	80,84:164:0.5122
chr15	55364128	.	C	A	.	PASS	CSQ=9236|protein_coding||intron_variant|||||||NM_001204450.1:c.828+1060G>T||MODIFIER||||||CCPG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	72,72:144:0.5
chr15	55472143	.	A	C	.	PASS	CSQ=161582|protein_coding||intron_variant|||||||NM_130810.3:c.406-4982T>G||MODIFIER||||||DNAAF4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	94,79:173:0.4566
chr15	56238289	.	T	C	.	PASS	CSQ=64864|protein_coding||intron_variant|||||||NM_022841.6:c.161+4836A>G||MODIFIER||||||RFX7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	74,84:158:0.5316
chr15	56360266	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	81,82:163:0.5031
chr15	56360645	.	C	T	.	PASS	CSQ=374618|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TEX9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	64,90:154:0.5844
chr15	56564863	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	137,17:154:0.1104
chr15	56727465	.	G	GA	.	PASS	CSQ=54816|protein_coding||intron_variant||||rs1244959358|||NM_017661.3:c.-86+5992dup||MODIFIER||||||ZNF280D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	82,70:154:0.4545
chr15	56951318	.	C	T	.	PASS	CSQ=6938|protein_coding||intron_variant|||||||NM_003205.3:c.148+30220C>T||MODIFIER||||||TCF12|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TCF12|y|n|extraskeletal_myxoid_chondrosarcoma|||M|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:102:0	62,89:151:0.5894
chr15	58597627	.	T	A	.	PASS	CSQ=102|protein_coding||missense_variant|||||||NM_001110.4:c.2167A>T|NP_001101.1:p.Arg723Trp|MODERATE|D|T|D|D|D|ADAM10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	101,0:101:0	68,64:132:0.4848
chr15	58631481	.	C	T	.	PASS	CSQ=102|protein_coding||intron_variant|||||||NM_001110.4:c.1176+1715G>A||MODIFIER||||||ADAM10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	76,75:151:0.4967
chr15	58688524	.	C	CA	.	PASS	CSQ=102|protein_coding||intron_variant|||||||NM_001110.4:c.207-6211dup||MODIFIER||||||ADAM10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	92,65:157:0.414
chr15	58759122	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	71,97:168:0.5774
chr15	59501174	.	G	A	.	PASS	CSQ=145773|protein_coding||intron_variant|||||||NM_152450.3:c.414-6039G>A||MODIFIER||||||FAM81A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	71,66:137:0.4818
chr15	59849989	.	GA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	80,77:157:0.4904
chr15	60085249	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs200319537||7.24848e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	90,83:173:0.4798
chr15	60101578	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	86,62:148:0.4189
chr15	60780576	.	C	G	.	PASS	CSQ=6095|protein_coding||intron_variant|||||||NM_134261.3:c.167-101890G>C||MODIFIER||||||RORA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	76,94:170:0.5529
chr15	61300541	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs545739435||0.229182|||MODIFIER||||||||0.2091;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:112:0	87,51:141:0.3617
chr15	61415034	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	83,76:159:0.478
chr15	61456648	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	180,15:195:0.0769
chr15	61711656	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57203e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	57,79:136:0.5809
chr15	61804269	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	90,74:164:0.4512
chr15	61851921	.	A	T	.	PASS	CSQ=54832|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||VPS13C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	61,84:145:0.5793
chr15	62130112	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	57,79:136:0.5809
chr15	62623168	.	G	C	.	PASS	CSQ=|||intergenic_variant||||||1.31366e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	80,79:159:0.4969
chr15	62625583	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	187,8:195:0.041
chr15	63191772	.	C	T	.	PASS	CSQ=51762|protein_coding||intron_variant|||||||NM_016530.3:c.124+2024C>T||MODIFIER||||||RAB8B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	86,76:162:0.4691
chr15	63192040	.	C	T	.	PASS	CSQ=51762|protein_coding||intron_variant|||||||NM_016530.3:c.124+2292C>T||MODIFIER||||||RAB8B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	63,83:146:0.5685
chr15	63576269	.	G	C	.	PASS	CSQ=9960|protein_coding||intron_variant|||||||NM_006537.4:c.1096+1866G>C||MODIFIER||||||USP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	80,67:147:0.4558
chr15	64291040	.	CAGA	C	.	PASS	CSQ=53944|protein_coding||intron_variant|||||||NM_022048.5:c.181+9276_181+9278del||MODIFIER||||||CSNK1G1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	79,57:136:0.4191
chr15	64291045	.	G	A	.	PASS	CSQ=53944|protein_coding||intron_variant|||||||NM_022048.5:c.181+9274C>T||MODIFIER||||||CSNK1G1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:108:0	81,59:140:0.4214
chr15	64849733	.	G	A	.	PASS	CSQ=80301|protein_coding||intron_variant||||rs1227924823||5.32177e-05|NM_025201.5:c.162+991G>A||MODIFIER||||||PLEKHO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:147:0	86,69:156:0.4423
chr15	64892149	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	68,85:153:0.5556
chr15	65598952	.	G	T	.	PASS	CSQ=81556|protein_coding||synonymous_variant|||||||NM_001366360.1:c.525C>A|NP_001353289.1:p.Leu175=|LOW||||||INTS14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	77,66:143:0.4615
chr15	66697582	.	C	A	.	PASS	CSQ=4091|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SMAD6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	87,78:165:0.4727
chr15	66900424	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	78,59:137:0.4307
chr15	67097908	.	C	G	.	PASS	CSQ=4088|protein_coding||intron_variant|||||||NM_005902.4:c.206+31548C>G||MODIFIER||||||SMAD3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/SMAD3|y|n|colorectal_carcinoma,oral_squamous_cell_carcinoma|||E|Rec|TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	83,61:144:0.4236
chr15	67708150	.	T	TA	.	PASS	CSQ=5607|protein_coding||intron_variant|||||||NM_145160.3:c.1044+4749dup||MODIFIER||||||MAP2K5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	71,69:140:0.4929
chr15	67959619	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	66,85:151:0.5629
chr15	67989479	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	62,92:155:0.5935
chr15	68079851	.	A	T	.	PASS	CSQ=8554|protein_coding||intron_variant|||||||NM_016166.2:c.25-6455A>T||MODIFIER||||||PIAS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	78,73:151:0.4834
chr15	68320866	.	G	T	.	PASS	CSQ=22801|protein_coding||intron_variant|||||||NM_001004439.2:c.2409-474C>A||MODIFIER||||||ITGA11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	83,92:175:0.5257
chr15	68509978	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs749611227||5.91467e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	86,88:174:0.5057
chr15	68638571	.	C	T	.	PASS	CSQ=10391|protein_coding||intron_variant|||||||NM_006091.4:c.16-6589C>T||MODIFIER||||||CORO2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	70,75:145:0.5172
chr15	68773315	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	74,84:158:0.5316
chr15	69426822	.	C	T	.	PASS	CSQ=9493|protein_coding||intron_variant|||||||NM_138555.4:c.969+365C>T||MODIFIER||||||KIF23|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	103,98:201:0.4876
chr15	70127481	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	94,62:156:0.3974
chr15	70773385	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	88,90:178:0.5056
chr15	72199940	.	C	G	.	PASS	CSQ=5315|protein_coding||intron_variant|||||||NM_002654.6:c.1490-184G>C||MODIFIER||||||PKM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	89,70:159:0.4403
chr15	72516680	.	C	A	.	PASS	CSQ=25820|protein_coding||intron_variant|||||||NM_005744.4:c.376-1387C>A||MODIFIER||||||ARIH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	79,71:150:0.4733
chr15	72900443	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	88,73:161:0.4534
chr15	73581960	.	G	C	.	PASS	CSQ=27020|protein_coding||intron_variant|||||||NM_012428.3:c.706+5564C>G||MODIFIER||||||NPTN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	62,92:154:0.5974
chr15	73689516	.	G	T	.	PASS	CSQ=80381|protein_coding||intron_variant|||||||NM_001024736.2:c.-55+5056G>T||MODIFIER||||||CD276|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	79,67:146:0.4589
chr15	73740342	COSV65838057;COSV65838057	G	A	.	PASS	CSQ=388135|protein_coding||stop_gained|COSV65838057&COSV65838057|p.R153*&p.R153*||COSM964700|||NM_001039614.2:c.457C>T|NP_001034703.1:p.Arg153Ter|HIGH|.&.&.||D|.&.&.|.&.&.|C15orf59|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	138,0:138:0	79,86:165:0.5212
chr15	73792857	COSV64957842	C	CT	.	PASS	CSQ=|||intergenic_variant|||COSV64957842|rs1160781111||0.00688703|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	83,70:153:0.4575
chr15	74142673	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	83,88:171:0.5146
chr15	74148007	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	84,63:147:0.4286
chr15	74584599	.	ATGGGGAG	A	.	PASS	CSQ=10620|protein_coding||intron_variant|||||||NM_006465.3:c.698-5220_698-5214del||MODIFIER||||||ARID3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	81,65:146:0.4452
chr15	74903625	.	GAAAA	G	.	PASS	CSQ=4351|protein_coding||downstream_gene_variant||||||1.6726e-05|||MODIFIER||||||MPI|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,0:72:0	71,43:114:0.3772
chr15	75682491	.	G	C	.	PASS	CSQ=1464|protein_coding||intron_variant|||||||NM_001897.5:c.4784-32C>G||MODIFIER||||||CSPG4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	96,0:96:0	87,87:174:0.5
chr15	75732477	.	G	A	.	PASS	CSQ=100128285|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_024595.3:n.617-325C>T||MODIFIER||||||DNM1P35|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	71,85:156:0.5449
chr15	75786575	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	84,104:188:0.5532
chr15	77559400	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	85,85:170:0.5
chr15	77686193	.	C	T	.	PASS	CSQ=84894|protein_coding||intron_variant|||||||NM_001301191.1:c.-99+4527G>A||MODIFIER||||||LINGO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	81,80:162:0.4938
chr15	77937606	.	T	A	.	PASS	CSQ=440292|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||LOC440292|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	102,73:175:0.4171
chr15	77976539	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	109,97:206:0.4709
chr15	77995901	.	C	A	.	PASS	CSQ=23102|protein_coding||3_prime_UTR_variant|||||||NM_144572.1:c.*2259G>T||MODIFIER||||||TBC1D2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	96,53:149:0.3557
chr15	78038822	.	C	T	.	PASS	CSQ=23102|protein_coding||intron_variant|||||||NM_144572.1:c.683+6078G>A||MODIFIER||||||TBC1D2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	100,85:185:0.4595
chr15	78572089	.	G	A	.	PASS	CSQ=1138|protein_coding||intron_variant|||||||NM_000745.3:c.106+6264G>A||MODIFIER||||||CHRNA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	76,85:161:0.528
chr15	78690723	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	72,62:134:0.4627
chr15	78956006	.	C	T	.	PASS	CSQ=5923|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||RASGRF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	97,70:167:0.4192
chr15	79444508	.	G	C	.	PASS	CSQ=23251|protein_coding||intron_variant|||||||NM_015206.2:c.-50-11590G>C||MODIFIER||||||KIAA1024|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	66,82:148:0.5541
chr15	79498718	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs1003653084||6.56978e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	95,74:169:0.4379
chr15	79734510	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	87,68:155:0.4387
chr15	79950251	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs772874202||6.60205e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	76,58:134:0.4328
chr15	80058480	.	G	A	.	PASS	CSQ=54469|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ZFAND6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	65,69:134:0.5149
chr15	80413504	.	C	G	.	PASS	CSQ=9915|protein_coding||intron_variant|||||||NM_014862.4:c.31+8958C>G||MODIFIER||||||ARNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	91,92:183:0.5027
chr15	80589642	.	G	A	.	PASS	CSQ=9915|protein_coding||intron_variant|||||||NM_014862.4:c.1919-1926G>A||MODIFIER||||||ARNT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	94,64:158:0.4051
chr15	81406191	.	GA	G	.	PASS	CSQ=101929655|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120365.1:n.905+25943del||MODIFIER||||||TMC3-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	76,67:143:0.4685
chr15	81513588	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs946085411||1.97241e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:103:0	75,78:153:0.5098
chr15	81762855	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1006488529||0.00225342|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	77,73:150:0.4867
chr15	81809137	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	59,65:124:0.5242
chr15	81922986	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:131:0	75,86:161:0.5342
chr15	81922997	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	75,81:156:0.5192
chr15	82003329	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs902765076||1.97465e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	75,70:145:0.4828
chr15	82379153	.	C	T	.	PASS	CSQ=100134869|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_004847.3:n.240-21507C>T||MODIFIER||||||UBE2Q2P2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	101,75:177:0.4237
chr15	82934502	.	C	T	.	PASS	CSQ=9455|protein_coding||intron_variant||||rs1237202404||6.57307e-06|NM_004839.4:c.5+18029G>A||MODIFIER||||||HOMER2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	106,57:163:0.3497
chr15	82947611	.	T	A	.	PASS	CSQ=9455|protein_coding||intron_variant|||||||NM_004839.4:c.5+4920A>T||MODIFIER||||||HOMER2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	98,79:177:0.4463
chr15	83314608	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs934719423||3.29303e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	81,63:144:0.4375
chr15	83353617	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1016973528||3.28623e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	67,82:149:0.5503
chr15	83355863	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs779880438||0.00506198|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,1:93:0.0108	97,71:168:0.4226
chr15	83363764	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	105,78:183:0.4262
chr15	83479436	.	C	T	.	PASS	CSQ=6457|protein_coding||intron_variant|||||||NM_003027.5:c.45+31858C>T||MODIFIER||||||SH3GL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	61,57:118:0.4831
chr15	83860007	.	T	TA	.	PASS	CSQ=57188|protein_coding||intron_variant||||rs1033754122||0.000270702|NM_207517.3:c.802+1178dup||MODIFIER||||||ADAMTSL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	109,52:161:0.323
chr15	84002939	.	T	TTC	.	PASS	CSQ=57188|protein_coding||intron_variant||||rs199999385||0.00303899|NM_207517.3:c.3974-11602_3974-11601insCT||MODIFIER||||||ADAMTSL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	97,48:146:0.3288
chr15	84115699	.	C	T	.	PASS	CSQ=648809|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_036652.1:n.609-346C>T||MODIFIER||||||EFL1P1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,1:143:0.007	104,81:185:0.4378
chr15	84636277	.	G	A	.	PASS	CSQ=54581|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_004859.1:n.1398-1070G>A||MODIFIER||||||SCAND2P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	76,67:143:0.4685
chr15	85631002	.	G	GA	.	PASS	CSQ=11214|protein_coding||intron_variant||||rs200406710||0.00255926|NM_007200.4:c.4162-8362dup||MODIFIER||||||AKAP13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,2:107:0.0187	94,57:151:0.3775
chr15	85777624	.	T	A	.	PASS	CSQ=64410|protein_coding||intron_variant|||||||NM_022480.4:c.-10-7804A>T||MODIFIER||||||KLHL25|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,1:120:0.0083	92,75:167:0.4491
chr15	86010232	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	86,74:160:0.4625
chr15	86433571	COSV66869765;COSV66869765	G	A	.	PASS	CSQ=123624|protein_coding||intron_variant|COSV66869765&COSV66869765|p.?&p.?|||||NM_152336.3:c.2555+36025G>A||MODIFIER||||||AGBL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	118,13:131:0.0992
chr15	86510441	.	G	T	.	PASS	CSQ=123624|protein_coding||intron_variant|||||||NM_152336.3:c.2556-12369G>T||MODIFIER||||||AGBL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	66,74:140:0.5286
chr15	86867615	.	G	T	.	PASS	CSQ=123624|protein_coding||intron_variant|||||||NM_152336.3:c.3222-120372G>T||MODIFIER||||||AGBL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	60,65:125:0.52
chr15	87065875	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	157,0:157:0	95,76:171:0.4444
chr15	87159157	.	A	G	.	PASS	CSQ=|||intergenic_variant||||||1.3143e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	128,9:137:0.0657
chr15	87206841	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	119,6:125:0.048
chr15	87726113	.	A	AG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	64,53:117:0.453
chr15	87877934	.	G	A	.	PASS	CSQ=4916|protein_coding||intron_variant||||rs568484003||0.000236602|NM_001012338.2:c.2335-814C>T||MODIFIER||||||NTRK3|EntrezGene|0.0002;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NTRK3|y|n|congenital_fibrosarcoma,secretory_breast|||E,M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	61,71:132:0.5379
chr15	87917340	.	T	A	.	PASS	CSQ=4916|protein_coding||intron_variant|||||||NM_001012338.2:c.2133+11851A>T||MODIFIER||||||NTRK3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NTRK3|y|n|congenital_fibrosarcoma,secretory_breast|||E,M|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	64,73:137:0.5328
chr15	88526361	.	G	A	.	PASS	CSQ=55070|protein_coding||intron_variant|||||||NM_001144074.2:c.1271+1238C>T||MODIFIER||||||DET1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	75,75:150:0.5
chr15	88876030	.	G	C	.	PASS	CSQ=145864|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||HAPLN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	76,72:148:0.4865
chr15	89366408	.	C	T	.	PASS	CSQ=254559|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_133001.1:n.691+4139C>T||MODIFIER||||||MIR9-3HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	64,94:158:0.5949
chr15	89716976	.	G	A	.	PASS	CSQ=56964|protein_coding||intron_variant|||||||NM_020212.2:c.795+27G>A||MODIFIER||||||WDR93|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	147,14:161:0.087
chr15	89820521	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs545110926||5.92183e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	63,75:138:0.5435
chr15	90110606	.	G	A	.	PASS	CSQ=105370966|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149130.1:n.320+7154G>A||MODIFIER||||||IDH2-DT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	88,103:191:0.5393
chr15	90125801	.	G	A	.	PASS	CSQ=105370966|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_149130.1:n.321-7596G>A||MODIFIER||||||IDH2-DT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	86,66:152:0.4342
chr15	90240125	.	A	G	.	PASS	CSQ=390637|protein_coding||intron_variant|||||||NM_001013657.2:c.-9-775A>G||MODIFIER||||||GDPGP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:105:0	71,90:161:0.559
chr15	90739761	.	A	T	.	PASS	CSQ=641|protein_coding||intron_variant|||||||NM_000057.4:c.-4-7628A>T||MODIFIER||||||BLM|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/BLM|n|y||leukaemia,lymphoma,skin_squamous_cell,other_tumour_types|Bloom_syndrome|L,E|Rec|TSG|Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	74,70:144:0.4861
chr15	90780075	.	G	A	.	PASS	CSQ=641|protein_coding||intron_variant|||||||NM_000057.4:c.2556-2747G>A||MODIFIER||||||BLM|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/BLM|n|y||leukaemia,lymphoma,skin_squamous_cell,other_tumour_types|Bloom_syndrome|L,E|Rec|TSG|Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	77,66:143:0.4615
chr15	90828411	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	95,86:181:0.4751
chr15	90870959	COSV51577158;COSV51577158;COSV51577158;COSV51577158;COSV51577158	G	GA	.	PASS	CSQ=5045|protein_coding||intron_variant|COSV51577158|p.?|COSV51577158&COSV51577158&COSV51577158&COSV51577158|rs1372690475||1.31721e-05|NM_002569.4:c.-160+2256dup||MODIFIER||||||FURIN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	106,80:186:0.4301
chr15	90876326	.	G	T	.	PASS	CSQ=5045|protein_coding||synonymous_variant|||||||NM_002569.4:c.249G>T|NP_002560.1:p.Arg83=|LOW||||||FURIN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	143,11:154:0.0714
chr15	90963391	.	C	T	.	PASS	CSQ=9055|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PRC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	75,90:165:0.5455
chr15	91321010	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	88,55:143:0.3846
chr15	91517548	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	105,74:179:0.4134
chr15	91733173	.	GCT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	111,20:131:0.1527
chr15	91759715	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	87,87:174:0.5
chr15	91957210	.	C	G	.	PASS	CSQ=28232|protein_coding||intron_variant|||||||NM_013272.4:c.646+40752C>G||MODIFIER||||||SLCO3A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	37,0:37:0	50,38:88:0.4318
chr15	92207962	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs954839172||5.91716e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,74:141:0.5248
chr15	92914548	.	G	C	.	PASS	CSQ=1106|protein_coding||intron_variant|||||||NM_001271.4:c.63-9773G>C||MODIFIER||||||CHD2|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/CHD2|y|n|melanoma,large_intestine,CLL,monoclonal_B_lymphocytosis|||E,L||TSG|Mis,F,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	100,92:192:0.4792
chr15	93425767	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	72,59:131:0.4504
chr15	94292871	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	71,75:146:0.5137
chr15	94558430	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	140,14:154:0.0909
chr15	94690888	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	68,61:129:0.4729
chr15	94836141	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	88,63:151:0.4172
chr15	95046148	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	77,68:145:0.469
chr15	95055134	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	75,74:149:0.4966
chr15	95076405	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	92,0:92:0	67,69:136:0.5074
chr15	95370835	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	88,65:153:0.4248
chr15	95371946	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	68,80:148:0.5405
chr15	95444415	.	AC	A	.	PASS	CSQ=145820|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027132.1:n.88-7379del||MODIFIER||||||LINC00924|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	85,67:152:0.4408
chr15	95505416	.	TC	T	.	PASS	CSQ=145820|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027132.1:n.891-635del||MODIFIER||||||LINC00924|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	109,0:109:0	70,60:130:0.4615
chr15	95531027	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	73,59:132:0.447
chr15	95741927	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||1.31498e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	58,67:125:0.536
chr15	95852119	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs187725986||4.60811e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	94,80:174:0.4598
chr15	96315407	.	T	G	.	PASS	CSQ=644192|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125738.1:n.163+11549A>C||MODIFIER||||||NR2F2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	88,64:152:0.4211
chr15	96744135	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	77,74:151:0.4901
chr15	96755601	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	150,0:150:0	72,76:148:0.5135
chr15	96955525	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	62,85:147:0.5782
chr15	97127053	.	TCA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	57,82:139:0.5899
chr15	97225013	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	121,13:134:0.097
chr15	97350629	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	42,66:108:0.6111
chr15	97372421	.	C	T	.	PASS	CSQ=101927286|lncRNA||intron_variant&non_coding_transcript_variant||||||1.97397e-05|NR_120324.1:n.756-1080G>A||MODIFIER||||||LINC02254|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	73,89:162:0.5494
chr15	97683524	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	43,54:97:0.5567
chr15	97776612	.	G	T	.	PASS	CSQ=91948|lncRNA||intron_variant&non_coding_transcript_variant||||rs953402847||1.3155e-05|NR_024173.1:n.478-33129C>A||MODIFIER||||||LINC00923|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	77,76:153:0.4967
chr15	98068191	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	132,9:141:0.0638
chr15	98105907	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1418996233||4.61115e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	74,54:128:0.4219
chr15	98348741	.	T	TCAAA	.	PASS	CSQ=105371011|lncRNA||intron_variant&non_coding_transcript_variant||||rs1349970234||1.97407e-05|NR_146567.1:n.191-21292_191-21289dup||MODIFIER||||||LINC02351|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	160,34:195:0.1744
chr15	98414176	.	C	T	.	PASS	CSQ=105371011|lncRNA||intron_variant&non_coding_transcript_variant||||||6.57168e-06|NR_146567.1:n.190+6633G>A||MODIFIER||||||LINC02351|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	112,156:268:0.5821
chr15	98428302	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1004771119|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	196,81:277:0.2924
chr15	98492984	.	G	A	.	PASS	CSQ=283777|protein_coding||intron_variant||||rs1329605247||0.000118977|NM_182562.2:c.-80-7007C>T||MODIFIER||||||FAM169B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	167,87:254:0.3425
chr15	98542810	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	144,75:219:0.3425
chr15	98808685	.	TTTTC	T	.	PASS	CSQ=3480|protein_coding||intron_variant|||||||NM_000875.5:c.641-82636_641-82633del||MODIFIER||||||IGF1R|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	78,0:78:0	135,61:196:0.3112
chr15	99139442	.	G	T	.	PASS	CSQ=23336|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SYNM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	80,66:146:0.4521
chr15	99481336	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	134,7:141:0.0496
chr15	99621725	.	C	CT	.	PASS	CSQ=4205|protein_coding||intron_variant|||||||NM_001365208.1:c.-142-11251dup||MODIFIER||||||MEF2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	145,30:175:0.1714
chr15	99887729	.	T	TA	.	PASS	CSQ=400464|transcribed_pseudogene||downstream_gene_variant||||rs573800404||0.000608712|||MODIFIER||||||LOC400464|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,1:100:0.01	85,61:146:0.4178
chr15	99964951	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	76,66:142:0.4648
chr15	100280543	.	C	T	.	PASS	CSQ=170691|protein_coding||intron_variant|||||||NM_139057.4:c.789+686G>A||MODIFIER||||||ADAMTS17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	76,86:162:0.5309
chr15	100601528	.	G	A	.	PASS	CSQ=140460|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ASB7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	67,53:120:0.4417
chr15	100822634	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	95,77:172:0.4477
chr15	100994614	.	A	T	.	PASS	CSQ=79705|protein_coding||intron_variant|||||||NM_024652.6:c.762+5216A>T||MODIFIER||||||LRRK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	117,98:215:0.4558
chr15	101404592	.	G	C	.	PASS	CSQ=5046|protein_coding||intron_variant||||||6.57091e-06|NM_002570.5:c.824-6016C>G||MODIFIER||||||PCSK6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	99,104:203:0.5123
chr15	101543032	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1028267884||3.31935e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	74,0:74:0	52,50:102:0.4902
chr16	204319	.	G	A	.	PASS	CSQ=55692|protein_coding||intron_variant||||rs371366782||2.65678e-05|NM_201412.2:c.510+1685C>T||MODIFIER||||||LUC7L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,68:68:1
chr16	653732	.	C	T	.	PASS	CSQ=197335|protein_coding||intron_variant||||||6.56806e-06|NM_145294.5:c.1380-14C>T||MODIFIER||||||WDR90|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	154,0:154:0	0,94:94:1
chr16	1118990	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1400422203||6.56858e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	0,114:114:1
chr16	1182673	.	C	T	.	PASS	CSQ=8912|protein_coding||intron_variant|||||||NM_021098.3:c.300-12299C>T||MODIFIER||||||CACNA1H|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,77:78:0.9872
chr16	1992376	.	G	A	.	PASS	CSQ=2671|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||GFER|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,73:73:1
chr16	2817877	.	G	T	.	PASS	CSQ=10942|protein_coding||missense_variant|||||||NM_006799.4:c.168G>T|NP_006790.1:p.Gln56His|MODERATE|D&D|D&D|D|D&D|D&D|PRSS21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	126,0:126:0	0,93:93:1
chr16	3179344	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,50:50:1
chr16	3547381	.	G	A	.	PASS	CSQ=197358|protein_coding||intron_variant|||||||NM_178844.4:c.2771+754C>T||MODIFIER||||||NLRC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,75:75:1
chr16	4487939	.	G	T	.	PASS	CSQ=3163|protein_coding||intron_variant|||||||NM_002134.4:c.-42+11452G>T||MODIFIER||||||HMOX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	63,69:133:0.5188
chr16	5728729	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,86:86:1
chr16	6186549	.	G	A	.	PASS	CSQ=54715|protein_coding||intron_variant|||||||NM_018723.3:c.-126-130446G>A||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,74:74:1
chr16	6286195	.	C	T	.	PASS	CSQ=54715|protein_coding||intron_variant|||||||NM_018723.3:c.-126-30800C>T||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	0,76:76:1
chr16	6346857	.	G	A	.	PASS	CSQ=54715|protein_coding||intron_variant|||||||NM_018723.3:c.-64+29800G>A||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	49,5:54:0.0926
chr16	6359290	.	C	A	.	PASS	CSQ=54715|protein_coding||intron_variant|||||||NM_018723.3:c.-64+42233C>A||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,56:56:1
chr16	6371628	.	A	AT	.	PASS	CSQ=54715|protein_coding||intron_variant|||||||NM_018723.3:c.-64+54576dup||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	4,70:74:0.9459
chr16	6433616	.	G	A	.	PASS	CSQ=54715|protein_coding||intron_variant|||||||NM_018723.3:c.-64+116559G>A||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,68:68:1
chr16	6478979	.	G	T	.	PASS	CSQ=54715|protein_coding||intron_variant|||||||NM_018723.3:c.-64+161922G>T||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,61:61:1
chr16	6635949	.	G	A	.	PASS	CSQ=54715|protein_coding||intron_variant||||rs1009617004|||NM_018723.3:c.-63-18654G>A||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,73:73:1
chr16	6672810	.	A	T	.	PASS	CSQ=54715|protein_coding||intron_variant||||rs751556798||5.25769e-05|NM_018723.3:c.-16+18160A>T||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,71:71:1
chr16	6783316	.	CT	C	.	PASS	CSQ=54715|protein_coding||intron_variant||||rs1442970559||0.00112886|NM_018723.3:c.-16+128677del||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	8,55:63:0.873
chr16	7047753	.	A	AT	.	PASS	CSQ=54715|protein_coding||intron_variant||||rs1436037964||0.000311774|NM_018723.3:c.-15-4295dup||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	8,46:54:0.8519
chr16	7245063	.	C	T	.	PASS	CSQ=54715|protein_coding||intron_variant|||||||NM_018723.3:c.27+192965C>T||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,63:63:1
chr16	7483296	.	C	T	.	PASS	CSQ=54715|protein_coding||intron_variant||||||1.31437e-05|NM_018723.3:c.28-34851C>T||MODIFIER||||||RBFOX1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,81:81:1
chr16	7781496	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs939014079||6.57117e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,63:63:1
chr16	8122007	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	2,68:70:0.9714
chr16	8392451	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	58,14:72:0.1944
chr16	9481024	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,102:102:1
chr16	9579307	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,82:82:1
chr16	10587788	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,89:89:1
chr16	11445340	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	73,18:91:0.1978
chr16	12631512	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	79,13:92:0.1413
chr16	12740431	.	C	T	.	PASS	CSQ=55313|protein_coding||intron_variant||||rs369458969||3.43926e-05|NM_018340.3:c.290-35382G>A||MODIFIER||||||CPPED1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,74:74:1
chr16	13556920	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs555275946||6.57895e-06|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,62:62:1
chr16	13870038	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs914783919||0.000118696|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,79:79:1
chr16	14273319	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,73:73:1
chr16	14359751	.	G	T	.	PASS	CSQ=105447648|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC02130|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,80:80:1
chr16	14455519	.	C	T	.	PASS	CSQ=5073|protein_coding||intron_variant|||||||NM_002582.4:c.1671-8438G>A||MODIFIER||||||PARN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,105:105:1
chr16	15123077	.	C	G	.	PASS	CSQ=105369154|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_123722.1:n.1888+2614G>C||MODIFIER||||||PKD1P6-NPIPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,0:72:0	4,26:30:0.8667
chr16	16964398	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs566666311||3.95935e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,103:103:1
chr16	17194562	.	C	A	.	PASS	CSQ=64131|protein_coding||intron_variant|||||||NM_022166.3:c.1289+3650G>T||MODIFIER||||||XYLT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,66:66:1
chr16	17575485	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1399410208||1.31473e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,69:69:1
chr16	17971501	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,63:63:1
chr16	18217703	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	173,0:173:0	31,54:85:0.6353
chr16	18718244	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	66,20:86:0.2326
chr16	20186730	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,73:73:1
chr16	20274630	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,83:83:1
chr16	20287700	.	TGGGTATG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	0,65:65:1
chr16	20288255	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,80:80:1
chr16	20453715	.	G	C	.	PASS	CSQ=123876|protein_coding||intron_variant|||||||NM_001308172.2:c.-9+2034G>C||MODIFIER||||||ACSM2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,73:73:1
chr16	20570381	.	T	C	.	PASS	CSQ=348158|protein_coding||intron_variant|||||||NM_001105069.1:c.-8-5528A>G||MODIFIER||||||ACSM2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,84:84:1
chr16	20846743	.	G	A	.	PASS	CSQ=81691|protein_coding||intron_variant|||||||NM_001199053.1:c.2243+404G>A||MODIFIER||||||REXO5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	54,13:67:0.194
chr16	21200416	.	G	A	.	PASS	CSQ=7783|protein_coding||intron_variant|||||||NM_003460.2:c.1695-538C>T||MODIFIER||||||ZP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,81:81:1
chr16	22056168	.	T	C	.	PASS	CSQ=730094|protein_coding||intron_variant|||||||NM_001164579.2:c.107-19319T>C||MODIFIER||||||MOSMO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,99:99:1
chr16	22076794	.	C	T	.	PASS	CSQ=730094|protein_coding||intron_variant||||rs1256500169||6.5716e-06|NM_001164579.2:c.319+1095C>T||MODIFIER||||||MOSMO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	74,13:87:0.1494
chr16	22550373	.	C	T	.	PASS	CSQ=653786|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003676.3:n.1360-2011C>T||MODIFIER||||||LOC653786|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	202,0:202:0	67,76:143:0.5315
chr16	22753997	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,78:78:1
chr16	23523196	.	C	A	.	PASS	CSQ=124454|protein_coding||3_prime_UTR_variant|||||||NM_001083614.1:c.*1175G>T||MODIFIER||||||EARS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	146,1:147:0.0068	77,6:83:0.0723
chr16	24090224	.	GG	TA	.	PASS	CSQ=5579|protein_coding||intron_variant|||||||NM_002738.6:c.530-2567_530-2566delinsTA||MODIFIER||||||PRKCB|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/PRKCB|y|n|adult_T-cell_lymphoma-leukaemia|||L|||Mis;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	114,0:114:0	0,79:79:1
chr16	24560860	.	G	C	.	PASS	CSQ=5930|protein_coding||intron_variant|||||||NM_006910.5:c.848-752G>C||MODIFIER||||||RBBP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,71:71:1
chr16	25419047	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,71:71:1
chr16	25528519	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:109:0	3,73:76:0.9605
chr16	25598137	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,81:81:1
chr16	25734207	.	C	T	.	PASS	CSQ=9951|protein_coding||intron_variant|||||||NM_006040.3:c.734+41056C>T||MODIFIER||||||HS3ST4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,73:73:1
chr16	25739128	.	G	A	.	PASS	CSQ=9951|protein_coding||intron_variant|||||||NM_006040.3:c.734+45977G>A||MODIFIER||||||HS3ST4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,59:59:1
chr16	25815397	.	C	T	.	PASS	CSQ=9951|protein_coding||intron_variant|||||||NM_006040.3:c.734+122246C>T||MODIFIER||||||HS3ST4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,79:79:1
chr16	26152933	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,71:71:1
chr16	26250031	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1218410982||1.97761e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,63:63:1
chr16	26787383	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,70:70:1
chr16	27253474	.	G	C	.	PASS	CSQ=197370|protein_coding||intron_variant|||||||NM_145080.4:c.136+3961C>G||MODIFIER||||||NSMCE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,87:87:1
chr16	31106789	.	G	A	.	PASS	CSQ=10295|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||BCKDK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,85:85:1
chr16	31685862	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,87:87:1
chr16	31803985	.	G	T	.	PASS	CSQ=317702|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||VN1R3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,80:80:1
chr16	31936164	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs971651715||6.57177e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,97:97:1
chr16	32463677	.	CT	C	.	PASS	CSQ=|||intergenic_variant||||rs915996118||0.000377844|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	5,39:44:0.8864
chr16	32930771	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,64:64:1
chr16	33618788	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,64:64:1
chr16	34607363	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1425478975||2.68738e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	90,71:161:0.441
chr16	34721034	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	77,64:141:0.4539
chr16	34756119	.	CCATTCGATGATGATTCCATTCGAGTCCATTCCATGATTCCATTTGATTG	C	.	PASS	CSQ=|||intergenic_variant||||||2.64715e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	177,0:177:0	137,34:171:0.1988
chr16	34941792	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	78,0:78:0	53,63:116:0.5431
chr16	35018565	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	99,37:136:0.2721
chr16	35035712	.	C	T	.	PASS	CSQ=102724928|transcribed_pseudogene||intron_variant&non_coding_transcript_variant||||rs1019726469|||NR_158158.1:n.824+898C>T||MODIFIER||||||CCNYL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	78,72:150:0.48
chr16	35113555	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	119,8:127:0.063
chr16	35154826	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1005701496||1.97187e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	65,75:140:0.5357
chr16	35341252	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	83,87:170:0.5118
chr16	35508787	.	C	CAT	.	PASS	CSQ=100130700|transcribed_pseudogene||upstream_gene_variant||||rs544181179||7.25307e-05|||MODIFIER||||||TP53TG3HP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	79,66:145:0.4552
chr16	35544515	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	71,57:128:0.4453
chr16	35579947	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	73,64:137:0.4672
chr16	35594876	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	85,82:167:0.491
chr16	35869115	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	112,33:145:0.2276
chr16	35883686	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	85,75:160:0.4688
chr16	35967179	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	62,66:128:0.5156
chr16	35967181	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	64,66:130:0.5077
chr16	46633459	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs192040810||5.25576e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	98,73:171:0.4269
chr16	46745406	.	T	A	.	PASS	CSQ=91807|protein_coding||intron_variant|||||||NM_182493.3:c.477+2311A>T||MODIFIER||||||MYLK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	78,88:166:0.5301
chr16	46867703	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	78,84:162:0.5185
chr16	46880536	.	GC	CT	.	PASS	CSQ=84706|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GPT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	116,0:116:0	93,73:167:0.4371
chr16	47179106	.	G	C	.	PASS	CSQ=81533|protein_coding||intron_variant|||||||NM_030790.4:c.1454-16442C>G||MODIFIER||||||ITFG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	88,81:169:0.4793
chr16	47931138	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	89,89:178:0.5
chr16	47956703	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	75,84:159:0.5283
chr16	48157487	.	TGTATCCAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	95,0:95:0	78,62:140:0.4429
chr16	48157497	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	104,0:104:0	82,65:147:0.4422
chr16	48851451	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	71,78:149:0.5235
chr16	48982913	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	71,75:146:0.5137
chr16	49168344	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	79,70:149:0.4698
chr16	49486342	.	T	C	.	PASS	CSQ=23090|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZNF423|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	79,77:156:0.4936
chr16	49741529	.	G	A	.	PASS	CSQ=23090|protein_coding||intron_variant|||||||NM_015069.4:c.77-10558C>T||MODIFIER||||||ZNF423|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	67,74:141:0.5248
chr16	49946019	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,1:74:0.0135	67,66:133:0.4962
chr16	50145963	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	67,66:133:0.4962
chr16	50203051	.	CG	C	.	PASS	CSQ=64282|protein_coding||intron_variant|||||||NM_001365324.1:c.639-8271del||MODIFIER||||||PAPD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	172,11:183:0.0601
chr16	50392713	.	G	A	.	PASS	CSQ=105371248|lncRNA||intron_variant&non_coding_transcript_variant||||rs564398730||8.53993e-05|NR_146572.1:n.200-1572C>T||MODIFIER||||||LINC02178|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	90,83:173:0.4798
chr16	50935150	COSV65181872	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV65181872|rs745941295||0.000191475|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	89,94:183:0.5137
chr16	51002542	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs8062410||2.62864e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	80,90:170:0.5294
chr16	51060480	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	94,84:178:0.4719
chr16	51293610	.	CT	C	.	PASS	CSQ=|||intergenic_variant||||rs1221127547||0.000858763|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	89,58:147:0.3946
chr16	51562270	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	75,74:149:0.4966
chr16	51772755	.	TA	T	.	PASS	CSQ=101927364|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01571|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	101,77:178:0.4326
chr16	51924225	.	TCTAATGGCTCAGACAATAACAAAGCAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	166,0:166:0	88,70:158:0.443
chr16	52522374	.	C	A	.	PASS	CSQ=27324|protein_coding||intron_variant|||||||NM_001080430.4:c.87+24263G>T||MODIFIER||||||TOX3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	89,67:156:0.4295
chr16	52730046	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	69,78:147:0.5306
chr16	52730082	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	64,65:129:0.5039
chr16	53063725	.	GT	TA	.	PASS	CSQ=80205|protein_coding||intron_variant|||||||NM_025134.5:c.-165+8648_-165+8649delinsTA||MODIFIER||||||CHD9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	87,0:87:0	71,59:131:0.4504
chr16	53076449	.	CCTATAATTCCAGCTACTCAGGAGG	C	.	PASS	CSQ=80205|protein_coding||intron_variant|||||||NM_025134.5:c.-165+21375_-165+21398del||MODIFIER||||||CHD9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	94,77:171:0.4503
chr16	53101325	.	A	T	.	PASS	CSQ=80205|protein_coding||intron_variant|||||||NM_025134.5:c.-165+46248A>T||MODIFIER||||||CHD9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	67,79:146:0.5411
chr16	53470011	.	G	T	.	PASS	CSQ=5934|protein_coding||missense_variant||||COSM4849810|||NM_005611.4:c.2071G>T|NP_005602.3:p.Asp691Tyr|MODERATE|B&.|D&D|D|D&D|D&D|RBL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	126,0:126:0	105,81:186:0.4355
chr16	53473018	.	T	A	.	PASS	CSQ=5934|protein_coding||intron_variant|||||||NM_005611.4:c.2703+2096T>A||MODIFIER||||||RBL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	88,90:178:0.5056
chr16	53621715	.	GC	G	.	PASS	CSQ=23322|protein_coding||intron_variant|||||||NM_015272.5:c.3432+503del||MODIFIER||||||RPGRIP1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	88,85:173:0.4913
chr16	53772176	.	T	C	.	PASS	CSQ=79068|protein_coding||intron_variant|||||||NM_001080432.3:c.46-37964T>C||MODIFIER||||||FTO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	158,20:178:0.1124
chr16	53938161	.	CT	C	.	PASS	CSQ=79068|protein_coding||intron_variant|||||||NM_001080432.3:c.1364+4055del||MODIFIER||||||FTO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	82,69:151:0.457
chr16	54132426	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs770608806||5.25825e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	86,87:173:0.5029
chr16	54185263	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57626e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	72,91:163:0.5583
chr16	54219885	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	85,76:161:0.472
chr16	54347769	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs76148807||0.0143495|||MODIFIER||||||||0.0178;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	74,53:127:0.4173
chr16	54510136	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1336209688||1.97106e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:141:0	95,99:194:0.5103
chr16	54614133	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	77,75:152:0.4934
chr16	54754028	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	64,77:141:0.5461
chr16	54888702	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	66,88:154:0.5714
chr16	55248485	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	83,108:191:0.5654
chr16	55380819	COSV62443715	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV62443715|rs199879659||0.0114349|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	94,64:158:0.4051
chr16	55394340	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1484366074||2.62878e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	74,91:165:0.5515
chr16	55586729	.	G	A	.	PASS	CSQ=54947|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LPCAT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	104,0:104:0	173,10:183:0.0546
chr16	56053865	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	82,90:172:0.5233
chr16	56059766	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1348392456||1.97156e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	157,12:169:0.071
chr16	56098441	.	G	A	.	PASS	CSQ=283856|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027078.1:n.2146+2605C>T||MODIFIER||||||LOC283856|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	94,73:167:0.4371
chr16	56128582	.	C	T	.	PASS	CSQ=283856|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027078.1:n.1692-26263G>A||MODIFIER||||||LOC283856|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	84,69:153:0.451
chr16	56152618	.	C	G	.	PASS	CSQ=283856|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027078.1:n.1691+34985G>C||MODIFIER||||||LOC283856|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	81,86:167:0.515
chr16	56274163	.	C	T	.	PASS	CSQ=2775|protein_coding||intron_variant||||rs1037475134||1.97132e-05|NM_020988.3:c.162-1768C>T||MODIFIER||||||GNAO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	100,84:184:0.4565
chr16	56584080	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	91,77:168:0.4583
chr16	56929166	.	C	T	.	PASS	CSQ=9709|protein_coding||upstream_gene_variant||||||1.3223e-05|||MODIFIER||||||HERPUD1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/HERPUD1|y|n|prostate|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	79,95:174:0.546
chr16	56952220	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	101,97:198:0.4899
chr16	57099381	.	G	A	.	PASS	CSQ=221184|protein_coding||intron_variant|||||||NM_152727.6:c.-36+6591G>A||MODIFIER||||||CPNE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	96,84:180:0.4667
chr16	57100207	.	A	G	.	PASS	CSQ=221184|protein_coding||intron_variant|||||||NM_152727.6:c.-36+7417A>G||MODIFIER||||||CPNE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	100,77:177:0.435
chr16	59052946	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	80,89:169:0.5266
chr16	59139240	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	74,76:150:0.5067
chr16	59160576	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	139,6:145:0.0414
chr16	59206340	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1177012161||3.95689e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	46,44:91:0.4835
chr16	59393041	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs893536066|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	98,0:98:0	126,15:141:0.1064
chr16	59546171	.	TGCCAGGAGTTTAAGACCAGCCTG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	79,54:133:0.406
chr16	59932473	.	AGCATGTTTAAGAGATGATTAT	A	.	PASS	CSQ=101927580|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110917.1:n.173+76950_173+76970del||MODIFIER||||||LINC02141|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	150,10:160:0.0625
chr16	60212253	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	60,69:129:0.5349
chr16	60375496	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	58,82:140:0.5857
chr16	60479963	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1460043419||2.6364e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	80,60:140:0.4286
chr16	60622267	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	79,79:158:0.5
chr16	60648319	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	74,68:142:0.4789
chr16	60648327	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,62:133:0.4662
chr16	60669843	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs966444177||0.000407659|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	129,9:138:0.0652
chr16	60713075	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	69,65:134:0.4851
chr16	60812553	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	74,62:136:0.4559
chr16	60816768	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	74,68:142:0.4789
chr16	61030808	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	71,40:111:0.3604
chr16	61039062	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	122,5:127:0.0394
chr16	61042298	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	82,63:145:0.4345
chr16	61097604	.	CC	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	126,0:126:0	75,58:133:0.4361
chr16	61163755	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.58553e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	97,28:126:0.2222
chr16	61233508	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	62,67:129:0.5194
chr16	61519056	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	100,20:120:0.1667
chr16	61530636	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1232600370||6.57289e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	119,24:143:0.1678
chr16	61612255	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1415684176||6.99418e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	37,0:37:0	24,16:40:0.4
chr16	61653247	.	G	A	.	PASS	CSQ=1006|protein_coding||3_prime_UTR_variant||||rs1048453043||1.98015e-05|NM_001796.5:c.*361C>T||MODIFIER||||||CDH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	65,69:134:0.5149
chr16	61726238	.	TGA	T	.	PASS	CSQ=1006|protein_coding||intron_variant|||||||NM_001796.5:c.1536+854_1536+855del||MODIFIER||||||CDH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	74,70:144:0.4861
chr16	61779958	.	C	CAT	.	PASS	CSQ=1006|protein_coding||intron_variant|||||||NM_001796.5:c.1414+9386_1414+9387dup||MODIFIER||||||CDH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	80,68:148:0.4595
chr16	61893663	.	A	G	.	PASS	CSQ=1006|protein_coding||intron_variant|||||||NM_001796.5:c.547+7516T>C||MODIFIER||||||CDH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	67,65:132:0.4924
chr16	61908206	.	T	A	.	PASS	CSQ=1006|protein_coding||intron_variant|||||||NM_001796.5:c.253-6733A>T||MODIFIER||||||CDH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	65,79:144:0.5486
chr16	61913181	.	T	G	.	PASS	CSQ=1006|protein_coding||intron_variant|||||||NM_001796.5:c.253-11708A>C||MODIFIER||||||CDH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	72,73:145:0.5034
chr16	62077673	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs111881517||0.0466315|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,1:101:0.0099	63,45:108:0.4167
chr16	62137552	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1174299998||0.00805698|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,7:94:0.0745	89,52:141:0.3688
chr16	62251837	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||8.18572e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	93,36:129:0.2791
chr16	62326410	.	A	T	.	PASS	CSQ=|||intergenic_variant||||||6.57281e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	57,67:124:0.5403
chr16	62405707	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	69,71:140:0.5071
chr16	62423889	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	77,0:77:0	101,5:106:0.0472
chr16	62533728	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	61,71:132:0.5379
chr16	62607709	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||6.57393e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	62,87:149:0.5839
chr16	63049813	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	69,1:70:0.0143	48,62:110:0.5636
chr16	63110730	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,83:152:0.5461
chr16	63453936	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:131:0	75,66:141:0.4681
chr16	63993813	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	67,70:137:0.5109
chr16	64000248	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1449801593||2.66057e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	48,49:97:0.5052
chr16	64022289	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	64,73:137:0.5328
chr16	64448314	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	65,68:133:0.5113
chr16	64464170	.	TTTTCTCC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	77,69:146:0.4726
chr16	64474246	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs112232077||6.57479e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	85,76:161:0.472
chr16	64508563	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	71,78:149:0.5235
chr16	64866420	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs1044977974||0.000654236|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	49,39:88:0.4432
chr16	65060962	.	G	C	.	PASS	CSQ=1009|protein_coding||intron_variant|||||||NM_001797.4:c.-297-7034C>G||MODIFIER||||||CDH11|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/CDH11|y|n|aneurysmal_bone_cyst|||M|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	68,72:140:0.5143
chr16	65329272	.	A	T	.	PASS	CSQ=283867|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027755.1:n.686-17725T>A||MODIFIER||||||LINC00922|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	82,88:170:0.5176
chr16	65537310	.	C	A	.	PASS	CSQ=283867|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027755.1:n.217+34461G>T||MODIFIER||||||LINC00922|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	72,58:130:0.4462
chr16	65661548	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	74,73:147:0.4966
chr16	65724736	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1190610151|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	65,71:136:0.5221
chr16	66184617	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	101,95:196:0.4847
chr16	66459404	.	C	G	.	PASS	CSQ=146227|protein_coding||intron_variant|||||||NM_001178020.3:c.26-10198C>G||MODIFIER||||||BEAN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	107,98:205:0.478
chr16	66848393	.	G	T	.	PASS	CSQ=766|protein_coding||intron_variant|||||||NM_005182.3:c.238+1166G>T||MODIFIER||||||CA7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	89,92:181:0.5083
chr16	67330017	.	T	C	.	PASS	CSQ=55282|protein_coding||intron_variant||||rs931042516||3.94177e-05|NM_018296.6:c.70+3085T>C||MODIFIER||||||LRRC36|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	78,88:166:0.5301
chr16	67835335	.	C	G	.	PASS	CSQ=80152|protein_coding||intron_variant||||||6.57765e-06|NM_025082.4:c.-370-35G>C||MODIFIER||||||CENPT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	93,68:161:0.4224
chr16	67930529	.	C	T	.	PASS	CSQ=5681|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PSKH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	141,0:142:0	89,91:180:0.5056
chr16	68015263	.	C	T	.	PASS	CSQ=100131303|protein_coding||intron_variant|||||||NM_001282442.1:c.67+441G>A||MODIFIER||||||DPEP2NB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:100:0	70,76:146:0.5205
chr16	68135350	.	C	T	.	PASS	CSQ=4775|protein_coding||intron_variant||||rs1403974716|||NM_173165.3:c.1401+8740C>T||MODIFIER||||||NFATC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,1:100:0.01	59,59:118:0.5
chr16	68520275	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	121,6:127:0.0472
chr16	68541634	.	T	G	.	PASS	CSQ=146198|protein_coding||intron_variant|||||||NM_001305203.2:c.33+1809T>G||MODIFIER||||||ZFP90|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:111:0	82,94:176:0.5341
chr16	68790497	.	A	T	.	PASS	CSQ=999|protein_coding||intron_variant||||rs1017176450|||NM_004360.5:c.164-11173A>T||MODIFIER||||||CDH1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/CDH1|y|y|lobular_breast,gastric|gastric|familial_gastric_carcinoma|E|Rec|TSG|Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	88,83:171:0.4854
chr16	68841778	.	C	T	.	PASS	CSQ=79613|protein_coding||upstream_gene_variant||||rs193202366||3.94472e-05|||MODIFIER||||||TANGO6|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	108,84:192:0.4375
chr16	69139681	.	A	G	.	PASS	CSQ=84916|protein_coding||intron_variant|||||||NM_032830.3:c.437-144A>G||MODIFIER||||||UTP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	83,87:170:0.5118
chr16	69770863	.	T	TCAC	.	PASS	CSQ=11060|protein_coding||intron_variant|||||||NM_007014.4:c.-68-5326_-68-5325insCAC||MODIFIER||||||WWP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	127,38:165:0.2303
chr16	70071321	.	G	C	.	PASS	CSQ=|||intergenic_variant||||rs1006243026||1.32165e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	68,94:162:0.5802
chr16	70597845	COSV71271022	C	CT	.	PASS	CSQ=146433|protein_coding||intron_variant|COSV71271022|p.?||rs1376487442||4.63275e-05|NM_152456.2:c.-401+17805dup||MODIFIER||||||IL34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	100,68:169:0.4024
chr16	70845502	.	C	CT	.	PASS	CSQ=54768|protein_coding||intron_variant|||||||NM_001270974.2:c.12873+4223dup||MODIFIER||||||HYDIN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	51,0:51:0	21,39:60:0.65
chr16	70978245	.	C	A	.	PASS	CSQ=54768|protein_coding||intron_variant|||||||NM_001270974.2:c.4638+669G>T||MODIFIER||||||HYDIN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	71,65:136:0.4779
chr16	71068746	.	G	A	.	PASS	CSQ=54768|protein_coding||intron_variant|||||||NM_001270974.2:c.1974+521C>T||MODIFIER||||||HYDIN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	85,72:157:0.4586
chr16	71326515	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	95,76:171:0.4444
chr16	71839467	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	172,17:189:0.0899
chr16	72275222	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	81,71:152:0.4671
chr16	73124439	.	A	C	.	PASS	CSQ=388289|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||C16orf47|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	84,78:162:0.4815
chr16	73140623	.	AG	A	.	PASS	CSQ=388289|protein_coding||intron_variant|||||||NM_207385.1:c.30+3128del||MODIFIER||||||C16orf47|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	89,66:155:0.4258
chr16	73154891	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	111,41:152:0.2697
chr16	73402798	.	A	T	.	PASS	CSQ=100506172|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038234.1:n.450+15544A>T||MODIFIER||||||LINC01568|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	77,74:151:0.4901
chr16	73423849	.	G	A	.	PASS	CSQ=100506172|lncRNA||downstream_gene_variant||||rs865998916|||||MODIFIER||||||LINC01568|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	73,77:150:0.5133
chr16	73514456	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	59,69:128:0.5391
chr16	73515077	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	112,87:199:0.4372
chr16	73834631	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs976876148||0.000105118|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	159,0:159:0	96,93:189:0.4921
chr16	73836486	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs527243004||1.31468e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	82,69:151:0.457
chr16	74785667	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	88,92:180:0.5111
chr16	74795302	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	101,80:181:0.442
chr16	75015405	.	A	G	.	PASS	CSQ=84937|protein_coding||intron_variant|||||||NM_032268.4:c.424+15310A>G||MODIFIER||||||ZNRF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	69,80:149:0.5369
chr16	75881750	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	64,48:112:0.4286
chr16	76367359	.	G	A	.	PASS	CSQ=85445|protein_coding||intron_variant||||rs1011438041||5.26399e-05|NM_033401.5:c.390+11848G>A||MODIFIER||||||CNTNAP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	81,89:170:0.5235
chr16	76502068	.	C	CA	.	PASS	CSQ=85445|protein_coding||intron_variant||||rs562234201||0.0580365|NM_033401.5:c.2365+3387dup||MODIFIER||||||CNTNAP4|EntrezGene|0.0541;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	87,52:139:0.3741
chr16	76533039	.	A	T	.	PASS	CSQ=85445|protein_coding||intron_variant|||||||NM_033401.5:c.2756-2506A>T||MODIFIER||||||CNTNAP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	114,49:163:0.3006
chr16	76575377	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	70,78:148:0.527
chr16	76641152	.	T	G	.	PASS	CSQ=101928203|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110934.1:n.279+5529T>G||MODIFIER||||||LINC02125|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	80,72:152:0.4737
chr16	76918456	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,1:135:0.0074	73,76:149:0.5101
chr16	77129953	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs952067804||1.97259e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	80,82:162:0.5062
chr16	77683475	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	73,80:153:0.5229
chr16	78212873	.	C	T	.	PASS	CSQ=51741|protein_coding||intron_variant||||rs910924998||8.54701e-05|NM_016373.4:c.516+48584C>T||MODIFIER||||||WWOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	75,65:140:0.4643
chr16	78453287	.	G	GGTAGCGGT	.	PASS	CSQ=51741|protein_coding||intron_variant|||||||NM_016373.4:c.1056+20537_1056+20544dup||MODIFIER||||||WWOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	57,47:104:0.4519
chr16	78561498	.	G	C	.	PASS	CSQ=51741|protein_coding||intron_variant||||rs983452633|||NM_016373.4:c.1056+128746G>C||MODIFIER||||||WWOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	66,80:146:0.5479
chr16	78562836	.	T	G	.	PASS	CSQ=51741|protein_coding||intron_variant|||||||NM_016373.4:c.1056+130084T>G||MODIFIER||||||WWOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	135,8:143:0.0559
chr16	78709507	.	C	T	.	PASS	CSQ=51741|protein_coding||intron_variant|||||||NM_016373.4:c.1056+276755C>T||MODIFIER||||||WWOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	62,76:138:0.5507
chr16	79054522	.	G	C	.	PASS	CSQ=51741|protein_coding||intron_variant|||||||NM_016373.4:c.1057-157086G>C||MODIFIER||||||WWOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	81,78:159:0.4906
chr16	79058239	.	GTGGGCAACTTTCTT	G	.	PASS	CSQ=51741|protein_coding||intron_variant|||||||NM_016373.4:c.1057-153366_1057-153353del||MODIFIER||||||WWOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	91,69:160:0.4313
chr16	79058258	.	TCTCTGA	T	.	PASS	CSQ=51741|protein_coding||intron_variant|||||||NM_016373.4:c.1057-153349_1057-153344del||MODIFIER||||||WWOX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	81,51:132:0.3864
chr16	79290830	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	82,56:138:0.4058
chr16	79432951	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	97,82:179:0.4581
chr16	79518533	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	87,88:175:0.5029
chr16	79757107	.	G	A	.	PASS	CSQ=102467146|lncRNA||intron_variant&non_coding_transcript_variant||||rs112394687|||NR_104663.1:n.221+544C>T||MODIFIER||||||MAFTRR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	71,59:130:0.4538
chr16	79853008	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	70,77:147:0.5238
chr16	80585114	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	83,89:172:0.5174
chr16	80982654	.	G	A	.	PASS	CSQ=56942|protein_coding||intron_variant|||||||NM_001351973.1:c.184-777C>T||MODIFIER||||||CMC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:114:0	92,114:206:0.5534
chr16	81164988	.	G	A	.	PASS	CSQ=114780|protein_coding||intron_variant||||rs968320597||6.57298e-06|NM_052892.4:c.3219-218C>T||MODIFIER||||||PKD1L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	88,102:190:0.5368
chr16	81568599	.	G	A	.	PASS	CSQ=80790|protein_coding||intron_variant|||||||NM_198390.2:c.301-38968G>A||MODIFIER||||||CMIP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	153,15:168:0.0893
chr16	82540430	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	91,82:173:0.474
chr16	83598343	.	C	G	.	PASS	CSQ=1012|protein_coding||intron_variant|||||||NM_001257.5:c.961-4111C>G||MODIFIER||||||CDH13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	69,81:150:0.54
chr16	84140121	.	C	G	.	PASS	CSQ=83693|protein_coding||intron_variant|||||||NM_031463.5:c.-68-4516G>C||MODIFIER||||||HSDL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	82,87:169:0.5148
chr16	84812323	.	A	AG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	106,87:193:0.4508
chr16	84812327	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	98,80:178:0.4494
chr16	84832712	.	G	A	.	PASS	CSQ=83716|protein_coding||intron_variant||||rs1043588783||0.0001051|NM_031476.4:c.-74-5710G>A||MODIFIER||||||CRISPLD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	91,87:178:0.4888
chr16	85920970	.	C	T	.	PASS	CSQ=3394|protein_coding||intron_variant|||||||NM_002163.4:c.1105-136C>T||MODIFIER||||||IRF8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	95,0:95:0	151,10:161:0.0621
chr16	86357354	.	TCTTTCCCTCTA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	65,63:128:0.4922
chr16	86471739	.	C	T	.	PASS	CSQ=400550|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||FENDRR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	92,89:181:0.4917
chr16	86943265	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	92,81:173:0.4682
chr16	86959312	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	87,93:181:0.5138
chr16	87153570	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	89,79:168:0.4702
chr16	87210779	.	C	T	.	PASS	CSQ=101928708|lncRNA||upstream_gene_variant||||rs1469149603||4.47982e-05|||MODIFIER||||||LOC101928708|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	68,37:106:0.3491
chr16	87634654	.	G	A	.	PASS	CSQ=57338|protein_coding||intron_variant|||||||NM_020655.4:c.383-9604G>A||MODIFIER||||||JPH3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	96,88:184:0.4783
chr16	88042189	.	G	A	.	PASS	CSQ=54971|protein_coding||intron_variant|||||||NM_001173543.1:c.1278+4178G>A||MODIFIER||||||BANP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	111,83:194:0.4278
chr16	88184761	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs923546107||1.31415e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	87,98:185:0.5297
chr16	88322797	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	82,76:158:0.481
chr16	88451129	.	G	A	.	PASS	CSQ=161882|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ZFPM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	79,90:169:0.5325
chr16	88556091	.	T	C	.	PASS	CSQ=400555|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||ZC3H18-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	166,10:176:0.0568
chr16	88768963	.	G	T	.	PASS	CSQ=9780|protein_coding||intron_variant|||||||NM_001142864.4:c.64+15938C>A||MODIFIER||||||PIEZO1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	102,86:188:0.4574
chr16	89089116	.	C	T	.	PASS	CSQ=197322|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ACSF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	72,67:139:0.482
chr16	89146758	.	G	T	.	PASS	CSQ=197322|protein_coding||intron_variant|||||||NM_001243279.2:c.1613+709G>T||MODIFIER||||||ACSF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	85,91:176:0.517
chr16	89361000	.	T	A	.	PASS	CSQ=29123|protein_coding||intron_variant|||||||NM_013275.6:c.-59-43922A>T||MODIFIER||||||ANKRD11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	78,61:139:0.4388
chr16	89543555	.	C	T	.	PASS	CSQ=6687|protein_coding||intron_variant|||||||NM_003119.3:c.1325-1093C>T||MODIFIER||||||SPG7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	63,84:147:0.5714
chr17	1736050	.	A	G	.	PASS	CSQ=124997|protein_coding||synonymous_variant|||||||NM_001163809.1:c.5337A>G|NP_001157281.1:p.Arg1779=|LOW||||||WDR81|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	0,102:102:1
chr17	2180033	.	GA	G	.	PASS	CSQ=23293|protein_coding||intron_variant|||||||NM_017575.5:c.3155+6629del||MODIFIER||||||SMG6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	1,79:80:0.9875
chr17	2678460	.	G	A	.	PASS	CSQ=5048|protein_coding||intron_variant|||||||NM_000430.4:c.1003-1704G>A||MODIFIER||||||PAFAH1B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,84:84:1
chr17	3081041	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs980001033||0.00109252|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,82:82:1
chr17	6034256	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	79,8:87:0.092
chr17	6056815	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs935390210||3.28666e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,85:85:1
chr17	7057464	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,79:79:1
chr17	7408235	.	AG	A	.	PASS	CSQ=57555|protein_coding||5_prime_UTR_variant||||rs918766240||2.27063e-05|NM_020795.4:c.-14del||MODIFIER||||||NLGN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	88,0:88:0	4,83:87:0.954
chr17	7632049	.	A	T	.	PASS	CSQ=6462|protein_coding||intron_variant|||||||NM_001040.5:c.852+34A>T||MODIFIER||||||SHBG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	114,0:114:0	0,73:73:1
chr17	7675217	COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171;COSV52759171	T	G	.	PASS	CSQ=7157|protein_coding|uncertain_significance&likely_pathogenic|missense_variant|COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171&COSV52759171|p.?&p.?&p.K93T&p.?&p.K132T&p.K132T&p.K121T&p.K132T&p.?&p.K93T&p.?&p.K132T&p.K132T&p.K93T&p.?&p.K93T&p.K132T&p.K132T&p.K93T|COSV52759171&COSV52759171&COSV52759171|rs1057519996&TP53_g.12383A>C&COSM11582&COSM1646844&COSM179831&COSM179832&COSM179833&COSM2744954&COSM308310&COSM308311&COSM308312&COSM3388223&COSM3388224&COSM43592&COSM43912&COSM4946815&COSM4946816&COSM4946817&COSM4946818&COSM4946819&COSM5635464&COSM5635465&COSM5635466&COSM5635467&COSM5635468&COSM5635469|||NM_000546.5:c.395A>C|NP_000537.3:p.Lys132Thr|MODERATE|D&.&.&D&.&D&P&D&.&.&D&.&.&D&.|D&D&.&D&.&.&D&D&.&.&D&.&.&D&D|D|D&D&D&D&D&D&D&D&D&D&D&D&D&.&.|D&D&.&D&.&.&D&D&.&.&D&.&.&D&D|TP53|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TP53|y|y|breast,colorectal,lung,sarcoma,adrenocortical,glioma,Spitzoid_tumour,multiple_other_tumour_types|breast,sarcoma,adrenocortical_carcinoma,glioma,multiple_other_tumour_types|Li-Fraumeni_syndrome|L,E,M,O|Rec|oncogene,TSG,fusion|Mis,N,F,T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	145,0:145:0	0,84:84:1
chr17	8310862	.	G	A	.	PASS	CSQ=22899|protein_coding||intron_variant||||rs1379507024||6.57973e-06|NM_173728.4:c.-50+519G>A||MODIFIER||||||ARHGEF15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	104,0:104:0	0,64:64:1
chr17	8863543	.	G	GT	.	PASS	CSQ=146850|protein_coding||intron_variant||||rs1443446221||7.98244e-05|NM_001010855.3:c.-92+3985dup||MODIFIER||||||PIK3R6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	8,70:78:0.8974
chr17	9175956	.	G	GA	.	PASS	CSQ=101928266|lncRNA||non_coding_transcript_exon_variant|||||||NR_110828.1:n.2060dup||MODIFIER||||||LOC101928266|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	5,70:76:0.9211
chr17	9659189	.	A	T	.	PASS	CSQ=124739|protein_coding||intron_variant|||||||NM_153210.5:c.636+2655A>T||MODIFIER||||||USP43|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,78:78:1
chr17	9834611	.	G	A	.	PASS	CSQ=9340|protein_coding||intron_variant||||rs1020426552||7.88654e-05|NM_004246.3:c.277+717G>A||MODIFIER||||||GLP2R|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,0:127:0	0,80:80:1
chr17	10078896	COSV60433076;COSV60433076	T	A	.	PASS	CSQ=8522|protein_coding||intron_variant|COSV60433076&COSV60433076|p.?&p.?||rs1050931380||0.000803033|NM_201433.1:c.184-58999A>T||MODIFIER||||||GAS7|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GAS7|y|n|AML*|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,69:69:1
chr17	10376154	.	C	A	.	PASS	CSQ=8735|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MYH13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,99:99:1
chr17	10380433	.	A	G	.	PASS	CSQ=100128560|lncRNA||upstream_gene_variant||||rs1259520261||6.56944e-06|||MODIFIER||||||MYHAS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,72:72:1
chr17	11269844	.	G	T	.	PASS	CSQ=388336|protein_coding||intron_variant|||||||NM_207386.3:c.799+6318G>T||MODIFIER||||||SHISA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,82:82:1
chr17	11337622	.	G	T	.	PASS	CSQ=388336|protein_coding||intron_variant|||||||NM_207386.3:c.800-41792G>T||MODIFIER||||||SHISA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,75:75:1
chr17	11480647	.	T	A	.	PASS	CSQ=388336|protein_coding||intron_variant|||||||NM_207386.3:c.896-71249T>A||MODIFIER||||||SHISA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,72:72:1
chr17	11506967	.	G	A	.	PASS	CSQ=388336|protein_coding||intron_variant|||||||NM_207386.3:c.896-44929G>A||MODIFIER||||||SHISA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,67:67:1
chr17	12171077	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,91:91:1
chr17	12942490	.	T	A	.	PASS	CSQ=9912|protein_coding||intron_variant|||||||NM_014859.6:c.652-1098T>A||MODIFIER||||||ARHGAP44|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,67:67:1
chr17	13152226	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,80:80:1
chr17	13337152	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1314606926||1.97249e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,66:66:1
chr17	13410825	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1337201184|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	50,10:60:0.1667
chr17	13580172	.	A	T	.	PASS	CSQ=9955|protein_coding||intron_variant|||||||NM_006042.3:c.599+20359T>A||MODIFIER||||||HS3ST3A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,73:73:1
chr17	13622715	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,84:84:1
chr17	13993464	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	66,0:66:0	1,48:49:0.9796
chr17	14297985	.	G	C	.	PASS	CSQ=9953|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||HS3ST3B1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,87:87:1
chr17	15927051	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,73:73:1
chr17	17381154	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	64,4:68:0.0588
chr17	17518414	.	G	C	.	PASS	CSQ=10400|protein_coding||intron_variant|||||||NM_148172.3:c.320+3866C>G||MODIFIER||||||PEMT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,102:102:1
chr17	17633485	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,80:80:1
chr17	17725397	.	C	T	.	PASS	CSQ=10743|protein_coding||intron_variant||||rs896146728||6.57255e-06|NM_030665.4:c.-17+1238C>T||MODIFIER||||||RAI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,72:72:1
chr17	17913540	.	C	G	.	PASS	CSQ=146691|protein_coding||intron_variant|||||||NM_001082968.1:c.53-6009G>C||MODIFIER||||||TOM1L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,90:90:1
chr17	19319632	.	CT	C	.	PASS	CSQ=22905|protein_coding||intron_variant||||rs1395267090||2.70786e-05|NM_014964.4:c.1147+6363del||MODIFIER||||||EPN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	18,70:89:0.7865
chr17	19593086	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,63:63:1
chr17	21710691	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,94:94:1
chr17	22060495	COSV73890004;COSV73890004	A	AT	.	PASS	CSQ=|||intergenic_variant|||COSV73890004&COSV73890004|rs1246458838||0.000508056|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	9,74:84:0.881
chr17	22153959	.	AAAAAGG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	187,0:187:0	123,40:163:0.2454
chr17	22255399	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	0,79:79:1
chr17	22258361	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs921851330|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,74:74:1
chr17	22353094	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,62:62:1
chr17	22496576	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,79:79:1
chr17	26640943	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	2,43:45:0.9556
chr17	26765816	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	4,81:85:0.9529
chr17	26773008	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	118,0:118:0	77,14:91:0.1538
chr17	27160980	.	AATGGGATGGCT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	69,0:69:0	0,35:35:1
chr17	27226506	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs577302131||0.0556106|||MODIFIER||||||||0.0437;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	5,58:63:0.9206
chr17	28145010	.	C	G	.	PASS	CSQ=51701|protein_coding||intron_variant|||||||NM_016231.5:c.644+12335C>G||MODIFIER||||||NLK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,83:83:1
chr17	28265126	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,78:78:1
chr17	28535446	.	A	T	.	PASS	CSQ=8456|protein_coding||intron_variant|||||||NM_003593.2:c.1627+248A>T||MODIFIER||||||FOXN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,83:83:1
chr17	28621023	.	T	G	.	PASS	CSQ=9703|protein_coding||missense_variant|||||||NM_014680.5:c.5207A>C|NP_055495.2:p.Asn1736Thr|MODERATE|B&.&.|T&T&T|D|T&T&T|T&T&.|KIAA0100|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	97,0:97:0	0,73:73:1
chr17	29416239	.	G	T	.	PASS	CSQ=57551|protein_coding||intron_variant|||||||NM_020791.2:c.-95+25215G>T||MODIFIER||||||TAOK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,79:79:1
chr17	29709577	.	T	G	.	PASS	CSQ=85464|protein_coding||intron_variant|||||||NM_001282129.2:c.189-6515A>C||MODIFIER||||||SSH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,97:97:1
chr17	30164633	.	C	CA	.	PASS	CSQ=84081|protein_coding||intron_variant||||rs1249812871|||NM_032141.4:c.115-7902dup||MODIFIER||||||NSRP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	9,59:68:0.8676
chr17	30299800	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,77:77:1
chr17	30556640	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,82:82:1
chr17	30885026	.	C	T	.	PASS	CSQ=79915|protein_coding||intron_variant||||rs775540890||0.00023655|NM_024857.5:c.4078-2166C>T||MODIFIER||||||ATAD5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	69,7:76:0.0921
chr17	30952409	.	T	A	.	PASS	CSQ=55803|protein_coding||intron_variant|||||||NM_018404.3:c.742-879T>A||MODIFIER||||||ADAP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,78:78:1
chr17	31182664	.	A	C	.	PASS	CSQ=4763|protein_coding||missense_variant&splice_region_variant||||CD000954&CM143484|||NM_001042492.2:c.887A>C|NP_001035957.1:p.Lys296Thr|MODERATE|P&B&D&.&.|.&T&T&T&.|D|.&D&D&D&.|.&D&D&D&.|NF1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NF1|y|y|neurofibroma,glioma|neurofibroma,glioma|neurofibromatosis_type_1|O|Rec|TSG,fusion|D,Mis,N,F,S,O;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	0,89:89:1
chr17	31995631	.	A	T	.	PASS	CSQ=23512|protein_coding||stop_gained|||||||NM_015355.4:c.1663A>T|NP_056170.2:p.Arg555Ter|HIGH|.&.||D|.&.|.&.|SUZ12|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/SUZ12|y|n|endometrial_stromal_tumour|||M|Dom|oncogene,TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	20,18:38:0.4737
chr17	32297345	.	C	T	.	PASS	CSQ=162494|protein_coding||intron_variant|||||||NM_138328.3:c.669-747C>T||MODIFIER||||||RHBDL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,79:80:0.9875
chr17	32356992	.	G	A	.	PASS	CSQ=7756|protein_coding||intron_variant||||rs1054327463||1.97361e-05|NM_001098507.1:c.169-1511G>A||MODIFIER||||||ZNF207|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	78,70:148:0.473
chr17	32472794	.	C	G	.	PASS	CSQ=5717|protein_coding||intron_variant||||rs1017802242|||NM_002815.4:c.644-1007C>G||MODIFIER||||||PSMD11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	74,54:128:0.4219
chr17	32479163	.	A	G	.	PASS	CSQ=5717|protein_coding||intron_variant|||||||NM_002815.4:c.913-88A>G||MODIFIER||||||PSMD11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	139,0:139:0	87,95:182:0.522
chr17	32648411	.	TATG	T	.	PASS	CSQ=4642|protein_coding||intron_variant||||rs1278747796||1.31409e-05|NM_015194.3:c.2595+5429_2595+5431del||MODIFIER||||||MYO1D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	4,153:157:0.9745
chr17	33537135	.	C	G	.	PASS	CSQ=100506677|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||AA06|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	0,66:66:1
chr17	33634964	.	T	G	.	PASS	CSQ=40|protein_coding||intron_variant|||||||NM_001094.4:c.555+521014A>C||MODIFIER||||||ASIC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,75:75:1
chr17	33815721	.	A	C	.	PASS	CSQ=40|protein_coding||intron_variant|||||||NM_001094.4:c.555+340257T>G||MODIFIER||||||ASIC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,71:71:1
chr17	33987076	.	C	T	.	PASS	CSQ=40|protein_coding||intron_variant|||||||NM_001094.4:c.555+168902G>A||MODIFIER||||||ASIC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:139:0	0,61:61:1
chr17	34180251	.	G	GA	.	PASS	CSQ=101927239|lncRNA||intron_variant&non_coding_transcript_variant||||rs1237324228||2.16581e-05|NR_110748.1:n.186-879dup||MODIFIER||||||LINC01989|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	39,27:66:0.4091
chr17	34429829	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs562292263||0.0540033|||MODIFIER||||||||0.0629;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	41,22:64:0.3438
chr17	34569345	.	G	A	.	PASS	CSQ=400591|protein_coding||downstream_gene_variant||||rs980612084||2.6322e-05|||MODIFIER||||||C17orf102|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,66:66:1
chr17	35197411	.	G	GT	.	PASS	CSQ=146861|protein_coding||upstream_gene_variant||||rs202108879||0.066921|||MODIFIER||||||SLC35G3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	65,0:65:0	13,33:46:0.7174
chr17	36396307	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,77:77:1
chr17	36500334	.	C	T	.	PASS	CSQ=80179|protein_coding||intron_variant||||||6.56944e-06|NM_001163735.1:c.2377+496G>A||MODIFIER||||||MYO19|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,88:88:1
chr17	36506563	.	C	G	.	PASS	CSQ=80179|protein_coding||missense_variant|||||||NM_001163735.1:c.1690G>C|NP_001157207.1:p.Asp564His|MODERATE|D||D|D||MYO19|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	110,0:110:0	0,77:77:1
chr17	36709897	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,76:76:1
chr17	37551489	.	G	C	.	PASS	CSQ=11276|protein_coding||intron_variant|||||||NM_007247.6:c.2608+1626C>G||MODIFIER||||||SYNRG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,65:65:1
chr17	37677939	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,86:86:1
chr17	37812519	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1471113168||0.000705075|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	3,60:63:0.9524
chr17	38718208	.	C	G	.	PASS	CSQ=4302|protein_coding||intron_variant||||||6.57186e-06|NM_005937.3:c.1942+255C>G||MODIFIER||||||MLLT6|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MLLT6|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,91:91:1
chr17	38718375	.	C	G	.	PASS	CSQ=4302|protein_coding||intron_variant|||||||NM_005937.3:c.1942+422C>G||MODIFIER||||||MLLT6|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MLLT6|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	0,89:89:1
chr17	39488870	.	G	A	.	PASS	CSQ=51755|protein_coding||intron_variant|||||||NM_016507.3:c.1932-1687G>A||MODIFIER||||||CDK12|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/CDK12|y|n|serous_ovarian|||E|Rec|TSG|Mis,N,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,77:77:1
chr17	40703313	.	T	A	.	PASS	CSQ=192666|protein_coding||synonymous_variant|||||||NM_019016.3:c.381A>T|NP_061889.2:p.Gly127=|LOW||||||KRT24|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	81,0:81:0	0,140:140:1
chr17	40718399	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs779746339||1.97293e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,156:156:1
chr17	41545528	.	G	T	.	PASS	CSQ=147093|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00974|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,134:135:0.9926
chr17	43634766	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1409136158||6.57255e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:110:0	145,8:153:0.0523
chr17	43732912	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs886266363|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,152:152:1
chr17	44484862	.	T	C	.	PASS	CSQ=23131|protein_coding||intron_variant||||||6.57324e-06|NM_001002909.4:c.46-9959A>G||MODIFIER||||||GPATCH8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,164:164:1
chr17	44656169	.	C	G	.	PASS	CSQ=284071|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MEIOC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,164:164:1
chr17	44823827	.	G	A	.	PASS	CSQ=10052|protein_coding||intron_variant||||rs367572374||0.000126445|NM_005497.4:c.-97+6235C>T||MODIFIER||||||GJC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:111:0	0,167:167:1
chr17	45050954	.	G	A	.	PASS	CSQ=79877|protein_coding||intron_variant|||||||NM_001288655.2:c.-115+407C>T||MODIFIER||||||DCAKD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,162:162:1
chr17	46960679	.	G	A	.	PASS	CSQ=9570|protein_coding||intron_variant|||||||NM_001321133.1:c.584-5855G>A||MODIFIER||||||GOSR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	162,10:172:0.0581
chr17	47210913	.	CCCT	C	.	PASS	CSQ=4635|protein_coding||intron_variant|||||||NM_002476.2:c.135+1361_135+1363del||MODIFIER||||||MYL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	6,120:126:0.9524
chr17	47641727	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,160:160:1
chr17	48268503	.	G	GT	.	PASS	CSQ=8631|protein_coding||intron_variant||||rs879394500||0.000238619|NM_003726.4:c.280+77401dup||MODIFIER||||||SKAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	134,11:145:0.0759
chr17	49257670	.	A	T	.	PASS	CSQ=124871|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_034161.1:n.490-763A>T||MODIFIER||||||FLJ40194|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,176:176:1
chr17	49784750	.	C	T	.	PASS	CSQ=11143|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||KAT7|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/KAT7|y|n|CCRCC|||E||oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,161:161:1
chr17	51211783	COSV64504051;COSV64504051;COSV64504051	G	GA	.	PASS	CSQ=54799|protein_coding||intron_variant|COSV64504051&COSV64504051|p.?&p.?|COSV64504051|rs201136496||0.00140641|NM_017643.3:c.487-4779dup||MODIFIER||||||MBTD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	32,103:136:0.7574
chr17	52461417	.	C	T	.	PASS	CSQ=105371830|lncRNA||intron_variant&non_coding_transcript_variant||||rs776272239||2.62957e-05|NR_146898.1:n.69+70827C>T||MODIFIER||||||LINC01982|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	113,4:117:0.0342
chr17	52916120	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,126:126:1
chr17	53289673	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	120,15:135:0.1111
chr17	53840796	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	1,131:132:0.9924
chr17	53865112	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	107,0:107:0	126,8:134:0.0597
chr17	53868054	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,125:125:1
chr17	53945746	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,119:119:1
chr17	53985093	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	0,125:125:1
chr17	54538470	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	109,48:157:0.3057
chr17	54602733	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,129:129:1
chr17	54629986	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,152:152:1
chr17	55005264	.	G	T	.	PASS	CSQ=252983|protein_coding||intron_variant|||||||NM_178509.6:c.575-2242G>T||MODIFIER||||||STXBP4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,144:144:1
chr17	55412200	.	T	C	.	PASS	CSQ=23531|protein_coding||intron_variant|||||||NM_012329.3:c.109-783A>G||MODIFIER||||||MMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	157,6:163:0.0368
chr17	55943591	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	16,112:128:0.875
chr17	56338640	COSV59452638;COSV59452638	G	GT	.	PASS	CSQ=162282|protein_coding||intron_variant|COSV59452638&COSV59452638|p.?&p.?||rs1169134674||0.000427037|NM_001365758.1:c.-16-12123dup||MODIFIER||||||ANKFN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,2:89:0.0225	11,128:141:0.9078
chr17	57220470	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	11,136:147:0.9252
chr17	58603851	.	C	CA	.	PASS	CSQ=56155|protein_coding||intron_variant||||rs1248380277||0.00577087|NM_031272.4:c.1336+1126dup||MODIFIER||||||TEX14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	21,69:91:0.7582
chr17	58865700	.	C	CA	.	PASS	CSQ=22843|protein_coding||intron_variant|||||||NM_014906.5:c.465-89943dup||MODIFIER||||||PPM1E|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	133,24:157:0.1529
chr17	59082144	.	G	A	.	PASS	CSQ=4591|protein_coding||intron_variant||||rs1033485023||7.97406e-05|NM_015294.6:c.370-925C>T||MODIFIER||||||TRIM37|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:83:0	0,118:118:1
chr17	61593456	.	TTA	T	.	PASS	CSQ=342538|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NACA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	2,104:106:0.9811
chr17	62620641	.	TAATAATAAAATAAAGACC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	0,151:151:1
chr17	62826732	.	C	G	.	PASS	CSQ=101927877|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135634.1:n.451-8281C>G||MODIFIER||||||LOC101927877|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	0,119:119:1
chr17	63535371	.	C	T	.	PASS	CSQ=81033|protein_coding||intron_variant|||||||NM_001278919.1:c.1102-298C>T||MODIFIER||||||KCNH6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,136:136:1
chr17	63592331	.	G	A	.	PASS	CSQ=10238|protein_coding||3_prime_UTR_variant|||||||NM_005828.5:c.*3159G>A||MODIFIER||||||DCAF7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	0,177:177:1
chr17	66383214	.	G	T	.	PASS	CSQ=5578|protein_coding||intron_variant|||||||NM_002737.3:c.205+77087G>T||MODIFIER||||||PRKCA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,133:133:1
chr17	66454397	.	T	G	.	PASS	CSQ=5578|protein_coding||intron_variant|||||||NM_002737.3:c.206-41804T>G||MODIFIER||||||PRKCA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	131,44:175:0.2514
chr17	66588467	.	G	T	.	PASS	CSQ=5578|protein_coding||intron_variant|||||||NM_002737.3:c.289-52888G>T||MODIFIER||||||PRKCA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,150:150:1
chr17	68487129	.	C	T	.	PASS	CSQ=5573|protein_coding||intron_variant|||||||NM_001278433.1:c.-6-28265C>T||MODIFIER||||||PRKAR1A|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PRKAR1A|y|y|papillary_thyroid|myxoma,endocrine,papillary_thyroid|Carney_complex|E,M|Dom/Rec|oncogene,TSG,fusion|T,Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,163:163:1
chr17	68917414	COSV52194068;COSV52194068;COSV52194068;COSV52194068;COSV52194068	G	A	.	PASS	CSQ=10351|protein_coding||synonymous_variant|COSV52194068&COSV52194068&COSV52194068&COSV52194068|p.C695&p.?&p.C695&p.C655|COSV52194068|rs781158837&COSM1243943&COSM4658158|0.000107805|2.63154e-05|NM_001288985.2:c.2085C>T|NP_001275914.1:p.Cys695=|LOW||||||ABCA8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	98,0:98:0	0,157:157:1
chr17	69005761	.	C	T	.	PASS	CSQ=104355297|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126414.1:n.80+968C>T||MODIFIER||||||ABCA9-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	158,5:163:0.0307
chr17	69205308	.	A	T	.	PASS	CSQ=10349|protein_coding||intron_variant|||||||NM_080282.3:c.1007-3640T>A||MODIFIER||||||ABCA10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,156:156:1
chr17	69427381	.	A	T	.	PASS	CSQ=5608|protein_coding||intron_variant|||||||NM_002758.4:c.16+12381A>T||MODIFIER||||||MAP2K6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,181:181:1
chr17	69766700	.	A	G	.	PASS	CSQ=101928122|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109971.1:n.317-78740A>G||MODIFIER||||||LINC01483|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	122,6:129:0.0465
chr17	69781050	.	C	G	.	PASS	CSQ=101928122|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109971.1:n.317-64390C>G||MODIFIER||||||LINC01483|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,184:184:1
chr17	69812242	.	G	A	.	PASS	CSQ=101928122|lncRNA||intron_variant&non_coding_transcript_variant||||||6.57151e-06|NR_109971.1:n.317-33198G>A||MODIFIER||||||LINC01483|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,133:133:1
chr17	69910251	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,129:129:1
chr17	70846505	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	122,40:162:0.2469
chr17	71107867	.	T	A	.	PASS	CSQ=101928165|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104152.1:n.218-8249A>T||MODIFIER||||||CASC17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	141,17:158:0.1076
chr17	71161821	.	G	C	.	PASS	CSQ=101928165|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104152.1:n.136+23775C>G||MODIFIER||||||CASC17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	1,200:201:0.995
chr17	71183460	.	G	A	.	PASS	CSQ=101928165|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_104152.1:n.136+2136C>T||MODIFIER||||||CASC17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	149,7:156:0.0449
chr17	72032738	.	G	A	.	PASS	CSQ=102723517|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC102723517|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,162:162:1
chr17	72203572	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,158:158:1
chr17	72865740	.	T	A	.	PASS	CSQ=201266|protein_coding||intron_variant|||||||NM_139177.3:c.431-15936A>T||MODIFIER||||||SLC39A11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,147:147:1
chr17	73438683	.	G	A	.	PASS	CSQ=54549|protein_coding||intron_variant|||||||NM_001144952.2:c.726-529C>T||MODIFIER||||||SDK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,156:156:1
chr17	73890231	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	1,152:153:0.9935
chr17	74586222	.	TGGGAA	T	.	PASS	CSQ=146723|protein_coding||intron_variant|||||||NM_001302809.1:c.-291+1309_-291+1313del||MODIFIER||||||C17orf77|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	1,172:173:0.9942
chr17	74701867	.	C	A	.	PASS	CSQ=326624|protein_coding||intron_variant||||rs951952424|||NM_175738.4:c.73-27389C>A||MODIFIER||||||RAB37|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,3:97:0.0309	0,148:148:1
chr17	75934242	.	A	T	.	PASS	CSQ=85302|protein_coding||intron_variant|||||||NM_001319193.1:c.74-1154T>A||MODIFIER||||||FBF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,176:176:1
chr17	76049033	.	G	T	.	PASS	CSQ=6730|protein_coding||intron_variant|||||||NM_014230.4:c.1078-1063C>A||MODIFIER||||||SRP68|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,183:183:1
chr17	76821943	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs539274672||0.000355147|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,169:169:1
chr17	77647885	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:99:0	0,156:156:1
chr17	77735721	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs561236010||1.31498e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,155:155:1
chr17	78250727	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	170,9:179:0.0503
chr17	78427191	.	G	A	.	PASS	CSQ=9489|protein_coding||downstream_gene_variant||||rs1246289003||2.6286e-05|||MODIFIER||||||PGS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	125,0:126:0	0,163:163:1
chr17	78466683	.	C	T	.	PASS	CSQ=8632|protein_coding||missense_variant||||rs747523018|8.12064e-06||NM_173628.3:c.8912G>A|NP_775899.3:p.Arg2971His|MODERATE|.&.|T&.|N|.&.|.&.|DNAH17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	113,0:113:0	0,150:150:1
chr17	79018276	.	G	A	.	PASS	CSQ=100507410|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||C1QTNF1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,154:154:1
chr17	79079237	.	C	G	.	PASS	CSQ=64772|protein_coding||intron_variant||||rs1229925619||6.5697e-06|NM_001042573.2:c.417-252C>G||MODIFIER||||||ENGASE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,169:169:1
chr17	79466061	.	C	A	.	PASS	CSQ=146713|protein_coding||intron_variant|||||||NM_001350451.1:c.-175+16393G>T||MODIFIER||||||RBFOX3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,167:167:1
chr17	79472925	.	G	C	.	PASS	CSQ=146713|protein_coding||intron_variant|||||||NM_001350451.1:c.-175+9529C>G||MODIFIER||||||RBFOX3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,161:161:1
chr17	79936867	.	CAT	C	.	PASS	CSQ=125058|protein_coding||3_prime_UTR_variant||||||8.40506e-06|NM_019020.4:c.*3990_*3991del||MODIFIER||||||TBC1D16|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	142,0:143:0	20,155:175:0.8857
chr17	80991075	.	CAGGGCTGAAAG	C	.	PASS	CSQ=79643|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CHMP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,177:177:1
chr17	81523549	.	C	G	.	PASS	CSQ=25794|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||FSCN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,190:190:1
chr17	82824282	.	C	T	.	PASS	CSQ=6904|protein_coding||intron_variant||||rs1314632760|||NM_005993.5:c.1318+9348C>T||MODIFIER||||||TBCD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,151:151:1
chr18	104245	.	C	T	.	PASS	CSQ=727758|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||ROCK1P1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	72,54:126:0.4286
chr18	507423	.	G	GTA	.	PASS	CSQ=105376854|lncRNA||downstream_gene_variant||||rs1212083046||0.0191306|||MODIFIER||||||LINC01925|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	88,26:115:0.2261
chr18	1091649	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	68,46:114:0.4035
chr18	1091860	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1243944302||0.00156397|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	76,71:148:0.4797
chr18	1112811	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs755430304||0.139565|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	84,2:86:0.0233	63,41:104:0.3942
chr18	1266653	.	T	C	.	PASS	CSQ=56651|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00470|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	86,55:141:0.3901
chr18	1369801	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	56,70:126:0.5556
chr18	1588221	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs369425489|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	83,54:137:0.3942
chr18	1809213	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	74,54:128:0.4219
chr18	1846042	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs755052559||6.57696e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:92:0	52,62:114:0.5439
chr18	2124446	.	GC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	80,62:142:0.4366
chr18	2523560	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	52,79:131:0.6031
chr18	2726437	.	G	GT	.	PASS	CSQ=23347|protein_coding||intron_variant||||rs1006967651||4.61315e-05|NM_015295.2:c.2701-8dup||MODIFIER||||||SMCHD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	82,78:160:0.4875
chr18	3273270	.	G	A	.	PASS	CSQ=103910|protein_coding||intron_variant|||||||NM_033546.3:c.184+188G>A||MODIFIER||||||MYL12B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	86,83:170:0.4882
chr18	3632304	.	C	CT	.	PASS	CSQ=9229|protein_coding||intron_variant||||rs1228609653||0.0132604|NM_004746.4:c.1592-50057dup||MODIFIER||||||DLGAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	104,51:157:0.3248
chr18	4180780	.	G	A	.	PASS	CSQ=9229|protein_coding||intron_variant|||||||NM_004746.4:c.-266-29493C>T||MODIFIER||||||DLGAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	70,80:150:0.5333
chr18	4225854	.	C	CAG	.	PASS	CSQ=9229|protein_coding||intron_variant||||rs1012301048||7.9187e-05|NM_004746.4:c.-266-74569_-266-74568dup||MODIFIER||||||DLGAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	65,63:128:0.4922
chr18	4661241	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	77,57:134:0.4254
chr18	4686514	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	66,78:144:0.5417
chr18	4938680	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	51,65:116:0.5603
chr18	4956479	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	70,69:139:0.4964
chr18	4961205	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,66:146:0.4521
chr18	5035915	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	60,69:129:0.5349
chr18	5174738	.	CA	C	.	PASS	CSQ=642597|protein_coding||intron_variant||||rs1407952540||0.000386778|NM_001145194.1:c.16+22299del||MODIFIER||||||AKAIN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	74,51:127:0.4016
chr18	5281444	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	53,67:120:0.5583
chr18	5537890	.	A	C	.	PASS	CSQ=23136|protein_coding||intron_variant|||||||NM_012307.3:c.-12+6023T>G||MODIFIER||||||EPB41L3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	63,73:136:0.5368
chr18	5672214	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	76,116:192:0.6042
chr18	5786668	.	G	A	.	PASS	CSQ=645355|lncRNA||intron_variant&non_coding_transcript_variant||||rs994713176||0.000190674|NR_038839.1:n.427-6919G>A||MODIFIER||||||MIR3976HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	71,62:133:0.4662
chr18	6000885	.	GTC	G	.	PASS	CSQ=91133|protein_coding||intron_variant||||||6.56961e-06|NM_001330559.1:c.1445-31325_1445-31324del||MODIFIER||||||L3MBTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	90,52:142:0.3662
chr18	6063950	.	G	GT	.	PASS	CSQ=91133|protein_coding||intron_variant|||||||NM_001330559.1:c.1444+16930dup||MODIFIER||||||L3MBTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	74,78:152:0.5132
chr18	6171300	.	GCT	G	.	PASS	CSQ=91133|protein_coding||intron_variant|||||||NM_001330559.1:c.1096+526_1096+527del||MODIFIER||||||L3MBTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	79,47:126:0.373
chr18	6320490	.	A	T	.	PASS	CSQ=91133|protein_coding||intron_variant|||||||NM_001330559.1:c.-90-8434T>A||MODIFIER||||||L3MBTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	101,39:140:0.2786
chr18	6446659	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	64,62:126:0.4921
chr18	6472017	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	78,53:131:0.4046
chr18	6578677	.	G	T	.	PASS	CSQ=100130480|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_120518.1:n.398+2573G>T||MODIFIER||||||LINC01387|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	111,19:130:0.1462
chr18	6732080	.	C	A	.	PASS	CSQ=79822|protein_coding||intron_variant|||||||NM_001366230.1:c.122+2137C>A||MODIFIER||||||ARHGAP28|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	71,66:137:0.4818
chr18	6736333	.	T	TA	.	PASS	CSQ=79822|protein_coding||intron_variant||||rs534649483||0.00066471|NM_001366230.1:c.122+6396dup||MODIFIER||||||ARHGAP28|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	88,30:118:0.2542
chr18	6897232	.	G	T	.	PASS	CSQ=79822|protein_coding||intron_variant|||||||NM_001366230.1:c.2030+606G>T||MODIFIER||||||ARHGAP28|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	93,66:159:0.4151
chr18	6910235	.	C	G	.	PASS	CSQ=79822|protein_coding||intron_variant||||rs1461485276||1.31454e-05|NM_001366230.1:c.2095+1211C>G||MODIFIER||||||ARHGAP28|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	54,87:141:0.617
chr18	7207757	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	91,71:162:0.4383
chr18	7345440	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1246464920||1.32622e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	53,81:134:0.6045
chr18	7364286	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs918121400||5.93042e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	153,0:153:0	65,79:144:0.5486
chr18	7535026	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	56,78:134:0.5821
chr18	7742232	.	A	G	.	PASS	CSQ=5797|protein_coding||intron_variant||||||6.56866e-06|NM_002845.3:c.74-31917A>G||MODIFIER||||||PTPRM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,54:128:0.4219
chr18	8013849	.	CC	TT	.	PASS	CSQ=5797|protein_coding||intron_variant|||||||NM_002845.3:c.1133-55837_1133-55836delinsTT||MODIFIER||||||PTPRM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	100,0:101:0	134,12:147:0.0816
chr18	8015425	.	C	T	.	PASS	CSQ=5797|protein_coding||intron_variant|||||||NM_002845.3:c.1133-54261C>T||MODIFIER||||||PTPRM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	126,10:136:0.0735
chr18	8191673	.	G	T	.	PASS	CSQ=5797|protein_coding||intron_variant|||||||NM_002845.3:c.2300+47894G>T||MODIFIER||||||PTPRM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	88,68:156:0.4359
chr18	9826365	.	G	A	.	PASS	CSQ=11031|protein_coding||intron_variant|||||||NM_006868.4:c.380+11143G>A||MODIFIER||||||RAB31|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	64,67:131:0.5115
chr18	9840487	.	C	T	.	PASS	CSQ=11031|protein_coding||intron_variant||||rs1446182471||6.57142e-06|NM_006868.4:c.381-5095C>T||MODIFIER||||||RAB31|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	60,101:161:0.6273
chr18	10164047	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	70,77:147:0.5238
chr18	10382361	COSV74120058	AT	A	.	PASS	CSQ=|||intergenic_variant|||COSV74120058|rs1008480165||0.00026293|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	94,77:171:0.4503
chr18	10487762	.	G	C	.	PASS	CSQ=147495|protein_coding||missense_variant|||||||NM_153000.5:c.1269G>C|NP_694545.1:p.Glu423Asp|MODERATE|D|T|D|D|T|APCDD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	87,91:178:0.5112
chr18	10582387	.	CAGGG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	67,68:135:0.5037
chr18	11003438	.	C	CA	.	PASS	CSQ=63895|protein_coding||intron_variant|||||||NM_022068.3:c.161-23779dup||MODIFIER||||||PIEZO2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	94,56:150:0.3733
chr18	11315570	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	81,69:151:0.457
chr18	11379288	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1265741483||6.57358e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	91,79:170:0.4647
chr18	11529271	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1315603632||1.97171e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	69,98:167:0.5868
chr18	11534650	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	66,76:142:0.5352
chr18	11734796	.	A	T	.	PASS	CSQ=2774|protein_coding||intron_variant|||||||NM_182978.4:c.377-18057A>T||MODIFIER||||||GNAL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	80,58:139:0.4173
chr18	12028351	.	TG	T	.	PASS	CSQ=3613|protein_coding||intron_variant||||rs1339344990|||NM_014214.3:c.599+203del||MODIFIER||||||IMPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	164,62:226:0.2743
chr18	12031341	COSV52318873;COSV52318873;COSV52318873;COSV52318873;COSV52318873;COSV52318873;COSV52318873;COSV52318873;COSV52318873	A	T	.	PASS	CSQ=3613|protein_coding||downstream_gene_variant|||COSV52318873&COSV52318873&COSV52318873&COSV52318873&COSV52318873&COSV52318873&COSV52318873&COSV52318873&COSV52318873|rs1288874498||1.31607e-05|||MODIFIER||||||IMPA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	119,47:166:0.2831
chr18	12303205	.	C	T	.	PASS	CSQ=84617|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TUBB6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	95,83:178:0.4663
chr18	12501494	.	C	T	.	PASS	CSQ=56907|protein_coding||intron_variant|||||||NM_020148.2:c.972+4983G>A||MODIFIER||||||SPIRE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	71,79:150:0.5267
chr18	12761577	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	80,73:153:0.4771
chr18	12911304	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	101,73:174:0.4195
chr18	13360457	.	C	T	.	PASS	CSQ=753|protein_coding||intron_variant|||||||NM_181481.4:c.-382-26884C>T||MODIFIER||||||LDLRAD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	89,64:153:0.4183
chr18	13370716	.	T	TTTTTTTTTGTTTG	.	PASS	CSQ=753|protein_coding||intron_variant||||rs1388038060||0.030888|NM_181481.4:c.-382-16617_-382-16616insGTTTGTTTTTTTT||MODIFIER||||||LDLRAD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,1:83:0.012	58,59:117:0.5043
chr18	13465231	.	T	C	.	PASS	CSQ=753|protein_coding||intron_variant|||||||NM_181481.4:c.181+26847T>C||MODIFIER||||||LDLRAD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	92,57:149:0.3826
chr18	13500295	.	T	C	.	PASS	CSQ=753|protein_coding||intron_variant|||||||NM_181481.4:c.181+61911T>C||MODIFIER||||||LDLRAD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	73,81:154:0.526
chr18	13706238	.	C	A	.	PASS	CSQ=125228|protein_coding||intron_variant|||||||NM_152352.4:c.-29+20091G>T||MODIFIER||||||FAM210A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,57:132:0.4318
chr18	13975633	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	70,47:117:0.4017
chr18	14069216	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1487667170|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	123,17:140:0.1214
chr18	14202097	.	G	T	.	PASS	CSQ=440482|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_040113.1:n.1192+896G>T||MODIFIER||||||ANKRD20A5P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	63,0:63:0	40,45:85:0.5294
chr18	14357640	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	76,72:148:0.4865
chr18	14473711	.	G	A	.	PASS	CSQ=440224|transcribed_pseudogene||downstream_gene_variant||||||6.57203e-06|||MODIFIER||||||CXADRP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	122,0:122:0	127,8:135:0.0593
chr18	14489689	.	G	A	.	PASS	CSQ=440224|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_024076.1:n.171+836C>T||MODIFIER||||||CXADRP3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	176,0:176:0	165,72:237:0.3038
chr18	14592497	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1461975084|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	65,65:130:0.5
chr18	14627663	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	72,0:72:0	35,44:79:0.557
chr18	14745059	.	G	A	.	PASS	CSQ=374860|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ANKRD30B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	71,43:114:0.3772
chr18	14790863	.	GTGTCTC	G	.	PASS	CSQ=374860|protein_coding||intron_variant|||||||NM_001367607.1:c.1735-535_1735-530del||MODIFIER||||||ANKRD30B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	92,21:113:0.1858
chr18	14892407	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1363539972||6.57047e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	56,63:119:0.5294
chr18	15008451	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	57,47:104:0.4519
chr18	15106219	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	61,54:115:0.4696
chr18	15191813	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	68,40:108:0.3704
chr18	15203621	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	77,46:123:0.374
chr18	15263264	.	CAGT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,77:141:0.5461
chr18	15330619	.	C	T	.	PASS	CSQ=644669|transcribed_pseudogene||upstream_gene_variant||||rs1386772486||0.000118244|||MODIFIER||||||LOC644669|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	71,96:167:0.5749
chr18	15528132	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	130,30:160:0.1875
chr18	15783797	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	66,63:129:0.4884
chr18	21432472	COSV52564401;COSV52564401;COSV52564401	A	AT	.	PASS	CSQ=80000|protein_coding||intron_variant|COSV52564401&COSV52564401&COSV52564401|p.?&p.?&p.?||rs368054179||0.000788826|NM_001142966.2:c.833-7039dup||MODIFIER||||||GREB1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	11,53:64:0.8281
chr18	21494932	.	G	C	.	PASS	CSQ=80000|protein_coding||intron_variant|||||||NM_001142966.2:c.3031-738G>C||MODIFIER||||||GREB1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	65,91:156:0.5833
chr18	21732107	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	105,0:105:0	110,4:114:0.0351
chr18	22212562	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	51,69:120:0.575
chr18	22431279	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57713e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	76,65:141:0.461
chr18	22460157	COSV64762481	CA	C	.	PASS	CSQ=|||intergenic_variant|||COSV64762481|rs976182700||0.000231559|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	81,46:127:0.3622
chr18	22522049	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	162,80:242:0.3306
chr18	22540578	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1044589969||4.60181e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	48,165:213:0.7746
chr18	22628993	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	141,78:219:0.3562
chr18	22640223	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	68,173:241:0.7178
chr18	22810298	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||1.9748e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	149,58:207:0.2802
chr18	23016238	.	A	AT	.	PASS	CSQ=5932|protein_coding||intron_variant||||rs886271922||0.000421236|NM_002894.3:c.2358-580dup||MODIFIER||||||RBBP8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:133:0	153,78:233:0.3348
chr18	23079729	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1251557279|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	115,78:193:0.4041
chr18	23313200	.	C	CA	.	PASS	CSQ=85019|protein_coding||intron_variant|||||||NM_032933.6:c.766-3457dup||MODIFIER||||||TMEM241|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	55,50:105:0.4762
chr18	23571818	.	C	A	.	PASS	CSQ=4864|protein_coding||intron_variant|||||||NM_000271.5:c.287+256G>T||MODIFIER||||||NPC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	91,62:153:0.4052
chr18	23835356	.	A	C	.	PASS	CSQ=3909|protein_coding||intron_variant|||||||NM_198129.2:c.2984+1368A>C||MODIFIER||||||LAMA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	75,84:159:0.5283
chr18	24484705	.	G	A	.	PASS	CSQ=59340|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||HRH4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	142,11:153:0.0719
chr18	24494570	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	85,65:150:0.4333
chr18	24873565	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	88,70:158:0.443
chr18	24940593	.	T	C	.	PASS	CSQ=105372030|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146903.1:n.624-6946A>G||MODIFIER||||||LINC01894|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	73,64:137:0.4672
chr18	25317003	.	C	T	.	PASS	CSQ=25925|protein_coding||intron_variant||||rs774896769||0.00125|NM_015461.3:c.220+5005G>A||MODIFIER||||||ZNF521|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ZNF521|y|n|ALL|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	49,72:121:0.595
chr18	25497774	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	60,62:122:0.5082
chr18	25640581	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	121,6:127:0.0472
chr18	25728576	.	AC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	54,40:94:0.4255
chr18	25728583	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	50,44:94:0.4681
chr18	25800349	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	66,91:157:0.5796
chr18	25829888	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1436921240||4.63043e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	73,56:129:0.4341
chr18	25837984	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	69,49:118:0.4153
chr18	25866093	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	103,61:164:0.372
chr18	26127948	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	71,59:130:0.4538
chr18	26206513	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	79,72:151:0.4768
chr18	26275318	.	G	A	.	PASS	CSQ=6875|protein_coding||intron_variant|||||||NM_005640.2:c.882+265G>A||MODIFIER||||||TAF4B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	39,79:118:0.6695
chr18	27236828	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,1:118:0.0085	51,87:138:0.6304
chr18	27672513	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	74,56:130:0.4308
chr18	27804100	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1179935445||6.57999e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	63,55:118:0.4661
chr18	28034683	.	T	TA	.	PASS	CSQ=1000|protein_coding||intron_variant||||rs202127259||0.00805829|NM_001792.5:c.173-20775dup||MODIFIER||||||CDH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	81,74:155:0.4774
chr18	28237084	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.57722e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	69,66:135:0.4889
chr18	28240324	.	CTT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	47,77:124:0.621
chr18	28286859	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	69,72:141:0.5106
chr18	28298804	.	TG	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:106:0	57,61:119:0.5126
chr18	28412237	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	82,52:134:0.3881
chr18	28760246	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,79:79:1
chr18	28783072	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1243531578||0.000359717|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	39,23:62:0.371
chr18	28855301	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	5,67:72:0.9306
chr18	29201281	.	GA	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	88,0:88:0	53,4:57:0.0702
chr18	29402836	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,84:84:1
chr18	29857421	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs539273358||0.000256606|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	0,69:69:1
chr18	29904578	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	59,10:69:0.1449
chr18	30088336	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	62,7:69:0.1014
chr18	30611308	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,81:81:1
chr18	30663582	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,74:74:1
chr18	31177810	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,75:75:1
chr18	31388712	.	A	G	.	PASS	CSQ=147409|protein_coding||intron_variant|||||||NM_177986.4:c.373-162A>G||MODIFIER||||||DSG4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,64:64:1
chr18	32377294	.	AGGAAG	A	.	PASS	CSQ=64762|protein_coding||intron_variant|||||||NM_001242409.2:c.262+15596_262+15600del||MODIFIER||||||GAREM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,71:71:1
chr18	32419189	.	C	T	.	PASS	CSQ=64762|protein_coding||intron_variant|||||||NM_001242409.2:c.122-26154G>A||MODIFIER||||||GAREM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,84:84:1
chr18	32812914	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,58:58:1
chr18	32828890	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,66:66:1
chr18	34033394	.	G	C	.	PASS	CSQ=8715|protein_coding||intron_variant|||||||NM_003787.4:c.773-13793C>G||MODIFIER||||||NOL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	0,46:46:1
chr18	34041678	.	C	CT	.	PASS	CSQ=8715|protein_coding||intron_variant||||rs1047929217||5.933e-05|NM_003787.4:c.773-22078dup||MODIFIER||||||NOL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	19,66:85:0.7765
chr18	34252533	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	0,65:65:1
chr18	34298208	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	122,0:122:0	77,5:82:0.061
chr18	34644151	COSV52023944;COSV52023944;COSV52023944;COSV52023944;COSV52023944;COSV52023944;COSV52023944	T	C	.	PASS	CSQ=1837|protein_coding||intron_variant|COSV52023944&COSV52023944&COSV52023944&COSV52023944&COSV52023944&COSV52023944&COSV52023944|p.?&p.?&p.?&p.?&p.?&p.?&p.?||rs1395800990|||NM_001198938.1:c.-126-35317T>C||MODIFIER||||||DTNA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	0,73:73:1
chr18	35316783	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1021419751||6.57099e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,80:80:1
chr18	35593943	.	C	T	.	PASS	CSQ=100616257|miRNA||downstream_gene_variant||||rs1033678464|||||MODIFIER||||||MIR3975|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,63:63:1
chr18	36269036	.	T	C	.	PASS	CSQ=55034|protein_coding||3_prime_UTR_variant|||||||NM_017947.4:c.*351T>C||MODIFIER||||||MOCOS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	75,4:79:0.0506
chr18	36416566	.	C	G	.	PASS	CSQ=80206|protein_coding||intron_variant|||||||NM_001281740.2:c.337+43822C>G||MODIFIER||||||FHOD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,84:84:1
chr18	36529435	.	T	A	.	PASS	CSQ=80206|protein_coding||intron_variant|||||||NM_001281740.2:c.511+16892T>A||MODIFIER||||||FHOD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,87:87:1
chr18	37742615	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,63:63:1
chr18	38124763	COSV50269002	AT	A	.	PASS	CSQ=|||intergenic_variant|||COSV50269002|rs1472339943||5.38112e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	3,63:66:0.9545
chr18	38150972	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	9,58:67:0.8657
chr18	38783054	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,60:60:1
chr18	39021224	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||6.58944e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,62:62:1
chr18	39434438	.	GTATT	G	.	PASS	CSQ=647946|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_024391.1:n.281+101016_281+101019del||MODIFIER||||||MIR924HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,48:48:1
chr18	39602985	.	C	T	.	PASS	CSQ=647946|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_024391.1:n.124-67370G>A||MODIFIER||||||MIR924HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	0,65:65:1
chr18	39760264	.	AAAT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	4,58:62:0.9355
chr18	39857923	.	C	T	.	PASS	CSQ=105372079|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_151703.1:n.205-6130C>T||MODIFIER||||||LINC01902|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,72:72:1
chr18	39914467	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	41,37:78:0.4744
chr18	39915299	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,80:80:1
chr18	40078131	.	T	TA	.	PASS	CSQ=101927900|lncRNA||intron_variant&non_coding_transcript_variant||||rs58787578||0.145526|NR_110791.1:n.884-4521_884-4520insA||MODIFIER||||||LINC01477|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	18,47:65:0.7231
chr18	40180723	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,63:63:1
chr18	40745226	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,61:61:1
chr18	40946893	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	0,62:62:1
chr18	40982267	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1056777750|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	1,62:63:0.9841
chr18	41273103	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs528137608||2.63877e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,45:45:1
chr18	41489043	.	C	T	.	PASS	CSQ=641516|lncRNA||intron_variant&non_coding_transcript_variant||||rs1353038950||6.57203e-06|NR_002838.2:n.588-6466G>A||MODIFIER||||||KC6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	0,72:72:1
chr18	41730347	.	ATATG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,56:56:1
chr18	42647278	.	C	A	.	PASS	CSQ=284260|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046174.2:n.1272-31570C>A||MODIFIER||||||LINC00907|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	32,48:80:0.6
chr18	43053815	.	A	G	.	PASS	CSQ=6014|protein_coding||intron_variant|||||||NM_002930.4:c.104-19948T>C||MODIFIER||||||RIT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,80:80:1
chr18	43759655	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,52:52:1
chr18	43801316	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,62:62:1
chr18	44571443	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,65:65:1
chr18	44921365	.	G	A	.	PASS	CSQ=26040|protein_coding||intron_variant|||||||NM_015559.3:c.541-28516G>A||MODIFIER||||||SETBP1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/SETBP1|y|y|aCML,sAML,MDS/MPN-U,CMML,JMML|neuroepithelial_tumours|Schinzel-Giedion_syndrome|L|Dom|oncogene,fusion|Mis,T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,77:77:1
chr18	46068694	.	CA	AC	.	PASS	CSQ=9050|protein_coding||intron_variant|||||||NM_024430.4:c.33+3461_33+3462delinsGT||MODIFIER||||||PSTPIP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	105,0:105:0	0,76:76:1
chr18	46087708	.	C	T	.	PASS	CSQ=498|protein_coding||intron_variant||||rs937682010||2.62975e-05|NM_004046.6:c.800-216G>A||MODIFIER||||||ATP5F1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,74:74:1
chr18	46241277	.	A	AT	.	PASS	CSQ=147339|protein_coding||intron_variant||||rs576947893||0.000507099|NM_145055.4:c.898+1098dup||MODIFIER||||||C18orf25|EntrezGene|0.0010;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	6,67:73:0.9178
chr18	46402608	.	C	A	.	PASS	CSQ=494470|protein_coding||intron_variant|||||||NM_152470.3:c.62-30582C>A||MODIFIER||||||RNF165|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,92:92:1
chr18	47766334	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,76:76:1
chr18	48968217	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,81:81:1
chr18	48968410	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,68:68:1
chr18	48968496	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	1,44:45:0.9778
chr18	49486604	.	A	T	.	PASS	CSQ=100302257|miRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR1539|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,69:69:1
chr18	50011243	.	G	C	.	PASS	CSQ=4645|protein_coding||intron_variant|||||||NM_001080467.3:c.456-9832C>G||MODIFIER||||||MYO5B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,89:89:1
chr18	51047193	COSV61689152;COSV61689152;COSV61689152;COSV61689152;COSV61689152	G	GA	.	PASS	CSQ=4089|protein_coding||frameshift_variant|COSV61689152&COSV61689152&COSV61689152|p.D52Rfs*2&p.D52Rfs*2&p.D52Rfs*2|COSV61689152&COSV61689152||||NM_005359.5:c.153dup|NP_005350.1:p.Asp52ArgfsTer2|HIGH||||||SMAD4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/SMAD4|y|y|colorectal,pancreatic,small_intestine|gastrointestinal_polyp|juvenile_polyposis|E|Rec|TSG|D,Mis,N,F;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	109,0:109:0	12,79:91:0.8681
chr18	51961464	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,64:64:1
chr18	52144498	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,67:67:1
chr18	52475408	.	T	G	.	PASS	CSQ=1630|protein_coding||intron_variant|||||||NM_005215.4:c.91+134530T>G||MODIFIER||||||DCC|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/DCC|y|n|CRC,melanoma,SCC|||E|||Mis,N,D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,74:74:1
chr18	52570045	.	TC	AA	.	PASS	CSQ=1630|protein_coding||intron_variant|||||||NM_005215.4:c.92-182009_92-182008delinsAA||MODIFIER||||||DCC|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/DCC|y|n|CRC,melanoma,SCC|||E|||Mis,N,D;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	128,0:129:0	0,75:76:0.9868
chr18	53261573	.	G	T	.	PASS	CSQ=1630|protein_coding||intron_variant|||||||NM_005215.4:c.1912-44005G>T||MODIFIER||||||DCC|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/DCC|y|n|CRC,melanoma,SCC|||E|||Mis,N,D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	60,5:65:0.0769
chr18	53402397	.	A	AAT	.	PASS	CSQ=1630|protein_coding||intron_variant||||rs5825017|||NM_005215.4:c.2828-388_2828-387insTA||MODIFIER||||||DCC|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/DCC|y|n|CRC,melanoma,SCC|||E|||Mis,N,D;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	22,0:116:0	16,46:62:0.7419
chr18	53411650	.	G	A	.	PASS	CSQ=1630|protein_coding||intron_variant||||rs1303605784||6.57358e-06|NM_005215.4:c.3130+1004G>A||MODIFIER||||||DCC|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/DCC|y|n|CRC,melanoma,SCC|||E|||Mis,N,D;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,61:61:1
chr18	53712177	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,64:64:1
chr18	53713697	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,69:69:1
chr18	53969426	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	69,7:77:0.0909
chr18	54422095	.	G	GAA	.	PASS	CSQ=|||intergenic_variant||||rs5825072||0.00343899|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	11,0:81:0	14,45:59:0.7627
chr18	55242147	.	CT	AC	.	PASS	CSQ=6925|protein_coding||intron_variant|||||||NM_001083962.1:c.1351-7465_1351-7464delinsGT||MODIFIER||||||TCF4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	101,0:101:0	0,64:64:1
chr18	55268484	.	G	A	.	PASS	CSQ=6925|protein_coding||intron_variant|||||||NM_001083962.1:c.922+1347C>T||MODIFIER||||||TCF4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	0,71:71:1
chr18	55430270	.	A	G	.	PASS	CSQ=6925|protein_coding||intron_variant|||||||NM_001083962.1:c.305-26752T>C||MODIFIER||||||TCF4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,79:79:1
chr18	55848293	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,68:68:1
chr18	56517907	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,73:73:1
chr18	56589904	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1016366698||2.63106e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	71,7:78:0.0897
chr18	57993854	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,64:64:1
chr18	59087474	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,70:70:1
chr18	59923402	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,84:84:1
chr18	60602010	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	7,66:73:0.9041
chr18	61047635	COSV66714364	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV66714364|rs547224321|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,74:74:1
chr18	61086001	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||||6.58285e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	5,70:75:0.9333
chr18	61131462	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1446153692||6.57333e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,72:72:1
chr18	61546585	.	T	TG	.	PASS	CSQ=28316|protein_coding||intron_variant||||rs1020940421||0.000434634|NM_031891.4:c.1648+1445dup||MODIFIER||||||CDH20|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	5,81:86:0.9419
chr18	62428526	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,81:81:1
chr18	63202460	.	T	A	.	PASS	CSQ=596|protein_coding||intron_variant|||||||NM_000633.2:c.586-73701A>T||MODIFIER||||||BCL2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/BCL2|y|n|NHL,CLL|||L|Dom|oncogene,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,110:110:1
chr18	63485125	.	C	T	.	PASS	CSQ=5268|protein_coding||intron_variant|||||||NM_002639.5:c.168+529C>T||MODIFIER||||||SERPINB5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,0:73:0	0,69:69:1
chr18	63810536	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,69:69:1
chr18	64678962	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1255688372||5.92253e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	6,59:65:0.9077
chr18	64958116	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1031010906||1.31789e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	6,61:67:0.9104
chr18	65265691	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,52:52:1
chr18	65393130	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,58:59:0.9831
chr18	65431961	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	81,0:81:0	0,70:70:1
chr18	65807358	.	G	A	.	PASS	CSQ=1005|protein_coding||intron_variant|||||||NM_004361.5:c.211-2346G>A||MODIFIER||||||CDH7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,76:76:1
chr18	65832834	.	C	A	.	PASS	CSQ=1005|protein_coding||intron_variant|||||||NM_004361.5:c.981+8003C>A||MODIFIER||||||CDH7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	37,45:82:0.5488
chr18	65926341	.	CA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	1,65:66:0.9848
chr18	66122305	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,77:77:1
chr18	66831799	COSV70988993	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV70988993|||6.57315e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,64:64:1
chr18	66838589	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,83:83:1
chr18	67207697	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,79:79:1
chr18	68305179	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs952158934||2.63328e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,65:65:1
chr18	68856842	.	G	C	.	PASS	CSQ=79839|protein_coding||intron_variant|||||||NM_001093729.1:c.936+10421G>C||MODIFIER||||||CCDC102B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	68,0:68:0	0,67:67:1
chr18	68907900	.	G	T	.	PASS	CSQ=79839|protein_coding||intron_variant|||||||NM_001093729.1:c.1263+10472G>T||MODIFIER||||||CCDC102B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,66:66:1
chr18	69409356	.	G	T	.	PASS	CSQ=220164|protein_coding||intron_variant|||||||NM_152721.6:c.66+8046G>T||MODIFIER||||||DOK6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,78:78:1
chr18	69489578	.	CT	AC	.	PASS	CSQ=220164|protein_coding||intron_variant|||||||NM_152721.6:c.67-74909_67-74908delinsAC||MODIFIER||||||DOK6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	106,0:106:0	0,92:92:1
chr18	71092053	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1303891500||1.31525e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	79,7:86:0.0814
chr18	71810141	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1340972605||1.97262e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,58:58:1
chr18	71868985	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,70:70:1
chr18	71882086	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	61,8:69:0.1159
chr18	71898455	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,65:65:1
chr18	71936629	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:101:0	0,77:77:1
chr18	72255474	.	TAAAC	T	.	PASS	CSQ=|||intergenic_variant||||rs1413268255||0.00024056|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	118,0:118:0	15,29:44:0.6591
chr18	72981266	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	62,11:73:0.1507
chr18	72982648	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	10,76:87:0.8736
chr18	73082506	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,80:80:1
chr18	73112707	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,76:76:1
chr18	73124198	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs940109305||1.31503e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,70:70:1
chr18	73507041	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs200444068||0.00592967|||MODIFIER||||||||0.0058;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	7,53:60:0.8833
chr18	73696562	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,77:77:1
chr18	73897358	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	0,61:61:1
chr18	73904136	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1430751647||6.58172e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,91:91:1
chr18	73975093	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,79:79:1
chr18	75913982	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	1,76:77:0.987
chr18	75982057	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,70:70:1
chr18	76047514	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,67:67:1
chr18	76103328	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,67:67:1
chr18	76377217	.	G	A	.	PASS	CSQ=9658|protein_coding||intron_variant|||||||NM_014643.4:c.3259+1638C>T||MODIFIER||||||ZNF516|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	0,72:72:1
chr18	76620941	.	C	T	.	PASS	CSQ=400660|lncRNA||non_coding_transcript_exon_variant|||||||NR_120419.1:n.1165C>T||MODIFIER||||||LINC00683|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,1:130:0.0077	0,74:74:1
chr18	77138592	.	A	C	.	PASS	CSQ=|||intergenic_variant||||rs948421415|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	4,83:87:0.954
chr18	77203601	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,70:70:1
chr18	77267746	.	C	T	.	PASS	CSQ=2587|protein_coding||intron_variant|||||||NM_001480.3:c.733-839C>T||MODIFIER||||||GALR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,76:76:1
chr18	77369815	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:125:0	0,83:83:1
chr18	77674623	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,71:71:1
chr18	77793495	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1229493979||1.31411e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,83:83:1
chr18	78067096	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	0,70:70:1
chr18	78165418	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,85:85:1
chr18	78165592	.	CTCTCCT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,53:53:1
chr18	78238278	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,78:78:1
chr18	78293438	.	TC	AG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	107,0:107:0	0,51:51:1
chr18	78557195	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,63:63:1
chr18	78955246	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	0,72:72:1
chr18	79822675	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,69:69:1
chr18	80089725	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,59:59:1
chr18	80187809	.	T	C	.	PASS	CSQ=84552|protein_coding||intron_variant||||rs1439955194||1.97127e-05|NM_032510.4:c.295+14901A>G||MODIFIER||||||PARD6G|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,65:65:1
chr19	504486	.	C	T	.	PASS	CSQ=91978|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TPGS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,83:83:1
chr19	709645	.	T	C	.	PASS	CSQ=5064|protein_coding||intron_variant|||||||NM_002579.3:c.5+494T>C||MODIFIER||||||PALM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:95:0	0,88:88:1
chr19	717295	.	T	A	.	PASS	CSQ=5064|protein_coding||intron_variant|||||||NM_002579.3:c.5+8144T>A||MODIFIER||||||PALM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,87:87:1
chr19	1491410	.	C	G	.	PASS	CSQ=92840|protein_coding||intron_variant|||||||NM_138393.4:c.115+26C>G||MODIFIER||||||REEP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	129,0:129:0	0,99:99:1
chr19	2992863	.	C	T	.	PASS	CSQ=7089|protein_coding||downstream_gene_variant||||rs1286305831|||||MODIFIER||||||TLE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	58,0:58:0	0,38:38:1
chr19	3052433	.	C	T	.	PASS	CSQ=166|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||AES|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,84:84:1
chr19	3393711	.	G	A	.	PASS	CSQ=4782|protein_coding||intron_variant|||||||NM_001245002.2:c.562+11468G>A||MODIFIER||||||NFIC|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	76,0:76:0	0,50:50:1
chr19	3908844	.	C	G	.	PASS	CSQ=85300|protein_coding||intron_variant|||||||NM_033064.5:c.647+474C>G||MODIFIER||||||ATCAY|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	46,0:46:0	0,28:28:1
chr19	4040974	.	T	G	.	PASS	CSQ=51341|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZBTB7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,93:93:1
chr19	4758687	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,64:64:1
chr19	4855164	.	C	T	.	PASS	CSQ=10226|protein_coding||intron_variant|||||||NM_005817.5:c.349-2863G>A||MODIFIER||||||PLIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	50,12:62:0.1935
chr19	4860915	.	G	A	.	PASS	CSQ=10226|protein_coding||intron_variant|||||||NM_005817.5:c.66+414C>T||MODIFIER||||||PLIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	116,0:116:0	85,3:88:0.0341
chr19	4861006	.	G	A	.	PASS	CSQ=10226|protein_coding||intron_variant|||||||NM_005817.5:c.66+323C>T||MODIFIER||||||PLIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	71,9:80:0.1125
chr19	4864806	.	G	A	.	PASS	CSQ=10226|protein_coding||intron_variant|||||||NM_005817.5:c.-18+2803C>T||MODIFIER||||||PLIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	63,17:80:0.2125
chr19	4865093	.	G	A	.	PASS	CSQ=10226|protein_coding||intron_variant|||||||NM_005817.5:c.-18+2516C>T||MODIFIER||||||PLIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	80,15:95:0.1579
chr19	5340105	.	G	A	.	PASS	CSQ=5802|protein_coding||intron_variant|||||||NM_002850.3:c.-95+559C>T||MODIFIER||||||PTPRS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,81:81:1
chr19	5384469	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs961102869||3.97041e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	63,8:71:0.1127
chr19	6250621	.	C	T	.	PASS	CSQ=4298|protein_coding||intron_variant|||||||NM_005934.4:c.276+11607G>A||MODIFIER||||||MLLT1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MLLT1|y|n|AL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,97:97:1
chr19	6761153	.	C	T	.	PASS	CSQ=10045|protein_coding||intron_variant|||||||NM_005490.3:c.70-166G>A||MODIFIER||||||SH2D3A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,86:86:1
chr19	7063343	.	G	A	.	PASS	CSQ=653657|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MBD3L3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,96:96:1
chr19	8264504	.	A	G	.	PASS	CSQ=79603|protein_coding||downstream_gene_variant||||rs999592292|||||MODIFIER||||||CERS4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	59,0:59:0	0,56:56:1
chr19	9684275	.	C	T	.	PASS	CSQ=729648|transcribed_pseudogene||downstream_gene_variant||||rs762318883||3.29659e-05|||MODIFIER||||||ZNF812P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,84:84:1
chr19	10169316	.	G	C	.	PASS	CSQ=1786|protein_coding||intron_variant|||||||NM_001130823.3:c.769-952C>G||MODIFIER||||||DNMT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,76:76:1
chr19	10367492	.	G	A	.	PASS	CSQ=7297|protein_coding||intron_variant|||||||NM_003331.4:c.465+563C>T||MODIFIER||||||TYK2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,87:87:1
chr19	10582936	.	C	T	.	PASS	CSQ=10053|protein_coding||intron_variant|||||||NM_005498.4:c.267+670G>A||MODIFIER||||||AP1M2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,47:47:1
chr19	11101786	.	T	TTA	.	PASS	CSQ=3949|protein_coding||intron_variant|||||||NM_000527.4:c.191-878_191-877insTA||MODIFIER||||||LDLR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	4,52:56:0.9286
chr19	11231728	.	G	A	.	PASS	CSQ=57572|protein_coding||intron_variant|||||||NM_020812.4:c.2718+1475C>T||MODIFIER||||||DOCK6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	91,21:112:0.1875
chr19	11422189	.	C	A	.	PASS	CSQ=57139|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||RGL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	89,5:94:0.0532
chr19	11505294	.	C	G	.	PASS	CSQ=51295|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ECSIT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	76,14:90:0.1556
chr19	12070651	.	A	T	.	PASS	CSQ=284391|protein_coding||intron_variant|||||||NM_001136501.3:c.4-3380A>T||MODIFIER||||||ZNF844|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,93:93:1
chr19	12082656	.	C	G	.	PASS	CSQ=284391|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZNF844|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,79:79:1
chr19	12366510	.	A	C	.	PASS	CSQ=79973|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ZNF442|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,90:90:1
chr19	14904238	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,99:99:1
chr19	14920009	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,89:89:1
chr19	15044028	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1357527243||1.31458e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	10,73:83:0.8795
chr19	15044035	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,76:76:1
chr19	15668785	.	G	C	.	PASS	CSQ=66002|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CYP4F12|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,94:94:1
chr19	16543887	.	GA	TT	.	PASS	CSQ=10523|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CHERP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	88,0:88:0	0,71:71:1
chr19	17054604	.	C	T	.	PASS	CSQ=93323|protein_coding||intron_variant||||rs1022668229||6.578e-06|NM_033417.2:c.787+1257G>A||MODIFIER||||||HAUS8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,93:93:1
chr19	17574043	.	C	T	.	PASS	CSQ=79709|protein_coding||intron_variant|||||||NM_024656.4:c.949+1441C>T||MODIFIER||||||COLGALT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,109:109:1
chr19	18404589	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1218284019|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	80,0:80:0	58,2:61:0.0328
chr19	19212307	.	G	A	.	PASS	CSQ=1463|protein_coding||intron_variant||||rs969021473||6.57505e-06|NM_004386.3:c.-8+243G>A||MODIFIER||||||NCAN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	0,82:82:1
chr19	20598593	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,89:89:1
chr19	20660495	.	C	G	.	PASS	CSQ=199777|protein_coding||intron_variant|||||||NM_001076675.3:c.3+949G>C||MODIFIER||||||ZNF626|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,65:65:1
chr19	20778257	.	G	A	.	PASS	CSQ=7617|protein_coding||intron_variant||||rs780760105||5.92448e-05|NM_001355197.2:c.3+1807G>A||MODIFIER||||||ZNF66|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:98:0	0,56:56:1
chr19	20848186	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,1:118:0.0085	6,62:68:0.9118
chr19	21014687	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,84:84:1
chr19	21197047	.	A	G	.	PASS	CSQ=170959|protein_coding||downstream_gene_variant||||||6.56849e-06|||MODIFIER||||||ZNF431|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	0,86:86:1
chr19	22471038	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,71:71:1
chr19	22595193	.	C	T	.	PASS	CSQ=440518|transcribed_pseudogene||upstream_gene_variant||||rs1054310535|||||MODIFIER||||||GOLGA2P9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	42,4:46:0.087
chr19	22963574	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	8,56:64:0.875
chr19	23032096	COSV58852627	G	T	.	PASS	CSQ=|||intergenic_variant|||COSV58852627||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	0,51:51:1
chr19	23983795	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,66:67:0.9851
chr19	24017399	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,52:52:1
chr19	24245038	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	125,0:125:0	0,65:65:1
chr19	24367650	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	241,0:241:0	143,72:215:0.3349
chr19	27370634	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	343,0:344:0	236,69:305:0.2262
chr19	27374097	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	350,0:351:0	225,63:289:0.218
chr19	27411034	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,78:78:1
chr19	27476103	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	1,65:66:0.9848
chr19	27596786	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,76:76:1
chr19	27810499	.	C	T	.	PASS	CSQ=101927151|lncRNA||intron_variant&non_coding_transcript_variant||||rs761572193||0.000124933|NR_146733.1:n.179+16890C>T||MODIFIER||||||LOC101927151|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:136:0	45,10:55:0.1818
chr19	28578596	.	C	A	.	PASS	CSQ=100420587|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_110759.1:n.657-111816G>T||MODIFIER||||||LOC100420587|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	1,67:68:0.9853
chr19	29985372	.	A	G	.	PASS	CSQ=8725|protein_coding||intron_variant|||||||NM_003796.3:c.231+71A>G||MODIFIER||||||URI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	97,0:97:0	0,76:76:1
chr19	30111365	COSV101433754	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV101433754|rs955110244||1.31524e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,69:69:1
chr19	30243406	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,84:84:1
chr19	30596293	.	C	A	.	PASS	CSQ=9745|protein_coding||intron_variant||||rs955154461||6.57341e-06|NM_001352260.1:c.3895+46779C>A||MODIFIER||||||ZNF536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,80:80:1
chr19	30644668	.	C	T	.	PASS	CSQ=9745|protein_coding||intron_variant|||||||NM_001352260.1:c.*26+1092C>T||MODIFIER||||||ZNF536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	1,68:69:0.9855
chr19	30678351	.	C	T	.	PASS	CSQ=9745|protein_coding||intron_variant|||||||NM_001352260.1:c.*27-32406C>T||MODIFIER||||||ZNF536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,82:82:1
chr19	30700345	.	C	T	.	PASS	CSQ=9745|protein_coding||intron_variant||||||6.72305e-06|NM_001352260.1:c.*27-10412C>T||MODIFIER||||||ZNF536|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,58:59:0.9831
chr19	31121054	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1218123913||6.5703e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,94:94:1
chr19	31563094	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,66:66:1
chr19	35111065	.	C	T	.	PASS	CSQ=100128675|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||HPN-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,97:97:1
chr19	35320908	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,2:113:0.0177	0,85:85:1
chr19	35381676	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	3,76:79:0.962
chr19	36110188	.	G	A	.	PASS	CSQ=728361|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||OVOL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,88:88:1
chr19	36244526	.	G	A	.	PASS	CSQ=147929|protein_coding||intron_variant|||||||NM_001366188.1:c.-66+950C>T||MODIFIER||||||ZNF565|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,77:77:1
chr19	36967562	.	C	CA	.	PASS	CSQ=374900|protein_coding||intron_variant||||rs1474790936||7.90879e-05|NM_001204838.1:c.359-6850dup||MODIFIER||||||ZNF568|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	10,65:76:0.8553
chr19	37037053	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1193163267||6.5741e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	115,0:115:0	0,71:71:1
chr19	37631291	.	C	T	.	PASS	CSQ=22835|protein_coding||3_prime_UTR_variant|||||||NM_001320669.2:c.*3690G>A||MODIFIER||||||ZFP30|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,89:89:1
chr19	38389373	.	G	T	.	PASS	CSQ=199720|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GGN|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	89,76:165:0.4606
chr19	38827976	.	C	T	.	PASS	CSQ=1891|protein_coding||intron_variant||||rs889032401|||NM_001398.3:c.349+3102G>A||MODIFIER||||||ECH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	80,94:174:0.5402
chr19	38888271	.	C	G	.	PASS	CSQ=22933|protein_coding||intron_variant||||rs1454296596|||NM_012237.4:c.501+816G>C||MODIFIER||||||SIRT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	154,0:154:0	100,87:187:0.4652
chr19	39130342	.	G	A	.	PASS	CSQ=10298|protein_coding||intron_variant|||||||NM_005884.3:c.-96+4423G>A||MODIFIER||||||PAK4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	258,110:368:0.2989
chr19	39468041	.	C	T	.	PASS	CSQ=6829|protein_coding||intron_variant||||||1.31505e-05|NM_001111020.3:c.1038-715C>T||MODIFIER||||||SUPT5H|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	105,0:105:0	263,50:313:0.1597
chr19	39534735	.	G	A	.	PASS	CSQ=126272|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||EID2B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	257,77:334:0.2305
chr19	39624580	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57454e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	244,83:327:0.2538
chr19	39644122	.	AG	A	.	PASS	CSQ=100129935|transcribed_pseudogene||downstream_gene_variant||||rs1482307698||2.62988e-05|||MODIFIER||||||LOC100129935|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	78,229:307:0.7459
chr19	39703342	.	C	A	.	PASS	CSQ=56891|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||LGALS14|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	263,84:347:0.2421
chr19	40114499	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	170,76:246:0.3089
chr19	40300759	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	192,71:264:0.2689
chr19	41095002	COSV57837147	C	T	.	PASS	CSQ=1553|protein_coding||missense_variant|COSV57837147|p.P402L||rs140896123|5.1696e-05|0.000177512|NM_000766.4:c.1205C>T|NP_000757.2:p.Pro402Leu|MODERATE|B|T|N|D|D|CYP2A13|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	105,0:105:0	0,92:92:1
chr19	41510719	COSV74124695	G	A	.	PASS	CSQ=|||intergenic_variant|||COSV74124695||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,88:88:1
chr19	41556817	.	G	A	.	PASS	CSQ=90273|protein_coding||intron_variant|||||||NM_001288773.2:c.-779+7265G>A||MODIFIER||||||CEACAM21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,91:91:1
chr19	42224171	.	A	T	.	PASS	CSQ=162989|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||DEDD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	89,0:89:0	0,84:84:1
chr19	42519096	.	G	C	.	PASS	CSQ=634|protein_coding||synonymous_variant|||||||NM_001712.5:c.1098C>G|NP_001703.2:p.Leu366=|LOW||||||CEACAM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	123,0:123:0	55,25:80:0.3125
chr19	43069983	.	A	T	.	PASS	CSQ=5670|protein_coding||intron_variant|||||||NM_031246.4:c.964+1717T>A||MODIFIER||||||PSG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,86:86:1
chr19	43978940	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs376293123||0.209832|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	105,0:105:0	11,57:68:0.8382
chr19	44934225	.	C	G	.	PASS	CSQ=342|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||APOC1P1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	162,90:252:0.3571
chr19	45134603	.	GG	AC	.	PASS	CSQ=284352|protein_coding||intron_variant|||||||NM_019121.2:c.203-3911_203-3910delinsAC||MODIFIER||||||PPP1R37|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	101,0:101:0	0,85:85:1
chr19	45504152	.	C	T	.	PASS	CSQ=7408|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||VASP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,64:64:1
chr19	45985399	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1464023934||6.58848e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,87:87:1
chr19	46585782	.	C	T	.	PASS	CSQ=100506012|protein_coding||intron_variant|||||||NM_001205281.1:c.87+15101G>A||MODIFIER||||||PPP5D1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,88:88:1
chr19	47445726	.	G	A	.	PASS	CSQ=6543|protein_coding||intron_variant|||||||NM_015063.3:c.1763+2083C>T||MODIFIER||||||SLC8A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,99:99:1
chr19	47509710	.	C	T	.	PASS	CSQ=8775|protein_coding||intron_variant|||||||NM_003827.4:c.98+5133G>A||MODIFIER||||||NAPA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,75:75:1
chr19	47609517	.	A	T	.	PASS	CSQ=29998|protein_coding||intron_variant|||||||NM_015711.3:c.-108+1235A>T||MODIFIER||||||BICRA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:79:0	0,90:90:1
chr19	48019800	.	A	T	.	PASS	CSQ=64100|protein_coding||missense_variant||||rs375645287||6.58311e-06|NM_022142.5:c.437A>T|NP_071425.3:p.Asp146Val|MODERATE|B&.&.|T&T&.|N|T&T&T|T&.&.|ELSPBP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	104,0:104:0	0,71:71:1
chr19	49064973	.	C	T	.	PASS	CSQ=3743|protein_coding||downstream_gene_variant||||rs905902200|||||MODIFIER||||||KCNA7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	98,0:98:0	0,74:74:1
chr19	49226137	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,72:72:1
chr19	50026142	.	G	T	.	PASS	CSQ=25888|protein_coding||intron_variant|||||||NM_015428.4:c.-192+20G>T||MODIFIER||||||ZNF473|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	103,0:103:0	0,86:86:1
chr19	50030891	.	G	A	.	PASS	CSQ=25888|protein_coding||splice_acceptor_variant|||||||NM_015428.4:c.-191-1G>A||HIGH||||||ZNF473|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	131,0:131:0	0,102:102:1
chr19	51050957	.	G	C	.	PASS	CSQ=26085|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||KLK13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	77,62:139:0.446
chr19	51051206	.	G	C	.	PASS	CSQ=26085|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||KLK13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	63,0:63:0	61,42:103:0.4078
chr19	51287558	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	70,67:137:0.4891
chr19	51606205	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	76,87:163:0.5337
chr19	52149726	.	G	A	.	PASS	CSQ=162962|protein_coding||downstream_gene_variant||||rs576586657||7.23199e-05|||MODIFIER||||||ZNF836|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,80:152:0.5263
chr19	52242430	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1057433677||3.28614e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	122,33:155:0.2129
chr19	53137807	.	A	AT	.	PASS	CSQ=55786|protein_coding||upstream_gene_variant||||rs1043790764|||||MODIFIER||||||ZNF415|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:108:0	163,74:237:0.3122
chr19	53164349	.	CC	GT	.	PASS	CSQ=79788|protein_coding||3_prime_UTR_variant|||||||NM_024733.5:c.*103_*104delinsAC||MODIFIER||||||ZNF665|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2,lancet;num_callers=2	AD:DP:AF	117,0:117:0	140,69:210:0.3286
chr19	53164364	.	G	C	.	PASS	CSQ=79788|protein_coding||3_prime_UTR_variant||||rs1329160250|||NM_024733.5:c.*89C>G||MODIFIER||||||ZNF665|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2,lancet;num_callers=2	AD:DP:AF	125,0:126:0	144,70:214:0.3271
chr19	53164365	.	A	T	.	PASS	CSQ=79788|protein_coding||3_prime_UTR_variant||||rs1283575359|||NM_024733.5:c.*88T>A||MODIFIER||||||ZNF665|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	127,0:127:0	143,70:213:0.3286
chr19	53171078	.	G	T	.	PASS	CSQ=79788|protein_coding||intron_variant|||||||NM_024733.5:c.142+4367C>A||MODIFIER||||||ZNF665|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	139,89:228:0.3904
chr19	53172749	.	TG	CA	.	PASS	CSQ=79788|protein_coding||intron_variant|||||||NM_024733.5:c.142+2695_142+2696inv||MODIFIER||||||ZNF665|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	71,0:71:0	128,70:199:0.3518
chr19	53297094	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs905173556||1.97452e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	80,90:170:0.5294
chr19	54041591	.	G	A	.	PASS	CSQ=284415|protein_coding||intron_variant||||rs1262496696||2.62954e-05|NM_198481.4:c.591+188C>T||MODIFIER||||||VSTM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	90,88:179:0.4916
chr19	54303437	.	T	A	.	PASS	CSQ=353514|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LILRA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	87,80:167:0.479
chr19	54384571	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1444258353||2.89067e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:88:0	0,149:149:1
chr19	54594037	.	C	T	.	PASS	CSQ=11027|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LILRA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	166,12:178:0.0674
chr19	54830477	.	A	G	.	PASS	CSQ=3809|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||KIR2DS4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	60,4:64:0.0625	7,17:24:0.7083
chr19	54832549	.	G	A	.	PASS	CSQ=3811|protein_coding||downstream_gene_variant||||||0.0111994|||MODIFIER||||||KIR3DL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	59,8:67:0.1194	0,30:30:1
chr19	54836797	.	A	G	.	PASS	CSQ=3809|protein_coding||intron_variant||||||4.42022e-05|NM_001281971.2:c.71-779A>G||MODIFIER||||||KIR2DS4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	47,3:50:0.06	0,4:4:1
chr19	54837474	.	C	G	.	PASS	CSQ=3809|protein_coding||intron_variant||||||0.000334911|NM_001281971.2:c.71-102C>G||MODIFIER||||||KIR2DS4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	60,4:64:0.0625	0,10:10:1
chr19	54844699	.	T	C	.	PASS	CSQ=3809|protein_coding||intron_variant|||||||NM_001281971.2:c.693+1781T>C||MODIFIER||||||KIR2DS4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	67,12:79:0.1519	1,39:40:0.975
chr19	54897649	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs112290511||0.346498|||MODIFIER||||||||0.62;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	61,0:62:0	0,9:9:1
chr19	55162424	.	A	G	.	PASS	CSQ=352909|protein_coding||intron_variant||||rs1333693152||6.57298e-06|NM_001256715.1:c.323-134T>C||MODIFIER||||||DNAAF3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	99,108:207:0.5217
chr19	55217743	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	95,93:188:0.4947
chr19	55294586	.	C	T	.	PASS	CSQ=84446|protein_coding||intron_variant||||rs889406465|||NM_032430.1:c.678+189C>T||MODIFIER||||||BRSK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	85,92:177:0.5198
chr19	55439503	.	G	A	.	PASS	CSQ=729956|protein_coding||intron_variant||||rs1270249205||3.28839e-05|NM_001145176.1:c.826+1108C>T||MODIFIER||||||SHISA7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,141:141:1
chr19	56296951	.	C	G	.	PASS	CSQ=79149|protein_coding||intron_variant|||||||NM_001322064.1:c.-128+16332G>C||MODIFIER||||||ZSCAN5A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	73,76:149:0.5101
chr19	56318231	.	C	CT	.	PASS	CSQ=79149|protein_coding||upstream_gene_variant||||rs35648605||0.0971977|||MODIFIER||||||ZSCAN5A|EntrezGene|0.0944;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	82,73:155:0.471
chr19	56804286	.	G	A	.	PASS	CSQ=23619|protein_coding||intron_variant|||||||NM_001146326.1:c.397+14314C>T||MODIFIER||||||ZIM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	60,90:150:0.6
chr19	57019835	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1276842145||3.77763e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	75,0:76:0	0,127:128:0.9922
chr19	57027662	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,170:170:1
chr19	57076420	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	147,10:157:0.0637
chr19	57108492	.	CA	C	.	PASS	CSQ=|||intergenic_variant||||rs1229926046||0.000106193|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	81,64:145:0.4414
chr19	57469205	.	G	A	.	PASS	CSQ=400720|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZNF772|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	130,14:144:0.0972
chr19	57469447	COSV58410531;COSV58410531;COSV58410531;COSV58410531;COSV58410531;COSV58410531;COSV58410531;COSV58410531;COSV58410531	T	TA	.	PASS	CSQ=400720|protein_coding||downstream_gene_variant|COSV58410531&COSV58410531&COSV58410531|p.?&p.?&p.?|COSV58410531&COSV58410531&COSV58410531&COSV58410531&COSV58410531&COSV58410531|rs1432245466||0.000119188|||MODIFIER||||||ZNF772|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	89,64:153:0.4183
chr19	58083583	.	C	G	.	PASS	CSQ=65982|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZSCAN18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	70,98:168:0.5833
chr19	58094036	.	A	G	.	PASS	CSQ=65982|protein_coding||intron_variant|||||||NM_001145543.1:c.-119-3650T>C||MODIFIER||||||ZSCAN18|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	76,80:156:0.5128
chr19	58419792	.	A	C	.	PASS	CSQ=201514|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZNF584|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	151,6:157:0.0382
chr19	58526374	.	T	G	.	PASS	CSQ=84878|protein_coding||intron_variant|||||||NM_001316980.1:c.1-8701A>C||MODIFIER||||||ZBTB45|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	65,75:140:0.5357
chr20	242041	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	63,36:99:0.3636
chr20	964493	.	G	A	.	PASS	CSQ=343637|protein_coding||intron_variant|||||||NM_001029871.4:c.410-373C>T||MODIFIER||||||RSPO4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,60:60:1
chr20	1067802	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,91:91:1
chr20	3208872	.	C	T	.	PASS	CSQ=3704|protein_coding||upstream_gene_variant||||||6.57341e-06|||MODIFIER||||||ITPA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	107,0:107:0	0,93:94:0.9894
chr20	4199530	.	C	T	.	PASS	CSQ=728228|lncRNA||downstream_gene_variant||||rs1312825387||1.31453e-05|||MODIFIER||||||LINC01433|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,92:92:1
chr20	4433684	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,80:80:1
chr20	5670588	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,114:114:1
chr20	6662609	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	90,4:94:0.0426
chr20	7315710	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	44,34:78:0.4359
chr20	7766418	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	96,0:96:0	90,3:93:0.0323
chr20	8212950	.	G	A	.	PASS	CSQ=23236|protein_coding||intron_variant|||||||NM_015192.4:c.177+62579G>A||MODIFIER||||||PLCB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,85:85:1
chr20	8331129	.	G	A	.	PASS	CSQ=23236|protein_coding||intron_variant|||||||NM_015192.4:c.178-40253G>A||MODIFIER||||||PLCB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,72:72:1
chr20	8805021	.	A	T	.	PASS	CSQ=23236|protein_coding||intron_variant|||||||NM_015192.4:c.3423+14760A>T||MODIFIER||||||PLCB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	32,53:85:0.6235
chr20	9028391	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	0,99:99:1
chr20	9471449	.	GA	G	.	PASS	CSQ=5332|protein_coding||intron_variant|||||||NM_000933.3:c.3315-1339del||MODIFIER||||||PLCB4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	7,76:83:0.9157
chr20	11233604	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,68:68:1
chr20	11278708	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||||6.58016e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	5,81:86:0.9419
chr20	12012529	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,59:59:1
chr20	12844983	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	0,89:89:1
chr20	13748588	.	A	T	.	PASS	CSQ=51575|protein_coding||intron_variant||||rs1310523786||0.0472742|NM_001276380.1:c.1828+11104T>A||MODIFIER||||||ESF1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	55,0:55:0	0,58:58:1
chr20	13793640	.	A	G	.	PASS	CSQ=79133|protein_coding||intron_variant||||rs755585633||0.000157749|NM_024120.5:c.375+413A>G||MODIFIER||||||NDUFAF5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,73:73:1
chr20	13969511	.	CT	C	.	PASS	CSQ=80343|protein_coding||intron_variant|||||||NM_025229.1:c.59-13381del||MODIFIER||||||SEL1L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	1,82:83:0.988
chr20	14182392	.	T	C	.	PASS	CSQ=140733|protein_coding||intron_variant|||||||NM_001351661.1:c.271+96664T>C||MODIFIER||||||MACROD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,80:80:1
chr20	14344780	.	TAA	T	.	PASS	CSQ=140733|protein_coding||intron_variant|||||||NM_001351661.1:c.272-148697_272-148696del||MODIFIER||||||MACROD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	0,80:80:1
chr20	14413754	.	A	C	.	PASS	CSQ=140733|protein_coding||intron_variant|||||||NM_001351661.1:c.272-79725A>C||MODIFIER||||||MACROD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:124:0	0,91:91:1
chr20	14719009	.	A	G	.	PASS	CSQ=140733|protein_coding||intron_variant||||||6.57333e-06|NM_001351661.1:c.418+34050A>G||MODIFIER||||||MACROD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	69,5:74:0.0676
chr20	16894340	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	58,0:58:0	32,11:44:0.25
chr20	17146809	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,101:101:1
chr20	17164548	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1035832488||1.36288e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	0,93:93:1
chr20	18680430	.	TTTG	T	.	PASS	CSQ=92675|protein_coding||intron_variant||||rs768317243|||NM_080820.5:c.477+52198_477+52200del||MODIFIER||||||DTD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	8,58:66:0.8788
chr20	18825504	.	T	A	.	PASS	CSQ=100128496|protein_coding||intron_variant|||||||NM_001242671.2:c.34-156A>T||MODIFIER||||||C20orf78|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,66:66:1
chr20	19123175	.	TC	T	.	PASS	CSQ=|||intergenic_variant||||rs1013308726||2.64753e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,75:75:1
chr20	19613154	.	C	G	.	PASS	CSQ=57419|protein_coding||intron_variant|||||||NM_020689.3:c.612+27610C>G||MODIFIER||||||SLC24A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	3,89:92:0.9674
chr20	19713869	.	G	A	.	PASS	CSQ=57419|protein_coding||intron_variant|||||||NM_020689.3:c.1720-3659G>A||MODIFIER||||||SLC24A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,91:91:1
chr20	19817740	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,109:109:1
chr20	20305570	.	C	T	.	PASS	CSQ=26074|protein_coding||intron_variant||||rs775516495||3.9442e-05|NM_015585.4:c.3422+7184C>T||MODIFIER||||||CFAP61|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,70:70:1
chr20	20963921	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	65,22:87:0.2529
chr20	21474592	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs925698394||9.92576e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,70:70:1
chr20	21519711	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,84:84:1
chr20	21974838	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,89:89:1
chr20	21974990	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	7,77:84:0.9167
chr20	21976193	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,74:74:1
chr20	21976308	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1004621150||6.57575e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,85:85:1
chr20	21976325	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,84:84:1
chr20	21976781	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,97:97:1
chr20	21977697	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs752737294||7.24018e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,78:78:1
chr20	21977893	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,77:77:1
chr20	21978797	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	159,0:160:0	0,95:95:1
chr20	21978975	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,75:75:1
chr20	21979020	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs952907698||6.57047e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	0,88:88:1
chr20	21979223	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	116,0:116:0	0,84:84:1
chr20	21979231	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	124,0:124:0	0,86:86:1
chr20	21979304	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	138,0:138:0	0,91:91:1
chr20	21979429	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,72:72:1
chr20	21979621	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,104:104:1
chr20	22027944	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,90:90:1
chr20	22028559	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs974286139||6.57505e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,98:98:1
chr20	22029925	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	0,87:87:1
chr20	22029982	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,76:76:1
chr20	22523584	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs929071520||1.97176e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,104:104:1
chr20	22748832	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	75,24:99:0.2424
chr20	23453449	.	C	T	.	PASS	CSQ=140880|protein_coding||upstream_gene_variant||||rs1035523208||1.97316e-05|||MODIFIER||||||CST11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	0,99:99:1
chr20	23723703	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	73,15:88:0.1705
chr20	23856617	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,85:85:1
chr20	24146505	.	CCTTTGATGTG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,66:66:1
chr20	24647506	.	C	T	.	PASS	CSQ=79953|protein_coding||intron_variant|||||||NM_024893.3:c.619-17840C>T||MODIFIER||||||SYNDIG1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,75:75:1
chr20	25247250	.	T	G	.	PASS	CSQ=5834|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PYGB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,97:97:1
chr20	25630877	.	C	G	.	PASS	CSQ=102724826|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_126465.1:n.91+6742C>G||MODIFIER||||||ZNF337-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	89,94:183:0.5137
chr20	25755260	.	G	A	.	PASS	CSQ=105372582|lncRNA||non_coding_transcript_exon_variant||||||6.58215e-06|NR_135006.1:n.2829G>A||MODIFIER||||||LOC105372582|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	82,60:142:0.4225
chr20	26214034	.	G	A	.	PASS	CSQ=284801|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||MIR663AHG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	75,79:154:0.513
chr20	28754135	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	95,0:95:0	69,67:136:0.4926
chr20	28800018	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	94,75:169:0.4438
chr20	28926882	.	TAAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	62,80:142:0.5634
chr20	29107492	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	93,99:192:0.5156
chr20	29205629	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	73,80:153:0.5229
chr20	29331758	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	566,0:566:0	468,73:542:0.1347
chr20	29398108	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	165,0:165:0	185,15:200:0.075
chr20	29629407	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	77,86:163:0.5276
chr20	30256365	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	50,70:120:0.5833
chr20	30345165	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	67,80:147:0.5442
chr20	30462301	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	278,0:278:0	281,77:358:0.2151
chr20	30462553	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	227,0:227:0	218,83:301:0.2757
chr20	30557538	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||9.5378e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	57,48:106:0.4528
chr20	30620520	.	ACT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	72,62:134:0.4627
chr20	30814070	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1456377009|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	394,0:394:0	427,95:522:0.182
chr20	30917534	.	AAGTTATTGACC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	144,35:179:0.1955
chr20	31177056	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1183709766||7.31454e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	74,86:161:0.5342
chr20	31263364	.	G	C	.	PASS	CSQ=245929|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||DEFB115|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	65,63:128:0.4922
chr20	31487345	.	C	T	.	PASS	CSQ=28954|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||REM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	117,0:117:0	82,94:177:0.5311
chr20	31632734	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	107,116:223:0.5202
chr20	32268762	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	83,99:182:0.544
chr20	32851098	.	C	A	.	PASS	CSQ=22919|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MAPRE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	59,70:129:0.5426
chr20	32938367	.	ATTAAATACT	A	.	PASS	CSQ=388795|protein_coding||intron_variant|||||||NM_001143967.1:c.2791-5266_2791-5258del||MODIFIER||||||EFCAB8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	62,0:62:0	0,72:72:1
chr20	33306471	.	T	A	.	PASS	CSQ=92747|protein_coding||intron_variant|||||||NM_033197.3:c.1318+406T>A||MODIFIER||||||BPIFB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	134,0:134:0	89,97:186:0.5215
chr20	34104459	.	T	TTATC	.	PASS	CSQ=8894|protein_coding||intron_variant|||||||NM_003908.5:c.194-898_194-895dup||MODIFIER||||||EIF2S2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	97,69:166:0.4157
chr20	34296682	.	G	T	.	PASS	CSQ=191|protein_coding||intron_variant|||||||NM_000687.4:c.29-1097C>A||MODIFIER||||||AHCY|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	134,17:151:0.1126
chr20	34390420	.	G	GGTATA	.	PASS	CSQ=83737|protein_coding||intron_variant|||||||NM_031483.6:c.-21-3369_-21-3365dup||MODIFIER||||||ITCH|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	129,27:159:0.1698
chr20	34868911	.	A	C	.	PASS	CSQ=2686|protein_coding||intron_variant|||||||NM_178026.3:c.169+3736T>G||MODIFIER||||||GGT7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	166,25:191:0.1309
chr20	35419480	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	128,0:128:0	169,8:177:0.0452
chr20	35443580	.	C	T	.	PASS	CSQ=8200|protein_coding||intron_variant||||rs575465124||9.86894e-05|NM_001319138.1:c.-397-2193G>A||MODIFIER||||||GDF5|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	89,70:159:0.4403
chr20	35525453	.	G	A	.	PASS	CSQ=140873|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||C20orf173|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	101,84:185:0.4541
chr20	35525703	.	G	A	.	PASS	CSQ=140873|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||C20orf173|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	81,92:173:0.5318
chr20	35976073	.	G	A	.	PASS	CSQ=140894|protein_coding||intron_variant|||||||NM_001365709.1:c.243+71G>A||MODIFIER||||||CNBD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	140,0:140:0	72,85:157:0.5414
chr20	36212849	.	G	A	.	PASS	CSQ=2036|protein_coding||intron_variant|||||||NM_012156.2:c.2184+473G>A||MODIFIER||||||EPB41L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	92,105:197:0.533
chr20	36915994	.	C	T	.	PASS	CSQ=25939|protein_coding||intron_variant|||||||NM_015474.3:c.1062+728G>A||MODIFIER||||||SAMHD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	76,81:157:0.5159
chr20	36924705	.	C	T	.	PASS	CSQ=25939|protein_coding||intron_variant||||rs186337529||0.000138112|NM_015474.3:c.696+2477G>A||MODIFIER||||||SAMHD1|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	170,17:187:0.0909
chr20	37192838	.	C	G	.	PASS	CSQ=6185|protein_coding||intron_variant|||||||NM_002951.5:c.208-5559C>G||MODIFIER||||||RPN2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	69,90:159:0.566
chr20	37637745	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	66,71:137:0.5182
chr20	38003102	.	A	T	.	PASS	CSQ=9675|protein_coding||intron_variant|||||||NM_001303457.2:c.2504-326T>A||MODIFIER||||||TTI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,80:151:0.5298
chr20	38051402	.	CTAGCATTTAT	C	.	PASS	CSQ=58490|protein_coding||intron_variant|||||||NM_021215.3:c.415+2923_415+2932del||MODIFIER||||||RPRD1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	95,76:171:0.4444
chr20	38195837	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	87,90:177:0.5085
chr20	38203160	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	74,82:156:0.5256
chr20	38468265	.	T	G	.	PASS	CSQ=57148|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||RALGAPB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:120:0	200,89:289:0.308
chr20	38696190	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	197,100:297:0.3367
chr20	38804765	.	G	C	.	PASS	CSQ=26051|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PPP1R16B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	178,93:271:0.3432
chr20	38805848	.	G	A	.	PASS	CSQ=26051|protein_coding||intron_variant|||||||NM_015568.4:c.-102+56G>A||MODIFIER||||||PPP1R16B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	140,0:140:0	232,103:335:0.3075
chr20	38805854	.	G	A	.	PASS	CSQ=26051|protein_coding||intron_variant||||rs1221636824||6.56892e-06|NM_015568.4:c.-102+62G>A||MODIFIER||||||PPP1R16B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	140,0:140:0	229,96:325:0.2954
chr20	39117980	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	202,33:235:0.1404
chr20	39298849	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	144,86:230:0.3739
chr20	39428000	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	128,67:195:0.3436
chr20	39503642	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1364095047|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	92,164:257:0.6381
chr20	39749598	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	89,180:269:0.6691
chr20	39868900	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	143,65:208:0.3125
chr20	39883284	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	131,76:207:0.3671
chr20	39884103	.	AT	A	.	PASS	CSQ=|||intergenic_variant||||rs1356404973||0.000454491|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	167,59:226:0.2611
chr20	40097094	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1036801119||6.57151e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	174,61:235:0.2596
chr20	40216381	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs978322946||5.26129e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	63,136:199:0.6834
chr20	40219865	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1448542894||1.31544e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	135,74:209:0.3541
chr20	40306564	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs577039520||0.000118293|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	187,84:271:0.31
chr20	40471016	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	109,0:109:0	159,90:249:0.3614
chr20	40907684	.	CTGCCTCCACCACAGTCCAAGCTGCCACTTTCTTTCAACTGCAACCTCTTAATTGGTTTCCTGCTACTACACTGACCATCCCCACAGTATCCGGA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=mutect2;num_callers=1;supported_by=mantaSV	AD:DP:AF	216,0:216:0.004714	260,60:320:0.186
chr20	40952387	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	177,115:292:0.3938
chr20	41074173	.	C	A	.	PASS	CSQ=7150|protein_coding||intron_variant|||||||NM_003286.4:c.156-1998C>A||MODIFIER||||||TOP1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TOP1|y|n|AML*|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	186,82:268:0.306
chr20	41371454	.	AG	A	.	PASS	CSQ=90187|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||EMILIN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	176,73:249:0.2932
chr20	41574593	.	C	G	.	PASS	CSQ=84181|protein_coding||intron_variant|||||||NM_032221.5:c.-23-23233G>C||MODIFIER||||||CHD6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	169,92:261:0.3525
chr20	41679246	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	130,73:203:0.3596
chr20	41704607	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	176,70:246:0.2846
chr20	41715314	.	C	G	.	PASS	CSQ=|||intergenic_variant||||||6.57125e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	191,93:284:0.3275
chr20	41819725	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	152,75:228:0.3289
chr20	41823812	.	GAAGTTGATTTTTACTTAAGTAC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	152,0:152:0	197,84:281:0.2989
chr20	41936250	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	177,73:250:0.292
chr20	42020681	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:108:0	205,9:214:0.0421
chr20	42053274	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs756289249||6.57505e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	172,73:245:0.298
chr20	42198063	.	G	A	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.2491+1177C>T||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	204,28:232:0.1207
chr20	42253594	.	C	G	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.2177-4772G>C||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	61,167:228:0.7325
chr20	42369448	.	C	T	.	PASS	CSQ=11122|protein_coding||intron_variant||||rs562829573||6.57056e-06|NM_007050.5:c.1561-17163G>A||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	211,9:220:0.0409
chr20	42395364	.	A	G	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.1561-43079T>C||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	231,15:246:0.061
chr20	42462265	.	A	T	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.1450+10001T>A||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	143,66:209:0.3158
chr20	42650480	.	C	T	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.1153+27386G>A||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	142,70:212:0.3302
chr20	42656436	.	C	G	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.1153+21430G>C||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:90:0	182,58:240:0.2417
chr20	42677490	.	C	T	.	PASS	CSQ=11122|protein_coding||intron_variant||||rs1246596812||1.3157e-05|NM_007050.5:c.1153+376G>A||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	67,144:211:0.6825
chr20	42695227	.	T	G	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.860-17068A>C||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	58,164:222:0.7387
chr20	42745476	.	C	T	.	PASS	CSQ=11122|protein_coding||intron_variant||||rs1482494708||1.9713e-05|NM_007050.5:c.859+10986G>A||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	176,81:257:0.3152
chr20	42977949	.	C	A	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.89-92017G>T||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	167,78:245:0.3184
chr20	42996273	.	C	A	.	PASS	CSQ=11122|protein_coding||intron_variant||||rs980878267||1.31435e-05|NM_007050.5:c.89-110341G>T||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	80,155:235:0.6596
chr20	43021370	.	T	G	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.89-135438A>C||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	215,9:224:0.0402
chr20	43076877	.	C	G	.	PASS	CSQ=11122|protein_coding||intron_variant|||||||NM_007050.5:c.88+112769G>C||MODIFIER||||||PTPRT|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PTPRT|y|n|HNSCC,colorectal_cancer,gastric_cancer,lung_cancer,melanoma|||E||TSG|Mis,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	157,92:249:0.3695
chr20	43510061	.	C	G	.	PASS	CSQ=26013|protein_coding||intron_variant|||||||NM_032107.4:c.-12+2317C>G||MODIFIER||||||L3MBTL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,1:109:0.0092	244,92:336:0.2738
chr20	43510366	.	C	T	.	PASS	CSQ=26013|protein_coding||intron_variant|||||||NM_032107.4:c.-12+2622C>T||MODIFIER||||||L3MBTL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	255,90:346:0.2601
chr20	43510495	.	C	G	.	PASS	CSQ=26013|protein_coding||intron_variant|||||||NM_032107.4:c.-12+2751C>G||MODIFIER||||||L3MBTL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	233,70:304:0.2303
chr20	43609753	.	C	T	.	PASS	CSQ=51098|protein_coding||intron_variant|||||||NM_016004.4:c.486-4097C>T||MODIFIER||||||IFT52|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	182,65:248:0.2621
chr20	43679181	.	C	G	.	PASS	CSQ=4605|protein_coding||intron_variant|||||||NM_002466.4:c.115-2603C>G||MODIFIER||||||MYBL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	160,80:240:0.3333
chr20	43821725	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	150,81:231:0.3506
chr20	43827402	.	T	G	.	PASS	CSQ=|||intergenic_variant||||rs1431981340||6.57004e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	173,107:280:0.3821
chr20	43846594	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	177,88:265:0.3321
chr20	43897862	.	T	A	.	PASS	CSQ=105372626|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC01728|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,1:99:0.0101	160,57:217:0.2627
chr20	44041664	.	T	C	.	PASS	CSQ=84969|protein_coding||intron_variant|||||||NM_001098797.2:c.412-9642T>C||MODIFIER||||||TOX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	87,179:266:0.6729
chr20	44195485	.	T	A	.	PASS	CSQ=51526|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||OSER1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	177,87:264:0.3295
chr20	44457436	.	C	T	.	PASS	CSQ=140834|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_132343.1:n.239+4788G>A||MODIFIER||||||LINC01620|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	154,99:253:0.3913
chr20	44842389	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	178,90:268:0.3358
chr20	44882057	.	G	GA	.	PASS	CSQ=7529|protein_coding||upstream_gene_variant||||rs1387894821||0.000979677|||MODIFIER||||||YWHAB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	117,0:118:0	114,130:246:0.5285
chr20	45289267	.	G	A	.	PASS	CSQ=8785|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MATN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	88,182:270:0.6741
chr20	45447232	.	C	CT	.	PASS	CSQ=105372631|lncRNA||intron_variant&non_coding_transcript_variant||||rs1458344620||0.0054806|NR_159957.1:n.351-353dup||MODIFIER||||||LOC105372631|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	106,153:261:0.5862
chr20	45977989	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	151,100:251:0.3984
chr20	46017730	.	C	T	.	PASS	CSQ=4318|protein_coding||downstream_gene_variant||||||6.5703e-06|||MODIFIER||||||MMP9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	96,161:257:0.6265
chr20	46057190	COSV51642395;COSV51642395;COSV51642395;COSV51642395;COSV51642395;COSV51642395;COSV51642395;COSV51642395;COSV51642395	G	A	.	PASS	CSQ=57727|protein_coding||downstream_gene_variant|COSV51642395&COSV51642395&COSV51642395&COSV51642395&COSV51642395&COSV51642395|p.?&p.?&p.R1072H&p.?&p.?&p.R1049H|COSV51642395&COSV51642395&COSV51642395|COSM6477495&COSM6477496|||||MODIFIER||||||NCOA5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	132,0:133:0	179,97:276:0.3514
chr20	46274515	.	T	G	.	PASS	CSQ=64405|protein_coding||intron_variant|||||||NM_021248.2:c.-399-22822A>C||MODIFIER||||||CDH22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	216,112:328:0.3415
chr20	46461679	COSV68530439;COSV68530439;COSV68530439;COSV68530439	A	T	.	PASS	CSQ=7686|transcribed_pseudogene||downstream_gene_variant|||COSV68530439&COSV68530439&COSV68530439&COSV68530439|||6.58103e-06|||MODIFIER||||||MKRN7P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:121:0	149,96:245:0.3918
chr20	46490661	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs535853608||9.20471e-05|||MODIFIER||||||||0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	164,73:237:0.308
chr20	46675543	.	GC	G	.	PASS	CSQ=64849|protein_coding||intron_variant|||||||NM_001011554.2:c.-127-5405del||MODIFIER||||||SLC13A3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	160,63:223:0.2825
chr20	46909666	.	GT	G	.	PASS	CSQ=2139|protein_coding||intron_variant|||||||NM_005244.5:c.-11+14681del||MODIFIER||||||EYA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	169,77:246:0.313
chr20	47146199	.	G	A	.	PASS	CSQ=2139|protein_coding||intron_variant|||||||NM_005244.5:c.978+3051G>A||MODIFIER||||||EYA2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	79,139:218:0.6376
chr20	48169944	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	170,96:266:0.3609
chr20	48180228	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	155,88:243:0.3621
chr20	49414376	.	G	A	.	PASS	CSQ=3745|protein_coding||intron_variant||||rs922256119||1.31401e-05|NM_004975.4:c.568-39384C>T||MODIFIER||||||KCNB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	185,89:274:0.3248
chr20	49982303	.	C	T	.	PASS	CSQ=6615|protein_coding||upstream_gene_variant||||rs1227022190||6.56987e-06|||MODIFIER||||||SNAI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	239,43:282:0.1525
chr20	49983375	.	A	T	.	PASS	CSQ=6615|protein_coding||intron_variant|||||||NM_005985.4:c.82+234A>T||MODIFIER||||||SNAI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:88:0	136,49:186:0.2634
chr20	50040040	.	G	A	.	PASS	CSQ=100887755|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||TRERNA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	170,81:251:0.3227
chr20	50128326	.	C	T	.	PASS	CSQ=387521|protein_coding||intron_variant|||||||NM_199129.3:c.479-139G>A||MODIFIER||||||TMEM189|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	198,90:288:0.3125
chr20	50185873	.	C	T	.	PASS	CSQ=101927559|lncRNA||non_coding_transcript_exon_variant|||||||NR_125739.1:n.1703G>A||MODIFIER||||||CEBPB-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	178,80:258:0.3101
chr20	50218729	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	206,90:296:0.3041
chr20	50440833	.	GC	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	112,0:112:0	160,84:244:0.3443
chr20	50632372	.	G	T	.	PASS	CSQ=140876|protein_coding||intron_variant|||||||NM_001290268.1:c.4-1516C>A||MODIFIER||||||RIPOR3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	262,6:268:0.0224
chr20	50719315	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	204,75:279:0.2688
chr20	50984136	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1373981495||1.9735e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	170,82:252:0.3254
chr20	51245097	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	105,0:105:0	149,69:218:0.3165
chr20	51806566	.	A	C	.	PASS	CSQ=57167|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SALL4|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/SALL4|y|n|colorectal_cancer,breast_cancer,prostate_cancer,glioblastoma,melanoma|||E||oncogene|Mis,F;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	175,101:276:0.3659
chr20	51881594	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||6.57575e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	154,95:249:0.3815
chr20	52184630	.	T	A	.	PASS	CSQ=55734|protein_coding||intron_variant|||||||NM_018197.3:c.286+2202A>T||MODIFIER||||||ZFP64|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	97,175:272:0.6434
chr20	52301757	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	113,0:114:0	154,64:218:0.2936
chr20	52391821	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	132,93:225:0.4133
chr20	52429961	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs371927412|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	76,0:76:0	152,38:190:0.2
chr20	52458475	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	144,78:222:0.3514
chr20	52496596	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	151,78:229:0.3406
chr20	52885578	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	183,91:274:0.3321
chr20	52986024	.	C	G	.	PASS	CSQ=128553|protein_coding||intron_variant|||||||NM_173485.6:c.40+12691C>G||MODIFIER||||||TSHZ2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	252,17:269:0.0632
chr20	53240786	.	GGA	G	.	PASS	CSQ=128553|protein_coding||intron_variant|||||||NM_173485.6:c.41-12711_41-12710del||MODIFIER||||||TSHZ2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	155,77:232:0.3319
chr20	53328061	.	G	A	.	PASS	CSQ=128553|protein_coding||intron_variant|||||||NM_173485.6:c.*8+71490G>A||MODIFIER||||||TSHZ2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	83,161:244:0.6598
chr20	53371650	.	C	T	.	PASS	CSQ=128553|protein_coding||intron_variant||||rs920193297||6.578e-06|NM_173485.6:c.*8+115079C>T||MODIFIER||||||TSHZ2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	174,80:254:0.315
chr20	53404331	.	T	C	.	PASS	CSQ=128553|protein_coding||intron_variant|||||||NM_173485.6:c.*9-82813T>C||MODIFIER||||||TSHZ2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	178,73:251:0.2908
chr20	53545681	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	205,109:314:0.3471
chr20	54002178	.	C	T	.	PASS	CSQ=8537|protein_coding||intron_variant|||||||NM_001366298.1:c.724-6128G>A||MODIFIER||||||BCAS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	75,177:252:0.7024
chr20	54096418	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	176,66:242:0.2727
chr20	54097771	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	218,13:231:0.0563
chr20	54361649	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,1:104:0.0096	181,89:270:0.3296
chr20	54428214	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	161,66:227:0.2907
chr20	54489896	.	G	A	.	PASS	CSQ=55816|protein_coding||intron_variant|||||||NM_018431.4:c.66+13884G>A||MODIFIER||||||DOK5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,1:122:0.0082	159,93:252:0.369
chr20	54588366	.	C	G	.	PASS	CSQ=55816|protein_coding||intron_variant|||||||NM_018431.4:c.175-117C>G||MODIFIER||||||DOK5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	184,80:264:0.303
chr20	54588516	COSV52815843;COSV52815843	C	G	.	PASS	CSQ=55816|protein_coding||missense_variant|COSV52815843&COSV52815843|p.?&p.R70G||COSM3911623&COSM6093870|||NM_018431.4:c.208C>G|NP_060901.2:p.Arg70Gly|MODERATE|D|T|D|D|D|DOK5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	123,0:123:0	157,91:248:0.3669
chr20	54675787	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	171,88:259:0.3398
chr20	54682058	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	222,7:229:0.0306
chr20	54753275	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	49,163:212:0.7689
chr20	54952605	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs558741975||1.31489e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	75,162:237:0.6835
chr20	55087673	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	156,95:251:0.3785
chr20	55246768	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	174,55:229:0.2402
chr20	55275773	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	135,76:211:0.3602
chr20	55379771	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	120,66:186:0.3548
chr20	55421394	.	C	G	.	PASS	CSQ=101927796|lncRNA||non_coding_transcript_exon_variant|||||||NR_110064.1:n.1232G>C||MODIFIER||||||LINC01441|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	136,0:136:0	156,73:229:0.3188
chr20	55839509	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs917601726||2.63248e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	211,43:254:0.1693
chr20	55984228	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs1211693858||3.94296e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	101,133:234:0.5684
chr20	56507856	.	G	T	.	PASS	CSQ=140687|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_160308.1:n.407-3562C>A||MODIFIER||||||GCNT7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	175,50:225:0.2222
chr20	56530599	.	C	T	.	PASS	CSQ=388799|protein_coding||upstream_gene_variant||||rs1373172149||1.97548e-05|||MODIFIER||||||FAM209B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	211,42:253:0.166
chr20	56649226	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs942580449||0.000640715|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	84,0:85:0	153,46:199:0.2312
chr20	56751180	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	172,71:243:0.2922
chr20	56922078	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	171,102:273:0.3736
chr20	57207984	.	C	T	.	PASS	CSQ=655|protein_coding||intron_variant||||rs958177640||7.25393e-05|NM_001719.3:c.612-5361G>A||MODIFIER||||||BMP7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	164,77:241:0.3195
chr20	57235674	.	C	T	.	PASS	CSQ=655|protein_coding||intron_variant||||rs1285584792|||NM_001719.3:c.419-7253G>A||MODIFIER||||||BMP7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	208,78:286:0.2727
chr20	57455521	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	232,15:247:0.0607
chr20	57456128	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	279,20:299:0.0669
chr20	57638730	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:84:0	146,62:208:0.2981
chr20	58081863	.	GA	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	117,0:117:0	84,153:237:0.6456
chr20	58110842	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	185,83:268:0.3097
chr20	58122885	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	178,82:260:0.3154
chr20	58262573	.	C	A	.	PASS	CSQ=55370|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003505.3:n.306+10196G>T||MODIFIER||||||PPP4R1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	286,14:300:0.0467
chr20	58298346	.	C	T	.	PASS	CSQ=55370|transcribed_pseudogene||intron_variant&non_coding_transcript_variant|||||||NR_003505.3:n.66+10880G>A||MODIFIER||||||PPP4R1L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	205,93:298:0.3121
chr20	58378618	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:112:0	94,197:291:0.677
chr20	58511661	.	A	AT	.	PASS	CSQ=164284|protein_coding||intron_variant||||rs556309558||0.000184169|NM_153360.2:c.49+2997dup||MODIFIER||||||APCDD1L|EntrezGene|0.0012;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	165,63:228:0.2763
chr20	58558370	.	G	A	.	PASS	CSQ=149773|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_034147.1:n.943+10442G>A||MODIFIER||||||APCDD1L-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	202,99:301:0.3289
chr20	58571986	.	G	A	.	PASS	CSQ=149773|lncRNA||intron_variant&non_coding_transcript_variant||||rs541857655||0.000203709|NR_034147.1:n.943+24058G>A||MODIFIER||||||APCDD1L-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	257,7:264:0.0265
chr20	58976061	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	186,86:272:0.3162
chr20	59326086	.	G	A	.	PASS	CSQ=1908|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||EDN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	101,0:102:0	165,105:270:0.3889
chr20	59403242	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:134:0	178,101:279:0.362
chr20	59642376	.	G	A	.	PASS	CSQ=116154|protein_coding||intron_variant|||||||NM_080672.5:c.118+37244G>A||MODIFIER||||||PHACTR3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	165,83:248:0.3347
chr20	59745927	.	C	G	.	PASS	CSQ=116154|protein_coding||intron_variant|||||||NM_080672.5:c.281-1831C>G||MODIFIER||||||PHACTR3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	177,95:272:0.3493
chr20	60094707	.	C	G	.	PASS	CSQ=729296|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109917.1:n.441-4222C>G||MODIFIER||||||LOC729296|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	157,89:246:0.3618
chr20	60484651	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	148,57:205:0.278
chr20	60542310	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	176,81:257:0.3152
chr20	60581784	.	TC	T	.	PASS	CSQ=|||intergenic_variant||||rs888449470||3.28748e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	165,61:226:0.2699
chr20	60688335	COSV61829476	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV61829476||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	147,104:251:0.4143
chr20	60780838	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	246,13:259:0.0502
chr20	60839447	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	164,77:241:0.3195
chr20	60878836	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs141946209||1.31505e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	77,143:220:0.65
chr20	61076237	.	G	A	.	PASS	CSQ=100506470|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01718|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	123,0:123:0	177,12:189:0.0635
chr20	61111854	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	144,85:229:0.3712
chr20	61427244	.	G	A	.	PASS	CSQ=1002|protein_coding||intron_variant|||||||NM_001794.5:c.169+172307G>A||MODIFIER||||||CDH4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	151,73:224:0.3259
chr20	61502104	.	A	C	.	PASS	CSQ=1002|protein_coding||intron_variant|||||||NM_001794.5:c.170-241459A>C||MODIFIER||||||CDH4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	232,11:243:0.0453
chr20	61559017	.	G	A	.	PASS	CSQ=1002|protein_coding||intron_variant|||||||NM_001794.5:c.170-184546G>A||MODIFIER||||||CDH4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	160,99:259:0.3822
chr20	61598822	.	G	A	.	PASS	CSQ=1002|protein_coding||intron_variant||||rs1171085128||1.31413e-05|NM_001794.5:c.170-144741G>A||MODIFIER||||||CDH4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	179,70:249:0.2811
chr20	61867277	.	C	T	.	PASS	CSQ=1002|protein_coding||intron_variant||||rs1487033780||6.5703e-06|NM_001794.5:c.878-6451C>T||MODIFIER||||||CDH4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	83,191:274:0.6971
chr20	62302435	.	A	C	.	PASS	CSQ=11047|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ADRM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	91,223:314:0.7102
chr20	62594955	COSV55465788	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV55465788||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	154,105:259:0.4054
chr20	62646368	.	C	T	.	PASS	CSQ=28231|protein_coding||intron_variant|||||||NM_016354.4:c.-97+3815C>T||MODIFIER||||||SLCO4A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	104,200:304:0.6579
chr20	62671305	.	C	G	.	PASS	CSQ=100127888|lncRNA||upstream_gene_variant||||rs1356477560|||||MODIFIER||||||SLCO4A1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	187,81:268:0.3022
chr20	62679450	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	182,81:263:0.308
chr20	63015332	.	AG	A	.	PASS	CSQ=63930|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_033370.1:n.91+5862del||MODIFIER||||||LINC01749|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	190,98:288:0.3403
chr20	63063798	.	C	T	.	PASS	CSQ=63930|lncRNA||intron_variant&non_coding_transcript_variant||||rs535960820||2.62916e-05|NR_033370.1:n.92-16194C>T||MODIFIER||||||LINC01749|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	200,96:296:0.3243
chr20	63151457	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	175,88:263:0.3346
chr20	63262290	.	C	T	.	PASS	CSQ=100192386|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||FLJ16779|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	230,18:248:0.0726
chr20	63347121	.	G	A	.	PASS	CSQ=1137|protein_coding||intron_variant|||||||NM_000744.6:c.1759-258C>T||MODIFIER||||||CHRNA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:124:0	203,87:290:0.3
chr20	63478434	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	166,85:251:0.3386
chr20	63487243	.	C	T	.	PASS	CSQ=1917|protein_coding||downstream_gene_variant||||rs1378183168|||||MODIFIER||||||EEF1A2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	168,49:218:0.2248
chr20	63765883	.	C	G	.	PASS	CSQ=140685|protein_coding||intron_variant|||||||NM_025224.3:c.1222+9795G>C||MODIFIER||||||ZBTB46|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	222,82:304:0.2697
chr20	63766380	.	T	G	.	PASS	CSQ=140685|protein_coding||intron_variant|||||||NM_025224.3:c.1222+9298A>C||MODIFIER||||||ZBTB46|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	156,74:230:0.3217
chr20	63787835	.	C	T	.	PASS	CSQ=140685|protein_coding||intron_variant|||||||NM_025224.3:c.937+1986G>A||MODIFIER||||||ZBTB46|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	173,113:286:0.3951
chr21	7321335	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1339877755|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	69,33:102:0.3235
chr21	7929814	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	587,0:587:0	362,82:444:0.1847
chr21	8621495	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1384812840|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	113,50:163:0.3067
chr21	8700750	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	37,70:107:0.6542
chr21	9761438	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	301,0:301:0	207,61:268:0.2276
chr21	9909493	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	362,0:362:0	276,74:350:0.2114
chr21	9934389	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	305,0:305:0	190,47:237:0.1983
chr21	9983311	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	338,0:338:0	226,76:302:0.2517
chr21	10009707	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	196,0:196:0	115,51:166:0.3072
chr21	10583547	.	GAGTAGCTTTTGGTTAACAGA	G	.	PASS	CSQ=7179|protein_coding||intron_variant|||||||NM_199261.3:c.1027+4946_1027+4965del||MODIFIER||||||TPTE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	186,0:186:0	96,81:177:0.4576
chr21	10703259	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	271,0:272:0	126,65:192:0.3385
chr21	12974370	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	241,0:241:0	170,71:241:0.2946
chr21	13221639	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	5,69:74:0.9324
chr21	13530132	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,91:91:1
chr21	13543968	.	C	T	.	PASS	CSQ=102724188|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||LINC01674|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	0,76:76:1
chr21	13579671	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	1,64:65:0.9846
chr21	13869072	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,78:78:1
chr21	14951941	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,85:85:1
chr21	15955815	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs757431409||2.64309e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	65,7:72:0.0972
chr21	15959434	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1047673214||2.15193e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	51,0:51:0	3,33:36:0.9167
chr21	15979067	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs988134101||1.97221e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,86:86:1
chr21	16197130	.	CGAAA	C	.	PASS	CSQ=388815|lncRNA||intron_variant&non_coding_transcript_variant||||rs1372800790||1.31693e-05|NR_136541.1:n.462+15446_462+15449del||MODIFIER||||||MIR99AHG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	0,85:85:1
chr21	16607573	.	C	G	.	PASS	CSQ=388815|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_136541.1:n.737+486C>G||MODIFIER||||||MIR99AHG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	0,65:65:1
chr21	16766358	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	40,35:75:0.4667
chr21	16873350	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	77,7:84:0.0833
chr21	17083501	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,73:73:1
chr21	17222154	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,63:63:1
chr21	17522664	.	T	A	.	PASS	CSQ=1525|protein_coding||intron_variant||||rs1259850106||6.5703e-06|NM_001338.5:c.43+9492T>A||MODIFIER||||||CXADR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,85:85:1
chr21	18062929	.	T	A	.	PASS	CSQ=140578|protein_coding||intron_variant||||rs946002782||3.94664e-05|NM_001204177.1:c.-45+145529T>A||MODIFIER||||||CHODL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,63:63:1
chr21	18517887	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	56,17:73:0.2329
chr21	18991433	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,75:75:1
chr21	19387078	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,63:63:1
chr21	19511789	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1417114590||6.57678e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,74:74:1
chr21	19513076	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs948398682||6.57039e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	0,59:59:1
chr21	19734335	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1350307438||5.27273e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,64:64:1
chr21	20165827	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,56:56:1
chr21	20522416	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	60,5:65:0.0769
chr21	20575689	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,78:78:1
chr21	20586214	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	0,92:92:1
chr21	21257771	.	C	A	.	PASS	CSQ=4685|protein_coding||intron_variant|||||||NM_004540.5:c.56-22807C>A||MODIFIER||||||NCAM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:119:0	0,58:58:1
chr21	21744622	COSV69950937;COSV69950937	C	T	.	PASS	CSQ=101927821|lncRNA||upstream_gene_variant|||COSV69950937&COSV69950937|rs755463740||0.000124864|||MODIFIER||||||LINC01425|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	0,71:71:1
chr21	21754944	.	C	T	.	PASS	CSQ=101927821|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109958.1:n.349+6260C>T||MODIFIER||||||LINC01425|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	0,67:67:1
chr21	21759490	.	C	A	.	PASS	CSQ=101927821|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_109958.1:n.349+10806C>A||MODIFIER||||||LINC01425|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,62:62:1
chr21	22119674	.	G	A	.	PASS	CSQ=54143|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LINC00308|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,84:84:1
chr21	22233949	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,58:58:1
chr21	22269976	.	G	GTATATATA	.	PASS	CSQ=|||intergenic_variant||||rs10641209||0.00393497|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	14,0:68:0	17,32:50:0.64
chr21	22375458	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1034240754||5.91872e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,75:75:1
chr21	22551363	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,74:74:1
chr21	22611933	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,62:62:1
chr21	23392613	.	T	TAA	.	PASS	CSQ=|||intergenic_variant||||rs554403164||0.0175823|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	10,0:122:0	11,72:83:0.8675
chr21	23624512	.	TCA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	4,54:58:0.931
chr21	24179371	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,51:51:1
chr21	24786111	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,74:74:1
chr21	24853159	.	C	T	.	PASS	CSQ=339622|lncRNA||intron_variant&non_coding_transcript_variant||||rs1001598162|||NR_046198.3:n.330+8230C>T||MODIFIER||||||LINC01692|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,75:75:1
chr21	24923831	.	C	A	.	PASS	CSQ=339622|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_046198.3:n.330+78902C>A||MODIFIER||||||LINC01692|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	31,41:72:0.5694
chr21	25197534	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,75:75:1
chr21	25241768	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	0,89:89:1
chr21	25459976	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,79:79:1
chr21	25488521	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,68:68:1
chr21	25899294	.	T	G	.	PASS	CSQ=351|protein_coding||intron_variant|||||||NM_000484.4:c.1964-1621A>C||MODIFIER||||||APP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,65:65:1
chr21	26228533	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs956229151||5.26947e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,82:82:1
chr21	26504789	.	C	A	.	PASS	CSQ=100996571|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135516.1:n.184+1087C>A||MODIFIER||||||CYYR1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,79:79:1
chr21	26543505	.	C	T	.	PASS	CSQ=100996571|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_135515.1:n.308-6814C>T||MODIFIER||||||CYYR1-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,81:81:1
chr21	27050447	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,81:81:1
chr21	27417405	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1396192352||6.57134e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	0,75:75:1
chr21	27468201	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	0,68:68:1
chr21	27829608	COSV62772994	A	T	.	PASS	CSQ=|||intergenic_variant|||COSV62772994|rs181907260||0.000249924|||MODIFIER||||||||0.0004;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,74:74:1
chr21	28830877	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs67429357||0.263532|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,13:105:0.1238	1,91:92:0.9891
chr21	29219742	.	A	G	.	PASS	CSQ=193629|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_027072.2:n.767+25482A>G||MODIFIER||||||LINC00189|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,86:86:1
chr21	29658121	COSV58722331;COSV58722331;COSV58722331;COSV58722331;COSV58722331;COSV58722331;COSV58722331;COSV58722331	A	AT	.	PASS	CSQ=2897|protein_coding||intron_variant|COSV58722331&COSV58722331&COSV58722331&COSV58722331&COSV58722331&COSV58722331&COSV58722331|p.?&p.?&p.?&p.?&p.?&p.?&p.?|COSV58722331|rs1021593266||0.000694192|NM_001320616.1:c.727-3259dup||MODIFIER||||||GRIK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	6,68:75:0.9067
chr21	29768866	.	C	G	.	PASS	CSQ=2897|protein_coding||intron_variant|||||||NM_001320616.1:c.119-74803G>C||MODIFIER||||||GRIK1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,101:101:1
chr21	30026238	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1302904023||6.57082e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,68:68:1
chr21	30410507	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	0,69:69:1
chr21	30413945	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,67:67:1
chr21	30490135	.	C	A	.	PASS	CSQ=337970|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||KRTAP19-3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	0,60:60:1
chr21	33000156	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,92:92:1
chr21	34494357	.	G	T	.	PASS	CSQ=3753|protein_coding||intron_variant|||||||NM_000219.6:c.-162+16744C>A||MODIFIER||||||KCNE1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,81:81:1
chr21	34633760	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs548901196||5.2633e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	0,81:81:1
chr21	34965809	.	C	T	.	PASS	CSQ=861|protein_coding||intron_variant|||||||NM_001754.4:c.59-72846G>A||MODIFIER||||||RUNX1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/RUNX1|y|n|AML,pre_B-ALL,T-ALL|||L|Dom|oncogene,TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,95:95:1
chr21	35854644	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,91:91:1
chr21	36354285	.	G	T	.	PASS	CSQ=23515|protein_coding||intron_variant|||||||NM_015358.3:c.1104-2335G>T||MODIFIER||||||MORC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	0,91:91:1
chr21	36641596	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	0,62:62:1
chr21	36819544	.	C	G	.	PASS	CSQ=3141|protein_coding||intron_variant|||||||NM_001352514.1:c.1893-52259G>C||MODIFIER||||||HLCS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,93:93:1
chr21	37623305	.	G	T	.	PASS	CSQ=3763|protein_coding||3_prime_UTR_variant||||rs1177258568|||NM_002240.5:c.*1854C>A||MODIFIER||||||KCNJ6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,69:69:1
chr21	37645963	.	G	GA	.	PASS	CSQ=3763|protein_coding||intron_variant|||||||NM_002240.5:c.947-20480_947-20479insT||MODIFIER||||||KCNJ6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	1,72:73:0.9863
chr21	37676020	.	C	T	.	PASS	CSQ=3763|protein_coding||intron_variant|||||||NM_002240.5:c.946+38191G>A||MODIFIER||||||KCNJ6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	0,80:80:1
chr21	38047590	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	64,10:74:0.1351
chr21	38214085	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,51:51:1
chr21	38509880	.	C	T	.	PASS	CSQ=2078|protein_coding||intron_variant|||||||NM_001136154.1:c.40-64259G>A||MODIFIER||||||ERG|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ERG|y|n|Ewing_sarcoma,prostate,AML|||M,E,L|Dom|oncogene,fusion|T,A;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	0,81:81:1
chr21	38816821	.	G	A	.	PASS	CSQ=2114|protein_coding||intron_variant|||||||NM_005239.6:c.506-187G>A||MODIFIER||||||ETS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	0,91:91:1
chr21	39241995	.	C	T	.	PASS	CSQ=54014|protein_coding||intron_variant|||||||NM_033656.3:c.2482-3422G>A||MODIFIER||||||BRWD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	0,67:67:1
chr21	39679458	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	0,58:58:1
chr21	40056952	.	G	A	.	PASS	CSQ=1826|protein_coding||intron_variant|||||||NM_001389.5:c.4920-1112C>T||MODIFIER||||||DSCAM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,66:66:1
chr21	40181653	.	A	T	.	PASS	CSQ=1826|protein_coding||intron_variant||||rs1045609911|||NM_001389.5:c.2780-2559T>A||MODIFIER||||||DSCAM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	0,81:81:1
chr21	40255455	.	G	A	.	PASS	CSQ=1826|protein_coding||intron_variant||||rs540181867||1.31506e-05|NM_001389.5:c.2356+20642C>T||MODIFIER||||||DSCAM|EntrezGene|0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	75,8:83:0.0964
chr21	40633357	.	C	A	.	PASS	CSQ=1826|protein_coding||intron_variant|||||||NM_001389.5:c.508+59453G>T||MODIFIER||||||DSCAM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,64:64:1
chr21	40689431	.	G	A	.	PASS	CSQ=1826|protein_coding||intron_variant|||||||NM_001389.5:c.508+3379C>T||MODIFIER||||||DSCAM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	0,67:68:0.9853
chr21	40992411	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,1:119:0.0084	0,92:92:1
chr21	41058473	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	0,78:78:1
chr21	41361685	.	GC	TT	.	PASS	CSQ=4600|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	113,0:113:0	0,76:76:1
chr21	41361689	.	A	T	.	PASS	CSQ=54097|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FAM3B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,79:79:1
chr21	41501487	.	T	C	.	PASS	CSQ=7113|protein_coding||intron_variant|||||||NM_005656.3:c.-56-3298A>G||MODIFIER||||||TMPRSS2|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/TMPRSS2|y|n|prostate|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,70:70:1
chr21	41744296	.	C	T	.	PASS	CSQ=54101|protein_coding||intron_variant||||rs1035059902|||NM_020639.3:c.937-156G>A||MODIFIER||||||RIPK4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,98:98:1
chr21	42082704	.	C	T	.	PASS	CSQ=89766|protein_coding||intron_variant|||||||NM_001004416.2:c.320-1380C>T||MODIFIER||||||UMODL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,76:76:1
chr21	42481793	.	C	T	.	PASS	CSQ=89765|protein_coding||intron_variant||||rs1310276710|||NM_080860.4:c.573+844G>A||MODIFIER||||||RSPH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,86:86:1
chr21	43372693	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs545698659||5.92113e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	100,4:104:0.0385
chr21	45836089	.	C	T	.	PASS	CSQ=100129027|lncRNA||intron_variant&non_coding_transcript_variant||||rs1001601058|||NR_038876.1:n.134+197G>A||MODIFIER||||||LOC100129027|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,91:91:1
chr22	11332334	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,1:108:0.0093	28,21:49:0.4286
chr22	11333471	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	250,0:250:0	85,24:109:0.2202
chr22	11372571	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	235,0:235:0	59,82:141:0.5816
chr22	12092422	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs2152295|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,3:124:0.0242	0,4:4:1
chr22	12704071	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1474315597|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	277,0:278:0	142,37:179:0.2067
chr22	16527507	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	238,0:238:0	149,52:201:0.2587
chr22	16736147	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	40,37:77:0.4805
chr22	17534857	.	C	CA	.	PASS	CSQ=27443|protein_coding||intron_variant||||rs551773727||0.000604355|NM_001290047.1:c.1109-2235dup||MODIFIER||||||CECR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	66,0:68:0	10,43:54:0.7963
chr22	17713852	.	A	C	.	PASS	CSQ=23786|protein_coding||intron_variant|||||||NM_015367.3:c.600+11466A>C||MODIFIER||||||BCL2L13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	0,70:70:1
chr22	19192382	.	T	C	.	PASS	CSQ=8218|protein_coding||intron_variant|||||||NM_007098.4:c.4192-947A>G||MODIFIER||||||CLTCL1|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/CLTCL1|y|n|ALCL|||L|Dom|TSG,fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,75:75:1
chr22	19366355	.	C	A	.	PASS	CSQ=7290|protein_coding||intron_variant|||||||NM_003325.4:c.1776-4424G>T||MODIFIER||||||HIRA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	0,111:111:1
chr22	19876420	.	G	A	.	PASS	CSQ=10587|protein_coding||intron_variant||||rs1364865855|||NM_006440.5:c.*66-613C>T||MODIFIER||||||TXNRD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	144,0:144:0	0,93:93:1
chr22	20904296	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,99:99:1
chr22	21639776	.	C	G	.	PASS	CSQ=164592|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CCDC116|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:108:0	0,80:80:1
chr22	21639824	.	C	G	.	PASS	CSQ=23753|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SDF2L1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	0,90:90:1
chr22	21907248	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs13056460|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	0,67:67:1
chr22	22692613	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	0,94:94:1
chr22	23421678	.	TAAACAA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	4,91:95:0.9579
chr22	23604323	.	C	T	.	PASS	CSQ=51233|protein_coding||downstream_gene_variant||||rs1449153491||6.5735e-06|||MODIFIER||||||DRICH1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,59:59:1
chr22	24676153	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	0,82:82:1
chr22	24789667	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:104:0	0,81:81:1
chr22	25529822	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	0,71:71:1
chr22	25989642	.	A	C	.	PASS	CSQ=84700|protein_coding||intron_variant||||rs944329733|||NM_032608.6:c.6157-2721A>C||MODIFIER||||||MYO18B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	1,55:56:0.9821
chr22	26059480	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	39,39:78:0.5
chr22	26625365	.	G	A	.	PASS	CSQ=1413|protein_coding||intron_variant|||||||NM_001886.3:c.159-116G>A||MODIFIER||||||CRYBA4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	132,0:132:0	0,99:99:1
chr22	28055762	.	T	A	.	PASS	CSQ=23331|protein_coding||intron_variant|||||||NM_001145418.1:c.3933-25396A>T||MODIFIER||||||TTC28|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	0,66:66:1
chr22	28895666	.	C	CA	.	PASS	CSQ=84133|protein_coding||intron_variant||||rs909928672||0.000126815|NM_001206998.1:c.300+11609dup||MODIFIER||||||ZNRF3|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/ZNRF3|y|n|colorectal_cancer,adrenocortical_carcinoma,gastric_cancer|||E||TSG|N,F,Mis;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	10,80:92:0.8696
chr22	29801264	.	TA	T	.	PASS	CSQ=84164|protein_coding||intron_variant|||||||NM_032204.5:c.1569-155del||MODIFIER||||||ASCC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	1,85:86:0.9884
chr22	29986339	.	G	A	.	PASS	CSQ=8897|protein_coding||intron_variant|||||||NM_021090.3:c.211-2141G>A||MODIFIER||||||MTMR3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,103:103:1
chr22	30183347	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	0,104:104:1
chr22	30460035	.	G	A	.	PASS	CSQ=266629|protein_coding||missense_variant|||||||NM_174975.4:c.1189C>T|NP_777635.1:p.Leu397Phe|MODERATE|B&.&.&.|T&T&T&T|N|T&T&T&T|D&D&D&D|SEC14L3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	131,0:131:0	0,109:109:1
chr22	30888304	.	C	T	.	PASS	CSQ=107985544|lncRNA||non_coding_transcript_exon_variant|||||||NR_146603.1:n.2213G>A||MODIFIER||||||LOC107985544|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	141,0:141:0	70,12:82:0.1463
chr22	30890191	.	C	T	.	PASS	CSQ=23762|protein_coding||intron_variant|||||||NM_030758.4:c.1624-537C>T||MODIFIER||||||OSBP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	84,20:104:0.1923
chr22	31892979	.	G	T	.	PASS	CSQ=9681|protein_coding||intron_variant|||||||NM_001242896.2:c.4034-603G>T||MODIFIER||||||DEPDC5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	0,67:67:1
chr22	32383619	.	C	T	.	PASS	CSQ=51493|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||RTCB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	118,0:118:0	0,70:70:1
chr22	34128223	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,65:65:1
chr22	34555267	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1025003796||1.97387e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	0,78:78:1
chr22	34804408	.	A	T	.	PASS	CSQ=101926957|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_138042.1:n.461-43921T>A||MODIFIER||||||ISX-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	0,59:59:1
chr22	34810875	.	T	C	.	PASS	CSQ=101926957|lncRNA||intron_variant&non_coding_transcript_variant||||rs561689008||0.000486343|NR_138042.1:n.461-50388A>G||MODIFIER||||||ISX-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	0,72:72:1
chr22	34837003	.	G	T	.	PASS	CSQ=101926957|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_138042.1:n.460+60833C>A||MODIFIER||||||ISX-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,67:67:1
chr22	36558024	.	C	T	.	PASS	CSQ=10369|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CACNG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	0,73:73:1
chr22	36569598	.	G	T	.	PASS	CSQ=10369|protein_coding||intron_variant|||||||NM_006078.4:c.296-3105C>A||MODIFIER||||||CACNG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	0,97:97:1
chr22	36999571	.	A	AGGGGAGGGGGGAGGGGAGG	.	PASS	CSQ=339669|protein_coding||intron_variant|||||||NM_001163857.2:c.634+268_634+269insCCTCCCCTCCCCCCTCCCC||MODIFIER||||||TEX33|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	22,1:23:0.0435	1,12:13:0.9231
chr22	37462372	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	1,87:88:0.9886
chr22	38196823	.	A	AAG	.	PASS	CSQ=|||intergenic_variant||||rs1233312416||1.98043e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	18,66:88:0.75
chr22	38347258	.	C	T	.	PASS	CSQ=102800317|protein_coding||intron_variant|||||||NM_001289912.1:c.-111-10552G>A||MODIFIER||||||LOC400927-CSNK1E|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	142,0:142:0	0,94:94:1
chr22	40513359	.	A	G	.	PASS	CSQ=57591|protein_coding||intron_variant|||||||NM_001318139.1:c.46+20231T>C||MODIFIER||||||MKL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,88:88:1
chr22	40571172	.	T	C	.	PASS	CSQ=57591|protein_coding||intron_variant|||||||NM_020831.5:c.-21-18805A>G||MODIFIER||||||MKL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	0,82:82:1
chr22	41033628	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:107:0	0,91:91:1
chr22	41552462	.	G	A	.	PASS	CSQ=105373044|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_134631.1:n.165-574C>T||MODIFIER||||||LOC105373044|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	0,86:86:1
chr22	41759517	.	C	A	.	PASS	CSQ=150365|protein_coding||intron_variant|||||||NM_152513.4:c.2120+984C>A||MODIFIER||||||MEI1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	141,0:141:0	0,79:79:1
chr22	42498846	.	G	C	.	PASS	CSQ=94009|transcribed_pseudogene||upstream_gene_variant||||rs1412044166|||||MODIFIER||||||SERHL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	75,5:80:0.0625
chr22	42780622	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	5,79:84:0.9405
chr22	43078945	.	C	G	.	PASS	CSQ=25809|protein_coding||intron_variant|||||||NM_012263.5:c.-5+957G>C||MODIFIER||||||TTLL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	78,0:78:0	49,18:67:0.2687
chr22	43364694	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	0,80:80:1
chr22	43784738	.	A	AT	.	PASS	CSQ=64800|protein_coding||intron_variant|||||||NM_022785.4:c.-7-2414dup||MODIFIER||||||EFCAB6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	56,0:56:0	1,57:58:0.9828
chr22	43897417	.	CGG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	1,87:88:0.9886
chr22	44252113	.	A	AAAAC	.	PASS	CSQ=85352|protein_coding||intron_variant|||||||NM_001099294.2:c.*-2432_*-2429dup||MODIFIER||||||SHISAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	119,0:119:0	88,27:115:0.2348
chr22	44252261	.	C	CA	.	PASS	CSQ=85352|protein_coding||intron_variant|||||||NM_001099294.2:c.*-2577dup||MODIFIER||||||SHISAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	86,51:137:0.3723
chr22	44252339	.	CT	C	.	PASS	CSQ=85352|protein_coding||intron_variant|||||||NM_001099294.2:c.*-2655del||MODIFIER||||||SHISAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	76,42:118:0.3559
chr22	44252994	.	TTAAAAAAAA	T	.	PASS	CSQ=85352|protein_coding||intron_variant||||rs1027674012||5.30279e-05|NM_001099294.2:c.*-3318_*-3310del||MODIFIER||||||SHISAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	70,0:70:0	92,51:143:0.3566
chr22	44253054	.	G	GGAT	.	PASS	CSQ=85352|protein_coding||intron_variant|||||||NM_001099294.2:c.*-3372_*-3370dup||MODIFIER||||||SHISAL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	91,72:163:0.4417
chr22	44417551	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	75,69:144:0.4792
chr22	47097610	.	C	CAA	.	PASS	CSQ=25771|protein_coding||intron_variant||||rs376444943||3.5673e-05|NM_014346.4:c.1330-13889_1330-13888dup||MODIFIER||||||TBC1D22A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	74,0:118:0	12,63:75:0.84
chr22	47337583	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs888935320||7.22971e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	0,89:89:1
chr22	47483664	.	C	T	.	PASS	CSQ=101927722|lncRNA||intron_variant&non_coding_transcript_variant||||rs747735709||6.57601e-06|NR_109967.1:n.382+3066G>A||MODIFIER||||||LINC01644|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	0,83:83:1
chr22	47549609	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	0,90:90:1
chr22	47553936	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,1:131:0.0076	0,86:86:1
chr22	47811141	.	C	T	.	PASS	CSQ=284930|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_122046.1:n.1126-43770C>T||MODIFIER||||||LOC284930|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	0,74:74:1
chr22	47866620	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	0,73:73:1
chr22	48867687	.	G	A	.	PASS	CSQ=100128946|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038944.1:n.78+840G>A||MODIFIER||||||LINC01310|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,67:67:1
chr22	48889712	.	T	A	.	PASS	CSQ=100128946|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_038944.1:n.338+2500T>A||MODIFIER||||||LINC01310|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	0,64:64:1
chr22	49073206	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	73,70:143:0.4895
chr22	49084071	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	75,67:142:0.4718
chr22	49099500	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	0,177:177:1
chr22	49174110	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,81:163:0.4969
chr22	49461855	.	G	A	.	PASS	CSQ=348645|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_110523.1:n.139-20643C>T||MODIFIER||||||C22orf34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	83,19:102:0.1863
chr22	49595060	.	C	T	.	PASS	CSQ=348645|misc_RNA||intron_variant&non_coding_transcript_variant||||rs921302579||5.26739e-05|NR_110523.1:n.138+62345G>A||MODIFIER||||||C22orf34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	0,73:73:1
chr22	49601516	.	A	C	.	PASS	CSQ=348645|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_110523.1:n.138+55889T>G||MODIFIER||||||C22orf34|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	160,0:160:0	0,126:126:1
chr22	50242222	.	G	A	.	PASS	CSQ=85378|protein_coding||intron_variant|||||||NM_020461.4:c.741+1497C>T||MODIFIER||||||TUBGCP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	0,86:86:1
chrX	684108	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||1.31454e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	29,83:112:0.7411
chrX	688870	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs781203304||5.97498e-05|||MODIFIER||||||||0.0002;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	120,0:120:0	73,22:95:0.2316
chrX	888434	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	96,9:105:0.0857
chrX	1456804	.	A	G	.	PASS	CSQ=8623|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||ASMTL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	72,28:100:0.28
chrX	1547611	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	29,78:107:0.729
chrX	1691118	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	85,0:85:0	56,28:84:0.3333
chrX	1838786	.	GT	G	.	PASS	CSQ=|||intergenic_variant||||||0.000226238|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	21,73:94:0.7766
chrX	2288790	.	G	C	.	PASS	CSQ=207063|protein_coding||intron_variant|||||||NM_145177.2:c.388+2712C>G||MODIFIER||||||DHRSX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	71,30:101:0.297
chrX	2290868	.	G	C	.	PASS	CSQ=207063|protein_coding||intron_variant|||||||NM_145177.2:c.388+634C>G||MODIFIER||||||DHRSX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	70,40:110:0.3636
chrX	2423493	.	G	A	.	PASS	CSQ=207063|protein_coding||intron_variant|||||||NM_145177.2:c.217+1704C>T||MODIFIER||||||DHRSX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	92,12:104:0.1154
chrX	2429023	.	G	C	.	PASS	CSQ=207063|protein_coding||intron_variant|||||||NM_145177.2:c.110-3719C>G||MODIFIER||||||DHRSX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	30,71:101:0.703
chrX	2484637	.	C	T	.	PASS	CSQ=207063|protein_coding||intron_variant||||||6.57376e-06|NM_145177.2:c.109+16180G>A||MODIFIER||||||DHRSX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	23,86:109:0.789
chrX	2801148	.	GT	G	.	PASS	CSQ=7499|protein_coding||intron_variant|||||||NM_175569.2:c.373+3791del||MODIFIER||||||XG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	147,0:147:0	115,9:124:0.0726
chrX	3266409	.	GT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	35,85:120:0.7083
chrX	3543279	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	71,36:107:0.3364
chrX	3704049	.	T	C	.	PASS	CSQ=5613|protein_coding||intron_variant|||||||NM_005044.4:c.166+9039A>G||MODIFIER||||||PRKX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	28,81:109:0.7431
chrX	4151070	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	28,76:104:0.7308
chrX	4631584	.	T	C	.	PASS	CSQ=101928201|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110390.1:n.66-1234A>G||MODIFIER||||||LOC101928201|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	26,64:90:0.7111
chrX	4663836	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	99,6:105:0.0571
chrX	4682401	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	71,26:97:0.268
chrX	5042884	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,1:107:0.0093	80,35:115:0.3043
chrX	5106307	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	33,65:98:0.6633
chrX	5235055	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	26,67:93:0.7204
chrX	5246731	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	41,67:108:0.6204
chrX	5386843	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	30,80:110:0.7273
chrX	5443149	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,1:101:0.0099	68,34:102:0.3333
chrX	5537859	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	53,34:87:0.3908
chrX	5613402	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1420712755||5.44109e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	74,23:97:0.2371
chrX	5613787	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	71,31:102:0.3039
chrX	5698309	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	60,33:93:0.3548
chrX	5740660	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	52,24:76:0.3158
chrX	5843742	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	34,66:100:0.66
chrX	5873172	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	155,0:155:0	76,35:111:0.3153
chrX	5945180	.	G	T	.	PASS	CSQ=57502|protein_coding||intron_variant|||||||NM_181332.3:c.626-35941C>A||MODIFIER||||||NLGN4X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	128,0:128:0	96,5:101:0.0495
chrX	6171640	.	AGTT	A	.	PASS	CSQ=57502|protein_coding||intron_variant|||||||NM_181332.3:c.-305-19872_-305-19870del||MODIFIER||||||NLGN4X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	36,56:92:0.6087
chrX	6321324	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	117,0:117:0	105,8:113:0.0708
chrX	6328851	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:97:0	54,25:79:0.3165
chrX	6465753	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	32,52:84:0.619
chrX	6510589	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	122,0:122:0	85,6:91:0.0659
chrX	6555297	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	34,62:96:0.6458
chrX	6663466	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	99,37:136:0.2721
chrX	6669996	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:134:0	68,33:101:0.3267
chrX	6799900	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	53,31:84:0.369
chrX	6838389	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	35,76:111:0.6847
chrX	7486661	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	66,33:99:0.3333
chrX	7594277	.	GCC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	28,64:92:0.6957
chrX	7855982	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	32,67:99:0.6768
chrX	8384890	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	86,29:115:0.2522
chrX	8385071	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	72,30:102:0.2941
chrX	8497081	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	125,41:166:0.247
chrX	8497211	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	105,41:146:0.2808
chrX	8497224	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	111,46:157:0.293
chrX	8517030	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	144,38:182:0.2088
chrX	8517102	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	152,31:183:0.1694
chrX	8990251	.	AT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	74,78:152:0.5132
chrX	9001457	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,1:110:0.0091	65,74:139:0.5324
chrX	9400247	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	69,78:147:0.5306
chrX	9677938	.	C	A	.	PASS	CSQ=6907|protein_coding||intron_variant|||||||NM_005647.3:c.212-6105C>A||MODIFIER||||||TBL1X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	81,70:151:0.4636
chrX	9783181	.	G	GA	.	PASS	CSQ=357|protein_coding||upstream_gene_variant||||rs1209941642||0.000173284|||MODIFIER||||||SHROOM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	81,57:138:0.413
chrX	9791001	.	G	A	.	PASS	CSQ=357|protein_coding||intron_variant|||||||NM_001649.4:c.165+4291G>A||MODIFIER||||||SHROOM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	71,71:142:0.5
chrX	9898480	.	C	T	.	PASS	CSQ=357|protein_coding||intron_variant|||||||NM_001649.4:c.2891+190C>T||MODIFIER||||||SHROOM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:127:0	78,90:168:0.5357
chrX	10039992	.	T	A	.	PASS	CSQ=55841|protein_coding||intron_variant|||||||NM_015691.3:c.-94-23453T>A||MODIFIER||||||WWC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	101,81:182:0.4451
chrX	10204447	.	C	G	.	PASS	CSQ=1183|protein_coding||intron_variant|||||||NM_001830.4:c.556-1911C>G||MODIFIER||||||CLCN4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	86,95:181:0.5249
chrX	10643408	.	G	GA	.	PASS	CSQ=4281|protein_coding||intron_variant|||||||NM_001098624.2:c.-57+34056dup||MODIFIER||||||MID1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	123,72:195:0.3692
chrX	11088035	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	91,77:168:0.4583
chrX	11270500	.	C	T	.	PASS	CSQ=395|protein_coding||intron_variant|||||||NM_013427.3:c.589-15793G>A||MODIFIER||||||ARHGAP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	88,75:163:0.4601
chrX	11441896	.	T	TA	.	PASS	CSQ=395|protein_coding||intron_variant||||rs747908927||0.000111066|NM_013427.3:c.589-187190dup||MODIFIER||||||ARHGAP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	67,48:115:0.4174
chrX	11655812	.	G	A	.	PASS	CSQ=395|protein_coding||intron_variant|||||||NM_013427.3:c.588+8429C>T||MODIFIER||||||ARHGAP6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	79,87:166:0.5241
chrX	11727611	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||||8.92331e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	87,56:143:0.3916
chrX	11763286	.	A	G	.	PASS	CSQ=10943|protein_coding||intron_variant|||||||NM_078629.3:c.749+289A>G||MODIFIER||||||MSL3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	74,88:162:0.5432
chrX	11952638	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	131,0:131:0	137,14:151:0.0927
chrX	12159447	.	A	C	.	PASS	CSQ=9758|protein_coding||intron_variant|||||||NM_014728.3:c.41+20435A>C||MODIFIER||||||FRMPD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	80,79:159:0.4969
chrX	12260899	.	AT	A	.	PASS	CSQ=9758|protein_coding||intron_variant||||||8.97811e-06|NM_014728.3:c.41+121893del||MODIFIER||||||FRMPD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	86,67:153:0.4379
chrX	12401835	.	A	C	.	PASS	CSQ=9758|protein_coding||intron_variant|||||||NM_014728.3:c.42-96845A>C||MODIFIER||||||FRMPD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	69,65:134:0.4851
chrX	12474818	.	A	T	.	PASS	CSQ=9758|protein_coding||intron_variant|||||||NM_014728.3:c.42-23862A>T||MODIFIER||||||FRMPD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	57,65:122:0.5328
chrX	12641116	.	A	C	.	PASS	CSQ=9758|protein_coding||intron_variant|||||||NM_014728.3:c.422+26235A>C||MODIFIER||||||FRMPD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	76,75:152:0.4934
chrX	12711805	.	G	T	.	PASS	CSQ=9758|protein_coding||intron_variant|||||||NM_014728.3:c.1609+1268G>T||MODIFIER||||||FRMPD4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	69,0:69:0	40,52:92:0.5652
chrX	12805333	.	TTCCTTATCTGTAAATTAAGTACGA	T	.	PASS	CSQ=5634|protein_coding||intron_variant|||||||NM_002765.4:c.307-3900_307-3877del||MODIFIER||||||PRPS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	81,86:167:0.515
chrX	13274779	.	AT	A	.	PASS	CSQ=109729169|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146309.1:n.134-7445del||MODIFIER||||||LINC02154|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	97,71:169:0.4201
chrX	13308691	.	G	C	.	PASS	CSQ=100093698|lncRNA||upstream_gene_variant|||||||||MODIFIER||||||GS1-600G8.3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	85,84:169:0.497
chrX	13545503	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	82,59:141:0.4184
chrX	14019064	.	C	G	.	PASS	CSQ=54960|protein_coding||intron_variant|||||||NM_001042479.1:c.472+1014G>C||MODIFIER||||||GEMIN8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	82,77:159:0.4843
chrX	14242133	.	C	T	.	PASS	CSQ=286480|transcribed_pseudogene||upstream_gene_variant|||||||||MODIFIER||||||UBE2E4P|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	66,69:135:0.5111
chrX	14443498	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	72,70:142:0.493
chrX	14471467	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1291108137||8.05578e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	66,72:138:0.5217
chrX	14755767	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs948450881|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	64,80:144:0.5556
chrX	14882199	.	C	A	.	PASS	CSQ=158747|protein_coding||intron_variant|||||||NM_152581.4:c.79+8441C>A||MODIFIER||||||MOSPD2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	83,69:152:0.4539
chrX	15296833	.	G	A	.	PASS	CSQ=140456|protein_coding||intron_variant|||||||NM_080873.2:c.369+741C>T||MODIFIER||||||ASB11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	59,72:131:0.5496
chrX	15458016	.	A	G	.	PASS	CSQ=8544|protein_coding||intron_variant|||||||NM_001018109.3:c.273+1641T>C||MODIFIER||||||PIR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	77,71:148:0.4797
chrX	15596813	.	C	T	.	PASS	CSQ=59272|protein_coding||intron_variant|||||||NM_021804.2:c.187-1810G>A||MODIFIER||||||ACE2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	68,63:131:0.4809
chrX	16032113	COSV51177802	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV51177802|rs1158900937||0.00294783|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	87,64:151:0.4238
chrX	16068335	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	80,78:158:0.4937
chrX	16344092	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1211133605|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	78,74:152:0.4868
chrX	16501698	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	62,41:103:0.3981
chrX	16560071	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	77,77:154:0.5
chrX	16682884	.	G	A	.	PASS	CSQ=56474|protein_coding||intron_variant||||rs1483070729||3.56968e-05|NM_175859.3:c.1005+210C>T||MODIFIER||||||CTPS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	77,104:181:0.5746
chrX	16715951	.	A	G	.	PASS	CSQ=56474|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CTPS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	66,59:125:0.472
chrX	16725480	.	C	G	.	PASS	CSQ=94056|protein_coding||intron_variant|||||||NM_032796.4:c.175+5581C>G||MODIFIER||||||SYAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	86,75:161:0.4658
chrX	16730434	.	C	A	.	PASS	CSQ=94056|protein_coding||intron_variant|||||||NM_032796.4:c.176-4793C>A||MODIFIER||||||SYAP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	91,71:162:0.4383
chrX	16774603	.	GC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	69,60:129:0.4651
chrX	16866360	.	T	C	.	PASS	CSQ=5931|protein_coding||intron_variant|||||||NM_002893.3:c.161+2716A>G||MODIFIER||||||RBBP7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	59,76:135:0.563
chrX	16937525	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1400556050||0.000400776|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	66,52:118:0.4407
chrX	17118202	.	G	A	.	PASS	CSQ=9185|protein_coding||intron_variant||||rs1269030666||9.2596e-06|NM_004726.3:c.1578+14423G>A||MODIFIER||||||REPS2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	94,67:161:0.4161
chrX	17361203	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	68,64:132:0.4848
chrX	17770575	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	69,71:140:0.5071
chrX	17919161	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	133,16:149:0.1074
chrX	18262606	.	GC	AA	.	PASS	CSQ=10389|protein_coding||intron_variant|||||||NM_006089.3:c.949-2316_949-2315delinsTT||MODIFIER||||||SCML2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	131,0:131:0	101,67:168:0.3988
chrX	18268389	.	C	T	.	PASS	CSQ=10389|protein_coding||intron_variant|||||||NM_006089.3:c.731-2587G>A||MODIFIER||||||SCML2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	73,59:132:0.447
chrX	18517983	COSV66111831;COSV66111831;COSV66111831;COSV66111831	C	T	.	PASS	CSQ=6792|protein_coding||intron_variant|COSV66111831&COSV66111831&COSV66111831&COSV66111831|p.?&p.?&p.?&p.?||rs1156559573||1.79669e-05|NM_001323289.1:c.99+7129C>T||MODIFIER||||||CDKL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:121:0	129,10:139:0.0719
chrX	19014642	.	A	AT	.	PASS	CSQ=10149|protein_coding||intron_variant||||rs1247232484||9.13793e-06|NM_001079858.3:c.711-569dup||MODIFIER||||||ADGRG2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	81,57:139:0.4101
chrX	19341771	.	C	A	.	PASS	CSQ=5160|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||PDHA1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	69,64:133:0.4812
chrX	19417309	.	G	T	.	PASS	CSQ=389840|protein_coding||intron_variant|||||||NM_001001671.3:c.1440-2052C>A||MODIFIER||||||MAP3K15|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	81,77:158:0.4873
chrX	19565462	.	C	A	.	PASS	CSQ=30011|protein_coding||intron_variant|||||||NM_031892.3:c.1384+3641G>T||MODIFIER||||||SH3KBP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	61,68:129:0.5271
chrX	19618629	.	C	CT	.	PASS	CSQ=30011|protein_coding||intron_variant|||||||NM_031892.3:c.898-10585dup||MODIFIER||||||SH3KBP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	85,67:152:0.4408
chrX	20644464	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	80,58:138:0.4203
chrX	20810313	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	83,68:151:0.4503
chrX	20852224	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	56,65:121:0.5372
chrX	21077197	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	70,56:126:0.4444
chrX	21217575	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	122,12:134:0.0896
chrX	21580342	.	T	C	.	PASS	CSQ=22866|protein_coding||intron_variant|||||||NM_014927.5:c.1609-10230T>C||MODIFIER||||||CNKSR2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	68,88:156:0.5641
chrX	21772737	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	78,66:144:0.4583
chrX	22096301	.	C	G	.	PASS	CSQ=5251|protein_coding||intron_variant||||rs1013175009|||NM_000444.6:c.850-654C>G||MODIFIER||||||PHEX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	90,79:169:0.4675
chrX	22189572	COSV65079707	G	GA	.	PASS	CSQ=100873065|lncRNA||downstream_gene_variant|COSV65079707|p.?||rs1368231123||0.000274913|||MODIFIER||||||PTCHD1-AS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	93,57:151:0.3775
chrX	22248741	.	G	A	.	PASS	CSQ=100873065|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_073010.2:n.850+5198C>T||MODIFIER||||||PTCHD1-AS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	121,0:121:0	61,73:134:0.5448
chrX	22338259	.	A	T	.	PASS	CSQ=100873065|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_073010.2:n.511+51404T>A||MODIFIER||||||PTCHD1-AS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	89,74:163:0.454
chrX	22450223	.	G	C	.	PASS	CSQ=100873065|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_073010.2:n.454-60503C>G||MODIFIER||||||PTCHD1-AS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	69,73:142:0.5141
chrX	22692346	.	G	T	.	PASS	CSQ=100873065|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_073010.2:n.453+50883C>A||MODIFIER||||||PTCHD1-AS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	58,67:125:0.536
chrX	23121943	.	G	A	.	PASS	CSQ=100873065|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_073010.2:n.260-57822C>T||MODIFIER||||||PTCHD1-AS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	72,71:143:0.4965
chrX	23183190	.	C	G	.	PASS	CSQ=100873065|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_073010.2:n.259+86861G>C||MODIFIER||||||PTCHD1-AS|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	89,71:160:0.4437
chrX	23369568	.	G	T	.	PASS	CSQ=139411|protein_coding||intron_variant|||||||NM_173495.3:c.352-10023G>T||MODIFIER||||||PTCHD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	72,68:140:0.4857
chrX	23411209	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	181,6:187:0.0321
chrX	23537213	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	84,68:152:0.4474
chrX	23815868	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	84,68:152:0.4474
chrX	24066124	COSV53405772;COSV53405772	G	GT	.	PASS	CSQ=1968|protein_coding||intron_variant|COSV53405772|p.?|COSV53405772|rs150782745&TMP_ESP_X_24084242_24084243|0.500184|0.628804|NM_001415.4:c.867+44dup||MODIFIER||||||EIF2S3|EntrezGene|0.4599;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:106:0.0094	80,66:147:0.449
chrX	24323000	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:120:0	60,54:114:0.4737
chrX	24408532	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1000391803|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	71,71:142:0.5
chrX	24661205	.	C	T	.	PASS	CSQ=9468|protein_coding||intron_variant|||||||NM_001163264.1:c.63+11365G>A||MODIFIER||||||PCYT1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	80,67:147:0.4558
chrX	25350742	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	68,79:147:0.5374
chrX	25357845	.	GG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	139,0:140:0	76,72:148:0.4865
chrX	25372618	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	72,68:140:0.4857
chrX	25414694	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	60,58:118:0.4915
chrX	25555549	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	84,73:157:0.465
chrX	25616000	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	77,65:142:0.4577
chrX	25616518	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	89,69:158:0.4367
chrX	25909352	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	72,73:145:0.5034
chrX	25964513	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1036741910|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	74,69:143:0.4825
chrX	26160093	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1425486075||5.38218e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	62,73:135:0.5407
chrX	26180273	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	69,63:132:0.4773
chrX	26210502	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	87,39:126:0.3095
chrX	26447658	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	72,76:148:0.5135
chrX	26770236	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||||8.95784e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	65,65:131:0.4962
chrX	26860605	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	54,62:116:0.5345
chrX	26879514	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	82,60:142:0.4225
chrX	26962890	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	73,77:150:0.5133
chrX	27097296	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	78,66:144:0.4583
chrX	27182018	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	137,5:142:0.0352
chrX	27620853	.	G	A	.	PASS	CSQ=347442|protein_coding||intron_variant|||||||NM_001353448.1:c.-533-11026G>A||MODIFIER||||||DCAF8L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	63,72:135:0.5333
chrX	27669468	.	A	G	.	PASS	CSQ=347442|protein_coding||intron_variant|||||||NM_001353448.1:c.-411-7478A>G||MODIFIER||||||DCAF8L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	58,62:120:0.5167
chrX	27674632	.	G	T	.	PASS	CSQ=347442|protein_coding||intron_variant||||rs1349046779|||NM_001353448.1:c.-411-2314G>T||MODIFIER||||||DCAF8L2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	105,12:117:0.1026
chrX	27759675	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	65,81:146:0.5548
chrX	27957586	.	T	C	.	PASS	CSQ=|||intergenic_variant||||||8.93336e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	68,73:141:0.5177
chrX	27963724	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	88,16:104:0.1538
chrX	27966202	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	70,56:126:0.4444
chrX	27971887	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	66,80:146:0.5479
chrX	28006496	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	52,72:124:0.5806
chrX	28030948	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	88,30:118:0.2542
chrX	28138328	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,1:114:0.0088	57,61:118:0.5169
chrX	28193739	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	75,76:151:0.5033
chrX	28196931	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	67,76:143:0.5315
chrX	28206232	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	68,63:131:0.4809
chrX	28212784	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1282013963||1.82978e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	123,7:130:0.0538
chrX	28218199	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1289093416|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	54,56:110:0.5091
chrX	28267028	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	66,63:129:0.4884
chrX	28368417	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	70,65:135:0.4815
chrX	28403999	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	106,8:114:0.0702
chrX	28417697	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	75,78:153:0.5098
chrX	28543836	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	79,63:142:0.4437
chrX	29070599	.	C	A	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.83-212339C>A||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	65,74:139:0.5324
chrX	29094170	.	C	T	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.83-188768C>T||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	64,70:134:0.5224
chrX	29244922	.	C	T	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.83-38016C>T||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	71,62:133:0.4662
chrX	29252411	.	G	A	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.83-30527G>A||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	320,0:320:0	363,17:380:0.0447
chrX	29260739	.	G	C	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.83-22199G>C||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	74,70:144:0.4861
chrX	29410661	.	G	T	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.703+11353G>T||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	73,70:143:0.4895
chrX	29419785	.	C	T	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.703+20477C>T||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	79,69:148:0.4662
chrX	29559115	.	T	G	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.704-109315T>G||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	92,82:174:0.4713
chrX	29575127	.	C	A	.	PASS	CSQ=100847047|miRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR4666B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	65,80:145:0.5517
chrX	29655571	.	G	A	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.704-12859G>A||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	44,75:119:0.6303
chrX	29765892	.	C	T	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.778+97388C>T||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	67,62:129:0.4806
chrX	29899031	.	C	A	.	PASS	CSQ=11141|protein_coding||intron_variant|||||||NM_014271.3:c.779-18433C>A||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	57,69:126:0.5476
chrX	29907350	.	C	CT	.	PASS	CSQ=11141|protein_coding||intron_variant||||||9.02372e-06|NM_014271.3:c.779-10108dup||MODIFIER||||||IL1RAPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	70,60:130:0.4615
chrX	30107395	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	60,62:122:0.5082
chrX	30256252	.	G	T	.	PASS	CSQ=4112|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||MAGEB1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	94,65:159:0.4088
chrX	30352898	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	56,74:130:0.5692
chrX	30352900	.	CTAGT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	57,63:120:0.525
chrX	30368515	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	135,6:141:0.0426
chrX	30369189	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	124,8:132:0.0606
chrX	30650759	.	C	A	.	PASS	CSQ=2710|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:108:0	77,54:131:0.4122
chrX	30742024	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	76,76:152:0.5
chrX	30862508	.	C	G	.	PASS	CSQ=257397|protein_coding||intron_variant|||||||NM_152787.4:c.-90-2830G>C||MODIFIER||||||TAB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	70,61:131:0.4656
chrX	30934081	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	131,8:139:0.0576
chrX	31010388	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs927095163||8.95063e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	66,68:134:0.5075
chrX	31071139	.	C	A	.	PASS	CSQ=53940|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||FTHL17|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	116,0:116:0	75,32:107:0.2991
chrX	31525882	.	C	A	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.8218-18429G>T||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	70,72:142:0.507
chrX	31748128	.	G	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.7543-18380C>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	64,76:140:0.5429
chrX	31752742	.	G	A	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.7542+21218C>T||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	79,69:148:0.4662
chrX	31874296	.	G	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.7098+892C>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	59,63:122:0.5164
chrX	32104077	.	G	A	.	PASS	CSQ=1756|protein_coding||intron_variant||||rs896434960||8.99669e-06|NM_004006.2:c.6438+112839C>T||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	54,68:122:0.5574
chrX	32245047	.	C	A	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.6291-27984G>T||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	70,26:96:0.2708
chrX	32261214	.	C	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.6290+26315G>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	114,8:122:0.0656
chrX	32265368	.	G	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.6290+22161C>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	128,8:136:0.0588
chrX	32340457	.	G	A	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.5922+1643C>T||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	81,69:150:0.46
chrX	32464320	.	T	C	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.3276+266A>G||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	56,77:133:0.5789
chrX	32656623	.	C	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.961-11471G>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	112,9:121:0.0744
chrX	32659534	.	C	A	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.961-14382G>T||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	65,69:134:0.5149
chrX	32818236	.	A	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.358-1596T>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	68,67:135:0.4963
chrX	32915997	.	C	A	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.94-66177G>T||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	57,66:123:0.5366
chrX	32942557	COSV55866208;COSV55866208;COSV55866208;COSV55866208;COSV55866208	G	GA	.	PASS	CSQ=1756|protein_coding||intron_variant|COSV55866208&COSV55866208&COSV55866208&COSV55866208&COSV55866208|p.?&p.?&p.?&p.?&p.?||||4.67237e-05|NM_004006.2:c.93+77581dup||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,1:115:0.0087	59,57:116:0.4914
chrX	33014262	.	G	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.93+5877C>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	63,51:114:0.4474
chrX	33080156	.	A	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_004006.2:c.32-59956T>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	76,59:135:0.437
chrX	33241308	.	G	T	.	PASS	CSQ=1756|protein_coding||intron_variant|||||||NM_000109.3:c.7+97951C>A||MODIFIER||||||DMD|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	65,83:148:0.5608
chrX	33413654	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	73,68:141:0.4823
chrX	33424774	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs781404508||1.81722e-05|||MODIFIER||||||||0.0011;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	72,47:119:0.395
chrX	33442110	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	55,63:118:0.5339
chrX	33611659	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	56,54:110:0.4909
chrX	33628768	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	75,76:151:0.5033
chrX	33632541	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	56,69:125:0.552
chrX	33645299	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	60,70:130:0.5385
chrX	33651075	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	78,60:138:0.4348
chrX	33900231	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	117,12:129:0.093
chrX	33904226	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	70,50:120:0.4167
chrX	33908892	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	117,10:127:0.0787
chrX	34159692	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	67,70:138:0.5072
chrX	34170886	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	69,81:150:0.54
chrX	34261302	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	141,9:150:0.06
chrX	34332640	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	70,72:142:0.507
chrX	34361489	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	127,6:133:0.0451
chrX	34406467	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1303299296|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	60,66:126:0.5238
chrX	34512851	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	63,69:132:0.5227
chrX	34537786	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	60,62:122:0.5082
chrX	34652889	.	A	T	.	PASS	CSQ=83604|protein_coding||intron_variant|||||||NM_031442.4:c.226+3915T>A||MODIFIER||||||TMEM47|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	62,84:146:0.5753
chrX	34691677	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	85,66:151:0.4371
chrX	34792285	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	66,58:124:0.4677
chrX	34891618	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	62,75:137:0.5474
chrX	34942650	.	G	A	.	PASS	CSQ=170062|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||FAM47B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	82,71:153:0.4641
chrX	35031840	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	58,69:127:0.5433
chrX	35042213	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	65,85:150:0.5667
chrX	35142688	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	72,67:139:0.482
chrX	35146124	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	65,70:135:0.5185
chrX	35250055	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	59,63:122:0.5164
chrX	35283152	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	76,59:135:0.437
chrX	35351795	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1372480063|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	67,82:149:0.5503
chrX	35818249	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	69,67:137:0.4891
chrX	36099854	.	C	T	.	PASS	CSQ=286464|protein_coding||missense_variant|||||||NM_001304548.2:c.5102C>T|NP_001291477.1:p.Thr1701Ile|MODERATE|.&.||D|D&D|.&D|CFAP47|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	133,0:133:0	60,80:140:0.5714
chrX	36186401	.	G	T	.	PASS	CSQ=286464|protein_coding||intron_variant||||||8.96885e-06|NM_001304548.2:c.6105-2219G>T||MODIFIER||||||CFAP47|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	63,70:133:0.5263
chrX	36396207	.	G	T	.	PASS	CSQ=101928627|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110412.1:n.1405-16723C>A||MODIFIER||||||LOC101928627|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	67,70:137:0.5109
chrX	37926624	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	96,74:170:0.4353
chrX	37974783	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	67,68:135:0.5037
chrX	37977757	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:92:0	59,56:115:0.487
chrX	38028754	.	C	T	.	PASS	CSQ=94122|protein_coding||intron_variant|||||||NM_138780.3:c.-356-4780C>T||MODIFIER||||||SYTL5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	74,68:142:0.4789
chrX	38287495	.	T	G	.	PASS	CSQ=6103|protein_coding||intron_variant|||||||NM_000328.2:c.1754-250A>C||MODIFIER||||||RPGR|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	141,0:141:0	61,89:150:0.5933
chrX	38431626	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	74,71:145:0.4897
chrX	39030440	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	120,8:128:0.0625
chrX	39347139	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	144,0:144:0	94,44:138:0.3188
chrX	39500949	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	145,5:150:0.0333
chrX	39638877	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	80,77:157:0.4904
chrX	39924953	.	C	CTTTCTTG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	98,41:142:0.2887
chrX	40125866	.	G	C	.	PASS	CSQ=54880|protein_coding||intron_variant|||||||NM_001123383.1:c.-40-47897C>G||MODIFIER||||||BCOR|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/BCOR|y|n|retinoblastoma,AML,APL_(translocation)|||L,M|Rec|TSG,fusion|F,N,S,T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	62,68:130:0.5231
chrX	40265254	.	C	T	.	PASS	CSQ=101927476|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110386.1:n.636+1702C>T||MODIFIER||||||LOC101927476|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:141:0	78,86:164:0.5244
chrX	40637555	.	C	T	.	PASS	CSQ=159013|protein_coding||intron_variant|||||||NM_144970.3:c.472-399G>A||MODIFIER||||||CXorf38|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	89,76:165:0.4606
chrX	40876935	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1446461123||0.00133295|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,1:107:0.0093	88,58:147:0.3946
chrX	40888482	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	63,68:131:0.5191
chrX	41323599	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	143,8:151:0.053
chrX	41397574	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	68,86:154:0.5584
chrX	41514315	.	G	T	.	PASS	CSQ=8573|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||CASK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	149,0:149:0	76,50:126:0.3968
chrX	41578340	.	C	T	.	PASS	CSQ=8573|protein_coding||missense_variant&splice_region_variant|||||||NM_001126055.2:c.1485G>A|NP_001119527.1:p.Met495Ile|MODERATE|D&B&.&P&.&P&.&D&.&.&.&.&.&.&.|.&T&.&.&.&T&.&T&.&.&.&T&.&.&.|D|.&.&.&.&.&D&.&D&.&.&.&D&.&.&.|.&T&.&.&.&D&.&D&.&.&.&D&.&.&.|CASK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	84,0:84:0	57,67:124:0.5403
chrX	41744342	.	T	A	.	PASS	CSQ=8573|protein_coding||intron_variant|||||||NM_001126055.2:c.356+1182A>T||MODIFIER||||||CASK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	106,53:159:0.3333
chrX	41994834	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	134,16:150:0.1067
chrX	42029453	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	71,63:134:0.4701
chrX	42086363	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	77,76:153:0.4967
chrX	42479991	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	112,44:156:0.2821
chrX	42958867	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	61,74:135:0.5481
chrX	43030046	.	GTT	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	91,68:160:0.425
chrX	43239911	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1030933205||2.88215e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	60,59:120:0.4917
chrX	43284959	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	111,37:148:0.25
chrX	43375896	COSV51177989	GA	G	.	PASS	CSQ=|||intergenic_variant|||COSV51177989|rs761202103|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	70,43:114:0.3772
chrX	43391795	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	63,66:129:0.5116
chrX	43535701	COSV67765116	T	TG	.	PASS	CSQ=|||intergenic_variant|||COSV67765116|rs1275266180||0.00120659|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	55,0:55:0	42,26:68:0.3824
chrX	43720811	.	G	C	.	PASS	CSQ=4128|protein_coding||intron_variant||||rs975568228|||NM_000240.3:c.504-7362G>C||MODIFIER||||||MAOA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	80,60:140:0.4286
chrX	43837937	.	G	T	.	PASS	CSQ=4129|protein_coding||intron_variant|||||||NM_000898.5:c.279+931C>A||MODIFIER||||||MAOB|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	100,0:100:0	148,11:159:0.0692
chrX	43931630	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs201331726||0.0105158|||MODIFIER||||||||0.0103;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	71,60:131:0.458
chrX	44048062	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	73,62:135:0.4593
chrX	44788570	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs868472752|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	147,5:152:0.0329
chrX	44807200	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	76,70:146:0.4795
chrX	44866996	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	80,59:139:0.4245
chrX	44867056	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	90,64:154:0.4156
chrX	45027424	.	TC	T	.	PASS	CSQ=7403|protein_coding||intron_variant|||||||NM_001291415.1:c.564+6696del||MODIFIER||||||KDM6A|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/KDM6A|y|n|renal_cell_carcinoma,bladder_carcinoma,oesophageal_SCC,MM,medulloblastoma,T-ALL,other_tumour_types|||E,L|Rec|oncogene,TSG|D,N,F,S;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	72,70:142:0.493
chrX	45277630	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	72,74:146:0.5068
chrX	45337123	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	89,36:125:0.288
chrX	45360246	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	155,6:161:0.0373
chrX	45781747	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	131,41:172:0.2384
chrX	45812453	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs201003817||0.0148048|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	89,50:140:0.3571
chrX	45986825	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	82,75:158:0.4747
chrX	46725112	.	C	T	.	PASS	CSQ=84679|protein_coding||intron_variant|||||||NM_001257291.2:c.325+33593G>A||MODIFIER||||||SLC9A7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	93,81:174:0.4655
chrX	47592754	.	A	AT	.	PASS	CSQ=6853|protein_coding||intron_variant||||rs1447327928|||NM_006950.3:c.774+12223dup||MODIFIER||||||SYN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	70,61:131:0.4656
chrX	47751587	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||8.91512e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	87,88:175:0.5029
chrX	47892111	.	C	G	.	PASS	CSQ=347344|protein_coding||intron_variant|||||||NM_007137.3:c.182-3734C>G||MODIFIER||||||ZNF81|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	72,74:146:0.5068
chrX	48133322	.	C	G	.	PASS	CSQ=729201|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SPACA5B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	215,1:216:0.0046	178,61:240:0.2542
chrX	48294359	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1238293494||3.59596e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:100:0	78,82:160:0.5125
chrX	48591624	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	88,60:148:0.4054
chrX	49019010	.	TG	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	83,0:83:0	58,49:107:0.4579
chrX	49150010	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	57,85:142:0.5986
chrX	49243784	.	C	T	.	PASS	CSQ=28952|protein_coding||intron_variant|||||||NM_014008.5:c.714+322C>T||MODIFIER||||||CCDC22|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	89,65:154:0.4221
chrX	49637183	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	168,7:175:0.04
chrX	49671116	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1048991828||6.37006e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	68,62:130:0.4769
chrX	49704188	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	76,70:146:0.4795
chrX	50380960	.	GA	G	.	PASS	CSQ=139189|protein_coding||intron_variant||||||8.96982e-06|NM_001013742.4:c.2658-884del||MODIFIER||||||DGKK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	78,73:151:0.4834
chrX	50896036	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	81,72:153:0.4706
chrX	51028194	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	79,69:148:0.4662
chrX	51034387	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	130,10:140:0.0714
chrX	51148781	.	G	A	.	PASS	CSQ=101926971|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110382.2:n.94+22547C>T||MODIFIER||||||LINC01284|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	69,69:138:0.5
chrX	51448605	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||8.956e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	69,78:147:0.5306
chrX	51498329	.	G	T	.	PASS	CSQ=55190|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NUDT11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	54,80:134:0.597
chrX	51740220	.	G	A	.	PASS	CSQ=23708|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GSPT2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	69,77:146:0.5274
chrX	51851598	.	C	T	.	PASS	CSQ=9500|protein_coding||intron_variant|||||||NM_001005332.1:c.-36-42671C>T||MODIFIER||||||MAGED1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	64,85:149:0.5705
chrX	51891355	.	CTAAGCAATTGTCCAAGGTGATGAGATTTAGTGATGTTTATT	C	.	PASS	CSQ=9500|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MAGED1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	101,76:177:0.4294
chrX	52030623	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	70,63:133:0.4737
chrX	52102204	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	78,71:149:0.4765
chrX	52144484	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	62,64:126:0.5079
chrX	52144879	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1359954994||1.7977e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	115,0:115:0	126,6:132:0.0455
chrX	52416986	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	64,58:122:0.4754
chrX	52440801	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	65,67:132:0.5076
chrX	53020472	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	68,85:153:0.5556
chrX	53255218	.	A	G	.	PASS	CSQ=23096|protein_coding||intron_variant|||||||NM_001111125.3:c.1000-287T>C||MODIFIER||||||IQSEC2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	86,88:174:0.5057
chrX	53419604	.	T	A	.	PASS	CSQ=8243|protein_coding||intron_variant|||||||NM_006306.3:c.109+2888A>T||MODIFIER||||||SMC1A|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/SMC1A|y|n|AML|||L||TSG|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	61,73:134:0.5448
chrX	53419606	.	A	G	.	PASS	CSQ=158787|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||RIBC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	61,72:133:0.5414
chrX	53494312	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	73,61:134:0.4552
chrX	53793318	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	73,54:127:0.4252
chrX	54128290	.	C	T	.	PASS	CSQ=54954|protein_coding||intron_variant|||||||NM_017848.6:c.2062+4402G>A||MODIFIER||||||FAM120C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	87,62:149:0.4161
chrX	54176981	.	C	T	.	PASS	CSQ=54954|protein_coding||intron_variant|||||||NM_017848.6:c.699+5519G>A||MODIFIER||||||FAM120C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	78,72:150:0.48
chrX	54212913	.	C	T	.	PASS	CSQ=65267|protein_coding||intron_variant|||||||NM_001002838.3:c.4700-10720G>A||MODIFIER||||||WNK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	75,67:142:0.4718
chrX	54527915	.	C	G	.	PASS	CSQ=54552|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||GNL3L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	89,63:152:0.4145
chrX	54571194	.	AT	A	.	PASS	CSQ=54552|protein_coding||downstream_gene_variant||||rs1449454751||0.000874919|||MODIFIER||||||GNL3L|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	79,40:119:0.3361
chrX	54628715	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs928666062|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:109:0	81,64:147:0.4354
chrX	54723036	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	69,73:142:0.5141
chrX	54764406	.	C	T	.	PASS	CSQ=347365|protein_coding||intron_variant||||rs1333971198||1.85996e-05|NM_198510.2:c.904-4479G>A||MODIFIER||||||ITIH6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	54,72:126:0.5714
chrX	54904145	.	CT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	77,56:133:0.4211
chrX	54934680	.	G	A	.	PASS	CSQ=7216|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TRO|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:146:0	74,71:145:0.4897
chrX	55406586	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs5960083||0.000226048|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:129:0	66,63:129:0.4884
chrX	55813332	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	82,88:170:0.5176
chrX	55847341	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	59,71:130:0.5462
chrX	55956221	.	A	G	.	PASS	CSQ=11279|protein_coding||intron_variant|||||||NM_001324104.1:c.-96+47704A>G||MODIFIER||||||KLF8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	88,72:160:0.45
chrX	55989955	.	T	G	.	PASS	CSQ=11279|protein_coding||intron_variant|||||||NM_001324104.1:c.-95-24890T>G||MODIFIER||||||KLF8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	68,59:127:0.4646
chrX	56122923	.	C	T	.	PASS	CSQ=11279|protein_coding||intron_variant|||||||NM_001324104.1:c.22+107962C>T||MODIFIER||||||KLF8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	117,6:123:0.0488
chrX	57045321	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1308369703||8.96797e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	72,63:135:0.4667
chrX	57307792	.	C	G	.	PASS	CSQ=158584|protein_coding||intron_variant|||||||NM_174912.3:c.276-2801C>G||MODIFIER||||||FAAH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,66:132:0.5
chrX	57574769	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	69,80:149:0.5369
chrX	57652845	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	71,70:141:0.4965
chrX	57881947	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs747754539||8.92937e-06|||MODIFIER||||||||0.0003;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	62,76:138:0.5507
chrX	57974892	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs996804590||8.92913e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	82,59:141:0.4184
chrX	58037613	.	C	T	.	PASS	CSQ=|||intergenic_variant||||||8.95263e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	82,73:156:0.4679
chrX	62528774	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1392444416|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	94,34:128:0.2656
chrX	62562133	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1370869116|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	72,63:135:0.4667
chrX	62678911	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	78,68:146:0.4658
chrX	62990853	.	GG	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	98,0:98:0	89,71:161:0.441
chrX	62995648	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	66,59:125:0.472
chrX	63078830	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	142,6:148:0.0405
chrX	63105555	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	60,79:139:0.5683
chrX	63287500	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	173,0:173:0	136,76:212:0.3585
chrX	63323723	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	54,67:121:0.5537
chrX	63382579	.	GA	G	.	PASS	CSQ=|||intergenic_variant||||rs1298484138||0.000765986|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	86,47:134:0.3507
chrX	63403622	.	AAGATT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	63,71:134:0.5299
chrX	63437300	.	G	A	.	PASS	CSQ=92249|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_152611.1:n.265-4809C>T||MODIFIER||||||LINC01278|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	81,60:141:0.4255
chrX	63484581	.	A	C	.	PASS	CSQ=92249|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_152611.1:n.265-52090T>G||MODIFIER||||||LINC01278|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,72:138:0.5217
chrX	63699295	.	A	T	.	PASS	CSQ=23229|protein_coding||intron_variant|||||||NM_001353921.1:c.403-1991T>A||MODIFIER||||||ARHGEF9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	65,65:130:0.5
chrX	63773251	.	T	A	.	PASS	CSQ=23229|protein_coding||intron_variant|||||||NM_001353921.1:c.30+11865A>T||MODIFIER||||||ARHGEF9|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	73,63:136:0.4632
chrX	64173521	.	C	CG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	78,69:147:0.4694
chrX	64214837	.	AG	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	114,0:114:0	54,63:117:0.5385
chrX	64215242	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	66,75:141:0.5319
chrX	64217570	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs971038037|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	64,60:124:0.4839
chrX	64321539	.	GA	AT	.	PASS	CSQ=55613|protein_coding||intron_variant|||||||NM_017677.4:c.1481+7232_1481+7233delinsAT||MODIFIER||||||MTMR8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	118,0:118:0	79,64:143:0.4476
chrX	64333031	.	T	C	.	PASS	CSQ=55613|protein_coding||intron_variant|||||||NM_017677.4:c.1152-1274A>G||MODIFIER||||||MTMR8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	76,62:138:0.4493
chrX	64451420	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	73,71:144:0.4931
chrX	64545961	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	73,57:130:0.4385
chrX	64595370	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	69,73:142:0.5141
chrX	64751895	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	75,75:150:0.5
chrX	65000175	.	A	G	.	PASS	CSQ=55906|protein_coding||intron_variant|||||||NM_001178032.2:c.-272+34454T>C||MODIFIER||||||ZC4H2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	123,5:128:0.0391
chrX	65023499	.	T	TA	.	PASS	CSQ=55906|protein_coding||intron_variant||||rs888736294||0.000279647|NM_001178032.2:c.-272+11129dup||MODIFIER||||||ZC4H2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	64,62:127:0.4882
chrX	65231052	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	70,60:131:0.458
chrX	65451116	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	78,0:78:0	57,75:132:0.5682
chrX	65571813	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1440945728||1.78771e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	86,83:169:0.4911
chrX	65625404	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	129,0:129:0	67,95:162:0.5864
chrX	65631501	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs889319831||8.95472e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	85,66:151:0.4371
chrX	65727490	.	C	T	.	PASS	CSQ=4478|protein_coding||intron_variant|||||||NM_002444.3:c.97-324C>T||MODIFIER||||||MSN|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/MSN|y|n|ALCL|||L|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	136,14:150:0.0933
chrX	65834066	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	68,55:123:0.4472
chrX	65991738	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	79,73:152:0.4803
chrX	65997738	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	73,68:141:0.4823
chrX	66328583	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	78,60:138:0.4348
chrX	66387909	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	53,63:116:0.5431
chrX	66610961	.	G	A	.	PASS	CSQ=60401|protein_coding||intron_variant||||||9.00155e-06|NM_021783.5:c.87+4973C>T||MODIFIER||||||EDA2R|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	54,68:122:0.5574
chrX	66648142	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	108,0:108:0	117,5:122:0.041
chrX	66929754	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	79,0:79:0	48,26:74:0.3514
chrX	67356028	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	74,72:146:0.4932
chrX	67459662	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs1451278206||0.00838519|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	73,61:134:0.4552
chrX	67505962	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	71,66:137:0.4818
chrX	67516143	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	99,66:165:0.4
chrX	67707843	.	G	A	.	PASS	CSQ=367|protein_coding||intron_variant||||rs1160247540|||NM_000044.4:c.1886-3559G>A||MODIFIER||||||AR|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/AR|y|y|prostate|||E|Dom|oncogene|Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	66,63:129:0.4884
chrX	68246042	.	T	A	.	PASS	CSQ=4983|protein_coding||intron_variant|||||||NM_002547.3:c.385-11454A>T||MODIFIER||||||OPHN1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	67,50:117:0.4274
chrX	68528870	.	T	C	.	PASS	CSQ=286451|protein_coding||intron_variant|||||||NM_173834.4:c.593-3011T>C||MODIFIER||||||YIPF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	81,88:169:0.5207
chrX	69077882	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	66,68:134:0.5075
chrX	69274720	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	84,77:161:0.4783
chrX	69453903	.	CATGCTGCTAT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	46,38:84:0.4524
chrX	69997910	.	G	T	.	PASS	CSQ=1896|protein_coding||intron_variant|||||||NM_001399.5:c.503-25308G>T||MODIFIER||||||EDA|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	151,0:151:0	65,79:144:0.5486
chrX	70157936	.	AT	A	.	PASS	CSQ=3476|protein_coding||intron_variant|||||||NM_001551.3:c.871+7615del||MODIFIER||||||IGBP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	142,0:142:0	85,53:138:0.3841
chrX	70320069	.	G	C	.	PASS	CSQ=24137|protein_coding||intron_variant|||||||NM_012310.5:c.779-9336G>C||MODIFIER||||||KIF4A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	85,70:155:0.4516
chrX	70439891	.	G	A	.	PASS	CSQ=1741|protein_coding||upstream_gene_variant||||rs1193176804||3.36101e-05|||MODIFIER||||||DLG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	68,47:115:0.4087
chrX	70455154	.	C	T	.	PASS	CSQ=1741|protein_coding||intron_variant||||rs1417722732||2.70646e-05|NM_021120.4:c.1405+838C>T||MODIFIER||||||DLG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	104,0:104:0	85,87:172:0.5058
chrX	70521993	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	68,72:140:0.5143
chrX	70609852	.	T	TA	.	PASS	CSQ=56159|protein_coding||intron_variant|||||||NM_031276.2:c.1792+650dup||MODIFIER||||||TEX11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	63,54:119:0.4538
chrX	70713661	COSV60227678;COSV60227678;COSV60227678;COSV60227678	G	A	.	PASS	CSQ=56159|protein_coding||intron_variant|COSV60227678&COSV60227678&COSV60227678&COSV60227678|p.?&p.?&p.?&p.?||rs1348016130||9.94737e-05|NM_031276.2:c.1004+8957C>T||MODIFIER||||||TEX11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	70,87:157:0.5541
chrX	70800922	.	C	T	.	PASS	CSQ=56159|protein_coding||intron_variant|||||||NM_031276.2:c.692+5783G>A||MODIFIER||||||TEX11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	79,74:153:0.4837
chrX	70805450	.	G	A	.	PASS	CSQ=56159|protein_coding||intron_variant|||||||NM_031276.2:c.692+1255C>T||MODIFIER||||||TEX11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	68,65:133:0.4887
chrX	70828963	COSV60226662;COSV60226662;COSV60226662	G	GA	.	PASS	CSQ=56159|protein_coding||intron_variant|COSV60226662&COSV60226662&COSV60226662|p.?&p.?&p.?||rs1327504668||0.00016368|NM_031276.2:c.606+4549dup||MODIFIER||||||TEX11|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	85,62:147:0.4218
chrX	71282068	.	C	T	.	PASS	CSQ=4841|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||NONO|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/NONO|y|n|papillary_renal|||E|Dom|fusion|T;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	96,68:164:0.4146
chrX	72364060	.	G	T	.	PASS	CSQ=55869|protein_coding||intron_variant|||||||NM_018486.3:c.1006-12222C>A||MODIFIER||||||HDAC8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,81:155:0.5226
chrX	72738755	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	75,63:138:0.4565
chrX	73043712	.	CAATTG	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,65:134:0.4851
chrX	73384304	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1461162344|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	67,46:113:0.4071
chrX	73433667	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	64,74:138:0.5362
chrX	73582797	.	G	A	.	PASS	CSQ=53344|protein_coding||intron_variant|||||||NM_001039840.3:c.352-1620G>A||MODIFIER||||||CHIC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	51,80:131:0.6107
chrX	73702714	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	80,75:155:0.4839
chrX	73757080	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	68,66:134:0.4925
chrX	73780204	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	89,58:147:0.3946
chrX	73844791	.	G	C	.	PASS	CSQ=7503|lncRNA||non_coding_transcript_exon_variant|||||||NR_001564.2:n.7963C>G||MODIFIER||||||XIST|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	120,0:120:0	86,62:148:0.4189
chrX	74798686	.	T	C	.	PASS	CSQ=340533|protein_coding||intron_variant|||||||NM_001008537.3:c.-47-52989A>G||MODIFIER||||||NEXMIF|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	82,66:148:0.4459
chrX	75598916	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs988260457||4.48712e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	67,67:134:0.5
chrX	75685316	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1167265336||8.97432e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	69,65:134:0.4851
chrX	75692722	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	67,71:138:0.5145
chrX	75771478	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	68,64:132:0.4848
chrX	75921677	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	59,69:128:0.5391
chrX	76202206	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	79,60:139:0.4317
chrX	76245188	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	81,64:145:0.4414
chrX	76477229	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	58,62:120:0.5167
chrX	76784799	.	G	T	.	PASS	CSQ=101928469|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110404.2:n.307-126131C>A||MODIFIER||||||MIR325HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	60,52:112:0.4643
chrX	76903184	.	G	A	.	PASS	CSQ=101928469|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110404.2:n.306+111043C>T||MODIFIER||||||MIR325HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	64,72:136:0.5294
chrX	76941391	.	G	A	.	PASS	CSQ=101928469|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110404.2:n.306+72836C>T||MODIFIER||||||MIR325HG|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	84,72:156:0.4615
chrX	77111873	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1333979713||8.88668e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	90,80:171:0.4678
chrX	77132170	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	109,10:119:0.084
chrX	77194377	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	57,65:122:0.5328
chrX	77364236	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	100,32:132:0.2424
chrX	77414427	.	G	A	.	PASS	CSQ=|||intergenic_variant||||||8.96531e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	65,67:132:0.5076
chrX	77698193	.	A	G	.	PASS	CSQ=546|protein_coding||intron_variant|||||||NM_000489.5:c.189+381T>C||MODIFIER||||||ATRX|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ATRX|y|n|pancreatic_neuroendocrine_tumours,paediatric_GBM|||E|Rec|TSG|Mis,F,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	52,83:135:0.6148
chrX	77703856	.	A	T	.	PASS	CSQ=546|protein_coding||intron_variant|||||||NM_000489.5:c.134-5227T>A||MODIFIER||||||ATRX|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/ATRX|y|n|pancreatic_neuroendocrine_tumours,paediatric_GBM|||E|Rec|TSG|Mis,F,N;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	74,76:150:0.5067
chrX	77884972	.	G	T	.	PASS	CSQ=84061|protein_coding||intron_variant||||rs907782709|||NM_032121.5:c.199-9375C>A||MODIFIER||||||MAGT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	105,0:105:0	109,7:116:0.0603
chrX	77899316	.	CC	GA	.	PASS	CSQ=84061|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||MAGT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	119,0:120:0	76,73:149:0.4899
chrX	77917209	.	G	A	.	PASS	CSQ=538|protein_coding||intron_variant|||||||NM_000052.7:c.-22+6374G>A||MODIFIER||||||ATP7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	89,56:145:0.3862
chrX	77964424	.	C	CT	.	PASS	CSQ=538|protein_coding||intron_variant||||rs1366068646||4.69263e-05|NM_000052.7:c.-21-7187dup||MODIFIER||||||ATP7A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	137,0:137:0	83,66:151:0.4371
chrX	78146813	.	G	T	.	PASS	CSQ=|||intergenic_variant||||||8.93463e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	83,69:152:0.4539
chrX	78622530	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	55,60:115:0.5217
chrX	78827680	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	121,7:128:0.0547
chrX	78975954	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	59,68:127:0.5354
chrX	79241556	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	78,67:145:0.4621
chrX	79344786	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	88,36:124:0.2903
chrX	79390545	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	49,62:111:0.5586
chrX	79455232	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	80,68:148:0.4595
chrX	79600381	.	TT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	114,0:115:0	61,70:131:0.5344
chrX	79725789	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	79,85:164:0.5183
chrX	79808444	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	74,69:143:0.4825
chrX	79860472	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	60,73:133:0.5489
chrX	79999831	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,1:124:0.0081	67,73:140:0.5214
chrX	80167343	.	GC	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	110,0:111:0	59,73:133:0.5489
chrX	80416100	.	C	CT	.	PASS	CSQ=169966|protein_coding||intron_variant||||rs754316479||0.0182431|NM_001170574.1:c.-141-22500dup||MODIFIER||||||FAM46D|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	68,53:121:0.438
chrX	80503215	.	CA	C	.	PASS	CSQ=|||intergenic_variant||||rs1373317746||9.01982e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	79,41:120:0.3417
chrX	80503221	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs1409479839|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	75,41:116:0.3534
chrX	80513661	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1489347735||8.91909e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	75,64:139:0.4604
chrX	80515990	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	69,69:138:0.5
chrX	80545319	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	71,60:131:0.458
chrX	80554713	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	64,58:122:0.4754
chrX	80757186	.	G	A	.	PASS	CSQ=254065|protein_coding||intron_variant|||||||NM_153252.4:c.431-11457C>T||MODIFIER||||||BRWD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	66,81:147:0.551
chrX	80796627	.	C	CA	.	PASS	CSQ=254065|protein_coding||intron_variant||||rs751660111||0.00485737|NM_153252.4:c.181-2856dup||MODIFIER||||||BRWD3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,1:118:0.0085	72,53:125:0.424
chrX	80828273	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:115:0	70,76:147:0.517
chrX	80901183	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	62,60:122:0.4918
chrX	80979199	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	61,63:124:0.5081
chrX	81011006	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	60,70:130:0.5385
chrX	81077346	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	50,0:50:0	49,17:66:0.2576
chrX	81155128	.	T	TAG	.	PASS	CSQ=79366|protein_coding||intron_variant|||||||NM_030763.2:c.-123-33457_-123-33456insCT||MODIFIER||||||HMGN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	60,46:106:0.434
chrX	81205327	.	G	T	.	PASS	CSQ=79366|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||HMGN5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	71,69:140:0.4929
chrX	81459916	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	54,82:136:0.6029
chrX	81598805	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	47,55:102:0.5392
chrX	81626140	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	63,68:131:0.5191
chrX	81679615	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	61,83:144:0.5764
chrX	81760008	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	94,11:105:0.1048
chrX	81859905	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	111,35:146:0.2397
chrX	81891853	.	GT	G	.	PASS	CSQ=|||intergenic_variant||||rs1423950324||2.80628e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	65,50:115:0.4348
chrX	82063211	.	GAGA	G	.	PASS	CSQ=|||intergenic_variant||||rs916438245|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	104,36:140:0.2571
chrX	82082198	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	132,9:141:0.0638
chrX	82119594	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	56,48:104:0.4615
chrX	82170067	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	134,11:145:0.0759
chrX	82213463	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	65,71:136:0.5221
chrX	82232392	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	84,67:151:0.4437
chrX	82379641	.	AG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	95,0:96:0	64,55:119:0.4622
chrX	82410686	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	72,55:127:0.4331
chrX	82514115	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs949832338||9.01437e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	63,73:136:0.5368
chrX	82548716	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:95:0	64,56:120:0.4667
chrX	82630063	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	81,79:160:0.4938
chrX	82750082	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	79,66:145:0.4552
chrX	82896257	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	84,54:138:0.3913
chrX	83047768	.	CT	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	136,0:137:0	69,71:140:0.5071
chrX	83091702	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1426660861||8.99402e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	84,81:165:0.4909
chrX	83127829	.	CT	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	104,0:104:0	62,65:127:0.5118
chrX	83326784	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	66,51:117:0.4359
chrX	83692008	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	52,0:52:0	20,25:45:0.5556
chrX	83865003	.	G	A	.	PASS	CSQ=1538|protein_coding||intron_variant|||||||NM_021118.2:c.17+3804G>A||MODIFIER||||||CYLC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	70,59:129:0.4574
chrX	84122426	.	G	T	.	PASS	CSQ=27330|protein_coding||intron_variant|||||||NM_014496.5:c.647-2399C>A||MODIFIER||||||RPS6KA6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,37:101:0.3663
chrX	84225021	.	G	A	.	PASS	CSQ=100302191|miRNA||downstream_gene_variant|||||||||MODIFIER||||||MIR548I4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	66,56:122:0.459
chrX	84235485	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:117:0	56,75:131:0.5725
chrX	84447360	.	G	A	.	PASS	CSQ=139324|protein_coding||intron_variant|||||||NM_001177479.2:c.1252-6775C>T||MODIFIER||||||HDX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	67,54:121:0.4463
chrX	84674649	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	58,63:121:0.5207
chrX	84971755	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	64,81:145:0.5586
chrX	84986776	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	78,89:167:0.5329
chrX	85288089	.	A	AT	.	PASS	CSQ=79983|protein_coding||intron_variant|||||||NM_024921.4:c.1650-5773dup||MODIFIER||||||POF1B|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	64,57:121:0.4711
chrX	85647024	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	72,65:137:0.4745
chrX	85649901	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	64,63:127:0.4961
chrX	85718655	.	CA	TT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	121,0:122:0	56,70:126:0.5556
chrX	85935029	.	G	A	.	PASS	CSQ=1121|protein_coding||intron_variant||||rs188058199||8.93975e-06|NM_000390.4:c.1166+21124C>T||MODIFIER||||||CHM|EntrezGene|0.0003;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	60,48:108:0.4444
chrX	85948808	.	G	A	.	PASS	CSQ=1121|protein_coding||intron_variant|||||||NM_000390.4:c.1166+7345C>T||MODIFIER||||||CHM|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	73,73:146:0.5
chrX	86114488	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	65,84:149:0.5638
chrX	86340447	.	G	A	.	PASS	CSQ=117154|protein_coding||intron_variant||||rs915745252||8.99491e-06|NM_053281.3:c.489-36377G>A||MODIFIER||||||DACH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	56,71:127:0.5591
chrX	86435085	.	C	A	.	PASS	CSQ=117154|protein_coding||intron_variant|||||||NM_053281.3:c.527+58223C>A||MODIFIER||||||DACH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	61,81:142:0.5704
chrX	86542822	.	C	T	.	PASS	CSQ=117154|protein_coding||intron_variant|||||||NM_053281.3:c.640+28431C>T||MODIFIER||||||DACH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	66,74:140:0.5286
chrX	86622420	.	T	A	.	PASS	CSQ=117154|protein_coding||intron_variant|||||||NM_053281.3:c.641-28616T>A||MODIFIER||||||DACH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,1:103:0.0097	72,57:129:0.4419
chrX	86653581	.	G	T	.	PASS	CSQ=117154|protein_coding||intron_variant|||||||NM_053281.3:c.772+2414G>T||MODIFIER||||||DACH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	61,64:125:0.512
chrX	86738652	.	T	G	.	PASS	CSQ=117154|protein_coding||intron_variant|||||||NM_053281.3:c.1105-1095T>G||MODIFIER||||||DACH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	57,54:111:0.4865
chrX	86869304	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	58,65:123:0.5285
chrX	86914625	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	65,57:122:0.4672
chrX	87033197	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	139,0:139:0	76,60:137:0.438
chrX	87035265	.	GT	TG	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	103,0:103:0	61,67:128:0.5234
chrX	87083590	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	60,66:126:0.5238
chrX	87101690	.	G	GA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	66,63:129:0.4884
chrX	87244217	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	61,59:120:0.4917
chrX	87310138	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	69,53:122:0.4344
chrX	87319226	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	76,68:144:0.4722
chrX	87319918	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	70,74:144:0.5139
chrX	87359688	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	51,50:101:0.495
chrX	87364922	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	68,52:120:0.4333
chrX	87551898	.	C	A	.	PASS	CSQ=56062|protein_coding||intron_variant|||||||NM_019117.5:c.422+33583C>A||MODIFIER||||||KLHL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	71,79:150:0.5267
chrX	87813308	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	127,6:133:0.0451
chrX	87836334	COSV61985220	C	A	.	PASS	CSQ=|||intergenic_variant|||COSV61985220|||8.97094e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:126:0	130,5:135:0.037
chrX	87847459	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	61,76:137:0.5547
chrX	87981132	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	84,43:127:0.3386
chrX	88011844	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	75,67:142:0.4718
chrX	88222222	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	79,73:152:0.4803
chrX	88277691	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	121,4:125:0.032
chrX	88400018	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	69,61:130:0.4692
chrX	88443621	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	120,0:120:0	61,62:123:0.5041
chrX	88493431	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	51,65:116:0.5603
chrX	88731431	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	50,59:109:0.5413
chrX	88870919	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:128:0	59,62:121:0.5124
chrX	88948202	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	62,62:124:0.5
chrX	88982538	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	65,77:142:0.5423
chrX	89013558	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	113,28:141:0.1986
chrX	89149844	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	79,69:148:0.4662
chrX	89339117	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	76,51:127:0.4016
chrX	89382441	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	61,70:131:0.5344
chrX	89451677	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	60,69:129:0.5349
chrX	89509258	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	69,57:126:0.4524
chrX	89582909	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	47,49:96:0.5104
chrX	89635370	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,1:100:0.01	60,70:130:0.5385
chrX	89636737	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	63,43:106:0.4057
chrX	89720807	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	53,61:114:0.5351
chrX	89729220	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	88,56:144:0.3889
chrX	90038562	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	65,61:126:0.4841
chrX	90221409	.	GAGTTTGTTGTAAGGTTGAGGATTTCTGTATGCATTGGGA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	92,22:114:0.193
chrX	90263260	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	60,67:127:0.5276
chrX	90266918	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	67,60:127:0.4724
chrX	90372463	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	115,14:129:0.1085
chrX	90375055	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	106,17:123:0.1382
chrX	90430522	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	77,66:143:0.4615
chrX	90708375	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	51,97:148:0.6554
chrX	90918814	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	54,56:110:0.5091
chrX	90950159	.	TG	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	144,0:144:0	73,99:172:0.5756
chrX	90973668	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	87,0:87:0	43,85:128:0.6641
chrX	90987712	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	47,108:155:0.6968
chrX	91040013	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	102,62:164:0.378
chrX	91054013	.	AATAAAGACC	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	145,6:151:0.0397
chrX	91066608	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	75,110:185:0.5946
chrX	91080326	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	61,112:173:0.6474
chrX	91089339	.	GT	G	.	PASS	CSQ=|||intergenic_variant||||rs1456863824||0.000614331|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:113:0	84,62:146:0.4247
chrX	91175781	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	109,83:192:0.4323
chrX	91210878	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	75,100:175:0.5714
chrX	91325013	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	108,68:176:0.3864
chrX	91352694	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	109,60:169:0.355
chrX	91587325	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1439453007|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	43,75:118:0.6356
chrX	91858919	.	C	T	.	PASS	CSQ=27328|protein_coding||intron_variant|||||||NM_032968.4:c.541-17862C>T||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	130,59:191:0.3089
chrX	91863498	.	G	A	.	PASS	CSQ=27328|protein_coding||intron_variant|||||||NM_032968.4:c.541-13283G>A||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	80,105:185:0.5676
chrX	91949942	.	G	A	.	PASS	CSQ=27328|protein_coding||intron_variant|||||||NM_032968.4:c.3033+70669G>A||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	80,46:126:0.3651
chrX	91984618	.	G	A	.	PASS	CSQ=27328|protein_coding||intron_variant|||||||NM_032968.4:c.3033+105345G>A||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	66,86:152:0.5658
chrX	92125865	.	G	A	.	PASS	CSQ=27328|protein_coding||intron_variant||||rs1376295416|||NM_032968.4:c.3034-75510G>A||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:94:0	54,79:133:0.594
chrX	92222776	.	CT	AA	.	PASS	CSQ=27328|protein_coding||intron_variant|||||||NM_032968.4:c.3114+21321_3114+21322delinsAA||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	116,0:116:0	109,56:165:0.3394
chrX	92306163	.	G	A	.	PASS	CSQ=27328|protein_coding||intron_variant|||||||NM_032968.4:c.3144+43020G>A||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	109,59:168:0.3512
chrX	92347094	.	T	C	.	PASS	CSQ=27328|protein_coding||intron_variant|||||||NM_032968.4:c.3145-40641T>C||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	53,101:154:0.6558
chrX	92411612	.	CT	C	.	PASS	CSQ=27328|protein_coding||intron_variant||||rs1295318045||0.000338589|NM_032968.4:c.3343+23687del||MODIFIER||||||PCDH11X|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,0:74:0	56,69:125:0.552
chrX	92821335	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	56,93:149:0.6242
chrX	92839809	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	66,94:160:0.5875
chrX	92991239	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	64,128:192:0.6667
chrX	93000687	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	55,92:147:0.6259
chrX	93297456	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	82,92:174:0.5287
chrX	93500313	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	65,99:164:0.6037
chrX	93665386	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	63,136:199:0.6834
chrX	93678214	.	G	C	.	PASS	CSQ=286499|protein_coding||intron_variant|||||||NM_001171109.1:c.-193+3462G>C||MODIFIER||||||FAM133A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	118,73:191:0.3822
chrX	93678383	.	A	T	.	PASS	CSQ=286499|protein_coding||intron_variant|||||||NM_001171109.1:c.-193+3631A>T||MODIFIER||||||FAM133A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	114,61:175:0.3486
chrX	93821214	.	C	A	.	PASS	CSQ=|||intergenic_variant||||||8.9744e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	106,68:174:0.3908
chrX	93858287	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	70,116:186:0.6237
chrX	94273929	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	55,88:143:0.6154
chrX	94384103	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1196183578||8.99734e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	64,118:182:0.6484
chrX	94388900	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	66,112:178:0.6292
chrX	94503563	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	68,88:156:0.5641
chrX	94741879	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	77,96:173:0.5549
chrX	94751862	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	97,65:162:0.4012
chrX	94857173	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	111,56:167:0.3353
chrX	95023743	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	62,101:163:0.6196
chrX	95246721	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	52,58:110:0.5273
chrX	95281301	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	116,10:126:0.0794
chrX	95518296	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	114,0:114:0	125,6:131:0.0458
chrX	95574746	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	143,6:149:0.0403
chrX	95665279	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:116:0	65,47:112:0.4196
chrX	95905274	.	GCCA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	52,53:105:0.5048
chrX	96006559	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	65,73:138:0.529
chrX	96454849	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	70,47:117:0.4017
chrX	97257821	.	C	T	.	PASS	CSQ=1730|protein_coding||intron_variant|||||||NM_006729.5:c.2844+9982C>T||MODIFIER||||||DIAPH2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	67,65:132:0.4924
chrX	97535615	.	C	A	.	PASS	CSQ=10824|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_125391.1:n.157-2186G>T||MODIFIER||||||DIAPH2-AS1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	122,6:128:0.0469
chrX	97987426	.	T	TA	.	PASS	CSQ=|||intergenic_variant||||rs1056291586||0.000611654|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	69,50:120:0.4167
chrX	98123152	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	87,57:144:0.3958
chrX	98160522	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	115,5:120:0.0417
chrX	98251063	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:132:0	44,63:107:0.5888
chrX	98376285	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	69,66:135:0.4889
chrX	98612256	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	62,46:108:0.4259
chrX	98751433	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	75,62:137:0.4526
chrX	98774087	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	68,53:121:0.438
chrX	98934097	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:122:0	109,8:117:0.0684
chrX	99116840	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	114,4:118:0.0339
chrX	99321706	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	50,73:123:0.5935
chrX	99377007	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	58,63:121:0.5207
chrX	99667661	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	61,68:129:0.5271
chrX	99719511	.	C	CT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	128,0:128:0	61,62:123:0.5041
chrX	99754876	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	55,64:119:0.5378
chrX	99876801	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	81,48:129:0.3721
chrX	99894155	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	58,67:125:0.536
chrX	100026102	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	64,83:147:0.5646
chrX	100037934	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	51,77:128:0.6016
chrX	100038068	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	59,79:138:0.5725
chrX	100177636	.	GA	G	.	PASS	CSQ=|||intergenic_variant||||rs1352785244||0.000118411|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	69,47:116:0.4052
chrX	100200160	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	56,51:107:0.4766
chrX	100779506	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	82,58:140:0.4143
chrX	101257645	.	GA	G	.	PASS	CSQ=1821|protein_coding||intron_variant||||rs1284750395||0.000819186|NM_001939.2:c.2391-651del||MODIFIER||||||DRP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	62,45:108:0.4167
chrX	101947569	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	67,54:121:0.4463
chrX	102020189	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	60,65:125:0.52
chrX	102072096	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:109:0	70,41:111:0.3694
chrX	102143164	.	G	C	.	PASS	CSQ=158931|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||TCEAL6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	71,49:120:0.4083
chrX	102489838	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1440955197||1.79186e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	107,5:112:0.0446
chrX	102700029	.	C	T	.	PASS	CSQ=100528062|misc_RNA||intron_variant&non_coding_transcript_variant||||rs991762501||3.59534e-05|NR_146584.1:n.667-13753C>T||MODIFIER||||||ARMCX5-GPRASP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	78,69:147:0.4694
chrX	102804696	.	C	T	.	PASS	CSQ=100528062|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_146584.1:n.1236-21297C>T||MODIFIER||||||ARMCX5-GPRASP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	63,61:124:0.4919
chrX	102849843	.	G	A	.	PASS	CSQ=100528062|misc_RNA||intron_variant&non_coding_transcript_variant|||||||NR_146584.1:n.1924+3823G>A||MODIFIER||||||ARMCX5-GPRASP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	98,12:110:0.1091
chrX	102954330	.	G	T	.	PASS	CSQ=100287765|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146589.1:n.1910-4318G>T||MODIFIER||||||LINC00630|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	56,91:147:0.619
chrX	102959070	.	C	T	.	PASS	CSQ=100287765|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_146589.1:n.1963+369C>T||MODIFIER||||||LINC00630|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	110,12:122:0.0984
chrX	103114045	.	T	C	.	PASS	CSQ=|||intergenic_variant||||rs1235817237|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	71,49:120:0.4083
chrX	103305578	.	C	G	.	PASS	CSQ=84707|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||BEX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	68,56:124:0.4516
chrX	103528948	.	A	G	.	PASS	CSQ=105373300|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LOC105373300|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	77,48:125:0.384
chrX	104011456	.	C	G	.	PASS	CSQ=158983|protein_coding||3_prime_UTR_variant|||||||NM_001002916.4:c.*30G>C||MODIFIER||||||H2BFWT|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	106,0:106:0	63,73:136:0.5368
chrX	104022048	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	76,68:144:0.4722
chrX	104145888	.	G	C	.	PASS	CSQ=401612|protein_coding||intron_variant|||||||NM_001012755.5:c.-32+10990C>G||MODIFIER||||||SLC25A53|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	54,83:137:0.6058
chrX	105214870	.	A	C	.	PASS	CSQ=56157|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||TEX13A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	129,6:135:0.0444
chrX	105223083	.	G	C	.	PASS	CSQ=26280|protein_coding||intron_variant|||||||NM_017416.1:c.357-10735G>C||MODIFIER||||||IL1RAPL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	66,53:119:0.4454
chrX	105292141	.	C	T	.	PASS	CSQ=26280|protein_coding||intron_variant|||||||NM_017416.1:c.697+24600C>T||MODIFIER||||||IL1RAPL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	72,65:137:0.4745
chrX	105472852	.	A	T	.	PASS	CSQ=26280|protein_coding||intron_variant|||||||NM_017416.1:c.698-11461A>T||MODIFIER||||||IL1RAPL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	74,68:142:0.4789
chrX	105489926	.	C	G	.	PASS	CSQ=26280|protein_coding||intron_variant|||||||NM_017416.1:c.772+5539C>G||MODIFIER||||||IL1RAPL2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	47,49:96:0.5104
chrX	105877281	.	G	A	.	PASS	CSQ=203447|protein_coding||intron_variant|||||||NM_198465.4:c.124-2918G>A||MODIFIER||||||NRK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	67,83:150:0.5533
chrX	105914397	.	A	G	.	PASS	CSQ=203447|protein_coding||intron_variant|||||||NM_198465.4:c.2350-1333A>G||MODIFIER||||||NRK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	51,75:126:0.5952
chrX	105947368	.	G	A	.	PASS	CSQ=203447|protein_coding||intron_variant||||||1.80099e-05|NM_198465.4:c.4353+904G>A||MODIFIER||||||NRK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	75,48:123:0.3902
chrX	105952844	.	A	T	.	PASS	CSQ=203447|protein_coding||intron_variant|||||||NM_198465.4:c.4514-190A>T||MODIFIER||||||NRK|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:106:0	49,73:122:0.5984
chrX	106359112	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1203537264||9.10067e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	64,63:127:0.4961
chrX	106745729	.	G	A	.	PASS	CSQ=79589|protein_coding||intron_variant||||||8.95231e-06|NM_194463.2:c.484+18332G>A||MODIFIER||||||RNF128|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	76,60:136:0.4412
chrX	106891977	.	G	C	.	PASS	CSQ=|||intergenic_variant||||||1.78461e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	78,54:132:0.4091
chrX	107020089	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	148,0:148:0	79,93:172:0.5407
chrX	107031721	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	82,50:132:0.3788
chrX	107340315	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	74,55:129:0.4264
chrX	107466620	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	90,57:147:0.3878
chrX	107667252	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	68,67:135:0.4963
chrX	107678819	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	77,70:147:0.4762
chrX	107755493	.	C	T	.	PASS	CSQ=1831|protein_coding||intron_variant||||rs1435212868||8.88328e-06|NM_198057.2:c.320+19607G>A||MODIFIER||||||TSC22D3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	97,68:165:0.4121
chrX	108179106	.	TAAC	T	.	PASS	CSQ=1288|protein_coding||intron_variant|||||||NM_001847.3:c.2356+108_2356+110del||MODIFIER||||||COL4A6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	66,82:148:0.5541
chrX	108179110	.	C	T	.	PASS	CSQ=1288|protein_coding||intron_variant|||||||NM_001847.3:c.2356+107G>A||MODIFIER||||||COL4A6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	67,84:151:0.5563
chrX	108219895	.	G	A	.	PASS	CSQ=1288|protein_coding||intron_variant||||rs781240134||1.81585e-05|NM_001847.3:c.283-153C>T||MODIFIER||||||COL4A6|EntrezGene|0.0000;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	81,58:139:0.4173
chrX	108575571	.	G	A	.	PASS	CSQ=1287|protein_coding||intron_variant|||||||NM_033380.2:c.547-339G>A||MODIFIER||||||COL4A5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	60,78:138:0.5652
chrX	109108378	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	57,75:132:0.5682
chrX	109147382	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	93,49:142:0.3451
chrX	109187671	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs768421385||4.48302e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	64,66:130:0.5077
chrX	109530693	COSV51348911	C	CT	.	PASS	CSQ=|||intergenic_variant|||COSV51348911|rs1337624274|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	75,63:138:0.4565
chrX	109608032	COSV51088361	G	GA	.	PASS	CSQ=|||intergenic_variant|||COSV51088361|rs1232600866||0.000360737|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	44,71:116:0.6121
chrX	109672641	.	G	GT	.	PASS	CSQ=2182|protein_coding||intron_variant||||rs1229048123||0.000367682|NM_001318510.1:c.1002+1760dup||MODIFIER||||||ACSL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	91,51:142:0.3592
chrX	109822652	.	ACAGCATGTATGGCTGGTTAGTT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	68,62:130:0.4769
chrX	109901437	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1225546224||1.76991e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	100,66:166:0.3976
chrX	109962944	.	G	GT	.	PASS	CSQ=|||intergenic_variant||||rs778985366||2.71523e-05|||MODIFIER||||||||0.0005;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	79,54:133:0.406
chrX	110240907	.	T	G	.	PASS	CSQ=9949|protein_coding||intron_variant||||rs935201159||8.9273e-06|NM_015365.3:c.584+23582A>C||MODIFIER||||||AMMECR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	69,81:150:0.54
chrX	110314820	.	TC	AA	.	PASS	CSQ=9949|protein_coding||intron_variant|||||||NM_015365.3:c.473+2778_473+2779delinsTT||MODIFIER||||||AMMECR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	109,0:109:0	62,62:124:0.5
chrX	110380711	.	G	A	.	PASS	CSQ=9949|protein_coding||intron_variant|||||||NM_001171689.1:c.-148+45947C>T||MODIFIER||||||AMMECR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	56,94:150:0.6267
chrX	110695431	.	C	T	.	PASS	CSQ=91851|protein_coding||intron_variant|||||||NM_001143981.1:c.610-1100G>A||MODIFIER||||||CHRDL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	87,62:149:0.4161
chrX	110799509	.	G	T	.	PASS	CSQ=91851|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||CHRDL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	71,59:130:0.4538
chrX	110860216	.	G	GA	.	PASS	CSQ=|||intergenic_variant||||rs777214267||2.70609e-05|||MODIFIER||||||||0.0003;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	83,43:126:0.3413
chrX	111049407	.	C	T	.	PASS	CSQ=5063|protein_coding||intron_variant|||||||NM_001128166.2:c.-28+35507C>T||MODIFIER||||||PAK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	55,74:129:0.5736
chrX	111091883	.	C	CT	.	PASS	CSQ=5063|protein_coding||upstream_gene_variant||||rs1429711553||6.34794e-05|||MODIFIER||||||PAK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	125,0:125:0	116,12:128:0.0938
chrX	111092756	.	G	A	.	PASS	CSQ=5063|protein_coding||upstream_gene_variant||||rs1258294694||8.92427e-06|||MODIFIER||||||PAK3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:107:0	60,65:125:0.52
chrX	111267316	.	G	A	.	PASS	CSQ=827|protein_coding||intron_variant|||||||NM_014289.4:c.-16+3055C>T||MODIFIER||||||CAPN6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	113,6:119:0.0504
chrX	111317352	.	C	T	.	PASS	CSQ=1641|protein_coding||intron_variant|||||||NM_178152.2:c.947-4616G>A||MODIFIER||||||DCX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	59,57:116:0.4914
chrX	111404485	.	G	A	.	PASS	CSQ=1641|protein_coding||intron_variant||||rs1286099777||1.78551e-05|NM_178152.2:c.365-3155C>T||MODIFIER||||||DCX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	51,67:118:0.5678
chrX	111525142	.	G	T	.	PASS	CSQ=401613|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||SERTM2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	61,43:104:0.4135
chrX	111855556	.	G	A	.	PASS	CSQ=7224|protein_coding||intron_variant||||rs1188504482|||NM_012471.2:c.901-1450C>T||MODIFIER||||||TRPC5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	63,73:136:0.5368
chrX	111963045	.	C	T	.	PASS	CSQ=7224|protein_coding||intron_variant||||rs899610366||0.000107014|NM_012471.2:c.-21-10604G>A||MODIFIER||||||TRPC5|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	86,56:142:0.3944
chrX	112116569	.	A	T	.	PASS	CSQ=340595|protein_coding||intron_variant|||||||NM_001004308.2:c.-348-14414A>T||MODIFIER||||||RTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	61,73:135:0.5407
chrX	112280945	.	GC	G	.	PASS	CSQ=340595|protein_coding||intron_variant|||||||NM_001004308.2:c.-230+149845del||MODIFIER||||||RTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	73,81:154:0.526
chrX	112302192	COSV66599839	C	T	.	PASS	CSQ=340595|protein_coding||intron_variant|||COSV66599839|rs191754088||0.00505837|NM_001004308.2:c.-229-152308C>T||MODIFIER||||||RTL4|EntrezGene|0.0056;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	55,51:106:0.4811
chrX	112373280	.	G	A	.	PASS	CSQ=340595|protein_coding||intron_variant|||||||NM_001004308.2:c.-229-81220G>A||MODIFIER||||||RTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	75,54:129:0.4186
chrX	112427108	.	A	T	.	PASS	CSQ=340595|protein_coding||intron_variant|||||||NM_001004308.2:c.-229-27392A>T||MODIFIER||||||RTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	62,49:111:0.4414
chrX	112428183	.	T	A	.	PASS	CSQ=340595|protein_coding||intron_variant|||||||NM_001004308.2:c.-229-26317T>A||MODIFIER||||||RTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	66,48:114:0.4211
chrX	112445337	.	C	A	.	PASS	CSQ=340595|protein_coding||intron_variant|||||||NM_001004308.2:c.-229-9163C>A||MODIFIER||||||RTL4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	67,52:119:0.437
chrX	112527354	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	66,74:140:0.5286
chrX	112595863	.	C	G	.	PASS	CSQ=|||intergenic_variant||||rs1248214564||8.97449e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	84,55:139:0.3957
chrX	112630123	.	G	T	.	PASS	CSQ=340596|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||LHFPL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	69,77:146:0.5274
chrX	113105924	.	G	A	.	PASS	CSQ=101928437|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110399.2:n.116-6026G>A||MODIFIER||||||LOC101928437|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	74,51:125:0.408
chrX	113430093	.	A	T	.	PASS	CSQ=101928437|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110399.2:n.232-87080A>T||MODIFIER||||||LOC101928437|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	62,63:125:0.504
chrX	113432286	.	G	A	.	PASS	CSQ=101928437|lncRNA||intron_variant&non_coding_transcript_variant||||rs1314019461||8.96708e-06|NR_110399.2:n.232-84887G>A||MODIFIER||||||LOC101928437|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	51,90:141:0.6383
chrX	113549751	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	58,76:134:0.5672
chrX	113847007	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	141,8:149:0.0537
chrX	113944882	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	62,0:62:0	26,39:65:0.6
chrX	113954517	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	56,80:136:0.5882
chrX	114032201	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	69,62:131:0.4733
chrX	114107234	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	70,57:127:0.4488
chrX	114708566	.	G	T	.	PASS	CSQ=3358|protein_coding||intron_variant|||||||NM_000868.3:c.-79-18292G>T||MODIFIER||||||HTR2C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	70,75:145:0.5172
chrX	114956189	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	63,51:114:0.4474
chrX	115274236	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	81,61:142:0.4296
chrX	115491335	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	52,75:127:0.5906
chrX	115669390	.	GC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	76,49:125:0.392
chrX	115913201	.	C	CA	.	PASS	CSQ=642776|lncRNA||intron_variant&non_coding_transcript_variant||||rs200273453||0.0495807|NR_132337.1:n.151+55759dup||MODIFIER||||||DANT2|EntrezGene|0.0522;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,1:92:0.0109	70,59:130:0.4538
chrX	115985452	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	65,72:137:0.5255
chrX	116090448	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	72,69:141:0.4894
chrX	116532835	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	61,66:127:0.5197
chrX	116777884	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1483956317||9.28255e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	42,57:99:0.5758
chrX	116825562	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs1029360221||8.98561e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	60,56:116:0.4828
chrX	117075729	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,1:123:0.0081	86,27:113:0.2389
chrX	117149631	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	69,60:129:0.4651
chrX	117263247	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	73,61:134:0.4552
chrX	117513569	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:132:0	48,56:104:0.5385
chrX	117575435	.	CT	C	.	PASS	CSQ=|||intergenic_variant||||rs1164084334||0.000967471|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	70,52:123:0.4228
chrX	117879271	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	87,72:159:0.4528
chrX	117942469	.	C	T	.	PASS	CSQ=90293|protein_coding||intron_variant|||||||NM_033495.3:c.240+2965G>A||MODIFIER||||||KLHL13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	68,68:136:0.5
chrX	117964206	.	T	A	.	PASS	CSQ=90293|protein_coding||intron_variant||||rs1036376191||0.000183174|NM_033495.3:c.98+8525A>T||MODIFIER||||||KLHL13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	57,68:125:0.544
chrX	118048943	.	T	A	.	PASS	CSQ=90293|protein_coding||intron_variant|||||||NM_001168301.1:c.-24-20446A>T||MODIFIER||||||KLHL13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	105,6:111:0.0541
chrX	118372115	.	C	A	.	PASS	CSQ=54521|protein_coding||intron_variant||||rs763991942|||NM_019045.5:c.78-6304C>A||MODIFIER||||||WDR44|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	70,65:135:0.4815
chrX	118378871	.	T	TA	.	PASS	CSQ=54521|protein_coding||intron_variant||||rs541856981||0.133648|NM_019045.5:c.111+432dup||MODIFIER||||||WDR44|EntrezGene|0.1754;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,1:96:0.0104	66,40:106:0.3774
chrX	119052151	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	44,55:99:0.5556
chrX	119229388	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,1:111:0.009	83,57:140:0.4071
chrX	119283189	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs773078482||0.000537533|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	76,75:151:0.4967
chrX	119319409	.	T	A	.	PASS	CSQ=101928336|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_110396.1:n.94-5496T>A||MODIFIER||||||LOC101928336|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	71,60:132:0.4545
chrX	119407797	.	AC	A	.	PASS	CSQ=203427|protein_coding||intron_variant|||||||NM_145305.3:c.517+1098del||MODIFIER||||||SLC25A43|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	47,67:114:0.5877
chrX	119513423	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	87,49:136:0.3603
chrX	119729078	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	71,70:141:0.4965
chrX	119979951	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	85,66:151:0.4371
chrX	120344608	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1037415992||5.3158e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	66,90:156:0.5769
chrX	120459066	.	C	T	.	PASS	CSQ=3920|protein_coding||intron_variant|||||||NM_002294.2:c.65-2297G>A||MODIFIER||||||LAMP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	134,8:142:0.0563
chrX	120509550	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	63,0:63:0	0,52:52:1
chrX	120639432	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs953881370||0.000898992|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	68,37:105:0.3524
chrX	120656604	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,1:117:0.0085	49,59:108:0.5463
chrX	121003746	.	A	AT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	79,53:132:0.4015
chrX	121037077	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	51,81:132:0.6136
chrX	121095347	.	GTGGATC	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	59,79:138:0.5725
chrX	121102809	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	50,73:123:0.5935
chrX	121169937	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	79,57:136:0.4191
chrX	121637101	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	119,6:125:0.048
chrX	121660668	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs927444005||0.000143265|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	54,63:117:0.5385
chrX	121716332	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	48,72:120:0.6
chrX	121720175	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1358308488||9.04552e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	66,53:119:0.4454
chrX	121768980	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	69,43:112:0.3839
chrX	121824884	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	64,59:123:0.4797
chrX	122111126	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	43,55:98:0.5612
chrX	122220524	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	73,46:119:0.3866
chrX	122244111	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	70,53:123:0.4309
chrX	122330719	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs1433297514||1.80382e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	74,57:131:0.4351
chrX	122351898	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	43,79:122:0.6475
chrX	122383775	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	72,68:140:0.4857
chrX	122392510	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	63,57:120:0.475
chrX	122524308	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	47,63:110:0.5727
chrX	122700472	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs1256565419||0.00044261|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,0:137:0	73,54:127:0.4252
chrX	123006414	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	51,73:124:0.5887
chrX	123130103	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	57,67:124:0.5403
chrX	123274207	.	T	A	.	PASS	CSQ=2892|protein_coding||intron_variant|||||||NM_007325.4:c.508+20665T>A||MODIFIER||||||GRIA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	75,49:124:0.3952
chrX	123503348	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	61,82:143:0.5734
chrX	123503362	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	67,88:155:0.5677
chrX	123812317	.	C	CA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	69,33:102:0.3235
chrX	123812318	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	66,31:97:0.3196
chrX	123887835	.	T	A	.	PASS	CSQ=331|protein_coding||intron_variant|||||||NM_001167.3:c.878-784T>A||MODIFIER||||||XIAP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	107,0:107:0	78,40:118:0.339
chrX	123902204	.	G	C	.	PASS	CSQ=331|protein_coding||intron_variant|||||||NM_001167.3:c.1300+1511G>C||MODIFIER||||||XIAP|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	68,82:150:0.5467
chrX	124135235	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	65,50:115:0.4348
chrX	124199918	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	49,83:132:0.6288
chrX	124318591	.	GACCTCA	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	40,75:115:0.6522
chrX	124365382	.	C	G	.	PASS	CSQ=4068|protein_coding||intron_variant|||||||NM_002351.4:c.138-379C>G||MODIFIER||||||SH2D1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	79,49:128:0.3828
chrX	124368712	.	G	A	.	PASS	CSQ=4068|protein_coding||intron_variant|||||||NM_002351.4:c.202-1464G>A||MODIFIER||||||SH2D1A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	79,63:142:0.4437
chrX	124414889	.	T	C	.	PASS	CSQ=10178|protein_coding||intron_variant|||||||NM_014253.3:c.4961+5422A>G||MODIFIER||||||TENM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,1:126:0.0079	91,54:145:0.3724
chrX	124676672	.	T	G	.	PASS	CSQ=10178|protein_coding||intron_variant|||||||NM_014253.3:c.1016-4837A>C||MODIFIER||||||TENM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,1:86:0.0116	80,32:112:0.2857
chrX	124757241	.	C	T	.	PASS	CSQ=10178|protein_coding||intron_variant|||||||NM_014253.3:c.536-20044G>A||MODIFIER||||||TENM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	121,7:128:0.0547
chrX	124829238	.	A	G	.	PASS	CSQ=10178|protein_coding||intron_variant|||||||NM_014253.3:c.535+65058T>C||MODIFIER||||||TENM1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,1:117:0.0085	69,45:114:0.3947
chrX	125272413	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	42,0:42:0	86,33:119:0.2773
chrX	125415146	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	49,70:119:0.5882
chrX	125442179	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1024033813|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	70,53:123:0.4309
chrX	125491573	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	75,57:132:0.4318
chrX	125510300	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	132,5:137:0.0365
chrX	125714591	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||||8.96371e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	51,61:112:0.5446
chrX	125822005	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	44,65:109:0.5963
chrX	125917940	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1327259067||8.95464e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	74,53:127:0.4173
chrX	125955173	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	66,50:116:0.431
chrX	126065208	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1489040464||3.57462e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	70,65:135:0.4815
chrX	126092312	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,1:107:0.0093	64,69:133:0.5188
chrX	126136148	.	A	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	63,45:108:0.4167
chrX	126201622	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	66,52:118:0.4407
chrX	126210270	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1006161889|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	75,0:75:0	37,28:65:0.4308
chrX	126383749	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	51,68:119:0.5714
chrX	126581182	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	67,55:122:0.4508
chrX	126862147	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	40,57:97:0.5876
chrX	126888349	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	76,43:119:0.3613
chrX	126895953	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs191508843||8.9214e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	60,63:123:0.5122
chrX	127024212	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	57,80:137:0.5839
chrX	127075912	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	48,48:96:0.5
chrX	127230343	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	61,41:102:0.402
chrX	127253849	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1342347314||1.7865e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	80,64:144:0.4444
chrX	127274863	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1231565817||6.56008e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	77,0:77:0	33,55:88:0.625
chrX	127571493	.	TA	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	36,65:101:0.6436
chrX	127705862	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs778253914||0.000117529|||MODIFIER||||||||0.0016;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	72,59:131:0.4504
chrX	127764929	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	61,64:125:0.512
chrX	127809652	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	89,0:89:0	41,55:96:0.5729
chrX	127823473	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	52,60:112:0.5357
chrX	127942196	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	60,48:108:0.4444
chrX	128093690	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs907719501||1.81457e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	64,57:121:0.4711
chrX	128303746	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	54,78:132:0.5909
chrX	128304901	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	88,28:116:0.2414
chrX	128305676	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	107,32:139:0.2302
chrX	128328030	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	38,48:86:0.5581
chrX	128440748	.	T	TAAATA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	99,0:99:0	76,50:126:0.3968
chrX	128440750	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs866737929||0.000767607|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	101,0:102:0	79,49:128:0.3828
chrX	128440752	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs370816540|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	105,1:106:0.0094	79,53:132:0.4015
chrX	128689224	.	AT	TA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	111,0:111:0	76,58:134:0.4328
chrX	128764687	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	68,34:102:0.3333
chrX	128999835	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	89,55:144:0.3819
chrX	129132218	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	77,58:135:0.4296
chrX	129159099	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	72,58:130:0.4462
chrX	129230383	COSV58251878	CA	C	.	PASS	CSQ=|||intergenic_variant|||COSV58251878|rs1281454050|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,1:94:0.0106	77,51:128:0.3984
chrX	129261240	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	84,36:120:0.3
chrX	129261242	.	A	AGGTAGTACAT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	84,52:136:0.3824
chrX	129748522	.	G	T	.	PASS	CSQ=7512|protein_coding||intron_variant|||||||NM_003399.6:c.637+769G>T||MODIFIER||||||XPNPEP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	71,50:121:0.4132
chrX	129755188	.	G	A	.	PASS	CSQ=7512|protein_coding||intron_variant||||rs534422763||3.56729e-05|NM_003399.6:c.1218-106G>A||MODIFIER||||||XPNPEP2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	122,0:122:0	63,87:150:0.58
chrX	130178537	.	G	C	.	PASS	CSQ=9363|protein_coding||intron_variant|||||||NM_004794.3:c.259-5748G>C||MODIFIER||||||RAB33A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	53,55:108:0.5093
chrX	130266140	.	A	G	.	PASS	CSQ=55609|protein_coding||intron_variant|||||||NM_017666.5:c.-17+2622T>C||MODIFIER||||||ZNF280C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	86,53:139:0.3813
chrX	130572777	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	50,88:138:0.6377
chrX	130622605	.	T	C	.	PASS	CSQ=10495|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ENOX2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	73,57:130:0.4385
chrX	131006692	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs778491645||0.00013567|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	54,58:112:0.5179
chrX	131010509	.	G	T	.	PASS	CSQ=|||intergenic_variant||||rs1487165621||3.66932e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	86,55:141:0.3901
chrX	131266461	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	68,46:114:0.4035
chrX	131443281	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	69,65:134:0.4851
chrX	131977019	.	ACAGTG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	138,0:138:0	71,38:109:0.3486
chrX	132105608	.	T	G	.	PASS	CSQ=90167|protein_coding||intron_variant|||||||NM_194277.2:c.58-4892A>C||MODIFIER||||||FRMD7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	89,61:150:0.4067
chrX	132776696	.	C	T	.	PASS	CSQ=90161|protein_coding||intron_variant||||rs987104856|||NM_147175.3:c.948-147603G>A||MODIFIER||||||HS6ST2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	71,68:139:0.4892
chrX	132875920	.	A	C	.	PASS	CSQ=90161|protein_coding||intron_variant|||||||NM_147175.3:c.947+80888T>G||MODIFIER||||||HS6ST2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	60,61:121:0.5041
chrX	133196782	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	78,67:145:0.4621
chrX	133353326	.	ATATTGGAGTTACTATACAATGTAATGCCTGTCACAGGACC	A	.	PASS	CSQ=2239|protein_coding||intron_variant|||||||NM_001448.3:c.161-14025_161-13986del||MODIFIER||||||GPC4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	176,0:176:0	125,38:163:0.2331
chrX	133489130	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	58,75:133:0.5639
chrX	133490277	.	CACA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	132,0:132:0	46,52:98:0.5306
chrX	133638642	.	C	T	.	PASS	CSQ=2719|protein_coding||intron_variant|||||||NM_004484.3:c.1413+23088G>A||MODIFIER||||||GPC3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPC3|n|y||Wilms_tumour|Simpson-Golabi-Behmel_syndrome|O|Rec/X|oncogene,TSG|D,Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	67,49:116:0.4224
chrX	133794112	.	C	CT	.	PASS	CSQ=2719|protein_coding||intron_variant|||||||NM_004484.3:c.338-39937dup||MODIFIER||||||GPC3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPC3|n|y||Wilms_tumour|Simpson-Golabi-Behmel_syndrome|O|Rec/X|oncogene,TSG|D,Mis,N,F,S;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	125,7:132:0.053
chrX	133910638	.	G	A	.	PASS	CSQ=2719|protein_coding||intron_variant|||||||NM_004484.3:c.337+42412C>T||MODIFIER||||||GPC3|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/GPC3|n|y||Wilms_tumour|Simpson-Golabi-Behmel_syndrome|O|Rec/X|oncogene,TSG|D,Mis,N,F,S;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	63,74:137:0.5401
chrX	134025636	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	105,0:105:0	52,50:102:0.4902
chrX	134079822	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	61,82:143:0.5734
chrX	134122035	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	112,13:125:0.104
chrX	134123721	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	124,10:134:0.0746
chrX	134389611	.	T	C	.	PASS	CSQ=84295|protein_coding||intron_variant|||||||NM_001015877.1:c.241-3890T>C||MODIFIER||||||PHF6|EntrezGene|;CancerGeneCensus=1|https://cancer.sanger.ac.uk/cosmic/census-page/PHF6|y|n|ETP_ALL|||L|Rec|TSG|F,N,S,Mis;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	65,76:141:0.539
chrX	134585859	.	TG	T	.	PASS	CSQ=10761|protein_coding||intron_variant|||||||NM_021796.4:c.-59+16191del||MODIFIER||||||PLAC1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	75,74:149:0.4966
chrX	135167444	.	C	T	.	PASS	CSQ=54967|protein_coding||intron_variant|||||||NM_001031705.2:c.279+2150G>A||MODIFIER||||||CT55|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	61,91:152:0.5987
chrX	135419522	.	T	A	.	PASS	CSQ=399668|protein_coding||upstream_gene_variant|||||||||MODIFIER||||||SMIM10L2A|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	83,69:152:0.4539
chrX	135628011	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	55,89:144:0.6181
chrX	135713496	.	C	A	.	PASS	CSQ=541466|protein_coding||5_prime_UTR_variant|||||||NM_001017417.2:c.-201C>A||MODIFIER||||||CT45A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	93,0:93:0	43,34:77:0.4416
chrX	136026555	.	A	T	.	PASS	CSQ=10479|protein_coding||intron_variant|||||||NM_001042537.1:c.1616+2072A>T||MODIFIER||||||SLC9A6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	59,69:128:0.5391
chrX	136086236	.	A	G	.	PASS	CSQ=|||intergenic_variant||||rs1380149367|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	50,73:123:0.5935
chrX	136089707	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1293615204||8.93807e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	82,64:146:0.4384
chrX	136184088	.	G	C	.	PASS	CSQ=2273|protein_coding||intron_variant|||||||NM_001449.5:c.-27+14108G>C||MODIFIER||||||FHL1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	54,80:134:0.597
chrX	136341984	.	G	T	.	PASS	CSQ=139378|protein_coding||intron_variant|||||||NM_153834.3:c.686-2408G>T||MODIFIER||||||ADGRG4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	90,57:147:0.3878
chrX	136344706	.	G	A	.	PASS	CSQ=139378|protein_coding||missense_variant|||||||NM_153834.3:c.1000G>A|NP_722576.3:p.Asp334Asn|MODERATE|B&B&B|T&T&T|N|T&T&T|T&T&T|ADGRG4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	94,0:94:0	65,54:119:0.4538
chrX	136389652	.	G	A	.	PASS	CSQ=139378|protein_coding||intron_variant|||||||NM_153834.3:c.7911+1778G>A||MODIFIER||||||ADGRG4|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	52,96:148:0.6486
chrX	136465050	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	112,7:119:0.0588
chrX	136600032	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	88,0:88:0	65,49:114:0.4298
chrX	136760049	.	G	A	.	PASS	CSQ=9459|protein_coding||intron_variant||||rs1023856933||2.67707e-05|NM_004840.3:c.250-12457C>T||MODIFIER||||||ARHGEF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	86,46:132:0.3485
chrX	136766293	.	T	TA	.	PASS	CSQ=9459|protein_coding||intron_variant|||||||NM_004840.3:c.249+13120_249+13121insT||MODIFIER||||||ARHGEF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	134,0:134:0	67,55:123:0.4472
chrX	136772358	.	A	C	.	PASS	CSQ=9459|protein_coding||intron_variant|||||||NM_004840.3:c.249+7056T>G||MODIFIER||||||ARHGEF6|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	90,0:90:0	47,67:114:0.5877
chrX	136865297	.	G	A	.	PASS	CSQ=27316|protein_coding||downstream_gene_variant||||||9.28867e-06|||MODIFIER||||||RBMX|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	96,0:96:0	63,56:119:0.4706
chrX	136976985	.	C	CT	.	PASS	CSQ=|||intergenic_variant||||rs1450504321||0.000311656|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	79,34:115:0.2957
chrX	137164699	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:118:0	55,92:147:0.6259
chrX	137211806	.	TTAAC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	50,46:96:0.4792
chrX	137368832	.	CTTTTCTGTCTTCAGA	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	60,53:113:0.469
chrX	137580062	.	G	C	.	PASS	CSQ=7547|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZIC3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	40,55:95:0.5789
chrX	137616476	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	146,0:146:0	64,52:116:0.4483
chrX	137726168	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	74,56:130:0.4308
chrX	137872378	.	CT	AA	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	107,0:107:0	64,55:119:0.4622
chrX	137989548	.	CA	AC	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=MNV;called_by=mutect2;num_callers=1;supported_by=strelka2_SNVs	AD:DP:AF	142,0:143:0	83,45:128:0.3516
chrX	138225654	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	61,56:117:0.4786
chrX	138359528	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:85:0	58,65:123:0.5285
chrX	138508458	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:129:0	65,54:119:0.4538
chrX	138539162	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	78,0:78:0	50,43:93:0.4624
chrX	138737950	.	C	T	.	PASS	CSQ=2258|protein_coding||intron_variant||||rs910345942|||NM_001139500.1:c.218-29022G>A||MODIFIER||||||FGF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:109:0	52,81:133:0.609
chrX	138821376	.	G	T	.	PASS	CSQ=2258|protein_coding||intron_variant|||||||NM_001139500.1:c.217+36136C>A||MODIFIER||||||FGF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	57,44:101:0.4356
chrX	138836607	.	T	C	.	PASS	CSQ=2258|protein_coding||intron_variant|||||||NM_001139500.1:c.217+20905A>G||MODIFIER||||||FGF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	42,70:112:0.625
chrX	138868824	.	C	T	.	PASS	CSQ=2258|protein_coding||intron_variant|||||||NM_001139500.1:c.50-11145G>A||MODIFIER||||||FGF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	64,41:105:0.3905
chrX	138899174	.	G	T	.	PASS	CSQ=2258|protein_coding||intron_variant|||||||NM_001139500.1:c.50-41495C>A||MODIFIER||||||FGF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	61,58:119:0.4874
chrX	138957102	.	G	A	.	PASS	CSQ=2258|protein_coding||intron_variant|||||||NM_001139500.1:c.50-99423C>T||MODIFIER||||||FGF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	63,48:111:0.4324
chrX	139002072	.	C	G	.	PASS	CSQ=2258|protein_coding||intron_variant|||||||NM_001139500.1:c.50-144393G>C||MODIFIER||||||FGF13|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	50,43:93:0.4624
chrX	139219961	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	64,54:118:0.4576
chrX	139402024	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	67,71:138:0.5145
chrX	139867025	.	G	A	.	PASS	CSQ=286410|protein_coding||intron_variant|||||||NM_001353812.1:c.28-40202C>T||MODIFIER||||||ATP11C|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	56,78:134:0.5821
chrX	139985331	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	75,48:123:0.3902
chrX	140212449	.	C	CA	.	PASS	CSQ=|||intergenic_variant||||rs995629221||3.65858e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	93,37:130:0.2846
chrX	140218016	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	42,71:113:0.6283
chrX	140239833	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	60,66:126:0.5238
chrX	140497885	COSV62519036	T	A	.	PASS	CSQ=|||intergenic_variant|||COSV62519036|rs757469979||0.000804876|||MODIFIER||||||||0.0003;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	78,66:144:0.4583
chrX	140706586	.	A	AT	.	PASS	CSQ=286411|lncRNA||upstream_gene_variant||||rs1323986716||0.00100209|||MODIFIER||||||LINC00632|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	82,42:124:0.3387
chrX	140877410	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	65,48:113:0.4248
chrX	140993649	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1030393484||8.92594e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	65,87:152:0.5724
chrX	141096651	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	83,34:117:0.2906
chrX	141145095	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	55,53:108:0.4907
chrX	141316171	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:108:0	63,56:119:0.4706
chrX	141472364	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1295295822||7.13063e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	125,0:125:0	82,61:143:0.4266
chrX	141490745	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	95,27:122:0.2213
chrX	141604156	.	C	A	.	PASS	CSQ=619455|lncRNA||intron_variant&non_coding_transcript_variant||||rs1048023348||5.39205e-05|NR_037183.2:n.558-44643C>A||MODIFIER||||||SPANXA2-OT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	64,63:127:0.4961
chrX	141604158	.	A	C	.	PASS	CSQ=619455|lncRNA||intron_variant&non_coding_transcript_variant|||||||NR_037183.2:n.558-44641A>C||MODIFIER||||||SPANXA2-OT1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	95,0:95:0	61,64:125:0.512
chrX	141980292	COSV67333608	C	CT	.	PASS	CSQ=|||intergenic_variant|||COSV67333608|rs901188940||0.000185175|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,1:98:0.0102	76,59:136:0.4338
chrX	142003741	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,0:99:0	80,54:134:0.403
chrX	142115364	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1458088009||8.09236e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	67,54:121:0.4463
chrX	142117349	COSV64209804	T	TA	.	PASS	CSQ=|||intergenic_variant|||COSV64209804|rs945590899||0.000107903|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2;num_callers=1;supported_by=lancet	AD:DP:AF	106,0:106:0	105,25:131:0.1908
chrX	142150082	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1010236788||5.36514e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:111:0	88,39:127:0.3071
chrX	142409540	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	73,62:135:0.4593
chrX	142410902	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	119,0:119:0	59,69:128:0.5391
chrX	142410962	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	117,0:117:0	68,59:127:0.4646
chrX	142432365	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	66,60:126:0.4762
chrX	142500202	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	86,0:86:0	46,66:112:0.5893
chrX	142588673	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs917829631|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	82,30:112:0.2679
chrX	142684197	.	TC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	64,40:104:0.3846
chrX	142752084	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	52,58:110:0.5273
chrX	142767406	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	48,45:93:0.4839
chrX	142840877	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	69,54:123:0.439
chrX	142861202	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	68,53:121:0.438
chrX	142897995	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	53,63:116:0.5431
chrX	142913116	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	62,69:131:0.5267
chrX	142953623	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	127,0:127:0	68,53:121:0.438
chrX	143099202	.	A	AT	.	PASS	CSQ=|||intergenic_variant||||rs781077515||0.293826|||MODIFIER||||||||0.2744;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	137,2:140:0.0143	85,59:146:0.4041
chrX	143175230	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	41,67:108:0.6204
chrX	143176476	.	TA	T	.	PASS	CSQ=|||intergenic_variant||||rs926194666||4.52894e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	57,50:107:0.4673
chrX	143349659	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	79,26:105:0.2476
chrX	143510215	.	C	T	.	PASS	CSQ=139067|protein_coding||intron_variant|||||||NM_001009609.4:c.79-1053G>A||MODIFIER||||||SPANXN3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	40,71:111:0.6396
chrX	143604955	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	74,57:131:0.4351
chrX	143771208	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	63,53:116:0.4569
chrX	143835103	.	C	G	.	PASS	CSQ=|||intergenic_variant||||||1.87543e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	84,0:84:0	98,5:103:0.0485
chrX	143876213	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	91,6:97:0.0619
chrX	143887082	.	C	G	.	PASS	CSQ=389898|transcribed_pseudogene||downstream_gene_variant|||||||||MODIFIER||||||UBE2NL|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:125:0	66,52:118:0.4407
chrX	143902149	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	48,50:98:0.5102
chrX	143944044	.	A	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	60,71:131:0.542
chrX	143946386	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	113,0:113:0	73,44:117:0.3761
chrX	143972182	.	AAATGCTACTGGATTT	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	143,0:143:0	52,73:125:0.584
chrX	144022557	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	62,61:123:0.4959
chrX	144307218	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	75,0:75:0	33,40:73:0.5479
chrX	144402063	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	73,0:76:0	43,57:102:0.5588
chrX	144840164	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	48,88:136:0.6471
chrX	144969688	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	70,54:124:0.4355
chrX	145067569	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	69,44:113:0.3894
chrX	145067579	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	73,47:120:0.3917
chrX	145100095	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:132:0	51,54:105:0.5143
chrX	145104282	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	62,65:127:0.5118
chrX	145334477	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	135,0:135:0	57,68:125:0.544
chrX	145464441	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	56,69:125:0.552
chrX	145511921	COSV52657715	C	T	.	PASS	CSQ=|||intergenic_variant|||COSV52657715|rs1363743757||9.06208e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	94,0:94:0	61,53:114:0.4649
chrX	145588179	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	67,77:144:0.5347
chrX	145603462	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	50,56:106:0.5283
chrX	145643410	.	A	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	62,57:119:0.479
chrX	146044995	.	T	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	50,68:118:0.5763
chrX	146057942	.	T	A	.	PASS	CSQ=|||intergenic_variant||||rs1363579002||8.96298e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	78,51:129:0.3953
chrX	146199358	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs782338528||5.43843e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	64,39:103:0.3786
chrX	146256889	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	93,0:93:0	52,73:125:0.584
chrX	146311021	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	116,0:116:0	62,79:141:0.5603
chrX	146312660	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1165843493||1.79934e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	81,53:134:0.3955
chrX	146376411	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:109:0	56,67:123:0.5447
chrX	146389012	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	124,8:132:0.0606
chrX	146571364	.	G	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	121,0:121:0	60,54:114:0.4737
chrX	146571898	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	67,38:105:0.3619
chrX	146662616	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	92,0:92:0	47,66:113:0.5841
chrX	146712281	.	G	A	.	PASS	CSQ=|||intergenic_variant||||rs1270416163|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	49,68:117:0.5812
chrX	146757937	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,0:98:0	75,42:117:0.359
chrX	146799017	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	75,53:128:0.4141
chrX	146847505	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	140,0:140:0	56,77:133:0.5789
chrX	146915308	.	AG	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	53,61:114:0.5351
chrX	146926785	.	C	T	.	PASS	CSQ=|||intergenic_variant||||rs1320115545||9.0247e-06|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	91,0:91:0	63,46:109:0.422
chrX	147120645	.	A	T	.	PASS	CSQ=|||intergenic_variant||||rs782405091||7.57502e-05|||MODIFIER||||||||0.0024;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	82,0:82:0	35,52:87:0.5977
chrX	147214634	COSV66096468	C	CA	.	PASS	CSQ=574509|miRNA||upstream_gene_variant|||COSV66096468|rs1397840320||0.00456377|||MODIFIER||||||MIR513A1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	75,48:124:0.3871
chrX	147402934	.	G	GT	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	118,0:118:0	68,62:130:0.4769
chrX	147610029	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	66,53:119:0.4454
chrX	147704367	.	C	G	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	87,43:130:0.3308
chrX	147845134	.	C	A	.	PASS	CSQ=|||intergenic_variant||||rs1166014271|||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	104,0:104:0	48,78:126:0.619
chrX	148259758	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	73,56:129:0.4341
chrX	148327406	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	80,56:136:0.4118
chrX	148526223	.	T	C	.	PASS	CSQ=2334|protein_coding||intron_variant|||||||NM_001169124.1:c.47+25079T>C||MODIFIER||||||AFF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	128,0:128:0	68,61:129:0.4729
chrX	148544631	.	G	T	.	PASS	CSQ=2334|protein_coding||intron_variant|||||||NM_001169124.1:c.47+43487G>T||MODIFIER||||||AFF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	136,0:136:0	71,44:115:0.3826
chrX	148584758	.	G	A	.	PASS	CSQ=2334|protein_coding||intron_variant||||||9.11502e-06|NM_001169124.1:c.48-67241G>A||MODIFIER||||||AFF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	97,0:97:0	57,64:121:0.5289
chrX	148911794	.	T	A	.	PASS	CSQ=2334|protein_coding||intron_variant|||||||NM_001169124.1:c.1292+7536T>A||MODIFIER||||||AFF2|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:122:0	78,49:127:0.3858
chrX	149148055	.	CTTT	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	76,45:121:0.3719
chrX	149303851	.	T	C	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	111,0:111:0	71,56:127:0.4409
chrX	149465519	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	68,56:124:0.4516
chrX	149642008	.	C	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	100,0:100:0	71,78:149:0.5235
chrX	150320343	.	TACAC	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	106,0:106:0	69,50:119:0.4202
chrX	150366797	.	A	T	.	PASS	CSQ=10046|protein_coding||intron_variant|||||||NM_001177465.3:c.-64+3267A>T||MODIFIER||||||MAMLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	69,41:110:0.3727
chrX	150398453	.	G	A	.	PASS	CSQ=10046|protein_coding||intron_variant||||rs1249663405||2.701e-05|NM_001177465.3:c.-64+34923G>A||MODIFIER||||||MAMLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	89,52:141:0.3688
chrX	150403882	.	A	C	.	PASS	CSQ=10046|protein_coding||intron_variant|||||||NM_001177465.3:c.-64+40352A>C||MODIFIER||||||MAMLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=mutect2;num_callers=1;supported_by=lancet	AD:DP:AF	114,0:114:0	126,36:162:0.2222
chrX	150408196	.	T	A	.	PASS	CSQ=10046|protein_coding||intron_variant|||||||NM_001177465.3:c.-63-37258T>A||MODIFIER||||||MAMLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	114,0:114:0	63,48:111:0.4324
chrX	150433977	.	G	T	.	PASS	CSQ=10046|protein_coding||intron_variant|||||||NM_001177465.3:c.-63-11477G>T||MODIFIER||||||MAMLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	53,84:137:0.6131
chrX	150482225	.	T	C	.	PASS	CSQ=10046|protein_coding||intron_variant|||||||NM_001177465.3:c.1842+10735T>C||MODIFIER||||||MAMLD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	130,0:130:0	85,63:148:0.4257
chrX	150698871	COSV104427854;COSV104427854;COSV104427854;COSV104427854;COSV104427854	CA	C	.	PASS	CSQ=8776|protein_coding||intron_variant|COSV104427854&COSV104427854&COSV104427854|p.?&p.?&p.?|COSV104427854&COSV104427854|rs1243278672|||NM_001306144.3:c.147-313del||MODIFIER||||||MTMR1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=DEL;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	99,2:101:0.0198	84,41:126:0.3254
chrX	150836348	.	A	AT	.	PASS	CSQ=83692|protein_coding||intron_variant||||rs113158535||0.272122|NM_031462.4:c.68-5056dup||MODIFIER||||||CD99L2|EntrezGene|0.2721;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	123,0:123:0	116,39:156:0.25
chrX	151025408	.	T	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	80,54:134:0.403
chrX	151073372	COSV50061711	T	A	.	PASS	CSQ=|||intergenic_variant|||COSV50061711|rs980804986||0.000674827|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	98,1:99:0.0101	104,35:139:0.2518
chrX	151394483	.	C	G	.	PASS	CSQ=203547|protein_coding||upstream_gene_variant||||rs1040428546||2.70783e-05|||MODIFIER||||||VMA21|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	52,70:122:0.5738
chrX	151657708	.	C	T	.	PASS	CSQ=139135|protein_coding||intron_variant||||rs1262636846||9.04486e-06|NM_173493.3:c.718-2005C>T||MODIFIER||||||PASD1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	84,68:152:0.4474
chrX	151702878	.	G	T	.	PASS	CSQ=79057|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||PRRG3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	145,0:145:0	77,64:141:0.4539
chrX	152364266	.	C	T	.	PASS	CSQ=2556|protein_coding||intron_variant|||||||NM_000808.4:c.140+165G>A||MODIFIER||||||GABRA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	79,56:135:0.4148
chrX	152403059	.	A	G	.	PASS	CSQ=2556|protein_coding||intron_variant|||||||NM_000808.4:c.-26-38463T>C||MODIFIER||||||GABRA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	107,0:107:0	75,53:128:0.4141
chrX	152458380	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	102,0:102:0	47,70:117:0.5983
chrX	152981812	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	129,0:129:0	77,57:134:0.4254
chrX	153014909	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	110,0:110:0	69,48:117:0.4103
chrX	153249327	.	G	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	131,0:131:0	75,45:120:0.375
chrX	153353157	.	C	T	.	PASS	CSQ=10838|protein_coding||downstream_gene_variant|||||||||MODIFIER||||||ZNF275|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	120,0:120:0	80,50:130:0.3846
chrX	153661697	COSV71212330;COSV71212330	C	CA	.	PASS	CSQ=|||intergenic_variant|||COSV71212330&COSV71212330|rs1180334898||8.9703e-05|||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	103,0:103:0	70,70:140:0.5
chrX	153892218	.	C	T	.	PASS	CSQ=100996465|lncRNA||downstream_gene_variant|||||||||MODIFIER||||||LCA10|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	126,0:126:0	90,53:143:0.3706
chrX	154371431	.	G	A	.	PASS	CSQ=2316|protein_coding||intron_variant|||||||NM_001110556.2:c.-116-70C>T||MODIFIER||||||FLNA|EntrezGene|;CancerGeneCensus=2|https://cancer.sanger.ac.uk/cosmic/census-page/FLNA|y|n|phyllodes_tumour_of_the_breast|||E|||Mis,F,O;HighConfidence;TYPE=SNV;called_by=strelka2,lancet;num_callers=2	AD:DP:AF	125,0:125:0	87,74:161:0.4596
chrX	154472293	.	C	T	.	PASS	CSQ=55558|protein_coding||intron_variant||||||9.04126e-06|NM_017514.5:c.5521-297C>T||MODIFIER||||||PLXNA3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	101,0:101:0	83,42:125:0.336
chrX	154730226	.	G	C	.	PASS	CSQ=139716|protein_coding||intron_variant|||||||NM_001081573.3:c.73-13897C>G||MODIFIER||||||GAB3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	122,0:123:0	88,59:147:0.4014
chrX	154790149	.	C	T	.	PASS	CSQ=4354|protein_coding||intron_variant|||||||NM_002436.4:c.412-127G>A||MODIFIER||||||MPP1|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2,lancet;num_callers=3	AD:DP:AF	98,0:98:0	78,44:122:0.3607
chrX	154870240	.	C	CA	.	PASS	CSQ=2157|protein_coding||intron_variant|||||||NM_000132.3:c.6430-7014dup||MODIFIER||||||F8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=INS;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	112,0:112:0	85,57:143:0.3986
chrX	154958980	.	C	T	.	PASS	CSQ=2157|protein_coding||intron_variant||||||8.95367e-06|NM_000132.3:c.1538-1809G>A||MODIFIER||||||F8|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	133,0:133:0	97,67:164:0.4085
chrX	155398282	.	G	T	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	53,86:139:0.6187
chrX	155604724	.	C	T	.	PASS	CSQ=55217|protein_coding||intron_variant|||||||NM_018196.4:c.-2+8068G>A||MODIFIER||||||TMLHE|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	124,0:124:0	71,49:120:0.4083
chrX	155666039	.	G	A	.	PASS	CSQ=10251|protein_coding||intron_variant|||||||NM_001304990.1:c.-282+53392G>A||MODIFIER||||||SPRY3|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	108,0:108:0	58,52:110:0.4727
chrX	155906892	.	T	C	.	PASS	CSQ=6845|protein_coding||intron_variant||||||6.57082e-06|NM_005638.6:c.433+6305T>C||MODIFIER||||||VAMP7|EntrezGene|;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	115,0:115:0	73,47:120:0.3917
chrX	155964707	.	C	A	.	PASS	CSQ=|||intergenic_variant|||||||||MODIFIER||||||||;CancerGeneCensus=||||||||||;HighConfidence;TYPE=SNV;called_by=strelka2,mutect2;num_callers=2	AD:DP:AF	109,0:109:0	63,42:105:0.4
